Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,chemical synaptic transmission (GO:0007268),0.6006641519493766,2.7550561710959767,0.0,0.0,0.0,109/284,15.04%,NLGN1;KCND2;DLG2;NRXN1;GRM7;GRID2;ASIC2;GRIA4;GRIK5;GRIK2;GABRB3;GRM5;ERC2;DLGAP1;HTR2C;GRIN2A;CHRM2;GRIK1;KCNQ3;CDH8;RIMS1;GABRB1;GABRG3;CACNA1E;SYN2;PTPRN2;DTNA;SHISA6;SYT1;CHRM3;RIT2;GRIN2B;GRIA3;SYN3;AMPH;UNC13C;GLRA1;HCRTR2;GABRA2;SYT10;SNPH;SNAP25;APBA2;DLGAP2;GRM1;CAMK4;CACNB2;GRID1;CPLX1;SLC1A2;SLC17A6;SYN1;SCN2B;GRIA2;PLP1;GRIK4;GRIA1;KIF1B;NRXN2;GABRA3;SLC1A6;PNOC;HRH3;NOVA1;SLC5A7;KIF5A;GABRA5;SYT5;GRM3;HOMER1;KCNIP2;GABRB2;NTSR1;RIMBP2;KCNA1;NSG1;GABRG2;CHRNA5;SLC1A1;PCDHB6;SLC6A1;GLRA2;PCDHB14;CORT;SLC6A2;CHAT;PDYN;SLC12A5;NAPB;BRSK1;DOC2A;UNC13B;HTR1B;CALM1;PCDHB11;PDLIM4;SLC18A3;PRKACB;NLGN2;PCDHB16;GLRA3;OPRK1;RIC3;HRH2;CHRNA7;CHRFAM7A;PRKAR1A;HTR7;PENK
prerank,anterograde trans-synaptic signaling (GO:0098916),0.609248302458811,2.7200894881711215,0.0,0.0,0.0,88/224,15.04%,NLGN1;KCND2;DLG2;NRXN1;GRM7;ASIC2;GRIA4;GRIK2;GABRB3;GRM5;DLGAP1;HTR2C;GRIN2A;CHRM2;GRIK1;KCNQ3;GABRB1;GABRG3;CACNA1E;SYN2;DTNA;SYT1;CHRM3;RIT2;GRIN2B;GRIA3;AMPH;UNC13C;GLRA1;HCRTR2;GABRA2;SYT10;SNAP25;APBA2;GRM1;CAMK4;CACNB2;CPLX1;SLC1A2;SYN1;SCN2B;GRIA2;PLP1;GRIK4;GRIA1;NRXN2;GABRA3;SLC1A6;PNOC;HRH3;NOVA1;KIF5A;GABRA5;SYT5;GRM3;HOMER1;KCNIP2;GABRB2;NTSR1;KCNA1;GABRG2;CHRNA5;SLC1A1;PCDHB6;SLC6A1;GLRA2;PCDHB14;CORT;SLC6A2;PDYN;SLC12A5;DOC2A;UNC13B;HTR1B;CALM1;PCDHB11;SLC18A3;PRKACB;NLGN2;PCDHB16;GLRA3;OPRK1;HRH2;CHRNA7;CHRFAM7A;PRKAR1A;HTR7;PENK
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.5977409105603142,2.5423528135689395,0.0,0.0,0.0,63/159,14.30%,NLGN1;LRRC4C;ROBO1;GRID2;LRFN5;PTPRD;TENM2;ADGRL3;IL1RAPL1;CDH18;KIRREL3;ROBO2;CDH8;CNTN6;GPC6;TENM3;CDH10;CNTN4;CDH2;PTPRT;TENM1;DSCAM;PCDHGB4;CDH20;TENM4;CDH11;UNC5D;NTNG1;CDH13;SLITRK1;CDH12;CDH22;CDH19;CDH7;ACVR1;NECTIN3;VCAM1;SDK1;DCHS1;FAT4;FLRT3;DSCAML1;CDH6;PCDHB6;PCDHB14;CDH17;ROBO3;CRB1;CDHR3;TGFB2;SLITRK3;CDH9;PKD1;CADM3;AMIGO2;CLDN5;PCDHB11;TRO;VSTM2L;PTPRS;CDH1;CDH5;PCDHB16
prerank,regulation of synapse assembly (GO:0051963),0.7126797347661464,2.518011636488419,0.0,0.0,0.0,17/46,7.07%,NLGN1;NRXN1;GRID2;LRFN5;PTPRD;IL1RAPL1;ROBO2;GPC6;SYNDIG1;IL1RAPL2;SLITRK1;SLIT1;CLSTN2;EPHB1;CUX2;CLSTN1;BDNF
prerank,modulation of chemical synaptic transmission (GO:0050804),0.6173688396002447,2.5137996631357677,0.0,0.0,0.0,36/107,9.24%,NLGN1;RIMS2;LRRC4C;NRG3;GRM7;GRID2;GRIK5;GRIK2;GRM5;DLGAP1;GRIK1;RIMS1;SYT1;CDH2;GRM8;CNTNAP4;SLC8A3;SYN3;SLC12A2;DLGAP2;GRM1;GRID1;CPLX1;SNCAIP;SYN1;TMEM108;GRIK4;CLSTN2;CLSTN1;GRM3;HOMER1;BDNF;FMR1;CX3CR1;SLC8A2;CAMK2A
prerank,glutamate receptor signaling pathway (GO:0007215),0.7381701816506665,2.476806595503385,0.0,0.0,0.0,19/37,8.42%,GRM7;GRID2;GRIA4;GRIK2;GRM5;GRIN2A;GRIK1;PLCB1;GRIN2B;GRM8;GRIA3;GRIN3A;GRM1;GRIA2;GRIK4;GRM3;HOMER1;FMR1;TRPM1
prerank,synapse assembly (GO:0007416),0.6492174994502987,2.4052730597175245,0.0,9.602761505924776e-05,0.001,29/67,14.30%,NLGN1;NRXN1;GRID2;GABRB3;ADGRL3;DNM3;KIRREL3;CDH2;DSCAM;GPM6A;GABRA2;SLITRK1;NRCAM;LRRTM3;NRXN2;SHANK3;SDK1;GABRB2;BDNF;FLRT3;GABRG2;PCDHB6;PCDHB14;DNER;CBLN4;PCDHB11;CDH1;NLGN2;PCDHB16
prerank,neurotransmitter secretion (GO:0007269),0.7056069170727852,2.3675824071813487,0.0,8.402416317684178e-05,0.001,15/44,5.49%,RIMS2;NRXN1;RIMS1;SYN2;PTPRN2;SYT1;SYN3;PCLO;SYT10;SNPH;SNAP25;CPLX1;SYN1;NRXN2;HRH3
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.8566540479951344,2.3394048607618223,0.0,7.468814504608158e-05,0.001,10/18,3.36%,GRID2;GRIK5;GRIK2;GRIK1;CDH8;UNC13C;GRID1;SLC17A6;GRIA2;GRIK4
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.638954170985512,2.3104907385922937,0.0,6.721933054147343e-05,0.001,22/57,10.87%,NLGN1;DLG2;GRIA4;DLGAP1;LRRC7;GRIN2A;SHISA6;GRIN2B;DLG3;GRIA3;DLGAP2;GRIA2;GRIA1;GSG1L;SHISA9;CACNG4;NETO1;CACNG2;NEFL;CAMK2A;DLGAP3;RELN
prerank,regulation of cation channel activity (GO:2001257),0.5864794355031391,2.306383301092397,0.0,6.110848231043039e-05,0.001,33/89,13.07%,NLGN1;DLG2;FGF14;GRIA4;LRRC7;GRIN2A;FGF12;ANK3;ANK2;DMD;SHISA6;GRIN2B;DLG3;GRIA3;CACNB2;GRIA2;PDE4D;GRIA1;GSG1L;SHISA9;HOMER1;CACNG4;NETO1;CACNG2;JPH4;NEFL;CAMK2A;PIRT;RELN;KCNG1;STAC;CALM1;CALM2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.7143154967095773,2.3033395696168615,0.0,5.601610878456119e-05,0.001,22/35,14.30%,NLGN1;CDH18;CDH8;CDH10;PCDHGB4;CDH20;CDH11;CDH13;CDH12;CDH22;CDH19;CDH7;DCHS1;CDH6;PCDHB6;PCDHB14;CDH17;CDHR3;CDH9;PCDHB11;CDH5;PCDHB16
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.6481514159073287,-2.291420081907852,0.0,0.0,0.0,23/56,12.22%,CTSB;MAPKAPK3;SFTPA1;SFTPA2;PLCG2;TLR8;CD36;TLR7;UNC93B1;ALPK1;IRAK2;MAPKAPK2;TAB2;TLR4;IRAK4;TRAF3;MYD88;NOD1;LY96;UBC;RPS27A;HSP90B1;CTSS
prerank,synapse organization (GO:0050808),0.5557478905876629,2.290422042424682,0.0,5.1707177339594945e-05,0.001,36/125,8.97%,NLGN1;LRRC4C;NRXN1;LRFN5;PTPRD;ADGRL3;GRM5;CTNND2;DNM3;KIRREL3;ANK3;PPFIA2;GPC6;CDH2;GPHN;DSCAM;SLC8A3;UNC13C;GPM6A;CACNB2;NTNG1;PAK3;SLITRK1;SEMA3E;NRCAM;NRXN2;SHANK3;SDK1;BDNF;FLRT3;PCDHB6;SLC6A1;CX3CR1;NEDD4;SLC8A2;PCDHB14
prerank,positive regulation of synapse assembly (GO:0051965),0.7456948103567432,2.277423244137306,0.0,4.801380752962388e-05,0.001,11/27,7.07%,NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;SYNDIG1;CLSTN2;EPHB1;CUX2;CLSTN1;BDNF
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.6244293851638915,-2.276130450173208,0.0,0.0,0.0,38/72,21.40%,PTPRC;RUNX1;CD74;BIRC3;SYK;AXL;ELF1;VRK2;USP18;RNASEL;PIAS1;RIPK1;IRAK2;CFLAR;IFNAR2;RNF31;ABCE1;RBCK1;IRAK3;GAS6;JAK1;CBFB;PTPN6;OTULIN;IFNGR2;TRAF1;HSP90AB1;TRAF2;AGPAT1;IKBKB;CASP8;SOCS3;PTPN11;TRADD;IL7;PTPN1;STAT1;RACK1
prerank,positive regulation of nervous system development (GO:0051962),0.6714651657308821,2.259295072574094,0.0,4.481288702764895e-05,0.001,16/42,9.67%,NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;SOX11;SYNDIG1;MME;CLSTN2;EPHB1;CUX2;CLSTN1;BDNF;NUMB;CX3CR1;RASSF10
prerank,signal release from synapse (GO:0099643),0.6775792119034826,2.257115904212668,0.0,4.201208158842089e-05,0.001,14/43,5.49%,NRXN1;RIMS1;SYN2;PTPRN2;SYT1;SYN3;PCLO;SYT10;SNPH;SNAP25;CPLX1;SYN1;NRXN2;HRH3
prerank,neuron cell-cell adhesion (GO:0007158),0.875183508355961,2.246736314682952,0.0,7.908156534290992e-05,0.002,9/14,4.05%,NLGN1;NRXN1;NRXN3;ASTN2;NCAM2;CNTN4;ASTN1;NINJ2;NRXN2
prerank,regulation of potassium ion transport (GO:0043266),0.7172882143361784,2.2443677543929432,0.0,7.468814504608158e-05,0.002,9/31,6.77%,DPP10;KCNIP4;DPP6;ANK3;ANK2;KCNN2;KCNIP1;CASQ2;KCNIP2
prerank,B cell receptor signaling pathway (GO:0050853),-0.7209305444756151,-2.2107690622368246,0.0,0.00041120705436403164,0.001,16/32,13.98%,RFTN1;PTPRC;VAV3;PRKCB;CD38;SYK;PLCG2;TEC;BLNK;BCL2;MEF2C;NCKAP1L;LCK;ITK;PIK3CD;NFAM1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.6139388819534183,-2.2094419233191456,0.0,0.00030840529077302375,0.001,35/71,15.26%,LYN;VAV3;FGR;ABI1;GRB2;WIPF1;ARPC2;SYK;PLCG2;PRKCD;RAC1;ACTR2;WASF2;VAV1;CDC42;ACTR3;ACTB;ARPC3;MYO1G;PLD2;PIK3CB;WASL;BAIAP2;VAV2;NCKAP1L;CRK;ARPC1B;PIK3CA;ARPC1A;HSP90AB1;FCGR2B;FCER1G;MYO10;BRK1;ARPC5
prerank,neurotransmitter transport (GO:0006836),0.5812145635197546,2.198038219526733,0.0,0.00031840735519645313,0.008,27/73,13.08%,NRXN1;PPFIA2;RIMS1;SYN2;PTPRN2;SYT1;SYN3;GABRA2;SNPH;SNAP25;CPLX1;SLC1A2;SLC17A6;SYN1;SLC6A16;NRXN2;SLC1A6;SLC6A15;HRH3;SLC5A7;GLUL;SLC1A1;SLC6A2;CHAT;BRSK1;UNC13B;SLC18A3
prerank,toll-like receptor signaling pathway (GO:0002224),-0.5817848382413078,-2.197643828959302,0.0,0.00024672423261841897,0.001,31/84,12.22%,RFTN1;CTSB;BIRC3;MAPKAPK3;SFTPA1;SFTPA2;PLCG2;TLR8;CD36;ITGB2;MAP3K1;PIK3AP1;TLR7;UNC93B1;RIPK1;IRAK2;MAPKAPK2;TAB2;TLR4;IRAK4;TRAF3;IRAK3;EPG5;MYD88;LY96;UBC;RPS27A;TNIP2;HSP90B1;TICAM1;CTSS
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.6109112130049262,-2.1940799832812203,0.0,0.00020560352718201582,0.001,34/70,15.26%,LYN;VAV3;FGR;ABI1;GRB2;WIPF1;ARPC2;SYK;PLCG2;PRKCD;RAC1;ACTR2;WASF2;VAV1;CDC42;ACTR3;ACTB;ARPC3;MYO1G;PLD2;PIK3CB;WASL;BAIAP2;VAV2;NCKAP1L;CRK;ARPC1B;PIK3CA;ARPC1A;HSP90AB1;FCGR2B;MYO10;BRK1;ARPC5
prerank,neutrophil activation involved in immune response (GO:0002283),-0.4789889429498775,-2.186711647485143,0.0,0.00017623159472744213,0.001,140/428,15.44%,IQGAP2;DOCK2;IQGAP1;DIAPH1;PTPRC;CYBB;CD44;CTSB;ATP8B4;APAF1;CLEC12A;ADGRE5;FGR;CTSD;SDCBP;CTSZ;LILRB3;C3AR1;PSAP;SYK;TSPAN14;CD300A;CYBA;PRKCD;OSTF1;FTL;CD36;RAB7A;RAC1;ANPEP;ROCK1;ITGB2;RAP1B;PTPRJ;ACTR2;IDH1;ANO6;HPSE;RHOA;TNFRSF1B;ARL8A;RAP2B;CRACR2A;ANXA2;PLAU;C5AR1;FABP5;CDK13;RAB31;ITGAL;S100A11;RAP1A;LAMP2;GYG1;PSMB7;PLEKHO2;ATG7;TCIRG1;GNS;SYNGR1;TOM1;IMPDH2;NFKB1;DYNC1H1;GALNS;DNAJC13;ITGAV;DERA;CTSA;CFP;MAPK14;STOM;CAP1;CD53;ARSA;C3;CYB5R3;MVP;CAB39;SRP14;PRCP;GRN;PLAC8;SIRPA;AP2A2;TIMP2;VAT1;CTSC;BST2;VPS35L;HMOX2;B2M;PLAUR;CPPED1;CD63;PTPN6;IGF2R;GUSB;CTSH;ADAM8;MAGT1;CLEC4D;NCKAP1L;TMC6;HK3;PSMC3;ITGAX;EEF2;RAB3D;NPC2;DGAT1;TXNDC5;XRCC6;RAB24;ACTR1B;DNASE1L1;LAMP1;CTSS;CAMP;HSP90AB1;CPNE3;EEF1A1;PKM;FRK;RAB10;FCER1G;DPP7;STK11IP;GGH;GMFG;CREG1;NFAM1;KCMF1;NEU1;PDXK;ABCA13;PGRMC1;COTL1;ARPC5;CST3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.6042503136476474,-2.1829558221397654,0.0,0.00030840529077302375,0.002,35/73,15.26%,LYN;VAV3;FGR;ABI1;GRB2;WIPF1;ARPC2;SYK;PLCG2;PRKCD;RAC1;ACTR2;WASF2;VAV1;CDC42;ACTR3;ACTB;ARPC3;MYO1G;PLD2;PIK3CB;WASL;BAIAP2;VAV2;NCKAP1L;CRK;ARPC1B;PIK3CA;ARPC1A;HSP90AB1;FCGR2B;FCER1G;MYO10;BRK1;ARPC5
prerank,neutrophil degranulation (GO:0043312),-0.4771948390923317,-2.175794341636643,0.0,0.0002741380362426878,0.002,139/425,15.44%,IQGAP2;DOCK2;IQGAP1;DIAPH1;PTPRC;CYBB;CD44;CTSB;ATP8B4;APAF1;CLEC12A;ADGRE5;FGR;CTSD;SDCBP;CTSZ;LILRB3;C3AR1;PSAP;TSPAN14;CD300A;CYBA;PRKCD;OSTF1;FTL;CD36;RAB7A;RAC1;ANPEP;ROCK1;ITGB2;RAP1B;PTPRJ;ACTR2;IDH1;ANO6;HPSE;RHOA;TNFRSF1B;ARL8A;RAP2B;CRACR2A;ANXA2;PLAU;C5AR1;FABP5;CDK13;RAB31;ITGAL;S100A11;RAP1A;LAMP2;GYG1;PSMB7;PLEKHO2;ATG7;TCIRG1;GNS;SYNGR1;TOM1;IMPDH2;NFKB1;DYNC1H1;GALNS;DNAJC13;ITGAV;DERA;CTSA;CFP;MAPK14;STOM;CAP1;CD53;ARSA;C3;CYB5R3;MVP;CAB39;SRP14;PRCP;GRN;PLAC8;SIRPA;AP2A2;TIMP2;VAT1;CTSC;BST2;VPS35L;HMOX2;B2M;PLAUR;CPPED1;CD63;PTPN6;IGF2R;GUSB;CTSH;ADAM8;MAGT1;CLEC4D;NCKAP1L;TMC6;HK3;PSMC3;ITGAX;EEF2;RAB3D;NPC2;DGAT1;TXNDC5;XRCC6;RAB24;ACTR1B;DNASE1L1;LAMP1;CTSS;CAMP;HSP90AB1;CPNE3;EEF1A1;PKM;FRK;RAB10;FCER1G;DPP7;STK11IP;GGH;GMFG;CREG1;NFAM1;KCMF1;NEU1;PDXK;ABCA13;PGRMC1;COTL1;ARPC5;CST3
prerank,neutrophil mediated immunity (GO:0002446),-0.47547600859977807,-2.175259467904022,0.0,0.00024672423261841897,0.002,140/432,15.44%,IQGAP2;DOCK2;IQGAP1;DIAPH1;PTPRC;CYBB;CD44;CTSB;ATP8B4;APAF1;CLEC12A;ADGRE5;FGR;CTSD;SDCBP;CTSZ;LILRB3;C3AR1;PSAP;TSPAN14;CD300A;CYBA;PRKCD;OSTF1;FTL;CD36;RAB7A;RAC1;ANPEP;ROCK1;ITGB2;RAP1B;PTPRJ;ACTR2;IDH1;ANO6;HPSE;RHOA;TNFRSF1B;ARL8A;RAP2B;CRACR2A;ANXA2;PLAU;C5AR1;FABP5;CDK13;RAB31;ITGAL;S100A11;RAP1A;LAMP2;GYG1;PSMB7;PLEKHO2;ATG7;TCIRG1;GNS;SYNGR1;TOM1;IMPDH2;NFKB1;DYNC1H1;GALNS;DNAJC13;ITGAV;DERA;CTSA;IRAK4;CFP;MAPK14;STOM;CAP1;CD53;ARSA;C3;CYB5R3;MVP;CAB39;SRP14;PRCP;GRN;PLAC8;SIRPA;AP2A2;TIMP2;VAT1;CTSC;BST2;VPS35L;HMOX2;B2M;PLAUR;CPPED1;CD63;PTPN6;IGF2R;GUSB;CTSH;ADAM8;MAGT1;CLEC4D;NCKAP1L;TMC6;HK3;PSMC3;ITGAX;EEF2;RAB3D;NPC2;DGAT1;TXNDC5;XRCC6;RAB24;ACTR1B;DNASE1L1;LAMP1;CTSS;CAMP;HSP90AB1;CPNE3;EEF1A1;PKM;FRK;RAB10;FCER1G;DPP7;STK11IP;GGH;GMFG;CREG1;NFAM1;KCMF1;NEU1;PDXK;ABCA13;PGRMC1;COTL1;ARPC5;CST3
prerank,innate immune response (GO:0045087),-0.5165008686473417,-2.175097559977503,0.0,0.00022429475692583545,0.002,87/217,22.03%,LYN;CYBB;CD74;FGR;SP100;MFHAS1;SYK;PLCG2;REL;TLR8;CYBA;NRROS;FES;PPARG;MALT1;KYNU;ALPK1;DHX58;TLR4;PTK2B;NLRC5;IRF5;IRAK4;CFP;CIITA;C3;PIK3CG;NUB1;RNASE7;MYD88;BST2;B2M;ATAD3A;IFITM2;OTULIN;CLEC4D;MSRB1;CHGA;RELA;LCK;NCF1;APP;CD300LB;RNASE6;IFIT1;CLEC6A;ADAM15;CAMP;CXCL16;NCF2;TRIM68;FRK;CAPZA1;FCER1G;DEFA6;PIK3CD;TRIM11;GCH1;CD40;IKBKB;RELB;ANG;TREML1;MAVS;TRIM14;ISG15;SKP2;ZAP70;POLR3A;HCK;TRIM39;ZDHHC1;DDX3X;TTC4;NOD2;HMGB1;CYBC1;AGER;CD300E;SLA;SERINC3;TRIM25;ANKHD1;IFITM1;SRPK1;RNF135;MASP1
prerank,nervous system development (GO:0007399),0.4538595226099068,2.163902563295979,0.0,0.0007730223012269445,0.022,124/429,14.80%,LSAMP;NLGN1;RBFOX1;NRXN1;NRG1;ROBO1;ASIC2;ADGRL3;NAV3;MYT1L;NELL1;CHRM2;SPOCK1;GRIK1;FGF12;DNM3;KIRREL3;ROBO2;CNTN6;KALRN;TRPC5;CHRM3;CNTN4;EFNA5;DCLK1;ERBB4;CDH2;TENM1;DSCAM;ADAM22;LDB2;GPM6A;ST8SIA2;SERPINI1;LRCH4;APBA2;AHI1;SRRM4;DPF3;NAV2;SCN2A;SEMA6A;SH3GL2;NINJ2;IL1RAPL2;SLITRK1;SEMA5A;NRCAM;VCAN;POU6F2;SOX6;NRXN2;PAX8;PTN;POU3F2;GDNF;RBFOX2;ACVR1C;ADAM23;EPHB1;MAL;SHANK3;GPM6B;APC2;SDK1;RPS6KA6;DCHS1;FEZ1;GSS;MOG;SH3GL3;CYP51A1;FAT4;YAP1;BDNF;RBFOX3;FLRT3;DSCAML1;ADGRV1;PTS;NCKAP1;DPYSL5;GFRA2;ADGRA2;NDUFV2;PCDHB6;PTPRZ1;PCDHB14;GBX2;B3GNT5;PCDHA11;PCDHA4;NEUROD1;DNER;MBD5;CHST8;GSN;GSTP1;RELN;NBL1;SMO;PKD1;DPYSL4;RAPGEF5;HES5;ZIC2;TYRO3;DOC2A;ATXN10;VLDLR;PCDHB11;TEAD1;CDK5RAP2;PRKN;FKTN;CDH1;HES1;ZIC4;NLGN2;ARNT2;PCDHB16;INHBA;BTBD3;PAFAH1B3
prerank,presynapse assembly (GO:0099054),0.8001647324320665,2.1562885130328278,0.0,0.0009282669455727283,0.028,5/16,3.96%,NLGN1;PTPRD;IL1RAPL1;PCLO;LRRTM3
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.5963537593395626,-2.1540635776449855,0.0,0.0003084052907730237,0.003,30/67,12.51%,CYBB;NRP1;VAV3;ABI1;MAPKAPK3;PAK2;CYBA;AXL;RAC1;ROCK1;RHOA;WASF2;VAV1;MAPKAPK2;CDC42;FLT1;PTK2B;ITGAV;MAPK14;PIK3CB;NRP2;BAIAP2;VEGFA;VAV2;NCKAP1L;NCF1;NCF4;CRK;PIK3CA;NCF2
prerank,cell junction assembly (GO:0034329),0.5452653849221176,2.152798923538346,0.0,0.000916627234656456,0.029,42/100,14.30%,NLGN1;NRXN1;ADGRL3;CDH18;CTNND2;DNM3;KIRREL3;CDH8;CDH10;CDH2;DSCAM;CDH20;TJP1;CDH11;GPM6A;SLITRK1;NRCAM;CDH12;CDH22;NRXN2;CDH19;CDH7;SHANK3;SDK1;DCHS1;BDNF;FLRT3;CDH6;TLN2;PCDHB6;PCDHB14;DNER;ARVCF;CDHR3;CDH9;FERMT2;CLDN5;PCDHB11;CDH1;CDH5;NLGN2;PCDHB16
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.6686525898699895,2.151840907697751,0.0,0.0008767738766279143,0.029,11/34,8.14%,MPP2;GRID2;GRIN2A;GABRG3;GRIN2B;GLRA1;GABRA2;GABRA3;GABRA5;GABRG2;INSYN1
prerank,positive regulation of synaptic transmission (GO:0050806),0.571271554131876,2.1422706417957436,0.0,0.0011483302300835043,0.035,23/72,9.50%,NLGN1;MPP2;RIMS2;NRXN1;GRIK2;GRIN2A;RIMS1;SYT1;GRIN2B;ADCY8;SLC24A2;SLC8A3;CLSTN2;SHANK3;PRKCZ;CLSTN1;TSHZ3;CACNG4;CACNG2;FMR1;ADCY1;SLC8A2;NFATC4
prerank,potassium ion transmembrane transport (GO:0071805),0.5103095279341286,2.141535047220447,0.0,0.0011023970208801643,0.035,42/135,13.91%,KCND2;KCNB2;KCNQ3;KCNN2;KCNQ5;KCNC2;KCNK10;KCND3;SLC24A4;SLC24A2;SLC12A2;NALCN;KCNT2;KCNH7;KCNH5;KCNH1;SLC24A3;SLC12A8;SLC12A1;KCNJ3;SLC9A2;KCNJ10;KCNJ6;KCNK2;KCNJ9;HCN2;KCNIP2;KCNA1;KCNH4;ATP1A3;KCNJ16;KCNF1;ATP1B1;HCN1;TMEM175;KCNG1;SLC12A5;KCNJ12;KCNV1;KCNH8;KCNA2;KCNS3
prerank,potassium ion transport (GO:0006813),0.5177202629458789,2.141389759416559,0.0,0.0010599971354616964,0.035,37/120,13.91%,KCND2;KCNB2;KCNQ3;KCNN2;KCNQ5;KCNC2;KCNK10;KCND3;SLC24A4;SLC24A2;NALCN;KCNMB3;KCNMB2;KCNH7;KCNH5;KCNH1;SLC24A3;KCNJ3;SLC9A2;KCNJ10;KCNJ6;KCNK2;HCN2;KCNIP2;KCNA1;KCNH4;KCNJ16;KCNF1;HCN1;TMEM175;KCNG1;KCNMA1;KCNJ12;KCNV1;KCNH8;KCNA2;KCNS3
prerank,regulation of dendrite development (GO:0050773),0.6507100277867198,2.1398314183100555,0.0,0.0010456340306451422,0.036,19/37,14.11%,ADGRB3;CSMD3;HECW1;DCC;CDKL5;HECW2;LZTS1;PTN;MARK1;KNDC1;ALK;NEDD4;BMP7;COBL;MFSD2A;TNIK;VLDLR;SDC2;PACSIN1
prerank,cell-cell junction organization (GO:0045216),0.5557622089054206,2.132491937432989,0.0,0.0011043175731813492,0.04,34/79,14.94%,CADM2;CDH18;CTNND2;CDH8;CDH10;CDH2;CDH20;TJP1;CDH11;CDH13;CSF1R;CDH12;CDH22;AFDN;CDH19;CDH7;NECTIN3;SDK1;DCHS1;PRKCI;CDH6;TLN2;OCLN;CDH17;ARVCF;CDHR3;TGFB2;CDH9;CADM3;CLDN5;CDH1;CDH5;NLGN2;CTNND1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.7232875450495604,2.1298537880570314,0.0,0.0011357748953559302,0.043,10/21,13.07%,AKAP6;ANK2;CACNA1C;DMD;RYR2;PDE4D;CASQ2;CALM1;CALM3;CALM2
prerank,B cell activation (GO:0042113),-0.5899673201022455,-2.118593908628316,0.0,0.001138727227469626,0.009,36/68,26.18%,ITGA4;PTPRC;BANK1;PRKCB;PLCG2;TPD52;PTPRJ;MALT1;LYL1;CD22;ITGB1;BLNK;HHEX;BCL2;KLF6;FCRL1;CEBPG;MEF2C;DNAJB9;HDAC5;PIK3CD;NFAM1;CD40;TCF3;CHRNB2;CASP8;ZAP70;LAT2;CD79A;LAX1;ZBTB7A;RABL3;FLT3;DCAF1;MS4A1;GPS2
prerank,positive regulation of phagocytosis (GO:0050766),-0.6278100550301781,-2.1173888165645893,0.0,0.0011455053657283738,0.01,22/47,19.96%,DOCK2;PTPRC;CYBA;PTPRJ;CAMK1D;ANO6;CD300LF;RAB31;C4B;IL15;STAP1;C3;GAS6;SIRPA;NCKAP1L;IL2RG;FCGR2B;FCER1G;APPL2;IL2RB;PLA2G5;C2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6156520010146801,2.114640963354758,0.0,0.0013443866108294685,0.053,15/46,7.48%,NLGN1;NRXN1;GRM7;GRM5;GRIK1;SYT1;CDH2;GRM8;GRM1;SHANK3;GRM3;TSHZ3;HOMER1;CACNG4;CACNG2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.7040869288308578,2.1144135324600564,0.0,0.0013010193008027116,0.053,10/26,5.48%,NLGN1;RIMS2;NRXN1;RIMS1;SLC8A3;MTMR2;TMEM108;SHANK3;PRKCZ;CUX2
prerank,regulation of presynapse assembly (GO:1905606),0.7459141014364594,2.1099940752799444,0.0,0.0012425391403120846,0.054,6/18,3.22%,LRFN5;PTPRD;IL1RAPL1;GPC6;IL1RAPL2;SLITRK1
prerank,regulation of presynapse organization (GO:0099174),0.7459141014364594,2.1099940752799444,0.0,0.0012425391403120846,0.054,6/18,3.22%,LRFN5;PTPRD;IL1RAPL1;GPC6;IL1RAPL2;SLITRK1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.7590379427383894,-2.1077475526457135,0.0,0.0012336211630920948,0.012,12/21,5.28%,LYN;PRKCH;FOXP1;RUNX1;PRKCB;ELF2;CD300A;LPXN;ELF1;CD22;STAP1;PTPN22
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.7448860181405567,2.099878524657696,0.0,0.001640942480865381,0.075,7/18,5.48%,NLGN1;RIMS2;NRXN1;RIMS1;SHANK3;PRKCZ;CUX2
prerank,regulation of B cell proliferation (GO:0030888),-0.6356582362598476,-2.099489508664826,0.0,0.001387823808478607,0.014,22/44,19.63%,LYN;PTPRC;VAV3;CD38;CD74;CD300A;SASH3;CD22;RC3H1;BCL2;TNFRSF21;AHR;MEF2C;NCKAP1L;IKZF3;FCGR2B;CD40;BST1;CHRNB2;IRS2;IL7;ATM
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.5343903291758558,-2.099394237907057,0.0,0.0013061871138622184,0.014,49/112,22.98%,PTPRC;FOXP1;IGF1;CCR2;LILRB1;SYK;PLCG2;CYBA;PTPRJ;ARHGEF2;RIPK1;MAPKAPK2;STAT3;TLR4;DHX9;PTPN22;PF4;IRAK3;GAS6;SIRPA;PTPN6;LY96;SELENOS;LPL;APP;ARFGEF2;CD2;NLRC3;OAS3;NFKBIL1;MAVS;ARG2;SPN;SPHK2;RARA;LILRA5;PTPN11;MMP8;LGALS9;HSPB1;NOD2;HMGB1;AGER;OAS2;ZC3H12A;TMEM106A;NR1H4;IL6;IFNGR1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5785804039505966,2.0965044389516367,0.0,0.001632469456007212,0.076,22/59,13.97%,ROBO1;KIRREL3;ROBO2;CNTN6;TENM3;CNTN4;CDH2;PTPRT;DSCAM;CDH13;NECTIN3;SDK1;DSCAML1;PCDHB6;CDH17;ROBO3;PKD1;CADM3;AMIGO2;TRO;VSTM2L;CDH1
prerank,protein targeting to ER (GO:0045047),-0.5473467474223414,-2.0964396213570606,0.0,0.001233621163092095,0.014,51/99,24.31%,RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;SEC63;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SRP14;RPS14;ZFAND2A;RPL32;RPS15A;RPS28;RPS13;RPS27A;RPL28;RPS4X;RPS23;RPL22;RPL14;RPL34;RPS11;RPL6;RPS10;RPL18A;RPL37A;GET3;SRPRB;RPS9;RPS27;RPS3;RPL23A;RPS16;RPL9;SGTA;RPLP2;RPL41;RPLP0;CHMP4B;CHMP4A;RPL7A;RPL19;RPS15;RPL39;EDEM1
prerank,regulation of NMDA receptor activity (GO:2000310),0.6460109113934523,2.088796917993593,0.0,0.0017364993723213969,0.083,10/32,3.60%,NLGN1;DLG2;GRIA4;LRRC7;GRIN2A;GRIN2B;DLG3;GRIA3;GRIA2;GRIA1
prerank,positive regulation of cell communication (GO:0010647),0.6887976359770825,2.0859297898214573,0.0,0.0017259017301189123,0.085,9/28,6.74%,RIMS2;GRIK2;ANK3;RIMS1;SYT1;SOX11;CLSTN2;CLSTN1;HOMER1
prerank,regulation of cation transmembrane transport (GO:1904062),0.6728238243534563,2.085854931554899,0.0,0.001680483263536836,0.085,8/29,6.77%,DPP10;KCNIP4;DPP6;FGF12;KCNN2;KCNIP1;HOMER1;KCNIP2
prerank,axonogenesis (GO:0007409),0.4654636979248614,2.0856177065483563,0.0,0.0016373939490871734,0.085,83/237,16.11%,NRXN1;ROBO1;CTNNA2;NRXN3;UNC5C;AUTS2;NCAM1;DAB1;ANK3;ROBO2;CNTN6;KIF5C;MAP1B;CNTN4;EFNA5;SLIT3;SLIT2;DCC;DSCAM;EPHA6;SEMA6D;PARD3;UNC5D;SHC3;EPHA7;TNR;DOK6;PLPPR4;EPHA5;GRB10;SEMA6A;NTNG2;NTNG1;PAK3;SLITRK1;SEMA3E;NEFH;SEMA5A;NRCAM;GAB1;DOK5;SLIT1;SPTB;SPTBN2;GDNF;EPHB1;SHANK3;SOS1;KIF5A;FEZ1;BDNF;DSCAML1;FYN;GFRA2;SPTBN4;EPHA10;SEMA3F;PLA2G10;LGR6;POU4F2;ROBO3;RELN;SLITRK3;SEMA5B;CDK5R1;BRSK1;RET;ARHGAP35;VLDLR;EPHB4;SLITRK5;VSTM2L;ENAH;HSP90AA1;KLF7;SEMA4G;ZDHHC17;EPHB3;UNC5A;EMB;NRTN;PRKCA;EPHA3
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6377911305322624,2.083840007097635,0.0,0.0016132639329953624,0.086,12/37,6.81%,NLGN1;GRID2;PTPRD;TENM2;IL1RAPL1;TENM3;TENM1;TENM4;NECTIN3;VCAM1;DCHS1;FAT4
prerank,positive regulation of cytokine production (GO:0001819),-0.47206709946890535,-2.083811353935224,0.0,0.001428403452001373,0.018,117/292,21.90%,RFTN1;PTPRC;FOXP1;RUNX1;CD74;FGR;PAEP;CCR2;LILRB1;SYK;PLCG2;TLR8;CYBA;RAB7B;CREBBP;CGAS;HPSE;GAPDH;LY9;ARHGEF2;TLR7;MALT1;RIPK1;BRCA1;IL6R;HTR2B;STAT3;DHX58;PIBF1;IL15;CARD11;TLR4;IL18;STAT6;DHX9;RAB1A;NFKB1;TMED10;IRF5;PTGER4;PTPN22;ANXA1;IL17RA;MAPK14;BATF;C3;PIK3CG;CYRIB;CTNNB1;POLR2H;EIF2AK2;GBP5;MDK;SULF2;LAPTM5;MYD88;POLR2F;CEBPG;CD28;NOD1;POLR3G;HIF1A;POLR2L;LPL;CLEC9A;EGR1;ARNT;SCRIB;AFAP1L2;RELA;AGT;APP;XBP1;XRCC6;TICAM1;CD46;CLEC6A;CD2;ITK;SERPINE1;FCER1G;TRAF2;PIK3CD;DHX36;SLC7A5;NFAM1;CD40;AGPAT1;POU2AF1;TXK;MAVS;POLR3B;ISG15;IL18R1;SPHK2;G3BP1;CD226;HSPA1A;RARA;LILRA5;GATA3;RPS3;POLR3A;PTPN11;MMP8;LGALS9;NOD2;HMGB1;IL7;AGER;CD274;APPL1;LRRFIP1;SLAMF6;TMEM106A;NLRP3;CEBPB
prerank,synaptic membrane adhesion (GO:0099560),0.7958624066555808,2.0769042787605456,0.0,0.0018362353708890305,0.1,6/14,3.22%,LRRC4C;LRFN5;PTPRD;GPC6;NTNG1;SLITRK1
prerank,cytoplasmic translation (GO:0002181),-0.5467245783244736,-2.0728015956509416,0.0,0.0017887506864835375,0.023,45/91,23.52%,RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;RPL36;RPS6;RPS20;RPL11;RPL10A;EIF4A2;RPL12;EIF2B3;RPS14;RPL32;RPS15A;RPS28;RPS13;RPS27A;RPL28;RPS4X;RPS23;EIF4A1;RPL22;RPL14;RPL34;RPS11;RPL6;RPS10;RPL18A;RPL37A;RPS9;RPS27;RPS3;RPL23A;RPS16;RPL9;RPL41;RPLP0;RPL7A;RPL19;RPS15;RPL39
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.5525079514807146,-2.071064061395959,0.0,0.0018210598121835688,0.025,44/87,23.52%,RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;SEC63;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SRP14;RPS14;RPL32;RPS15A;RPS28;RPS13;RPS27A;RPL28;RPS4X;RPS23;RPL22;RPL14;RPL34;RPS11;RPL6;RPS10;RPL18A;RPL37A;RPS9;RPS27;RPS3;RPL23A;RPS16;RPL9;RPLP2;RPL41;RPLP0;RPL7A;RPL19;RPS15;RPL39
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.8548799631463999,-2.0703208157943327,0.0,0.0017943580554066836,0.026,9/12,8.87%,LYN;PTPRC;RUNX1;ELF2;CD300A;ELF1;RC3H1;PTPN22;CBFB
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.5700052227515342,-2.069571245014275,0.0,0.001716342487780306,0.026,29/68,22.63%,CD74;SYK;PLCG2;TLR8;CYBA;RAB7B;ARHGEF2;TLR7;IL6R;STAT3;TLR4;DHX9;IL17RA;MYD88;LPL;APP;XBP1;POU2AF1;MAVS;SPHK2;LILRA5;PTPN11;MMP8;LGALS9;NOD2;HMGB1;AGER;TMEM106A;IL6
prerank,regulation of trans-synaptic signaling (GO:0099177),0.6548403169433284,2.0682634816111243,0.0,0.002128612133813325,0.117,9/33,3.36%,NLGN1;LRRC4C;NRG3;GRID2;GRIK5;GRIK2;GRIK1;GRID1;GRIK4
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.6029138007921605,-2.0652336840995655,0.0,0.0019018326264336463,0.029,28/51,22.63%,P2RX7;TLR8;CD36;USP50;MALT1;STAT3;TLR4;NLRC4;TMED10;AIM2;PANX1;GBP5;MYD88;LPL;EGR1;APP;CASP1;CASP8;LILRA5;TRIM16;LGALS9;HSPB1;NOD2;HMGB1;AGER;TMEM106A;NLRP3;IL6
prerank,regulation of interferon-beta production (GO:0032648),-0.6123653473704929,-2.058418923674349,0.0,0.0020231387074710356,0.033,27/46,23.01%,LILRB1;REL;TLR8;TLR7;DHX58;RIOK3;TLR4;DHX9;IRF5;TRAF3;PPM1B;SIRPA;POLR3G;NLRC3;OAS3;YY1;RELB;RNF216;MAVS;POLR3B;ISG15;POLR3A;PTPN11;DDX3X;OAS2;RNF135;TOMM70
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5237038279386201,-2.0551300735746745,0.0,0.00204021961588308,0.035,54/110,23.52%,DCP1A;RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SMG9;RPS14;RPL32;RPS15A;RPS28;RPS13;SMG8;HELZ2;RPS27A;RPL28;RPS4X;RPS23;UPF2;EIF3E;RPL22;RPL14;RPL34;RPS11;RPL6;NCBP1;EIF4G1;RPS10;RPL18A;RPL37A;RPS9;RNPS1;RPS27;RPS3;RPL23A;RPS16;MAGOH;RPL9;RPLP2;RPL41;RPLP0;RPL7A;SMG1;RPL19;RPS15;RPL39
prerank,regulation of cholesterol storage (GO:0010885),-0.8089688552258885,-2.0543158317726986,0.0,0.001964655926405929,0.035,9/15,14.42%,ABCA1;MSR1;ABCG1;PPARD;PPARG;NR1H2;LPL;TTC39B;EHD1
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.5467558625675358,-2.0536644070240686,0.0,0.0019385475420018634,0.036,45/91,23.52%,RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;SEC63;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SRP14;RPS14;SIL1;RPL32;RPS15A;RPS28;RPS13;RPS27A;RPL28;RPS4X;RPS23;RPL22;RPL14;RPL34;RPS11;RPL6;RPS10;RPL18A;RPL37A;RPS9;RPS27;RPS3;RPL23A;RPS16;RPL9;RPLP2;RPL41;RPLP0;RPL7A;RPL19;RPS15;RPL39
prerank,adherens junction organization (GO:0034332),0.5913746223957393,2.049983826186062,0.0,0.003079583282946573,0.167,25/48,14.94%,CADM2;CDH18;CDH8;CDH10;CDH2;CDH20;TJP1;CDH11;CDH13;CDH12;CDH22;AFDN;CDH19;CDH7;NECTIN3;DCHS1;CDH6;CDH17;CDHR3;CDH9;CADM3;FERMT2;CDH1;CDH5;CTNND1
prerank,positive regulation of immune response (GO:0050778),-0.5707836132194845,-2.0427408321310234,0.0,0.002212010361406515,0.044,28/64,19.35%,PTPRC;CD74;LILRB1;TLR8;CYBA;ITGB2;SASH3;IL15;RIOK3;DHX9;RSAD2;IFI35;GRN;GBP5;POLR3G;ADAM8;XBP1;CD46;CCL5;FCGR2B;KARS1;POLR3B;SPHK2;CD226;STX4;MYB;LGALS9;NOD2
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.49101934964452165,-2.0411650180844383,0.0,0.002220518093565771,0.045,76/168,23.52%,CNOT4;DCP1A;RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;TUT7;CNOT1;RC3H1;CNOT2;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SMG9;PATL1;RPS14;EXOSC5;RPL32;DCP2;RPS15A;RPS28;RPS13;SMG8;HELZ2;DDX5;RPS27A;RPL28;RPS4X;RPS23;UPF2;CSDE1;EIF3E;MTPAP;RPL22;RPL14;RPL34;RPS11;RPL6;NCBP1;EIF4G1;RPS10;RPL18A;RPL37A;POLR2G;PAN3;CNOT6L;RPS9;RNPS1;RPS27;TENT4B;RPS3;RPL23A;RPS16;EXOSC10;MAGOH;RPL9;ATM;CNOT8;ZC3H12A;RPLP2;EXOSC4;PNLDC1;XRN2;RPL41;RPLP0;RPL7A;SMG1;RPL19;RPS15;RPL39
prerank,heart contraction (GO:0060047),0.5924544111142289,2.033433590857295,0.0,0.003727617420936254,0.204,12/41,11.10%,SGCZ;SGCD;DMD;RYR2;SCN2B;CASQ2;TNNI1;SGCG;TNNT2;MYH7;ATP1B1;TTN
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.5635153456495094,-2.0329917215821487,0.0,0.0025866250193866507,0.054,33/69,22.98%,PTPRC;CCR2;SYK;PLCG2;CYBA;PTPRJ;ARHGEF2;RIPK1;STAT3;TLR4;DHX9;PF4;LY96;LPL;APP;ARFGEF2;CD2;OAS3;MAVS;SPN;SPHK2;LILRA5;PTPN11;MMP8;LGALS9;HSPB1;NOD2;HMGB1;AGER;OAS2;TMEM106A;IL6;IFNGR1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.6050547875195881,-2.030434499516667,0.0,0.002582894310224074,0.056,26/45,22.63%,P2RX7;TLR8;CD36;USP50;MALT1;STAT3;TLR4;NLRC4;AIM2;PANX1;GBP5;MYD88;LPL;EGR1;APP;CASP1;CASP8;LILRA5;TRIM16;LGALS9;HSPB1;NOD2;AGER;TMEM106A;NLRP3;IL6
prerank,chloride transmembrane transport (GO:1902476),0.5867452646179165,2.0293680715900666,0.0,0.0038240330263593775,0.212,18/48,8.86%,GABRB3;GABRB1;GABRG3;SLC12A2;GLRA1;GABRA2;ANO4;GABRA3;SLC12A8;SLC12A1;GABRA5;GABRB2;ANO3;GABRG2;ANO5;SLC1A1;SLC6A1;GLRA2
prerank,regulation of immune response (GO:0050776),-0.5105828153410301,-2.0262756143273304,0.0,0.0027663020020853033,0.063,78/135,33.68%,LYN;ITGA4;FOXP1;FGR;SLAMF7;BIRC3;LILRB1;SYK;CD300A;BCL6;SAMHD1;ADCY7;ITGB2;RAET1E;CD300LF;ITGAL;DHX58;IL15;CD22;ITGB1;CLEC2D;PTPN22;RSAD2;TRAF3;C3;AHR;B2M;NPDC1;ITGB7;JAML;CD300LD;CD300LB;IL4I1;CXADR;FCGR2B;CD40;ULBP1;PILRA;TREML1;SPN;APPL2;GPR108;CD226;CASP8;HCST;DENND1B;CD300E;CD300LG;APPL1;SLAMF6;IFITM1;RNF135;CD3E;CD247;TREML4;CD96;ZMPSTE24;FCRLB;CD300C;SELL;CRTAM;SPINK5;CD19;RIPK3;KIR3DL2;CD8B;TKFC;XIAP;NCR1;FCGR3B;FCGR3A;KLRD1;CD8A;KLRC1;ERAP1;IRF4;SLA2;PLSCR1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.5540069614228348,-2.024650966900653,0.0,0.0027937891046497442,0.065,34/73,22.98%,PTPRC;CCR2;SYK;PLCG2;CYBA;PTPRJ;ARHGEF2;RIPK1;STAT3;TLR4;DHX9;PF4;LY96;ADAM8;LPL;APP;ARFGEF2;CD2;OAS3;MAVS;SPN;SPHK2;LILRA5;PTPN11;MMP8;LGALS9;HSPB1;NOD2;HMGB1;AGER;OAS2;TMEM106A;IL6;IFNGR1
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.7858107006756565,-2.024043500035768,0.0,0.0027139665588026087,0.065,7/15,12.29%,OSBPL8;PLIN2;PPARG;LPL;OSBPL11;APOC4;ABHD5
prerank,regulation of interleukin-6 production (GO:0032675),-0.5264884169714787,-2.02036953015152,0.0,0.0028784493805482213,0.071,41/96,21.48%,CD74;SYK;PLCG2;TLR8;CYBA;RAB7B;ARHGEF2;TLR7;IL6R;MAPKAPK2;STAT3;TLR4;DHX9;PTPN22;IL17RA;ARRB1;IRAK3;GAS6;SIRPA;MYD88;PTPN6;SELENOS;LPL;NCKAP1L;AFAP1L2;APP;XBP1;FOXJ1;NLRC3;POU2AF1;MAVS;SPHK2;LILRA5;PTPN11;MMP8;LGALS9;NOD2;HMGB1;AGER;ZC3H12A;TMEM106A
prerank,neuronal action potential (GO:0019228),0.6864328817607505,2.0186256695857288,0.0,0.004413095179027169,0.245,11/22,15.84%,ANK3;KCNMB3;KCNMB2;SCN2A;SCN1A;SCN3A;SCN9A;KCNA1;KCNA2;CACNA1G;SCN10A
prerank,regulation of mast cell degranulation (GO:0043304),-0.8118300136575302,-2.017745924253103,0.0,0.0029673590139242287,0.076,7/14,3.09%,LYN;CD84;FGR;GAB2;SYK;CD300A;FES
prerank,cardiac muscle cell action potential (GO:0086001),0.6467074347291176,2.0135113984948467,0.0,0.004819769019675861,0.267,10/30,6.77%,FGF12;ANK2;CACNA1C;DMD;CACNA2D1;KCND3;SCN2B;SCN1A;HCN2;KCNIP2
prerank,regulation of innate immune response (GO:0045088),-0.5783902198577541,-2.0090461361322896,0.0,0.0035385449151852195,0.093,31/57,22.76%,FGR;BIRC3;TLR8;SAMHD1;USP18;RNASEL;DHX58;RIOK3;DHX9;IFNAR2;PTPN22;ABCE1;IFI35;IRAK3;GBP5;POLR3G;PARP9;PTPN6;ADAM8;CCL5;HSP90AB1;NLRC3;FCGR2B;POLR3B;APPL2;CASP8;PTPN11;APPL1;PTPN1;RNF135;SLC15A4
prerank,regulation of defense response (GO:0031347),-0.5498591515468274,-2.006949301652617,0.0,0.0036376008655279717,0.097,35/76,23.82%,APOE;FOXP1;FGR;BIRC3;CCR2;BCL6;SAMHD1;PIK3AP1;SBNO2;BRD4;USP18;DHX58;AREL1;PTPN22;ANXA1;TRAF3;GRN;MYD88;CASP4;DAGLB;RELA;CELF1;FCGR2B;CASP1;TMSB4X;BST1;APPL2;CASP8;HCK;NOD2;APPL1;RNF135;SETD6;LRRC19;SEMA7A
prerank,positive regulation of defense response (GO:0031349),-0.5313613969202845,-2.0069186508175503,0.0,0.003546660843889773,0.097,32/89,18.62%,CCR2;TLR8;CYBA;OPTN;TLR7;RIPK1;IL15;RIOK3;TLR4;IL18;DHX9;PTGER4;IL17RA;IFI35;GRN;GBP5;MDK;POLR3G;ABCC1;MEF2C;ADAM8;NFKBIZ;LPL;AGT;APP;CCL5;SERPINE1;PLA2G7;POLR3B;GPRC5B;LILRA5;TRADD
prerank,heart process (GO:0003015),0.7545458878080595,2.0066464555042622,0.0,0.005335534361729453,0.294,5/14,9.27%,SGCZ;SGCD;RAMP3;FYN;SGCG
prerank,detection of calcium ion (GO:0005513),0.7775094866048731,2.0060071282357077,0.0,0.005295237058981377,0.294,9/13,13.07%,RYR2;SYT1;KCNMB3;KCNMB2;CASQ2;KCNIP2;CALM1;CALM3;CALM2
prerank,axon development (GO:0061564),0.5278637186700236,2.005833958564552,0.0,0.005229663916126634,0.295,34/78,18.79%,GRM7;CTNNA2;ANK3;MAP1B;CNTN4;DCC;PARD3;PLPPR4;NTNG2;NTNG1;PAK3;SLITRK1;NEFH;PLP1;SEMA5A;NRCAM;DSCAML1;SPTBN4;SLITRK3;CDK5R1;BRSK1;ARHGAP35;RTN4RL1;SLITRK5;DHFR;KLF7;FOLR1;ZDHHC17;EPHB3;RAB3A;MAP1A;DOCK7;ADGRB1;S100B
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.4876062470323279,-2.0045989842949483,0.0,0.003640686847174231,0.102,68/163,21.22%,RFTN1;PTPRC;VAV3;PRKCB;CD38;SYK;PLCG2;PAK2;PTPRJ;THEMIS2;PSME4;GRAP2;MALT1;TAB2;PSMB7;TEC;CARD11;PSME3;RC3H1;BLNK;NFKB1;FBXW11;BCL2;PTPN22;RNF31;PSMB9;FYB1;RBCK1;PIK3CB;SPG21;TNFRSF21;EIF2B3;CD28;MEF2C;PSMA8;NFKBIZ;NCKAP1L;RELA;PSMC3;LCK;PIK3CA;PSMD8;ITK;PSMC4;PSMB10;LCP2;PIK3CD;PSMA1;NFAM1;IKBKB;TXK;PSMB8;THEMIS;ZAP70;GATA3;LAT2;PSMA5;DENND1B;PRAM1;PSMD4;NFKBID;PSMB3;EIF2B1;WNK1;CD79A;PSMD3;ZC3H12A;LAX1
prerank,positive regulation of B cell activation (GO:0050871),-0.5903127030986104,-2.001392805799372,0.0,0.003700863489276285,0.105,22/50,19.53%,PTPRC;VAV3;CD38;CD74;SYK;SASH3;SH3KBP1;BCL2;KMT5B;MEF2C;KMT5C;NCKAP1L;CD27;TNIP2;XBP1;CD40;BST1;CHRNB2;IRS2;SHLD2;NOD2;IL7
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6481473951556014,1.9998997433776051,0.0,0.005614791139346605,0.313,6/27,3.39%,PDE4B;ANK2;CTNNA3;CACNA1C;RYR2;PDE4D
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.6643067594428704,1.995039146468428,0.0,0.005855837833709129,0.33,5/25,1.86%,MPP2;GRID2;GRIN2A;GRIN2B;GLRA1
prerank,muscle cell differentiation (GO:0042692),0.6191692724414538,1.9928156496342038,0.0,0.005948276608292649,0.339,10/32,10.61%,SGCZ;RORA;DMD;FBXO40;MRTFA;GLMN;NEBL;MYOCD;POPDC2;TBX1
prerank,synaptic vesicle exocytosis (GO:0016079),0.578763623737286,1.9905927144844417,0.0,0.0060870838212556495,0.351,12/40,6.50%,RIMS2;RIMS1;SYT1;PCLO;UNC13C;SYT10;SNPH;SNAP25;CPLX1;SYT2;STX2;SYT5
prerank,defense response to virus (GO:0051607),-0.5183066611171898,-1.9832863532555092,0.0,0.004762351466820646,0.134,45/100,22.63%,PTPRC;LYST;LILRB1;TLR8;SAMHD1;CGAS;FLNA;IRF2;TLR7;RNASEL;ATG7;NLRC5;BCL2;IFNAR2;RSAD2;ABCE1;EXOSC5;EIF2AK2;MYD88;BST2;ATAD3A;IFITM2;RELA;MOV10;RNASE6;IFIT1;OASL;IFIT2;OAS3;CD40;MAVS;ISG15;G3BP1;BNIP3L;SKP2;MLKL;ZDHHC1;TTC4;OAS2;SERINC3;STAT1;EXOSC4;IFITM1;RNF135;IL6
prerank,regulation of B cell activation (GO:0050864),-0.6928358823985112,-1.9781427877549727,0.0,0.005046632030831298,0.144,12/25,14.64%,BANK1;THEMIS2;SH3KBP1;CD22;AHR;LAPTM5;TNIP2;IKZF3;FOXJ1;IL4I1;FCGR2B;SAMSN1
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.49551927642274507,-1.9775251763640014,0.0,0.004934484652368379,0.144,59/132,24.51%,APOE;IGF1;TFEB;MSN;DAPK1;P2RX7;ZC3HAV1;PRKCD;ROCK1;SNX9;TNFRSF1B;INSR;OPTN;ABCD2;FOXO3;CNOT1;RC3H1;PHKG2;ADAM9;PFKFB3;PIK3CB;SNX33;ATF6;PLK2;ZSWIM8;LAPTM5;HIF1A;DAGLB;ADAM8;ARNT;MOV10;ZBTB20;PFKFB4;GTPBP1;APP;FLCN;TICAM1;STK11;ABHD5;TRIM68;SH3GLB1;PIK3C2A;TRIM14;FAF1;IRS2;TMEM59;HMGB1;CNOT8;GSK3B;GRSF1;DTX3L;PTPN1;ZC3H12A;MEFV;MTDH;PIM2;GPLD1;FURIN;DCN
prerank,type I interferon signaling pathway (GO:0060337),-0.595592259803346,-1.9674789300088922,0.0,0.005643160639676604,0.172,25/41,23.03%,SP100;SAMHD1;IRF2;RNASEL;IRF5;IFNAR2;RSAD2;IFI35;MYD88;BST2;JAK1;IFITM2;GBP2;EGR1;IFNAR1;IFIT1;OASL;IFIT2;OAS3;ISG15;PSMB8;OAS2;STAT1;IFITM1;TYK2
prerank,cellular response to type I interferon (GO:0071357),-0.595592259803346,-1.9674789300088922,0.0,0.005643160639676604,0.172,25/41,23.03%,SP100;SAMHD1;IRF2;RNASEL;IRF5;IFNAR2;RSAD2;IFI35;MYD88;BST2;JAK1;IFITM2;GBP2;EGR1;IFNAR1;IFIT1;OASL;IFIT2;OAS3;ISG15;PSMB8;OAS2;STAT1;IFITM1;TYK2
prerank,neuropeptide signaling pathway (GO:0007218),0.544346647076198,1.9671795163275811,0.0,0.008958503506709094,0.47,20/58,16.00%,SORCS1;GLRA1;HCRTR2;SORCS3;GPR37;PNOC;OPRD1;GPR149;NTSR1;GLRA2;GALR1;PDYN;CPE;NTS;GLRA3;OPRK1;PENK;OPRL1;OPRM1;GRP
prerank,B cell differentiation (GO:0030183),-0.5856379503222028,-1.9670162240713605,0.0,0.00570549787930094,0.178,17/46,14.63%,ITGA4;PTPRC;PLCG2;TPD52;PTPRJ;LYL1;ITGB1;BLNK;HHEX;KLF6;FNIP1;CEBPG;DNAJB9;IRF2BP2;HDAC5;NFAM1;TCF3
prerank,synaptic vesicle cycle (GO:0099504),0.6288048482951439,1.9625995915481305,0.0,0.00932668211262944,0.492,8/30,3.08%,NLGN1;RIMS1;PCLO;SYT10;SYNDIG1;SNAP25;CPLX1;SLC17A6
prerank,central nervous system development (GO:0007417),0.43460284139821387,1.9606264108934564,0.0,0.009328156220755349,0.499,75/250,15.04%,CNTNAP2;ASIC2;ADGRL3;GRIN2A;SPOCK1;GRIK1;ROBO2;CNTN6;CNTN4;EML1;DCLK1;GRIN2B;SOX11;CDH2;ADAM22;SLC8A3;AFF2;SERPINI1;AHI1;EPHA7;MEIS1;NFIB;SH3GL2;SYNJ2;IL1RAPL2;SMARCA1;NRCAM;VCAN;POU6F2;SOX6;PAX8;SHROOM4;ADAM23;SLC6A17;SOX12;MAL;APOD;RPS6KA6;VIT;MOG;SH3GL3;DSCAML1;PTS;NCKAP1;ADGRA2;SOX9;CX3CR1;ADGRL2;PTPRZ1;CDK5RAP3;B3GNT5;DNER;ZFHX2;CHST8;GSN;GSTP1;RELN;MFSD2A;SMO;CDK5R1;PKD1;EEF1AKMT4-ECE2;HES5;ZIC2;AMIGO2;PBX1;CDK5RAP2;ADGRG1;PAFAH1B2;PRKN;ZIC4;ARNT2;PAFAH1B3;ATP6AP2;UFC1
prerank,axon guidance (GO:0007411),0.4447755899760321,1.9605126423918895,0.0,0.009178915480835683,0.499,61/201,12.61%,NRXN1;ROBO1;NRXN3;UNC5C;NCAM1;DAB1;ROBO2;CNTN6;KIF5C;CNTN4;EFNA5;SLIT3;SLIT2;DCC;DSCAM;EPHA6;SEMA6D;UNC5D;SHC3;EPHA7;TNR;DOK6;EPHA5;GRB10;SEMA6A;NFIB;SEMA3E;SEMA5A;GAB1;DOK5;SLIT1;SPTB;SPTBN2;GDNF;EPHB1;SHANK3;TMEFF1;SOS1;KIF5A;FEZ1;BDNF;DSCAML1;FYN;GFRA2;SPTBN4;EPHA10;PLXNA4;SEMA3F;PLA2G10;LGR6;POU4F2;ROBO3;RELN;SEMA5B;SMO;CDK5R1;PLXNA2;RET;ARHGAP35;VLDLR;EPHB4
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5490987291157514,1.958956097971592,0.0,0.00920563035212043,0.504,16/54,8.49%,DPP10;KCNIP4;DPP6;AKAP6;KCNN2;KCNIP1;KCNMB3;KCNMB2;KCNJ3;KCNJ10;KCNJ6;KCNJ9;KCNIP2;GABBR1;KCNJ16;NEDD4
prerank,excitatory postsynaptic potential (GO:0060079),0.6919226385142212,1.957858033790594,0.0,0.009265064392966421,0.514,4/19,1.30%,MPP2;GRID2;GRIN2A;GRIN2B
prerank,action potential (GO:0001508),0.5701884285219243,1.9542996313586212,0.0,0.009520901899644761,0.53,11/44,7.11%,KCND2;AKAP6;ANK3;DMD;KCNMB3;KCNMB2;SCN2A;SCN1A;SCN3A;SCN9A;KCNA1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.6534233775430259,-1.9539734233433823,0.0,0.006898208136474164,0.209,13/27,10.64%,PRKCH;ABCA1;MSR1;ABCG1;CD36;PPARG;IL18;NFKB1;ITGAV;NR1H2;PF4;LPL;AGT
prerank,positive regulation of interferon-beta production (GO:0032728),-0.6220885194781144,-1.951871873534261,0.0,0.00703164062962494,0.217,19/33,24.98%,TLR8;TLR7;DHX58;RIOK3;TLR4;DHX9;IRF5;POLR3G;OAS3;MAVS;POLR3B;ISG15;POLR3A;PTPN11;DDX3X;OAS2;RNF135;TOMM70;POLR3D
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.5467355586910467,-1.9509671132042188,0.0,0.006990519924188538,0.22,22/59,14.85%,BIRC3;REL;TLR8;ROCK1;TLR7;RIPK1;IRAK2;TAB2;CARD11;TLR4;RNF31;RBCK1;LY96;UBC;RPS27A;RELA;TICAM1;NLRC3;TRAF2;NFKBIL1;IKBKB;RELB
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.4411937928950741,-1.9508025564745797,0.0,0.006856086848723374,0.22,127/306,23.52%,EXT1;APOE;B4GALT5;FAM111A;RBMS1;TOP3A;MEF2A;AGO2;RPS18;RPL7;RPS12;RPS21;BRCA1;RPS8;RPS24;GSPT1;POLE2;SARS1;RPL36;BLM;RPS6;RPS20;RPL11;RPL10A;RAD1;RPL12;RRBP1;MRPL42;TUFM;RPS14;EEF1B2;POLR2H;MCM6;E2F1;PCLAF;RPL32;RPS15A;RPS28;RPS13;POLR2F;THAP1;POLR2L;RPS27A;DARS1;RPL28;RPS4X;MCM9;MCM3;DBF4;RPS23;EEF2;EIF4EBP2;GTPBP1;TIMELESS;WRN;CDK1;ORC5;EXO1;RPL22;RPL14;FEN1;KAT7;EEF1A1;MRPS6;TICRR;RPL34;GCNT1;RPA3;RFC2;MRPS11;RPS11;POLR2A;RPL6;DUT;POLD2;EPC1;RHNO1;LARGE1;TOP1MT;EIF4G1;RPS10;RPL18A;NFKBIB;MRPS16;TOPBP1;MCM2;BRIP1;RPL37A;POLR2G;MRPL34;RPS9;MRPS15;RNPS1;RPS27;RAD9A;DNA2;ABCF1;DTX1;RPS3;POLR3A;RBBP8;GTPBP2;RPL23A;RPS16;RPL9;COPS5;MED20;ATM;CHEK1;MMS19;RFC3;TIPIN;NBN;POLR2I;RPLP2;XAB2;MRPL51;SET;RPL41;TOPORS;INHA;RPLP0;CDC45;RPL7A;RPL19;RPS15;RPL39
prerank,defense response to symbiont (GO:0140546),-0.5158705377253751,-1.9485236980941194,0.0,0.006959485429519554,0.225,42/92,22.63%,PTPRC;LYST;LILRB1;TLR8;SAMHD1;CGAS;FLNA;IRF2;TLR7;RNASEL;ATG7;NLRC5;BCL2;IFNAR2;RSAD2;ABCE1;EXOSC5;EIF2AK2;MYD88;BST2;IFITM2;RELA;MOV10;RNASE6;IFIT1;OASL;IFIT2;OAS3;CD40;MAVS;ISG15;G3BP1;BNIP3L;SKP2;MLKL;TTC4;OAS2;SERINC3;STAT1;EXOSC4;IFITM1;IL6
prerank,Fc receptor signaling pathway (GO:0038093),-0.4999857495219068,-1.9479683305444782,0.0,0.0068991405787743095,0.228,37/110,14.72%,LYN;VAV3;GRB2;GAB2;SYK;PLCG2;PAK2;JUN;RAC1;MAP3K1;PSME4;VAV1;GRAP2;MALT1;TAB2;PSMB7;TEC;CARD11;PSME3;NFKB1;FBXW11;PSMB9;PIK3CB;NFATC3;VAV2;PSMA8;RELA;PSMC3;PIK3CA;PSMD8;ITK;FCER1G;PSMC4;PSMB10;LCP2;PSMA1;IKBKB
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.6228266519867546,1.9465573570582364,0.0,0.010169634201274529,0.551,7/30,3.31%,FGF12;ANK2;CACNA1C;RYR2;CACNA2D1;SCN2B;SCN1A
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.6972916136541967,-1.9464082139351677,0.0,0.006930707989008315,0.231,8/20,4.06%,BIRC3;SDCBP;NUPR1;OGT;PDCD6IP;RIPK1;PELI1;CFLAR
prerank,positive regulation of type I interferon production (GO:0032481),-0.5311580720990233,-1.9462893123937268,0.0,0.0068069453463474525,0.231,40/73,26.38%,TLR8;CREBBP;CGAS;GAPDH;TLR7;DHX58;RIOK3;TLR4;STAT6;DHX9;NFKB1;IRF5;PTPN22;CTNNB1;POLR2H;MYD88;POLR2F;POLR3G;POLR2L;RELA;XRCC6;OAS3;DHX36;MAVS;POLR3B;ISG15;G3BP1;POLR3A;PTPN11;DDX3X;OAS2;STAT1;LRRFIP1;RNF135;PRKDC;TOMM70;POLR3GL;POLR3D;MRE11;POLR1C
prerank,sensory perception of smell (GO:0007608),0.7984637874033111,1.9447220549716293,0.0,0.010328303486372425,0.567,5/11,14.27%,SLC24A4;SYT10;ADCY3;UBR3;MKKS
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.5004705609408308,-1.9433598748485599,0.0,0.007120374783461389,0.243,37/109,14.72%,LYN;VAV3;GRB2;GAB2;SYK;PLCG2;PAK2;JUN;RAC1;MAP3K1;PSME4;VAV1;GRAP2;MALT1;TAB2;PSMB7;TEC;CARD11;PSME3;NFKB1;FBXW11;PSMB9;PIK3CB;NFATC3;VAV2;PSMA8;RELA;PSMC3;PIK3CA;PSMD8;ITK;FCER1G;PSMC4;PSMB10;LCP2;PSMA1;IKBKB
prerank,bone development (GO:0060348),-0.5922092098343117,-1.9380442065617105,0.0,0.007635689612932105,0.264,11/39,10.16%,PTPRC;AKAP13;SH3PXD2B;SLC10A7;MBTPS2;PTGER4;DYM;LRP6;SKI;SULF2;TGM2
prerank,regulation of interleukin-8 production (GO:0032677),-0.5339957136706098,-1.9364559504503127,0.0,0.007631724144552791,0.267,26/69,19.36%,PTPRC;CD74;SYK;TLR8;ANXA4;TLR7;RIPK1;STAT3;TLR4;RAB1A;PTPN22;ANXA1;ARRB1;MAP2K5;MYD88;NOD1;AFAP1L2;RELA;CD2;SERPINE1;TMSB4X;MAVS;HSPA1A;LGALS9;NOD2;HMGB1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7125979734689096,1.934643442820854,0.0022988505747126436,0.01178438888555206,0.612,8/16,13.07%,ANK2;CACNA1C;DMD;RYR2;CASQ2;CALM1;CALM3;CALM2
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.5454964646930341,-1.9293500695134451,0.0,0.008614787788926463,0.3,23/62,15.14%,LYN;RUNX1;PRKCB;CDK6;CNOT4;CREBBP;FES;SPI1;CTR9;HSPA9;PTK2B;PF4;PRMT1;WDR5;KMT2C;CBFB;MEF2C;MOV10;NFE2;KMT2D;TNRC6C;SIN3A;PRMT6
prerank,plasma membrane invagination (GO:0099024),-0.6361436144736735,-1.9281622309278983,0.0,0.008635348141644664,0.304,13/29,12.80%,MSR1;ARHGAP25;MYH9;CD36;ITGB2;SNX9;RHOA;CDC42;SNX33;SH3BP1;ARHGAP12;SNX18;FCGR2B
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5997842525983069,-1.927935459320941,0.0,0.008535862563975948,0.305,18/38,23.45%,SP100;ARHGEF2;RIPK1;BRCA1;CFLAR;SERPINE1;TRAF2;RNF34;TNFSF10;STX4;CASP8;TRADD;DDX3X;TMC8;GSK3B;SFRP1;FEM1B;HMOX1
prerank,fatty acid transport (GO:0015908),-0.7193183705913202,-1.927626565674196,0.0,0.008419953970311124,0.306,7/17,10.36%,APOE;CD36;PPARD;FABP5;PPARG;SLC27A1;FABP4
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.6555107177860742,-1.9257132055301671,0.0,0.00861607281097135,0.317,10/25,11.72%,RBPJ;BCAR3;CBL;ARAP1;DGKD;HIP1;PLAUR;AFAP1L2;AGT;CCDC88A
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.57647256604345,-1.9251494941121168,0.0,0.008559432993146689,0.32,18/47,14.18%,PID1;GRB2;SYK;PLCG2;XDH;CYBA;PRKCD;CD36;ITGB2;RIPK1;RNF41;TLR4;MAPK14;AGT;GADD45A;CBR1;TGFBR2;SLC5A3
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5411248688369779,1.9191460698493021,0.0,0.01473654554178456,0.697,21/57,15.71%,GRM7;CHRM2;CHRM3;ADCY2;GRM8;ADCY8;GPR37;P2RY12;ADCY5;HRH3;GNAI1;GABBR1;ADCY3;ADCY1;CORT;NPY1R;HTR1B;GNAL;OPRK1;OPRL1;OPRM1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.7360938236942594,1.9189220096881163,0.0023752969121140144,0.014533634042830696,0.698,8/15,11.25%,GRM7;GRM5;GRM8;GRM1;GRM3;HOMER1;TRPM1;HOMER3
prerank,superoxide metabolic process (GO:0006801),-0.6322271933369342,-1.918645557849602,0.0,0.00928954118267835,0.345,10/29,14.89%,CYBB;SH3PXD2B;CYBA;NRROS;ATP7A;NCF1;NCF4;PRDX1;NCF2;PRDX2
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.6006734906373006,-1.9160401820623798,0.0,0.0095743732060879,0.359,18/38,16.99%,SASH1;TLR8;CYBA;DHX58;RIOK3;DHX9;DDX60;IFI35;GRN;PUM2;GBP5;POLR3G;LY96;ADAM8;OASL;CCL5;POLR3B;ZCCHC3
prerank,calcium ion transport into cytosol (GO:0060402),0.6451243729060615,1.9149618105567965,0.0,0.015029038380765252,0.718,11/21,17.38%,GRIN2A;CACNA1C;RYR2;GRIN2B;CACNA2D1;TRPM1;JPH4;ADRA1A;ATP2B4;JPH3;TRPM2
prerank,regulation of cellular component size (GO:0032535),-0.6328487876248673,-1.9144038104986998,0.0,0.009633129964733858,0.367,12/30,10.78%,VAV3;MSN;RIN3;RAC1;EPS8;VAV1;RARG;PICALM;PPP1CA;VAV2;HP1BP3;MTPN
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.41160763501223424,-1.9143339487553235,0.0,0.009493519385534816,0.367,198/532,24.61%,F13A1;CD44;MAP3K8;MSN;SP100;GRB2;BIRC3;CCR2;GAB2;SYK;VIM;PAK2;BCL6;MCL1;SAMHD1;PRKCD;CBL;CD36;ITGB2;RAP1B;PTPRJ;PITPNA;TNFRSF1B;BCL2L11;CSF2RA;CANX;ANXA2;IRF2;PSME4;VAV1;GRAP2;CD300LF;RNASEL;RIPK1;IRAK2;TRAF5;SPI1;IL10RB;IL6R;ABL2;CTR9;STAT3;FOXO3;TAB2;IL15;CCR1;PELI1;PSMB7;TEC;SLC27A1;CDC42;IL18;STAT6;PSME3;HSPA9;ITGB1;PIM1;PTK2B;NFKB1;ADIPOR1;FBXW11;BCL2;IRF5;IFNAR2;IRAK4;AIM2;ANXA1;IL17RA;PSMB9;CIITA;STX3;BATF;RSAD2;PF4;PIK3CB;TRAF3;FN1;HGF;IFI35;IRAK3;IL18RAP;STAT5B;HNRNPDL;STAT4;VEGFA;MYD88;BST2;B2M;JAK1;IFITM2;LMNB1;NOD1;HIF1A;PTPN6;PSMA8;UBC;RPS27A;LCP1;GBP2;EGR1;CD27;TNIP2;RELA;IFNGR2;TRAF1;PSMC3;LCK;ITGAX;IL2RG;IL7R;IL4R;IFNAR1;CRK;IFIT1;HSP90B1;PIK3CA;IL20RA;CSF2RB;PSMD8;OASL;CCL5;IFIT2;TRIM68;CAPZA1;FCER1G;CASP1;OAS3;TRAF2;PSMC4;PSMB10;SOCS6;PIK3CD;MT2A;CNTFR;PSMA1;CD40;TMSB4X;IKBKB;IL34;CRKL;IL31RA;APPL2;IL27RA;ISG15;PSMB8;IL2RB;IL18R1;STX4;IRS2;TNFRSF25;LIMS1;GATA3;HCK;SOCS3;CFL1;PTPN11;TRADD;IL1R2;NOD2;IL7;CSF1;PSMA5;PSMD4;OAS2;SLA;PSMB3;APPL1;MMP2;PSMD3;MMP1;STAT1;TRIM25;PLP2;IFITM1;SOCS5;RPS6KA5;RPLP0;TNFSF9;ILK;IL6;GSTO1;CNN2;IFNGR1;TYK2;MTAP;P4HB;TGFB1;HMOX1;GREM2;IL2RA;MAP3K3;CCL7;PSMB1;FLT3;ITGAM;SHC1;TNFRSF13B;MYC
prerank,response to alcohol (GO:0097305),0.6212251446446189,1.9110295843462926,0.0,0.01566803513356403,0.737,6/27,1.86%,GRIN2A;GRIN2B;SLIT3;SLIT2;GRIN3A;GLRA1
prerank,myeloid leukocyte differentiation (GO:0002573),-0.5271736570067556,-1.9102113114084467,0.0,0.010009954580518714,0.385,27/65,19.75%,FOXP1;RUNX1;SNX10;GAB2;MYH9;DEK;SBNO2;PPARG;SPI1;IL15;CDC42;MT1G;MAPK14;BATF;CBFA2T3;VEGFA;E2F1;PIK3CD;RXRA;TGFBR2;BATF3;IL31RA;CASP8;RARA;OSTM1;LGALS9;CSF1
prerank,protein localization to synapse (GO:0035418),0.7698220006604364,1.9089753863972478,0.0,0.015820897507152584,0.746,4/12,4.05%,NLGN1;NRXN1;PCLO;NRXN2
prerank,sodium ion transport (GO:0006814),0.48531602628295056,1.903964668757178,0.0,0.01667039397428541,0.769,27/85,10.58%,ASIC2;SLC24A4;SLC24A2;SLC8A3;SLC12A2;NALCN;SLC4A4;SCN2A;SLC24A3;SCN2B;SCN1A;SLC9B2;SLC6A16;SCN3A;SLC6A15;SLC12A1;SLC6A17;SCN9A;HCN2;SLC6A1;SLC8A2;SLC6A13;SLC5A10;SLC6A2;SLC4A11;ATP1B1;HCN1
prerank,regulation of necroptotic process (GO:0060544),-0.6677432071610393,-1.9031047156819982,0.0,0.011102590467828855,0.428,12/23,17.71%,BIRC3;SDCBP;OGT;PDCD6IP;ARHGEF2;RIPK1;PELI1;CFLAR;FLOT2;SLC25A4;CASP8;MLKL
prerank,mitotic sister chromatid segregation (GO:0000070),-0.49891411597332874,-1.902966085905214,0.0,0.010948387822442344,0.428,52/98,25.37%,RB1;PDCD6IP;EML4;CSNK2A1;NCAPG2;PIBF1;CHMP5;NIPBL;DLGAP5;KIF23;SMC4;NCAPH;KLHL22;MCPH1;CENPE;CENPK;KIFC1;KIF14;CHMP7;NAA50;CDK1;CHMP1A;KNSTRN;CHMP2A;NUSAP1;KIF2C;INO80;POGZ;SGO1;NCAPD3;KMT5A;NDC80;CEP55;KIF18B;PHF13;PRC1;SMC1A;RAB11A;VPS4A;KIF22;PDS5B;NCAPG;NUP62;SET;CHMP4B;CHMP4A;BECN1;NSL1;CCNB1;AKAP8L;CHMP2B;NUDC
prerank,central nervous system neuron differentiation (GO:0021953),0.595467455553605,1.9022567742387249,0.0,0.01680483263536836,0.782,7/33,6.94%,MDGA2;GRID2;SPOCK1;MAP2;NTRK2;KNDC1;TOX
prerank,cellular response to cadmium ion (GO:0071276),-0.6478575170365859,-1.8970286296569938,0.0,0.012251717030709161,0.465,11/24,13.43%,JUN;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;NCF1;MT2A
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.6558443225831222,1.8937789976869026,0.00228310502283105,0.01824257942750543,0.812,9/20,13.07%,ANK2;CACNA1C;DMD;RYR2;CASQ2;ATP1B1;CALM1;CALM3;CALM2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.624464341854274,1.8927457170398831,0.002551020408163265,0.018241300520912176,0.814,9/24,15.15%,AKAP6;DMD;PDE4D;CASQ2;JPH4;CALM1;CALM3;CALM2;JPH3
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.7484881609507319,1.8926273665166158,0.0,0.018012963846451596,0.814,5/13,5.21%,ANK2;CACNA1C;KCNN2;CACNB2;KCNJ3
prerank,response to cadmium ion (GO:0046686),-0.6349576084953658,-1.8920660991978298,0.0,0.013119727775047009,0.499,9/26,4.19%,JUN;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.682137182512288,1.891647921994076,0.004576659038901602,0.017969967698087234,0.815,6/17,6.48%,ANK2;CACNA1C;CACNA2D1;CACNB2;SCN2B;HCN2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.45992710485844324,-1.890030600350549,0.0,0.01335600512574375,0.51,66/158,23.88%,AKAP13;PRKCB;CD74;BIRC3;REL;LITAF;RHOA;GAPDH;FLNA;BRD4;MALT1;RIPK1;ALPK1;TRAF5;HTR2B;TAB2;PELI1;CFLAR;CARD11;IRAK4;RNF31;TFG;RBCK1;PLK2;MYD88;WLS;BST2;NEK6;NOD1;TNIP2;RELA;PLEKHG5;TICAM1;CLEC6A;JMJD8;TRIM68;LGALS1;CASP1;TRAF2;DHX36;CD40;IKBKB;MAVS;DDX1;TRIM14;TNFSF10;GPRC5B;CASP8;TRADD;MIER1;LGALS9;SHISA5;NDFIP2;NOD2;TMED4;TICAM2;S100A4;TRIM25;NUP62;TMEM106A;ZDHHC13;TMEM9B;MTDH;HMOX1;PIM2;MAP3K3
prerank,sodium ion transmembrane transport (GO:0035725),0.4899171255400584,1.8875193810939,0.0,0.01885679114663439,0.833,26/84,10.58%,ASIC2;SLC24A4;SLC24A2;SLC8A3;SLC12A2;NALCN;SLC4A4;SCN2A;SLC24A3;SCN2B;SCN1A;SLC6A16;SCN3A;SLC6A15;SLC12A1;SLC6A17;SLC9A2;SCN9A;HCN2;ATP1A3;SLC6A1;SLC8A2;SLC6A13;SLC6A2;ATP1B1;HCN1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.5931811304494747,1.8819146354703387,0.002331002331002331,0.01974676956945622,0.851,11/32,9.10%,ADGRB3;PTPRD;HECW1;IL1RAPL1;CDKL5;HECW2;LZTS1;CUX2;KNDC1;NEDD4;CAPRIN2
prerank,positive regulation of response to external stimulus (GO:0032103),-0.4718482524291464,-1.8808831825076087,0.0,0.015257945964560121,0.558,41/128,18.62%,SASH1;CCR2;TLR8;CYBA;OPTN;TLR7;RIPK1;DHX58;IL15;RIOK3;TLR4;IL18;DHX9;PTGER4;IL17RA;STX3;DDX60;IFI35;GRN;PUM2;GBP5;MDK;POLR3G;ABCC1;LY96;ADAM8;NFKBIZ;LPL;AGT;APP;OASL;CCL5;SERPINE1;PLA2G7;POLR3B;GPRC5B;ZCCHC3;STX4;LILRA5;PDGFRB;TRADD
prerank,regulation of platelet activation (GO:0010543),-0.67152354128992,-1.8764790335752828,0.001644736842105263,0.01624534882305694,0.584,9/21,14.93%,LYN;APOE;SYK;PLEK;TEC;TLR4;FCER1G;PLA2G4A;TXK
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.5674049396320745,-1.8762853722338655,0.0,0.016131969055819703,0.588,20/42,21.40%,ARID2;PPP4C;PPP4R2;ACTR2;CGAS;SPIDR;ERCC6;RTEL1;FUS;WDR48;RAD51;TIMELESS;RADX;RAD51AP1;UBQLN4;WRAP53;SHLD2;CHEK1;MMS19;KDM1A
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.7475423918418539,1.872476902315559,0.002183406113537118,0.02192384319198826,0.872,8/12,13.01%,RIMS2;RIMS1;SYT1;UNC13C;SYT2;SYT5;UNC13B;SYT7
prerank,positive regulation of cell junction assembly (GO:1901890),0.5235764825327516,1.8715248274615315,0.0,0.02185053681398782,0.875,13/56,7.07%,CNTNAP2;NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;SYNDIG1;CLSTN2;EPHB1;TSC1;CUX2;CLSTN1;BDNF
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5616956640411974,1.8705143511157143,0.0,0.021821075177025813,0.88,16/41,13.03%,AKAP6;ANK3;ANK2;KCNN2;KCNMB3;KCNMB2;KCNJ3;KCNJ10;KCNJ6;KCNJ9;GABBR1;KCNJ16;PIRT;STAC;KCNMA1;KCNJ12
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5670213850532543,1.8704078960179271,0.0,0.02158487391831758,0.88,12/39,8.69%,FGF14;HECW1;FGF12;ANK3;DMD;PRKCE;HECW2;SCN2B;PTPN3;NETO1;NEDD4;FXYD6
prerank,regulation of cytokine production (GO:0001817),-0.47195041810832344,-1.8682497649913878,0.0,0.018301316495492853,0.647,34/126,14.93%,LYN;PTPRC;ATP2B1;FOXP1;FGR;CCR2;BCL6;TNFRSF1B;GAPDH;PLD3;MAPKAPK2;HTR2B;IL15;SRGN;PTGER4;ANXA1;MAPK14;BATF;TRAF3;PIK3CG;EIF2AK2;SIRPA;CD28;CLEC9A;AFAP1L2;AGT;CLEC6A;ITK;FCGR2B;PIK3CD;MAST2;NFAM1;AGPAT1;TXK
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.6170517245503631,1.8662269354548475,0.0,0.022297143789366796,0.89,7/25,11.21%,AKAP6;ANK2;TRPC1;CACNB2;RAMP3;NPSR1;CAPN3
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.48835122866575803,-1.8656607374057796,0.0,0.018658520091767935,0.66,49/95,26.01%,NSMCE2;ZFYVE26;SAMHD1;SPIDR;RAD51B;BRCA1;NIPBL;NABP1;BLM;MORF4L1;MCM6;RAD51;RFWD3;NUCKS1;MCM9;AP5Z1;MCM3;GEN1;WRN;RAD54L;FEN1;RPA3;ERCC4;RAD51AP1;YY1;INO80;RAD54B;RAD52;LIG3;SLX4;MCM2;XRCC3;RBBP8;POLN;NBN;FAN1;SMC6;GINS4;PALB2;CDC45;MMS22L;SMC5;MCM5;RAD51C;RECQL5;AP5S1;UBE2N;XRCC1;MRE11
prerank,lysosome localization (GO:0032418),-0.5769266100281348,-1.8646648846570053,0.0,0.01868707613720988,0.667,16/37,17.80%,TFEB;PLEKHM1;PLEKHM2;MYH9;ARL8B;MILR1;PIK3CG;BORCS6;PIP4P1;CHGA;KXD1;FLCN;PIK3CD;SPAG9;RAB34;VPS33A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.5103147625230409,-1.864345310081681,0.0,0.018519361606906936,0.669,29/70,20.83%,CYBB;CYBA;CD36;PSME4;PSMB7;PSME3;ITGAV;LNPEP;PSMB9;TAPBP;B2M;PSMA8;ITGB5;PSMC3;NCF1;TAP2;NCF4;PSMD8;NCF2;FCER1G;PSMC4;PSMB10;PSMA1;IKBKB;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3
prerank,response to exogenous dsRNA (GO:0043330),-0.6918299247493814,-1.863079169857487,0.0,0.018682672313334498,0.675,9/18,17.46%,RFTN1;CGAS;DHX9;IRAK3;IFIT1;TICAM1;MAVS;ZCCHC3;RALB
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.7048482412506509,-1.8614394508287568,0.0,0.018988954331881892,0.682,10/15,22.63%,STAT3;TLR4;IL17RA;GBP5;MYD88;HIF1A;TICAM1;NOD2;APPL1;IL6
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5911497114079178,-1.8613010333964477,0.0,0.018809094439615943,0.682,20/36,20.02%,CD74;AXL;CD300LF;RIPK1;PARP14;NLRC5;GAS6;LAPTM5;CASP4;PARP9;HIF1A;CASP1;AGPAT1;TXK;MAVS;CXCR4;HSPA1A;IL7;CSF1;TICAM2
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.6796679296385069,-1.8569841060025167,0.0,0.01995310509140819,0.71,10/19,16.92%,RUNX1;ELF1;IRAK2;DHX9;MAP2K5;CBFB;PARP9;MAPK7;MAVS;TAF9
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.5768722474841393,-1.855409060151598,0.0,0.020205863878232592,0.722,19/37,23.13%,ADCY7;PLD3;ABCD2;STAT3;TLR4;IL17RA;MAPK14;SIRPA;GBP5;MYD88;HIF1A;TICAM1;NLRC3;APPL2;NOD2;APPL1;ZC3H12A;IL6;MEFV
prerank,negative regulation of lipid storage (GO:0010888),-0.6723014120280756,-1.8547955891259722,0.0018083182640144665,0.02006036232255441,0.722,9/19,12.50%,OSBPL8;ABCA1;ABCG1;PPARD;PPARG;ITGAV;NR1H2;ABHD5;TTC39B
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.6388964328703024,-1.8527231345247657,0.001697792869269949,0.020347818735047134,0.732,13/23,22.98%,PPARG;PIAS1;PARP14;NLRC5;NR1H2;JAK1;PARP9;IFNGR2;HSP90AB1;TXK;SOCS3;STAT1;IFNGR1
prerank,regulation of interleukin-10 production (GO:0032653),-0.563851897837652,-1.8519347850769872,0.0,0.020327335387395295,0.733,21/44,23.76%,LILRB1;SYK;PLCG2;STAT3;PIBF1;TLR4;TNFRSF21;CD28;TRIB2;CD46;FCGR2B;ISG15;LILRA5;MMP8;LGALS9;NOD2;HMGB1;AGER;CD274;IL6;CD47
prerank,cell differentiation in spinal cord (GO:0021515),0.802191370109724,1.8518976182592979,0.0,0.02598067619000564,0.928,3/10,4.35%,MDGA2;SOX6;SOX13
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.5584997538155086,1.8517598679040184,0.0,0.025727398534623462,0.928,8/38,5.21%,ANK2;CTNNA3;CACNA1C;CACNA2D1;KCND3;CACNB2;SCN2B;KCNJ3
prerank,positive regulation of immune effector process (GO:0002699),-0.6245273517010402,-1.850757830000584,0.003436426116838488,0.020415752435348294,0.738,12/27,19.28%,PTPRC;CCR2;LILRB1;PTPRJ;DHX58;DDX60;XBP1;CD46;APPL2;MYB;LGALS9;PLA2G5
prerank,phospholipid transport (GO:0015914),-0.533837054677897,-1.846009598510209,0.0,0.021735868536655278,0.76,14/52,11.01%,OSBPL8;APOE;ABCA1;ATP8B4;ABCG1;PLTP;PITPNC1;PITPNA;PITPNM1;ATP11C;OSBPL5;ABCC1;PRELID2;NPC2
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.5877116330152659,-1.8446152210484121,0.003215434083601286,0.02196641554925279,0.765,14/35,13.27%,LYN;CDK6;SPI1;STAT3;FOXO3;HSPA9;MAPK14;STAT5B;PRMT1;HIF1A;NCKAP1L;ARNT;HMGB2;ACVR2A
prerank,positive regulation of B cell proliferation (GO:0030890),-0.6140282460065593,-1.8439261375055296,0.0016666666666666668,0.02195583197716037,0.769,13/29,19.53%,PTPRC;VAV3;CD38;CD74;SASH3;BCL2;MEF2C;NCKAP1L;CD40;BST1;CHRNB2;IRS2;IL7
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.5133033701077926,-1.8437062017990782,0.0,0.021815616357839154,0.77,31/66,23.13%,FOXP1;IGF1;P2RX7;TLR8;CD36;USP50;MALT1;STAT3;TLR4;NLRC4;AIM2;PANX1;SIRPA;GBP5;MYD88;LPL;EGR1;APP;CASP1;CASP8;LILRA5;TRIM16;LGALS9;HSPB1;NOD2;AGER;ZC3H12A;TMEM106A;NLRP3;IL6;MEFV
prerank,natural killer cell mediated immunity (GO:0002228),-0.7213570635714814,-1.8414435396374906,0.0017301038062283738,0.02229513247879984,0.785,7/15,14.18%,LYST;SLAMF7;PLEKHM2;ARL8B;RAET1E;CEBPG;ULBP1
prerank,lymphocyte differentiation (GO:0030098),-0.5122512724612992,-1.8401069495050355,0.0,0.022510406790443385,0.793,32/68,26.18%,ITGA4;PTPRC;PLCG2;TPD52;AXL;PTPRJ;IKZF1;LYL1;ITGB1;BLNK;HHEX;PTPN22;KLF6;CEBPG;DNAJB9;LCK;KAT7;HDAC5;PIK3CD;NFAM1;TCF3;RELB;ZAP70;GATA3;CD79A;ZBTB7A;CHD7;RABL3;FLT3;DCAF1;MS4A1;GPS2
prerank,receptor clustering (GO:0043113),0.6084521607219291,1.8393151624814625,0.0044444444444444444,0.029260179176876674,0.95,8/27,4.17%,NLGN1;DLG2;NRXN1;MAGI2;LRRC7;DLG3;NRXN2;PTN
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.7720045463241999,1.8388631606359473,0.004301075268817204,0.02904500375489712,0.95,7/10,19.75%,GNB5;FMR1;CALM1;CALM3;CBARP;CRHR1;GPR35
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.6678065068563375,-1.8387667322706198,0.0,0.02282199151720376,0.799,13/20,23.13%,C3AR1;P2RX7;ANO6;P2RX4;PSTPIP1;IL18;C3;APP;HSP90AB1;CASP1;TXNIP;NLRP3;MEFV
prerank,negative regulation of type I interferon production (GO:0032480),-0.5741101859369172,-1.8352054581980588,0.0017482517482517483,0.023974617351405964,0.812,21/40,21.85%,LILRB1;REL;OTUD5;DHX58;NLRC5;PPM1B;SIRPA;UBA7;PIN1;PCBP2;NLRC3;YY1;RELB;RNF216;MAVS;NLRX1;ISG15;GPATCH3;RNF125;TRIM25;RNF135
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6915795548876683,1.8352040422200588,0.002421307506053269,0.029870107111877733,0.956,11/15,20.37%,SCN1A;COL11A1;TMC1;KCNA1;ADGRV1;WHRN;PDZD7;MKKS;TMC2;TMEM120A;KIT
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.6321822953575785,-1.8338535041301798,0.0,0.024228319643128743,0.815,7/24,4.47%,ITGA4;MSN;SYK;ROCK1;ITGB2;ITGAL;ITGB1
prerank,positive regulation of inflammatory response (GO:0050729),-0.48391164330170927,-1.8337375476556739,0.0,0.024025077502991588,0.816,27/86,18.62%,CCR2;NUPR1;TLR7;RIPK1;IL15;TLR4;IL18;DHX9;PTGER4;IL17RA;IFI35;GRN;MDK;ABCC1;ADAM8;NFKBIZ;LPL;AGT;APP;SERPINE1;PLA2G7;KARS1;GPRC5B;LILRA5;SNX4;MMP8;TRADD
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.5410839166292353,-1.8315393495485879,0.001692047377326565,0.024672423261841894,0.825,19/49,19.36%,CD74;SYK;TLR8;TLR7;RIPK1;STAT3;TLR4;RAB1A;MYD88;NOD1;AFAP1L2;RELA;CD2;SERPINE1;MAVS;HSPA1A;LGALS9;NOD2;HMGB1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.766444939605057,1.828249503161627,0.0,0.03181460360286782,0.968,6/10,7.52%,GABRG3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2
prerank,DNA replication (GO:0006260),-0.46708912405588654,-1.8267687991364496,0.0,0.02620546703733499,0.843,49/105,26.01%,FAM111A;RBMS1;TOP3A;BRCA1;POLE2;RFC1;BLM;RAD1;MCM6;PCLAF;MCM9;MCM3;DBF4;TIMELESS;WRN;CDK1;ORC5;EXO1;FEN1;KAT7;BAZ1A;TICRR;RPA3;RFC2;DUT;POLD2;RHNO1;MCMBP;TOP1MT;TOPBP1;MCM2;BRIP1;RAD9A;DNA2;RBBP8;ATM;CHEK1;RFC3;TIPIN;NBN;SET;POLB;POLG2;CDC45;MCM5;POLD4;CDK2AP1;RECQL5;MRE11
prerank,ventricular septum morphogenesis (GO:0060412),0.5993806570528396,1.8267446153457074,0.0024691358024691358,0.03197072204292775,0.968,7/27,5.01%,ROBO1;ROBO2;SOX11;SLIT3;SLIT2;ZFPM2;ACVR1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.6642459442370696,-1.8264862525555823,0.0035460992907801418,0.026024661844462078,0.844,8/21,13.54%,APOE;PLTP;LRP1;EEPD1;PPARG;NR1H2;ZDHHC8;RXRA
prerank,regulation of inflammatory response (GO:0050727),-0.43387476157114163,-1.8243781319541643,0.0,0.026552226938934616,0.851,50/190,13.02%,APOE;FOXP1;AOAH;BIRC3;CCR2;MFHAS1;BCL6;PRKCD;RB1;TNFRSF1B;PPARD;METRNL;PIK3AP1;SBNO2;BRD4;TLR7;PPARG;USP18;RIPK1;IL15;AREL1;TLR4;IL18;DHX9;SNX6;TNFAIP8L2;PTGER4;ANXA1;IL17RA;IFI35;GRN;SIRPA;MDK;MYD88;CASP4;ABCC1;DAGLB;MAPK7;OTULIN;SELENOS;NFKBIZ;LPL;RELA;AGT;APP;CELF1;CCL5;NLRC3;SERPINE1;CASP1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.6549271401382786,-1.8237392461989042,0.0,0.02658104468398438,0.855,13/21,18.15%,PTPRC;PRKCH;FOXP1;PRKCB;CARD11;STAP1;RELA;LCK;RAB29;NFAM1;CD226;TESPA1;RPS3
prerank,androgen receptor signaling pathway (GO:0030521),-0.763295449343967,-1.8225726052448519,0.005050505050505051,0.026805319665318884,0.858,5/11,9.07%,ZMIZ1;KDM3A;PMEPA1;ARID1A;DDX5
prerank,mesonephric tubule development (GO:0072164),0.692442306077351,1.822187574813691,0.002631578947368421,0.03337066320658926,0.976,6/15,11.28%,ROBO2;SLIT2;WT1;BMP7;SALL1;PKD1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.46905550299604204,1.8211301707441898,0.0,0.03338806308213845,0.976,32/75,18.79%,CTNNA2;MAP2;ANK3;MAP1B;CNTN4;DCC;PARD3;PLPPR4;NTNG2;NTNG1;PAK3;SLITRK1;NEFH;NRCAM;DCDC2;DSCAML1;SPTBN4;CDHR1;MFSD2A;SLITRK3;BRSK1;SLITRK5;SDC2;BTBD3;KLF7;ZDHHC17;RAB3A;MAP1A;DOCK7;ADGRB1;CELSR2;S100B
prerank,long-term synaptic potentiation (GO:0060291),0.6309194927874647,1.8208334166483615,0.004608294930875576,0.03314935898550706,0.977,9/21,9.50%,MPP2;GRIN2A;GRIN2B;SLC24A2;SLC8A3;PRKCZ;TSHZ3;SLC8A2;NFATC4
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.6783814517738034,-1.8199930120412642,0.0,0.02731100186067777,0.865,11/18,23.36%,BIRC3;DHX58;DDX60;PUM2;OASL;SEC14L1;ZCCHC3;GPATCH3;C1QBP;RNF125;PUM1
prerank,T cell activation (GO:0042110),-0.5078898925991231,-1.8197822760743925,0.0,0.027117030337327153,0.865,38/69,33.43%,PTPRC;CD44;MSN;CD74;KIF13B;DPP4;PTPN22;PIK3CG;MDK;CD28;JAML;LCP1;SCRIB;LCK;RAB29;CD2;ITK;CXADR;NLRC3;PIK3CD;CASP8;ZAP70;GATA3;CD3E;CHD7;DDOST;NCK1;CRTAM;IL2;LAT;CD8B;NCK2;ADA;CD4;CCL19;CD8A;IRF4;SLA2
prerank,negative regulation of programmed cell death (GO:0043069),-0.4041415469954529,-1.8185187368903568,0.0,0.027319101393566754,0.869,152/355,29.31%,DAB2;CD44;IGF1;NOTCH2;CD38;CD74;ARHGAP10;BIRC3;TNFAIP8;PAK2;MCL1;AXL;CBL;RAB7A;NIBAN2;BFAR;BIRC6;NUPR1;ANXA4;FLNA;IGF1R;SON;MALT1;RIPK1;HTR2B;AREL1;CFLAR;HSPA9;PIM1;PTK2B;NFKB1;ANXA5;BCL2;ANXA1;HGF;CTNNB1;GAS6;GRK5;HIGD2A;WFS1;PLK2;BABAM2;VEGFA;LAPTM5;MYD88;DNAJA1;PLAUR;CD28;ATAD3A;ZFAND6;CTSH;SERPINB9;UBC;RPS27A;MGMT;PRDX5;NCKAP1L;CD27;TPT1;SPRY2;RELA;KIF14;XBP1;TXNDC5;CDK1;WDR73;OSR1;HSP90B1;HTATIP2;TMBIM6;CIB1;PLK3;AVEN;GREM1;GPX4;IKBKB;PRDX2;RASA1;AATF;BAG3;IL31RA;ANKLE2;CLN3;BID;BNIP2;IL2RB;STIL;TAF9;DNAJC3;VHL;BNIP3L;HSPA1A;ATF5;HCK;API5;CFL1;THOC6;HSPB1;CASP2;DDX3X;COPS5;IL7;NAA16;GSK3B;CAT;SFRP1;PPT1;KDR;NUP62;HAX1;HNRNPK;HYPK;BCL2L2;MAP4K4;UFM1;TOPORS;NR1H4;IL6;TCIM;CRYAB;PRKDC;MTDH;PIM2;FANK1;LRP2;SHC1;MYC;PKHD1;VDAC1;PSEN2;TMEM14A;MT3;MRE11;SIAH2;VIP;RPS6KA3;HIPK3;PDPN;HIGD1A;NAA38;APIP;FFAR4;BCL2L1;CITED2;AQP1;GHRL;LEF1;PRELID1;RIPK3;BNIP3;RIPK2;IL2
prerank,regulation of RNA metabolic process (GO:0051252),-0.5185917347144533,-1.818374440521179,0.0,0.027161892996370087,0.87,23/59,15.03%,MBNL1;AHNAK;MITF;PTBP3;TNFRSF1B;MBNL2;SON;TRA2B;RC3H1;AHNAK2;FUS;HNRNPH1;MBNL3;USP36;HNRNPL;METTL4;PCBP2;CELF1;HNRNPLL;OASL;OAS3;ZNF326;RASA1
prerank,recombinational repair (GO:0000725),-0.4985864914893376,-1.8182725496298455,0.0,0.026941405043957714,0.87,42/77,26.01%,NSMCE2;ZFYVE26;SAMHD1;SPIDR;RAD51B;BRCA1;NABP1;BLM;MORF4L1;RAD51;RFWD3;NUCKS1;MCM9;AP5Z1;GEN1;WRN;FEN1;RPA3;ERCC4;RHNO1;RAD51AP1;YY1;INO80;RAD54B;RAD52;LIG3;SLX4;XRCC3;RBBP8;POLN;NBN;FAN1;SMC6;PALB2;MMS22L;SMC5;RAD51C;RECQL5;AP5S1;UBE2N;XRCC1;MRE11
prerank,regulation of apoptotic process (GO:0042981),-0.3807529233869132,-1.8158954758403916,0.0,0.02771826666452061,0.88,227/676,22.81%,DAB2;CD44;CTSB;VAV3;MAP3K5;AKAP13;APAF1;IGF1;NOTCH2;CD38;CD74;ABR;CTSD;ARHGAP10;BIRC3;ITSN1;LILRB1;TNFAIP8;DAPK1;PAK2;BCL6;MCL1;CRADD;AXL;CBL;JUN;ARHGEF3;DNM2;NIBAN2;BFAR;BIRC6;CREBBP;NUPR1;ANO6;BCL2L11;ANXA4;MAP3K20;CTNNBL1;FLNA;IGF1R;ARHGEF2;SON;CALHM2;VAV1;MALT1;RIPK1;HTR2B;SGK1;FOXO3;ANP32A;AREL1;CFLAR;FGD4;ATG7;NLRC4;HSPA9;ITGB1;RYBP;PIM1;PTK2B;NFKB1;ANXA5;TOP2A;RARG;PRMT2;BCL2;ANP32B;IRF5;STEAP3;DAPK3;ANXA1;RPS6;FGD3;STK3;HGF;CTNNB1;GAS6;ARHGEF18;USP36;GRK5;HIGD2A;ATF6;WFS1;PLK2;HIP1;BABAM2;NF2;VEGFA;NME1;E2F1;MYD88;DNAJA1;PLAUR;CD28;ATAD3A;VAV2;ZFAND6;PTPN6;MEF2C;SOS2;CTSH;SERPINB9;UBC;RPS27A;MGMT;PRDX5;NCKAP1L;SUDS3;TGM2;CD27;TPT1;SCRIB;SPRY2;RELA;PLEKHG5;KIF14;AGT;IKZF3;GNA13;XBP1;DUSP6;TXNDC5;FLCN;OSGIN1;WRN;PSENEN;CDK1;WDR73;OSR1;ARHGEF11;HSP90B1;GADD45A;MLLT11;TRIM24;IGFBP3;HTATIP2;EEF1E1;STK17B;TMBIM6;USP42;FBXO10;CIB1;IFIT2;PLK3;LGALS1;CASP1;TRAF2;AVEN;DFFA;TFAP4;GREM1;TRIO;IKBKB;PRDX2;RASA1;MAP3K10;AATF;BAG3;IL31RA;SHQ1;ANKLE2;QRICH1;LATS2;ARHGEF5;CLN3;FAF1;BID;KLF11;RABGGTA;BNIP2;TNFSF10;IL2RB;STIL;TAF9;SPHK2;DNAJC3;VHL;BNIP3L;SKP2;CASP8;HSPA1A;RNPS1;PHLDA1;TNFRSF25;ATF5;RPS3;HCK;API5;CFL1;THOC6;IFT57;TRADD;PDCD5;HSPB1;CASP2;DDX3X;RABGGTB;HMGB1;COPS5;IL7;ATM;NAA16;C1QBP;GSK3B;CAT;SFRP1;STAT1;PPT1;KDR;CDK5;RACK1;NUP62;HAX1;HNRNPK;ZBTB7A;HYPK;BCL2L2;MAP4K4;UFM1;TOPORS;TNFSF9;CD3E;NR1H4;IL6;TCIM;CRYAB;PRKDC
prerank,negative chemotaxis (GO:0050919),0.5683452037736922,1.8138598319527315,0.002457002457002457,0.03523593939674011,0.979,12/33,9.91%,ROBO1;UNC5C;SLIT3;SLIT2;SEMA6D;EPHA7;SEMA6A;SEMA3E;SLIT1;ITGB3;SEMA3F;LGR6
prerank,double-strand break repair (GO:0006302),-0.44052456388415856,-1.8129653916674329,0.0,0.028416571704209134,0.886,76/158,27.75%,NSMCE2;ZFYVE26;SAMHD1;SPIDR;RAD51B;SMARCA5;BRCA1;DCLRE1C;NABP1;BLM;ABRAXAS1;MORF4L1;BABAM2;KDM2A;RAD51;PARP9;RFWD3;NUCKS1;RNF8;MCM9;AP5Z1;APTX;GEN1;DCLRE1A;XRCC6;WRN;BABAM1;FEN1;CIB1;HMGB2;RPA3;XRCC4;ERCC4;APLF;RAD51AP1;YY1;INO80;RAD54B;RAD52;LIG3;SLX4;DDX1;BRIP1;XRCC3;EYA1;DNA2;EYA3;RBBP8;BRCC3;UBXN1;HMGB1;POLN;ATM;BAP1;DTX3L;NBN;FAN1;SMC6;POLB;PALB2;PRKDC;UBE2V2;MMS22L;DNTT;SMC5;RAD51C;RECQL5;BAZ1B;AP5S1;UBE2N;XRCC1;MRE11;DCLRE1B;VCP;UIMC1;RAD51AP2
prerank,regulation of exocytosis (GO:0017157),0.5238679707351108,1.8128319093937577,0.0024271844660194173,0.03527584654905196,0.98,11/46,5.14%,RIMS2;CADPS;IL1RAPL1;STXBP5L;SYT1;RAB3C;CPLX1;CADPS2;RAB15;CLASP2;RAB27B
prerank,DNA metabolic process (GO:0006259),-0.40908279502121386,-1.8124990888451848,0.0,0.028405468172764063,0.889,111/270,26.18%,SP100;SAMHD1;TOP3A;DDB2;BACH1;RAD51B;PSME4;BRCA1;UVRAG;POLE2;RFC1;NOC3L;TOP2A;NABP1;PARP4;BLM;RAD1;PRIMPOL;RTEL1;UHRF2;REXO4;PWWP3A;KMT5B;ALKBH1;MCM6;USP3;CNBP;NEIL3;RAD51;KMT5C;UBC;RPS27A;MGMT;MCM3;DBF4;GEN1;TIMELESS;LIG1;XRCC6;WRN;CDK1;DNASE1L1;PCNA;RAD54L;GADD45A;ORC5;EXO1;ASF1A;FEN1;HMGB2;TICRR;UHRF1;RPA3;RFC2;ENDOG;POLD2;ERCC4;RAD51AP1;DOT1L;INO80;TOP1MT;RAD52;UBE2T;NSMCE3;CDC34;LIG3;SLX4;TOPBP1;MCM2;USP7;PRIM1;XRCC3;LRWD1;RAD9A;DNA2;RBBP8;ADPRS;HMGB1;PRIM2;HMGB3;ATM;CHEK1;SMC1A;MMS19;RFC3;PDS5B;DMC1;NBN;ALKBH3;FAN1;POLB;CDC45;PRKDC;ZRANB3;UBE2V2;NUDT15;DNTT;EID3;MCM5;POLD4;RAD51C;DNASE2;DDB1;TRIM28;TSN;MPG;RECQL5;UBE2N;XRCC1;MRE11;DCLRE1B
prerank,positive regulation of chemokine production (GO:0032722),-0.5517778443518075,-1.8123474868581024,0.0017152658662092624,0.028256305433928413,0.889,21/44,23.45%,CD74;SYK;TLR7;IL6R;TLR4;IL18;IL17RA;EIF2AK2;HIF1A;LPL;EGR1;APP;OAS3;MAVS;LGALS9;DDX3X;HMGB1;IL7;AGER;IL6;HMOX1
prerank,T cell receptor signaling pathway (GO:0050852),-0.45143163829383554,-1.8110559383740858,0.0,0.02856307462236312,0.893,55/138,20.90%,RFTN1;PTPRC;PLCG2;PAK2;PTPRJ;THEMIS2;PSME4;GRAP2;MALT1;TAB2;PSMB7;TEC;CARD11;PSME3;RC3H1;NFKB1;FBXW11;PTPN22;RNF31;PSMB9;FYB1;RBCK1;PIK3CB;TNFRSF21;EIF2B3;CD28;PSMA8;NFKBIZ;RELA;PSMC3;LCK;PIK3CA;PSMD8;ITK;PSMC4;PSMB10;LCP2;PIK3CD;PSMA1;IKBKB;TXK;PSMB8;THEMIS;ZAP70;GATA3;PSMA5;DENND1B;PRAM1;PSMD4;NFKBID;PSMB3;EIF2B1;WNK1;PSMD3;ZC3H12A
prerank,inorganic anion transmembrane transport (GO:0098661),0.49657711625857986,1.8069488796100672,0.0,0.03699185895482349,0.983,21/63,13.02%,GABRB3;GABRB1;GABRG3;SLC12A2;GLRA1;GABRA2;ANO4;GABRA3;SLC12A8;SLC12A1;GABRA5;GABRB2;ANO3;GABRG2;ANO5;SLC1A1;SLC6A1;GLRA2;SLC25A11;SLC12A5;CLCN3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.49832790813335837,-1.805043829104631,0.0,0.030547805411483914,0.913,27/67,20.83%,CYBB;CYBA;CD36;PSME4;PSMB7;PSME3;ITGAV;PSMB9;TAPBP;B2M;PSMA8;ITGB5;PSMC3;NCF1;TAP2;NCF4;PSMD8;NCF2;PSMC4;PSMB10;PSMA1;IKBKB;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5889732449460512,-1.8036875128916152,0.0017094017094017094,0.03080942938411518,0.915,14/30,20.02%,BIRC3;CD300LF;RIPK1;TLR4;TRAF3;LY96;UBC;RPS27A;TICAM1;CD40;IKBKB;TNIP3;CASP8;TICAM2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.6774362281103128,-1.802684892597494,0.0,0.030984451546329783,0.918,13/19,22.81%,ZMIZ1;SYK;AXL;GAS6;MDK;NCKAP1L;CD27;XBP1;XRCC6;ZAP70;GATA3;IL7;PRKDC
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.6913217721374998,-1.802457923387644,0.0017211703958691911,0.03076916256373506,0.92,6/16,8.66%,LYST;SLAMF7;PLEKHM2;ARL8B;RAET1E;CEBPG
prerank,polarized epithelial cell differentiation (GO:0030859),-0.7372957968876566,-1.8021038105961393,0.0,0.030668631046379704,0.921,8/13,12.98%,MSN;RHOA;RAP2A;CDC42;ZDHHC7;SH3BP1;SCRIB;RAB10
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.672801004149712,-1.8017412575056952,0.0,0.030629910829945185,0.921,8/18,6.62%,ROCK1;RAP1B;PTK2B;ARFGEF1;RUFY3;KIF20B;RIPOR2;CYRIB
prerank,reverse cholesterol transport (GO:0043691),-0.727669138527802,-1.7995608349528458,0.001763668430335097,0.03134790552341283,0.925,3/13,0.54%,APOE;ABCA1;ABCG1
prerank,cellular response to cytokine stimulus (GO:0071345),-0.3955583117001508,-1.7989241977494113,0.0,0.03135371548114869,0.927,158/416,24.81%,PID1;F13A1;GRB2;CCR2;GAB2;DAPK1;SYK;VIM;BCL6;MCL1;AXL;CBL;CD36;ITGB2;PTPRJ;RHOA;TNFRSF1B;BCL2L11;GAPDH;CSF2RA;NFE2L2;ARHGEF2;SBNO2;VAV1;GRAP2;RIPK1;IRAK2;IL10RB;BRCA1;IL6R;ABL2;LRCH1;STAT3;FOXO3;CCR1;TEC;TLR4;MT1X;IL18;STAT6;DHX9;ITGB1;PTPN12;PIM1;RC3H1;DOCK8;NFKB1;BCL2;IRF5;IFNAR2;IRAK4;AIM2;DAPK3;ANXA1;RIPOR2;STX3;BATF;PF4;PIK3CB;FN1;HGF;TNFRSF21;IRAK3;GAS6;STAT5B;STAT4;VEGFA;SIRPA;GBP5;ERBIN;JAK1;IFITM2;GSDME;HIF1A;ZFAND6;PTPN6;UBC;RPS27A;GBP2;EGR1;RELA;IFNGR2;LCK;ITGAX;IL2RG;XBP1;IL4R;IFNAR1;TPR;CRK;IFIT1;HSP90B1;PIK3CA;IL20RA;CSF2RB;CCL5;TCF7;CIB1;CASP1;SOCS6;PIK3CD;MT2A;CNTFR;CD40;IKBKB;IL34;CDC34;CRKL;IL31RA;CXCR4;HCLS1;IL27RA;IL2RB;IL18R1;STX4;GATA3;RPS3;HCK;SOCS3;PTPN13;PTPN11;TRADD;IL1R2;LGALS9;GBP3;IL7;GBP7;CSF1;GBP6;SLA;WNK1;GSK3B;MMP2;SFRP1;MMP1;ZC3H12A;STAT1;ASAH1;PLP2;HAX1;SOCS5;SHMT1;PTPN7;IL6;IFNGR1;TYK2;TGFB1;HMOX1;CD47;GREM2;IL2RA;CCL7;FLT3;ITGAM;SHC1;MYC;GBP4;STAT2
prerank,inorganic cation transmembrane transport (GO:0098662),0.3895815994113557,1.7987753959851616,0.0,0.03979944529143073,0.986,74/268,17.46%,KCND2;ASIC2;KCNB2;KCNQ3;TRPM3;CACNA1C;RYR3;KCNN2;TRPC5;KCNQ5;KCNC2;KCNK10;KCND3;SLC24A4;SLC24A2;SLC8A3;SLC12A2;NALCN;TRPC1;KCNH7;KCNH5;SLC4A4;SCN2A;KCNH1;SLC24A3;SCN2B;SCN1A;SLC6A16;SCN3A;SLC6A15;SLC12A1;SLC6A17;SLC9A2;KCNJ10;KCNK2;SCN9A;HCN2;KCNA1;KCNH4;ATP1A3;KCNJ16;SLC6A1;TRPM1;SLC8A2;SLC6A13;SLC6A2;SLC4A11;KCNF1;ATP1B1;HCN1;TMEM175;KCNG1;COX15;PKD1;SCARA5;KCNJ12;KCNV1;KCNH8;ATP2B4;KCNA2;KCNS3;ATP2A1;TRPV3;SLC39A6;CACNA1G;KCNK12;SCN10A;SLC39A13;UCP3;SLC6A5;KCND1;TRPM2;TRPC7;SLC6A11
prerank,neuron projection fasciculation (GO:0106030),0.7696298134925508,1.798712304262068,0.0022935779816513763,0.039396071559616136,0.986,6/10,15.52%,CNTN4;SEMA5A;NRCAM;CDK5R1;ARHGAP35;EPHB3
prerank,negative regulation of apoptotic process (GO:0043066),-0.39244079946015786,-1.798358444824471,0.0,0.031339851929030126,0.932,182/444,28.72%,DAB2;APOE;PRKCH;CD44;IGF1;NOTCH2;CD38;CD74;ARHGAP10;BIRC3;RNF213;TNFAIP8;PAK2;MCL1;PRKCD;RB1;AXL;CBL;ITGA5;NIBAN2;BFAR;BIRC6;NUPR1;ANXA4;FLNA;IGF1R;CSNK2A1;SON;MALT1;RIPK1;HTR2B;AREL1;CFLAR;HSPA9;ITGB1;SNX6;PIM1;PTK2B;NFKB1;ANXA5;BCL2;ANXA1;HGF;CTNNB1;GAS6;GRN;GRK5;HIGD2A;WFS1;PLK2;BABAM2;VEGFA;MAP2K5;MDK;MYD88;DNAJA1;FNIP1;PLAUR;CD28;ATAD3A;YWHAE;ZFAND6;MEF2C;CTSH;SERPINB9;ADAM8;UBC;RPS27A;MGMT;PRDX5;NCKAP1L;CD27;TPT1;SPRY2;RELA;KIF14;XBP1;TXNDC5;CDK1;WDR73;OSR1;HSP90B1;PIK3CA;MAEA;HTATIP2;TMBIM6;CIB1;PLK3;RETREG1;AVEN;DFFA;GREM1;IKBKB;PRDX2;RASA1;AATF;BAG3;IL31RA;ANKLE2;HCLS1;CLN3;BID;BNIP2;IL2RB;STIL;TAF9;DNAJC3;VHL;BNIP3L;HSPA1A;ATF5;HCK;API5;CFL1;THOC6;HSPB1;CASP2;DDX3X;BEX3;COPS5;IL7;NAA16;NDNF;GSK3B;CAT;DNAJB6;MAZ;SFRP1;ZC3H12A;CPEB4;PPT1;KDR;NUP62;HAX1;APOH;HNRNPK;SFN;SNAI2;HYPK;BCL2L2;MAP4K4;SET;UFM1;MAPK1;TOPORS;NR1H4;IL6;TCIM;CRYAB;PRKDC;MTDH;PIM2;FANK1;LRP2;SHC1;MYC;PKHD1;VDAC1;PSEN2;TMEM14A;MT3;MRE11;SIAH2;VIP;RPS6KA3;HIPK3;PDPN;HIGD1A;KDM2B;CARD16;NAA38;POU3F4;FGF20;APIP;FFAR4;BCL2L1;CITED2;AQP1;GHRL;LEF1;SLC30A10;PRELID1
prerank,regulation of establishment of cell polarity (GO:2000114),-0.6952134847012453,-1.7981746557211087,0.0034965034965034965,0.031131935651261135,0.933,8/16,6.62%,ROCK1;RAP1B;PTK2B;ARFGEF1;RUFY3;KIF20B;RIPOR2;CYRIB
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.573912376202853,1.7980548690040572,0.0025,0.03924099898242546,0.986,12/31,15.39%,NLGN1;PPFIA2;TANC2;SRCIN1;SHANK3;CUX2;ABI2;CAPRIN2;RELN;CDK5R1;ARC;SIPA1L1
prerank,regulation of chemokine production (GO:0032642),-0.5637029808025618,-1.7979772505105107,0.0033613445378151263,0.03098509405735223,0.933,17/36,23.45%,FOXP1;CD74;TLR7;IL6R;TLR4;IL18;EIF2AK2;HIF1A;LPL;EGR1;APP;LGALS9;IL7;AGER;SNAI2;IL6;HMOX1
prerank,regulation of neuron projection development (GO:0010975),0.4195468565043827,1.7964895630768645,0.0,0.039428550752963254,0.986,43/163,12.47%,LRRC4C;CSMD3;MAGI2;CTNNA2;IL1RAPL1;LRRC7;SPOCK1;PPFIA2;TENM3;RIT2;CDH2;DCC;NTRK3;SERPINI1;NTRK2;FUT9;CDKL5;TANC2;NCS1;NTNG2;NTNG1;PAK3;PTN;MARK1;SRCIN1;SHANK3;KNDC1;ABI2;PRKCI;TOX;PRKD1;BDNF;KANK1;TSKU;LTK;RELN;MFSD2A;CDK5R1;DPYSL3;BRSK1;RET;ARHGAP35;RTN4RL1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.6225574320367644,-1.7962089473206542,0.0,0.03150993590998801,0.936,13/23,22.49%,LILRB1;AXL;TLR4;GAS6;LAPTM5;RARA;LGALS9;HMGB1;C1QBP;CD274;ZC3H12A;INHA;NR1H4
prerank,response to muramyl dipeptide (GO:0032495),-0.7669565406891728,-1.795455183073399,0.003527336860670194,0.03158070177515763,0.938,7/12,8.97%,VIM;ARHGEF2;CHMP5;IRF5;PTPN22;ERBIN;NOD1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.5310872212443537,-1.7949893740087512,0.0,0.031518549869230854,0.939,22/48,20.12%,ZMIZ1;DEK;ARID1B;ATAD2;SMARCA5;ERCC6;ACTB;POLR2H;ARID1A;POLR2F;WBP2;ATAD2B;POLR2L;ASF1A;ELOF1;ZMIZ2;SPHK2;TAF1A;POLR1F;SERTAD1;CHEK1;SF3B1
prerank,response to interferon-gamma (GO:0034341),-0.498960665824858,-1.7941053437358927,0.0,0.031737708105005716,0.94,30/67,25.96%,CD74;SP100;DAPK1;GAPDH;KYNU;TLR4;DAPK3;CIITA;NUB1;SIRPA;GBP5;BST2;IFITM2;GBP2;CXCL16;CCL5;CASP1;GCH1;CD40;LGALS9;GBP3;GBP7;GBP6;STAT1;IFITM1;MEFV;CD47;CCL7;GBP4;IL12RB1
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.7174084700758567,-1.7940386177408392,0.006802721088435374,0.03152690476203031,0.94,8/13,17.10%,FGR;GAB2;SYK;ITGB2;AP1G1;LAMP1;SPHK2;STX4
prerank,cellular response to copper ion (GO:0071280),-0.6857045955572492,-1.793729120514482,0.001736111111111111,0.031438927402682865,0.94,8/16,4.19%,MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.6168081748032892,-1.7928601294715618,0.0,0.0313575614765395,0.942,9/23,12.65%,DAB2;ZEB2;SDCBP;CREBBP;RNF111;TGFB1I1;FLCN;STK11;HSP90AB1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.6168081748032892,-1.7928601294715618,0.0,0.0313575614765395,0.942,9/23,12.65%,DAB2;ZEB2;SDCBP;CREBBP;RNF111;TGFB1I1;FLCN;STK11;HSP90AB1
prerank,regulation of phagocytosis (GO:0050764),-0.5223426803936805,-1.7917399542706653,0.001610305958132045,0.03155188726623869,0.943,15/53,13.01%,DOCK2;PTPRC;FGR;SYK;CYBA;SNX3;CAMK1D;IL15;ITGAV;GAS6;SIRPA;TGM2;IL2RG;FCGR2B;FCER1G
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.633897401085315,-1.791596557433493,0.005119453924914676,0.03141264323989581,0.944,10/22,11.99%,SASH1;MFHAS1;XDH;RELL1;MINK1;SPI1;VEGFA;PRMT1;NCF1;GADD45A
prerank,protein transport (GO:0015031),-0.40192227163325683,-1.7910361195377071,0.0,0.03142627725546121,0.945,142/332,25.00%,APOE;ABCA1;RAB8B;PRKCB;ABCG1;ATP6V0D2;CD74;LRP1;MYH9;ATP6V1E1;CD36;RAB7A;DNM2;SNX9;SNX27;SLC10A7;SNX8;CANX;OPTN;STX7;ARHGEF2;TBC1D15;GOLGA4;PPARG;UNC93B1;RAB31;SGSM2;TLK1;ATP6V1A;KIF3B;TBC1D2B;RAB20;TBC1D9;GGA3;LAMP2;TCIRG1;RAB1A;COG7;SNX6;TOM1;TMED10;CENPF;STX8;CTSA;STEAP3;TBC1D5;MACF1;TBC1D1;ARL11;STX3;TBC1D22A;PREB;RAB32;SNX33;GOLPH3L;TBC1D16;TBC1D22B;SIL1;LAPTM5;WLS;TBC1D8B;SYS1;RAB5A;RCN3;TMED3;TBC1D8;RAB21;ATP6V1G1;TBC1D17;VPS26B;SEL1L;RAB3D;SNX13;RAB24;CHMP1A;RAB11B;SAR1A;HSP90B1;RAB29;ARRDC4;VPS26A;STX5;TBC1D10B;RAB10;ARL5A;MIA2;SEC31A;ATP6V0B;MIA3;COPA;ARRDC1;EHD1;CHMP2A;TBC1D30;STX16;VAMP4;RAB13;LMAN2L;ARFIP1;ATP6V0E1;AP3B1;STX4;AP3D1;TBC1D9B;TMED2;RAB34;VPS33A;ARL1;RILP;PDIA4;SNX1;SNX4;TBC1D25;RAB12;ARFIP2;SLU7;TMED4;TICAM2;TXNIP;ATP6V0D1;GOLGA7;PPT1;BLZF1;NEURL1B;TBC1D10C;TBC1D4;TVP23A;TMED5;SCFD2;RABL3;VMP1;TANGO6;MON1A;RAB26;LRP2;ARRDC2;ARCN1;FAM91A1;RAB19;COPB2;RAB1B;CHMP2B
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.5815399783893476,-1.788152344576879,0.003430531732418525,0.032356120791958376,0.949,14/30,22.00%,SDCBP;OGT;UCHL5;RYBP;RPL11;HSP90AB1;WAC;USP7;TAF9;TRIM39;UBXN1;SGTA;BAG6;EIF3H
prerank,positive regulation of T cell activation (GO:0050870),-0.5057002308589148,-1.7880995101272126,0.0,0.032126644757972854,0.949,33/62,32.12%,PTPRC;ZMIZ1;CCR2;IL15;DOCK8;ANXA1;CYRIB;SIRPA;MDK;CD28;NCKAP1L;LCK;XBP1;CD46;CCL5;FLOT2;ZAP70;GATA3;LGALS9;NOD2;IL7;CD274;CD3E;IL6;CD47;NCK1;TNFRSF13C;PNP;ZBTB1;NCK2;SLC7A1;CCL19;CD80
prerank,positive regulation of potassium ion transport (GO:0043268),0.5456783865285676,1.7868528128772019,0.002336448598130841,0.043127922475409364,0.994,11/38,7.72%,AKAP6;ANK2;KCNN2;KCNMB3;KCNMB2;KCNJ3;KCNJ10;KCNJ6;KCNJ9;GABBR1;KCNJ16
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.6886549178124306,-1.7853735459229771,0.0033277870216306157,0.03301239732218282,0.954,9/15,16.47%,IQGAP2;ARPC2;ACTR2;ACTR3;ARPC3;ARPC1B;ARPC1A;ARPC5;ARPC5L
prerank,mononuclear cell differentiation (GO:1903131),-0.6193734772677804,-1.7823925356289385,0.006589785831960461,0.03404104272420564,0.961,12/24,15.67%,LYN;LILRB1;MYH9;AXL;PPARG;IKZF1;MT1G;GAS6;VEGFA;BATF3;RELB;IL31RA
prerank,adipose tissue development (GO:0060612),-0.7409675829348845,-1.7822552077248106,0.0035398230088495575,0.03388174791686969,0.962,4/11,2.25%,SH3PXD2B;NAMPT;SPTLC2;ARID5B
prerank,lipoprotein biosynthetic process (GO:0042158),-0.7666132571304738,-1.7816710333149517,0.004991680532445923,0.03384375852951968,0.963,3/11,4.80%,APOE;ATG7;ATG10
prerank,regulation of response to biotic stimulus (GO:0002831),-0.5898569532251887,-1.780387623876953,0.005110732538330494,0.03422031308577386,0.966,8/28,6.22%,FOXP1;FGR;BIRC3;SAMHD1;CD36;DHX58;PTPN22;TRAF3
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.6893546095293779,-1.7803021092061977,0.0017331022530329288,0.03399591382099372,0.966,8/15,10.64%,PRKCH;MSR1;CD36;IL18;NFKB1;PF4;LPL;AGT
prerank,microvillus organization (GO:0032528),-0.7156902616543186,-1.779672285854848,0.005385996409335727,0.034099622825741624,0.967,6/13,3.69%,RAP1B;RAP2B;RAP2A;FXYD5;MINK1;RAP1A
prerank,lipoprotein catabolic process (GO:0042159),-0.7422299286309008,-1.7777139104034245,0.005190311418685121,0.034615906596564085,0.97,3/11,3.48%,APOE;CTSD;ABHD17C
prerank,positive regulation of dendrite development (GO:1900006),0.7605503277113423,1.7761272438901972,0.008830022075055188,0.04727315889466196,0.998,6/10,14.11%,PTN;ALK;BMP7;COBL;VLDLR;PACSIN1
prerank,phagosome maturation (GO:0090382),-0.5702572729679825,-1.7742463978923793,0.0016863406408094434,0.035799686152932594,0.972,13/35,17.66%,ATP6V0D2;ATP6V1E1;RAB7A;RAB31;ATP6V1A;RAB20;TCIRG1;RAB32;ATP6V1G1;ATP6V0B;ATP6V0E1;RAB39A;RAB34
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.43618320747198114,-1.7727524386776703,0.0,0.03621617626481627,0.975,39/140,11.55%,ARHGAP15;VAV3;AKAP13;ABR;ARHGAP10;ARHGAP25;ITSN1;STARD8;ARHGAP22;MYO9B;RAC1;ARHGEF3;ARHGAP30;ARHGAP24;ARHGAP19;RHOA;ARHGAP17;ARHGEF2;VAV1;CDC42;FGD4;ITGAV;ARAP1;ARHGAP18;FGD3;RHOQ;CYRIB;ARHGEF18;SH3BP1;VAV2;SOS2;ARHGAP12;TGM2;PLEKHG5;GNA13;TRIP10;FLCN;ARHGEF11;FAM13B
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.5970294208694424,-1.7720701136570565,0.0,0.03635124466769403,0.975,9/27,10.70%,CD44;CCR2;ITGB2;RHOA;CYRIB;SIRPA;MDK;RELA;LCK
prerank,chloride transport (GO:0006821),0.4695259849302661,1.77114053525142,0.0,0.049162373121509,1.0,19/74,8.86%,GABRB3;GABRB1;GABRG3;SLC12A2;GLRA1;GABRA2;SLC4A10;ANO4;GABRA3;SLC12A8;SLC12A1;GABRA5;GABRB2;ANO3;GABRG2;ANO5;SLC1A1;SLC6A1;GLRA2
prerank,DNA repair (GO:0006281),-0.39997404059033487,-1.7710609645026323,0.0,0.036508736120790884,0.977,120/284,26.18%,FAM111A;DDB2;BACH1;RAD51B;PSME4;SMARCA5;BRCA1;UVRAG;ERCC6;POLE2;DCLRE1C;NABP1;PARP4;BLM;ABRAXAS1;RAD1;PRIMPOL;WDR48;TEX264;REXO4;PWWP3A;KMT5B;ALKBH1;BABAM2;USP3;ATXN3;NEIL3;RAD51;PARP9;RFWD3;KMT5C;UBC;RPS27A;MGMT;NUCKS1;RNF8;APTX;FTO;TIMELESS;DCLRE1A;LIG1;WRN;CDK1;PCNA;CUL4B;RAD54L;GADD45A;BABAM1;EXO1;ASF1A;MLH3;FEN1;CIB1;TICRR;WDR33;RPA3;RFC2;XRCC4;POLD2;ERCC4;APLF;RHNO1;RAD51AP1;DOT1L;INO80;RAD52;PRMT6;UBE2T;NSMCE3;LIG3;SLX4;DDX1;TOPBP1;BRIP1;NEIL2;XRCC3;EYA1;RAD9A;DNA2;EYA3;RBBP8;HUWE1;ADPRS;BRCC3;UBXN1;POLN;ATM;FAAP24;CHEK1;SMC1A;MMS19;RFC3;BAP1;DTX3L;PDS5B;NBN;EXO5;ALKBH3;CETN2;FAN1;FANCD2;POLB;PRKDC;ZRANB3;UBE2V2;MLH1;EID3;ASCC3;POLD4;RAD51C;DDB1;TRIM28;MPG;RECQL5;BAZ1B;UBE2N;XRCC1;ASCC2;MRE11;DCLRE1B
prerank,regulation of fibroblast proliferation (GO:0048145),-0.5341417706248184,-1.7707122591440208,0.0,0.03642386641934906,0.977,15/45,14.06%,IGF1;CD74;CD300A;CDK6;DHX9;FN1;CTNNB1;GAS6;SKI;E2F1;MORC3;AGT;B4GALT7;NLRC3;S100A6
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.47100970746075965,-1.770610144885701,0.0,0.036228667963840104,0.977,28/86,16.21%,PTPRC;NRP1;CD44;BANK1;IGF1;CD74;PLCG2;PAK2;PRKCD;ITGB2;ITGA5;PTPRJ;RAP2B;ARHGEF2;IL6R;IL15;TEC;PTK2B;HGF;VEGFA;PTPN6;AGT;APP;CLEC6A;SAMSN1;CSPG4;BST1;HCLS1
prerank,neutrophil activation (GO:0042119),-0.7394480864083558,-1.7685796486110783,0.0,0.03695328009698307,0.977,5/12,13.01%,SYK;PRKCD;IL15;CCL5;FCER1G
prerank,translation (GO:0006412),-0.41788903245385506,-1.7683843876582837,0.0,0.03680434094218709,0.977,81/208,26.21%,RARS1;AGO2;RPS18;FARS2;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;NOA1;SARS1;RPL36;RPS6;RPS20;RPL11;ABCE1;RPL10A;RPL12;RRBP1;MRPL42;TUFM;RPS14;EEF1B2;RPL32;RPS15A;RPS28;RPS13;RPS27A;DARS1;RPL28;RPS4X;FASTKD2;RPS23;EEF2;EIF4EBP2;GTPBP1;RPL22;EEF1E1;RPL14;EEF1A1;MRPS6;RPL34;MRPS11;RPS11;RPL6;EIF4G1;RPS10;RPL18A;KARS1;MRPS16;RPL37A;MRPL34;RPS9;MRPS15;RPS27;ABCF1;RPS3;GTPBP2;RPL23A;RPS16;RPL9;AARS1;COPS5;DARS2;RPLP2;MRPL51;MRPL47;RPL41;RPLP0;RPL7A;RPL19;RPS15;RPL39;IARS1;MRPL18;MRPS7;EEFSEC;EEF1D;RPL5;RPL13
prerank,negative regulation of B cell activation (GO:0050869),-0.6456087985784295,-1.7677699193413146,0.0032626427406199023,0.036836864857395596,0.977,15/21,25.73%,LYN;BANK1;CD300A;RC3H1;TNFRSF21;LAPTM5;FOXJ1;FCGR2B;ID2;SAMSN1;ATM;SFRP1;INHA;TNFRSF13B;BLK
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.6519449947215284,-1.7676211860504023,0.005405405405405406,0.036651738204069535,0.977,5/17,4.75%,PPARD;PANK2;PRKAG2;PPARG;ADIPOR1
prerank,positive regulation of signaling (GO:0023056),0.5472292271750279,1.7673691922454682,0.0022675736961451248,0.05062986080978164,1.0,9/37,6.74%,RIMS2;GRIK2;RIMS1;SYT1;SOX11;CLSTN2;RAMP3;CLSTN1;HOMER1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.5997612253640006,-1.7672995195391237,0.0035335689045936395,0.03654602695660331,0.977,9/26,4.19%,SLC30A5;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,neuromuscular synaptic transmission (GO:0007274),0.6309605267300079,1.7665303988519805,0.005115089514066497,0.05055669264378896,1.0,6/18,10.75%,ERC2;DTNA;KIF1B;SLC5A7;RIMBP2;CHAT
prerank,positive regulation of programmed cell death (GO:0043068),-0.4026929009335209,-1.7656164677551802,0.0,0.03711590629824912,0.979,87/272,19.87%,VAV3;MAP3K5;AKAP13;APAF1;ABR;CTSD;ITSN1;LILRB1;TNFAIP8;DAPK1;SYK;BCL6;CRADD;JUN;ARHGEF3;DNM2;ANO6;BCL2L11;MAP3K20;CTNNBL1;ARHGEF2;CALHM2;VAV1;RIPK1;FOXO3;FGD4;ATG7;NLRC4;ITGB1;RYBP;TOP2A;RARG;PRMT2;IRF5;DAPK3;RPS6;FGD3;STK3;CTNNB1;ARHGEF18;ATF6;E2F1;LAPTM5;DNAJA1;VAV2;SOS2;UBC;RPS27A;SUDS3;TGM2;SCRIB;PLEKHG5;GNA13;DUSP6;FLCN;PSENEN;ARHGEF11;GADD45A;MLLT11;IGFBP3;HTATIP2;EEF1E1;STK17B;IFIT2;TFAP4;TRIO;MAP3K10;SHQ1;QRICH1;LATS2;ARHGEF5;FAF1;BID;KLF11;TNFSF10;SPHK2;BNIP3L;CASP8;RNPS1;PHLDA1;TRADD;PDCD5;CASP2;DDX3X;HMGB1;ATM;C1QBP
prerank,inhibitory synapse assembly (GO:1904862),0.7193940427249611,1.765034587507191,0.012254901960784314,0.05084982309437366,1.0,8/11,21.58%,GABRB3;GABRA2;GABRB2;GABRG2;CBLN4;PLXNB1;WNT5A;LGI2
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.4585376431283086,-1.7645079179619498,0.0,0.03741984194712687,0.979,44/101,23.39%,LYN;LILRB1;VIM;AXL;RHOA;TNFRSF1B;SBNO2;CTR9;TLR4;IL18;CHMP5;STAP1;NFKB1;PTPN22;ADAM9;MAPK14;PF4;SIRPA;MYD88;MEF2C;LY96;SELENOS;TNIP2;RELA;XBP1;TICAM1;CCL5;HMGB2;SERPINE1;CASP1;DEFA6;NFKBIL1;NFKBIB;TNIP3;HCK;NOD2;HMGB1;TICAM2;CD274;ZC3H12A;NLRP3;IL6;MTDH;TGFB1
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.5870196546428629,-1.7624225532505082,0.0,0.03820441491588279,0.984,14/30,22.63%,SYK;PLCG2;STAT3;PIBF1;TLR4;CD28;CD46;ISG15;LILRA5;LGALS9;NOD2;HMGB1;CD274;IL6
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.6006724400756815,-1.7612488212630493,0.0016835016835016834,0.03855066134662796,0.984,7/26,5.20%,PLCG2;CYBA;CD36;ABCB7;ABCD2;TLR4;COA8
prerank,tryptophan metabolic process (GO:0006568),-0.7390529790627574,-1.760998899828928,0.0,0.03842169186139561,0.985,5/11,12.50%,KYNU;ATP7A;KMO;KYAT1;IL4I1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5501707019947024,-1.759845475990816,0.0016835016835016834,0.038769889203924456,0.986,17/37,26.76%,SDCBP;OGT;CSNK2A1;UCHL5;RYBP;RPL11;HSP90AB1;WAC;USP7;TAF9;TRIM39;UBXN1;SGTA;BAG6;EIF3H;RPL5;PML
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.7238335604531217,-1.759523132819974,0.0017605633802816902,0.03869286019327182,0.986,8/13,10.46%,PIK3AP1;TLR7;UNC93B1;IRAK2;IRAK4;EPG5;MYD88;TNIP2
prerank,response to copper ion (GO:0046688),-0.6394958007706086,-1.759348401162977,0.005309734513274336,0.03858737626219618,0.986,8/20,4.19%,MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.5806350639460438,-1.757110826826616,0.0034071550255536627,0.03943208001789051,0.987,13/29,20.02%,BIRC3;CD300LF;RIPK1;TLR4;TRAF3;LY96;UBC;RPS27A;TICAM1;CD40;IKBKB;CASP8;TICAM2
prerank,cellular response to zinc ion (GO:0071294),-0.684084926714277,-1.7561202057133516,0.0,0.03970808826141143,0.987,9/15,4.19%,P2RX4;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,regulation of type I interferon production (GO:0032479),-0.4687794323023683,-1.7561006836088042,0.001610305958132045,0.039475877218947034,0.987,43/84,27.84%,CREBBP;CGAS;GAPDH;OTUD5;DHX58;STAT6;DHX9;NFKB1;NLRC5;IRF5;PTPN22;TRAF3;CTNNB1;POLR2H;MYD88;POLR2F;UBA7;POLR3G;POLR2L;RELA;PIN1;XRCC6;PCBP2;DHX36;RNF216;MAVS;POLR3B;NLRX1;ISG15;G3BP1;GPATCH3;POLR3A;RNF125;TRIM25;LRRFIP1;RNF135;PRKDC;POLR3GL;POLR3D;MRE11;POLR1C;EP300;RNF26
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.5958856904533877,1.7558336054229289,0.007371007371007371,0.055405216126495606,1.0,9/22,14.48%,AKAP6;ANK2;RYR2;ATP1B1;STAC;CALM1;CALM3;CALM2;ATP2A1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.4785139532165069,-1.7545127719232378,0.0,0.040243304337847355,0.989,23/73,12.32%,DAB2;NEDD9;NRP1;FGR;SYK;PLEK;MYH9;ITGB2;ITGA5;TEC;CDC42;ITGB1;PTK2B;ITGAV;ADAM9;FYB1;FN1;ERBIN;ITGB7;ITGB1BP1;ITGB5;ZYX;ADAM15
prerank,inflammatory response (GO:0006954),-0.4133754073543261,-1.7542466684351907,0.0,0.04016756076125879,0.989,48/195,14.85%,CYBB;CD44;ADGRE5;CCR2;MFHAS1;C3AR1;REL;CYBA;RAC1;ITGB2;NRROS;SIGLEC1;CDO1;NFX1;C5AR1;IL10RB;ITGAL;MAPKAPK2;STAT3;CCR1;TLR4;IL18;NLRC4;BLNK;NFKB1;PTGER4;TPST1;ANXA1;PARP4;CIITA;PF4;PIK3CG;NFATC3;HRH1;NOD1;ADAM8;PRDX5;AFAP1L2;RELA;CCL5;CCRL2;FCGR2B;HDAC5;PIK3CD;NFAM1;CD40;IKBKB;RELB
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.46927638005948713,-1.7526982833460663,0.0,0.04052516418525526,0.99,22/86,11.34%,LYN;DENND1A;AKAP13;IGF1;NOTCH2;GRB2;STARD8;DENND4C;MYO9B;EPS8;OGT;ARHGAP17;ARHGEF2;VAV1;RASGRP4;ARHGEF18;ERBIN;SH3BP1;SPRY2;KIF14;RASAL3;FLCN
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.5252616216840256,-1.7523887352320586,0.001718213058419244,0.040490971204577106,0.99,14/44,11.64%,LYN;APOE;CD300A;PRKCD;PTPRJ;PTPN22;PIK3CB;IRAK3;STK38;DNAJA1;SPRY2;AGT;PAQR3;AIDA
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.48927031354613626,-1.7521927127945582,0.0,0.04035903782434252,0.99,30/67,23.32%,NEDD9;NRP1;RREB1;RSU1;CDK6;CD36;RAC1;FLNA;CDC42;PTK2B;TRIOBP;FN1;DOCK5;MYADM;UTRN;MDK;CRK;CIB1;PLEKHA2;CRKL;LIMS1;CSF1;C1QBP;NDNF;GSK3B;SFRP1;JUP;CD3E;ILK;P4HB
prerank,negative regulation of T cell activation (GO:0050868),-0.5551087015817939,-1.7518264507872614,0.005199306759098787,0.04030526093876602,0.991,16/35,21.90%,LILRB1;TNFAIP8L2;PTPN22;RIPOR2;DUSP3;TNFRSF21;LAPTM5;NCKAP1L;SDC4;IL4I1;FCGR2B;VSIG4;SPN;CD274;LAX1;CEBPB
prerank,fatty acid transmembrane transport (GO:1902001),-0.6392379555778382,-1.7515163660460373,0.001736111111111111,0.04021743600799677,0.991,6/19,4.13%,CD36;ABCD2;PRKAG2;CPT1A;SLC27A1;SLC2A1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5646993923826032,-1.7504316692405417,0.008291873963515755,0.040413153633363376,0.991,15/30,28.51%,ARHGEF2;RIPK1;BRCA1;CFLAR;SERPINE1;TRAF2;RNF34;TNFSF10;CASP8;TRADD;DDX3X;GSK3B;HMOX1;SCRT2;BCL2L1
prerank,response to lipid (GO:0033993),-0.4518819096893086,-1.749232822508186,0.0,0.04082600704744228,0.991,30/105,14.81%,FOXP1;ABCG1;MAPKAPK3;CD36;PPARD;OTUD5;PPARG;MAPKAPK2;STAT3;FOXO3;TAB2;PELI1;TLR4;RARG;PTPN22;ANXA1;IRAK3;CTNNB1;STAT5B;ERBIN;TRIB1;CTSH;LY96;ASXL1;IFNAR1;HMGB2;RXRA;GCH1;TMEM161A;SPP1
prerank,protein sumoylation (GO:0016925),-0.5111796027217839,-1.7482610358035255,0.0,0.041070724468469405,0.991,26/49,30.35%,NSMCE2;NUP50;PIAS1;NUP42;NUP88;RAE1;NUP205;TPR;NUP188;UBA2;UBE2I;EYA1;NUP153;NUP35;NUP107;NUP62;EGR2;TOPORS;SUMO3;SAE1;RANBP2;TRIM28;NUP37;PIAS2;AAAS;NUP133
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.7049906212363848,-1.7471501574960657,0.0036231884057971015,0.04141442476094889,0.992,9/14,20.33%,ARID2;ACTR2;ERCC6;FUS;WDR48;TIMELESS;RAD51AP1;WRAP53;MMS19
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.475325859094906,-1.7470536771997838,0.0,0.04121508082592933,0.992,29/74,20.83%,RBPJ;CREBBP;BACH1;NFE2L2;PSME4;PSMB7;PSME3;PSMB9;VEGFA;EGLN1;HIF1A;PSMA8;UBC;RPS27A;ARNT;PSMC3;PSMD8;PSMC4;PSMB10;CUL2;PSMA1;PSMB8;VHL;ELOC;PSMA5;PSMD4;PSMB3;SIRT2;PSMD3
prerank,superoxide anion generation (GO:0042554),-0.7192800720912126,-1.7466011664829273,0.0035714285714285713,0.041239150946627584,0.992,5/13,12.51%,CYBB;CYBA;NCF1;NCF4;NCF2
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.5841080951888407,-1.745931519334016,0.0,0.041422998189881585,0.992,9/27,14.06%,IGF1;CD74;CDK6;DHX9;FN1;GAS6;E2F1;AGT;S100A6
prerank,T cell activation involved in immune response (GO:0002286),-0.7240039054081269,-1.7452939743862044,0.0017605633802816902,0.04147222114416596,0.993,6/12,13.01%,CD74;LILRB1;ITGAL;MDK;LCP1;FCER1G
prerank,brain development (GO:0007420),0.4193036435690831,1.7452809416352981,0.002583979328165375,0.06061047673496595,1.0,41/136,15.04%,CNTNAP2;CTNNA2;ADGRL3;GRIN2A;ROBO2;CNTN4;EML1;GRIN2B;CDH2;AFF2;EPHA7;MEIS1;NFIB;SYNJ2;SMARCA1;SOX6;SHROOM4;SLC6A17;SHANK3;APOD;DSCAML1;CX3CR1;ADGRL2;CDK5RAP3;B3GNT5;ZFHX2;RELN;MFSD2A;CDK5R1;EEF1AKMT4-ECE2;HES5;ZIC2;AMIGO2;PBX1;CDK5RAP2;ADGRG1;PAFAH1B2;ARNT2;MKKS;PAFAH1B3;UFC1
prerank,negative regulation of cytokine production (GO:0001818),-0.4243228796090193,-1.7448628315317953,0.0,0.041461545508202226,0.995,64/163,23.13%,PTPRC;CD84;ATP2B1;LILRB1;TLR8;AXL;RAC1;ADCY7;ANXA4;ABCD2;OTUD5;DHX58;PIBF1;TLR4;SRGN;NLRC5;PTGER4;SARS1;PTPN22;ANXA1;FN1;TNFRSF21;ARRB1;IRAK3;GAS6;SIRPA;MAP2K5;LAPTM5;UBA7;PTPN6;SELENOS;NCKAP1L;TRIB2;PIN1;PCBP2;FOXJ1;NLRC3;FCGR2B;VSIG4;TMSB4X;RNF216;MAVS;NLRX1;APPL2;ISG15;GPATCH3;RARA;LILRA5;CMKLR1;MMP8;LGALS9;HMGB1;C1QBP;AGER;CD274;ZC3H12A;RNF125;TRIM25;RNF135;RPS6KA5;INHA;NR1H4;IL6;MEFV
prerank,response to lipopolysaccharide (GO:0032496),-0.43574004763465424,-1.744528762140253,0.0,0.041385365295860864,0.995,40/138,14.06%,FOXP1;MAPKAPK3;LILRB1;VIM;AXL;RHOA;TNFRSF1B;SBNO2;OTUD5;MAPKAPK2;CTR9;TAB2;PELI1;TLR4;CHMP5;STAP1;NFKB1;PTPN22;ADAM9;MAPK14;PF4;IRAK3;SIRPA;ERBIN;MYD88;TRIB1;MEF2C;LY96;SELENOS;TNIP2;RELA;XBP1;IFNAR1;TICAM1;HMGB2;SERPINE1;CASP1;DEFA6;NFKBIL1;GCH1
prerank,neuron migration (GO:0001764),0.5046659508805611,1.743761041704874,0.0047169811320754715,0.061020214502648655,1.0,18/48,11.20%,ADGRL3;ASTN2;AUTS2;SPOCK1;MAP1B;GPM6A;NTRK2;CDKL5;ASTN1;NRCAM;MARK1;TUBB2A;DCDC2;PEX13;DNAAF4;DNER;RELN;CDK5R1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.40836270128187635,-1.7429545193654072,0.0,0.042106296947656635,0.998,82/208,23.88%,AKAP13;PRKCB;CD74;BIRC3;PLCG2;REL;LITAF;RHOA;GAPDH;FLNA;OPTN;BRD4;MALT1;RIPK1;ALPK1;TRAF5;HTR2B;TAB2;PELI1;RIOK3;CFLAR;CARD11;IRAK4;RNF31;TFG;RBCK1;TRAF3;PPM1B;PLK2;MYD88;WLS;BST2;NEK6;NOD1;ZFAND6;TNIP2;RELA;PLEKHG5;TRAF1;TICAM1;CLEC6A;JMJD8;TRIM68;NLRC3;LGALS1;CASP1;TRAF2;DHX36;CD40;IKBKB;MAVS;DDX1;TRIM14;NLRX1;TNIP3;TNFSF10;GPRC5B;SPHK2;CASP8;TRIM39;TRADD;MIER1;LGALS9;SHISA5;HSPB1;NDFIP2;NOD2;TMED4;TICAM2;S100A4;ZC3H12A;STAT1;TRIM25;NUP62;TMEM106A;ZDHHC13;NR1H4;TMEM9B;MTDH;HMOX1;PIM2;MAP3K3
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.5816114039917806,-1.7416532044697315,0.0017064846416382253,0.042520973668895415,0.998,10/28,12.64%,MITF;RAC1;TNFRSF1B;MFSD12;PRKAG2;ADIPOR1;C3;SIRPA;CTNS;CCL5
prerank,postsynaptic membrane organization (GO:0001941),0.6366824982106518,1.7386729876558205,0.0071090047393364926,0.06330334201910319,1.0,5/17,5.24%,NLGN1;NRXN1;GPHN;NRXN2;SHANK3
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.4612024185947993,-1.7362183966307976,0.0,0.044972273081729096,0.998,34/86,20.83%,CREBBP;BACH1;NFE2L2;PSME4;ATF3;PSMB7;PSME3;PSMB9;VEGFA;EGLN1;HIF1A;MAPK7;PSMA8;UBC;RPS27A;ARNT;PSMC3;PSMD8;PSMC4;PSMB10;CUL2;PSMA1;KLF2;INO80;BAG3;PSMB8;VHL;HSPA1A;ELOC;PSMA5;PSMD4;CHEK1;PSMB3;PSMD3
prerank,regulation of myoblast fusion (GO:1901739),-0.7455826580924525,-1.7353618060235865,0.005190311418685121,0.04522635086981904,0.998,5/11,14.42%,CFLAR;RIPOR2;MAPK14;CD53;EHD1
prerank,regulation of synapse maturation (GO:0090128),0.7465625632989974,1.7346718180137046,0.01485148514851485,0.0650010926336048,1.0,4/10,10.87%,NRXN1;ANAPC2;ARHGEF15;RELN
prerank,positive regulation of transport (GO:0051050),-0.4625762523971647,-1.734319537618426,0.0,0.04559924029792231,0.999,23/85,17.14%,DOCK2;DAB2;APOE;LRP1;CYBA;CAMK1D;ANXA2;SGK1;IL15;DYNC1H1;ACTB;ANXA1;GAS6;CBLL1;SIRPA;NEDD4L;IL2RG;FCGR2B;FCER1G;RXRA;BID;IL2RB;KMT2A
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.7217694901479743,-1.733746501584371,0.0017241379310344827,0.04571393062612923,0.999,9/13,13.01%,ABCA1;SYK;CD36;ITGB2;PPARG;CD9;ITGB1;LPL;FCER1G
prerank,sensory perception of sound (GO:0007605),0.443871001194868,1.7337255861222944,0.0,0.06505135573662231,1.0,31/88,18.66%,GRM7;PCDH15;LHFPL3;PAX3;COL11A1;TMC1;DCDC2;ADGRV1;COL4A3;SPTBN4;TSPEAR;TFAP2A;ESPNL;OTOS;WHRN;TBX1;EML2;NDUFB9;TMIE;CLRN1;TIMM10;PDZD7;USH2A;MKKS;ATP2B2;TMC2;USP53;EPS8L2;ROR1;COL1A1;ALDH7A1
prerank,axonal fasciculation (GO:0007413),0.70532720106111,1.7337107021425413,0.004640371229698376,0.06447054006040247,1.0,7/12,16.11%,CNTN4;SEMA5A;NRCAM;CDK5R1;ARHGAP35;EPHB3;EPHA3
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.7389834942709693,-1.7330061683129079,0.003676470588235294,0.0458843810046511,1.0,3/11,6.32%,NRP1;RAC1;HGF
prerank,gene expression (GO:0010467),-0.3855903356884348,-1.7323117054369281,0.0,0.04606568006464818,1.0,142/348,26.82%,APOBEC1;RBM39;RBMS1;TSPAN14;MEF2A;AGO2;RPS18;NUP50;RPL7;RPS12;SRRM1;RNASEL;RPS21;RPS8;RPS24;GSPT1;RBPMS;MPHOSPH10;HHEX;NUP42;SARS1;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;RRBP1;CHTOP;NUP88;MRPL42;HNRNPH1;RPS14;RAE1;POLR2H;HNRNPL;E2F1;RPL32;CDC40;RPS15A;RPS28;RPS13;POLR2F;THAP1;AGFG1;POLR2L;RPS27A;DARS1;RPL28;ANGPT2;RPS4X;FASTKD2;NUP205;DUSP11;RPS23;UPF2;EIF4EBP2;ALYREF;HNRNPUL1;TPR;TSPAN17;RPL22;RPL14;EEF1A1;MRPS6;NUP188;RPL34;WDR33;MRPS11;RPS11;YTHDC1;POLR2A;RPL6;EPC1;RBMS2;NCBP1;EIF4G1;RPS10;THOC2;RPL18A;NFKBIB;MRPS16;NUFIP1;RPL37A;POLR2G;MRPL34;ATXN1;RPS9;TFIP11;MRPS15;RNPS1;RPS27;ABCF1;DTX1;RPS3;POLR3A;NUP153;THOC6;RPL23A;RPS16;NUP35;MAGOH;RPL9;SLU7;COPS5;MED20;CPSF3;RBM3;MMS19;NUP107;POLR2I;RPLP2;NOL9;DDX54;NUP62;XAB2;HNRNPK;XRN2;MRPL51;RPL41;TOPORS;RPLP0;RPL7A;SRSF11;SMG1;RPL19;RPS15;RPL39;DDX39B;DHX38;MRPL18;RANBP2;MRPS7;RBM15B;CPSF1;DEDD2;RPL5;RPL13;NUP37;U2AF2;LMF1;NKX2-8
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5642879542640659,1.7320243923068874,0.007246376811594203,0.06489937134579427,1.0,7/27,6.74%,CTNNA2;IL1RAPL1;NCS1;NTNG2;NTNG1;MARK1;HOMER1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5800450787971891,-1.7307926202791721,0.0034542314335060447,0.04658328848853855,1.0,11/27,9.70%,CD36;MAP3K1;IRAK2;TAB2;TLR4;IRAK4;IRAK3;MYD88;LY96;UBC;RPS27A
prerank,negative regulation of chemotaxis (GO:0050922),0.5344428081645056,1.7302599741920068,0.004761904761904762,0.06538554003284201,1.0,7/31,3.44%,ROBO1;ROBO2;SLIT2;SEMA6D;SEMA6A;SEMA3E;SEMA5A
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.6576748380231594,-1.7296626366074146,0.00505902192242833,0.046890065017328814,1.0,7/17,12.13%,BACH2;STAT3;TLR4;IL18;MYO1G;JAG1;CD46
prerank,response to zinc ion (GO:0010043),-0.5937154831142981,-1.727285710936806,0.0,0.047956247827539926,1.0,11/25,6.66%,SLC30A5;P2RX4;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;CRIP1
prerank,regulation of protein metabolic process (GO:0051246),-0.5154397302815713,-1.725510902675179,0.0,0.048697195413060446,1.0,18/44,19.56%,APOE;GSAP;TRAF3;WFS1;MAP2K5;PLAUR;MAPK7;NEDD4L;ZDHHC2;MTPN;APP;LTBP4;HSP90AB1;KLF2;SSH1;FAF1;FAM83D;LDLR
prerank,response to laminar fluid shear stress (GO:0034616),-0.7471908195045216,-1.7236115307956301,0.0035650623885918,0.04973764132188227,1.0,7/10,17.79%,ABCA1;NFE2L2;MAP2K5;MAPK7;KLF2;ASS1;SMAD7
prerank,phagosome acidification (GO:0090383),-0.5903431355357495,-1.722763288309946,0.006700167504187605,0.04996776414069069,1.0,10/26,16.62%,ATP6V0D2;ATP6V1E1;RAB7A;ATP6V1A;RAB20;TCIRG1;ATP6V1G1;ATP6V0B;ATP6V0E1;RAB39A
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.6289286337913764,-1.722464383502371,0.007207207207207207,0.049861387404781465,1.0,9/19,20.94%,TLR8;TLR7;TLR4;DHX9;IRF5;DHX36;MAVS;DDX3X;STAT1
prerank,regulation of interferon-alpha production (GO:0032647),-0.5969790161507725,-1.7205862697669951,0.0053475935828877,0.050856637164728026,1.0,10/23,20.94%,TLR8;TLR7;TLR4;DHX9;IRF5;NLRC3;DHX36;MAVS;DDX3X;STAT1
prerank,protein modification by small protein conjugation (GO:0032446),-0.3840972594660438,-1.7201485011009436,0.0,0.05084926257623513,1.0,126/361,23.32%,NSMCE2;RNF213;WWP1;CBL;ZNRF3;CNOT4;PEX14;KLHL24;BIRC6;FBXW8;NFE2L2;RNF111;NFX1;NUP50;MKRN2;PIAS1;BRCA1;ARRB2;MYLIP;WWP2;FBXL17;RNF41;CTR9;AMFR;AREL1;TNFAIP1;ATG7;RNF20;FBXO32;ATG10;NUP42;FBXW11;UBE2R2;KLHL25;UHRF2;ARRB1;NUP88;MGRN1;NUB1;UBR2;USP9X;RAE1;DET1;KCTD10;ZSWIM8;CBLL1;RNF38;TRIM47;UBA7;HIF1A;RFWD3;SPSB2;OTULIN;SELENOS;UBC;RPS27A;UBE2L3;RNF8;NUP205;EIPR1;DERL1;NEDD4L;KLHL18;DCUN1D4;TPR;PCNA;CUL4B;TSPAN17;ARRDC4;ASB5;TRIM24;FBXO10;TRIM68;UHRF1;UBE2H;NUP188;MOCS3;CUL2;TRIM11;WAC;ARIH1;ARRDC1;RNF25;RNF34;RNF43;UBE2G1;UBE2T;CDC34;HLTF;BRAP;TRIM14;USP7;UBE2C;ISG15;MIB1;UBA2;UBE2I;VHL;EYA1;ANAPC7;FBXO7;DTX1;NUP153;HUWE1;TRIM39;UBE2M;NUP35;ELOC;DTX3;RTF1;VPS18;NUP107;DTX3L;RACK1;NUP62;SMURF2;RNF135;EGR2;CCNF;UFM1;TOPORS;SUMO3;PRKDC;UBE2V2;MEFV;TRIM72
prerank,lymphocyte proliferation (GO:0046651),-0.6059911205005197,-1.7193776817140083,0.003430531732418525,0.05107550922336154,1.0,7/22,14.15%,PTPRC;ELF4;MSN;BCL2;PIK3CG;MEF2C;CD40
prerank,response to interferon-alpha (GO:0035455),-0.6711844837243149,-1.7181952636376265,0.0,0.05146643654330112,1.0,10/16,21.77%,AXL;IFNAR2;GAS6;EIF2AK2;BST2;IFITM2;IFNAR1;TPR;GATA3;IFITM1
prerank,negative regulation of viral genome replication (GO:0045071),-0.525609412854274,-1.7170006573189007,0.0016638935108153079,0.051984084108183705,1.0,19/40,21.84%,FAM111A;ZC3HAV1;RNASEL;RSAD2;EIF2AK2;BST2;IFITM2;RESF1;IFIT1;OASL;CCL5;OAS3;SETDB1;MAVS;ISG15;PARP10;OAS2;IFITM1;SRPK1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.4528325968006638,-1.7159170011134668,0.0,0.05244955815902562,1.0,23/91,11.05%,FTL;IREB2;SLC30A5;ABCB7;FRRS1;ATP6V1A;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;ATP7A;TMEM199;HMOX2;FLVCR1;SLC31A1;ATP6V1G1;CP;LCK;APP
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.46418589055751663,-1.7157107864485033,0.0,0.052358406793523056,1.0,27/74,20.30%,IGF1;MCL1;BIRC6;ARHGEF2;RIPK1;BRCA1;CFLAR;PSME3;ITGAV;BCL2;EYA4;PF4;MAP2K5;TGFBR1;MAPK7;RELA;SERPINE1;TRAF2;RNF34;TNFSF10;CASP8;EYA1;HSPA1A;EYA3;TRADD;DDX3X;GSK3B
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.6933740207901986,-1.7156464298132192,0.007067137809187279,0.05217457468925998,1.0,7/14,18.85%,CCR2;SYK;IL18;PTPN22;RASAL3;TGFBR2;LGALS9
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.7229409090920625,1.7153461674175363,0.013392857142857142,0.07381851525289286,1.0,3/11,9.60%,RTP4;PKD1L3;RTP2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.5251271904854409,-1.7130123415045646,0.010309278350515464,0.05376144304626351,1.0,20/42,22.34%,NRP1;CDK6;CD36;RAC1;ROCK1;PTPRJ;RIN2;PTK2B;UTRN;VEGFA;CIB1;PLEKHA2;LIMS1;CSF1;GSK3B;SFRP1;JUP;KDR;MAP4K4;CD3E
prerank,myoblast fusion (GO:0007520),0.693895432360216,1.7128655425138952,0.014285714285714285,0.07490899016462302,1.0,3/12,2.80%,ADGRB3;ADAM12;KCNH1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.7488123423764474,-1.7123574713072427,0.0035335689045936395,0.0538507491757291,1.0,7/10,16.42%,CD300A;ANO6;RAB31;STAP1;C3;NCKAP1L;APPL2
prerank,macrophage activation (GO:0042116),-0.5521965213752262,-1.712282607321745,0.005199306759098787,0.05364522683988335,1.0,16/34,24.41%,FOXP1;SYK;PLCG2;ITGB2;C1QA;SBNO2;C5AR1;TLR4;IFI35;APP;CRTC3;AGER;CD93;TMEM106A;IFNGR1;ITGAM
prerank,microvillus assembly (GO:0030033),-0.6743464255011284,-1.7116348262430734,0.0053285968028419185,0.053751456073705794,1.0,6/14,3.69%,RAP1B;RAP2B;RAP2A;FXYD5;MINK1;RAP1A
prerank,mitotic nuclear division (GO:0140014),-0.46906116209357546,-1.7114713314340324,0.0017421602787456446,0.05359969729453385,1.0,33/71,22.85%,RHOA;EPS8;STAG1;FLNA;NCAPG2;KIF3B;KIF11;PIBF1;SMC4;ABRAXAS1;STAG2;ARHGEF10;KLHL22;CENPK;TPX2;KIFC1;PPP2R2D;CHMP7;KNSTRN;CHMP2A;NUSAP1;INO80;SGO1;UBE2C;NDC80;KIF18B;SMC1A;RAB11A;CEP192;LSM14A;NUP62;CHMP4B;NSL1
prerank,histone methylation (GO:0016571),-0.5821433365298434,-1.7113237620581379,0.0017331022530329288,0.053415227872872464,1.0,10/26,15.15%,CREBBP;NSD3;PRMT2;SMYD2;SMYD3;EZH2;PRMT1;SMYD1;PRMT6;NSD1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.455659700740497,1.7110688790437072,0.0,0.07537182883534957,1.0,25/75,17.38%,CACNA2D1;SLC24A2;SLC8A3;SLC12A2;SLC12A8;SLC39A10;SLC12A1;KCNJ3;SLC9A2;KCNJ10;KCNJ6;KCNJ9;HCN2;ATP1A3;KCNJ16;SLC6A1;SLC8A2;ATP1B1;SLC12A5;KCNJ12;ATP2B4;TRPV3;SLC39A6;ATP1B2;TRPM2
prerank,regulation of nervous system process (GO:0031644),0.6193809927262177,1.7109640027050836,0.009779951100244499,0.07479005005754277,1.0,7/18,10.68%,DLGAP1;HTR2C;SLC8A3;DLGAP2;TMEM108;SLC8A2;DLGAP3
prerank,positive regulation of apoptotic process (GO:0043065),-0.38592791885826944,-1.7107714257608952,0.0,0.05346446215089043,1.0,97/293,21.40%,VAV3;MAP3K5;AKAP13;APAF1;ABR;CTSD;ITSN1;LILRB1;TNFAIP8;DAPK1;BCL6;CRADD;JUN;ARHGEF3;DNM2;NUPR1;ANO6;BCL2L11;MAP3K20;CTNNBL1;ARHGEF2;CALHM2;VAV1;RIPK1;FOXO3;FGD4;ATG7;NLRC4;ITGB1;RYBP;TOP2A;RARG;PRMT2;IRF5;DAPK3;RPS6;FGD3;STK3;CTNNB1;ARHGEF18;GRN;ATF6;E2F1;DNAJA1;TGFBR1;VAV2;SOS2;UBC;RPS27A;SIK1;SUDS3;TGM2;SCRIB;PLEKHG5;GNA13;DUSP6;FLCN;PSENEN;ARHGEF11;FAP;GADD45A;MLLT11;IGFBP3;EEF1E1;STK17B;IFIT2;TFAP4;TRIO;BTG1;MAP3K10;SHQ1;QRICH1;LATS2;ARHGEF5;FAF1;BID;KLF11;TNFSF10;SPHK2;BNIP3L;CASP8;RNPS1;PHLDA1;RPS3;TRIM39;TRADD;PDCD5;CASP2;DDX3X;HMGB1;ATM;C1QBP;SIRT2;SFRP1;ZC3H12A;CDK5;RACK1
prerank,regulation of mast cell activation (GO:0033003),-0.7314067197119987,-1.7097172148492104,0.0017211703958691911,0.05393008682851012,1.0,4/10,5.83%,LYN;CD84;CD300LF;MILR1
prerank,generation of neurons (GO:0048699),0.39058828923024286,1.709309113597967,0.0,0.0752461094237788,1.0,40/190,11.92%,PTPRD;ADGRL3;IL1RAPL1;ASTN2;AUTS2;MYT1L;SPOCK1;TAFA1;MAP1B;EML1;SOX11;GPM6A;NTRK2;SNPH;FUT9;CDKL5;ASTN1;SMARCA1;NRCAM;WNT9A;POU3F2;MARK1;TUBB2A;DCDC2;YAP1;FZD8;OLIG1;CX3CR1;PEX13;DNAAF4;EN1;POU4F2;NEUROD1;DNER;RELN;TGFB2;CDK5R1;PER2;BRSK1;HES5
prerank,cytosolic transport (GO:0016482),-0.44243084820102296,-1.7071996175627049,0.0,0.05513725862129349,1.0,47/108,22.68%,VPS13C;RAB7A;SNX2;VTI1A;VPS54;VPS13A;SNX6;KIF16B;STX8;SNX5;ANKFY1;TBC1D5;AP1G1;EPS15;EEA1;LAPTM5;SYS1;RAB5A;CORO7;TBC1D17;VPS26B;DCTN1;LAMP1;RAB29;VPS26A;WDR91;STX5;TBC1D10B;TBC1D23;TMEM87B;STX16;SNX16;BAIAP3;CLN3;SPAG9;ARL1;RILP;TMEM87A;SNX1;DOP1B;VPS51;TBC1D10C;SNX32;VPS50;PHETA1;BECN1;BET1L
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.5609821844595502,-1.7067290369322607,0.010638297872340425,0.05509430262316279,1.0,11/29,19.94%,CCR2;ANO6;CCR1;GAS6;CCL5;SERPINE1;PLA2G7;LGALS9;HMGB1;C1QBP;AGER
prerank,regulation of RNA splicing (GO:0043484),-0.4748049512258415,-1.7065970780831738,0.0,0.05496282398263022,1.0,37/69,26.35%,MBNL1;AHNAK;PTBP3;RBM39;ERN1;MBNL2;SON;TRA2B;AHNAK2;FUS;HNRNPH1;MBNL3;HNRNPL;RPS13;CWC22;METTL4;DYRK1A;CELF1;HNRNPLL;TMBIM6;YTHDC1;POLR2A;ZNF326;SRSF10;HSPA1A;SNRNP70;SLC38A2;GRSF1;HNRNPH2;HNRNPK;RBM38;SRPK1;RBM22;ESRP1;CLK4;LARP7;U2AF2
prerank,endosome organization (GO:0007032),-0.5258732717939502,-1.7064720018061286,0.0034482758620689655,0.054777205188062436,1.0,13/41,7.90%,TMCC1;SNX10;CORO1C;SNX3;PI4K2A;USP50;DNAJC13;USP8;PI4K2B;WASHC4;SNX33;ALS2;EEA1
prerank,protein deubiquitination (GO:0016579),-0.3961439271856239,-1.70606355820552,0.0,0.054852083858916365,1.0,103/242,27.93%,BIRC3;USP12;SNX3;DDB2;USP50;RHOA;OGT;ATXN7;PSME4;OTUD5;UCHL5;USP18;RIPK1;BRCA1;ARRB2;PSMB7;PSME3;ACTB;USP8;MINDY2;PSMB9;ABRAXAS1;TRAF3;WDR48;USP36;USP9X;BABAM2;USP3;ATXN3;TGFBR1;RNF123;HIF1A;PSMA8;OTULIN;UBC;RPS27A;ASXL1;SUDS3;TNIP2;PSMC3;WDR20;CDC25A;CDK1;STAM2;BABAM1;PSMD8;USP42;RNF128;TRAF2;PSMC4;USP35;PSMB10;USP40;PSMA1;JOSD1;YY1;INO80;USP30;OTUD4;USP11;INO80E;USP7;TNIP3;PSMB8;STAMBPL1;MINDY1;SKP2;SMAD7;INO80C;GATA3;ADRB2;MDM4;BRCC3;COPS5;MBD6;PSMA5;PSMD4;PSMB3;BAP1;PSMD3;ZC3H12A;USP9Y;NLRP3;SMURF2;ZRANB1;POLB;BECN1;PSMB1;MYC;RCE1;TADA3;USP34;USP16;SIAH2;SMAD4;ENY2;VCP;STAMBP;ESR1;USP28;UIMC1;EP300;JOSD2
prerank,response to ethanol (GO:0045471),0.6585887021844054,1.7058310468354465,0.01485148514851485,0.07699414152437936,1.0,4/14,1.86%,GRIN2A;GRIN2B;GRIN3A;GLRA1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.5934066666298272,-1.7050635862682648,0.007352941176470588,0.05532105571377439,1.0,9/22,20.25%,CD44;MYADM;GCNT2;MAP2K5;MAPK7;LCK;FLOT2;AGER;WNK1
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.36846680483951,-1.7049235286288413,0.0,0.055136315789350666,1.0,186/509,24.51%,IQGAP1;LYN;SASH1;PTPRC;OSBPL8;AKAP13;PRKCB;IGF1;BCAR3;CD74;FGR;GRB2;BIRC3;GAB2;MFHAS1;PLCG2;REL;LITAF;AXL;CBL;RAC1;ROCK1;PTPRJ;CGAS;NUPR1;HPSE;RHOA;BCL2L11;PIK3R5;GAPDH;INSR;FLNA;IGF1R;P2RX4;PIK3AP1;BRD4;TLR7;VAV1;MALT1;RIPK1;ALPK1;TRAF5;HTR2B;DHX58;TAB2;PELI1;CFLAR;CARD11;TLR4;IL18;FLT1;ITGB1;ITGAV;BCL2;IRAK4;RNF31;RPS20;TFG;DDX60;RBCK1;PIK3CB;FN1;HGF;PIK3CG;GCNT2;IFI35;GAS6;PLK2;HIP1;VEGFA;EIF2AK2;PUM2;LAPTM5;MYD88;WLS;FRS2;BST2;FNIP1;TGFBR1;NEK6;CD28;GSDME;NOD1;ITGB1BP1;PTPN6;ADAM8;FIS1;TGM2;CD27;SPRY2;TNIP2;RELA;PLEKHG5;AGT;STYXL1;LCK;NCF1;APP;STRN;RRAGD;FLCN;PIK3CA;F7;TICAM1;OASL;CLEC6A;JMJD8;CCL5;HSP90AB1;TRIM68;LGALS1;CASP1;TRAF2;KSR1;PIK3CD;DHX36;BBC3;CD40;IKBKB;MAVS;DDX1;TRIM14;HCLS1;BID;TNFSF10;GPRC5B;SPHK2;ZCCHC3;CASP8;IRS2;LILRA5;LIMS1;GATA3;RPS3;RYK;HCST;PTPN11;MMP8;PDGFRB;TRADD;MIER1;RHEB;ADRB2;LGALS9;SHISA5;DDX3X;NDFIP2;NOD2;HMGB1;F10;TMED4;C1QBP;AGER;TICAM2;S100A4;MAZ;KDR;TRIM25;PDGFA;RACK1;NUP62;HAX1;TMEM106A;ZDHHC13;HTR6;FGF18;ILK;BECN1;IL6;TCIM;TMEM9B;WDR24;MTDH;KITLG;PUM1;TGFB1;HMOX1;RPS15;PIM2;LRRC19;MAP3K3;LRP2;FGF9;FLT3;SHC1;DCN
prerank,organophosphate ester transport (GO:0015748),-0.5850976315607366,-1.704909471946428,0.006993006993006993,0.0548988589848297,1.0,9/24,11.01%,OSBPL8;PLTP;PITPNC1;PITPNA;PITPNM1;EPG5;OSBPL5;PRELID2;NPC2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.7330610942792454,-1.70478174825866,0.006644518272425249,0.05473382318350716,1.0,4/10,9.54%,PTPRC;IRAK3;MAP2K5;MAPK7
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.45076112833164145,-1.7028277783153358,0.001639344262295082,0.055642240146629905,1.0,39/95,21.62%,LILRB1;VIM;AXL;RHOA;TNFRSF1B;SBNO2;CTR9;TLR4;CHMP5;STAP1;NFKB1;ADAM9;MAPK14;PF4;CYRIB;SIRPA;MYD88;MEF2C;LY96;SELENOS;TNIP2;RELA;XBP1;TICAM1;HMGB2;SERPINE1;FCGR2B;CASP1;DEFA6;NFKBIL1;NFKBIB;TNIP3;NOD2;HMGB1;TICAM2;CD274;SIRT2;ZC3H12A;NLRP3
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.6367654336609339,-1.702779400622394,0.008503401360544218,0.05542177164448094,1.0,6/17,5.26%,RBPJ;CREBBP;PLXND1;MAML1;MAML2;DLGAP5
prerank,defense response to bacterium (GO:0042742),-0.4434771267169395,-1.7023761876244417,0.0,0.05546488917694588,1.0,38/105,24.80%,LYST;FGR;STAB1;SYK;PRKCD;OPTN;IL6R;TLR4;NLRC4;RAB1A;LYZL4;CFP;RNASE7;MYD88;NOD1;GBP2;CHGA;RNASE6;CAMP;HMGB2;SERPINE1;FCER1G;OAS3;DEFA6;ANG;MAVS;SPN;ISG15;PLA2G6;NOD2;GBP7;GBP6;OAS2;CEBPB;IL6;RPL39;SHC1;GBP4
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.6396914696350977,-1.702311247062629,0.0034662045060658577,0.05526835503956567,1.0,13/18,28.75%,CCR2;NCKAP1L;IKZF3;XRCC6;CD2;IL4I1;PRKDC;ZFP36L1;METTL3;TBX21;CRTAM;PRELID1;SPINK5
prerank,cardiac muscle cell contraction (GO:0086003),0.6050285703658098,1.7022814007770053,0.011389521640091117,0.07886327407989725,1.0,5/19,3.31%,FGF12;CACNA1C;CACNA2D1;SCN2B;SCN1A
prerank,phagosome-lysosome fusion (GO:0090385),-0.7436954016594416,-1.700289307010516,0.006700167504187605,0.056428902816461575,1.0,8/10,19.28%,RAB7B;RAB7A;ARL8B;RAB20;CLN3;RAB39A;RAB34;PLA2G5
prerank,membrane assembly (GO:0071709),0.5160378707531525,1.7002483945506315,0.007352941176470588,0.07955022084899946,1.0,7/34,4.49%,NLGN1;NRXN1;PTPRD;IL1RAPL1;ANK3;NRXN2;STX2
prerank,natural killer cell activation (GO:0030101),-0.593010765588151,-1.6999323688965373,0.0016722408026755853,0.05635645398912178,1.0,11/23,17.31%,PTPRC;ELF4;SLAMF7;AXL;SNX27;PRDX1;CD2;KAT7;PIK3CD;ULBP1;CASP8
prerank,long-chain fatty acid transport (GO:0015909),-0.5606921070775103,-1.6996998660811014,0.0,0.056295120651062236,1.0,8/30,4.06%,APOE;CD36;FABP5;ABCD2;PRKAG2;PPARG;CPT1A;SLC27A1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.5614438945745341,1.6996333022959345,0.007194244604316547,0.07934613497005306,1.0,4/25,1.17%,ANK2;CTNNA3;CACNA1C;RYR2
prerank,DNA recombination (GO:0006310),-0.5362332503839566,-1.698911244965067,0.005405405405405406,0.05658975725269076,1.0,21/37,26.01%,RAD51B;BLM;RTEL1;RAD51;HDAC10;GEN1;WRN;RAD54L;EXO1;ENDOG;RHNO1;RAD54B;RAD52;XRCC3;HMGB1;HMGB3;DMC1;RAD51C;TSN;RECQL5;MRE11
prerank,regulation of actin filament-based movement (GO:1903115),0.718159821446985,1.6977703425459159,0.011627906976744186,0.0798825850692865,1.0,3/10,3.39%,PDE4B;ANK2;PDE4D
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6729499325402951,1.697442468127324,0.006787330316742082,0.07955004453600131,1.0,3/12,1.17%,CTNNA3;CACNA1C;RYR2
prerank,regulation of p38MAPK cascade (GO:1900744),-0.5325734123111585,-1.6971676528402218,0.0066555740432612314,0.057412833033357834,1.0,11/35,11.99%,SASH1;MFHAS1;XDH;RELL1;MINK1;SPI1;PTPN22;VEGFA;PRMT1;NCF1;GADD45A
prerank,regulation of autophagy (GO:0010506),-0.3975621373689939,-1.6966159296329038,0.0,0.05749814942092693,1.0,74/216,23.50%,ATP6V0D2;TFEB;DAPK1;PSAP;MCL1;GPR137B;ATP6V1E1;ROCK1;NUPR1;ITPR1;ERN1;GAPDH;OPTN;PIP4K2A;PRKAG2;ABL2;HTR2B;ATP6V1A;STAT3;FOXO3;TAB2;MTMR3;SNX6;BCL2;CTSA;SNX5;PTPN22;DAPK3;EIF4G3;PIK3CB;HGF;KLHL22;EXOC4;USP36;ATF6;PLK2;ATP6V1G1;VPS26B;RRAGD;FLCN;TICAM1;STK11;VPS26A;TRIM68;EEF1A1;SH3GLB1;RB1CC1;ATP6V0B;CAPNS1;PIK3C2A;EIF4G1;TRIM14;ATP6V0E1;RMC1;TMEM59;RHEB;HSPB1;DCAF12;HMGB1;ATM;GSK3B;ATP6V0D1;SIRT2;ZC3H12A;CDK5;HAX1;PRKAG1;SNX32;GFAP;MEFV;WDR24;TPCN2;MTDH;PIM2
prerank,positive regulation of organelle assembly (GO:1902117),-0.514086209385405,-1.692901643459845,0.003436426116838488,0.05991579272457339,1.0,16/44,17.46%,SDCBP;ASAP1;PDCD6IP;PIP4K2A;CNOT1;CNOT2;DYNC1H1;RAB3GAP1;CAPG;LCP1;SDC4;CCDC88A;SH3GLB1;G3BP1;CNOT6L;RALB
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.43850990056627,-1.692564351113172,0.001644736842105263,0.05985632685086435,1.0,34/98,15.13%,PID1;APOE;GRB2;XDH;PPARD;INSR;ANXA2;PPARG;RIPK1;IL10RB;ARRB2;RNF41;RAB1A;TBC1D5;NR1H2;MAPK14;ARRB1;VEGFA;CD63;SCRIB;AGT;CDK1;IFNAR1;RAB29;GADD45A;CCL5;CBR1;UHRF1;TGFBR2;GREM1;AGPAT1;ACACB;GHITM;EIF4G1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.5661659032648264,-1.6919119832896181,0.003527336860670194,0.06004817371051189,1.0,12/29,15.67%,CCR2;PIAS1;CTR9;STAT3;IL15;STAT6;IFNAR2;STAT5B;STAT4;IFNAR1;SOCS6;IL31RA
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.7078222699185293,-1.6911092071446852,0.011784511784511785,0.06033019200493778,1.0,5/11,3.98%,BIRC3;NUPR1;ARHGEF2;RIPK1;PELI1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.6638927679983708,-1.6909731568024378,0.0052173913043478265,0.06017329895526996,1.0,6/15,9.63%,APOE;SNX9;TNFRSF1B;ADAM9;SNX33;ADAM8
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.6768676857142563,-1.690709155862414,0.0,0.06005813850971719,1.0,3/14,4.21%,CD84;PAEP;IL18
prerank,negative regulation of interferon-beta production (GO:0032688),-0.7479336466274663,-1.6901273860213386,0.005338078291814947,0.06019567757047344,1.0,7/10,14.85%,LILRB1;REL;PPM1B;SIRPA;NLRC3;YY1;RELB
prerank,receptor internalization (GO:0031623),-0.5173359327313529,-1.6896061229120976,0.005,0.06030702482660786,1.0,15/44,8.68%,GRB2;LILRB1;SYK;LRP1;CD36;ITGB2;DNM2;RAB31;CD9;ARRB2;GRK3;ITGB1;ARRB1;PICALM;RAB5A
prerank,DNA-dependent DNA replication (GO:0006261),-0.4183732417832438,-1.6890292027016405,0.0,0.06040248723253359,1.0,53/128,25.44%,PSME4;PSMB7;POLE2;RFC1;PSME3;NOC3L;BLM;PSMB9;PRIMPOL;GINS3;MCM6;RAD51;PSMA8;UBC;RPS27A;SSBP1;MCM3;PSMC3;DBF4;WRN;PSMD8;ORC5;BAZ1A;PSMC4;PSMB10;RPA3;RFC2;PSMA1;POLD2;MCMBP;CDC34;TOPBP1;MCM2;PSMB8;PRIM1;LRWD1;DNA2;PRIM2;PSMA5;PSMD4;PSMB3;RFC3;PSMD3;GINS4;POLB;POLG2;CDC45;TWNK;PSMB1;MCM5;POLD4;CDK2AP1;RECQL5
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.5360163641639292,-1.6880458697050937,0.005084745762711864,0.06082548218665377,1.0,14/34,29.86%,PTPRC;SASH3;PTPN22;LAPTM5;DNAJB9;XBP1;SLC7A5;SPHK2;STX4;NOD2;IL6;RBP4;IL2;VAMP3
prerank,Rap protein signal transduction (GO:0032486),-0.7413511083217339,-1.6871907440745202,0.005434782608695652,0.061131130648166096,1.0,5/10,7.62%,RAP1B;RAP2B;RAP2A;RAP1A;PLK2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.5185283064462876,-1.6871151230897132,0.0034071550255536627,0.06092114751814001,1.0,16/41,22.49%,IGF1;LILRB1;TLR4;PTPN22;IRAK3;GAS6;SIRPA;PTPN6;SELENOS;NLRC3;NFKBIL1;ARG2;RARA;LGALS9;ZC3H12A;NR1H4
prerank,regulation of AMPA receptor activity (GO:2000311),0.559458095810224,1.6868551277718116,0.02097902097902098,0.0866649225909711,1.0,10/25,14.13%,NLGN1;SHISA6;GSG1L;SHANK3;SHISA9;CACNG4;CACNG2;RELN;ARC;NLGN2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.48130409680026676,-1.6865508292292004,0.005,0.0611060235885419,1.0,24/55,26.05%,PID1;GRB2;XDH;RAC1;RIPK1;BRCA1;RNF41;MAPK14;AGT;BCO2;GADD45A;CBR1;TGFBR2;MPV17;AATF;BST1;SPHK2;PDGFRB;SIRT2;ZC3H12A;CYP1B1;DHRS4;MT3;EIF6
prerank,regulation of integrin activation (GO:0033623),-0.6697909791612964,-1.6859251432286149,0.007017543859649123,0.0612453744898619,1.0,6/15,10.62%,FBLIM1;PLEK;RAP1B;PIEZO1;PTGER4;KIF14
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.5884282061468303,-1.6858523531745557,0.00847457627118644,0.06105205764061707,1.0,13/22,29.31%,RFTN1;LY9;IL15;IL18;MYD88;SLC7A5;NOD2;SLAMF6;NR1H4;IL6;TGFB1;ZBTB7B;IL2
prerank,ventricular septum development (GO:0003281),0.5094733287567521,1.685422313417018,0.00477326968973747,0.08700404373549137,1.0,8/37,5.02%,ROBO1;ROBO2;SOX11;SLIT3;SLIT2;ZFPM2;ACVR1;MATR3
prerank,regulation of T cell cytokine production (GO:0002724),-0.667522578009589,-1.68487545363195,0.003395585738539898,0.061389651580645986,1.0,6/15,17.79%,CCR2;TNFRSF1B;MALT1;B2M;TRAF2;SMAD7
prerank,response to ionizing radiation (GO:0010212),-0.46894110356656776,-1.6841533526912476,0.0,0.06164235631419401,1.0,35/70,27.50%,GRB2;SPIDR;BRCA1;NABP1;ANXA1;BLM;ABRAXAS1;MAPK14;RAD1;BABAM2;RAD51;RFWD3;RNF8;GADD45A;BABAM1;STK11;TICRR;XRCC4;RHNO1;RAD51AP1;INO80;TOPBP1;EYA1;RAD9A;EYA3;BRCC3;ATM;FANCD2;MYC;ECT2;EEF1D;CLOCK;USP28;COP1;UIMC1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.7134112252146829,-1.6839478274500295,0.006711409395973154,0.06153649317455489,1.0,6/11,17.14%,TET3;OGT;CTR9;KMT2D;TET2;KMT2A
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.5141798042305304,-1.6834592790005647,0.0,0.06159465667236483,1.0,17/43,22.49%,IGF1;LILRB1;TLR4;PTPN22;IRAK3;GAS6;SIRPA;PTPN6;SELENOS;NLRC3;NFKBIL1;ARG2;RARA;LGALS9;CD274;ZC3H12A;NR1H4
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.43270075761004384,-1.6833277017883235,0.0,0.06144198428578845,1.0,35/105,20.83%,LYN;SYK;PLCG2;PAK2;PRKCD;CREBBP;PSME4;MALT1;TAB2;PSMB7;CARD11;PSME3;NFKB1;FBXW11;CLEC10A;PSMB9;PSMA8;CLEC4D;RELA;PSMC3;PSMD8;CLEC6A;FCER1G;PSMC4;PSMB10;PSMA1;IKBKB;RELB;PSMB8;KRAS;NRAS;PSMA5;PSMD4;PSMB3;PSMD3
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5464890488434425,-1.683299496563567,0.003669724770642202,0.061228571627601855,1.0,17/34,23.32%,NEDD9;NRP1;RREB1;RAC1;FLNA;CDC42;TRIOBP;DOCK5;MYADM;MDK;CRK;CIB1;CRKL;LIMS1;C1QBP;ILK;P4HB
prerank,regulation of immunoglobulin production (GO:0002637),-0.6027031093380842,-1.6832900573380338,0.006802721088435374,0.06100256651490409,1.0,11/23,29.86%,PTPRC;SASH3;CD22;DNAJB9;XBP1;FCGR2B;STX4;IL6;RBP4;IL2;VAMP3
prerank,positive regulation of T cell proliferation (GO:0042102),-0.4792284341585642,-1.6830329340773782,0.001694915254237288,0.06094372136746924,1.0,29/55,32.12%,PTPRC;IGF1;CCR2;SYK;IL15;IL18;ANXA1;CD28;NCKAP1L;CD46;CCL5;IL27RA;RPS3;HMGB1;AGER;CD274;TNFSF9;CD3E;IL6;NCK1;IL12RB1;TNFRSF13C;PNP;IL2;IGFBP2;NCK2;SLC7A1;CCL19;CD80
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.5851707796196625,-1.6824589130506575,0.010398613518197574,0.061073664528502145,1.0,9/22,12.80%,CD300A;PTPRJ;DGKZ;LPXN;CD22;PTPN22;DUSP3;LAPTM5;FCGR2B
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.7443253028279413,-1.682296396031478,0.007029876977152899,0.06092587561750274,1.0,5/10,8.31%,MSN;RHOA;RAP2A;CDC42;SH3BP1
prerank,actin nucleation (GO:0045010),-0.5911329174615749,-1.681454922287972,0.008532423208191127,0.061265178292804756,1.0,9/21,16.47%,IQGAP2;ARPC2;ACTR2;ACTR3;ARPC3;ARPC1B;ARPC1A;ARPC5;ARPC5L
prerank,cellular response to lectin (GO:1990858),-0.4327138543172541,-1.680839191295423,0.0,0.0611430880233315,1.0,35/104,20.83%,LYN;SYK;PLCG2;PAK2;PRKCD;CREBBP;PSME4;MALT1;TAB2;PSMB7;CARD11;PSME3;NFKB1;FBXW11;CLEC10A;PSMB9;PSMA8;CLEC4D;RELA;PSMC3;PSMD8;CLEC6A;FCER1G;PSMC4;PSMB10;PSMA1;IKBKB;RELB;PSMB8;KRAS;NRAS;PSMA5;PSMD4;PSMB3;PSMD3
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.4327138543172541,-1.680839191295423,0.0,0.0611430880233315,1.0,35/104,20.83%,LYN;SYK;PLCG2;PAK2;PRKCD;CREBBP;PSME4;MALT1;TAB2;PSMB7;CARD11;PSME3;NFKB1;FBXW11;CLEC10A;PSMB9;PSMA8;CLEC4D;RELA;PSMC3;PSMD8;CLEC6A;FCER1G;PSMC4;PSMB10;PSMA1;IKBKB;RELB;PSMB8;KRAS;NRAS;PSMA5;PSMD4;PSMB3;PSMD3
prerank,inorganic ion transmembrane transport (GO:0098660),0.6809430473912779,1.6807232105903194,0.023809523809523808,0.08993736366041202,1.0,1/12,0.21%,ASIC2
prerank,cellular response to interferon-gamma (GO:0071346),-0.4418400703123486,-1.6801111407312743,0.0016638935108153079,0.06139921961172602,1.0,37/88,26.76%,CD44;SP100;DAPK1;PRKCD;GAPDH;IRF2;TLR4;IRF5;DAPK3;CIITA;SIRPA;GBP5;B2M;JAK1;GBP2;IFNGR2;OASL;CCL5;TRIM68;CASP1;OAS3;MT2A;HCK;LGALS9;GBP3;GBP7;GBP6;OAS2;STAT1;TRIM25;IFNGR1;CD47;CCL7;GBP4;MID1;IL12RB1;PML
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.4695211417785909,-1.6794634161718445,0.0034129692832764505,0.06157058461761142,1.0,23/65,11.72%,BCAR3;GRB2;CBL;PTPRJ;SH3KBP1;CDC42;PTPN12;ARAP1;TSG101;DUSP3;MVP;DGKD;RHBDF1;EPS15;HIP1;RHBDF2;PLAUR;MVB12B;AFAP1L2;SPRY2;AGT;STAM2;CCDC88A
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.6771869667969879,-1.678486885441342,0.01340033500837521,0.061933285529958144,1.0,8/13,19.93%,ZMIZ1;ARID1B;SPI1;ARID1A;ELOF1;ZMIZ2;SERTAD1;CHEK1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.5893376306525971,1.6772432755313555,0.01583710407239819,0.09177262399197134,1.0,9/20,20.62%,B3GALT1;FUT9;B3GALT5;FUT8;ST3GAL6;B4GALNT2;B3GALT4;ST6GALNAC5;MPDU1
prerank,spinal cord development (GO:0021510),0.671658129244158,1.6764609090779858,0.01834862385321101,0.0917078497295056,1.0,5/12,11.28%,SOX11;SOX12;VIT;RELN;PKD1
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.3759847650748099,-1.6763460706463622,0.0,0.06318881735393952,1.0,136/336,27.53%,LYN;FNIP2;VAV3;FOXP1;TAOK3;FAM111A;SUSD6;GRB2;BCL6;MCL1;SAMHD1;DDB2;CGAS;TNFRSF1B;BCL2L11;BACH1;SPIDR;RAD51B;PSME4;BRCA1;MAPKAPK2;UVRAG;DYRK2;POLE2;NIPBL;TOP2A;RNF169;BCL2;NABP1;PARP4;BLM;MAPK14;BATF;RAD1;RTEL1;CRIP1;MACROD1;WDR48;REXO4;PWWP3A;KMT5B;ALKBH1;BABAM2;USP3;E2F1;PCLAF;UBA7;RAD51;MASTL;RFWD3;KMT5C;MGMT;RNF8;MCM9;APTX;TAOK1;TIMELESS;LIG1;WRN;CDK1;CUL4B;RAD54L;GADD45A;STK11;EXO1;ASF1A;FEN1;CIB1;TICRR;PLK3;WDR76;RFC2;WAC;ERCC4;APLF;RAD51AP1;DOT1L;YY1;INO80;RAD52;UBE2T;NSMCE3;SLX4;AATF;UBQLN4;TOPBP1;BID;TAF9;XRCC3;RAD9A;RPS3;NCOA6;RBBP8;TAOK2;CASP2;ADPRS;ATM;TRIP12;FBXO31;CHEK1;SMC1A;MMS19;RFC3;DTX3L;PDS5B;ZC3H12A;NBN;ALKBH3;FAN1;CCNK;SFN;SMC6;BCL2L2;TOPORS;POLB;PRKDC;ZRANB3;MTREX;EID3;SMC5;MYC;RAD51C;DDB1;TRIM28;RECQL5;BAZ1B;BLK;USP16;MRE11;RBBP5;PML;VCP;ASH2L;USP28;METTL3;BOD1L1
prerank,regulation of regulated secretory pathway (GO:1903305),0.5184988373460867,1.6761427735298866,0.019801980198019802,0.0912951396178546,1.0,12/34,13.01%,RIMS2;RIMS1;SYT1;SYT10;SYN1;SYT2;RAB15;SYT5;SYT11;SYT12;DOC2A;SYT7
prerank,V(D)J recombination (GO:0033151),-0.7155298525882601,-1.6760744458161247,0.014084507042253521,0.0631195241602767,1.0,8/11,25.05%,LIG1;HMGB2;XRCC4;TCF3;LIG3;HMGB1;PRKDC;DCAF1
prerank,lipoprotein localization (GO:0044872),-0.7113571796365149,-1.6760039521956753,0.005154639175257732,0.06295096229308189,1.0,4/11,3.16%,PRKCB;LRP1;CD36;PPARG
prerank,regulation of acrosome reaction (GO:0060046),0.7279249617877674,1.6758627566635462,0.01,0.09083266658092892,1.0,3/10,9.63%,PLCB1;GLRA1;PLA2G10
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.4109569104265016,-1.6751317892751476,0.0,0.06338463023697002,1.0,56/149,22.63%,PRKCH;PRKCB;CD36;RAB7B;ARHGEF2;MALT1;RIPK1;IRAK2;TRAF5;STAT3;TAB2;CFLAR;CARD11;TLR4;IL18;NLRC4;DHX9;NFKB1;AIM2;RNF31;RBCK1;IRAK3;IL18RAP;EIF2AK2;MYD88;NOD1;ADAM8;UBC;RPS27A;RELA;TRAF1;AGT;MTPN;APP;TICAM1;CIB1;TRIM68;TRAF2;CD40;RNF25;FLOT2;IKBKB;NFKBIB;TRIM14;IL18R1;HSPA1A;RPS3;TRADD;LGALS9;NOD2;AGER;TRIM25;NLRP3;ZBTB7A;RPS6KA5;IL6
prerank,regulation of interleukin-1 production (GO:0032652),-0.6429825568354206,-1.675096215048412,0.0,0.06320282440688624,1.0,6/15,7.96%,FOXP1;TLR4;TMED10;ANXA1;GAS6;SIRPA
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.4552740678770153,-1.674951677031488,0.0017064846416382253,0.06308962922809899,1.0,23/75,16.15%,LYN;APOE;CD300A;PRKCD;RB1;PTPRJ;IPO5;HHEX;PIK3CB;LRP6;IRAK3;PKIB;STK38;SLC8A1;INCA1;SPRY2;AGT;PAQR3;CDK5RAP1;GADD45A;TFAP4;RGS14;LATS2
prerank,activation of GTPase activity (GO:0090630),-0.44062280464051173,-1.674069344440144,0.0,0.06338846135859454,1.0,32/89,18.32%,ABR;CORO1C;ARHGAP25;ARHGAP22;ARHGAP24;SIPA1;TBC1D15;SGSM2;TBC1D2B;TBC1D9;TBC1D5;TBC1D1;SIPA1L2;ARHGEF10;TBC1D22A;SIPA1L3;TBC1D16;TBC1D22B;TBC1D8B;TBC1D8;SCRIB;TBC1D17;CCDC125;FOXJ1;TBC1D10B;RALGAPA2;TBC1D30;ARHGEF5;TBC1D7;TBC1D9B;GPR65;TBC1D25
prerank,zinc ion homeostasis (GO:0055069),-0.5611321184619331,-1.6740604296218398,0.009041591320072333,0.06316407565391763,1.0,9/28,4.19%,SLC30A5;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,synaptic vesicle endocytosis (GO:0048488),0.5216762644889652,1.6735532915132805,0.002551020408163265,0.09182261633665334,1.0,11/33,6.50%,NLGN1;DNAJC6;DNM3;SYT1;AMPH;SNAP91;SYNJ2;SYT2;DNM1;STON1;SYT5
prerank,nucleotide catabolic process (GO:0009166),-0.6385826363242687,-1.6735439150966582,0.007168458781362007,0.06331405307553241,1.0,5/16,9.96%,GDA;XDH;SAMHD1;DERA;NT5C2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.5325764155548202,-1.6733512230775558,0.0034662045060658577,0.06321534684131785,1.0,13/34,16.86%,LYN;MFHAS1;CD300A;RAB7B;CD300LF;TLR4;IRAK3;GRAMD4;LY96;TICAM1;NFKBIL1;OTUD4;GPR108
prerank,regulation of interleukin-12 production (GO:0032655),-0.49581157932846653,-1.6726337150813235,0.005190311418685121,0.06349183779042922,1.0,20/47,19.94%,FOXP1;LILRB1;SYK;PLCG2;TLR8;PIBF1;TLR4;IRF5;MAPK14;IRAK3;MDK;LAPTM5;MAST2;CD40;LILRA5;CMKLR1;LGALS9;HMGB1;C1QBP;AGER
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.6704480118639788,1.6713782261855636,0.022172949002217297,0.09277270888313503,1.0,8/12,16.28%,DPYD;DPYS;CDA;DPYSL5;DPYSL4;DPYSL3;CTPS1;DPYSL2
prerank,tryptophan catabolic process (GO:0006569),-0.6977090840813385,-1.6689097806779827,0.0051813471502590676,0.06586483384295623,1.0,4/11,12.50%,KYNU;KMO;KYAT1;IL4I1
prerank,kinetochore organization (GO:0051383),-0.6806441237442723,-1.6664888930813622,0.023636363636363636,0.06724985156104529,1.0,8/13,17.75%,CENPF;DLGAP5;CENPA;CENPE;POGZ;NUF2;NDC80;CENPH
prerank,mitotic chromosome condensation (GO:0007076),-0.5762933363352546,-1.6654228361650694,0.008635578583765112,0.06779249586009986,1.0,16/26,24.74%,RB1;CSNK2A1;NCAPG2;SMC4;NCAPH;MCPH1;CDK1;CHMP1A;NUSAP1;NCAPD3;KMT5A;PHF13;NCAPG;SET;CCNB1;AKAP8L
prerank,regulation of leukocyte activation (GO:0002694),-0.6571551469516437,-1.6627171021858904,0.01718213058419244,0.06954756493756173,1.0,4/14,1.45%,LYN;CD74;MFHAS1;GPR137B
prerank,myeloid cell development (GO:0061515),-0.6305379072543822,-1.6625580385534222,0.008517887563884156,0.06942040776726673,1.0,5/18,11.05%,FOXP1;NRROS;ANXA2;NCKAP1L;APP
prerank,regulation of interleukin-17 production (GO:0032660),-0.5437101417179832,-1.6613429273057665,0.005272407732864675,0.0699627107180202,1.0,13/31,23.39%,RFTN1;LY9;IL15;TLR4;IL18;MYD88;NCKAP1L;SLC7A5;NOD2;SLAMF6;NR1H4;IL6;TGFB1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.5552941762729033,1.6607554782838032,0.023474178403755867,0.10068459873178774,1.0,8/24,13.93%,AGBL4;TTLL11;TTLL7;TTLL10;TTLL5;NAA10;GGCX;TTLL9
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.45665045485134115,-1.6603979982533668,0.0051635111876075735,0.07040237292782377,1.0,19/72,12.02%,APOE;NRP1;ABCA1;AKAP13;STARD8;MYO9B;RAC1;ARHGEF3;EPS8;ARHGEF2;ABL2;TNFAIP1;RIPOR2;ARRB1;ARHGEF18;KCTD10;CCDC125;FLCN;ITGA3
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.7002859433192936,-1.6602204914857706,0.013445378151260505,0.07029498926216794,1.0,7/11,19.93%,ZMIZ1;ARID1B;ARID1A;ELOF1;ZMIZ2;SERTAD1;CHEK1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.4655909687970179,-1.659589663548974,0.0033333333333333335,0.07054690990457804,1.0,30/58,27.50%,NSMCE2;BRCA1;UVRAG;ERCC6;DCLRE1C;ABRAXAS1;BABAM2;KDM2A;RNF8;DCLRE1A;XRCC6;BABAM1;HMGB2;XRCC4;ERCC4;LIG3;BRCC3;HMGB1;ATM;NBN;ZBTB7A;POLB;PRKDC;UBE2V2;DNTT;SMC5;UBE2N;MRE11;DCLRE1B;UIMC1
prerank,membrane depolarization during action potential (GO:0086010),0.5476733828901403,1.6595597906678097,0.015659955257270694,0.1008833643883834,1.0,7/26,6.48%,CACNA1C;SCN2A;SCN2B;SCN1A;SCN3A;SCN9A;HCN2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.6828356013600538,-1.659004088195923,0.008333333333333333,0.07078007769892886,1.0,6/12,18.51%,PLCG2;CYBA;CD36;TLR4;SLC5A3;MMP8
prerank,ureteric bud development (GO:0001657),0.5989653197964738,1.6574282955174153,0.015228426395939087,0.10194768248107554,1.0,5/17,9.17%,ROBO2;SLIT2;WT1;BMP7;SALL1
prerank,positive regulation of lipid storage (GO:0010884),-0.5929323200987289,-1.6566081519957283,0.012345679012345678,0.07213928292899717,1.0,8/21,14.42%,MSR1;PLIN2;NFKB1;C3;LPL;OSBPL11;APOC4;EHD1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.5518945724791925,-1.6564426023404581,0.00684931506849315,0.07201474776050634,1.0,10/27,13.08%,VPS13C;OPTN;VPS13A;IFT20;COG7;TMED10;GBP5;SYS1;PAQR3;ARL5A
prerank,regulation of neuron differentiation (GO:0045664),0.43996209381858065,1.6563154836902616,0.004672897196261682,0.10212954372920821,1.0,24/76,13.98%,NLGN1;BRINP3;BRINP1;CNTN4;SOX11;NRCAM;ZEB1;VWC2;MOSMO;ALK;BDNF;HOXD3;BMP7;CDK5RAP3;ADRA2C;NEUROD1;ZFHX2;LTK;NBL1;CDK5R1;HES5;REST;CDK5RAP2;HES1
prerank,response to calcium ion (GO:0051592),0.4101565649271454,1.655726876916383,0.0026041666666666665,0.10182036003962038,1.0,34/102,13.07%,NLGN1;RYR3;RYR2;SYT1;ADCY8;SYT10;KCNMB3;KCNMB2;TRPC1;KCNH1;SYT2;CPNE4;PDCD6;AHCYL1;CASQ2;SYT5;HOMER1;KCNIP2;ADGRV1;NEDD4;ADCY1;SYT11;SYT12;TNNT2;RYR1;TTN;CAPN3;CPNE8;CALM1;KCNMA1;PPIF;CALM3;SYT7;CALM2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.662511253209237,-1.6556486597639493,0.0166358595194085,0.07241314124239229,1.0,3/13,17.36%,NAMPT;PARP9;PARP10
prerank,regulation of T cell activation (GO:0050863),-0.5004149527575754,-1.655250532903318,0.008488964346349746,0.07252769321104374,1.0,23/42,31.27%,CCR2;TNFRSF1B;TNFAIP8L2;PTPN22;DUSP3;CYRIB;SIRPA;LAPTM5;LCK;CD2;IL4I1;CCL5;LAX1;TNFSF9;CD47;METTL3;TBX21;CRTAM;PRELID1;SPINK5;IL27;LAT;CD4
prerank,lipoprotein transport (GO:0042953),-0.7246477428636234,-1.6552062165893164,0.005172413793103448,0.07231110899046951,1.0,4/10,3.16%,PRKCB;LRP1;CD36;PPARG
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5619242046531673,1.6551686576224212,0.009345794392523364,0.1016260250172019,1.0,7/22,7.07%,MAGI2;NTRK3;NTRK2;SH3GL2;TMEM108;WASF1;BDNF
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5302572098323218,-1.6550661280209547,0.010067114093959731,0.07219184387527455,1.0,18/32,21.01%,TAOK3;BRCA1;BLM;ABRAXAS1;BABAM2;RINT1;FOXN3;TAOK1;CDK1;BABAM1;TICRR;TOPBP1;TRIM39;TAOK2;BRCC3;ATM;CHEK1;NBN
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.6627096053390388,-1.6544851282418116,0.01730103806228374,0.07243889927382537,1.0,7/14,12.26%,MSN;RHOA;RAP2A;CDC42;SH3BP1;SCRIB;FOXJ1
prerank,neuron projection morphogenesis (GO:0048812),0.39751419579517117,1.6542592185868012,0.0,0.10155839705851125,1.0,32/137,8.93%,CNTNAP2;NLGN1;CTNNA2;MAP2;CTNND2;ANK3;MAP1B;CNTN4;DCLK1;NYAP2;DCC;MYO16;PARD3;GPM6A;PLPPR4;NTNG2;NTNG1;PAK3;SLITRK1;NEFH;NRCAM;EPB41L3;EPHB1;SHANK3;DCDC2;BDNF;FLRT3;DSCAML1;NCKAP1;SPTBN4;BMP7;SRGAP2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5483229863818728,-1.6540378515246636,0.00684931506849315,0.07263048089413023,1.0,14/29,20.81%,SAMHD1;YTHDF3;USP18;RNASEL;NLRC5;IFNAR2;ABCE1;PTPN6;HSP90AB1;OAS3;MAVS;ISG15;PTPN11;PTPN1
prerank,regulation of muscle contraction (GO:0006937),0.547200813522047,1.6537792047214228,0.00904977375565611,0.10123136504432462,1.0,7/26,7.70%,KCNB2;CHRM2;TNNI1;PLCE1;ENO1;KCNA1;PPP1R12B
prerank,positive regulation of proteolysis (GO:0045862),-0.4832235703055673,-1.652937628836876,0.006779661016949152,0.07330350235671322,1.0,15/55,11.31%,APOE;SNX9;TNFRSF1B;OGT;NLRC4;FBXW11;ADAM9;ASPH;SNX33;WDR48;CTSC;RCN3;CTSH;ADAM8;CLN6
prerank,protein modification by small protein removal (GO:0070646),-0.3835135128250686,-1.6526589237134108,0.0,0.0732729850171268,1.0,90/252,22.51%,BIRC3;USP12;SNX3;DDB2;USP50;RHOA;OGT;ATXN7;PSME4;OTUD5;UCHL5;USP18;RIPK1;BRCA1;ARRB2;PSMB7;PSME3;ACTB;USP8;PSMB9;ABRAXAS1;TRAF3;WDR48;USP36;USP9X;GPS1;BABAM2;USP3;ATXN3;SENP3;TGFBR1;RNF123;HIF1A;PSMA8;UBC;RPS27A;ASXL1;SUDS3;TNIP2;PSMC3;WDR20;CDC25A;CDK1;STAM2;BABAM1;PSMD8;COPS6;USP42;RNF128;TRAF2;PSMC4;USP35;PSMB10;USP40;PSMA1;JOSD1;YY1;INO80;USPL1;USP30;OTUD4;USP11;INO80E;USP7;TNIP3;PSMB8;STAMBPL1;SKP2;SMAD7;INO80C;GATA3;ADRB2;MDM4;BRCC3;COPS5;MBD6;PSMA5;PSMD4;PSMB3;BAP1;COPS4;PSMD3;COPS8;ZC3H12A;USP9Y;NLRP3;SMURF2;ZRANB1;POLB;BECN1
prerank,positive regulation of nervous system process (GO:0031646),0.6037299217611035,1.6518706166465786,0.016355140186915886,0.10211227394072919,1.0,4/18,1.83%,RIMS2;RIMS1;TENM4;PARD3
prerank,positive regulation of cell projection organization (GO:0031346),0.4071449380690528,1.6516426215660573,0.0,0.10160855332612863,1.0,32/115,12.27%,ROBO1;MAGI2;PTPRD;IL1RAPL1;LRRC7;ROBO2;GRIP1;TENM3;RIT2;SLIT2;NTRK3;SERPINI1;NTRK2;FUT9;CDKL5;SLITRK1;CARMIL1;PTN;CARMIL2;CUX2;PRKCI;TOX;PRKD1;BDNF;PLXNA4;CAPRIN2;LTK;RELN;DPYSL3;PLXNA2;RET;ARHGAP35
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.5662649705117736,-1.6511654574071288,0.009983361064891847,0.07413202524255752,1.0,9/25,19.35%,PLCG2;MALT1;LAPTM5;B2M;TRAF2;SLC7A5;SPHK2;CD226;NOD2
prerank,endocytic recycling (GO:0032456),-0.48735003326647713,-1.6495560786003671,0.001652892561983471,0.07523455159546424,1.0,27/50,35.54%,DENND1A;RAB7A;SNX3;SNX27;EHD4;EPS15;VPS35L;EIPR1;RAB11B;VPS26A;EHD1;ACAP2;RAB13;SNX4;DENND1B;VPS51;VPS50;MICALL1;RAB35;SNX31;MICALL2;DENND1C;RAB14;STX6;ARL4C;VPS53;TRARG1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.6623698990038468,-1.6491936470912125,0.01549053356282272,0.0752468195916439,1.0,8/13,19.53%,CD74;AXL;DHX9;GAS6;AGPAT1;MAVS;TAF9;IL7
prerank,B cell mediated immunity (GO:0019724),-0.7364277979734996,-1.6487103921695696,0.00530035335689046,0.07541726748706114,1.0,5/10,13.01%,CD74;TLR8;CD27;FCGR2B;FCER1G
prerank,establishment of epithelial cell polarity (GO:0090162),-0.6073175053279694,-1.6483309096892276,0.017152658662092625,0.07548952586213396,1.0,7/19,8.31%,MSN;RHOA;CYTH1;RAP2A;CDC42;SIPA1L3;SH3BP1
prerank,neuron differentiation (GO:0030182),0.38351313254124975,1.6481336210115416,0.0,0.10363366443135437,1.0,29/165,12.13%,PTPRD;TENM2;IL1RAPL1;MYT1L;SPOCK1;PHOX2A;TENM3;SOX11;TENM1;TENM4;NTRK2;SNPH;FUT9;ATP8A2;RORB;EPHA5;SMARCA1;WNT9A;POU3F2;ALK;FZD8;OLIG1;EN1;POU4F2;NEUROD1;TGFB2;CDK5R1;BRSK1;PBX1
prerank,positive regulation of behavior (GO:0048520),0.6888136752458776,1.647444470677749,0.023923444976076555,0.1034901446514548,1.0,2/10,0.93%,NLGN1;SGIP1
prerank,mesenchymal cell development (GO:0014031),0.5933682272909667,1.6462418670207188,0.03015075376884422,0.10361379664892832,1.0,4/18,4.88%,NRG1;SOX11;CDH2;PDCD6
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.538352530540684,-1.6456470537270607,0.0069084628670120895,0.07739561793804588,1.0,11/32,11.05%,PID1;IGF1;P2RX7;NUPR1;INSR;PFKFB3;HIF1A;ARNT;ZBTB20;PFKFB4;APP
prerank,negative regulation of protein transport (GO:0051224),-0.5526602362445394,-1.644164702771097,0.0136986301369863,0.0782646234317418,1.0,7/25,8.22%,APOE;SNX3;WWP2;PKDCC;RSAD2;RHBDF1;RHBDF2
prerank,negative regulation of bone mineralization (GO:0030502),-0.6661911690412627,-1.6437959400029372,0.01950354609929078,0.0783309385928315,1.0,6/13,19.32%,CCR1;SRGN;PTK2B;GREM1;RFLNB;ENPP1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.6192067599508585,-1.6436755391508593,0.016042780748663103,0.07815329413815808,1.0,12/18,28.83%,LYN;C3AR1;C5AR1;SPG21;FCER1G;CMKLR1;LAX1;BAG6;GPLD1;BLK;FPR2;CD19
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.5631355865103543,-1.6434319785950893,0.010948905109489052,0.07803250770023512,1.0,13/28,23.76%,CCR2;SH3KBP1;CYRIB;SIRPA;NCKAP1L;TNIP2;LCK;XRCC6;TICAM1;NOD2;IL6;PRKDC;CD47
prerank,regulation of cell size (GO:0008361),-0.5770908009824789,-1.6433691214022077,0.006791171477079796,0.07783316547328967,1.0,9/23,10.78%,VAV3;MSN;PLEK;RAC1;RHOA;VAV1;RARG;VAV2;MTPN
prerank,regulation of cholesterol efflux (GO:0010874),-0.5439108730385527,-1.64327269454355,0.01592920353982301,0.07767068630699074,1.0,9/30,13.54%,APOE;PLTP;LRP1;EEPD1;PPARG;NR1H2;ZDHHC8;TTC39B;RXRA
prerank,receptor signaling pathway via STAT (GO:0097696),-0.5652914311761702,-1.6419127229228796,0.00684931506849315,0.07849062448236124,1.0,11/25,15.67%,CCR2;PIAS1;CTR9;STAT3;STAT6;IFNAR2;STAT5B;STAT4;IFNAR1;SOCS6;IL31RA
prerank,myeloid cell differentiation (GO:0030099),-0.49197446897006253,-1.6417538775602567,0.0,0.0783585162352606,1.0,10/47,9.00%,LYN;RUNX1;MFHAS1;SPI1;RASGRP4;IKZF1;HSPA9;RPS14;ACIN1;FLVCR1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.44515316040111663,-1.641144394706597,0.0,0.07857579370247553,1.0,31/73,24.20%,RUNX1;PSME4;SPI1;PSMB7;PSME3;PSMB9;PUS7;EIF2AK2;CBFB;PSMA8;PSMC3;PSMD8;METTL14;PSMC4;PSMB10;DHX36;PSMA1;TCF3;PSMB8;KMT2A;GATA3;MYB;TCF12;LMO2;PSMA5;PSMD4;PSMB3;PSMD3;PRKDC;KITLG;PSMB1
prerank,positive regulation of innate immune response (GO:0045089),-0.5395153399876447,-1.6405582402577632,0.005172413793103448,0.07880731145360798,1.0,13/30,19.28%,TLR8;SPI1;RIOK3;DHX9;NLRC5;IFI35;GBP5;POLR3G;ADAM8;CCL5;MAVS;POLR3B;PLA2G5
prerank,oligosaccharide metabolic process (GO:0009311),0.47478075440454864,1.6402104938510753,0.002386634844868735,0.1081504526252409,1.0,18/46,17.48%,B3GALT1;ST8SIA2;FUT9;B3GALT5;ST8SIA3;GAL3ST3;ST6GAL2;FUT8;AMY1A;AMY1B;AMY1C;ST6GALNAC3;ST3GAL6;B4GALNT2;IDUA;ST8SIA1;ST8SIA5;B3GALT4
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5683137289223897,1.640005737454816,0.01348314606741573,0.10756897432422098,1.0,9/23,13.32%,KIF5C;KIF1B;DYNC1I1;KIF5A;HOOK3;HOOK1;MAP6D1;F8A1;DYNC1I2
prerank,positive regulation of cell killing (GO:0031343),-0.6517826366050039,-1.639856902617186,0.008417508417508417,0.07924362064367296,1.0,3/13,1.55%,SYK;CYBA;RAC1
prerank,regulation of T cell differentiation (GO:0045580),-0.5255014628192685,-1.6395720663724402,0.008960573476702509,0.07919615108341233,1.0,19/33,29.31%,ZMIZ1;RUNX1;CCR2;MDK;CBFB;XBP1;CD2;TCF7;ZAP70;GATA3;IL7;IL2RA;METTL3;TBX21;CRTAM;PRELID1;SPINK5;ZBTB1;IL2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.49948555563678465,-1.6387691794910626,0.007380073800738007,0.0795627642929679,1.0,24/41,30.35%,OGT;NUP50;PRKAG2;NUP42;NUP88;RAE1;HIF1A;NUP205;TPR;JMJD8;NUP188;NUP153;NUP35;NUP107;NUP62;PRKAG1;ZBTB7A;RANBP2;EIF6;NUP37;EP300;PGAM1;AAAS;NUP133
prerank,regulation of actomyosin structure organization (GO:0110020),-0.6738920049029528,-1.6387547655020878,0.022887323943661973,0.07932955091909104,1.0,6/13,8.82%,AKAP13;RAC1;ROCK1;CDC42;PTGER4;SLC9A1
prerank,stress-activated MAPK cascade (GO:0051403),-0.4630241878814376,-1.63853174882455,0.008726003490401396,0.07924382673819003,1.0,24/61,19.35%,MAP3K8;MAP3K5;MAP4K3;MAP3K20;MINK1;IRAK2;TAB2;NFKB1;FBXW11;PTGER4;MAPK14;GPS1;TRIB1;NOD1;UBC;RPS27A;TNIP2;IKBKB;MAP3K10;CRKL;MAP2K3;TAOK2;LGALS9;NOD2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.5322021329741665,-1.6380582161535842,0.013223140495867768,0.07938084005983916,1.0,9/30,10.16%,LYN;IGF1;NOTCH2;GRB2;VAV1;RASGRP4;ITGAV;ERBIN;TGM2
prerank,nucleosome assembly (GO:0006334),-0.5345725731974837,-1.6379877780793446,0.015734265734265736,0.07918091007190499,1.0,13/31,18.84%,SMARCA5;ANP32B;UBN1;ASF1B;ASF1A;HMGB2;SPTY2D1;PADI4;SART3;CHAF1A;RBBP4;BRD2;RSF1
prerank,dendrite self-avoidance (GO:0070593),0.5980283225460692,1.637805837007821,0.031746031746031744,0.10872054521777913,1.0,7/16,15.94%,CNTN6;CNTN4;DSCAM;DSCAML1;ROBO3;VSTM2L;EMB
prerank,regulation of dopamine secretion (GO:0014059),0.5476932877667868,1.6377602815674446,0.019656019656019656,0.10802725127483018,1.0,11/25,16.07%,SYT1;SYT10;SYT2;GDNF;SYT5;SYT11;SYT12;SYT7;PRKN;KCNA2;SNCA
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.4677968817538105,-1.6373093328852732,0.006896551724137931,0.07948480061947708,1.0,31/63,27.61%,CRADD;CNOT4;CNOT1;CNOT2;PLK2;E2F1;PRMT1;RFWD3;CDK1;PCNA;GADD45A;PLK3;E2F8;WAC;CNOT6L;AURKA;CASP2;MDM4;ATM;FBXO31;CNOT8;CDC25C;SFN;PRKDC;GTSE1;CCNB1;PCBP4;RBL2;CNOT3;PML;EP300
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.6215104378218723,1.6368320787434294,0.02696078431372549,0.10807276314292948,1.0,3/15,1.72%,NLGN1;CNTNAP4;SYN3
prerank,positive regulation of autophagy (GO:0010508),-0.4422775954637257,-1.6356712030737626,0.0016891891891891893,0.08051560649695236,1.0,31/81,24.51%,TFEB;DAPK1;ROCK1;GNAI3;OPTN;FOXO3;PIK3CB;CAMKK2;ATF6;PLK2;FLCN;SESN1;TICAM1;STK11;TRIM68;PLK3;SH3GLB1;WAC;PIK3C2A;TRIM14;BNIP3L;FBXO7;TMEM59;HMGB1;GSK3B;ZC3H12A;KDR;MEFV;MTDH;PIM2;DCN
prerank,sister chromatid segregation (GO:0000819),-0.5389099313884137,-1.6354182430867548,0.008726003490401396,0.08052216174673829,1.0,15/31,22.85%,RB1;NCAPG2;TOP2A;SMC4;KLHL22;CENPK;KIFC1;KNSTRN;NUSAP1;INO80;SGO1;NDC80;KIF18B;SMC1A;NSL1
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.4973496966465029,-1.634800196562219,0.007407407407407408,0.08077389211915854,1.0,24/41,30.35%,OGT;NUP50;PRKAG2;NUP42;NUP88;RAE1;HIF1A;NUP205;TPR;JMJD8;NUP188;NUP153;NUP35;NUP107;NUP62;PRKAG1;ZBTB7A;RANBP2;EIF6;NUP37;EP300;PGAM1;AAAS;NUP133
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.4253937554921287,-1.6309046362541104,0.001694915254237288,0.08367185980277388,1.0,25/93,13.07%,SASH1;MAP3K5;TAOK3;SDCBP;MFHAS1;XDH;RELL1;MINK1;RIPK1;TRAF5;SPI1;PTK2B;AXIN1;TRAF3;VEGFA;EIF2AK2;PRMT1;CD27;TAOK1;TRAF1;NCF1;APP;GADD45A;FCGR2B;TRAF2
prerank,dendrite morphogenesis (GO:0048813),0.5008372170715357,1.630647386881488,0.006741573033707865,0.11281424638195783,1.0,15/35,15.52%,CTNNA2;MAP2;CTNND2;PAK3;PTN;EPHB1;PHACTR1;SHANK3;DCDC2;SDC2;ARC;BTBD3;KLF7;CHRNA7;EPHB3
prerank,phagolysosome assembly (GO:0001845),-0.6855184898625484,-1.6305360403171436,0.0136986301369863,0.08370625788713655,1.0,8/12,19.28%,RAB7B;RAB7A;ARL8B;RAB20;CLN3;RAB39A;RAB34;PLA2G5
prerank,calcium ion import across plasma membrane (GO:0098703),0.6386808399547812,1.6304280686706791,0.028037383177570093,0.112230092654699,1.0,8/14,19.02%,CACNA2D1;SLC24A2;SLC8A3;SLC8A2;ATP2B4;TRPV3;TRPM2;SLC24A1
prerank,regulation of humoral immune response (GO:0002920),-0.4878033317955731,-1.6300378514689458,0.006932409012131715,0.0838488566307748,1.0,13/44,19.96%,C3AR1;C1QA;C1QB;C5AR1;C4B;CFP;C3;PROS1;CD46;FCGR2B;C1QC;C1QBP;C2
prerank,modification-dependent protein catabolic process (GO:0019941),-0.3880033287893528,-1.6283627932699447,0.0,0.08502668644949563,1.0,66/193,21.63%,RNF213;CBL;ZNRF3;CNOT4;RNF150;BFAR;BIRC6;RNF149;RNF19A;RNF111;MYLIP;AMFR;AREL1;RNF166;ANAPC1;RC3H1;RNF20;UBE2R2;KLHL25;ARRB1;UBE3B;NUB1;KCTD10;ATXN3;SPSB2;UBC;RPS27A;UBE2L3;RNF8;UBE4B;NEDD4L;XBP1;WDR91;RNF128;FBXO10;UHRF1;BUB1B;UBE2H;RNF185;PCYOX1;ARIH1;ARRDC1;RNF34;RNF43;UBE2G1;CDC34;UBQLN4;UBE2C;ISG15;MIB1;UBE2I;AURKA;ANAPC7;FBXO7;NDFIP2;TRIP12;ELOC;UBE3C;FBXO22;FBXW4;DTX3L;PSMD3;RNF125;TRIM25;BAG6;SMURF2
prerank,carbohydrate biosynthetic process (GO:0016051),0.5648876577913946,1.6277413132377458,0.013824884792626729,0.11385653574424796,1.0,9/21,20.62%,B3GALT1;FUT9;B3GALT5;FUT8;ST3GAL6;B4GALNT2;B3GALT4;ST6GALNAC5;MPDU1
prerank,regulation of intracellular signal transduction (GO:1902531),-0.35365609420345295,-1.627565803918803,0.0,0.08540968691215328,1.0,126/420,19.99%,ARHGAP15;LYN;VAV3;AKAP13;TAOK3;ABR;SGMS1;ARHGAP10;BIRC3;ARHGAP25;ITSN1;STARD8;PLCG2;PAK2;ARHGAP22;MYO9B;RAC1;ARHGEF3;TOP3A;ARHGAP30;ARHGAP24;ARHGAP19;RHOA;ARHGAP17;BRD7;PHF20;OPTN;CSNK2A1;ARHGEF2;PIP4K2A;MOB3B;VAV1;PRKAG2;VRK2;MINK1;GNA12;TRAF5;BRCA1;SGK1;RNF41;DYRK2;CDC42;FGD4;CHD3;ITGAV;ARAP1;PTPN22;BLM;ARHGAP18;FGD3;STK3;MAPK14;RPL11;SMYD2;RAD1;TRAF3;RHOQ;TAF6;ARHGEF18;NF2;VEGFA;RCN3;VAV2;PIP4P1;ZFAND6;SOS2;ARHGAP12;SPRED1;TPX2;TAOK1;RELA;PLEKHG5;PIN1;TRAF1;STYXL1;GNA13;TRIP10;FLCN;WRN;CDK1;ARHGEF11;FAM13B;CRK;STK11;EXO1;CLEC6A;PLK3;TRAF2;RPA3;RFC2;TRIO;ARHGAP36;RHNO1;RNF34;TMSB4X;RACGAP1;TAF4B;PAK1IP1;TOPBP1;BST1;ARHGEF5;BRIP1;USP7;KMT5A;ARHGAP31;TAF9;RBBP4;SPHK2;AURKA;TAF3;RAD9A;DNA2;CMKLR1;RBBP8;PTPN13;FAM83D;TAF4;TAOK2;HSPB1;PAK6;MDM4;AKAP7;ATM;CHEK1;AGER;PIP5K1A
prerank,B cell homeostasis (GO:0001782),-0.7250112773301369,-1.6258583253776946,0.01854974704890388,0.08642386820953599,1.0,5/10,9.89%,LYN;DOCK10;DOCK11;MEF2C;NCKAP1L
prerank,pinocytosis (GO:0006907),-0.7056856939349213,-1.623932608817981,0.01217391304347826,0.08784933941360921,1.0,5/10,6.98%,DOCK2;MAPKAPK3;MAPKAPK2;SNX5;SNX33
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.4781974044734192,-1.6237578999451536,0.005190311418685121,0.08770125856776517,1.0,19/49,18.87%,RUNX1;CNOT4;RAB7B;PF4;PRMT1;WDR5;KMT2C;CBFB;MEF2C;MOV10;NFE2;KMT2D;CIB1;HMGB2;TNRC6C;SIN3A;PRMT6;KMT2A;PITHD1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.45326355736079454,-1.6231371262164405,0.004991680532445923,0.08782942102228898,1.0,22/63,22.63%,PTPRC;VAV3;CD38;CD74;SASH3;IL15;IL18;BCL2;ANXA1;CD28;MEF2C;NCKAP1L;CD46;CCL5;CD40;BST1;CHRNB2;IRS2;IL7;CD274;CD3E;IL6
prerank,defense response to protozoan (GO:0042832),-0.663245538985542,-1.6230731838608738,0.019332161687170474,0.08760906616107747,1.0,9/12,24.80%,LYST;BATF;PF4;MYD88;GBP2;CD40;GBP7;GBP6;GBP4
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.608827500274528,-1.6226662712248165,0.010582010582010581,0.08765644814787824,1.0,7/17,19.36%,CCR2;ANO6;CCR1;CCL5;SERPINE1;PLA2G7;HMGB1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.6970308286421389,-1.6225237800181427,0.011965811965811967,0.08751796157039789,1.0,3/10,4.21%,ROCK1;IL15;IL18
prerank,regulation of glycolytic process (GO:0006110),-0.44785586775707004,-1.6224237385267697,0.006993006993006993,0.08731860856168928,1.0,21/68,13.15%,IGF1;P2RX7;NUPR1;OGT;INSR;NUP50;PRKAG2;NUP42;PFKFB3;CBFA2T3;NUP88;RAE1;HIF1A;ARNT;NUP205;ZBTB20;PFKFB4;APP;TPR;JMJD8;NUP188
prerank,regulation of programmed cell death (GO:0043067),-0.39283868537275035,-1.6221221965475687,0.0016207455429497568,0.08730492530469657,1.0,60/161,23.13%,CTSB;APAF1;BIRC3;DAPK1;BCL6;CRADD;CREBBP;ACER3;BCL2L11;MALT1;RIPK1;SGK1;ANP32A;NLRC4;RARG;ANP32B;STEAP3;DAPK3;USP36;WFS1;HIP1;NF2;NME1;PTPN6;TGM2;TPT1;AGT;IKZF3;OSGIN1;WRN;TRIM24;IGFBP3;HTATIP2;USP42;FBXO10;LGALS1;CASP1;TRAF2;DFFA;PRDX2;BID;RABGGTA;BNIP3L;SKP2;TNFRSF25;RPS3;IFT57;CASP2;RABGGTB;ATM;STAT1;ASAH1;CDK5;NUP62;HAX1;ZBTB7A;TNFSF9;CD3E;TOMM70;TARDBP
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.43652179226341115,-1.6220780616355,0.003389830508474576,0.08708571853956856,1.0,33/80,22.68%,RAB7B;RAB7A;SNX3;SNX2;VTI1A;VPS54;SNX8;SGSM2;SNX6;SNX5;ANKFY1;TBC1D5;TBC1D17;VPS26B;DCTN1;RAB29;VPS26A;STX5;TBC1D10B;TBC1D23;TMEM87B;STX16;BAIAP3;SPAG9;ARL1;TMEM87A;SNX1;VPS51;TBC1D10C;SNX32;VPS50;PHETA1;BET1L
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.5556239114749297,-1.6218028708886179,0.01692047377326565,0.08706560092167183,1.0,8/24,9.54%,RBPJ;NFE2L2;ATF3;MBTPS2;ATF6;VEGFA;HIF1A;MAPK7
prerank,transferrin transport (GO:0033572),-0.5301750844436325,-1.621469453319732,0.006932409012131715,0.08711373631928247,1.0,10/33,16.52%,ATP6V0D2;ATP6V1E1;DNM2;ATP6V1A;TCIRG1;STEAP3;ATP6V1G1;RAB11B;ATP6V0B;ATP6V0E1
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.4117208667456786,-1.6191618213757186,0.005008347245409015,0.08880999660208222,1.0,39/107,23.55%,MAP3K5;NIBAN1;JUN;ITPR1;ERN1;BCL2L11;ATF3;MBTPS2;ATG10;BCL2;PPP1R15B;ATF6;WFS1;CREB3L2;RCN3;CASP4;DNAJB9;ATP2A3;SELENOS;DERL1;SEL1L;HSP90B1;UBXN6;TRAF2;RNF185;BBC3;TMEM259;QRICH1;HYOU1;PDIA4;ERP44;ERLEC1;GSK3B;BAG6;CEBPB;UFM1;P4HB;ERO1A;PDIA3
prerank,regulation of striated muscle contraction (GO:0006942),0.5284380569196474,1.6167905421905961,0.007142857142857143,0.123058773136791,1.0,9/27,15.84%,ANK2;DMD;RYR2;SLC8A3;TNNI1;CALM1;CALM3;CALM2;SCN10A
prerank,osteoclast differentiation (GO:0030316),-0.5737358722628163,-1.6165829423693605,0.015384615384615385,0.09091003588590242,1.0,6/22,5.75%,FOXP1;SNX10;GAB2;ANXA2;SBNO2;MAPK14
prerank,response to molecule of bacterial origin (GO:0002237),-0.45118078201523876,-1.6161214925904146,0.0,0.09104621898209957,1.0,19/69,14.06%,FOXP1;MAPKAPK3;OTUD5;C4B;MAPKAPK2;TAB2;PELI1;TLR4;IRF5;PTPN22;CYRIB;IRAK3;ERBIN;TRIB1;LY96;IFNAR1;HMGB2;FCGR2B;GCH1
prerank,indolalkylamine catabolic process (GO:0046218),-0.7031726640142102,-1.6159795438411155,0.010434782608695653,0.09090157323324882,1.0,4/10,12.50%,KYNU;KMO;KYAT1;IL4I1
prerank,cell-cell junction assembly (GO:0007043),0.4455843791406086,1.6154904986657213,0.0023584905660377358,0.12343952349307136,1.0,25/63,16.74%,CDH18;CTNND2;CDH8;CDH10;CDH2;CDH20;TJP1;CDH11;CDH12;EPB41L3;CDH22;CDH19;CDH7;DCHS1;CDH6;TLN2;ARVCF;CDHR3;CDH9;CLDN5;PATJ;CDH5;CTNND1;PRKCA;RAMP2
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.5991645123748339,-1.6142646533868878,0.015332197614991482,0.09200551648746172,1.0,4/18,4.11%,LILRB1;LILRB3;GPR137B;TLR4
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.42219038507015216,-1.6138361954299432,0.0017152658662092624,0.09217969793813588,1.0,43/94,29.09%,FNIP2;MAP3K5;APAF1;MCL1;PRKCD;ITPR1;ERN1;TNFRSF1B;BCL2L11;BRCA1;BCL2;CRIP1;E2F1;CASP4;DDX5;ATP2A3;MLLT11;STK11;STK24;TRAF2;CUL2;BBC3;QRICH1;CASP2;DDX3X;ATM;C1QBP;BAG6;SFN;BCL2L2;CEBPB;TOPORS;PRKDC;RRP8;ERO1A;CYP1B1;ERN2;DIABLO;PML;CUL3;MYBBP1A;BCL2L1;BNIP3
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.6094715241670775,-1.6136251377097932,0.008605851979345954,0.09210686558733486,1.0,7/18,15.58%,DOCK2;SYK;PLCG2;SBNO2;IFI35;FCER1G;KARS1
prerank,secretory granule organization (GO:0033363),-0.7230309592626718,-1.6134966575161094,0.012237762237762238,0.0919433273117077,1.0,3/10,4.49%,ABCA1;LYST;SRGN
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5819464294695482,-1.613412389800921,0.010507880910683012,0.09174926350090613,1.0,8/22,9.63%,APOE;ROCK1;SNX9;TNFRSF1B;ADAM9;SNX33;TIMP2;ADAM8
prerank,regulation of monocyte differentiation (GO:0045655),-0.6389348537125205,-1.6132812536988634,0.013675213675213675,0.09161902259563354,1.0,9/14,26.84%,FOXP1;CD74;CDK6;FES;ACIN1;IL34;CSF1;MYC;ZFP36L1
prerank,striated muscle tissue development (GO:0014706),0.5048566850328426,1.6120345863863357,0.029612756264236904,0.12593839384105673,1.0,8/29,11.23%,SGCZ;SGCD;NDUFV2;BMP7;ZBTB18;SGCG;POPDC2;PGM5
prerank,regulation of dendrite extension (GO:1903859),0.5909242648602625,1.611854028389115,0.0364963503649635,0.1253788481678288,1.0,4/18,3.66%,RIMS2;RIMS1;SYT1;SYT2
prerank,calcium ion transport (GO:0006816),0.3926321416422816,1.6110998704951904,0.0,0.12535564904353028,1.0,16/113,3.14%,ANK2;TRPM3;CACNA1C;RYR3;CACNA1E;TRPC5;RYR2;CACNA2D1;GRIN3A;SLC24A4;SLC24A2;SLC8A3;NALCN;TRPC1;CACNB2;SLC24A3
prerank,regulation of DNA repair (GO:0006282),-0.4830289750920757,-1.6110394683340696,0.005025125628140704,0.0933138847676395,1.0,26/44,27.50%,DEK;BRCA1;ERCC6;DHX9;ABRAXAS1;EYA4;BABAM2;CEBPG;RNF8;PCNA;BABAM1;KAT7;RADX;TMEM161A;RAD52;EYA1;EYA3;RPS3;WRAP53;BRCC3;TRIP12;UBE2V2;TRIM28;UBE2N;PML;UIMC1
prerank,immunoglobulin mediated immune response (GO:0016064),-0.7103244776322144,-1.6102875022979326,0.0068143100511073255,0.093703229975206,1.0,5/10,13.01%,CD74;TLR8;CD27;FCGR2B;FCER1G
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6271675520824773,-1.6088027100313638,0.021314387211367674,0.09471584336233702,1.0,3/15,1.14%,APOE;ABCG1;PLTP
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.4082210144835307,-1.6082424224984493,0.0,0.09489234522131315,1.0,38/121,18.46%,LYN;PTPRC;NEDD9;NRP1;CD44;BANK1;IGF1;CD74;PLCG2;PAK2;ITGA5;PTPRJ;ARHGEF2;IL6R;STAT3;PIBF1;IL15;TEC;IL18;PARP14;PTK2B;HGF;GAS6;VEGFA;PARP9;AGT;CLEC6A;CCL5;GREM1;CD40;IL34;CSPG4;IL31RA;HCLS1;GPRC5B;LILRA5;SOCS3;PTPN11
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.6673230821847584,-1.6081491291172965,0.01718213058419244,0.09474485434199231,1.0,7/12,20.51%,DHRS3;CNOT1;EZH2;ASXL1;KLF2;TRIM16;CYP26C1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.6553174553170892,-1.6076966000284239,0.03163444639718805,0.09489288124540636,1.0,7/13,20.02%,NUPR1;MBTPS2;NR1H2;WFS1;FCGR2B;MANF;LPCAT3
prerank,regulation of actin filament depolymerization (GO:0030834),-0.6657242193065764,-1.6073806915254882,0.009242144177449169,0.09493415382787115,1.0,6/12,11.79%,PLEK;SH3BP1;LIMA1;WDR1;MTPN;PIK3CA
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.4522680706004003,-1.6063189069046857,0.003527336860670194,0.09561245572617377,1.0,18/55,18.47%,PAK2;CRADD;NUPR1;BCL2L11;RIPK1;BCL2;TGFBR1;GSDME;FIS1;AGT;STYXL1;LCK;TRAF2;BBC3;BID;TNFSF10;RPS3;TRIM39
prerank,presynaptic endocytosis (GO:0140238),0.5314535652905116,1.6058624057005475,0.019753086419753086,0.1298794369244817,1.0,7/24,6.50%,NLGN1;SYT1;AMPH;SYNJ2;SYT2;STON1;SYT5
prerank,regulation of organelle assembly (GO:1902115),-0.44091003093334347,-1.6051845194777978,0.0035026269702276708,0.09642635504566142,1.0,27/72,18.25%,MSN;PDCD6IP;TBC1D15;IFT20;ATG5;TBC1D2B;CEP295;MTMR3;TBC1D5;TBC1D1;TSG101;TBC1D22A;SDCCAG8;TBC1D16;PLK2;TBC1D22B;RNF4;RAB5A;TBC1D8;CEP295NL;TBC1D17;TBC1D10B;TBC1D24;DYNLT2B;STIL;TBC1D9B;HCK
prerank,regulation of ion transport (GO:0043269),0.4250093100114647,1.6048603224025133,0.0,0.13001546315966225,1.0,20/76,8.73%,NKAIN2;ANK3;SYT1;NKAIN3;SYT10;SYT2;GDNF;KCNJ3;KCNJ10;KCNJ6;CA2;ITGB3;KCNJ9;SYT5;KCNJ16;TOR1A;SPTBN4;NEDD4;SYT11;SYT12
prerank,positive regulation of viral transcription (GO:0050434),-0.5589221403647533,-1.6048458591761965,0.018083182640144666,0.09646307462936894,1.0,13/25,26.71%,MDFIC;NELFB;DHX9;POLR2H;POLR2F;POLR2L;POLR2A;POLR2G;RSF1;POLR2I;GTF2F2;GTF2F1;NELFE
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.5322829343890182,-1.6047179172172557,0.022413793103448276,0.09632384424143754,1.0,8/30,9.22%,PTPRC;CD300A;PRKCD;PIBF1;PARP14;MVP;NF2;PTPN6
prerank,iron ion transport (GO:0006826),-0.47437906997574725,-1.604367421666071,0.014778325123152709,0.09640446040098388,1.0,15/47,20.46%,ATP6V0D2;ATP6V1E1;IREB2;DNM2;ABCB7;ATP6V1A;TCIRG1;STEAP3;ATP6V1G1;CP;RAB11B;ATP6V0B;ATP6V0E1;SLC11A2;ATP6V0D1
prerank,receptor metabolic process (GO:0043112),-0.4758521008645375,-1.6042867988175642,0.011345218800648298,0.09619219843108032,1.0,20/53,13.45%,GRB2;LILRB1;SYK;LRP1;CD36;ITGB2;DNM2;RAB31;CD9;ARRB2;UVRAG;GRK3;ITGB1;KIF16B;PICALM;SNX25;ARFGEF2;RAB11B;FCER1G;SH3GLB1
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.6164878287059823,-1.603453049386397,0.014134275618374558,0.09665824080597137,1.0,3/16,1.57%,APOE;LRP1;ROCK1
prerank,negative regulation of protein binding (GO:0032091),-0.4477660653214004,-1.603132678826303,0.0,0.09672392273870051,1.0,27/71,21.40%,DAB2;ITGA4;CTSZ;PRKCD;ROCK1;PEX14;ARRB2;ACTB;PPP1CA;B2M;ITGB1BP1;ATP2A3;NES;PIN1;IFIT1;ADAM15;TMBIM6;IFIT2;TFIP11;AURKA;RALB;ADRB2;TMC8;GSK3B;DISC1;KDM1A;RACK1
prerank,response to estrogen (GO:0043627),-0.5146267795430243,-1.603021096841076,0.011824324324324325,0.09651585251132423,1.0,16/31,28.55%,BRCA1;WBP2;SERPINB9;KMT2D;TRIM24;RARA;GATA3;ARID5A;SFRP1;TRIM25;RBBP5;ASH2L;ESR1;EP300;CITED2;GHRL
prerank,mitotic recombination (GO:0006312),-0.6202514576859404,-1.602253935867113,0.023972602739726026,0.09695730321995255,1.0,10/15,24.24%,NSMCE2;TEP1;RAD51;GEN1;RAD54B;RAD52;XRCC3;DMC1;SMC6;SMC5
prerank,phosphorylation (GO:0016310),-0.3521342624685146,-1.602140629891625,0.0,0.09679283469981738,1.0,131/385,23.03%,LYN;PRKCH;FNIP2;MAP3K5;TAOK3;PRKCB;FGR;FAM20C;DAPK1;SYK;PAK2;CDK6;PRKCD;ROCK1;MAP4K3;BIRC6;RUNX3;MAP3K1;ERN1;MAP3K20;INSR;DGKZ;PEAK1;CSNK2A1;PANK2;PRKAG2;VRK2;CDK13;RNASEL;MINK1;MAML1;TLK1;MAPKAPK2;NADK;HTR2B;SGK1;GRK3;STAT3;DYRK2;TEC;PIM1;PTK2B;DAPK3;STK3;PIK3CB;PIK3CG;CDK18;IRAK3;GAS6;DGKD;CAMKK2;GRK5;PLK2;EIF2AK2;COQ8A;STK38;TGFBR1;TRIB1;JAK1;CDK14;NEK6;FGGY;RSKR;MORC3;SIK1;TRIB2;POMK;TAOK1;LCK;APP;GNPTAB;CDK1;DYRK1A;MAP2K1;PPP4R1;PIK3CA;STK11;IGFBP3;STK17B;FRK;STK24;MKNK1;ACVR2A;PIK3CD;GMFG;TGFBR2;MAST2;MARK2;IKBKB;GMFB;TXK;CCNE1;MKNK2;DGKG;LATS2;STRADA;SPHK2;CDKL4;AURKA;ZAP70;RARA;PGK1;BRD2;PKN3;RYK;HCK;HCST;STK10;TAOK2;IP6K3;MAK;PAK6;ATM;CHEK1;BMPR2;CDC42BPG;CDK16;WNK1;GSK3B;COPS8;CDK5;PRKAG1;GRK6;SRPK1;MAP4K4;MAPK1;RPS6KA5;ILK;NEK3;PRKDC;TYK2
prerank,cellular response to interleukin-12 (GO:0071349),-0.4799599625325685,-1.6010961682422622,0.006932409012131715,0.09739984786343751,1.0,26/48,28.03%,MSN;PAK2;RAP1B;PITPNA;ANXA2;CDC42;HSPA9;HNRNPDL;STAT4;SIRPA;JAK1;LMNB1;LCP1;CAPZA1;CFL1;RPLP0;GSTO1;CNN2;TYK2;MTAP;P4HB;CD47;IL12RB1;TALDO1;HNRNPF;SERPINB2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.6472363125670693,-1.6003041633870159,0.02422145328719723,0.0978881691365885,1.0,5/13,7.14%,NRP1;PLXNC1;PLXNA1;PLXND1;NRP2
prerank,DNA replication initiation (GO:0006270),-0.495695582727349,-1.599883113937682,0.012195121951219513,0.09800873416534076,1.0,20/37,34.41%,POLE2;NOC3L;MCM6;MCM3;DBF4;ORC5;RPA3;CDC34;TOPBP1;MCM2;PRIM1;LRWD1;PRIM2;CDC45;MCM5;ORC3;ORC6;MCM7;POLE;POLA2
prerank,regulation of immune effector process (GO:0002697),-0.4865241939081755,-1.5994857958132975,0.015517241379310345,0.09810897244665669,1.0,13/41,19.96%,C3AR1;C1QA;C1QB;C5AR1;C4B;CFP;C3;PROS1;CD46;FCGR2B;C1QC;C1QBP;C2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.5547179589070084,-1.5993618366363398,0.018803418803418803,0.09796653581383084,1.0,13/25,22.81%,STAT3;FOXO3;MAPK14;STAT5B;PRMT1;HIF1A;NCKAP1L;ARNT;HMGB2;ACVR2A;HSPA1A;STAT1;PRKDC
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.5133477192474879,-1.5987246575820182,0.015985790408525755,0.09827195889690254,1.0,14/33,18.15%,CD300A;PTPRJ;DGKZ;CARD11;RC3H1;PTPN22;DUSP3;LAPTM5;RELA;LCK;RAB29;CD226;TESPA1;RPS3
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.6773387329940236,-1.5986498830510514,0.021885521885521887,0.09807776487148022,1.0,3/11,1.27%,LYN;MFHAS1;CYBA
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.7008728733695486,-1.5984669261132416,0.023728813559322035,0.09798198406433055,1.0,3/10,0.99%,LYN;FGR;LILRB1
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.7096909987431177,-1.5979142996733324,0.017452006980802792,0.09821372897656828,1.0,5/10,18.40%,KYNU;ATP7A;KYAT1;IL4I1;QDPR
prerank,potassium ion import across plasma membrane (GO:1990573),0.48044057493341585,1.5978888785661178,0.012285012285012284,0.13602223304171532,1.0,13/41,13.03%,SLC12A2;SLC12A8;SLC12A1;KCNJ3;KCNJ10;KCNJ6;KCNJ9;HCN2;ATP1A3;KCNJ16;ATP1B1;SLC12A5;KCNJ12
prerank,histone H4-K5 acetylation (GO:0043981),-0.626954870686469,-1.5978765690120165,0.025362318840579712,0.09773307298094892,1.0,6/15,12.61%,OGT;PHF20;KANSL2;WDR5;JADE2;KAT7
prerank,histone H4-K8 acetylation (GO:0043982),-0.626954870686469,-1.5978765690120165,0.025362318840579712,0.09773307298094892,1.0,6/15,12.61%,OGT;PHF20;KANSL2;WDR5;JADE2;KAT7
prerank,cellular response to ionizing radiation (GO:0071479),-0.4779352743602256,-1.5973410892628983,0.006837606837606838,0.09799578114312829,1.0,23/47,25.98%,GRB2;MAP3K20;SPIDR;NIPBL;BLM;MAPK14;RAD1;RAD51;NUCKS1;XRCC6;WRN;GADD45A;RHNO1;RAD51AP1;INO80;TMEM109;RAD9A;ATM;KDM1A;CRYAB;ECT2;EEF1D;CLOCK
prerank,regulation of viral genome replication (GO:0045069),-0.4601537341361505,-1.5969457278892765,0.00667779632721202,0.09807448457122817,1.0,20/56,21.84%,FAM111A;ZC3HAV1;RNASEL;RSAD2;EIF2AK2;BST2;CD28;IFITM2;IFIT1;OASL;CCL5;OAS3;MAVS;VAPB;ISG15;PARP10;DDX3X;OAS2;IFITM1;SRPK1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.41145937449749165,1.5967354068694624,0.002347417840375587,0.13633637754884334,1.0,28/85,18.66%,GRM7;PCDH15;LHFPL3;PAX3;COL11A1;DCDC2;ADGRV1;COL4A3;SPTBN4;TSPEAR;TFAP2A;ESPNL;OTOS;WHRN;TBX1;EML2;NDUFB9;TMIE;CLRN1;TIMM10;PDZD7;USH2A;ATP2B2;USP53;EPS8L2;ROR1;COL1A1;ALDH7A1
prerank,snRNA transcription (GO:0009301),-0.4432489178852494,-1.59631204937182,0.0016474464579901153,0.09843402026745213,1.0,29/70,22.60%,GTF2A1;INTS8;NABP1;INTS11;SRRT;TAF6;POLR2H;POLR2F;POLR2L;SNAPC2;INTS6;INTS14;RPRD2;GTF2E2;POLR2A;NCBP1;USPL1;TAF8;INTS1;POLR2G;TAF9;SNAPC3;PHAX;INTS5;POLR2I;CCNK;GTF2F2;GTF2A2;ELL2
prerank,cardiac muscle contraction (GO:0060048),0.4886483889875182,1.5961795157635204,0.006696428571428571,0.1360763684088664,1.0,10/34,11.10%,DMD;RYR2;SCN2B;CASQ2;TNNI1;TNNT2;MYH7;ATP1B1;GSN;TTN
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.5575205057353892,-1.5958057089551059,0.008561643835616438,0.09864506592518855,1.0,8/24,12.16%,APOE;UCHL5;PSME3;PTK2B;NUB1;RHBDF1;CTSC;UBE3A
prerank,regulation of cellular component movement (GO:0051270),-0.47306266146908454,-1.5957084517264704,0.008375209380234505,0.09847349140022775,1.0,15/49,8.63%,DIAPH1;LYN;SP100;CDK6;ROCK1;RHOA;FES;CD9;ABL2;ARAP1;DAPK3;ARHGAP18;ZSWIM8;VEGFA;TGFBR1
prerank,peptide biosynthetic process (GO:0043043),-0.39249898257369836,-1.5954810416203824,0.0,0.09841696446118271,1.0,64/153,26.21%,AGO2;RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;SARS1;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;RRBP1;MRPL42;RPS14;RPL32;RPS15A;RPS28;RPS13;RPS27A;DARS1;RPL28;RPS4X;RPS23;EIF4EBP2;RPL22;RPL14;EEF1A1;MRPS6;RPL34;MRPS11;RPS11;RPL6;EIF4G1;RPS10;RPL18A;MRPS16;RPL37A;MRPL34;RPS9;MRPS15;RPS27;ABCF1;RPS3;RPL23A;RPS16;RPL9;COPS5;RPLP2;MRPL51;RPL41;RPLP0;RPL7A;RPL19;RPS15;RPL39;FURIN;MRPL18;MRPS7;RPL5;RPL13
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.6631411510953473,-1.5946932365822681,0.01721170395869191,0.09889845970573703,1.0,5/12,15.91%,RHOA;DOCK8;APP;CCL5;SPN
prerank,positive regulation of neurogenesis (GO:0050769),0.42357200546792956,1.5945129957314053,0.0025575447570332483,0.13693306515605216,1.0,17/68,9.67%,ROBO1;PTPRD;IL1RAPL1;ROBO2;SOX11;SLIT2;NTRK2;CDKL5;SLITRK1;MME;SHANK3;CUX2;NUMB;CX3CR1;PLXNA4;CAPRIN2;RASSF10
prerank,response to X-ray (GO:0010165),-0.6261012788616918,-1.5939598751228348,0.024671052631578948,0.09934594164563654,1.0,8/14,19.63%,NIPBL;ANXA1;BLM;NUCKS1;XRCC6;XRCC4;BRCC3;ATM
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.6531574346949665,-1.5938054263426353,0.02666666666666667,0.09923097580260189,1.0,6/12,17.46%,CGAS;DHX9;IFIT1;MAVS;ZCCHC3;RALB
prerank,negative regulation of MAPK cascade (GO:0043409),-0.42114105798091006,-1.593605954168993,0.0,0.09916367980468797,1.0,22/87,11.47%,LYN;PTPRC;APOE;P2RX7;CD300A;PRKCD;PTPRJ;TLR4;DUSP3;PIK3CB;IRAK3;SIRPA;STK38;ITGB1BP1;SPRED1;SPRY2;PIN1;AGT;PAQR3;DUSP6;FLCN;SPRED2
prerank,positive regulation of neutrophil migration (GO:1902624),-0.5963397165911212,-1.591500929712922,0.02292768959435626,0.10107552890086044,1.0,7/18,9.89%,CD74;RAC1;CAMK1D;RIPOR2;MDK;ADAM8;NCKAP1L
prerank,protein ubiquitination (GO:0016567),-0.3491480944330613,-1.5914282396243717,0.0,0.10088210331696419,1.0,151/471,22.26%,SASH1;RNF213;WWP1;CBL;ZNRF3;CNOT4;PEX14;KLHL24;BFAR;BIRC6;DDB2;RNF19A;FBXW8;NFE2L2;RNF111;NFX1;PSME4;MKRN2;BRCA1;ARRB2;MYLIP;WWP2;FBXL17;RNF41;CTR9;AMFR;AREL1;RNF166;PELI1;PSMB7;TNFAIP1;PSME3;RC3H1;RNF20;FBXO32;FBXW11;BCL2;UBE2R2;RNF31;LNPEP;PSMB9;KLHL25;FBXL20;RBCK1;UHRF2;ARRB1;KLHL22;UBE3B;MGRN1;NUB1;HERC6;UBR2;CTNNB1;USP9X;DET1;KCTD10;TPP2;ZSWIM8;CBLL1;RNF4;RNF38;TRIM47;CBFB;HIF1A;RFWD3;HECTD2;SPSB2;PSMA8;OTULIN;SELENOS;UBC;RPS27A;UBE2L3;RNF8;EIPR1;DERL1;PSMC3;UBE4B;NEDD4L;KLHL18;PCNA;CUL4B;TSPAN17;ARRDC4;PSMD8;ASB5;TRIM24;UBE3A;FBXO10;TRIM68;UHRF1;TRAF2;UBE2H;PSMC4;PSMB10;TNKS2;FBXW2;RNF185;CUL2;TRIM11;PSMA1;WAC;ARIH1;ARRDC1;RNF25;RNF34;RNF43;KLHL42;UBE2G1;UBE2T;CDC34;HLTF;BRAP;TRIM14;USP7;UBE2C;ISG15;MIB1;ASB4;PSMB8;FBXL8;VHL;SKP2;ANAPC7;FBXO7;DTX1;HUWE1;TRIM39;TRIP12;ELOC;DTX3;FBXO31;PSMA5;PSMD4;RTF1;UBE3C;PSMB3;FBXO22;VPS18;FBXW4;DTX3L;PSMD3;RNF125;TRIM25;RACK1;SMURF2;RUSC1;RNF135;CCNF;RNF115;TOPORS
prerank,positive regulation of dendrite extension (GO:1903861),0.5909265520194019,1.5912672881066492,0.03902439024390244,0.13936137013996616,1.0,4/17,3.66%,RIMS2;RIMS1;SYT1;SYT2
prerank,cellular response to fluid shear stress (GO:0071498),-0.6680887822508591,-1.590915787939723,0.017452006980802792,0.10109151606944841,1.0,7/12,16.40%,MTSS1;NFE2L2;MAP2K5;MEF2C;MAPK7;KLF2;ASS1
prerank,actin filament organization (GO:0007015),-0.3913824587007391,-1.5905135783967514,0.0032626427406199023,0.10121597517732696,1.0,34/151,11.84%,MYO5A;NEDD9;ABI1;CORO1C;ARHGAP25;RAC1;MYO1F;RHOA;EPS8;ARHGAP17;FLNA;ARHGEF2;GAS2L3;SVIL;CDC42;RUFY3;MYO1G;TRIOBP;WASL;TPM3;TPM4;CAPG;NRAP;HIP1;BAIAP2;MARCKSL1;SH3BP1;CORO7;LCP1;MYO1E;ARHGAP12;CDC42EP2;MYO7A;BAIAP2L2
prerank,regulation of complement activation (GO:0030449),-0.4806422503368604,-1.5903235830529285,0.011945392491467578,0.10114453717090763,1.0,16/40,28.83%,C3AR1;C1QA;C1QB;C5AR1;C4B;CFP;C3;PROS1;CD46;C1QC;C1QBP;C2;C6;C7;C8G;CD19
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.44615168414334533,-1.590285679218872,0.005084745762711864,0.10091886813155154,1.0,35/61,27.50%,BRCA1;ERCC6;DHX9;ABRAXAS1;EYA4;HGF;RTEL1;USP9X;BABAM2;CEBPG;RAD51;RNF8;WRN;PCNA;BABAM1;DHX36;APLF;TMEM161A;OTUD4;USP7;EYA1;EYA3;RPS3;PDGFRB;WRAP53;BRCC3;HMGB1;NBN;MYC;FGFR4;TRIM28;UBE2N;MRE11;PML;UIMC1
prerank,platelet degranulation (GO:0002576),-0.4017132131038986,-1.5899888823262458,0.0016313213703099511,0.1009040430351179,1.0,34/118,16.78%,F13A1;LYN;IGF1;PSAP;PLEK;PHACTR2;CD36;FLNA;TAGLN2;CD9;CYB5R1;LAMP2;LHFPL2;SRGN;ANXA5;TLN1;PF4;FN1;HGF;CYRIB;PROS1;TEX264;GAS6;VEGFA;CD63;WDR1;APP;SERPINE1;ABCC4;MANF;TMSB4X;LGALS3BP;APLP2;ENDOD1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.5645828098582233,-1.5896674564024154,0.017035775127768313,0.10099696454941015,1.0,7/20,11.08%,RBPJ;NFE2L2;RUNX2;VEGFA;HIF1A;RELA;XBP1
prerank,centromere complex assembly (GO:0034508),-0.49873512169924256,-1.5893701281983361,0.012110726643598616,0.10099736248678365,1.0,17/36,25.88%,SMARCA5;KNL1;MIS18BP1;CENPF;DLGAP5;CENPA;CENPE;CENPK;CENPN;CENPL;POGZ;RBBP4;CENPH;RSF1;CENPP;CENPO;HJURP
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3940860134170759,-1.5890986824864506,0.0,0.10099775844928183,1.0,47/136,21.77%,SP100;RB1;PEX14;NUPR1;ANXA4;FLNA;IRAK2;SPI1;ARRB2;WWP2;PIM1;NLRC5;PRMT2;AIM2;MDFI;RBCK1;TRAF3;ARRB1;IRAK3;GAS6;WFS1;BHLHE40;MAP2K5;ERBIN;EGLN1;CEBPG;TRIB1;OTULIN;SIK1;FOXJ1;NLRC3;NFKBIL1;ID2;TMSB4X;MAP3K10;USP7;PARP10;TAF3;SMAD7;CMKLR1;ID1;SUFU;ZC3H12A;KDM1A;NLRP3;ID3;HEYL
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.5556544831922556,-1.5882242066322012,0.01957585644371941,0.10155694619623758,1.0,10/21,14.64%,BANK1;PIBF1;TNFAIP8L2;PTPN22;DUSP3;LAPTM5;FOXJ1;IL4I1;FCGR2B;SAMSN1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6779606792932905,1.5881098682944517,0.03111111111111111,0.14170074947180247,1.0,4/10,8.49%,HECW1;PRKCE;HECW2;NEDD4
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.6907028652989197,-1.5878789429327997,0.025597269624573378,0.10160774014426197,1.0,4/10,12.65%,RB1;C5AR1;EGR1;HSP90AB1
prerank,regulation of hemopoiesis (GO:1903706),-0.69022191792201,-1.5878639873193225,0.017605633802816902,0.1013757056290755,1.0,4/10,8.87%,RUNX1;PRKCB;CREBBP;CBFB
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.6895231418143303,-1.5875869101351443,0.012237762237762238,0.10135698204864779,1.0,8/10,29.56%,NPL;ST3GAL1;GNPDA1;ST6GAL1;GNPDA2;AMDHD2;RENBP;GNE
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.6053564870599586,1.586717303519818,0.035794183445190156,0.14226235476194557,1.0,6/13,13.07%,ANK3;PDE4D;CASQ2;CALM1;CALM3;CALM2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4722784712288503,1.5860380005026042,0.007317073170731708,0.1421412055473463,1.0,17/44,15.28%,AKAP6;ANK2;KCNN2;KCNMB3;KCNMB2;KCNJ3;KCNJ10;KCNJ6;KCNJ9;KCNIP2;GABBR1;KCNJ16;ATP1B1;KCNMA1;KCNJ12;WNK4;WNK3
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.46717004076872704,1.5856221642119228,0.01927710843373494,0.14167161828740948,1.0,14/41,10.87%,GRM5;DLG3;NTRK2;DOCK3;TGFA;CSF1R;EGF;SRCIN1;PRNP;BDNF;FYN;AREG;FBXW7;RELN
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5785837801693388,1.5853604819650517,0.03317535545023697,0.14107461592361092,1.0,5/16,9.62%,PAX8;GDNF;WT1;SALL1;CITED1
prerank,ether lipid metabolic process (GO:0046485),-0.6360992243162824,-1.5853179889245388,0.015544041450777202,0.10304667367485708,1.0,9/14,24.16%,NCEH1;TMEM86B;AGMO;PLA2G7;PLAAT3;PEX7;PLA2G6;PAFAH1B1;LIPE
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6705578832164427,1.58456661855731,0.032679738562091505,0.14103625780314466,1.0,3/10,3.74%,UPP2;DPYD;DPYS
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.4289990508079776,-1.5843644572897158,0.008488964346349746,0.10350683324763697,1.0,30/78,15.33%,CD74;CTSD;RAB7A;KLC1;DNM2;CANX;CAPZB;KIF3B;KIF11;DYNC1H1;KIF23;KIF15;AP1G1;KIF4A;AP2A2;CENPE;AP1S3;SEC24A;DCTN1;ACTR1B;SEC24D;CTSS;FCGR2B;CAPZA1;FCER1G;SEC31A;RACGAP1;KIF2C;CTSE;DYNC1LI2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.4289990508079776,-1.5843644572897158,0.008488964346349746,0.10350683324763697,1.0,30/78,15.33%,CD74;CTSD;RAB7A;KLC1;DNM2;CANX;CAPZB;KIF3B;KIF11;DYNC1H1;KIF23;KIF15;AP1G1;KIF4A;AP2A2;CENPE;AP1S3;SEC24A;DCTN1;ACTR1B;SEC24D;CTSS;FCGR2B;CAPZA1;FCER1G;SEC31A;RACGAP1;KIF2C;CTSE;DYNC1LI2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.42785520695335716,-1.5843033918287666,0.008488964346349746,0.10329401145170644,1.0,30/79,15.33%,CD74;CTSD;RAB7A;KLC1;DNM2;CANX;CAPZB;KIF3B;KIF11;DYNC1H1;KIF23;KIF15;AP1G1;KIF4A;AP2A2;CENPE;AP1S3;SEC24A;DCTN1;ACTR1B;SEC24D;CTSS;FCGR2B;CAPZA1;FCER1G;SEC31A;RACGAP1;KIF2C;CTSE;DYNC1LI2
prerank,positive regulation of immune system process (GO:0002684),-0.6102600657370227,-1.5836978734674685,0.021238938053097345,0.10368705644834017,1.0,9/16,18.85%,IL15;ANXA1;RSAD2;PIK3CB;VEGFA;NCKAP1L;PIK3CD;MIA3;LGALS9
prerank,negative regulation of viral process (GO:0048525),-0.4568703854787867,-1.5834992234479106,0.0066555740432612314,0.10362417769973596,1.0,24/57,26.76%,FAM111A;ZC3HAV1;UBP1;RNASEL;RSAD2;EIF2AK2;BST2;IFITM2;IFIT1;OASL;CCL5;OAS3;TRIM11;MAVS;TRIM14;ISG15;PARP10;OAS2;STAT1;IFITM1;SRPK1;TRIM28;LARP7;PML
prerank,response to tumor necrosis factor (GO:0034612),-0.4187707424792417,-1.5834848865798201,0.0033500837520938024,0.10338281703739187,1.0,30/91,21.35%,PID1;MAP4K3;NFE2L2;ARHGEF2;RIPK1;BRCA1;DHX9;ADAM9;TNFRSF21;YTHDC2;NUB1;ERBIN;GSDME;ZFAND6;GBP2;RELA;CXCL16;CCL5;CIB1;GCH1;CD40;IKBKB;CASP8;GATA3;RPS3;TRADD;GBP3;SFRP1;ZC3H12A;ASAH1
prerank,regulation of translational initiation (GO:0006446),-0.4449140296352909,-1.5832393270875502,0.00676818950930626,0.10333583733149516,1.0,38/63,33.45%,YTHDF3;AGO2;ATF3;PPP1R15B;KLHL25;EIF4G3;EIF4A2;EIF5;ALKBH1;EIF4EBP1;CSDE1;EIF4EBP2;EIF3E;TPR;CCL5;BOLL;NCBP1;EIF4G1;DDX1;POLR2G;DNAJC3;HSPB1;DDX3X;EIF5B;CEBPB;EIF3H;EIF1;MIF4GD;NCK1;EIF1B;EIF2B2;EIF2AK3;NCK2;POLR2D;ATF4;CTIF;RPS6KB1;EIF4H
prerank,positive regulation of glycolytic process (GO:0045821),-0.5715299358887866,-1.5826291126714727,0.010327022375215147,0.10342596998288424,1.0,9/20,11.05%,IGF1;P2RX7;INSR;PFKFB3;HIF1A;ARNT;ZBTB20;PFKFB4;APP
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5715299358887866,-1.5826291126714727,0.010327022375215147,0.10342596998288424,1.0,9/20,11.05%,IGF1;P2RX7;INSR;PFKFB3;HIF1A;ARNT;ZBTB20;PFKFB4;APP
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.6965825151030007,-1.5823408260679386,0.017391304347826087,0.10347071286604986,1.0,4/10,7.18%,LYN;LILRB1;AXL;GAS6
prerank,nucleic acid metabolic process (GO:0090304),-0.4385096802434312,-1.5818163324394594,0.006745362563237774,0.10373900162661089,1.0,34/69,27.44%,HNRNPA3;HNRNPH1;POLR2H;HNRNPL;POLR2F;POLR2L;DUSP11;PCBP2;WRN;DNASE1L1;FEN1;METTL14;POLR2A;NCBP1;DDX1;WTAP;TOPBP1;POLR2G;DNA2;HNRNPA1;ENPP1;MMS19;POLR2I;HNRNPH2;DDX54;HNRNPK;XRN2;GTF2F2;DNTT;DNASE2;GTF2F1;RECQL5;HNRNPF;METTL3
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.44406569803772006,-1.5810174501814496,0.005119453924914676,0.1041793072231274,1.0,18/67,12.66%,LYN;FGR;ABI1;SYK;INSR;IGF1R;FES;ABL2;PIBF1;IL15;TEC;FLT1;PTK2B;PKDCC;PTPN6;LCK;DYRK1A;ITK
prerank,macrophage activation involved in immune response (GO:0002281),-0.6530875082228923,-1.5809510237522453,0.02872531418312388,0.1039992454167806,1.0,5/13,7.30%,SYK;PLCG2;SBNO2;IFI35;GRN
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.4649675643714958,-1.5809305988486517,0.01011804384485666,0.10375864825305882,1.0,26/49,33.28%,SGMS1;MCL1;NUPR1;BCL2L11;BCL2;PLAUR;GSDME;FIS1;STYXL1;LCK;BBC3;BID;DDX3X;RACK1;BCL2L2;BECN1;P4HB;URI1;RTKN2;NOC2L;EIF2AK3;BCL2L1;PTPMT1;CAV1;NDUFS3;MMP9
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.4913251888037858,-1.5807566250649048,0.008547008547008548,0.1036445922343498,1.0,13/36,20.64%,SGMS1;CRADD;RB1;CSNK2A1;BCL2;TGFBR1;TRAF1;STYXL1;TMBIM6;DEPTOR;RPS3;TRIM39;MAZ
prerank,regulation of interferon-gamma production (GO:0032649),-0.4288286846726102,-1.5802096983384966,0.01020408163265306,0.10400822957126465,1.0,29/71,22.49%,CCR2;LILRB1;TLR8;AXL;TLR7;TLR4;IL18;PTPN22;CYRIB;GAS6;SIRPA;LAPTM5;CEBPG;SCRIB;CD2;SLC7A5;TXK;ISG15;IL18R1;CD226;RARA;LGALS9;HMGB1;C1QBP;CD274;ZC3H12A;SLAMF6;INHA;NR1H4
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.5429226765377333,-1.580038000692173,0.02226027397260274,0.10391153886478566,1.0,13/24,25.67%,RFC1;UBC;RPS27A;LIG1;PCNA;RPA3;RFC2;POLD2;LIG3;RFC3;POLB;POLD4;XRCC1
prerank,regulation of response to external stimulus (GO:0032101),-0.3988570878613146,-1.5798907141740204,0.0,0.10379792715932641,1.0,44/121,25.52%,FOXP1;FGR;BIRC3;CCR2;BCL6;SAMHD1;CD36;P2RX4;PIK3AP1;SBNO2;BRD4;USP18;DHX58;AREL1;PTPN22;ANXA1;TRAF3;CYRIB;GRN;MYD88;CASP4;DAGLB;RELA;CELF1;FCGR2B;CASP1;STK24;TMSB4X;CXCR4;BST1;APPL2;CASP8;HCK;PPEF1;NOD2;APPL1;RNF135;NMT1;SETD6;LRRC19;SEMA7A;GUCY2F;GUCY2D;ZMPSTE24
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.6696764748308563,-1.5796143610369744,0.02456140350877193,0.10382352163475554,1.0,6/11,9.23%,PARP11;PARP14;PARP4;TIPARP;PARP9;PARP8
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.5798249676721536,1.5790077215899299,0.029484029484029485,0.14577323095700911,1.0,2/17,0.67%,AKAP6;ANK3
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.6325408034571229,-1.5790010097327325,0.03559322033898305,0.1041833424325394,1.0,4/13,8.64%,APOE;PLEK;NFKB1;ERLIN1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5637447438386987,1.5782779725501204,0.03722084367245657,0.14574687303232386,1.0,8/19,13.39%,DLG2;LRRC7;DLG3;PARD3;PRKCI;MTCL1;CRB1;PATJ
prerank,DNA conformation change (GO:0071103),-0.5892778258610692,-1.577947631770946,0.02218430034129693,0.10495844394606403,1.0,8/17,20.42%,TOP3A;HHEX;TOP2A;HMGB2;TOP1MT;HMGB1;HMGB3;PRM1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.38652262612498633,-1.5772726370320993,0.0,0.10533977178236174,1.0,50/148,21.67%,TOP3A;BRD7;PHF20;CSNK2A1;PIP4K2A;PRKAG2;BRCA1;SGK1;DYRK2;CHD3;BLM;MAPK14;RPS20;RPL11;SMYD2;RAD1;TAF6;PIP4P1;TPX2;PIN1;WRN;CDK1;STK11;EXO1;PLK3;RPA3;RFC2;RHNO1;RNF34;TAF4B;PAK1IP1;TOPBP1;BRIP1;USP7;KMT5A;TAF9;RBBP4;AURKA;TAF3;RAD9A;DNA2;RBBP8;TAF4;MDM4;ATM;CHEK1;RFC3;NBN;CDK5;PRKAG1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.5391895396326608,-1.5770106180233336,0.014059753954305799,0.10534724020595743,1.0,9/27,15.21%,APOE;PLTP;LRP1;EEPD1;PPARG;NR1H2;ZDHHC8;RXRA;ABCA13
prerank,potassium ion export across plasma membrane (GO:0097623),0.6079013919992001,1.575964388683119,0.03325942350332594,0.14747004493564617,1.0,3/13,6.77%,KCND3;KCNT2;KCNIP2
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.5519076714782946,-1.5757368963702851,0.019769357495881382,0.1062970235531022,1.0,8/22,23.85%,CCR2;LILRB1;TNFRSF1B;LAPTM5;SLC7A5;SPHK2;NOD2;TRIL
prerank,cholesterol transport (GO:0030301),-0.48154799232524026,-1.575594103038694,0.010362694300518135,0.10622532347780314,1.0,9/45,11.01%,APOE;ABCA1;MSR1;ABCG1;CD36;OSBPL5;LIMA1;STARD5;NPC2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.5819789170091427,-1.5752371471309146,0.0213903743315508,0.1063017609615626,1.0,10/18,23.69%,TNFAIP8L2;PTPN22;DUSP3;LAPTM5;IL4I1;MIA3;ASS1;WNK1;LAX1;ADTRP
prerank,cellular response to dsRNA (GO:0071359),-0.6154707579225119,-1.5747551418234889,0.028070175438596492,0.10656501711611874,1.0,7/15,17.46%,CGAS;RIOK3;DHX9;IFIT1;MAVS;ZCCHC3;RALB
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.4384245999927392,-1.574277798481264,0.005226480836236934,0.10682423626729827,1.0,20/63,20.25%,IGF1;SP100;PAK2;BIRC6;RIPK1;CFLAR;PSME3;ITGAV;TGFBR1;RELA;TRAF1;AGT;TRAF2;BID;TNFSF10;STX4;DEPTOR;CASP8;TRADD;TMC8
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6254491315257077,1.5734861882396936,0.03167420814479638,0.14926109312268535,1.0,3/13,3.44%,B3GALT1;B3GALT5;GAL3ST3
prerank,small GTPase mediated signal transduction (GO:0007264),-0.40514686134212685,-1.5733705741649522,0.0,0.1075988655661746,1.0,34/103,18.69%,IGF1;ABR;GRB2;RREB1;GNB1;RB1;JUN;RAC1;ARHGAP30;USP50;GRAP2;RGS19;RIN2;RGL2;USP8;ARHGAP18;MAPK14;PLD2;ARHGEF18;PLK2;CCDC88A;KSR1;ARL3;SETDB1;CRKL;GRAP;BRAP;ARHGAP31;G3BP1;RALB;KRAS;NRAS;ARFIP2;RHEB
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.663727700011789,1.5733198821941785,0.027227722772277228,0.1485849314317311,1.0,5/10,12.92%,PDE4B;CACNA2D1;CACNB2;CALM1;CALM3
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.542352245483634,-1.5731859039855973,0.025167785234899327,0.10752782822952053,1.0,9/22,20.57%,LYN;MFHAS1;RAB7B;PTPN22;IFI35;APPL2;WDFY1;TICAM2;APPL1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.6845708849878368,-1.5728282188046387,0.017889087656529516,0.10763695906851845,1.0,5/11,17.79%,PTPRC;LILRB1;AHR;IL4I1;SMAD7
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6169088743938158,-1.5726026897411562,0.029616724738675958,0.10760260595070797,1.0,7/15,21.24%,IGF1R;TEC;PTK2B;DYRK1A;ITK;TXK;KDR
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.3516145555207358,-1.5720631149505395,0.0,0.1078789119152985,1.0,114/341,22.28%,RNF213;WWP1;CBL;ZNRF3;CNOT4;RNF150;BFAR;BIRC6;RNF149;RNF19A;NFE2L2;RNF111;PSME4;ARRB2;MYLIP;WWP2;FBXL17;AMFR;AREL1;RNF166;PELI1;PSMB7;ANAPC1;TNFAIP1;PSME3;RC3H1;RNF20;FBXW11;UBE2R2;PSMB9;KLHL25;TSG101;RBCK1;ARRB1;UBAP1;KLHL22;UBE3B;NUB1;CTNNB1;TBL1XR1;USP9X;ZFAND2A;KCTD10;ZSWIM8;ATXN3;RNF4;MVB12B;TGFB1I1;ATE1;SPSB2;PSMA8;UBE2L3;RNF8;PSMC3;KIF14;UBE4B;NEDD4L;SPSB3;XBP1;PCBP2;PSMD8;MAEA;WDR91;RNF128;FBXO10;UHRF1;BUB1B;UBE2H;PSMC4;PSMB10;RNF185;PSMA1;ARIH1;ARRDC1;RNF34;RNF43;KLHL42;UBE2G1;RNF216;CDC34;UBQLN4;FAF1;UBE2C;MIB1;UBE2I;PSMB8;SKP2;AURKA;ANAPC7;FBXO7;HUWE1;NDFIP2;UBXN1;TRIP12;ELOC;PSMA5;PSMD4;UBE3C;PSMB3;FBXO22;VPS4A;FBXW4;SIRT2;DTX3L;PSMD3;RNF125;TRIM25;BAG6;SMURF2;ZRANB1;HECTD3;RNF115;TOPORS;FEM1B
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.5306773452621998,-1.5718206534614745,0.012433392539964476,0.1078776588141078,1.0,12/27,23.39%,AGO2;RIPK1;STAT3;DHX9;PUM2;DDX5;MAP2K1;EIF4G1;DDX6;IL6;PUM1;TGFB1
prerank,membrane raft organization (GO:0031579),-0.6108989839122954,-1.5715423298009399,0.03264604810996564,0.10787084197448867,1.0,7/15,21.12%,RFTN1;ANXA2;MYADM;FLOT2;NPC1;CLN3;PPT1
prerank,positive regulation of viral process (GO:0048524),-0.44994240831645804,-1.5715334069088722,0.01011804384485666,0.10764178175791428,1.0,30/60,35.10%,MDFIC;AXL;RAB7A;NELFB;DHX9;POLR2H;POLR2F;CD28;POLR2L;IFIT1;CCL5;POLR2A;VAPB;POLR2G;RSF1;DDX3X;VPS4A;POLR2I;SRPK1;GTF2F2;DDB1;GTF2F1;NELFE;HACD3;PPID;POLR2D;NELFA;ADARB1;RAD23A;POLR2B
prerank,regulation of B cell apoptotic process (GO:0002902),-0.64770186649302,-1.571516166850432,0.021666666666666667,0.10740266229590342,1.0,4/12,8.47%,LYN;FOXP1;BCL6;FNIP1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.5355701928774321,-1.5714761765327039,0.015228426395939087,0.1071950407525429,1.0,12/26,25.06%,SPTLC2;ACER3;CYB5R3;CYB5B;GCH1;ARG2;SPHK2;SPTLC3;ASAH1;CYP1B1;NQO1;ABCA2
prerank,cation transport (GO:0006812),0.35835939420865676,1.5711328472110355,0.0,0.15005682844171714,1.0,38/167,13.91%,KCNB2;TRPM3;KCNN2;KCND3;SLC8A3;SLC12A2;KCNMB3;KCNMB2;SLC4A4;SCN2A;KCNH1;SCN1A;SLC9B2;SCN3A;SLC47A1;SLC6A17;KCNJ3;KCNJ10;KCNJ6;SCN9A;KCNIP2;KCNA1;KCNH4;KCNJ16;SLC1A1;PKD1L3;TRPM1;SLC8A2;SLC5A10;SLC4A11;KCNF1;ATP1B1;KCNG1;KCNMA1;KCNJ12;KCNV1;KCNA2;KCNS3
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.4101564483514917,-1.571108054706525,0.0016420361247947454,0.1073278009679006,1.0,34/100,22.00%,DAB2;SDCBP;HECTD1;RNF19A;OGT;UCHL5;GNA12;PIAS1;RYBP;CBFA2T3;RPL11;NUB1;DET1;TRIB1;TRIB2;RNF180;HSP90AB1;WAC;ARIH1;GABARAP;UBQLN4;USP7;TAF9;HSPA1A;SMAD7;TRIM39;UBXN1;FBXO22;GSK3B;SIRT2;RACK1;BAG6;SOCS5;EIF3H
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.6665628851958054,-1.57091930579909,0.019784172661870502,0.10725895434098945,1.0,6/11,19.35%,LILRB1;AXL;GAS6;SELENOS;HCLS1;NOD2
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.675165708980653,1.5706406975656617,0.0447427293064877,0.14972358996662746,1.0,4/10,8.49%,HECW1;PRKCE;HECW2;NEDD4
prerank,calcium ion import into cytosol (GO:1902656),0.6012842940613973,1.5704377489594221,0.04578313253012048,0.14916377962421437,1.0,8/15,19.02%,CACNA2D1;SLC24A2;SLC8A3;SLC8A2;ATP2B4;TRPV3;TRPM2;SLC24A1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.5291830395338415,-1.570251161455299,0.02782608695652174,0.10761352720710729,1.0,10/27,14.72%,MAP3K8;MAP3K5;MAP3K20;NFKB1;FBXW11;UBC;RPS27A;TNIP2;KAT7;IKBKB
prerank,intracellular cholesterol transport (GO:0032367),-0.6168204140400148,-1.5696347573492098,0.01926444833625219,0.10793636900983344,1.0,7/15,20.48%,ABCA1;ABCG1;LRP6;NPC2;NPC1;LDLR;VPS4A
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.6549247851597176,-1.5689513207774708,0.018998272884283247,0.10829880867030002,1.0,6/12,14.83%,NOTCH2;DOCK10;DOCK11;PTK2B;FCGR2B;POU2AF1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.46431258235270273,-1.5679732628258074,0.008912655971479501,0.10901717641272264,1.0,27/54,27.61%,CRADD;CNOT4;CNOT1;CNOT2;PLK2;E2F1;PRMT1;CDK1;PCNA;GADD45A;PLK3;E2F8;CNOT6L;AURKA;CASP2;MDM4;ATM;CNOT8;CDC25C;SFN;GTSE1;CCNB1;PCBP4;RBL2;CNOT3;PML;EP300
prerank,positive regulation of DNA recombination (GO:0045911),-0.5269277353669339,-1.5678631496509157,0.019230769230769232,0.10888272618964952,1.0,12/27,20.33%,ARID2;ACTR2;ERCC6;FUS;WDR48;KMT5B;KMT5C;TIMELESS;RAD51AP1;WRAP53;SHLD2;MMS19
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.43626481490602426,-1.5678510906688983,0.008237232289950576,0.10865104807797468,1.0,28/69,22.60%,GTF2A1;INTS8;NABP1;INTS11;SRRT;TAF6;POLR2H;POLR2F;POLR2L;SNAPC2;INTS6;INTS14;RPRD2;GTF2E2;POLR2A;NCBP1;TAF8;INTS1;POLR2G;TAF9;SNAPC3;PHAX;INTS5;POLR2I;CCNK;GTF2F2;GTF2A2;ELL2
prerank,cellular response to estrogen stimulus (GO:0071391),-0.6197412142132621,-1.5665450634355547,0.029565217391304348,0.10972992464321597,1.0,6/14,20.84%,WBP2;SERPINB9;TRIM24;RARA;ARID5A;SFRP1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.6450653250396232,-1.5665238581577814,0.044169611307420496,0.10951093132010527,1.0,5/12,21.71%,MBNL1;LRP6;SKI;FBXW4;MEGF8
prerank,calcium ion transmembrane transport (GO:0070588),0.39824413110883217,1.5665160993232772,0.0026595744680851063,0.1524733858650356,1.0,13/86,3.14%,GRIN2A;TRPM3;CACNA1C;RYR3;TRPC5;GRIN2B;CACNA2D1;SLC24A4;SLC24A2;SLC8A3;NALCN;TRPC1;SLC24A3
prerank,negative regulation of RNA splicing (GO:0033119),-0.5720741123165174,-1.566232232326009,0.028523489932885907,0.10954393964866588,1.0,9/19,28.39%,PTBP3;RPS13;TMBIM6;SRSF10;RNPS1;C1QBP;PCBP4;U2AF2;SRSF7
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.48920015757357016,-1.5659386971106628,0.024390243902439025,0.10962528676386084,1.0,14/40,20.26%,SLC16A7;SLC38A6;SLC38A10;SLC27A1;SLC7A7;SLC38A7;SLC36A4;ABCC1;SLC7A5;SLC23A1;SLC23A2;SLC38A2;SLC25A10;SLC16A1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.3993282670079931,-1.5657603259514317,0.003125,0.10960952482436799,1.0,37/108,19.36%,MAP3K5;APAF1;CTSD;DAPK1;SYK;XDH;CRADD;PPARG;MALT1;RIPK1;CFLAR;NLRC4;ANP32B;HIP1;LAPTM5;CASP4;NOD1;GRAMD4;ATP2A3;FIS1;LCK;HSPE1;CASP1;TRAF2;BBC3;BID;TNFSF10;CASP8;RPS3;IFT57;TRADD;LGALS9;PDCD5;CASP2;DDX3X;BEX3;HMGB1
prerank,anterior/posterior axis specification (GO:0009948),-0.6079732392748234,-1.5656126954180374,0.027972027972027972,0.10952678678661794,1.0,4/15,19.11%,SKI;WLS;RIPPLY2;HOXD8
prerank,endothelial tube morphogenesis (GO:0061154),-0.6887854235046897,-1.5652868985043848,0.025684931506849314,0.10958623399337847,1.0,3/10,7.15%,RBPJ;RHOA;CTNNB1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.656452071098297,-1.5643794077327082,0.025225225225225224,0.11026490461014732,1.0,5/12,5.73%,ABCA1;ABCG1;PPARG;ITGAV;NR1H2
prerank,positive regulation of GTPase activity (GO:0043547),-0.3703439419468669,-1.563704092338387,0.0016181229773462784,0.11064222984570699,1.0,66/188,22.59%,BCAR3;ABR;CORO1C;ARHGAP25;RSU1;ARHGAP22;ARHGAP24;SNX9;DOCK10;SIPA1;TBC1D15;DOCK11;SGSM2;RGS1;TBC1D2B;RAP1A;TBC1D9;ITGB1;DOCK8;ARAP1;RAB3GAP1;TBC1D5;TBC1D1;SIPA1L2;ARHGEF10;TBC1D22A;PICALM;EZH2;SIPA1L3;TBC1D16;ALS2;TBC1D22B;SH3BP1;TBC1D8B;TBC1D8;TGM2;SCRIB;TBC1D17;PIN1;SNX13;CCDC125;FLCN;FOXJ1;SNX18;TBC1D10B;CCL5;CD40;RALGAPA2;TBC1D30;ARHGEF5;TBC1D7;AGRN;TBC1D9B;LIMS1;GPR65;TBC1D25;MMUT;PIP5K1A;GSK3B;SFRP1;RACK1;TBC1D10C;MAP4K4;RAP1GDS1;TBC1D4;RAP1GAP2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4429199432537878,1.563253012650488,0.007731958762886598,0.15510034055266206,1.0,14/48,16.07%,AKAP6;ANK2;DMD;TRPC1;PDE4D;CASQ2;JPH4;NPSR1;CAPN3;CALM1;CALM3;CALM2;JPH3;SNCA
prerank,receptor-mediated endocytosis (GO:0006898),-0.3930977541681073,-1.5625139370083472,0.0,0.11148585394814832,1.0,29/132,7.99%,DAB2;MRC1;APOE;MSR1;GRB2;CD163;LILRB1;STAB1;SYK;LRP1;CD36;ITGB2;DNM2;SNX9;CANX;INSR;RAB31;CD9;ARRB2;GRK3;ITGB1;DNAJC13;AP1G1;FCHO2;LRP6;PICALM;PI4KB;EPS15;AP2A2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.66526196336531,-1.5621968909105208,0.03832752613240418,0.11158302391323335,1.0,6/11,17.31%,RFTN1;UNC93B1;RIPK1;TNIP2;TICAM1;CASP8
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.6128562536996232,1.560556205853023,0.04066985645933014,0.15697540293677023,1.0,8/14,18.59%,ANK3;DMD;TESC;ATP1B1;GLRX;WNK4;WNK3;WNK2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.6229212949378294,-1.5593043694224917,0.022569444444444444,0.11412319386459273,1.0,6/12,13.07%,FOXP1;CD74;TLR4;MAP2K5;LPL;OAS3
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.686620892031585,-1.5578272778508198,0.029310344827586206,0.11543999667727547,1.0,7/10,23.69%,TNFRSF1B;DPP4;FAP;CHADL;CST3;TGFB1;ADTRP
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.6022863383620626,-1.557823534850337,0.0156794425087108,0.11520123784567718,1.0,9/17,21.90%,SYK;CD28;FCER1G;SLC7A5;RARA;GATA3;LGALS9;NLRP3;CEBPB
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.5106501016574145,-1.5564428515155029,0.01926444833625219,0.11631811316473054,1.0,11/29,20.84%,ADIPOR1;SDHAF2;SPRED1;SPRY2;SPRED2;LDLRAD4;VASN;SMAD7;GATA3;IL17RD;SFRP1
prerank,regulation of mRNA catabolic process (GO:0061013),-0.39437885399699235,-1.5559539138519691,0.0049586776859504135,0.11656932573456621,1.0,43/121,24.22%,VIM;ZC3HAV1;PRKCD;YTHDF3;DCP1A;PSME4;MAPKAPK2;ANP32A;PSMB7;CNOT1;PSME3;RC3H1;PSMB9;EXOSC5;PUM2;DCP2;PSMA8;UBC;RPS27A;ZC3H14;PSMC3;MOV10;GTPBP1;PSMD8;PSMC4;PSMB10;DHX36;PSMA1;EIF4G1;PSMB8;HSPA1A;HSPB1;PSMA5;PSMD4;CNOT8;PSMB3;PSMD3;ZC3H12A;EXOSC4;SET;PUM1;PSMB1;PCBP4
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.47553252597695794,-1.555699439047336,0.009819967266775777,0.11658636694844676,1.0,30/44,39.64%,CD44;CSNK2A1;HGF;GAS6;VEGFA;MAP2K5;FNIP1;CAST;YWHAE;CST7;DDX3X;BEX3;DNAJB6;SFN;MT3;SIAH2;RPS6KA3;CARD16;AQP1;PAX2;NGFR;XIAP;TNF;KLF4;LTF;NGF;LAMP3;USP47;RAF1;TRIAP1
prerank,cAMP-mediated signaling (GO:0019933),0.5238582263627624,1.555399902805605,0.03317535545023697,0.16188594880782742,1.0,7/24,8.71%,RIMS2;AKAP6;ADCY2;EPHA5;PDE4D;SOX9;ADCY1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.5989670209590472,-1.5549989495365184,0.02195945945945946,0.1170450350566807,1.0,11/15,30.08%,CD36;USP50;TLR4;EIF2AK2;GBP5;MYD88;NLRC3;DDX3X;MEFV;CPTP;PYDC1
prerank,regulation of lymphocyte migration (GO:2000401),-0.6832110942852027,-1.5549725203291027,0.0297723292469352,0.11682105525839559,1.0,7/10,23.69%,MSN;WASL;MIA3;SPN;STK10;SLC8B1;ADTRP
prerank,regulation of protein kinase activity (GO:0045859),-0.40001568818494265,-1.5546327426556463,0.001652892561983471,0.11694156059328503,1.0,28/106,13.36%,IQGAP1;PTPRC;FGR;PAK2;RB1;SNX9;RAP2B;C5AR1;PRKAG2;CEP85;UVRAG;RAP1A;TAB2;PTK2B;LRP6;GAS6;CAMKK2;ALS2;CENPE;SMG8;TRIB1;ITGB1BP1;TRIB2;SPRED1;XRCC6;CAMKK1;CACUL1;LCP2
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.3698728388738423,-1.554387631893029,0.0,0.11693170367801786,1.0,54/175,22.44%,PID1;BIRC3;TNFRSF1B;NFE2L2;ARHGEF2;PSME4;RIPK1;TRAF5;BRCA1;FOXO3;PSMB7;PSME3;DHX9;PTK2B;AIM2;PSMB9;TRAF3;TNFRSF21;ERBIN;GSDME;ZFAND6;PSMA8;GBP2;CD27;RELA;TRAF1;PSMC3;PSMD8;CCL5;CIB1;TRAF2;PSMC4;PSMB10;PSMA1;CD40;TMSB4X;IKBKB;PSMB8;TNFRSF25;LIMS1;GATA3;RPS3;TRADD;GBP3;PSMA5;PSMD4;PSMB3;PSMD3;SFRP1;ZC3H12A;STAT1;ASAH1;TNFSF9;ILK
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.40796974169500133,-1.5538087938358145,0.01011804384485666,0.11718364392935329,1.0,44/95,28.61%,DAB2;ZEB2;SDCBP;CREBBP;RNF111;PMEPA1;SNX6;SKI;TGFBR1;TGFB1I1;SNX25;UBC;RPS27A;SPRED1;SPRY2;PIN1;FLCN;SPRED2;LTBP4;ITGA3;STK11;HTRA3;HSP90AB1;TGFBR2;LDLRAD4;LATS2;VASN;HSPA1A;SMAD7;IL17RD;SMURF2;ZBTB7A;EID2;TGFB1;SKIL;SMAD4;SMURF1;ENG;BCL9;NREP;EP300;WFIKKN1;CITED2;DKK3
prerank,Golgi to endosome transport (GO:0006895),-0.6122436365664131,-1.5537544463345172,0.024096385542168676,0.11697159661528797,1.0,6/16,9.73%,VPS13C;VPS13A;KIF16B;EPS15;SYS1;CORO7
prerank,regulation of dendritic spine development (GO:0060998),0.5662808766935277,1.5530184091606103,0.019656019656019656,0.16372966506351902,1.0,9/19,13.71%,NLGN1;PPFIA2;GRIN3A;TANC2;SHANK3;FMR1;CPEB3;ARF6;PTPRS
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5643062562619446,1.552791253326284,0.042352941176470586,0.16308775543671925,1.0,2/17,1.49%,ANK2;CACNA2D1
prerank,regulation of axonogenesis (GO:0050770),0.44107765148441713,1.5525362967507284,0.009779951100244499,0.16248842959879042,1.0,9/51,3.22%,LRRC4C;ROBO1;ROBO2;CDH2;SLIT2;NTRK2;LINGO1;PAK3;SLITRK1
prerank,regulation of endocytosis (GO:0030100),-0.44372439653148543,-1.5522957546774614,0.01335559265442404,0.1181824559026701,1.0,15/61,10.66%,DAB2;APOE;MCTP1;LILRB1;LRP1;ROCK1;ABL2;CD22;PICALM;SNX33;HIP1;CBLL1;RAB5A;PACSIN2;NEDD4L
prerank,vesicle organization (GO:0016050),-0.46434346213251737,-1.551377083615695,0.020338983050847456,0.11896846765736166,1.0,14/46,11.59%,SNX10;PI4K2A;USP50;SRGN;DNAJC13;USP8;PI4K2B;WASL;WASHC4;SNX33;EPS15;ALS2;ARFGEF2;SAR1A
prerank,chromosome condensation (GO:0030261),-0.49420347307005824,-1.5510464460997218,0.017094017094017096,0.11906757263519513,1.0,20/36,26.19%,RB1;CSNK2A1;NCAPG2;TOP2A;INCENP;SMC4;NCAPH;MCPH1;ACIN1;CDK1;CHMP1A;NUSAP1;NCAPD3;KMT5A;PHF13;NCAPG;SET;CCNB1;AKAP8L;ERN2
prerank,regulation of cell adhesion (GO:0030155),-0.39080950478838,-1.5505703289220403,0.0016207455429497568,0.1193252769938104,1.0,39/129,15.96%,LYN;PLXNC1;RSU1;ROCK1;PTPRJ;PLXNA1;SIPA1;PLAU;PLXND1;CYTH1;LPXN;FES;MINK1;CYTIP;ABL2;IL18;PTK2B;ITGAV;TGFBI;RIPOR2;STX3;PIK3CG;MYADM;VEGFA;CBLL1;ATXN3;MDK;ITGB1BP1;ADAM8;TGM2;KIF14;ZDHHC2;FLCN;CCL5;MIA3;PPP1R12A;RASA1;SPN;CXCR4
prerank,mitochondrion distribution (GO:0048311),-0.644955269801973,-1.5505230563064363,0.02460456942003515,0.1191391392986245,1.0,3/12,2.65%,TRAK1;MEF2A;MTM1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.4679242406017351,-1.5500974474612632,0.012048192771084338,0.11932156003589335,1.0,24/46,28.03%,MSN;PAK2;RAP1B;PITPNA;ANXA2;CDC42;HSPA9;HNRNPDL;STAT4;JAK1;LMNB1;LCP1;CAPZA1;CFL1;RPLP0;GSTO1;CNN2;TYK2;MTAP;P4HB;IL12RB1;TALDO1;HNRNPF;SERPINB2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.6799680271062465,-1.5494292391639448,0.03656307129798903,0.11978104661056405,1.0,6/10,20.94%,DHX58;RIOK3;SEC14L1;GPATCH3;C1QBP;RNF125
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.419345218197418,-1.5492061357917633,0.0034662045060658577,0.11976299477152842,1.0,30/76,23.69%,SASH1;RHOA;TLR7;SPI1;TLR4;ADIPOR1;PTPN22;IFI35;PPM1B;EIF2AK2;LAPTM5;NOD1;CD27;RELA;APP;NLRC3;TMSB4X;LIMS1;RPS3;MMP8;TRADD;LGALS9;DDX3X;NOD2;AGER;ZC3H12A;NLRP3;ILK;TCIM;LRRC19
prerank,negative regulation of B cell proliferation (GO:0030889),-0.6649683293883579,-1.5491048106075596,0.02711864406779661,0.11963586966842925,1.0,8/11,25.73%,LYN;CD300A;RC3H1;TNFRSF21;FCGR2B;ATM;TNFRSF13B;BLK
prerank,mitotic cytokinesis (GO:0000281),-0.45802507893660876,-1.5488331715779649,0.0033613445378151263,0.11962832248087736,1.0,26/47,27.29%,ROCK1;SNX9;PDCD6IP;SON;INCENP;USP8;KIF23;CENPA;EFHC2;SNX33;KIF4A;SNX18;ARL3;CKAP2;RACGAP1;NUSAP1;RASA1;KIF20A;CEP55;JTB;CHMP4B;KLHDC8B;RAB35;ECT2;MITD1;STAMBP
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5097850496221823,-1.548651420060761,0.029565217391304348,0.11961827831220252,1.0,12/27,21.80%,CD44;CD74;SMYD2;DDX5;SPRED1;DYRK1A;SPRED2;EEF1E1;KMT5A;ATM;KDM1A;SNAI2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.5279656868480828,-1.5479355874143517,0.03035413153456998,0.12011534649959901,1.0,17/25,33.35%,HSPA9;DNAJB14;HSPE1;ST13;DNAJB13;HSPA1A;SDF2L1;HSPA2;DNAJC7;HSPA13;ERO1A;HSPA8;SDF2;GAK;HSPA1B;DNAJC18;DNAJB12
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.4637985294933064,1.5477973968932777,0.01818181818181818,0.16715918176980166,1.0,8/41,1.66%,HTR2C;GRIN2A;RYR3;RYR2;GRIN2B;CACNA2D1;SLC24A2;SLC8A3
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.5817836378084107,-1.547793946168531,0.034782608695652174,0.12001623360359848,1.0,6/17,14.65%,ANXA4;PTPN22;ANXA1;ARRB1;MAP2K5;TMSB4X
prerank,mitotic spindle organization (GO:0007052),-0.3743138478941524,-1.547219517181949,0.001610305958132045,0.12042504270502484,1.0,63/153,23.99%,RHOA;STAG1;FLNA;EML4;KIF3B;KIF11;PIBF1;DYNC1H1;KNL1;INCENP;CENPF;DLGAP5;KIF23;CENPA;ABRAXAS1;EFHC2;STAG2;ARHGEF10;KIF4A;PLK2;SUN2;ZWILCH;CENPE;CENPK;CKAP5;CENPN;NEK6;CENPL;TPX2;BUB1;KIFC1;TAOK1;TBCE;BUB1B;MAP4;SPC25;KIF2C;DYNC1LI2;TTK;SGO1;MAD1L1;STIL;PCNT;NUF2;AURKA;RPS27;NDC80;CENPH;RCC1;ERCC6L;PAFAH1B1;PRC1;SMC1A;RAB11A;NUP107;CEP192;LSM14A;NSL1;PPP1CC;CENPP;CCNB1;CENPO;SPC24
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.5745435742278852,-1.5469687296210863,0.02982456140350877,0.12051626260979986,1.0,6/19,9.89%,CD74;RAC1;CAMK1D;RIPOR2;MDK;NCKAP1L
prerank,neural crest cell development (GO:0014032),0.4538817901329897,1.5468293555776536,0.017632241813602016,0.1674716552548278,1.0,17/44,16.05%,NRG1;ERBB4;SOX11;CDH2;SEMA6D;SEMA6A;SEMA3E;SEMA5A;GDNF;PDCD6;SEMA3F;TBX1;SEMA5B;TAPT1;SEMA4G;RADIL;NRTN
prerank,chromatin disassembly (GO:0031498),-0.615392256830013,-1.546675642475245,0.030874785591766724,0.12030802990746528,1.0,5/14,11.99%,ARID2;SMARCD3;SMARCC2;ARID1A;NFE2
prerank,nucleosome disassembly (GO:0006337),-0.615392256830013,-1.546675642475245,0.030874785591766724,0.12030802990746528,1.0,5/14,11.99%,ARID2;SMARCD3;SMARCC2;ARID1A;NFE2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5049540944245523,1.5460547279756784,0.03787878787878788,0.16742540376175474,1.0,8/27,8.73%,RIMS2;RIMS1;SYT1;SYT10;SYT2;SYT5;SYT11;SYT12
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5609201263050438,1.5459336276376947,0.04491725768321513,0.1666829337020599,1.0,7/18,10.87%,NLGN1;NRXN1;SHANK3;TSHZ3;CACNG4;CACNG2;RELN
prerank,positive regulation of cation channel activity (GO:2001259),0.4620082149047214,1.5457876971491211,0.015345268542199489,0.16602129783683708,1.0,12/40,14.03%,AKAP6;ANK3;ANK2;SHANK3;KCNIP2;PIRT;RELN;STAC;CALM1;CALM3;CALM2;ARC
prerank,regulation of response to interferon-gamma (GO:0060330),-0.6122655674027796,-1.5455030925129536,0.03315881326352531,0.12130857320135517,1.0,8/14,22.98%,PIAS1;JAK1;PARP9;IFNGR2;HSP90AB1;SOCS3;STAT1;IFNGR1
prerank,regulation of ATP metabolic process (GO:1903578),-0.45149992591487187,-1.5454110459655226,0.012455516014234875,0.12116845932161427,1.0,28/54,30.35%,OGT;NUP50;PRKAG2;ATP7A;NUP42;NUP88;RAE1;HIF1A;FIS1;NUP205;TPR;JMJD8;NUP188;SPHK2;NUP153;COX7A2;NUP35;NUP107;NUP62;PRKAG1;ZBTB7A;RANBP2;EIF6;NUP37;EP300;PGAM1;AAAS;NUP133
prerank,positive regulation of endocytosis (GO:0045807),-0.4742090305349588,-1.544944351620005,0.010619469026548672,0.12140122955097457,1.0,21/45,16.42%,DAB2;APOE;LRP1;AXL;CBL;ANO6;RAB31;CDC42;STAP1;ANKFY1;C3;HIP1;CBLL1;B2M;RAB21;NCKAP1L;NEDD4L;SERPINE1;ABCA13;CLN3;APPL2
prerank,regulation of T cell proliferation (GO:0042129),-0.43991891633570396,-1.5445839352935087,0.012259194395796848,0.1215513189794498,1.0,28/61,32.12%,PTPRC;LILRB1;TNFRSF1B;IL15;ANXA1;TNFRSF21;CD28;NCKAP1L;SDC4;CD46;IL4I1;CCL5;VSIG4;SPN;CD274;CEBPB;TNFSF9;CD3E;IL6;NCK1;TNFRSF13C;PNP;RIPK3;IL27;NCK2;SLC7A1;CCL19;CD80
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.6197894036719093,-1.543886670516264,0.021352313167259787,0.12157447366568681,1.0,3/12,5.26%,NSMCE2;RB1;DLGAP5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.6197894036719093,-1.543886670516264,0.021352313167259787,0.12157447366568681,1.0,3/12,5.26%,NSMCE2;RB1;DLGAP5
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.6197894036719093,-1.543886670516264,0.021352313167259787,0.12157447366568681,1.0,3/12,5.26%,NSMCE2;RB1;DLGAP5
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.41359041571594385,-1.5435287985511048,0.006666666666666667,0.12165667191242481,1.0,23/87,11.79%,IQGAP2;IQGAP1;NOTCH2;LRP1;PRKCD;RAC1;ROCK1;RHOA;EPS8;ARHGAP17;ABL2;PTK2B;DAPK3;ARHGAP18;RHOQ;BAIAP2;MDK;SH3BP1;BST2;TAOK1;CRK;CCDC88A;PIK3CA
prerank,erythrocyte differentiation (GO:0030218),-0.4652867628220178,-1.543457396938275,0.01652892561983471,0.12148593302935769,1.0,10/44,9.89%,LYN;MFHAS1;IKZF1;HSPA9;RPS14;VEGFA;ACIN1;CEBPG;FLVCR1;NCKAP1L
prerank,regulation of coagulation (GO:0050818),0.6363135883913084,1.5427587441114814,0.05104408352668213,0.1686338968104624,1.0,1/11,0.53%,HS3ST5
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5112464561701442,1.541248675844443,0.036281179138321996,0.16954438735137586,1.0,12/25,18.59%,ANK3;ANK2;DMD;TCAF1;PIRT;ATP1B1;STAC;GLRX;WNK4;WNK3;ATP1B2;WNK2
prerank,regulation of defense response to virus by host (GO:0050691),-0.5120123399480232,-1.541205738965017,0.024691358024691357,0.12350163298836872,1.0,14/30,23.01%,LILRB1;CGAS;DHX9;PTPN22;AIM2;PARP9;SIN3A;RNF216;MAVS;ZDHHC1;DTX3L;ZC3H12A;STAT1;TOMM70
prerank,nucleosome organization (GO:0034728),-0.4518186898681503,-1.5404258441975025,0.01675041876046901,0.12405098990919358,1.0,18/55,18.84%,ARID2;BPTF;SMARCA5;SMARCD3;ANP32B;SMARCC2;ARID1A;RNF8;NFE2;ASF1A;HMGB2;SPTY2D1;PADI4;SART3;INO80;CHAF1A;BRD2;RSF1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.36005740066594544,-1.5401764966501932,0.0,0.12404962849891693,1.0,82/234,23.83%,PRKCH;PRKCB;PLCG2;CD36;RAB7B;CAMK1D;ARID5B;ARHGEF2;PPARG;MALT1;RIPK1;IRAK2;TRAF5;STAT3;MBTPS2;TAB2;CFLAR;CARD11;TLR4;IL18;NLRC4;DHX9;NFKB1;AIM2;RNF31;STK3;RBCK1;LRP6;IRAK3;CTNNB1;IL18RAP;VEGFA;EIF2AK2;MYD88;CEBPG;NOD1;ADAM8;UBC;RPS27A;RELA;TRAF1;AGT;MTPN;APP;TICAM1;CIB1;TRIM68;TRAF2;HDAC5;NFAM1;CRTC3;CD40;RNF25;TCF3;FLOT2;IKBKB;MAVS;NFKBIB;TRIM14;ARHGEF5;HCLS1;IL18R1;HSPA1A;PPARGC1B;RPS3;TRADD;LGALS9;NOD2;COPS5;AGER;JUP;TRIM25;KDM1A;NLRP3;ZBTB7A;RPS6KA5;IL6;PLPP3;ESR2;MTDH;FANK1;DVL2
prerank,neuromuscular process controlling balance (GO:0050885),0.6322977202977764,1.5400261234478505,0.0525164113785558,0.17007862450065053,1.0,2/12,0.23%,NRXN1;PCDH15
prerank,cellular protein metabolic process (GO:0044267),-0.33888574146100503,-1.5393783851371299,0.0,0.12469793094143347,1.0,133/396,23.55%,APOE;IGF1;FAM20C;SFTPA1;SFTPA2;ST3GAL1;PPP4R2;ST8SIA4;AGO2;CSF2RA;RPS18;RPL7;RPS12;RPS21;RIPK1;ABL2;WWP2;RPS8;RPS24;GSPT1;CCDC59;SARS1;MSRA;RPL36;PARP4;RPS6;RPS20;RPL11;RPL10A;FN1;RPL12;C3;RRBP1;MRPL42;GAS6;RPS14;WFS1;RPL32;STK38;RPS15A;RPS28;RPS13;UBA7;CTSH;RPS27A;DARS1;RPL28;UBE2L3;RPS4X;MSRB1;CP;KLK3;UBL5;ZDHHC2;RPS23;SEPHS1;EIF4EBP2;APP;B4GALT7;PSENEN;HSP90B1;CSF2RB;SERP1;RPL22;IGFBP3;RPL14;EEF1A1;MRPS6;LGALS1;RPL34;MRPS11;RPS11;PADI4;RPL6;FBXW2;MIA3;DENND3;SPP1;MFGE8;UBE2G1;FDXR;EIF4G1;RPS10;PIGH;CDC34;CST3;RPL18A;MRPS16;HM13;RPL37A;APLP2;RABGGTA;MRPL34;UBE2I;DNAJC3;RPS9;TTF1;MRPS15;RPS27;MAN2B1;GNMT;ABCF1;RPS3;RAB12;RPL23A;RPS16;UBE2M;SHISA5;RABGGTB;RPL9;COPS5;IGFALS;CSF1;FBXO22;F5;BAP1;MMP2;MMP1;RPLP2;CSNK1G3;MRPL51;MANBA;RPL41;RPLP0;D2HGDH;IL6;PRKDC;RPL7A;RPL19;P4HB;RPS15;RPL39;ERO1A
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6122709828877161,1.5386523224187048,0.04728132387706856,0.1707746332116855,1.0,5/12,9.55%,NFIB;MYCBP2;EPHB1;SPTBN4;TSKU
prerank,negative regulation of microtubule polymerization (GO:0031115),0.6200107727069861,1.538547239366586,0.050970873786407765,0.17000379778761734,1.0,6/12,16.07%,MAP2;ARHGEF7;TUBB4A;EML2;CDH5;SNCA
prerank,cell part morphogenesis (GO:0032990),-0.629749533830818,-1.5374524790819817,0.033928571428571426,0.12642674211200916,1.0,4/13,10.11%,PID1;MTM1;FIS1;PACSIN2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6596145848214502,-1.5372813840044028,0.035398230088495575,0.12636982527462656,1.0,4/10,7.44%,LYN;STAT3;STAT6;STAT5B
prerank,histone modification (GO:0016570),-0.39278172100583186,-1.5361497742621495,0.011589403973509934,0.12728551538084748,1.0,34/109,18.64%,RCOR1;MIDEAS;PRKCD;CREBBP;ATXN7;PHF20;NSD3;PRMT2;INCENP;EYA4;MORF4L1;TAF6;TBL1XR1;EZH2;USP36;USP3;PRMT1;SUDS3;HDAC10;NAA50;RBM14;UHRF1;MTA3;HDAC5;PADI4;SIN3A;PRMT6;NSD1;MRGBP;PHF20L1;EYA1;EYA3;HUWE1;MIER1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.31412888326550975,-1.5356346829644771,0.0,0.12756753326832188,1.0,309/1082,22.21%,PID1;RBPJ;MDFIC;DAB2;APOE;MITF;ZMIZ1;ZEB2;MAP3K5;FLI1;ELF4;RUNX1;IGF1;TFEB;NAMPT;CD38;CD74;SP100;TCF4;RREB1;ELF2;LILRB1;REL;LITAF;TET3;JUN;DNM2;NIBAN2;MEF2A;CREBBP;ACTR2;RUNX3;PPARD;OGT;AGO2;BPTF;TOX2;NFE2L2;BRD7;RNF111;IRF2;ARHGEF2;SBNO2;NFIC;BRD4;NFYA;ARID1B;ATF3;PAXBP1;ATAD2;ELF1;NSD3;UBP1;PPARG;KDM3A;ELK3;RNASEL;SMARCA5;RIPK1;MAML1;SPI1;BRCA1;ETV1;STAT3;ERCC6;FOXO3;MAML2;E2F2;LYL1;TLR4;ACTR3;IL18;STAT6;DHX9;USF2;RYBP;RNF20;NFKB1;HHEX;NLRC5;RUNX2;SMARCD3;FBXW11;RARG;PRMT2;NFATC2IP;MLXIP;IRF5;CRLF3;SNX5;MEF2B;KLF6;SMARCC2;BLM;TCF20;NR1H2;CIITA;JAG1;AXIN1;SS18;PF4;NRF1;WASL;HGF;RHOQ;LRP6;NFATC3;ARRB1;TAF6;PICALM;MED24;AHR;CTNNB1;TBL1XR1;CAMKK2;DPF2;STAT5B;ATF6;EDF1;PLAC8;NR2F1;CREB3L2;SKI;VEGFA;MAP2K5;E2F1;FIZ1;CNBP;ARID1A;ATMIN;RNF4;HELZ2;TGFBR1;WBP2;CEBPG;E2F3;KMT2C;SLC9A1;ITGB1BP1;MEF2D;PARP9;TGFB1I1;HIF1A;MEF2C;ATAD2B;TFEC;MAPK7;MRTFB;UBC;RPS27A;ASXL1;EGR1;ARNT;AFAP1L2;TNIP2;RELA;PIN1;PSMC3;AGT;NCF1;APP;XBP1;XRCC6;FLCN;ALYREF;OSR1;ARHGEF11;DYRK1A;MAP2K1;MLLT10;KLF10;MED4;PRDM2;NFE2;KMT2D;MLLT11;ASF1A;IER2;SPIN1;FOXJ1;HTATIP2;CHD8;RBM14;IL4I1;FOSL2;MLLT6;KAT7;HMGB2;SERPINE1;UHRF1;ZBED4;ACVR2A;HDAC5;DHX36;RXRA;FOXJ3;ELOF1;CALCOCO1;TET2;E2F8;TFAP4;GREM1;WAC;SIN3A;CRTC3;EPC1;PPP1R12A;CD40;DR1;KLF2;ID2;CKAP2;TFAM;TCF3;IKBKB;DOT1L;YY1;SPP1;POU2AF1;INO80;TXK;ZMIZ2;NSD1;POGZ;TFCP2;MAVS;AATF;KARS1;IL31RA;DNAJC2;HMGN1;QRICH1;NUFIP1;HCLS1;NR4A1;NRIP1;TNIP3;SOX10;FOXJ2;AGRN;TAF9;VHL;KMT2A;MAP2K3;GPATCH3;RARA;NFATC1;CSRNP1;ATF5;MED6;SMAD7;NR3C1;TFE3;GATA3;MYB;SERTAD1;PPARGC1B;TCF12;NCOA6;PLAG1;CXXC1;SSBP4;TRIM16;HAS3;CASZ1;RSF1;PITHD1;DDX3X;MEIS3;HOXD8;LMO2;NOD2;HMGB1;COPS5;ATM;NAA16;MAX;CHP2;RASL11A;CHEK1;EHF;BMPR2;MMS19;GLMP;MAML3;RLF;MAZ;SIRT2;DTX3L;SFRP1;ZC3H12A;STAT1;JUP;RAI1;POU3F1;ZSCAN21;KDM1A;HOXB2;NUP62;HAX1;CCNK;NLRP3;HEYL;CEBPB;EGR2;ZNF296;BARX2;RPS6KA5;MYRFL
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.31850170098239017,-1.535512802936089,0.0,0.12743162049761292,1.0,237/834,22.19%,PID1;RBPJ;DAB2;MITF;ZMIZ1;ZEB2;ELF4;RUNX1;IGF1;TFEB;NAMPT;TCF4;RREB1;LILRB1;REL;LITAF;TET3;JUN;MEF2A;CREBBP;ACTR2;PPARD;OGT;AGO2;BPTF;TOX2;NFE2L2;RNF111;IRF2;ARHGEF2;SBNO2;NFIC;BRD4;PLXND1;ATF3;PAXBP1;ATAD2;ELF1;UBP1;PPARG;CDK13;ELK3;RNASEL;SMARCA5;RIPK1;MAML1;SPI1;BRCA1;ETV1;STAT3;FOXO3;MAML2;EAPP;E2F2;TLR4;ACTR3;IL18;STAT6;DHX9;USF2;NFKB1;HHEX;NLRC5;RUNX2;SMARCD3;RARG;NFATC2IP;MLXIP;IRF5;CRLF3;DLGAP5;MEF2B;KLF6;TCF20;NR1H2;CIITA;JAG1;SS18;PF4;NRF1;WASL;HGF;RHOQ;LRP6;NFATC3;ARRB1;TAF6;MED24;AHR;CTNNB1;TBL1XR1;DPF2;STAT5B;ATF6;PLAC8;NR2F1;SKI;VEGFA;MAP2K5;E2F1;FIZ1;CNBP;ATMIN;RNF4;HELZ2;WBP2;CEBPG;E2F3;KMT2C;SLC9A1;ITGB1BP1;MEF2D;HIF1A;MEF2C;ATAD2B;TFEC;MAPK7;MRTFB;UBC;RPS27A;ASXL1;EGR1;ARNT;TNIP2;RELA;PIN1;PSMC3;APP;XBP1;XRCC6;FLCN;OSR1;MLLT10;KLF10;MED4;PRDM2;KMT2D;MICAL2;IER2;FOXJ1;HTATIP2;CHD8;RBM14;IL4I1;FOSL2;MLLT6;KAT7;HMGB2;SERPINE1;UHRF1;ZBED4;ACVR2A;HDAC5;DHX36;RXRA;FOXJ3;CALCOCO1;TET2;E2F8;GREM1;SIN3A;CRTC3;EPC1;PPP1R12A;CD40;DR1;KLF2;CKAP2;TCF3;IKBKB;DOT1L;YY1;POU2AF1;INO80;TXK;ZMIZ2;POGZ;TFCP2;MAVS;AATF;NUFIP1;HCLS1;NR4A1;NRIP1;TNIP3;FOXJ2;AGRN;TAF9;KMT2A;RARA;NFATC1;CSRNP1;ATF5;MED6;SMAD7;NR3C1;TFE3;GATA3;MYB;PPARGC1B;TCF12;NCOA6;PLAG1;SSBP4;CASZ1;RSF1;DDX3X;MEIS3;HOXD8;LMO2;NOD2;HMGB1;COPS5;ATM;MAX;CHP2;EHF;BMPR2;GLMP;MAML3;RLF;SIRT2;ZC3H12A;STAT1;JUP;ZSCAN21;KDM1A;HOXB2;HAX1;CCNK;NLRP3;HEYL;CEBPB;EGR2;ZNF296;BARX2;RPS6KA5
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.44951073843271805,-1.5355122613528314,0.008517887563884156,0.12718321577929398,1.0,32/54,36.02%,APOE;P2RX4;PPARG;MAPK14;PRCP;VEGFA;SH3BP1;HIF1A;MEF2C;ANGPT2;GADD45A;CD40;TMSB4X;MAP2K3;HSPB1;HMGB1;JUP;KDR;FGF18;TGFB1;ATP5F1B;NUS1;ETS1;AGTR2;ATP5F1A;CSNK2B;FGF2;PLCG1;TNF;GATA2;HRG;PDGFB
prerank,positive regulation of type 2 immune response (GO:0002830),-0.6130351740740958,-1.5351382133394804,0.03257328990228013,0.12734138457459215,1.0,8/14,22.63%,CD74;IL18;RSAD2;RARA;NOD2;DENND1B;NLRP3;IL6
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.5395673909726826,-1.5346062824582576,0.03345070422535211,0.12759714973900915,1.0,13/24,25.96%,LILRB1;CGAS;PTPN22;AIM2;PARP9;SIN3A;MAVS;ZDHHC1;DTX3L;ZC3H12A;STAT1;TOMM70;IL12RB1
prerank,regulation of postsynapse organization (GO:0099175),0.49573092671320185,1.5338568774993309,0.02702702702702703,0.17453718735720974,1.0,8/28,6.74%,IL1RAPL1;PPFIA2;CDKL5;TANC2;SRCIN1;SHANK3;ABI2;HOMER1
prerank,amino sugar biosynthetic process (GO:0046349),-0.632401226730716,-1.5335331112185229,0.027777777777777776,0.1284376545441795,1.0,8/12,30.31%,GNPDA1;UAP1L1;UAP1;GNPDA2;GFPT1;AMDHD2;RENBP;GNPNAT1
prerank,B cell proliferation (GO:0042100),-0.5783851725443393,-1.5333411837889601,0.018739352640545145,0.12841352056891156,1.0,8/17,28.83%,PTPRC;BCL2;MEF2C;CD40;CD79A;MS4A1;GAPT;CD19
prerank,regulation of DNA recombination (GO:0000018),-0.4855742054826023,-1.5332426136111685,0.023140495867768594,0.12825373381691443,1.0,13/32,22.95%,PPP4C;PPP4R2;SPIDR;BLM;RTEL1;RAD51;IL7R;ALYREF;RAD51AP1;SHLD2;CHEK1;KDM1A;ZRANB3
prerank,DNA geometric change (GO:0032392),-0.534460263375229,-1.5332336356863459,0.03832752613240418,0.12802087831240894,1.0,17/24,26.01%,DHX9;ANXA1;BLM;RTEL1;MCM9;WRN;HMGB2;DHX36;DDX1;DNA2;HMGB1;HMGB3;NBN;ZRANB3;ASCC3;RECQL5;MRE11
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.45197750862175123,-1.5322284830911541,0.012727272727272728,0.1288778263172655,1.0,21/48,28.51%,FNIP2;MCL1;TNFRSF1B;BCL2L11;BRCA1;DYRK2;BCL2;CRIP1;E2F1;TMEM109;CASP2;ATM;BAG6;SFN;BCL2L2;TOPORS;PRKDC;PML;USP28;EP300;BCL2L1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.5043415774929674,-1.531951086119894,0.020512820512820513,0.1289193310304708,1.0,17/30,33.35%,HSPA9;DNAJB14;HSPE1;ST13;DNAJB13;HSPA1A;SDF2L1;HSPA2;DNAJC7;HSPA13;ERO1A;HSPA8;SDF2;GAK;HSPA1B;DNAJC18;DNAJB12
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.6738510779534348,-1.5318098269652733,0.03208556149732621,0.12879997511433383,1.0,7/10,27.64%,MALT1;RC3H1;NFKBIZ;SMAD7;NFKBID;ZC3H12A;TBX21
prerank,negative regulation of binding (GO:0051100),-0.4175884256085506,-1.5311538115198622,0.006430868167202572,0.12922122714882853,1.0,29/81,21.40%,DAB2;SP100;CTSZ;PRKCD;JUN;ROCK1;PEX14;ACTB;MDFI;PPP1CA;E2F1;ITGB1BP1;NES;PIN1;IFIT1;TMBIM6;IFIT2;TFAP4;BTAF1;TFIP11;AURKA;RALB;RSF1;PLN;TMC8;GSK3B;DISC1;KDM1A;RACK1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.4304387992327244,-1.5311395499600058,0.01794453507340946,0.12898639294781064,1.0,14/62,8.11%,LYN;AKAP13;IGF1;NOTCH2;GRB2;RAC1;ARHGEF3;VAV1;RASGRP4;PIK3CB;PIK3CG;ARRB1;ALS2;ERBIN
prerank,regulation of hydrolase activity (GO:0051336),-0.4262299092571177,-1.5310502961287737,0.017271157167530225,0.12884409378253112,1.0,20/71,12.63%,ARHGAP15;VAV3;PLXNC1;FGD6;GPR137B;PLXNA1;PLXND1;TBC1D15;VAV1;FGD4;FBXW11;RAB3GAP1;FGD3;ITGB1BP1;VAV2;ARHGAP12;ADAP1;WRN;CRK;TBC1D10B
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.34913860478278763,-1.5309784126043058,0.0,0.1286929545291873,1.0,103/264,27.45%,CTNNBL1;TRA2B;DDX46;SRRM1;CDK13;HNRNPA3;DHX9;SF3B6;SMU1;SNRNP35;CRNKL1;SRRT;FUS;SNRPG;HNRNPH1;GCFC2;COIL;SNRPF;POLR2H;HNRNPL;CDC40;POLR2F;SPEN;CWC22;RBM19;DDX5;RALY;SF3B3;POLR2L;PRPF8;SART1;SF3B5;UBL5;PCBP2;ALYREF;HNRNPUL1;NUDT21;SNRPA;RBM14;CWC15;SMN1;METTL14;RBM10;WDR33;YTHDC1;POLR2A;NCBP1;PSPC1;SART3;ZRSR2;GEMIN7;SNUPN;PDCD7;SF3A1;DDX1;SRSF10;POLR2G;RBM4B;TFIP11;LSM6;RNPS1;WBP11;SNRNP70;TXNL4A;HNRNPA1;SCNM1;PAPOLA;MAGOH;SLU7;WDR77;BUD13;TGS1;CPSF3;SF3B1;LSM5;POLR2I;HNRNPH2;GEMIN6;PPIL1;XAB2;HNRNPK;SRPK1;GTF2F2;SNU13;SYF2;SRSF11;NONO;MTREX;RBM22;PRPF6;DHX35;DDX39B;DHX38;GTF2F1;RBM15B;CPSF1;U2AF2;ISY1;HSPA8;WDR83;HNRNPF;METTL3;BUD31
prerank,response to cytokine (GO:0034097),-0.3818588117820686,-1.529340182697936,0.00322061191626409,0.13008031884824992,1.0,45/141,18.85%,PID1;CD74;SP100;MAPKAPK3;REL;MCL1;MAP4K3;RHOA;KYNU;RIPK1;IRAK2;IL6R;MAPKAPK2;STAT3;PTPN12;BCL2;IFNAR2;ANXA1;ADAM9;CIITA;YTHDC2;NUB1;IRAK3;EIF2AK2;MYD88;TIMP2;BST2;IFITM2;PTPN6;RELA;APP;CXCL16;CASP1;GCH1;CD40;RELB;CXCR4;HCLS1;ISG15;IL18R1;TAF9;CASP8;PTPN13;PTPN11;LGALS9
prerank,phospholipid homeostasis (GO:0055091),-0.647450893577868,-1.5292234857220008,0.041237113402061855,0.13000684848313734,1.0,4/11,9.94%,ABCA1;ABCG1;RCN3;TLCD2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.6797251338816982,-1.528678016105132,0.017482517482517484,0.13036274151072644,1.0,4/10,9.89%,RUNX1;RUNX3;CBFB;NCKAP1L
prerank,engulfment of apoptotic cell (GO:0043652),0.5637108366653047,1.5283685291717328,0.04357798165137615,0.1800503378218637,1.0,4/15,6.42%,XKR4;XKR6;RHOBTB2;XKR8
prerank,protein ADP-ribosylation (GO:0006471),-0.5150879002586151,-1.5281959369644078,0.028419182948490232,0.13066608462955476,1.0,11/28,20.67%,ZC3HAV1;PARP11;PARP14;PARP4;TIPARP;PARP9;PARP8;SIRT3;TNKS2;PARP10;SIRT2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.6424474045305045,-1.5270642766090197,0.031141868512110725,0.13165827671109626,1.0,8/11,30.31%,GNPDA1;UAP1L1;UAP1;GNPDA2;GFPT1;AMDHD2;RENBP;GNPNAT1
prerank,epithelial cell migration (GO:0010631),-0.47792507884620633,-1.5270254359810678,0.02127659574468085,0.13144094362539907,1.0,10/37,11.83%,NRP1;ZEB2;ROCK1;RHOA;PLXND1;LPXN;DPP4;PLEKHG5;PIK3CA;FAP
prerank,actin filament-based transport (GO:0099515),-0.5457304309620593,-1.5267561567446548,0.027257240204429302,0.1315183658002724,1.0,7/21,11.64%,MYO5A;MYO1F;MYO1G;WASL;SUN2;MYO1E;MYO7A
prerank,cellular response to interleukin-6 (GO:0071354),-0.5178158785921363,-1.5263422214928775,0.03264604810996564,0.1316578721082052,1.0,10/26,10.48%,PID1;CBL;SBNO2;SPI1;IL6R;CTR9;STAT3;NFKB1;JAK1;RELA
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.6214744022616974,-1.5258337448731083,0.03735144312393888,0.13193751276816182,1.0,6/13,11.84%,AXL;IL18;AP1G1;GAS6;LAMP1;TICAM1
prerank,metal ion transport (GO:0030001),0.38073606154328854,1.5255347809742912,0.0025,0.1826325801094729,1.0,30/86,20.35%,CACNA1C;RYR3;CACNA1E;TRPC5;RYR2;CACNA2D1;GRIN3A;SLC8A3;TRPC1;NIPA1;RAMP3;FYN;SLC8A2;CAMK2A;RYR1;MMGT1;ATP2B2;ATP2A1;CHRNA7;SELENOK;NDFIP1;RAMP2;NIPAL4;TRPM2;TUSC3;NIPAL2;CCR5;SLC24A1;MRS2;CACNB3
prerank,positive regulation of protein kinase activity (GO:0045860),-0.37439175961209575,-1.5253099916270225,0.006430868167202572,0.13231277433768926,1.0,54/148,19.18%,IQGAP1;PTPRC;NEDD9;TAOK3;PAK2;PRKCD;SNX9;RHOA;INSR;PRKAG2;MINK1;IL6R;RAP1A;TAB2;SLC27A1;PTK2B;INCENP;STK3;AXIN1;CAB39;GAS6;EZH2;ALS2;VEGFA;CENPE;EGR1;TPX2;TAOK1;KIF14;AGT;XRCC6;MAP2K1;CCDC88A;CAMKK1;STK11;CCL5;HSP90AB1;CACUL1;CIB1;LCP2;TGFBR2;MARK2;CALCA;IL34;STRADA;GPRC5B;MAP2K3;RALB;LILRA5;TAOK2;ADRB2;DDX3X;PAK6;JTB
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.6166368810745516,-1.5245773528303692,0.0274442538593482,0.13285663449740248,1.0,5/13,13.58%,RUNX1;RUNX3;CBFB;NCKAP1L;TGFBR2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.4378514695758841,-1.5244114077162223,0.008347245409015025,0.13276561145761223,1.0,23/56,20.48%,ROCK1;SNX9;RHOA;PDCD6IP;SON;INCENP;USP8;KIF23;CENPA;EFHC2;SNX33;KIF4A;SNX18;ARL3;BIN3;CKAP2;RACGAP1;NUSAP1;RASA1;KIF20A;CEP55;JTB;VPS4A
prerank,DNA double-strand break processing (GO:0000729),-0.561668959554418,-1.5243113367621288,0.0338680926916221,0.13261313067139546,1.0,11/18,26.01%,BRCA1;BLM;RAD52;SLX4;DNA2;RBBP8;ATM;NBN;UBE2V2;UBE2N;MRE11
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.4102747621444053,-1.5240975394967542,0.009569377990430622,0.13260742158149413,1.0,38/80,31.13%,CD44;MAP3K5;CTSD;DAPK1;SYK;CSNK2A1;MALT1;HGF;GAS6;VEGFA;MAP2K5;FNIP1;NOD1;YWHAE;GRAMD4;FIS1;CASP1;TNFSF10;PDCD5;DDX3X;BEX3;HMGB1;DNAJB6;NLRP3;SFN;SOX7;CYCS;MYC;MT3;SIAH2;RPS6KA3;CARD16;AQP1;PAX2;NGFR;F2R;XIAP;BCL10
prerank,regulation of G0 to G1 transition (GO:0070316),-0.47339455156631555,-1.5240610474212266,0.01576182136602452,0.13239879037452182,1.0,15/38,19.93%,APAF1;BRCA1;RYBP;EZH2;EED;E2F1;RAD51;EPC1;RHNO1;PHC3;RBBP4;UXT;RBBP8;MAX;CHEK1
prerank,telomere maintenance (GO:0000723),-0.44613635917546113,-1.5238888066354321,0.018272425249169437,0.13233204436040127,1.0,23/50,26.18%,NSMCE2;SP100;TEP1;BLM;RTEL1;RAD51;XRCC6;WRN;PCNA;RPA3;POLD2;ERCC4;TEN1;XRCC3;DNA2;ATM;NBN;SMC6;PRKDC;SMC5;POLD4;MRE11;DCLRE1B
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.44757675095653465,-1.5234881445351314,0.014059753954305799,0.13250863344108568,1.0,22/50,23.69%,SASH1;RHOA;TLR7;TLR4;IFI35;EIF2AK2;LAPTM5;NOD1;CD27;RELA;APP;LIMS1;RPS3;MMP8;TRADD;LGALS9;DDX3X;NOD2;AGER;ILK;TCIM;LRRC19
prerank,mitotic metaphase plate congression (GO:0007080),-0.43971172696420446,-1.523286839545941,0.026833631484794274,0.13250315842028346,1.0,25/51,25.37%,PDCD6IP;EML4;PIBF1;CHMP5;CENPE;KIFC1;KIF14;CHMP7;CHMP1A;CHMP2A;KIF2C;MAD1L1;NUF2;NDC80;CEP55;RAB11A;VPS4A;KIF22;NUP62;CHMP4B;CHMP4A;BECN1;CCNB1;CHMP2B;NUDC
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4662807110692753,1.5230834019075963,0.029197080291970802,0.18474667292086744,1.0,9/32,17.62%,AKAP6;TRPC1;NPSR1;CAPN3;CALM1;CALM3;CALM2;SNCA;HAP1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.4732016557005832,-1.522954998138754,0.019130434782608695,0.13257239981860716,1.0,16/38,25.88%,SMARCA5;KNL1;MIS18BP1;UBN1;CENPA;ASF1B;CENPK;CENPN;CENPL;ASF1A;RBBP4;CENPH;RSF1;CENPP;CENPO;HJURP
prerank,rRNA processing (GO:0006364),-0.3651049816444046,-1.5225563963242377,0.0,0.1327430596593164,1.0,70/172,28.42%,RPL7;RPS24;RIOK3;ESF1;MPHOSPH10;RPL36;RPS6;RPL11;RPL10A;DDX49;RPL12;RPS14;EXOSC5;NOP14;RPL32;SENP3;WDR36;NVL;RPS28;NOL6;RPL28;SART1;DHX37;KRR1;RPL22;RPL14;RPL34;RPL6;NOLC1;EMG1;RPL18A;RPL37A;UTP6;RPS9;LSM6;RPS27;RPL23A;RPS16;EXOSC10;RPL9;THUMPD1;C1D;RPLP2;NOL9;DDX54;EXOSC4;XRN2;RPL41;RPLP0;SNU13;PRKDC;RPL7A;MTREX;RPL19;WDR12;RPS15;RPL39;NHP2;RCL1;MRM2;RPL5;PDCD11;EIF6;RPL13;IMP4;EXOSC8;RPL18;WDR3;RPL27A;PIH1D2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.4183558459678095,-1.522050961083137,0.006993006993006993,0.13307547343798035,1.0,25/70,20.83%,RUNX1;PSME4;PSMB7;PSME3;PSMB9;PUS7;EIF2AK2;CBFB;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;TCF3;PSMB8;KMT2A;GATA3;MYB;TCF12;LMO2;PSMA5;PSMD4;PSMB3;PSMD3
prerank,mitotic spindle assembly (GO:0090307),-0.4564330676414214,-1.5219610966667048,0.01718213058419244,0.13293618712422897,1.0,19/42,21.20%,RHOA;STAG1;FLNA;KIF3B;KIF11;PIBF1;KIF23;ABRAXAS1;STAG2;ARHGEF10;KIF4A;TPX2;KIFC1;RACGAP1;PRC1;SMC1A;RAB11A;CEP192;LSM14A
prerank,positive regulation of catalytic activity (GO:0043085),-0.48189207579926163,-1.521375451832499,0.026490066225165563,0.13335467243356386,1.0,16/37,25.76%,ABL2;ATP7A;MAPK14;CHTOP;SSBP1;WRN;PSENEN;CIB1;XRCC4;SLC5A3;STX4;NOD2;PHACTR4;FGFR4;PSEN2;MT3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.6402986832893641,-1.52127994806932,0.024734982332155476,0.13321314203339218,1.0,5/11,23.39%,RIPK1;DDX5;MAP2K1;IL6;TGFB1
prerank,purine nucleotide catabolic process (GO:0006195),-0.61243152233645,-1.520828326566516,0.036458333333333336,0.13347960094807187,1.0,3/13,9.96%,GDA;XDH;NT5C2
prerank,entry into host (GO:0044409),-0.608390338823193,-1.5203589924835597,0.04258943781942078,0.13367804980347237,1.0,5/13,7.85%,GRB2;CBL;ITGAV;CTNNB1;CBLL1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.5650477388239383,-1.5201629482814323,0.04007285974499089,0.13365047219380397,1.0,6/18,11.58%,DAB2;MSN;SNX3;DNAJC13;RAB21;MAP2K1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.5974922891571091,-1.5192599316107591,0.04785478547854786,0.13441126470499104,1.0,5/15,14.42%,RIPOR2;ADAM9;MAPK14;CD53;EHD1
prerank,proteasomal protein catabolic process (GO:0010498),-0.3582767038358706,-1.519097331014371,0.0,0.13432245136363674,1.0,85/201,27.64%,WWP1;BFAR;NFE2L2;PSME4;ARRB2;WWP2;FBXL17;RNF41;AREL1;PELI1;PSMB7;TNFAIP1;PSME3;FBXW11;PSMB9;RBCK1;DDI2;ARRB1;KLHL22;CTNNB1;TBL1XR1;ZFAND2A;KCTD10;ZSWIM8;ATXN3;RNF4;RCN3;ATE1;SPSB2;PSMA8;DERL1;PSMC3;KIF14;UBE4B;NEDD4L;SEL1L;SPSB3;PCBP2;CUL4B;PSMD8;UBXN6;MAEA;PSMC4;PSMB10;SOCS6;RNF185;PSMA1;RNF34;KLHL42;UBE2G1;RNF216;CDC34;FAF1;PSMB8;SKP2;HUWE1;UBXN1;ERLEC1;PSMA5;PSMD4;PSMB3;SIRT2;PSMD3;BAG6;SMURF2;HECTD3;TOPORS;FEM1B;TRIM72;ZNRF1;KCTD2;PSMB1;RNF187;DDB1;SPOP;CLOCK;SIAH2;FBXL19;SMURF1;PML;VCP;CUL3;DCAF11;COP1;TBX21
prerank,negative regulation of bone remodeling (GO:0046851),-0.645472699463206,-1.518683041346694,0.051601423487544484,0.1345379252993082,1.0,7/11,22.63%,P2RX7;GPR137B;GREM1;CALCA;UBASH3B;SFRP1;IL6
prerank,regulation of cellular metabolic process (GO:0031323),-0.4568464212632634,-1.51849236719151,0.022413793103448276,0.13448685437422134,1.0,19/45,27.28%,PID1;ABCG1;PANK2;RNF41;KIF16B;TBC1D16;BCO2;NPC2;AGPAT1;MPV17;RNF34;ACACB;SSH1;RSPO1;CYP1B1;ABCA2;LAMTOR1;EIF6;MKLN1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.5151587263165759,-1.5182354780913436,0.03281519861830743,0.13455092761101792,1.0,12/26,25.98%,DAB2;FOXP1;BRCA1;CNOT1;CNOT2;VPS18;SFRP1;ZBTB7A;HEYL;NCOR1;VPS11;CLOCK
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.4508135143315227,-1.518058985401747,0.029850746268656716,0.13452429134126642,1.0,25/48,30.35%,OGT;NUP50;PRKAG2;NOA1;NUP42;NUP88;RAE1;HIF1A;NUP205;TPR;JMJD8;NUP188;NUP153;NUP35;NUP107;NUP62;PRKAG1;ZBTB7A;RANBP2;EIF6;NUP37;EP300;PGAM1;AAAS;NUP133
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.48779180652617654,-1.5177863324649399,0.030612244897959183,0.13455722836427025,1.0,11/35,8.06%,IQGAP2;NRP1;NOTCH2;FES;ABL2;CDC42;PTK2B;STAP1;DAPK3;BAIAP2;MDK
prerank,response to unfolded protein (GO:0006986),-0.4526576342228833,-1.5170698441022745,0.018518518518518517,0.13512879517499524,1.0,19/48,21.32%,ERN1;OPTN;HSPA9;DNAJA1;DERL1;HSPE1;DNAJC4;TMBIM6;HSP90AB1;HSPA4;HSPH1;BAG3;HSPA1A;HSPB1;ERP44;HSPA2;STT3B;PTPN1;HSPA13
prerank,glial cell differentiation (GO:0010001),0.490395012363657,1.517014566429036,0.04086021505376344,0.1912505849302404,1.0,11/28,16.92%,SOX11;CDH2;SLC8A3;NFIB;FGF10;SOX9;PTPRZ1;RELN;HES5;ERBB3;GPR157
prerank,intracellular pH reduction (GO:0051452),-0.5007490615477945,-1.515869544871768,0.03583617747440273,0.13630855335532546,1.0,10/33,16.62%,ATP6V0D2;ATP6V1E1;RAB7A;ATP6V1A;RAB20;TCIRG1;ATP6V1G1;ATP6V0B;ATP6V0E1;RAB39A
prerank,regulation of macrophage cytokine production (GO:0010935),-0.612862456613321,-1.51569899532376,0.04436860068259386,0.13627021981147508,1.0,5/13,8.17%,CD74;LILRB1;PLCG2;IRAK3;LAPTM5
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.44291046528960953,-1.5152312628180225,0.02613240418118467,0.136553551122345,1.0,26/52,26.33%,ERN1;TATDN2;TLN1;PREB;WFS1;DNAJB9;XBP1;DCTN1;SERP1;SEC31A;VAPB;TPP1;SRPRB;DNAJC3;HYOU1;CXXC1;ATP6V0D1;GFPT1;ACADVL;LMNA;EDEM1;PPP2R5B;SHC1;KLHDC3;ERN2;PDIA5
prerank,cellular response to mechanical stimulus (GO:0071260),-0.45386183276602804,-1.5151007671684087,0.02037351443123939,0.13644286743856301,1.0,16/46,19.93%,TLR8;CRADD;MAP3K1;PIEZO1;TLR7;TLR4;NFKB1;PTGER4;MYD88;SLC9A1;GADD45A;CASP1;CD40;CASP8;CASP2;CHEK1
prerank,protein autophosphorylation (GO:0046777),-0.3699705597014606,-1.5149039294872464,0.00322061191626409,0.13640449977200647,1.0,48/157,20.30%,LYN;TAOK3;FGR;MAPKAPK3;DAPK1;PAK2;ERN1;INSR;IGF1R;PEAK1;FES;VRK2;MINK1;RIPK1;MAPKAPK2;TEC;FLT1;PIM1;PTK2B;DAPK3;ULK2;CAMKK2;GRK5;EIF2AK1;EIF2AK2;NEK6;SIK1;TAOK1;DYRK1A;STK11;HTATIP2;STK17B;ITK;STK24;MKNK1;MARK2;TXK;MAP3K10;MKNK2;AURKA;HCK;STK10;PDGFRB;TAOK2;MAK;ATM;STK16;GSK3B
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.5344263060235837,-1.5146719035960445,0.024179620034542316,0.1364206599086429,1.0,10/23,11.05%,IGF1;P2RX7;INSR;NFKB1;PFKFB3;HIF1A;ARNT;ZBTB20;PFKFB4;APP
prerank,regulation of amyloid-beta formation (GO:1902003),-0.4837868628763216,-1.5144516034752138,0.015625,0.1364324194069,1.0,10/34,10.58%,APOE;IGF1;ABCG1;GSAP;ROCK1;GGA3;TMED10;PICALM;RELA;PIN1
prerank,rRNA metabolic process (GO:0016072),-0.3650787668342931,-1.5144306551898046,0.003169572107765452,0.13622516439466711,1.0,66/160,28.42%,RPL7;RPS24;ESF1;MPHOSPH10;RPL36;RPS6;RPL11;RPL10A;DDX49;RPL12;RPS14;EXOSC5;NOP14;RPL32;SENP3;WDR36;NVL;RPS28;NOL6;RPL28;DHX37;KRR1;RPL22;RPL14;RPL34;NIFK;RPL6;NOLC1;EMG1;RPL18A;RPL37A;UTP6;RPS9;RPS27;RPL23A;RPS16;EXOSC10;RPL9;C1D;RPLP2;NOL9;DDX54;EXOSC4;XRN2;RPL41;RPLP0;SNU13;RPL7A;MTREX;RPL19;WDR12;RPS15;RPL39;RCL1;MRM2;DEDD2;RPL5;PDCD11;ERN2;RPL13;IMP4;EXOSC8;RPL18;WDR3;RPL27A;PIH1D2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.6261770126706349,-1.5143798054504454,0.051056338028169015,0.1360381148218944,1.0,7/12,32.32%,NELFB;EAPP;RNF8;RECQL5;LARP7;NELFE;NELFA
prerank,spindle assembly (GO:0051225),-0.41460369381319073,-1.5142383351715696,0.01867572156196944,0.1359316573370025,1.0,26/67,21.20%,GOLGA8B;RHOA;STAG1;FLNA;KIF3B;KIF11;PIBF1;HAUS5;ABRAXAS1;STAG2;ARHGEF10;HAUS6;STARD9;TUBGCP4;NEK6;TPX2;KIFC1;HAUS4;HAUS7;INO80;RPS3;RCC1;SMC1A;RAB11A;CEP192;LSM14A
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.49159397936739263,-1.5132079695330023,0.02866779089376054,0.1369427325049978,1.0,21/33,32.47%,RAB7B;FES;STAT3;FOXO3;MAPK14;STAT5B;PRMT1;HIF1A;NCKAP1L;ARNT;HMGB2;ACVR2A;HSPA1A;PITHD1;STAT1;PRKDC;HOXA5;ETS1;ANKRD54;MTURN;HSPA1B
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.3855608634557858,-1.5123540229758583,0.003316749585406302,0.13767901113392575,1.0,37/113,21.40%,ABCA1;FNIP2;ASAP1;SYK;PLEK;CD36;RAP1B;DDB2;USP50;BCL2L11;SPIDR;PIEZO1;TLR4;CAPG;VEGFA;GBP5;MYD88;FNIP1;LCP1;CDC42EP2;PSMC3;CUL4B;PSMC4;RPA3;SH3GLB1;ERCC4;BRK1;EIF4G1;FAF1;BID;ISG15;RPS3;DDX3X;ATM;GSK3B;MMP1;RACK1
prerank,neuromuscular junction development (GO:0007528),0.5065181434832742,1.5116039979056526,0.0387409200968523,0.19730521046533764,1.0,4/24,2.57%,ANK3;GPHN;UNC13C;CACNB2
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.34744493741524896,-1.5105825532354855,0.0,0.1394636664030875,1.0,94/241,27.45%,CTNNBL1;TRA2B;DDX46;SRRM1;HNRNPA3;DHX9;SF3B6;SMU1;SNRNP35;CRNKL1;SRRT;FUS;SNRPG;HNRNPH1;GCFC2;SNRPF;POLR2H;HNRNPL;CDC40;POLR2F;SPEN;CWC22;RBM19;DDX5;RALY;SF3B3;POLR2L;PRPF8;SART1;SF3B5;UBL5;PCBP2;ALYREF;HNRNPUL1;NUDT21;SNRPA;RBM14;CWC15;METTL14;RBM10;WDR33;YTHDC1;POLR2A;NCBP1;PSPC1;SART3;ZRSR2;GEMIN7;PDCD7;SF3A1;SRSF10;POLR2G;RBM4B;TFIP11;LSM6;RNPS1;WBP11;SNRNP70;TXNL4A;HNRNPA1;PAPOLA;MAGOH;SLU7;BUD13;CPSF3;SF3B1;LSM5;POLR2I;HNRNPH2;GEMIN6;PPIL1;XAB2;HNRNPK;GTF2F2;SNU13;SYF2;SRSF11;NONO;MTREX;RBM22;PRPF6;DHX35;DDX39B;DHX38;GTF2F1;RBM15B;CPSF1;U2AF2;ISY1;HSPA8;WDR83;HNRNPF;METTL3;BUD31
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.5554350780879517,-1.510309812791328,0.019434628975265017,0.1395493713970875,1.0,13/19,32.15%,GNPDA1;MPI;UAP1L1;NANS;PMM2;UAP1;GNPDA2;GFPT1;AMDHD2;RENBP;PMM1;GNPNAT1;UGP2
prerank,negative regulation of endocytosis (GO:0045806),-0.5266593882841233,-1.5099599215759987,0.04647160068846816,0.1397611393053834,1.0,7/24,6.98%,MCTP1;LILRB1;CD300A;RAC1;NR1H2;PICALM;SNX33
prerank,positive regulation of peptidase activity (GO:0010952),-0.5572751200210161,-1.5096561935664794,0.029159519725557463,0.13985885962709269,1.0,5/20,11.38%,PSME3;GRN;RCN3;CTSH;PSENEN
prerank,regulation of DNA binding (GO:0051101),-0.4620470672854695,-1.5096411128677192,0.014209591474245116,0.13963396362307476,1.0,22/44,23.39%,IGF1;SP100;JUN;PPARG;MDFI;EDF1;SKI;NME1;E2F1;PLAUR;CEBPG;HMGB2;TFAP4;DOT1L;MMP8;RSF1;HMGB1;SIRT2;KDM1A;ZBTB7A;SUMO3;TGFB1
prerank,transition metal ion homeostasis (GO:0055076),-0.5051448576571947,-1.5090344420975907,0.028070175438596492,0.14006181005068763,1.0,7/28,10.17%,FTL;IREB2;ABCB7;PICALM;HMOX2;B2M;CP
prerank,negative regulation of protein metabolic process (GO:0051248),-0.44935349414732384,-1.5085173673938208,0.0273972602739726,0.14043500781979612,1.0,18/48,20.67%,APOE;CD84;ROCK1;SNX3;FLNA;NFKB1;ITGAV;IRAK3;AZIN1;EIF2AK1;SF3B3;PIN1;HSP90AB1;FLOT2;RILP;MDM4;LDLR;SIRT2
prerank,positive regulation of T cell differentiation (GO:0045582),-0.4835321504328681,-1.5076465301881736,0.024778761061946902,0.14122520554345008,1.0,19/36,29.46%,ZMIZ1;BCL6;MDK;ADAM8;NCKAP1L;SART1;XBP1;CD46;IL4I1;TESPA1;ZAP70;GATA3;IL7;TNFSF9;IL12RB1;PNP;LEF1;ZBTB1;NKAP
prerank,histone H3-K9 demethylation (GO:0033169),-0.6549128795564434,-1.5073848115275872,0.04601769911504425,0.14127505866194368,1.0,6/11,21.40%,KDM3A;JMJD1C;KDM7A;KDM3B;HR;KDM1A
prerank,positive regulation of T cell migration (GO:2000406),-0.5474235020225198,-1.507298894145808,0.04745762711864407,0.14113853378971838,1.0,7/20,20.25%,CCR2;RHOA;DOCK8;APP;CCL5;SPN;WNK1
prerank,neuron development (GO:0048666),0.3550749133356875,1.5072577642133513,0.0,0.2019727748308584,1.0,22/141,5.31%,CNTNAP2;NLGN1;TENM2;MYT1L;MAP2;TENM3;CNTN4;TENM1;TENM4;GPM6A;RASGRF1;NTRK2;ATP8A2;SRRM4;EPHA5;SH3GL2;PLP1;TMEM108;BICDL1;POU3F2;GDNF;GPM6B
prerank,negative regulation of anoikis (GO:2000811),-0.6012651864915789,-1.5070697070316088,0.046875,0.14116724093883837,1.0,5/14,11.79%,MCL1;ITGA5;ITGB1;BCL2;PIK3CA
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.5745559493246396,-1.5068385285058388,0.047787610619469026,0.1412148287309833,1.0,6/17,9.89%,CD74;RAC1;CAMK1D;RIPOR2;MDK;NCKAP1L
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.3999520040168833,-1.5051419540315303,0.008547008547008548,0.14307689820743041,1.0,41/87,32.21%,CD44;GRB2;CBL;KIF16B;GALNT3;HNRNPH1;CEP57;POLR2H;FRS2;POLR2F;ITGB1BP1;POLR2L;SPRED1;SPRED2;CCL5;SHCBP1;POLR2A;NCBP1;NR4A1;POLR2G;PTPN11;HNRNPA1;NDNF;SFRP1;POLR2I;GTF2F2;MAPK1;FGF18;FGF9;FGFR4;ESRP1;GTF2F1;ZFP36L1;HNRNPF;FGF22;FGF20;FIBP;FGF16;RAB14;FGF2;POLR2D
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.5417330568533569,1.5050605894684512,0.03826530612244898,0.2037985683639934,1.0,6/19,10.87%,PTPRD;IL1RAPL1;CDKL5;CUX2;CAPRIN2;RELN
prerank,protein polyubiquitination (GO:0000209),-0.34169886925884096,-1.5049908631927187,0.0,0.14298446860868289,1.0,96/297,22.26%,SASH1;RNF213;WWP1;HECTD1;BFAR;DDB2;RNF19A;FBXW8;PSME4;TRAF5;BRCA1;MYLIP;WWP2;FBXL17;RNF41;AMFR;AREL1;RNF166;PELI1;PSMB7;ANAPC1;PSME3;RC3H1;RNF20;FBXO32;FBXW11;BCL2;UBE2R2;RNF31;LNPEP;PSMB9;FBXL20;RBCK1;TRAF3;UBE3B;HERC6;UBR2;CTNNB1;TPP2;RNF4;FBXO38;CBFB;ANKRD39;HECTD2;PSMA8;UBC;RPS27A;UBE2L3;RNF8;TRAF1;PSMC3;UBE4B;NEDD4L;PSMD8;UBE3A;FBXO10;TRIM68;TRAF2;UBE2H;PSMC4;PSMB10;TNKS2;FBXW2;PSMA1;ARIH1;RNF34;KLHL42;UBE2G1;UBE2T;RNF216;CDC34;TRIM14;UBE2C;PSMB8;FBXL8;SKP2;ANAPC7;FBXO7;HUWE1;TRIP12;FBXO31;PSMA5;PSMD4;UBE3C;PSMB3;FBXO22;FBXW4;DTX3L;PSMD3;RNF125;SMURF2;RUSC1;RNF135;CCNF;RNF115;TOPORS
prerank,pyroptosis (GO:0070269),-0.5872860497830827,-1.504719910428862,0.04340567612687813,0.14303501706824787,1.0,7/15,17.31%,NLRC4;DHX9;AIM2;CASP4;GSDME;CASP1;CASP8
prerank,regulation of protein import into nucleus (GO:0042306),-0.4725638215296495,-1.5046106184770591,0.021015761821366025,0.1429283113951286,1.0,17/36,25.23%,MDFIC;PRKCD;IPO5;FLNA;TPR;MAVS;BAG3;HCLS1;CHP2;SUFU;ZC3H12A;JUP;UFM1;TGFB1;RBM22;TRIM28;ECT2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.615178030210966,-1.5045549872948134,0.051457975986277875,0.1427383321030645,1.0,7/13,25.91%,BFAR;PPP1R15B;WFS1;DNAJB9;PTPN1;RACK1;NCK1
prerank,regulation of mRNA stability (GO:0043488),-0.37075133486541006,-1.5041796496240665,0.0032948929159802307,0.1429121938278568,1.0,53/145,27.44%,VIM;PRKCD;ROCK1;YTHDF3;DCP1A;PSME4;MAPKAPK2;ANP32A;PSMB7;PSME3;RC3H1;PSMB9;FUS;EXOSC5;PUM2;E2F1;DCP2;PSMA8;UBC;RPS27A;ZC3H14;TENT5A;PSMC3;FTO;CELF1;PSMD8;METTL14;PSMC4;PSMB10;DHX36;PSMA1;FASTKD3;EIF4G1;PSMB8;HSPA1A;TENT5C;HSPB1;PSMA5;PSMD4;PSMB3;PSMD3;EXOSC4;SET;PUM1;PSMB1;PCBP4;TENT5D;VIP;ZFP36L1;HSPA8;EXOSC8;TBRG4;METTL3
prerank,carboxylic acid metabolic process (GO:0019752),-0.47363078237462414,-1.5031086079666298,0.04121863799283154,0.14401485169334083,1.0,19/33,32.65%,TBXAS1;ST3GAL1;SLC2A1;CYB5R3;ST6GAL1;AGXT;PLA2G4A;SLC23A1;SLC23A2;GNMT;CARNMT1;ACOT4;GSTO1;CYB5A;PON3;CYP2S1;GNE;SLC2A3;DAO
prerank,positive regulation of protein import (GO:1904591),-0.49245613720081594,-1.5030660162427938,0.02664298401420959,0.14383440276113077,1.0,16/30,25.23%,PRKCD;IPO5;FLNA;TPR;MAVS;BAG3;ARHGEF5;HCLS1;PDCD5;CHP2;ZC3H12A;JUP;TGFB1;RBM22;TRIM28;ECT2
prerank,negative regulation of axon extension (GO:0030517),0.4831558490519389,1.5020453189770413,0.05037783375314862,0.2065289576056865,1.0,10/30,14.89%,MAP2;SEMA6D;SEMA6A;SEMA3E;SEMA5A;TRIM46;SEMA3F;SEMA5B;PTPRS;SEMA4G
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.5261223307865934,1.5013792317352712,0.04819277108433735,0.20642474703541422,1.0,6/21,8.71%,ADCY2;ADCY8;GUCY1B1;ADCY5;ADCY3;ADCY1
prerank,triglyceride catabolic process (GO:0019433),-0.5423405054916914,-1.5008004773538541,0.0506108202443281,0.1461342645470964,1.0,3/19,10.36%,FABP5;LPL;FABP4
prerank,actin filament capping (GO:0051693),-0.5649377278476532,-1.500714606059933,0.03806228373702422,0.14574530298316574,1.0,9/18,21.95%,EPS8;CAPZB;SVIL;TRIOBP;CAPG;CAPZA1;ADD3;TWF2;FLII
prerank,barbed-end actin filament capping (GO:0051016),-0.5649377278476532,-1.500714606059933,0.03806228373702422,0.14574530298316574,1.0,9/18,21.95%,EPS8;CAPZB;SVIL;TRIOBP;CAPG;CAPZA1;ADD3;TWF2;FLII
prerank,RNA metabolic process (GO:0016070),-0.37664170914443995,-1.5006824493217201,0.009836065573770493,0.14553216900404212,1.0,53/127,27.44%,APOBEC1;RBM39;RBMS1;AGO2;RNASEL;HNRNPA3;DHX9;RBPMS;MPHOSPH10;RNASE4;HNRNPH1;ALKBH1;POLR2H;HNRNPL;POLR2F;POLR2L;FASTKD2;DUSP11;FTO;PCBP2;HNRNPUL1;RNASE6;METTL14;DHX36;POLR2A;RBMS2;NCBP1;WTAP;NUFIP1;POLR2G;ATXN1;TFIP11;HNRNPA1;PAPOLA;DDX3X;RBM3;ZC3H12A;POLR2I;NOL9;HNRNPH2;DDX54;HNRNPK;XRN2;GTF2F2;MTREX;DDX39B;SND1;GTF2F1;DEDD2;RNASEH2B;TBRG4;HNRNPF;METTL3
prerank,histone H4-K16 acetylation (GO:0043984),-0.5472323578309517,-1.500012450639905,0.03723404255319149,0.1459757537503726,1.0,7/19,17.14%,OGT;PHF20;KANSL2;WDR5;JADE2;KAT7;KMT2A
prerank,kidney development (GO:0001822),0.4087432463797802,1.4999259210267926,0.021844660194174758,0.20737002660249002,1.0,20/65,11.28%,ROBO2;PCSK5;MME;PAX8;GREB1L;GDNF;HNF1B;WT1;TRAF3IP1;FGF10;BMP7;SALL1;TFAP2A;CITED1;AGTR1;HAS2;CEP290;TGFB2;PYGO2;PKD1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.41143274497998894,-1.4997999448739,0.008532423208191127,0.14596065557900842,1.0,31/72,27.61%,SP100;CRADD;CNOT4;CNOT1;CNOT2;BATF;PLK2;E2F1;PRMT1;CDK1;PCNA;GADD45A;PLK3;E2F8;TFAP4;CNOT6L;AURKA;CASP2;MDM4;ATM;CNOT8;NBN;CDC25C;SFN;GTSE1;CCNB1;PCBP4;RBL2;CNOT3;PML;EP300
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.5480452762055841,-1.4996686421856962,0.02355072463768116,0.14586336632400929,1.0,11/20,39.23%,CYP46A1;FDXR;TSPOAP1;FDX1;HSD17B10;HSD3B2;FDX2;STARD3;AKR1C1;AKR1D1;TSPO
prerank,lymphocyte migration (GO:0072676),-0.47943618678444583,-1.498848541652107,0.018518518518518517,0.1465792360691674,1.0,14/32,31.93%,MSN;CKLF;MYO1G;ADAM8;CCL5;ZAP70;GATA3;CCL7;TBX21;CRTAM;CCL24;CCL4;CCL25;CCL19
prerank,positive regulation of transmembrane transport (GO:0034764),-0.6030566652998137,-1.4988437762648874,0.04736842105263158,0.1463480441936016,1.0,5/13,11.30%,P2RX7;ANO6;C3;AZIN1;ACSL5
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6343330444755295,-1.4988131772357622,0.05016722408026756,0.14614012299224,1.0,2/11,1.90%,RUNX1;ETV6
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.42681982373688215,-1.4983431360879973,0.01794453507340946,0.14641694360885116,1.0,25/57,22.81%,TAOK3;BRCA1;BLM;ABRAXAS1;BABAM2;RINT1;RFWD3;FOXN3;TAOK1;CDK1;BABAM1;TICRR;WAC;TOPBP1;RAD9A;TRIM39;TAOK2;BRCC3;ATM;FBXO31;CHEK1;TIPIN;NBN;FANCD2;PRKDC
prerank,response to hydrogen peroxide (GO:0042542),-0.4465945461649099,-1.4972983132560236,0.016666666666666666,0.14732087443537828,1.0,22/45,30.94%,MAP3K5;PRKCD;NFE2L2;RIPK1;ANXA1;ADAM9;SIRPA;MAPK7;APTX;RELA;STK24;RPS3;CAT;HP;IL6;HMOX1;CYP1B1;ECT2;AQP1;RIPK3;PAX2;RHOB
prerank,error-prone translesion synthesis (GO:0042276),-0.5292927883562055,-1.4971533690002379,0.04864864864864865,0.1472121254623233,1.0,8/21,13.37%,POLE2;RFC1;PRIMPOL;UBC;RPS27A;PCNA;RPA3;RFC2
prerank,sulfation (GO:0051923),0.6144728168198553,1.49695995911566,0.07276995305164319,0.2101980475236894,1.0,4/11,18.29%,HS3ST5;CHST5;SULT4A1;SULT2B1
prerank,positive regulation of lipid transport (GO:0032370),-0.6184182708250002,-1.4964225378866953,0.043327556325823226,0.14777846664428104,1.0,2/12,1.17%,APOE;LRP1
prerank,metanephros development (GO:0001656),0.4901427392499185,1.4963740413614137,0.05084745762711865,0.20992501355594273,1.0,8/26,11.28%,ROBO2;PAX8;GDNF;WT1;FGF10;BMP7;CITED1;PKD1
prerank,protein mannosylation (GO:0035268),0.5155164864435117,1.4961356301377722,0.043256997455470736,0.20928041004997228,1.0,7/22,5.39%,TMTC2;TMTC1;CRPPA;DPY19L1;TMTC3;DPY19L2;POMT2
prerank,actin filament polymerization (GO:0030041),-0.49343756102849523,-1.4961276753104094,0.029950083194675542,0.14787830794348872,1.0,9/29,10.01%,DIAPH1;GAS7;RAC1;PSTPIP2;PSTPIP1;WASL;CORO7;MSRB1;DIAPH3
prerank,regulation of viral transcription (GO:0046782),-0.4710308368819075,-1.4956245398723746,0.03146853146853147,0.14826951503068797,1.0,17/39,26.71%,MDFIC;NELFB;UBP1;DHX9;POLR2H;POLR2F;POLR2L;POLR2A;TRIM11;TRIM14;POLR2G;RSF1;POLR2I;GTF2F2;GTF2F1;LARP7;NELFE
prerank,positive regulation of heart rate (GO:0010460),0.5647847209914921,1.495282451424538,0.05673758865248227,0.20950971436560273,1.0,8/17,17.04%,RYR2;PDE4D;ADRA1B;EDN1;ADRA1D;ADRA1A;ADRB1;TPM1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.5712354429117147,-1.495092740704717,0.05789473684210526,0.1486432608334952,1.0,4/16,6.62%,PTPRC;LILRB1;STX7;CYRIB
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.3176069536108862,-1.494966598398164,0.0,0.14855948474683525,1.0,135/572,18.15%,RBPJ;DAB2;MITF;FNIP2;ZEB2;FOXP1;RUNX1;TRPS1;SP100;RREB1;SDCBP;BCL6;RB1;JUN;ZNF568;MEF2A;CREBBP;ETV6;RUNX3;PPARD;ARID5B;BPTF;BACH1;DNMT3A;IRF2;ZNF148;NFIC;NFX1;ATF3;PPARG;GATAD2A;SPI1;WWP2;PHF21A;ZNF3;CTR9;STAT3;FOXO3;CNOT1;NIPBL;CHD3;NFKB1;CNOT2;HHEX;ZBTB21;RARG;SAP30;SARS1;NR1H2;CIITA;CUX1;MDFI;SMYD2;NFATC3;ZBTB2;TBL1XR1;MCPH1;EZH2;RPS14;DPF2;USP9X;WFS1;NR2F1;SKI;VEGFA;BHLHE40;MAP2K5;EED;E2F1;CNBP;FNIP1;SPEN;THAP1;CBFB;PARP9;DDX5;MEF2C;SAP130;TFEC;UBC;RPS27A;SUDS3;HDAC10;RELA;NEDD4L;FLCN;TCF25;OSR1;TPR;KLF10;PRDM2;GADD45A;FOXJ1;ZFP57;CHD8;UHRF1;FRK;PLK3;MTA3;IRF2BP2;HDAC5;TGIF1;SP2;RXRA;E2F8;BATF3;SIN3A;LIN37;EPC1;DR1;KLF2;ID2;TCF3;YY1;NSD1;BAG3;KLF8;ZNF177;KMT5A;NRIP1;KLF11;SOX10;UBE2I;ATXN1;VHL;UXT;HSPA1A;TAF3;RARA;SMAD7;NR3C1;GATA3;MYB;RIPPLY2;ARID5A
prerank,regulation of cell cycle (GO:0051726),-0.33997111894318816,-1.4945992573610254,0.0015220700152207,0.1487360104284959,1.0,100/271,28.92%,IQGAP1;PTPRC;NOTCH2;BIRC3;SDCBP;LILRB1;CDK6;RB1;JUN;NUPR1;RUNX3;ERN1;MAP3K20;SIPA1;APBB2;CSNK2A1;SON;BRCA1;FBXL17;STAT3;RNF20;CENPF;CRLF3;KIF20B;DLGAP5;DAPK3;UHRF2;LRP6;TAF6;GRK5;NF2;PCLAF;RPS15A;TGFBR1;THAP1;NEK6;MASTL;SIK1;AFAP1L2;CDKN3;CDC25A;CHMP1A;MAP2K1;FAP;GADD45A;STK11;MAEA;HSP90AB1;TFAP4;PRR11;LIN37;ID2;GADD45GIP1;PPP1R9B;NR4A1;RBBP4;FBXL8;SKP2;RARA;CDKN2C;DYNLT3;GATA3;FBXL6;ATM;LIN9;CHEK1;BAP1;SIRT2;SFRP1;NBN;GAS2L1;CDK5;RACK1;INHA;PHACTR4;RRP8;TARDBP;WDR12;CCNB1;PUM1;TGFB1;PIM2;MYC;NUDT6;CKS2;CCNB2;SND1;RNF40;BMP2;PML;TBRG4;TSC2;METTL3;EP300;MYBBP1A;FBXL3;CITED2;ZBTB17;USP51;RNF167
prerank,cellular response to chemokine (GO:1990869),-0.4485757051913507,-1.4943240974218377,0.01644736842105263,0.14884152503010512,1.0,8/46,6.05%,CCR2;RHOA;LRCH1;CCR1;DOCK8;PTK2B;RIPOR2;PF4
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.513938948119114,-1.494323646946904,0.03264604810996564,0.1486011212778787,1.0,8/25,18.51%,CD36;INSR;P2RX4;TLR4;HSP90AB1;KLF2;ASS1;MMP8
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.3919631135081631,-1.494012578701586,0.010507880910683012,0.1486884590818937,1.0,33/94,20.83%,MAP3K8;PSME4;IRAK2;TAB2;PELI1;PSMB7;PSME3;NFKB1;FBXW11;IRAK4;PSMB9;IRAK3;MYD88;NOD1;PSMA8;UBC;RPS27A;EGR1;TNIP2;RELA;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;IKBKB;PSMB8;IL1R2;NOD2;PSMA5;PSMD4;PSMB3;PSMD3
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.6117498764857021,-1.4938599149790077,0.04189435336976321,0.14859527646336598,1.0,7/12,28.82%,DAB2;FOXP1;SFRP1;ZBTB7A;HEYL;NCOR1;PIAS2
prerank,sterol transport (GO:0015918),-0.5544544726271319,-1.4934013673437,0.03527336860670194,0.14884828967377178,1.0,13/19,36.99%,MSR1;CD36;OSBPL5;NPC2;NPC1;LDLR;LCAT;LDLRAP1;CAV1;ARV1;STARD3;ABCG8;APOA2
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.584113479681338,-1.4929619044694913,0.03942652329749104,0.14912443788019103,1.0,4/14,7.44%,LYN;STAT3;STAT6;STAT5B
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.48161743820875347,-1.4923411564242692,0.02962962962962963,0.14965478836845666,1.0,13/32,22.65%,RB1;BACH1;BRD4;CDK18;E2F1;CDK14;PCNA;ID2;CCNE1;KLF11;CDK16;CDK5;CDC45
prerank,cytoplasmic translational initiation (GO:0002183),-0.5666482853384778,-1.4920767954795329,0.0375,0.14972778410297294,1.0,6/17,15.13%,EIF4A2;EIF2B3;EIF3A;EIF5;EIF4A1;EIF4G1
prerank,platelet aggregation (GO:0070527),-0.4843598222324782,-1.491789672180852,0.028960817717206135,0.14982040982164688,1.0,9/33,6.59%,PLEK;MYH9;RAP2B;FLNA;ACTB;TLN1;PIK3CB;FN1;PIK3CG
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4425698835382357,-1.4917884118909301,0.02422145328719723,0.14958350762310113,1.0,14/47,12.70%,NEDD9;NRP1;CORO1C;RREB1;RAC1;FLNA;CDC42;TRIOBP;DOCK5;MYADM;MDK;ITGB1BP1;CRK;CIB1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.4918598736260453,-1.4916498515194063,0.03225806451612903,0.14949983597665034,1.0,13/28,26.19%,MAP3K5;ITPR1;ERN1;BCL2;CASP4;ATP2A3;TRAF2;BBC3;QRICH1;BAG6;CEBPB;ERO1A;ERN2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.587663768424402,-1.491468290207195,0.04568527918781726,0.14946585643335697,1.0,9/14,21.87%,MALT1;IL18;ANXA1;NFKBIZ;RARA;MYB;NFKBID;NLRP3;SOCS5
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5920274636062131,-1.491336143230421,0.05660377358490566,0.14940830009827072,1.0,5/14,20.81%,BFAR;BCL2L11;DNAJB9;COPS5;PTPN1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4599027938340976,1.4906897166269208,0.043795620437956206,0.21460242438897228,1.0,8/35,3.86%,RIMS2;HTR2C;AKAP6;ADCY2;EPHA5;GUCY1B1;PDE4D;PDE9A
prerank,positive regulation of vacuole organization (GO:0044090),-0.6530643663718653,-1.490485305189148,0.06196213425129088,0.1502002738493872,1.0,6/10,17.46%,ANXA2;PIP4K2A;RAB3GAP1;GRN;SH3GLB1;RALB
prerank,vesicle transport along actin filament (GO:0030050),-0.5460918562042045,-1.489812847848085,0.046232876712328765,0.15076149161578128,1.0,6/19,11.64%,MYO5A;MYO1F;MYO1G;WASL;MYO1E;MYO7A
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.5019096931438638,-1.4891394333991403,0.03395585738539898,0.15135824499772627,1.0,6/26,9.13%,APOE;POR;HTR2B;ATP7A;PIK3CB;HIF1A
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.4470336852377701,-1.4890568041908265,0.023140495867768594,0.15120194526007164,1.0,20/43,25.10%,FOXP1;IGF1;JUN;ERN1;IL6R;IL18;MEF2D;CCL5;ID2;FOXJ2;PDGFRB;RBPMS2;ADAMTS1;MMP2;STAT1;IL6;P2RY6;HMOX1;FGF9;CCN4
prerank,regulation of cell cycle process (GO:0010564),-0.38378257026568224,-1.4888043789129735,0.011326860841423949,0.15125370336807267,1.0,35/104,21.28%,ZFYVE26;BIRC6;CSNK2A1;CDK13;CEP85;UVRAG;KIF11;CDC42;DYNC1H1;KIF20B;DAPK3;CTNNB1;PLK2;BUB1;PIN1;DBF4;FLCN;PLK3;MKI67;SH3GLB1;KNSTRN;RACGAP1;KIF20A;MAD1L1;AURKA;ATF5;RCC1;HORMAD1;CHEK1;PRC1;RAB11A;SFRP1;TIPIN;CDC25C;CETN2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.5368733213764076,-1.4871679577738008,0.030035335689045935,0.15296902422341976,1.0,8/21,21.55%,CNOT4;TUT7;CNOT1;CNOT2;PAN3;CNOT6L;CNOT8;PNLDC1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4704272491469935,1.486881695260317,0.0407673860911271,0.21866917197214852,1.0,11/31,15.66%,SYT1;SYT10;SYT2;SYT5;SYT11;SYT12;DOC2A;REST;SYT7;CBARP;CACNA1G
prerank,protein autoubiquitination (GO:0051865),-0.42170898400175527,-1.4864544301256368,0.029616724738675958,0.1535760751438654,1.0,20/61,16.71%,RNF213;CNOT4;KLHL24;BFAR;DDB2;NFX1;BRCA1;WWP2;RNF41;AMFR;UHRF2;RNF4;RNF8;UBE3A;TRIM68;UHRF1;TRAF2;RNF185;UBE2T;ASB4
prerank,ncRNA processing (GO:0034470),-0.3493532765211111,-1.4858137221858796,0.003076923076923077,0.15412274259395772,1.0,78/200,28.65%,AGO2;FARS2;RPL7;ADAT1;RPS24;TUT7;ESF1;MPHOSPH10;INTS8;SARS1;RPL36;RPS6;RPL11;RPL10A;DDX49;RPL12;INTS11;SRRT;RPS14;EXOSC5;NOP14;RPL32;SENP3;WDR36;NVL;RPS28;NOL6;RPL28;DHX37;INTS6;KRR1;RPL22;RPL14;RPL34;RPL6;NOLC1;EMG1;RPL18A;KARS1;RPL37A;INTS1;UTP6;RPS9;RPS27;RPL23A;RPS16;EXOSC10;RPL9;AARS1;INTS5;C1D;RPLP2;NOL9;DDX54;EXOSC4;XRN2;RPL41;RPLP0;SNU13;RPL7A;MTREX;RPL19;WDR12;RPS15;RPL39;RCL1;MRM2;RPL5;PDCD11;RPL13;IMP4;EXOSC8;METTL3;RPL18;WDR3;RPL27A;PIH1D2;THG1L
prerank,histone mRNA metabolic process (GO:0008334),-0.49239987042744204,-1.4857356359231593,0.05040650406504065,0.1539633150977732,1.0,11/27,21.34%,TUT7;SNRPG;SNRPF;DCP2;MTPAP;NCBP1;TENT4B;EXOSC10;ATM;CPSF3;EXOSC4
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.6003349153647649,-1.4854755519640648,0.06315789473684211,0.15401614517917825,1.0,7/13,32.32%,NELFB;EAPP;RNF8;RECQL5;LARP7;NELFE;NELFA
prerank,cAMP metabolic process (GO:0046058),0.5942615369274171,1.4848197783628125,0.03953488372093023,0.22071280462930187,1.0,6/13,8.71%,ADCY2;ADCY8;PDE4D;ADCY5;ADCY3;ADCY1
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.46146374994188377,-1.484697620383539,0.02772963604852686,0.154695317989382,1.0,14/36,19.93%,APAF1;BRCA1;RYBP;EZH2;EED;E2F1;RAD51;EPC1;PHC3;RBBP4;UXT;RBBP8;MAX;CHEK1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.481331027514352,-1.484338756474544,0.04159132007233273,0.15490563515449057,1.0,19/33,34.29%,APOE;RHOA;PPARG;MAP2K5;ITGB1BP1;MEF2C;ANGPT2;GADD45A;HDAC5;HMGB1;JUP;TGFB1;CARD10;TBXA2R;AGTR2;CSNK2B;FGF2;TNF;KLF4
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.4297760642128301,-1.4837957007319933,0.024549918166939442,0.1552680454819096,1.0,17/54,18.62%,BIRC3;SYK;RIPK1;CFLAR;RNF31;RBCK1;GAS6;LAPTM5;CASP4;OTULIN;TRAF1;CASP1;TRAF2;IKBKB;CASP8;HSPA1A;TRADD
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.5280881238341822,-1.4834546493828034,0.05272407732864675,0.15539765555858384,1.0,13/23,33.08%,LILRB1;RAET1E;ARRB2;AP1G1;LAMP1;CD226;LGALS9;SLAMF6;CRTAM;KLRC2;NCR1;KLRD1;KLRC1
prerank,interstrand cross-link repair (GO:0036297),-0.430731269706191,-1.48318478285781,0.02120141342756184,0.15544590421494062,1.0,22/53,22.32%,DCLRE1C;WDR48;NEIL3;RAD51;RFWD3;UBC;RPS27A;NUCKS1;RNF8;MCM9;DCLRE1A;RPA3;ERCC4;RAD51AP1;UBE2T;SLX4;XRCC3;POLN;FAAP24;EXO5;FAN1;FANCD2
prerank,aminoglycan biosynthetic process (GO:0006023),0.4239081107348036,1.4830750373938686,0.03764705882352941,0.22215833860706877,1.0,9/49,3.81%,B3GALT1;HS3ST6;HS3ST5;GPC6;GPC5;HS6ST2;B3GALT5;PXYLP1;HS3ST1
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.4883695988992368,-1.4824588389902713,0.04537521815008726,0.15599053003629745,1.0,12/31,29.86%,PTPRC;SASH3;KMT5B;KMT5C;DNAJB9;XBP1;STX4;SHLD2;IL6;RBP4;IL2;VAMP3
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.4520906264595127,-1.4822288183384007,0.022033898305084745,0.15606268477260712,1.0,19/43,21.01%,TAOK3;BRCA1;NABP1;BLM;ABRAXAS1;BABAM2;RINT1;FOXN3;TAOK1;CDK1;BABAM1;TICRR;TOPBP1;TRIM39;TAOK2;BRCC3;ATM;CHEK1;NBN
prerank,replication fork processing (GO:0031297),-0.4580485643272695,-1.4819174828489141,0.033928571428571426,0.1561921712747335,1.0,12/38,11.65%,FAM111A;SAMHD1;BLM;PRIMPOL;RTEL1;RAD51;RFWD3;NUCKS1;GEN1;ALYREF;WRN;PCNA
prerank,regulation of platelet aggregation (GO:0090330),-0.5580192126348575,-1.4814840184685174,0.05025125628140704,0.15641511812466616,1.0,4/17,3.36%,LYN;SYK;PRKCD;CD9
prerank,cellular response to glucagon stimulus (GO:0071377),0.5355223155605952,1.4812753598043091,0.07524271844660194,0.22357211007204655,1.0,7/17,14.85%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1;PRKACB;PRKAR1A
prerank,negative regulation of ossification (GO:0030279),-0.5279427315842603,-1.480956811713405,0.04288164665523156,0.1568114194430353,1.0,9/23,20.84%,RBPJ;CCR1;SRGN;PTK2B;MDK;MEF2C;GREM1;ENPP1;SFRP1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.6411594832172175,-1.480846256815104,0.04585537918871252,0.1566985321669474,1.0,7/10,28.53%,JUN;BAG3;VHL;HSPA1A;SIRT2;NCK1;CITED2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5394866922713156,1.4808232124663694,0.06575963718820861,0.2232172874108728,1.0,8/17,19.00%,CACNA1C;RYR2;GJC3;ATP1A3;ATP1B1;ATP1B2;GJD3;GJC1
prerank,retrograde axonal transport (GO:0008090),0.5573874551442463,1.4807051098936528,0.046189376443418015,0.22232793576592336,1.0,5/16,8.86%,DLG2;TMEM108;DST;KIF5A;NEFL
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.5962473290919773,-1.4806535240849164,0.04482758620689655,0.1567061146092938,1.0,6/13,26.43%,DAB2;RBPMS;TGFBR1;TGFB1;SH2B1;SMAD4
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.6041252795161463,-1.4798296277364378,0.06878306878306878,0.15742567104872623,1.0,8/13,20.90%,ZC3HAV1;CNOT1;RC3H1;MOV10;GTPBP1;NUDT21;CNOT8;ZC3H12A
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.5302670931691404,-1.4796696746835971,0.04915254237288136,0.15740359768026702,1.0,9/20,12.79%,NRP1;IGF1;LRP1;PLAU;S100A11;TRIB1;IGFBP3;CCL5;SERPINE1
prerank,positive regulation of vasoconstriction (GO:0045907),0.5718874597408712,1.47931220480096,0.058165548098434,0.22318946858836103,1.0,5/13,12.77%,SMTNL2;ADRA1B;OXTR;ADRA1D;ADRA1A
prerank,regulation of interleukin-4 production (GO:0032673),-0.5394353155809257,-1.478870997055886,0.0423728813559322,0.15812745856385718,1.0,9/21,21.90%,SYK;CD28;FCER1G;SLC7A5;RARA;GATA3;LGALS9;NLRP3;CEBPB
prerank,peptidyl-tyrosine modification (GO:0018212),-0.4296939199978862,-1.478842599493116,0.028716216216216218,0.1579186685828615,1.0,15/56,11.45%,LYN;FGR;ABI1;SYK;INSR;FES;ABL2;TEC;FLT1;PTK2B;TPST1;PKDCC;PTPN6;LCK;DYRK1A
prerank,cardiac muscle tissue development (GO:0048738),0.42282538350497856,1.4787742143812523,0.031476997578692496,0.22296833614473066,1.0,10/50,11.10%,SGCZ;NRG1;SGCD;CBY1;MSX1;NDUFV2;BMP7;SGCG;MYOCD;TTN
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.5445751153283992,-1.4782972774727976,0.047038327526132406,0.15839165958142887,1.0,10/18,25.06%,STX7;ACTB;STX8;ZDHHC7;ZDHHC2;CLN3;VPS4A;APPL1;CDK5;ABCA2
prerank,cholesterol efflux (GO:0033344),-0.5389595919623973,-1.4782365212009307,0.0547945205479452,0.15822088767425593,1.0,3/20,0.54%,APOE;ABCA1;ABCG1
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5414584796781454,-1.4774155509110085,0.054770318021201414,0.1589239814281319,1.0,9/18,22.90%,MDFIC;MFHAS1;FLCN;SIN3A;LATS2;SUFU;GSK3B;UFM1;CTNNA1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.43077317080867195,-1.4773335155934593,0.021314387211367674,0.15877363555876303,1.0,22/53,19.63%,PRKCD;BRCA1;ERCC6;DHX9;ABRAXAS1;EYA4;BABAM2;CEBPG;DDX5;RNF8;SPRED1;SPRED2;PCNA;BABAM1;EEF1E1;TMEM161A;EYA1;EYA3;RPS3;WRAP53;BRCC3;ATM
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.47344028024320073,-1.4769180830298463,0.028169014084507043,0.15903370143526732,1.0,8/33,10.48%,MAP3K5;PRKCD;NFE2L2;RIPK1;ANXA1;SIRPA;MAPK7;RELA
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5837341001530509,-1.4761653330614593,0.055267702936096716,0.15977741134270734,1.0,8/14,23.13%,LILRB1;TLR8;PIBF1;IRAK3;LILRA5;CMKLR1;C1QBP;MEFV
prerank,regulation of GTPase activity (GO:0043087),-0.35429411650692516,-1.4757526788313513,0.004885993485342019,0.16004453527130666,1.0,41/177,12.64%,ARHGAP15;VAV3;PLXNC1;BCAR3;RSU1;FGD6;GPR137B;SNX9;PLXNA1;DOCK10;PLXND1;TBC1D15;DOCK11;VAV1;SGSM2;RGS1;LRCH1;RAP1A;FGD4;ITGB1;DOCK8;ARFGEF1;ARAP1;RAB3GAP1;FGD3;PICALM;EZH2;ALS2;SH3BP1;ITGB1BP1;VAV2;ARHGAP12;TGM2;ADAP1;PIN1;SNX13;FLCN;CRK;SNX18;TBC1D10B;CCL5
prerank,positive regulation of bone resorption (GO:0045780),-0.6213716066113633,-1.4747241727915787,0.05423728813559322,0.16096603425184075,1.0,4/11,14.81%,PLEKHM1;SYK;ADAM8;SPP1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.5702357267725799,-1.4737300111252967,0.0436241610738255,0.16194268362342756,1.0,5/15,11.83%,RUNX1;LRP1;RB1;AGT;FAP
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.4936153876208137,1.4730899785992055,0.05,0.22989312477159435,1.0,7/23,14.38%,METAP2;GRK4;FNTB;CAMKMT;FNTA;CALM1;METAP1
prerank,regulation of anoikis (GO:2000209),-0.5363909334487255,-1.4724720232120383,0.043327556325823226,0.16321125257901647,1.0,6/19,11.79%,MCL1;ITGA5;ITGB1;BCL2;SIK1;PIK3CA
prerank,substrate-dependent cell migration (GO:0006929),-0.5882320397954223,-1.472230464482207,0.049069373942470386,0.16324236783690424,1.0,3/14,0.91%,PTPRC;NRP1;SDCBP
prerank,ERBB2 signaling pathway (GO:0038128),0.47201321705161176,1.471934738739987,0.04398148148148148,0.2306043158388423,1.0,7/31,7.63%,NRG1;ERBB4;PTPRR;EGF;GAB1;SOS1;NRG2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.637229769991907,1.471857305035497,0.08188585607940446,0.22968994622311564,1.0,5/10,15.81%,TGFA;EGF;AREG;FBXW7;ADAM17
prerank,secondary alcohol metabolic process (GO:1902652),-0.45922367479481596,-1.4707270010213105,0.036101083032490974,0.16480285619516294,1.0,12/42,13.54%,APOE;ABCA1;ABCG1;IDH1;PPARD;CYP27A1;NSDHL;OSBPL5;PIP4P1;CLN6;CH25H;RXRA
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5266084348200496,1.4698634337894843,0.053452115812917596,0.2314843388222033,1.0,3/17,3.78%,NLGN1;SYT10;RAB15
prerank,fibrinolysis (GO:0042730),-0.6068222409788793,-1.46980810298882,0.04220183486238532,0.1657176814841697,1.0,3/13,12.79%,PLAU;PLAUR;SERPINE1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.4401523561428524,-1.4695232577435402,0.031413612565445025,0.16583578570794122,1.0,20/46,25.23%,PRKCD;IPO5;FLNA;DHX9;ANP32B;GAS6;YWHAE;TPR;MAVS;BAG3;HCLS1;CHP2;GSK3B;ZC3H12A;JUP;GTSE1;TGFB1;RBM22;TRIM28;ECT2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4482018133623068,-1.4692508044897277,0.031914893617021274,0.16594056927617346,1.0,19/45,22.98%,CD44;SP100;PRKCD;IRF2;IRF5;CIITA;B2M;JAK1;GBP2;IFNGR2;OASL;TRIM68;OAS3;MT2A;HCK;OAS2;STAT1;TRIM25;IFNGR1
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.5718315805335483,-1.4685373158405917,0.0631768953068592,0.16656659962229994,1.0,6/15,10.78%,IGF1;ROCK1;MEF2A;SLC9A1;AGT;MTPN
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.4090522939791691,-1.468469072904681,0.02867383512544803,0.16640589186212945,1.0,25/62,23.39%,AGO2;NUP50;PPARG;STAT3;DHX9;NUP42;NUP88;RAE1;POLR2H;PUM2;POLR2F;POLR2L;NUP205;TPR;NUP188;POLR2A;EIF4G1;POLR2G;NUP153;NUP35;NUP107;POLR2I;NUP62;PUM1;TGFB1
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.39031727667521765,-1.467887293855343,0.024271844660194174,0.16692240440446293,1.0,31/84,24.13%,SASH1;NRP1;FOXP1;RAC1;P2RX4;RIN2;PTK2B;MAPK14;PIK3CB;PIK3CG;NRP2;GRN;VEGFA;ITGB1BP1;HIF1A;AGT;PIK3CD;CD40;TMSB4X;MAP2K3;GATA3;HSPB1;HMGB1;BMPR2;ZC3H12A;KDR;FGF18;PLPP3;TGFB1;GPLD1;ATP5F1B
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.4021299735405168,-1.4676737661659576,0.011864406779661017,0.16690894336636045,1.0,29/77,28.72%,IGF1;MCL1;RB1;BIRC6;CSNK2A1;RIPK1;CFLAR;PSME3;ITGAV;BCL2;SLC35F6;HGF;PLAUR;TGFBR1;RELA;TMBIM6;GHITM;HSPA1A;ACAA2;DDX3X;MAZ;BCL2L2;URI1;TMEM14A;SIAH2;RTKN2;NOC2L;BCL2L1;PRELID1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.6258447354035088,1.4675053225531893,0.08260869565217391,0.23393511510028198,1.0,4/10,8.01%,BMPR1B;SOX5;SOX6;SOX9
prerank,dendritic cell differentiation (GO:0097028),-0.5154769778056084,-1.4673243816559143,0.050761421319796954,0.16713268657880204,1.0,11/22,25.73%,LYN;LILRB1;AXL;BATF;GAS6;TGFBR2;BATF3;LGALS9;FLT3;PRTN3;BLK
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5484103420929677,-1.4672323945204544,0.050699300699300696,0.16697760025847302,1.0,6/18,17.07%,TLR4;CLEC4D;TNIP2;CD2;KARS1;CD226
prerank,regulation of sodium ion transport (GO:0002028),0.46070964611741316,1.467168582992984,0.030878859857482184,0.23335131633147466,1.0,15/34,19.95%,NKAIN2;FGF12;ANK3;NKAIN3;AHCYL1;SPTBN4;NEDD4;ATP2B4;WNK4;CNKSR3;WNK3;NKAIN4;WNK2;NKAIN1;PER1
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.4498097714009066,-1.4671311009123962,0.030612244897959183,0.1668633012163441,1.0,17/44,20.90%,ZC3HAV1;ROCK1;YTHDF3;AGO2;CNOT1;RC3H1;MOV10;FTO;GTPBP1;CELF1;METTL14;TNRC6C;DHX36;POLR2G;TOB1;CNOT8;ZC3H12A
prerank,actin polymerization or depolymerization (GO:0008154),-0.429191437292157,-1.4668743435615637,0.025252525252525252,0.1669012561128219,1.0,15/50,12.08%,DIAPH1;GAS7;ABI1;RAC1;PSTPIP2;SVIL;PSTPIP1;WASL;CAPG;CORO7;WDR1;MSRB1;DIAPH3;MICAL1;MICAL2
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6492875325612009,-1.466530244780557,0.05063291139240506,0.1670615468732022,1.0,3/10,9.66%,APOE;ABCA1;ZDHHC8
prerank,regulation of organelle organization (GO:0033043),-0.39587276420070544,-1.4661163872750766,0.008361204013377926,0.16731625733618613,1.0,19/80,16.22%,DIAPH1;MYO5A;ZEB2;MSN;CLIC4;PAK2;MTM1;PREB;ARMH3;FIS1;TAOK1;SAR1A;STX5;SPEF1;MARK2;PRMT6;MAVS;ARHGEF5;CLN3
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.40052586433393683,-1.4648486385078372,0.020869565217391306,0.1687054383511352,1.0,23/70,21.85%,P2RX7;MCL1;CRADD;TNFRSF1B;RIPK1;IL6R;RNF41;ITGAV;BCL2;CD27;MLLT11;CIB1;TRAF2;GABARAP;BAG3;BID;CASP8;TRADD;CASP2;DDX3X;GSK3B;APPL1;BCL2L2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.44981595029407007,-1.4648169536509312,0.03963963963963964,0.16848754177506062,1.0,13/40,11.65%,FAM111A;BLM;PRIMPOL;RTEL1;RAD51;RFWD3;NUCKS1;MCM9;GEN1;TIMELESS;ALYREF;WRN;PCNA
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5858581169084565,1.4644921341650075,0.06293706293706294,0.23625099644674627,1.0,8/12,18.59%,ANK3;DMD;ATP1B1;GLRX;WNK4;WNK3;ATP1B2;WNK2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5569799222086282,1.4643676764001847,0.08674698795180723,0.23539625039706244,1.0,5/15,10.56%,KCNN2;KCND3;KCNJ3;KCNIP2;ATP1B1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.5801344801642399,1.4639974562642015,0.057279236276849645,0.2348602670130875,1.0,5/13,8.85%,GRIK2;SHISA6;SLC4A10;SHISA9;SLC8A2
prerank,negative regulation of immune effector process (GO:0002698),-0.5883205715098,-1.46367721083518,0.061837455830388695,0.16958203146246853,1.0,4/13,7.30%,LILRB1;CD300A;RC3H1;GRN
prerank,Golgi to lysosome transport (GO:0090160),-0.631161096085286,-1.4635587185354053,0.05272407732864675,0.16949410536254608,1.0,5/11,16.22%,ANKFY1;AP1G1;LAPTM5;LAMP1;CLN3
prerank,cellular response to insulin stimulus (GO:0032869),-0.37083180082769185,-1.4627521661232572,0.00676818950930626,0.17025602387009797,1.0,36/124,20.57%,MYO5A;RAB8B;ATP6V0D2;NAMPT;BCAR3;GRB2;DENND4C;ATP6V1E1;INSR;IGF1R;PPARG;RAB31;ATP6V1A;SLC27A1;TCIRG1;AP3S1;RHOQ;ZDHHC7;BAIAP2;SELENOS;ATP6V1G1;XBP1;ZNF106;PKM;RAB10;HDAC5;ATP6V0B;PIK3C2A;RAB13;ATP6V0E1;IRS2;RAB12;ENPP1;GSK3B;ATP6V0D1;APPL1
prerank,regulation of neuron migration (GO:2001222),0.47479137333996196,1.4620233176169182,0.0630841121495327,0.2366497095101692,1.0,8/26,9.24%,CTNNA2;SEMA6A;NTNG2;NTNG1;PHACTR1;SRGAP2;NEXMIF;CAMK2A
prerank,protein-DNA complex assembly (GO:0065004),-0.37092235538758744,-1.4619828305816767,0.013605442176870748,0.17092164892091105,1.0,38/116,21.28%,TCF4;DDB2;PSME4;SMARCA5;PSMB7;PSME3;ANP32B;PSMB9;MCM6;RAD51;PSMA8;UBC;RPS27A;MCM3;PSMC3;CUL4B;PSMD8;ORC5;ASF1A;HMGB2;SPTY2D1;PSMC4;PSMB10;RPA3;PADI4;PSMA1;SART3;CHAF1A;MCM2;PSMB8;BRD2;RSF1;PSMA5;PSMD4;PSMB3;PSMD3;DMC1;CETN2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.4734388440056913,-1.4614360335743577,0.06315789473684211,0.17134329668628343,1.0,11/28,26.60%,CRADD;SPI1;BCL2;GABARAP;BAG3;BID;CASP8;TRADD;DDX3X;DEDD2;DIABLO
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.4969823492904624,-1.4609667219454099,0.04391891891891892,0.17166271333957409,1.0,9/26,21.48%,CD36;INSR;P2RX4;TLR4;HSP90AB1;KLF2;ASS1;MMP8;TMEM106A
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.3151880640772154,-1.4606965812232882,0.0,0.17170385774115268,1.0,121/476,18.87%,MDFIC;APOE;MITF;ZMIZ1;MAP3K5;FLI1;ELF4;RUNX1;IGF1;TFEB;CD38;CD74;SP100;TCF4;RREB1;ELF2;JUN;DNM2;NIBAN2;CREBBP;RUNX3;PPARD;BRD7;RNF111;BRD4;NFYA;ARID1B;ATAD2;ELF1;NSD3;PPARG;KDM3A;BRCA1;STAT3;FOXO3;LYL1;RYBP;RNF20;NFKB1;HHEX;RUNX2;SMARCD3;FBXW11;PRMT2;CRLF3;SNX5;KLF6;SMARCC2;BLM;NR1H2;CIITA;AXIN1;LRP6;PICALM;MED24;AHR;CTNNB1;TBL1XR1;CAMKK2;EDF1;CREB3L2;E2F1;CNBP;ARID1A;ATMIN;RNF4;TGFBR1;WBP2;PARP9;TGFB1I1;HIF1A;MEF2C;EGR1;AFAP1L2;RELA;AGT;NCF1;XRCC6;ARHGEF11;DYRK1A;MAP2K1;MED4;NFE2;MLLT11;SPIN1;CHD8;HMGB2;RXRA;CALCOCO1;TFAP4;WAC;EPC1;KLF2;ID2;TFAM;TCF3;IKBKB;SPP1;NSD1;KARS1;IL31RA;DNAJC2;QRICH1;SOX10;VHL;KMT2A;MAP2K3;GPATCH3;RARA;NFATC1;ATF5;TFE3;GATA3;MYB;NCOA6;CXXC1;TRIM16;HAS3;CASZ1;RSF1;PITHD1
prerank,cellular response to purine-containing compound (GO:0071415),0.6074529815729343,1.4604562842026796,0.075,0.23786699667274788,1.0,4/10,9.78%,RYR3;RYR2;CASQ2;RYR1
prerank,negative regulation of viral life cycle (GO:1903901),-0.5675389627027109,-1.4599904552619378,0.05982905982905983,0.17231313916712485,1.0,5/15,13.91%,SNX3;CIITA;BST2;IFITM2;TRIM11
prerank,protein-DNA complex disassembly (GO:0032986),-0.5623398204533057,-1.459888461869155,0.06724137931034482,0.17220956390687214,1.0,5/16,11.99%,ARID2;SMARCD3;SMARCC2;ARID1A;NFE2
prerank,regulation of cytoskeleton organization (GO:0051493),-0.3776334460920215,-1.4598021945046826,0.015228426395939087,0.17205249811700868,1.0,35/108,21.30%,IQGAP2;IQGAP1;DIAPH1;CLIC4;P2RX7;LRP1;PAK2;PRKCD;RAC1;ROCK1;RHOA;ARHGAP17;ARHGAP18;RHOQ;BAIAP2;SH3BP1;BST2;KATNBL1;TAOK1;CRK;CCDC88A;SPEF1;MARK2;BST1;RND2;ARHGEF5;CLN3;TWF2;CDK2AP2;PDGFRB;TAOK2;RHOBTB1;GSK3B;RHOF;PDGFA
prerank,pulmonary valve morphogenesis (GO:0003184),0.5243498182257046,1.4593590428784786,0.06091370558375635,0.23853382693044142,1.0,3/17,1.35%,ROBO1;ROBO2;SLIT2
prerank,regulation of heart contraction (GO:0008016),0.3716592055801307,1.459142579203136,0.020100502512562814,0.23777622510302393,1.0,30/90,17.68%,ANK2;RYR3;RYR2;SLC8A3;TRPC1;PDE4D;ADORA3;CORIN;AHCYL1;CASQ2;KCNIP2;APLN;ATP1A3;FXYD6;SLC8A2;TNNT2;RYR1;ATP1B1;TGFB2;CALM1;CALM3;KCNJ12;CALM2;ATP2B4;ATP2B2;ATP2A1;SCN10A;TPM1;ATP1B2;CELF2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5824158888992267,-1.4588637773922115,0.06091370558375635,0.17286810347828993,1.0,7/14,23.36%,DHX58;DDX60;PUM2;OASL;ZCCHC3;ZDHHC5;PUM1
prerank,positive regulation of viral life cycle (GO:1903902),-0.5151658441716065,-1.4582037198145428,0.044802867383512544,0.17348468052266874,1.0,11/22,25.00%,CD74;AXL;TSG101;LGALS1;TRIM11;CHMP2A;LGALS9;VPS4A;P4HB;DDB1;CHMP2B
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6337821490342481,-1.4571534399737303,0.07054673721340388,0.17431494879981393,1.0,5/10,21.40%,PRKCD;SIRT3;SPHK2;PLA2G6;RACK1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6337821490342481,-1.4571534399737303,0.07054673721340388,0.17431494879981393,1.0,5/10,21.40%,PRKCD;SIRT3;SPHK2;PLA2G6;RACK1
prerank,intermediate filament organization (GO:0045109),-0.5534540592040205,-1.4564387901518776,0.04225352112676056,0.17501399461841616,1.0,7/17,24.88%,VIM;KLHL24;MTM1;DNAJB6;BFSP2;GFAP;DSP
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.3980144352299426,-1.455756500854469,0.029513888888888888,0.1755421584454753,1.0,34/72,32.21%,GRB2;CBL;KIF16B;GALNT3;HNRNPH1;CEP57;POLR2H;FRS2;POLR2F;POLR2L;SPRED1;SPRED2;SHCBP1;POLR2A;NCBP1;POLR2G;PTPN11;HNRNPA1;POLR2I;GTF2F2;MAPK1;FGF18;FGF9;FGFR4;ESRP1;GTF2F1;HNRNPF;FGF22;FGF20;FIBP;FGF16;RAB14;FGF2;POLR2D
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.6399813184493345,-1.4549211105931221,0.05217391304347826,0.17630132665341341,1.0,5/10,13.88%,CD36;TLR4;MYD88;TICAM1;MIA3
prerank,regulation of B cell differentiation (GO:0045577),-0.5577248919956089,-1.4547663702859392,0.04674457429048414,0.17623944412318432,1.0,9/17,22.26%,SYK;NCKAP1L;CD27;IKZF3;XBP1;IL4I1;ID2;SFRP1;INHA
prerank,"transcription, DNA-templated (GO:0006351)",-0.3482632559596503,-1.452810991438205,0.003236245954692557,0.1785246282031712,1.0,78/207,27.09%,RREB1;AFF4;MEF2A;DEK;NELFB;NFIC;NFX1;NFYA;SMARCA5;ARRB2;GTF2A1;CTR9;KLF13;ERCC6;FOXO3;NFKB1;MAF;TAF6;POLR2H;E2F1;POLR2F;THAP1;CBFB;POLR3G;DDX5;POLR2L;SNAPC2;XBP1;MED4;TRIM24;SMN1;GTF2E2;POLR2A;EPC1;NCBP1;TFAM;TAF4B;NFKBIB;POLR2G;TAF9;TTF1;TAF3;RNPS1;TAF1A;SNAPC3;DTX1;POLR3A;NCOA6;GMEB2;TAF4;GTF3A;RSF1;MED20;ELOC;RTF1;GTF3C5;MMS19;PKNOX1;POLR2I;XAB2;CCNK;GTF2F2;GTF2A2;TOPORS;TWNK;DEAF1;TRIP11;DRAP1;POLR3GL;GTF2F1;BRF1;SSRP1;POLR1C;UBTF;NELFE;NKX2-8;HIPK3;ZBTB7B
prerank,positive regulation of protein catabolic process (GO:0045732),-0.39214395051619266,-1.4521328736918682,0.01824212271973466,0.1790924546126236,1.0,21/84,12.93%,APOE;MSN;WWP1;RAB7A;SNX9;TNFRSF1B;CSNK2A1;WWP2;RNF41;AREL1;ATG7;TIPARP;ADAM9;AXIN1;SNX33;PLK2;ADAM8;NEDD4L;ASB5;STX5;PLK3
prerank,regulation of protein export from nucleus (GO:0046825),-0.5125946620257216,-1.4515465972283086,0.05501618122977346,0.17956159029705593,1.0,9/23,23.56%,SP100;ANP32B;GAS6;YWHAE;TPR;BAG3;GSK3B;GTSE1;RBM22
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6126898352440183,-1.4514615731046874,0.0625,0.1794196242760616,1.0,3/12,3.68%,INSR;IGF1R;UVRAG
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.5512830986686837,-1.4513244083846946,0.05008944543828265,0.17931325933253342,1.0,6/17,19.35%,LYN;TAOK3;EIF2AK2;TAOK1;TAOK2;NOD2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.39676665772339426,-1.4509121681469523,0.023333333333333334,0.1796324628382294,1.0,29/72,22.51%,LYN;IGF1;FGR;CBL;PIK3R5;INSR;IGF1R;PIK3AP1;IL18;FLT1;PIK3CB;FN1;HGF;PIK3CG;PTPN6;AGT;NCF1;PIK3CA;CCL5;PIK3CD;HCLS1;IRS2;HCST;PDGFRB;MAZ;KDR;PDGFA;HAX1;BECN1
prerank,positive regulation of JNK cascade (GO:0046330),-0.3973829992956613,-1.450788171379997,0.016042780748663103,0.17952960733090476,1.0,24/70,19.94%,MAP3K5;TAOK3;SDCBP;MFHAS1;MINK1;RIPK1;TRAF5;PTK2B;AXIN1;TRAF3;CD27;TAOK1;TRAF1;NCF1;APP;GADD45A;FCGR2B;TRAF2;MAP3K10;MMP8;TAOK2;NOD2;HMGB1;AGER
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.5355125515062402,-1.4507733224678272,0.07450331125827815,0.17929386901480124,1.0,7/19,20.43%,CYBA;PRDX5;PRDX1;PRDX2;ACOX1;CAT;PXDNL
prerank,negative regulation of translation (GO:0017148),-0.3887887665754741,-1.4506350440611753,0.01779935275080906,0.1792180328298659,1.0,29/87,22.07%,DAPK1;ROCK1;YTHDF3;AGO2;GAPDH;CNOT1;DAPK3;PUS7;EIF2AK2;PCIF1;EIF4EBP1;FTO;EIF4EBP2;EIF3E;TPR;CELF1;METTL14;UNK;DHX36;NCL;TOB1;RPS3;DDX3X;CNOT8;DDX6;CPEB4;LSM14A;RACK1;SHMT1
prerank,positive regulation of macroautophagy (GO:0016239),-0.42929566158596266,-1.4505884358938574,0.03355704697986577,0.17901660308774536,1.0,21/48,29.09%,SPTLC2;GNAI3;OPTN;PIP4K2A;UVRAG;RAB3GAP1;SESN1;SH3GLB1;WAC;SLC25A4;BAG3;BNIP3L;RALB;ADRB2;KDR;DCN;VDAC1;LRSAM1;VPS13D;TSC2;BNIP3
prerank,intracellular protein transport (GO:0006886),-0.3286663574525878,-1.4494566315625796,0.003134796238244514,0.18036344043352712,1.0,104/304,22.38%,CD74;SYK;TRAK1;RAB7A;SNX9;SNX27;IPO5;KIF13B;SNX8;STX7;ARHGEF2;TBC1D15;NUP50;UNC93B1;RAB31;SGSM2;TLK1;TBC1D2B;RAB20;TBC1D9;STAT3;GGA3;LAMP2;RAB1A;COG7;SNX6;NUP42;TMED10;STX8;CTSA;TBC1D5;TBC1D1;XPO6;ARL11;STX3;FUT10;RPL11;TBC1D22A;PREB;RAB32;NUP88;TBC1D16;TBC1D22B;SIL1;LAPTM5;WLS;BCS1L;TBC1D8B;E2F3;RAB5A;TMED3;AP1S3;TBC1D8;RAB21;XPO5;TBC1D17;VPS26B;SNX13;RAB24;TPR;SAR1A;RAB29;VPS26A;STX5;TBC1D10B;ARL5A;NUP188;SEC31A;COPA;EHD1;GABARAP;BAG3;TBC1D30;STX16;ARFIP1;APPL2;STRADA;CCHCR1;AP3B1;MAIP1;STX4;AP3D1;TBC1D9B;TMED2;VPS33A;ARL1;SNX1;TBC1D25;NUP153;ARFIP2;SLU7;TMED4;TICAM2;FAM53A;TNPO3;APPL1;NUP107;NXT2;NUP62;TBC1D10C;EGR2;TBC1D4;HPS4;SPRN
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.5332901249045799,-1.4489672218432934,0.06239168110918544,0.18072550039299193,1.0,7/18,14.77%,ERN1;BCL2L11;ATXN3;XBP1;FCGR2B;RNF185;TMEM259
prerank,nuclear export (GO:0051168),-0.3911999860012459,-1.4486212611780849,0.01932367149758454,0.1809334238471379,1.0,41/80,32.74%,SRRM1;MALT1;NUP42;XPO6;WASHC4;CHTOP;RAE1;CDC40;XPO5;ALYREF;TPR;NUP188;NCBP1;THOC2;STRADA;CCHCR1;ATXN1;RNPS1;NUP153;PHAX;THOC6;HNRNPA1;MAGOH;SLU7;NUP62;EGR2;SRSF11;TGFB1;DDX39B;DHX38;U2AF2;SMURF1;SRSF7;EIF4A3;CSE1L;EIF4E;SRSF5;XPO7;SARNP;U2AF1L4;ANKLE1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.4932822841390922,-1.4484086567138286,0.05235602094240838,0.18094094972288402,1.0,11/26,26.84%,IQGAP1;PTPN12;DUSP3;STAT5B;EEF1A1;KNSTRN;PTPN11;SNAI2;INPP5K;PDE8A;ZFP36L1
prerank,adenine nucleotide transport (GO:0051503),-0.5445869718463059,-1.4468725820795714,0.06989247311827956,0.18277025783420714,1.0,6/17,15.51%,LRRC8D;SLC25A24;LRRC8C;SLC25A42;ABCC4;SLC25A4
prerank,mitochondrion morphogenesis (GO:0070584),-0.6206746813737184,-1.446832844613477,0.06457242582897033,0.18255340815571963,1.0,3/11,10.02%,PID1;MTM1;FIS1
prerank,negative regulation of autophagy (GO:0010507),-0.420007689598485,-1.4466553124493733,0.02631578947368421,0.18254997937823822,1.0,13/54,7.32%,MCL1;NUPR1;HTR2B;STAT3;TAB2;ATG7;BCL2;CTSA;PTPN22;EIF4G3;HGF;KLHL22;USP36
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5456379033555641,-1.4465957719358846,0.06724137931034482,0.18238069517484376,1.0,5/16,14.06%,APOE;HTR2B;PIK3CB;HIF1A;GCH1
prerank,iron ion homeostasis (GO:0055072),-0.40977338571019284,-1.4465542760765813,0.02152317880794702,0.18218427898515185,1.0,12/58,10.17%,FTL;IREB2;ABCB7;FRRS1;ATP6V1A;TMEM199;PICALM;HMOX2;B2M;FLVCR1;ATP6V1G1;CP
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.3950928229909781,-1.4460749216818833,0.019230769230769232,0.18253975051133822,1.0,23/72,20.89%,BIRC3;REL;PSME4;MALT1;PSMB7;PSME3;FBXW11;PSMB9;PSMA8;RELA;PSMC3;PSMD8;TRAF2;PSMC4;PSMB10;PSMA1;RELB;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3;COPS8
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.542663911187748,-1.4458658632732475,0.058519793459552494,0.1826000195801451,1.0,10/17,25.10%,NRP1;IGF1;S100A11;DOCK5;MDK;CCL5;PDGFRB;ADAMTS1;FGF9;CCN4
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5498391397294771,-1.4457381943079461,0.0684931506849315,0.18252438807789081,1.0,10/17,21.47%,NRP1;FES;CDC42;STAP1;BAIAP2;BAIAP2L2;HCLS1;HCK;CDK5;HAX1
prerank,"phototransduction, visible light (GO:0007603)",-0.5738046538575279,-1.4456923520247966,0.07773851590106007,0.18232714901016364,1.0,7/14,34.78%,GNB1;GNA11;ABCA4;RP1;GNAQ;CNGB1;SAG
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.4427512906118515,-1.4455508026450115,0.03935599284436494,0.18226581348413048,1.0,18/45,26.35%,ERN1;RIPK1;NFKB1;DIMT1;DDX5;RELA;DYRK1A;MAP2K1;HNRNPLL;POLR2A;HSPA1A;SLC38A2;GRSF1;IL6;TGFB1;RBM22;BUD23;U2AF2
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.5344457415249685,-1.4450780941627668,0.08732876712328767,0.1826392386328234,1.0,9/19,21.91%,NRP1;RAC1;ROCK1;PTPRJ;VEGFA;LIMS1;SFRP1;KDR;MAP4K4
prerank,response to glucagon (GO:0033762),0.5150545314734156,1.4445664200567732,0.0703883495145631,0.25844408454837603,1.0,10/19,22.52%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1;PRKACB;PRKAR1A;PRKAR2B;CRY1;PRKAR1B
prerank,lipid transport (GO:0006869),-0.37820034369765193,-1.4445411870611635,0.01282051282051282,0.18310560327413772,1.0,24/97,16.74%,OSBPL8;APOE;ABCA1;ABCG1;PLTP;PITPNC1;CD36;PITPNA;PPARD;FABP5;ABCD2;SLC27A1;PITPNM1;GLTP;OSBPL5;PRELID2;STARD5;NPC2;ABCC4;RXRA;ABCA9;ABCA13;CLN3;ABCD3
prerank,cardiolipin metabolic process (GO:0032048),-0.583659661190185,-1.4444182943189414,0.06474820143884892,0.18304003304546002,1.0,9/13,34.90%,SLC27A1;TAMM41;PLA2G4A;PLA2G6;PLA2G5;PNPLA8;LCLAT1;PTPMT1;PGS1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.6308596146600907,-1.4442389655133179,0.07972270363951472,0.18299679460625398,1.0,3/10,3.50%,PTPRC;LILRB1;ARRB2
prerank,cell differentiation in hindbrain (GO:0021533),0.5845367460313748,1.4441991188022507,0.10141509433962265,0.2578953285854471,1.0,2/11,5.54%,GRID2;KNDC1
prerank,T cell proliferation (GO:0042098),-0.585965163129603,-1.4439876682663033,0.06944444444444445,0.18303194658136618,1.0,4/13,6.59%,MSN;LILRB1;DOCK8;PIK3CG
prerank,cellular response to interleukin-2 (GO:0071352),-0.6250628591097137,-1.4437771795458565,0.059027777777777776,0.18280840270068868,1.0,9/11,29.31%,SYK;PTK2B;STAT5B;JAK1;IL2RG;IL2RB;IL2RA;SHC1;IL2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.6250628591097137,-1.4437771795458565,0.059027777777777776,0.18280840270068868,1.0,9/11,29.31%,SYK;PTK2B;STAT5B;JAK1;IL2RG;IL2RB;IL2RA;SHC1;IL2
prerank,regulation of catecholamine secretion (GO:0050433),0.4634579788230907,1.4435954739403014,0.0594059405940594,0.2577663622352149,1.0,11/29,16.07%,SYT1;SYT10;SYT2;HRH3;SYT5;SYT11;SYT12;SYT7;PRKN;KCNA2;SNCA
prerank,cellular response to starvation (GO:0009267),-0.35525517649225136,-1.4432750539695423,0.008156606851549755,0.1831656301661411,1.0,44/147,23.59%,MAP3K5;ATP6V0D2;TFEB;ATP6V1E1;PRKAG2;ATG5;ATP6V1A;FOXO3;LAMP2;ATG7;TCIRG1;MTMR3;EIF2AK2;FNIP1;SIK1;ATP6V1G1;XBP1;RRAGD;FLCN;WRN;KLF10;SESN1;STK24;XPR1;SH3GLB1;ATP6V0B;GABARAP;ATP6V0E1;RALB;RHEB;HNRNPA1;BMPR2;ATP6V0D1;SFRP1;ZC3H12A;CPEB4;GAS2L1;PRKAG1;CEBPB;MAPK1;BECN1;RRP8;WDR24;KPTN
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.49378206846226114,-1.4428495204194913,0.04325259515570934,0.1834220371877618,1.0,11/27,12.76%,TLR4;PTPN22;ARRB1;IRAK3;GAS6;SIRPA;PTPN6;SELENOS;NCKAP1L;FOXJ1;NLRC3
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.4333792164042963,-1.4425634236176172,0.0361247947454844,0.18354593014806136,1.0,31/50,39.64%,CD44;PAK2;CSNK2A1;HGF;GAS6;VEGFA;MAP2K5;FNIP1;PLAUR;YWHAE;RNF34;DDX3X;BEX3;DNAJB6;SFN;MT3;SIAH2;RPS6KA3;CARD16;AQP1;PAX2;NGFR;XIAP;MMP9;TNF;KLF4;NGF;LAMP3;USP47;RAF1;TRIAP1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.4405773215756068,-1.442474804710731,0.035653650254668934,0.18340284646035934,1.0,12/42,16.92%,ARID1B;SMARCA5;ERCC6;CHD3;ACTB;SMARCC2;ARID1A;RNF8;CHD8;SPTY2D1;INO80;RBBP4
prerank,peripheral nervous system development (GO:0007422),0.4940830267948637,1.4421990917022591,0.07042253521126761,0.2588141102547058,1.0,12/23,25.16%,ASIC2;SERPINI1;GDNF;BDNF;ADGRB2;ERBB3;ADGRB1;GPC1;NF1;GFRA3;SCN8A;ALDH3A2
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.5308140612982262,-1.4420821878685877,0.07363013698630137,0.18369832516306628,1.0,9/18,27.34%,PTBP3;RPS13;TMBIM6;SHQ1;ZC3H12A;TGFB1;NCOR1;NUDT16;ESR1
prerank,intracellular sterol transport (GO:0032366),-0.5910418862982194,-1.4417975820072575,0.059336823734729496,0.18382806603304686,1.0,5/13,20.48%,ABCA1;ABCG1;NPC2;NPC1;VPS4A
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.5281114635431906,-1.441208695330987,0.062388591800356503,0.18431880018412392,1.0,5/21,13.46%,MITF;JUN;MED24;MED4;DHX36
prerank,positive regulation of exosomal secretion (GO:1903543),-0.5660389157655955,-1.4410181610410924,0.06618962432915922,0.18430300176595898,1.0,6/15,14.44%,SDCBP;RAB7A;PDCD6IP;TSG101;SDC4;CHMP2A
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3988642348040438,-1.4404754791361132,0.04020100502512563,0.18476158702441278,1.0,23/67,17.60%,RAC1;P2RX4;CAPZB;TBC1D15;IFT20;ATG5;TBC1D2B;CDC42;TBC1D5;TBC1D1;TBC1D22A;SDCCAG8;TBC1D16;TBC1D22B;RAB5A;TBC1D8;TBC1D17;TBC1D10B;MYO10;TBC1D24;DYNLT2B;TBC1D9B;TWF2
prerank,telomere maintenance via recombination (GO:0000722),-0.610389185465493,-1.4392055584405863,0.06260869565217392,0.1861261498946427,1.0,7/11,24.24%,NSMCE2;TEP1;RAD51;ERCC4;XRCC3;SMC6;SMC5
prerank,regulation of lamellipodium organization (GO:1902743),-0.5737076684793967,-1.4386813543670944,0.06104129263913824,0.18653254635584005,1.0,4/14,4.09%,CD44;RAC1;CAPZB;CDC42
prerank,aortic valve morphogenesis (GO:0003180),0.44957144826397855,1.4379707183860753,0.06419753086419754,0.2640627376158607,1.0,7/30,10.02%,ROBO1;ROBO2;SLIT3;SLIT2;TIE1;SOX9;SNAI1
prerank,phospholipid translocation (GO:0045332),-0.48246810400018947,-1.4376247889395977,0.04293381037567084,0.18769737967263217,1.0,6/28,9.21%,ABCA1;ATP8B4;P2RX7;ANO6;ATP11C;ABCC1
prerank,regulation of endothelial cell migration (GO:0010594),-0.38336578242659447,-1.4373827356489044,0.025510204081632654,0.18772880107697823,1.0,16/85,8.99%,SASH1;APOE;NRP1;FOXP1;SP100;RAC1;RIN2;PTK2B;PIK3CB;PIK3CG;PRCP;NRP2;GRN;VEGFA;SH3BP1;ITGB1BP1
prerank,regulation of actin filament-based process (GO:0032970),-0.3988920257162105,-1.4364115353847873,0.03904923599320883,0.18881395980039128,1.0,25/70,21.30%,IQGAP2;IQGAP1;LRP1;PRKCD;RAC1;ROCK1;RHOA;ARHGAP17;ARHGAP18;RHOQ;BAIAP2;SH3BP1;BST2;TAOK1;CRK;CCDC88A;BST1;RND2;ARHGEF5;TWF2;PDGFRB;TAOK2;RHOBTB1;RHOF;PDGFA
prerank,postreplication repair (GO:0006301),-0.43013263111627476,-1.436208330875342,0.03709949409780776,0.18879225225730842,1.0,20/45,26.85%,BRCA1;RFC1;PRIMPOL;PCLAF;UBC;RPS27A;PCNA;WDR33;RPA3;RFC2;POLD2;ISG15;PARP10;POLN;RFC3;TRIM25;UBE2V2;POLD4;UBE2N;VCP
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.5050681162604831,-1.436164550204159,0.05944055944055944,0.18858796744255127,1.0,8/23,9.89%,CD74;MPP1;RAC1;CAMK1D;DPP4;RIPOR2;MDK;NCKAP1L
prerank,methylguanosine-cap decapping (GO:0110156),-0.6549432637674844,-1.4353851470267556,0.06666666666666667,0.18941556560235434,1.0,3/10,8.37%,DCP1A;PATL1;DCP2
prerank,endomembrane system organization (GO:0010256),-0.3426284017888329,-1.4346566419511468,0.004709576138147566,0.19010019329882533,1.0,78/178,30.77%,MYOF;ATP8B4;TMCC1;SNX10;PLEKHM2;GOLGA5;GOLGA8B;PI4K2A;USP50;FBXW8;OPTN;CDC42;SYNGR1;RAB1A;COG7;SRGN;DNAJC13;ARFGEF1;TMED10;USP8;PI4K2B;TRAPPC11;WASHC4;DYM;SNX33;GOLPH3L;SUN2;ALS2;TJAP1;TMED3;TLCD2;ARFGEF2;RAB29;SERP1;COG2;SEC31A;MIA3;LEMD2;LMAN2L;VAPB;AP3D1;TMED2;LAPTM4B;ARL1;HUWE1;DOP1B;TMED4;TICAM2;VPS51;VPS18;VPS4A;REEP3;BLZF1;PHETA1;TMED5;TLCD1;VMP1;COG4;TRIP11;CHMP2B;LAMTOR1;VPS11;OTOF;RAB22A;VAPA;RNF26;EIF2AK3;TRAPPC8;HACE1;SYNGR2;ATP8B2;RAB2A;MAPK15;REEP6;SQSTM1;GAK;ANXA8L1;ANXA8
prerank,regulation of Golgi organization (GO:1903358),-0.5433978602359102,-1.4343208205545233,0.0659536541889483,0.1902868912307915,1.0,6/17,22.16%,MYO5A;ARMH3;MAP2K1;STX5;CAMSAP2;MAPK1
prerank,negative regulation of phagocytosis (GO:0050765),-0.5446215308987308,-1.4337370006843309,0.07908611599297012,0.19080337609281722,1.0,10/17,25.28%,CD300A;SNX3;CD300LF;SIRPA;FCGR2B;HMGB1;APPL1;RACK1;CD47;PRTN3
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.4830898140342193,1.4337236963165498,0.055288461538461536,0.2694909426106707,1.0,4/24,1.32%,NRG1;CTNNA2;OLFM2;CDH2
prerank,positive regulation of binding (GO:0051099),-0.38566954292002986,-1.4335698642316685,0.018272425249169437,0.1907742353485001,1.0,28/84,20.74%,APOE;IGF1;LRP1;PPARG;AMFR;DHX9;STK3;RPL11;EDF1;SKI;NME1;NVL;B2M;PLAUR;CEBPG;PARP9;PIN1;DERL1;APP;HMGB2;NCBP1;RALB;RARA;MMP8;HMGB1;GSK3B;SIRT2;DTX3L
prerank,protein polyglutamylation (GO:0018095),0.5896104615246605,1.4334762384164077,0.08767772511848342,0.2687856594424281,1.0,3/11,5.31%,TTLL11;TTLL7;TTLL5
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.6363109272962266,-1.4334230256920724,0.054385964912280704,0.19021419899299388,1.0,7/10,21.01%,BLM;WRN;EXO1;SLX4;XRCC3;DNA2;NBN
prerank,t-circle formation (GO:0090656),-0.6363109272962266,-1.4334230256920724,0.054385964912280704,0.19021419899299388,1.0,7/10,21.01%,BLM;WRN;EXO1;SLX4;XRCC3;DNA2;NBN
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.6363109272962266,-1.4334230256920724,0.054385964912280704,0.19021419899299388,1.0,7/10,21.01%,BLM;WRN;EXO1;SLX4;XRCC3;DNA2;NBN
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.4831278661964365,-1.4332125906486712,0.0451505016722408,0.19022208671365698,1.0,11/26,23.65%,MFHAS1;CYBA;PTPN22;RSAD2;IFI35;WDFY1;DDX3X;HMGB1;TICAM2;SLC15A4;TREML4
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.5097414498870197,-1.4329085787516205,0.05786618444846293,0.19035282411797289,1.0,10/22,20.21%,NFE2L2;PSME4;PSMB7;PSMB9;PSMA8;PSMB10;PSMA1;PSMB8;PSMA5;PSMB3
prerank,positive regulation of protein metabolic process (GO:0051247),-0.36909740299349336,-1.4328577329926764,0.01948051948051948,0.1901723552944425,1.0,43/110,26.85%,APOE;PAEP;WWP1;RAB7A;CSNK2A1;WWP2;RNF41;AREL1;IL18;ATG7;RAB1A;TIPARP;NR1H2;AXIN1;WFS1;PLK2;MAP2K5;PRMT1;MAPK7;AGT;NEDD4L;MTPN;APP;ASB5;STX5;UHRF1;KLF2;EIF4G1;SLC6A9;RILP;HUWE1;CSF1;GSK3B;SMURF2;OAZ3;TGFB1;RAB1B;DDB1;ABCA2;RANBP9;VIP;SMURF1;VCP
prerank,cellular defense response (GO:0006968),-0.4483923670203584,-1.4328413748380302,0.03281519861830743,0.18994661434519086,1.0,26/40,36.26%,ZNF148;C5AR1;TCIRG1;ITGB1;PTK2B;LY96;RELA;NCF1;NCF2;ITK;CD5L;LGALS3BP;SPN;LSP1;BECN1;PRF1;CD300C;ADORA2A;KLRC2;KIR3DL2;TRAT1;CXCR2;NCR1;ADORA2B;FOSL1;CXCL9
prerank,alcohol catabolic process (GO:0046164),-0.622313812926138,-1.4328116576561494,0.07011686143572621,0.18973452478641975,1.0,3/10,14.91%,APOE;CYP27A1;CYP46A1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.4164014088470055,-1.4327639587069432,0.04318936877076412,0.1895392917543969,1.0,22/54,24.75%,BFAR;AMFR;PELI1;UBE2R2;RNF4;FBXO38;RNF8;NEDD4L;UBE3A;UBE2H;RNF34;UBE2G1;UBE2T;RNF216;CDC34;UBE2C;SKP2;DTX3L;RNF115;TOPORS;ZNRF1;RNF187
prerank,prostaglandin biosynthetic process (GO:0001516),-0.536814500760641,-1.4324947627929179,0.05679862306368331,0.18959520400625302,1.0,5/18,14.49%,TBXAS1;CD74;DAGLB;CBR1;PLA2G4A
prerank,synaptic vesicle localization (GO:0097479),0.5790401738086031,1.431332447247061,0.08083140877598152,0.27114839502081345,1.0,5/13,8.20%,NLGN1;KIF5C;SYNDIG1;KIF5A;TOR1A
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.6070915056678173,-1.4309338807394125,0.07653061224489796,0.19149733736057142,1.0,8/11,26.68%,LYN;ANXA1;PIK3CB;MEF2C;PIK3CD;LGALS9;BLK;RAPGEF2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.37345195104849066,-1.4308980304152004,0.024096385542168676,0.19129081638057935,1.0,45/96,32.71%,NUP50;SRRM1;HHEX;NUP42;CHTOP;NUP88;RAE1;CDC40;AGFG1;NUP205;UPF2;ALYREF;TPR;NUP188;WDR33;YTHDC1;NCBP1;THOC2;RNPS1;NUP153;THOC6;NUP35;MAGOH;SLU7;CPSF3;NUP107;NUP62;SRSF11;SMG1;DDX39B;DHX38;RANBP2;RBM15B;CPSF1;NUP37;U2AF2;SRSF7;AAAS;NUP133;EIF4A3;EIF4E;SRSF5;SARNP;ALKBH5;U2AF1L4
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.4401566614379386,-1.4308217634875564,0.039182282793867124,0.1911172592182243,1.0,9/40,9.10%,DAB2;SDCBP;JAG1;GCNT2;CTNNB1;EZH2;MDK;TGFBR1;TGFB1I1
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.5108680113653021,-1.4307694097843455,0.07917383820998279,0.1909506332881227,1.0,14/21,26.84%,IGF1;HTR2B;ITGAV;PTGER4;CTSH;CDK1;MAP2K1;KARS1;LGALS9;KDR;MAPK1;MYC;MT3;ZFP36L1
prerank,NAD biosynthetic process (GO:0009435),-0.5111445136319374,-1.4305915700323009,0.08536585365853659,0.19096067571796502,1.0,8/20,35.33%,NAMPT;KYNU;PARP9;PARP10;NMNAT3;NADSYN1;NUDT12;HAAO
prerank,protein O-linked mannosylation (GO:0035269),0.5058005366131161,1.4304312116271163,0.08095238095238096,0.27151650735682537,1.0,8/18,16.49%,TMTC2;TMTC1;CRPPA;TMTC3;POMT2;POMGNT2;FKTN;DPM2
prerank,regulation of cell junction assembly (GO:1901888),-0.4860150723692074,-1.4301429920831912,0.059027777777777776,0.19131139089722196,1.0,7/27,9.25%,PRKCH;RUNX1;ROCK1;RAP1B;RAP1A;CBFB;MEF2C
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.5810054906291159,-1.4298240148135914,0.08216783216783216,0.1914676799719958,1.0,3/13,1.62%,SYK;PRKCD;ITGB2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.5179148741818976,1.4293622614569546,0.07857142857142857,0.2719694113708015,1.0,6/17,16.91%,SLIT2;TWSG1;DOK5;PCSK6;ZDHHC17;TMEM204
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.47221352960107954,-1.4292453238188045,0.047872340425531915,0.19176134343152698,1.0,13/29,25.88%,SMARCA5;KNL1;MIS18BP1;CENPA;CENPK;CENPN;CENPL;RBBP4;CENPH;RSF1;CENPP;CENPO;HJURP
prerank,CENP-A containing chromatin organization (GO:0061641),-0.47221352960107954,-1.4292453238188045,0.047872340425531915,0.19176134343152698,1.0,13/29,25.88%,SMARCA5;KNL1;MIS18BP1;CENPA;CENPK;CENPN;CENPL;RBBP4;CENPH;RSF1;CENPP;CENPO;HJURP
prerank,mRNA export from nucleus (GO:0006406),-0.3680445950087068,-1.4289583889911337,0.02030456852791878,0.19189073568550905,1.0,47/102,32.71%,NUP50;SRRM1;HHEX;NUP42;CHTOP;NUP88;RAE1;CDC40;AGFG1;NUP205;UPF2;ALYREF;TPR;NUP188;WDR33;YTHDC1;NCBP1;THOC2;RNPS1;NUP153;THOC6;NUP35;MAGOH;SLU7;CPSF3;NUP107;NUP62;SRSF11;SMG1;DDX39B;DHX38;RANBP2;RBM15B;CPSF1;NUP37;U2AF2;ENY2;SRSF7;AAAS;NUP133;EIF4A3;EIF4E;SRSF5;POLR2D;SARNP;ALKBH5;U2AF1L4
prerank,purine ribonucleotide transport (GO:0015868),-0.5467245733143926,-1.4287076778226335,0.07857142857142857,0.19196845737807766,1.0,6/16,15.51%,LRRC8D;SLC25A24;LRRC8C;SLC25A42;ABCC4;SLC25A4
prerank,regulation of neutrophil migration (GO:1902622),-0.6200063353405225,-1.4286111087997373,0.07084019769357495,0.19182809086082075,1.0,4/10,16.06%,MPP1;RAC1;NCKAP1L;BST1
prerank,vacuolar acidification (GO:0007035),-0.5065474748850944,-1.4284453560578623,0.05749128919860627,0.19180009038046522,1.0,9/21,21.12%,ATP6V0D2;TCIRG1;TMEM199;GRN;CLN6;CLN3;ATP6V0E1;ATP6V0D1;PPT1
prerank,purine nucleotide metabolic process (GO:0006163),-0.4992814634660936,-1.4283921741390273,0.06260869565217392,0.19160277922352026,1.0,5/24,9.96%,GDA;XDH;GUK1;HPRT1;NT5C2
prerank,regulation of neurotransmitter transport (GO:0051588),0.5302783479934088,1.4280894721602604,0.056372549019607844,0.27289408703971346,1.0,6/16,9.24%,RIMS1;CPLX1;SNCAIP;SYN1;FMR1;CAMK2A
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.36018880249011925,-1.4280308203180772,0.011705685618729096,0.19178739572542766,1.0,41/122,22.81%,IGF1;NAMPT;BCAR3;VIM;NIBAN1;YTHDF3;INSR;DYRK2;TLR4;DHX9;NFKB1;NLRC5;CIITA;HGF;LARP4B;PRMT1;PCIF1;CD28;LARP4;RPS4X;MTPN;EEF2;XBP1;EIF3E;PCNA;KAT7;PPP1R3E;METTL14;HSPH1;FAF1;SLC6A9;IRS2;DNA2;PDGFRB;DDX3X;NOD2;RBM3;KDR;TMEM106A;IL6;PRKDC
prerank,regulation of mRNA metabolic process (GO:1903311),-0.5938035803384742,-1.4276534618210237,0.07931034482758621,0.19203847586537912,1.0,5/11,29.21%,DHX9;NCBP1;SRPK1;PTCD2;SAFB
prerank,detection of visible light (GO:0009584),-0.556056157169357,-1.427164052872383,0.07118055555555555,0.1924114742882701,1.0,8/16,41.85%,GNA11;ABCA4;RP1;REEP6;GNAQ;CNGB1;CACNA2D4;PDE6B
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5238154750782182,1.4270691651382583,0.06872037914691943,0.2733758465944385,1.0,4/18,3.20%,NLGN1;RIMS2;RIMS1;SYN1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.4733179811577839,-1.426724170692008,0.0625,0.1927119740653043,1.0,9/29,18.70%,RPS21;RPS8;RPS14;NOP14;DHX37;MRPS11;NGDN;UTP6;RPS16
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.47082667286553204,-1.4265696586021217,0.06010016694490818,0.1926909906061754,1.0,17/29,36.85%,STX7;RAET1E;SPI1;STAP1;AP1G1;CYRIB;LAMP1;CD226;SLAMF6;ITGAM;IL12RB1;CRTAM;KLRC2;KLRD1;IL12A;NOS2;IL12B
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5056084990550355,-1.4265058070396248,0.07155322862129145,0.19251942611417314,1.0,5/23,6.74%,PTPRC;CBL;SNX6;TSG101;MVP
prerank,Ras protein signal transduction (GO:0007265),-0.3516836263563638,-1.4262372151874658,0.013008130081300813,0.19264443451881044,1.0,39/137,18.37%,IGF1;GRB2;RREB1;GNB1;RB1;MYO9B;JUN;RAC1;ROCK1;ARHGEF3;RAP1B;USP50;RHOA;EPS8;RAP2B;RAP2A;GRAP2;GNA12;RAP1A;RGL2;USP8;MAPK14;PLK2;CDC42EP2;PLEKHG5;GNA13;ARHGEF11;KSR1;SETDB1;BRK1;CRKL;GRAP;BRAP;CDC42EP3;G3BP1;RALB;KRAS;NRAS;CFL1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.419925701883394,-1.4262132713107052,0.04186795491143317,0.19243224891761715,1.0,14/49,16.21%,LYN;IGF1;IL6R;STAT3;PIBF1;IL15;IL18;PARP14;VEGFA;PARP9;CCL5;CD40;IL31RA;HCLS1
prerank,histone exchange (GO:0043486),-0.4459779131290149,-1.4259926787520758,0.04974271012006861,0.19248912857753528,1.0,15/37,25.88%,SMARCA5;KNL1;MIS18BP1;CENPA;CENPK;CENPN;CENPL;RNF8;SPTY2D1;RBBP4;CENPH;RSF1;CENPP;CENPO;HJURP
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.35669550079727425,-1.4259319472195326,0.010101010101010102,0.19232500987152923,1.0,36/114,22.44%,BIRC3;TNFRSF1B;PSME4;RIPK1;TRAF5;FOXO3;PSMB7;PSME3;PTK2B;AIM2;PSMB9;TRAF3;PSMA8;CD27;RELA;TRAF1;PSMC3;PSMD8;TRAF2;PSMC4;PSMB10;PSMA1;CD40;TMSB4X;IKBKB;PSMB8;TNFRSF25;LIMS1;TRADD;PSMA5;PSMD4;PSMB3;PSMD3;STAT1;TNFSF9;ILK
prerank,manganese ion transport (GO:0006828),0.5447990523570099,1.4257444241867085,0.10386473429951691,0.2744446005905787,1.0,2/14,2.25%,TRPC5;TRPC1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.5479033619714417,-1.4255586838753145,0.08064516129032258,0.19255518685924605,1.0,13/16,38.49%,ITGB2;RHOA;MDK;RELA;IL6;FUT4;ST3GAL4;ETS1;TRAF6;TNF;SELE;SELP;FUT7
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.3673841777017743,-1.4255064858895528,0.011666666666666667,0.19238353508348852,1.0,38/100,24.51%,LYN;IGF1;FGR;CBL;PIK3R5;INSR;IGF1R;PIK3AP1;PIP4K2A;IL18;FLT1;PIK3CB;FN1;HGF;PIK3CG;PTPN6;AGT;NCF1;PIK3CA;CCL5;NLRC3;PIK3CD;HCLS1;IRS2;HCST;PTPN13;PDGFRB;PIP5K1A;MAZ;KDR;PDGFA;HAX1;MAPK1;BECN1;PIP5K1C;FLT3;PPP2R5B;DCN
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.5441436823709538,-1.4254838467243791,0.07001795332136446,0.19216517587927076,1.0,7/16,20.56%,LILRB1;TNFRSF21;TRIB2;FCGR2B;MMP8;AGER;CD274
prerank,pentose-phosphate shunt (GO:0006098),-0.5987454633158865,-1.42509825718008,0.08818011257035648,0.192459026875532,1.0,7/11,29.44%,PGD;DERA;RPE;TKT;PGLS;TALDO1;PGM2
prerank,transcription by RNA polymerase II (GO:0006366),-0.3223102859439039,-1.4246688361963022,0.002976190476190476,0.19281169604486179,1.0,92/305,22.63%,RBPJ;NOTCH2;RREB1;AFF4;CREBBP;DEK;PPARD;NELFB;NFIC;NFX1;NFYA;C5AR1;PPARG;CDK13;MAML1;ARRB2;GTF2A1;CTR9;KLF13;ERCC6;MAML2;E2F2;NFKB1;INTS8;RARG;NABP1;MAF;NR1H2;INTS11;SRRT;TAF6;SNRPG;TBL1XR1;NR2F1;SNRPF;POLR2H;SSU72;POLR2F;E2F3;CBFB;DDX5;POLR2L;NRBF2;SNAPC2;INTS6;HDAC10;INTS14;XBP1;RPRD2;NUDT21;MED4;TRIM24;WDR33;HDAC5;GTF2E2;RXRA;ELOF1;POLR2A;NCBP1;TAF4B;TFCP2;TAF8;NR4A1;INTS1;POLR2G;TAF9;ELP4;TAF3;RARA;TAF1A;SNAPC3;NR3C1;DTX1;PHAX;GMEB2;TAF4;PAPOLA;MED20;ELOC;CPSF3;RTF1;INTS5;MAML3;MAZ;PKNOX1;POLR2I;CCNK;GTF2F2;GTF2A2;NR1H4;ELL2;MED18
prerank,epithelial cell differentiation (GO:0030855),-0.37593247665124074,-1.4245411197976936,0.02640845070422535,0.19274547918768875,1.0,22/88,17.97%,DAB2;CTSB;ANXA4;TAGLN2;PPARG;CPT1A;MAF;ANXA1;JAG1;EDF1;ZDHHC7;VEGFA;SCRIB;CDK1;PCNA;CBR1;RAB10;E2F8;TPP1;TDRD7;PGK1;GATA3
prerank,homotypic cell-cell adhesion (GO:0034109),-0.4406429167819831,-1.4230341363537302,0.04436860068259386,0.19445403096654088,1.0,16/39,22.75%,PLEK;MYH9;RAP2B;FLNA;ACTB;TLN1;PIK3CB;FN1;PIK3CG;TJP2;CLIC1;HSPB1;UBASH3B;FERMT3;ILK;PLPP3
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.4076246520440345,-1.4228434038670703,0.03079416531604538,0.19445617240193974,1.0,15/57,16.21%,LYN;IGF1;IL6R;STAT3;PIBF1;IL15;IL18;PARP14;NF2;VEGFA;PARP9;CCL5;CD40;IL31RA;HCLS1
prerank,protein phosphorylation (GO:0006468),-0.30850880298239225,-1.4224644773536272,0.0,0.1946704101651638,1.0,146/479,23.07%,LYN;PRKCH;FNIP2;MAP3K5;TAOK3;PRKCB;FGR;ABI1;MAPKAPK3;FAM20C;DAPK1;SYK;PAK2;CDK6;PRKCD;ROCK1;MAP4K3;BIRC6;CAMK1D;RUNX3;MAP3K1;ERN1;MAP3K20;INSR;IGF1R;PEAK1;CSNK2A1;TLR7;FES;PRKAG2;VRK2;CDK13;RNASEL;MINK1;RIPK1;MAML1;TLK1;ABL2;MAPKAPK2;SGK1;GRK3;DYRK2;TEC;TLR4;FLT1;PIM1;PTK2B;INCENP;DAPK3;PKDCC;STK3;MAPK14;ULK2;CAB39;CDK18;IRAK3;GAS6;CAMKK2;GRK5;PLK2;VRK3;EIF2AK1;EIF2AK2;COQ8A;STK38;TGFBR1;TRIB1;JAK1;CDK14;NEK6;PTPN6;MASTL;RSKR;MORC3;SIK1;TRIB2;TAOK1;LCK;APP;CDK1;DYRK1A;MAP2K1;PPP4R1;STK11;IGFBP3;HTATIP2;STK17B;FRK;STK24;MKNK1;ACVR2A;PIK3CD;GMFG;TGFBR2;MAST2;MARK2;IKBKB;GMFB;TXK;CCNE1;MAP3K10;TTK;MKNK2;LATS2;STRADA;PNCK;CDKL4;AURKA;ZAP70;RARA;SMAD7;BRD2;PKN3;RYK;HCK;HCST;STK10;PDGFRB;TAOK2;IP6K3;MAK;PAK6;ATM;STK16;CHEK1;BMPR2;CDC42BPG;CDK16;WNK1;GSK3B;COPS8;KDR;CDK5;CSNK1G3;PRKAG1;GRK6;SRPK1;MAP4K4;MAST3;MAPK1;RPS6KA5;ILK;NEK3;PRKDC;TYK2;SMG1
prerank,regulation of establishment of protein localization (GO:0070201),-0.5814819786950047,-1.4219625584722067,0.06822262118491922,0.19508348004120266,1.0,4/13,8.47%,CTSD;SPIDR;CEP295;DNAJA1
prerank,presynapse organization (GO:0099172),0.6010385153496164,1.4218773323056528,0.09582309582309582,0.2795244321922219,1.0,2/10,3.96%,NLGN1;LRRTM3
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.6123349555859903,-1.4218494589473465,0.07207207207207207,0.1949759249383956,1.0,1/10,1.12%,GNB1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5837357725933884,-1.4218443045826306,0.08181818181818182,0.1947350243572254,1.0,4/12,11.08%,ERN1;BCL2L11;ATF6;XBP1
prerank,monocyte chemotaxis (GO:0002548),-0.4608791334136729,-1.4217944543780967,0.059726962457337884,0.19455214363039078,1.0,17/32,39.74%,IL6R;FLT1;ANXA1;CCL5;CALCA;PTPRO;IL6;CCL7;CCL24;CCL4;CCL25;CCL19;PDGFB;CCL8;MSMP;TNFRSF11A;CCL14
prerank,cAMP biosynthetic process (GO:0006171),0.6006701772082469,1.4216230381043407,0.11337868480725624,0.278761252528712,1.0,5/10,8.71%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1
prerank,regulation of membrane repolarization (GO:0060306),0.566818349238668,1.4209335467331041,0.10023310023310024,0.27882096257627187,1.0,3/13,5.76%,AKAP6;CACNA2D1;CASQ2
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.41896342873431214,-1.4205977812154573,0.04553415061295972,0.19589160177743817,1.0,17/48,18.85%,CCR2;LILRB1;TLR8;TLR7;TLR4;IL18;PTPN22;CYRIB;CEBPG;SCRIB;CD2;SLC7A5;TXK;ISG15;IL18R1;CD226;LGALS9
prerank,midbody abscission (GO:0061952),-0.531705749395485,-1.420130039294354,0.0759493670886076,0.19622934779589274,1.0,12/17,26.95%,PDCD6IP;CHMP5;CHMP7;CHMP1A;CHMP2A;KIF20A;CEP55;VPS4A;CHMP4B;CHMP4A;CHMP2B;MITD1
prerank,metal ion homeostasis (GO:0055065),0.42352891740132825,1.4200505240531995,0.0611764705882353,0.2791709490134948,1.0,11/40,16.07%,ANK3;TMTC2;SLC12A2;SLC12A8;SLC12A1;KCNA1;LETM1;SLC12A5;FAM20A;COX11;SNCA
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5762704588273038,1.4199001304985217,0.09750566893424037,0.27833319558079905,1.0,2/12,3.01%,B3GALT1;B3GALT5
prerank,regulation of MAP kinase activity (GO:0043405),-0.3703530036933343,-1.4196951411303895,0.0180623973727422,0.1965569719860071,1.0,25/92,14.89%,LYN;APOE;CD300A;PRKCD;PTPRJ;PIK3R5;HTR2B;FLT1;TSG101;PIK3CB;PIK3CG;IRAK3;EZH2;VEGFA;STK38;TRIB1;ADAM8;TRIB2;SPRY2;AGT;PAQR3;KSR1;CD40;IL34;RGS14
prerank,regulation of neurotransmitter secretion (GO:0046928),0.439438268431549,1.4191793297348816,0.045346062052505964,0.27842828924952273,1.0,8/32,9.24%,RIMS2;RIMS1;CPLX1;SNCAIP;SYN1;FMR1;SYT11;CAMK2A
prerank,focal adhesion assembly (GO:0048041),0.4993762726598338,1.4189103867959276,0.07191011235955057,0.2777871785278616,1.0,7/21,11.91%,SORBS1;ARHGEF7;DLC1;PTPRK;THSD1;TESK2;FERMT2
prerank,positive regulation of neuron projection development (GO:0010976),0.36662804325351595,1.4183382669753843,0.029925187032418952,0.27755019125880337,1.0,24/85,12.33%,MAGI2;LRRC7;TENM3;RIT2;NTRK3;SERPINI1;NTRK2;FUT9;PTN;CUX2;PRKCI;ALK;TOX;PRKD1;BDNF;BMP7;COBL;CAPRIN2;LTK;RELN;DPYSL3;RET;ARHGAP35;VLDLR
prerank,negative regulation of developmental growth (GO:0048640),0.44512339529968054,1.4182361435023654,0.04987531172069826,0.2766690103247672,1.0,7/30,15.44%,MAP2;DCC;TRIM46;WWC1;DUSP10;PTPRS;GDF15
prerank,Golgi organization (GO:0007030),-0.3648489019096435,-1.418033828502104,0.009836065573770493,0.19854352921985588,1.0,38/112,24.21%,ATP8B4;PLEKHM2;VTI1A;GOLGA5;GOLGA8B;PI4K2A;FBXW8;OPTN;CDC42;RAB1A;COG7;ARFGEF1;TMED10;PI4K2B;TRAPPC11;DYM;GOLPH3L;TJAP1;TMED3;CDK1;RAB29;STX5;PLK3;COG2;STX16;VAMP4;LMAN2L;TMED2;ARL1;HUWE1;TMED4;TICAM2;VPS51;BLZF1;TMED5;VMP1;COG4;TRIP11
prerank,embryonic limb morphogenesis (GO:0030326),-0.445073853879886,-1.4173029658668483,0.0632688927943761,0.19933004955887454,1.0,9/34,11.44%,MBNL1;CREBBP;MAP3K20;NIPBL;RARG;LRP6;CTNNB1;SKI;OSR1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.5167847935232439,-1.4171144547946632,0.09317803660565724,0.1993214538683421,1.0,11/20,33.13%,MBTPS2;NFKB1;ADAM9;RELA;PSENEN;HM13;TGFB1;PSEN2;NGFR;TRAF6;RHBDD1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4531227725764586,-1.4170570674434542,0.05935251798561151,0.19915598515130795,1.0,15/34,18.91%,NRP1;ERN1;MAPKAPK2;MT1G;FLT1;ANXA1;MAPK14;VEGFA;ITGB1BP1;SPRY2;RELA;PIK3CA;NR4A1;MAP2K3;HSPB1
prerank,mitotic cell cycle phase transition (GO:0044772),-0.33334872385538733,-1.4165906842597216,0.0,0.1994886785691131,1.0,72/203,23.50%,CDK6;RB1;DNM2;EPS8;OPTN;FBXL17;GSPT1;CNTRL;ANAPC1;GPR132;CCND3;DYNC1H1;FBXW11;CRLF3;CCNY;HAUS5;SDCCAG8;HAUS6;CEP57;PLK2;E2F1;CKAP5;E2F3;CDK14;YWHAE;MASTL;NES;EIF4EBP1;DBF4;PPP2R2D;CDKN3;CEP70;CHMP7;HAUS4;CDC25A;DCTN1;CDK1;CUL4B;HAUS7;CACUL1;PLK3;CUL2;PPP1R12A;CHMP2A;CCNE1;CDC34;ODF2;LATS2;NINL;UBE2C;PCNT;FBXL8;SKP2;AURKA;WEE1;PHLDA1;ANAPC7;CDKN2C;RCC1;FBXL6;MAX;PAFAH1B1;CEP192;CDC25C;CETN2;TUBA4A;CCNF;CHMP4B;CEP41;CCNB1;PPP1CB;PIM2
prerank,regulation of cellular response to stress (GO:0080135),-0.3609587941470859,-1.4156001509747134,0.02218430034129693,0.2005432254458495,1.0,39/115,23.07%,MCL1;CREBBP;NUPR1;ATF3;NUP50;MAPKAPK2;AMFR;MBTPS2;NUP42;ARMT1;NUP88;RAE1;NEK6;YWHAE;NUP205;TPR;HSP90AB1;NUP188;RPA3;MANF;HSPH1;EIF4G1;BAG3;DNAJC2;CLN3;HSPA1A;NUP153;NUP35;SLC38A2;ATM;GSK3B;DNAJB6;NUP107;DNAJC7;NUP62;CEBPB;MAPK1;CRYAB;SMG1
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.6013781619702865,-1.4148069193015858,0.09090909090909091,0.20131624667608128,1.0,4/11,16.92%,UBN1;ASF1B;ASF1A;RBBP4
prerank,protein-containing complex subunit organization (GO:0043933),-0.3649745686789554,-1.414549625921113,0.024232633279483037,0.20141697000073636,1.0,29/109,14.73%,MITF;SKAP2;CD74;WIPF1;PEX14;SNX9;CREBBP;LPXN;SLC2A1;PTK2B;TAPBP;WASL;CAPG;PICALM;DET1;TUBGCP4;REPS2;DARS1;NCKAP1L;NUP205;TRAF1;TPR;CAPZA1;TRAF2;KPNA3;TFAP4;NIFK;CD40;ST13
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.29348196224619805,-1.414516734429628,0.0,0.2012208854539055,1.0,219/807,23.03%,RBPJ;MDFIC;DAB2;MITF;FNIP2;ZEB2;FOXP1;RUNX1;TRPS1;CD38;SP100;RCOR1;RREB1;SDCBP;BCL6;WWP1;MIDEAS;RB1;JUN;PEX14;NIBAN2;ZNF568;MEF2A;CREBBP;ETV6;RUNX3;PPARD;ARID5B;BPTF;BACH1;DNMT3A;BRD7;FLNA;IRF2;ZNF148;SBNO2;NFIC;NFX1;ATF3;PPARG;ELK3;GATAD2A;SPI1;BRCA1;WWP2;PHF21A;ZNF3;CTR9;STAT3;FOXO3;CNOT1;IKZF1;NIPBL;CHD3;SNX6;NFKB1;CNOT2;HHEX;ZBTB21;RUNX2;FBXW11;RARG;PRMT2;SAP30;CENPF;SARS1;SMARCC2;NR1H2;CIITA;CUX1;MDFI;CBFA2T3;SMYD2;ZBTB2;AHR;CTNNB1;TBL1XR1;GAS6;GCFC2;MCPH1;EZH2;RPS14;PBXIP1;JARID2;DPF2;USP9X;WFS1;NR2F1;KDM2A;SKI;VEGFA;BHLHE40;MAP2K5;EED;E2F1;CNBP;FNIP1;SPEN;THAP1;CBFB;PARP9;DDX5;MEF2C;SAP130;TFEC;FOXN3;UBC;RPS27A;PRDX5;SUDS3;HDAC10;CIART;RELA;NEDD4L;TIMELESS;MAF1;XRCC6;FLCN;TCF25;OSR1;CHMP1A;TPR;KLF10;PRDM2;GADD45A;FOXJ1;ZFP57;CHD8;KAT7;CCDC85B;HMGB2;UHRF1;FRK;PLK3;MTA3;IRF2BP2;HDAC5;TGIF1;SP2;RXRA;E2F8;TFAP4;BATF3;SIN3A;CALCA;LIN37;EPC1;DR1;PSPC1;KLF2;ID2;TCF3;YY1;PRMT6;NSD1;MAP3K10;KLF8;ZNF177;BTAF1;PHC3;KMT5A;NRIP1;KLF11;IKZF4;SOX10;UBE2I;ATXN1;VHL;UXT;TAF3;RARA;ATF5;LIMS1;SMAD7;NR3C1;GATA3;MYB;RIPPLY2;SAMD1;ARID5A;MIER1;ID1;RSF1;MDM4;HMGB1;MAX;C1QBP;SUFU;RTF1;CIC;BAP1;CBFA2T2;MAZ;SIRT2;SFRP1;STAT1;GTF2IRD1;LRRFIP1;CDK5;KDM1A;ID3;SMURF2;ZBTB7A;TBX2;HEYL;SNAI2;CEBPB;SET;RPS6KA5;SCMH1;NR1H4;GATAD2B;EID2;HOXD9;CRYAB;NONO;ESR2;SOX7;HDAC8
prerank,lymphocyte mediated immunity (GO:0002449),-0.5823243582632833,-1.4137384613344786,0.09644670050761421,0.2020268400804435,1.0,8/12,33.43%,MYO1G;JAG1;CD46;GNL1;KLRC2;KLRD1;CD8A;SLA2
prerank,negative regulation of receptor binding (GO:1900121),-0.6259391780634878,-1.4134913109667078,0.08873720136518772,0.202124786662773,1.0,3/10,12.32%,B2M;ATP2A3;ADAM15
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.31232790953661255,-1.4132803699763326,0.0,0.20216157183807984,1.0,94/390,15.26%,LYN;NEDD9;CYBB;NRP1;VAV3;MTSS1;IGF1;ATP6V0D2;NAMPT;BCAR3;FGR;ABI1;GRB2;MAPKAPK3;SDCBP;ARPC2;ITSN1;SYK;PAK2;CYBA;AXL;CBL;ATP6V1E1;RAC1;ROCK1;PTPRJ;ACTR2;RHOA;INSR;IGF1R;WASF2;VAV1;FES;MAPKAPK2;ATP6V1A;RASGRP4;STAT3;CDC42;ACTR3;FLT1;TCIRG1;BLNK;PTK2B;STAP1;ACTB;KIF16B;ITGAV;ARPC3;AP3S1;MAPK14;PIK3CB;WASL;HGF;RHOQ;MVP;GALNT3;HNRNPH1;NRP2;CEP57;BAIAP2;POLR2H;VEGFA;AP2A2;SULF2;FRS2;POLR2F;VAV2;POLR2L;ANGPT2;NCKAP1L;ATP6V1G1;SPRED1;LCK;NCF1;NCF4;PSENEN;SPRED2;CRK;ARPC1B;ZNF106;PIK3CA;ARPC1A;NCF2;SHCBP1;FRK;LCP2;ATP6V0B;POLR2A;NCBP1;RGS14;PIK3C2A;RASA1;BRK1;ARPC5
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.6131139394268428,-1.4132747241401262,0.0705244122965642,0.20166971388361704,1.0,4/10,20.25%,MYADM;MAP2K5;MAPK7;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.6131139394268428,-1.4132747241401262,0.0705244122965642,0.20166971388361704,1.0,4/10,20.25%,MYADM;MAP2K5;MAPK7;WNK1
prerank,regulation of JUN kinase activity (GO:0043506),-0.455194756889095,-1.4126467554395759,0.06988352745424292,0.20229869705506062,1.0,10/33,18.15%,SASH1;MAP3K5;TAOK3;PTPN22;DNAJA1;AIDA;TRAF2;MAP3K10;ARHGEF5;RPS3
prerank,protein deacetylation (GO:0006476),-0.43015010897628925,-1.4116978867820207,0.03872053872053872,0.20327166997938143,1.0,12/41,14.02%,RCOR1;MIDEAS;FLNA;MORF4L1;TBL1XR1;SIRT3;SUDS3;HDAC10;RBM14;MTA3;HDAC5;SIN3A
prerank,nucleocytoplasmic transport (GO:0006913),-0.44040428595859754,-1.41143312051991,0.050590219224283306,0.20339915464150485,1.0,17/40,21.29%,BACH2;MALT1;ANP32A;SNRPG;SNRPF;NUP205;HTATIP2;SMN1;NCBP1;GEMIN7;RGS14;SNUPN;ATXN1;PHAX;HNRNPA1;GEMIN6;NXT2
prerank,striated muscle contraction (GO:0006941),0.3914292911622301,1.4110966603595356,0.04288939051918736,0.2869014821924795,1.0,11/53,11.89%,DMD;DTNA;RYR2;SCN2B;CASQ2;TNNI1;TNNT2;MYH7;ATP1B1;TTN;STAC
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.34607767982556475,1.4107458478018953,0.010075566750629723,0.2863595387885719,1.0,36/118,16.13%,ADGRB3;LRRC4C;HECW1;PPFIA2;EFNA5;CDH2;TANC2;HECW2;LZTS1;PAK3;CLASP2;GDNF;WARS1;SRCIN1;SHANK3;KNDC1;ABI2;ADGRA2;TSPAN12;NEDD4;TBX1;EMP2;CDK5R1;SH3D19;BRSK1;FERMT2;TNIK;ARHGAP35;WTIP;SDC2;ARC;SIPA1L1;EPHB3;BMPER;SPARC;PDZD8
prerank,positive regulation of biosynthetic process (GO:0009891),-0.4407482146565642,-1.410693345681033,0.06754530477759473,0.20418697935135735,1.0,11/40,14.18%,APOE;RUNX1;VIM;PLCG2;CYBA;CD36;TLR4;MTPN;ZBTB20;CCL5;SLC5A3
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.4619808317605889,-1.4103461754317643,0.06608695652173913,0.20439758825636561,1.0,15/31,25.73%,LYN;LILRB1;CD300A;RC3H1;TNFRSF21;SDC4;IL4I1;FCGR2B;VSIG4;SPN;ATM;CD274;CEBPB;TNFRSF13B;BLK
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.62265143067546,-1.4090339867829025,0.07903780068728522,0.205970999500769,1.0,4/10,8.66%,ZEB2;MFSD12;ATP7A;CTNS
prerank,protein import (GO:0017038),-0.3703340357649062,-1.4088848366753837,0.010273972602739725,0.20591230903602545,1.0,28/84,22.38%,APOE;RAB8B;SYK;PEX14;IPO5;NUP50;ABCD2;STAT3;LAMP2;PEX26;NUP88;SNX33;E2F3;FIS1;TPR;NUP188;HSPA4;APPL2;ABCD3;NUP153;TOMM22;FAM53A;TNPO3;APPL1;NUP107;NXT2;NUP62;SPRN
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.6134736033327279,-1.4083868724390733,0.0905982905982906,0.20638782941741257,1.0,6/10,22.34%,PIEZO1;DPP4;CCL5;WNK1;FERMT3;CD3E
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.5287353368879756,-1.408209707559,0.09281961471103327,0.20641291889925367,1.0,10/18,22.63%,CBL;SPI1;IL6R;CTR9;STAT3;JAK1;SOCS3;PTPN11;STAT1;IL6
prerank,regulation of phosphorylation (GO:0042325),-0.3553639667106642,-1.408159880283368,0.017684887459807074,0.20623984758730907,1.0,48/120,26.76%,LYN;NRP1;FNIP2;CORO1C;SDCBP;ROCK1;OGT;NUP50;PRKAG2;STAP1;NLRC5;NUP42;FN1;NUP88;RAE1;FNIP1;HIF1A;NCKAP1L;NUP205;PIN1;APP;FLCN;TPR;CCDC88A;JMJD8;CCL5;NUP188;IKBKB;ANG;ANKLE2;CDKN2C;NUP153;HSPB1;NUP35;SIRT2;NUP107;NUP62;PRKAG1;ZBTB7A;INHA;ILK;STAT2;RANBP2;EIF6;CCDC88C;NUP37;FZD7;PML
prerank,protein localization to membrane (GO:0072657),0.32068986898442764,1.4072597340527406,0.01098901098901099,0.29087355540615745,1.0,22/187,4.30%,NLGN1;DLG2;DPP10;KCNIP4;NRXN1;DPP6;MAGI2;LRRC7;KCNB2;ANK3;ANK2;DLG3;RAB3C;MAP7;CACNB2;FRMPD1;TESC;RAB15;EPB41L3;NRXN2;PTN;CLASP2
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.4994152329657839,-1.4057561962860587,0.08163265306122448,0.2092764106044095,1.0,14/24,30.66%,PID1;DAB2;RHOQ;PICALM;ITGB1BP1;PPFIA1;TMEM59;TGFB1;PPP2R5A;LZTFL1;GDI1;INPP5K;BCL2L1;ABI3
prerank,heart development (GO:0007507),0.3267875778470469,1.4055611458982042,0.013513513513513514,0.2924118142152418,1.0,47/150,19.08%,SGCZ;FGF12;CACNA1C;SGCD;PCSK5;ERBB4;NTRK3;ZFPM2;PRICKLE4;SCUBE1;DLC1;ACVR1;WT1;PLCE1;APLN;FLRT3;CACYBP;NDUFV2;SOX9;BMP7;SALL1;SGCG;DNAAF4;MYH7;POU4F2;MYOCD;POPDC2;TBX1;TGFB2;PKD1;EEF1AKMT4-ECE2;ALPK2;EPHB4;PDLIM4;FLRT2;MKKS;ECE1;ERBB3;RAMP2;TGFBR3;PDLIM7;KAT2A;ZDHHC16;RBM20;TEK;FOXC2;PTK2
prerank,regulation of MAPK cascade (GO:0043408),-0.34010021933798684,-1.4051692450173103,0.006482982171799027,0.20985632635348458,1.0,27/157,10.46%,IQGAP1;LYN;PTPRC;TAOK3;IGF1;BCAR3;CD74;P2RX7;SYK;PLCG2;PAK2;ROCK1;PTPRJ;INSR;IGF1R;VRK2;MINK1;RNF41;FLT1;STK3;DUSP3;FN1;LAPTM5;GSDME;PTPN6;SPRED1;TAOK1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.3395053149501408,-1.4050179285099076,0.011475409836065573,0.2097843814511134,1.0,46/166,20.57%,ZEB2;IGF1;BCAR3;VIM;NIBAN1;CD36;YTHDF3;INSR;P2RX4;DYRK2;SLC27A1;TLR4;DHX9;ATP7A;NR1H2;HGF;PAOX;LARP4B;PRMT1;PCIF1;CD28;HIF1A;LARP4;RPS4X;EGR1;ARNT;EEF2;EIF3E;PCNA;KAT7;CCL5;HSP90AB1;PPP1R3E;METTL14;KLF2;FAF1;ASS1;SLC6A9;IRS2;DNA2;MMP8;PDGFRB;DDX3X;LDLR;RBM3;APPL1
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.47148939617725383,-1.4050155317036503,0.05385996409335727,0.20953488566665596,1.0,14/28,25.23%,PRKCD;IPO5;FLNA;TPR;MAVS;BAG3;HCLS1;CHP2;ZC3H12A;JUP;TGFB1;RBM22;TRIM28;ECT2
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.4988462526971869,-1.4047075186728184,0.07666098807495741,0.20974543136926177,1.0,6/22,12.50%,RUNX1;BCL6;MDK;CBFB;CD46;IL4I1
prerank,synaptic vesicle recycling (GO:0036465),0.4415220593985656,1.403860909579015,0.07049608355091384,0.2940512180160058,1.0,12/31,16.97%,NLGN1;SYT1;AMPH;SYNJ2;SYT2;STON1;SYT5;SYT7;PACSIN1;NLGN2;SNCA;RAB3A
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.5317798835557414,-1.4031772639049354,0.07775768535262206,0.21166287171135825,1.0,4/17,8.64%,APOE;ABCG1;MBTPS2;ERLIN1
prerank,regulation of Notch signaling pathway (GO:0008593),-0.37918441439137207,-1.40237220660857,0.023972602739726026,0.21255188474236728,1.0,16/76,12.13%,RBPJ;ZMIZ1;TSPAN14;NIBAN2;CREBBP;MAML1;WWP2;STAT3;MAML2;JAG1;ARRB1;POFUT1;ITGB1BP1;ENHO;RFNG;CD46
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.5393917541402931,-1.401986880527694,0.06712564543889846,0.2128635611273779,1.0,6/16,18.32%,INSR;IGF1R;GSPT1;IRAK3;CLN3;TBC1D25
prerank,cell-substrate junction assembly (GO:0007044),0.4418772654462868,1.4018613045037687,0.05145413870246085,0.2962992308115009,1.0,9/33,11.91%,SORBS1;ARHGEF7;DST;DLC1;PTPRK;THSD1;CD151;TESK2;FERMT2
prerank,carboxylic acid catabolic process (GO:0046395),-0.5762110458983787,-1.4016755075295757,0.0740072202166065,0.2130661187426223,1.0,8/12,26.02%,NPL;GNPDA1;IL4I1;ACOT4;GNPDA2;AMDHD2;RENBP;PON3
prerank,regulation of adaptive immune response (GO:0002819),-0.5248886082210684,-1.4016308428671298,0.07155322862129145,0.21287230380284733,1.0,6/18,14.64%,ADCY7;SASH3;AHR;IL4I1;FCGR2B;SAMSN1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.3823014924236759,-1.4006739691403307,0.02586206896551724,0.21392294193255249,1.0,30/74,31.24%,DAB2;SDCBP;ADIPOR1;GCNT2;CTNNB1;EZH2;SDHAF2;MDK;TGFBR1;TGFB1I1;SPRED1;SPRY2;SPRED2;TGFBR2;GREM1;LDLRAD4;VASN;SMAD7;GATA3;IL17RD;SFRP1;IL6;TGFB1;SMAD4;BMP2;PDPN;LEF1;DAG1;SMAD2;GLIPR2
prerank,mRNA destabilization (GO:0061157),-0.4379830936467422,-1.4003283075764077,0.059602649006622516,0.21412941733077223,1.0,16/38,27.44%,ROCK1;YTHDF3;TUT7;CNOT1;RC3H1;MOV10;FTO;CELF1;METTL14;DHX36;ZC3H12A;TARDBP;PUM1;ZC3H12D;ZFP36L1;METTL3
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.515151281871415,-1.4002305373249728,0.08361204013377926,0.21400594007011053,1.0,5/20,6.87%,PID1;DAB2;PKDCC;RHOQ;PICALM
prerank,mitotic cytokinetic process (GO:1902410),-0.5009895747114821,-1.3998794273112964,0.10070671378091872,0.21419854161737117,1.0,14/20,26.95%,RHOA;PDCD6IP;CHMP5;CHMP7;CHMP1A;CHMP2A;KIF20A;CEP55;VPS4A;CHMP4B;CHMP4A;KLHDC8B;CHMP2B;MITD1
prerank,Notch signaling involved in heart development (GO:0061314),-0.6080362209541339,-1.3997163223562286,0.08680555555555555,0.21414896983865614,1.0,3/11,5.78%,RBPJ;NOTCH2;JAG1
prerank,RNA biosynthetic process (GO:0032774),-0.45846965874733736,-1.3995130639008775,0.08848080133555926,0.21421139609329723,1.0,10/31,19.39%,SMARCA5;TAF6;SMN1;POLR2A;PRIM1;TTF1;NCOA6;TAF4;RSF1;PRIM2
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.491925220727567,-1.3993227143621854,0.0735042735042735,0.21419868583801344,1.0,7/23,18.15%,SASH1;MAP3K5;TAOK3;TRAF2;MAP3K10;ARHGEF5;RPS3
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5687261511264177,-1.3992916574906746,0.08093525179856115,0.213998025477533,1.0,6/13,22.14%,MDFIC;SP100;TPR;NUP153;SUFU;UFM1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.5245993876655511,1.398788291592432,0.09719222462203024,0.3004653151468604,1.0,7/16,16.28%,UPP2;DPYD;DPYS;DPYSL5;DPYSL4;DPYSL3;DPYSL2
prerank,myoblast differentiation (GO:0045445),-0.5566743259410806,-1.3985876060679998,0.08576329331046312,0.21476889725817963,1.0,6/14,9.07%,MBNL1;PLEKHM3;IGF1;RB1;JAG1;DDX5
prerank,mitochondrial genome maintenance (GO:0000002),-0.5883801979754663,-1.3985431984846308,0.09169550173010381,0.2145709665314604,1.0,4/11,15.51%,TOP3A;MEF2A;MPV17;SLC25A4
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.51838784741006,-1.3977886462877245,0.09932659932659933,0.21539640123114073,1.0,8/18,22.23%,GINS3;MCM3;LIG1;PCNA;POLD2;LIG3;RFC3;GINS4
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.6094015892711252,-1.3973344579454667,0.10196779964221825,0.21580039026351444,1.0,5/10,25.55%,OGT;SELENOS;USP7;GNMT;ZNF692
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.5510527235632082,-1.3971671524097902,0.09243697478991597,0.21577129072507154,1.0,8/15,23.56%,ANP32B;GAS6;YWHAE;TPR;BAG3;GSK3B;GTSE1;RBM22
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.4986521567014288,-1.3963992682825432,0.09417808219178082,0.21661716860617017,1.0,11/23,24.97%,DDB2;GPS1;UBC;RPS27A;CUL4B;COPS6;COPS5;COPS4;COPS8;CETN2;DDB1
prerank,RNA export from nucleus (GO:0006405),-0.3601944828107758,-1.3961329873246058,0.028960817717206135,0.2167473840012271,1.0,47/100,32.71%,NUP50;SRRM1;HHEX;NUP42;CHTOP;NUP88;RAE1;CDC40;AGFG1;NUP205;XPO5;UPF2;ALYREF;TPR;NUP188;WDR33;YTHDC1;NCBP1;THOC2;RNPS1;NUP153;THOC6;HNRNPA1;NUP35;MAGOH;SLU7;CPSF3;NUP107;NUP62;SRSF11;SMG1;DDX39B;DHX38;RANBP2;RBM15B;CPSF1;NUP37;U2AF2;SRSF7;AAAS;NUP133;EIF4A3;EIF4E;SRSF5;SARNP;ALKBH5;U2AF1L4
prerank,defense response to fungus (GO:0050832),-0.5372023450943925,-1.3955673014869738,0.0981067125645439,0.21729043899478415,1.0,5/17,12.30%,PLCG2;GAPDH;RNASE7;CLEC4D;CLEC6A
prerank,ureteric bud morphogenesis (GO:0060675),0.5134795323336329,1.3955039803783824,0.07913669064748201,0.3047749812535515,1.0,5/16,9.62%,PAX8;GDNF;WT1;SALL1;CITED1
prerank,retinoic acid metabolic process (GO:0042573),-0.5556255991436472,-1.394545449640273,0.10344827586206896,0.21853693351026404,1.0,8/14,31.70%,BCO2;CYP26C1;ALDH8A1;CYP2S1;UGT1A7;UGT1A8;UGT1A1;SCPEP1
prerank,organelle organization (GO:0006996),-0.3066896078331558,-1.3944765170143483,0.0,0.21836836169548565,1.0,121/388,24.61%,DIAPH1;APOE;NEDD9;ATP8B4;TMCC1;VPS13C;ARHGAP10;PLEKHM2;FGD6;RAB7A;YTHDF3;PEX14;GOLGA5;GOLGA8B;PI4K2A;FBXW8;PDCD6IP;ATXN7;OPTN;STX7;CAPZB;SIPA1;ABCD2;RAB31;SH3KBP1;CDC42;FGD4;PYROXD2;CHMP5;RAB1A;COG7;ATP7A;ARFGEF1;TMED10;RAB3GAP1;FGD3;PI4K2B;PLD2;TRAPPC11;NRF1;WASL;DYM;RAB32;GOLPH3L;SIPA1L3;KIF4A;EPS15;MDK;TJAP1;BCS1L;ATAD3A;TMED3;LARP4;SIRT3;DIAPH3;PACSIN2;SSBP1;CHGA;CHMP7;SYNE3;WDR73;SPRYD3;CHMP1A;TMEM11;SAR1A;MICAL1;FMNL2;RAB29;MICAL2;CXADR;COG2;SEC31A;MAST2;MIA3;CHMP2A;AFG1L;ZMYM6;TFAM;PLAAT3;PEX7;ODF2;NIPSNAP2;LMAN2L;VAPB;ABCD3;STX4;TMED2;RAB34;CEP55;ARL1;HUWE1;CFL1;DOP1B;PAK6;TTC17;TMED4;TICAM2;VPS51;VPS18;VPS4A;CYP26C1;MTX1;BLZF1;FAF2;HAX1;ZRANB1;MAST3;POLG2;CHMP4B;CHMP4A;CNN2;TWNK;TMED5;VMP1;COG4;ATP5F1B;CCL7;TRIP11;CYCS;PTCD2;MYC
prerank,negative regulation of cell junction assembly (GO:1901889),0.45776498187264747,1.394325634432092,0.07537688442211055,0.3056508446485825,1.0,6/25,5.44%,ROBO2;ARHGAP6;SLIT1;CLASP2;DLC1;APOD
prerank,O-glycan processing (GO:0016266),-0.4048629678850896,-1.3939040674255618,0.04436860068259386,0.21889600057625805,1.0,15/54,13.17%,B4GALT5;ST3GAL1;GALNT7;GALNT10;GALNT3;POFUT1;GALNT1;XXYLT1;ST6GAL1;C1GALT1;B3GNT2;GXYLT1;GALNT12;POMGNT1;GCNT1
prerank,mRNA processing (GO:0006397),-0.31607220415650183,-1.393887102069877,0.00625,0.21865645533374733,1.0,106/287,27.45%,ERN1;CTNNBL1;SON;TRA2B;DDX46;SRRM1;HNRNPA3;DHX9;SF3B6;SMU1;SNRNP35;CRNKL1;CHTOP;SRRT;FUS;SNRPG;HNRNPH1;GCFC2;SNRPF;POLR2H;HNRNPL;CDC40;POLR2F;SPEN;CWC22;RBM19;DDX5;RALY;SF3B3;POLR2L;PRPF8;SART1;CMTR2;SF3B5;UBL5;PCBP2;ALYREF;HNRNPUL1;RPRD2;NUDT21;SNRPA;CELF1;RBM14;CWC15;METTL14;RBM10;WDR33;YTHDC1;POLR2A;NCBP1;PSPC1;SART3;ZRSR2;GEMIN7;PDCD7;THOC2;SF3A1;SRSF10;PRPF18;POLR2G;RBM4B;TFIP11;LSM6;RNPS1;WBP11;SNRNP70;TXNL4A;THOC6;HNRNPA1;PAPOLA;MAGOH;SLU7;BUD13;CPSF3;SF3B1;LSM5;POLR2I;HNRNPH2;GEMIN6;PPIL1;XAB2;HNRNPK;GTF2F2;SNU13;SYF2;SRSF11;NONO;MTREX;RBM22;PRPF6;DHX35;DDX39B;DHX38;AKAP8L;GTF2F1;RBM15B;CPSF1;U2AF2;RAMAC;ISY1;HSPA8;TBRG4;WDR83;HNRNPF;METTL3;BUD31
prerank,innate immune response in mucosa (GO:0002227),-0.6066407230730605,-1.3938537127227573,0.09540034071550256,0.21844639603935714,1.0,6/10,39.36%,CAMP;DEFA6;RPL39;LTF;NOS2;RNASE3
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.489931497888977,-1.393763373783573,0.08260105448154657,0.2183307225695452,1.0,6/24,7.83%,NRP1;RAC1;ROCK1;PTPRJ;DUSP3;VEGFA
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.4980179172699385,-1.3937186986092645,0.08460236886632826,0.21812297844768846,1.0,13/21,36.77%,ROCK1;CCR1;SRGN;PTK2B;GAS6;GREM1;ENPP1;TGFB1;HEY2;ASPN;ROCK2;HEY1;FGF23
prerank,regulation of ion transmembrane transport (GO:0034765),0.43796778477707493,1.3935165385955561,0.07125307125307126,0.30588068247670186,1.0,10/33,8.49%,AKAP6;CHRM3;KCNJ3;KCNJ10;AHCYL1;KCNJ6;CASQ2;KCNJ9;KCNJ16;NEDD4
prerank,regulation of secretion (GO:0051046),0.5466943684332308,1.3929190092943042,0.1079136690647482,0.3057777248123921,1.0,8/13,20.54%,NRG1;EGF;MYO6;FGF10;OPRK1;ERBB3;ACSL3;POFUT2
prerank,mitotic DNA replication (GO:1902969),-0.6251687542387478,-1.3927144653136292,0.08732876712328767,0.21937271853626375,1.0,6/10,22.65%,GINS3;MCM6;MCM3;LIG1;MCM2;CDC45
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.4192601840320069,1.392274317886108,0.06100217864923747,0.30578548246691833,1.0,10/39,8.69%,FGF12;ANK2;CHRM3;SCN2B;TCAF1;AHCYL1;PTPN3;HOMER1;NEDD4;FXYD6
prerank,ribosome biogenesis (GO:0042254),-0.3272456220140499,-1.3921415775280255,0.015384615384615385,0.21995450943286043,1.0,74/187,28.42%,RPL7;RPS24;ESF1;MPHOSPH10;RPL36;RPS6;RPL11;ABCE1;RPL10A;DDX49;RPL12;RPS14;EXOSC5;NOP14;RPL32;SENP3;WDR36;NVL;RPS28;NOL6;RPL28;DHX37;KRR1;CUL4B;RPL22;RPL14;RPL34;RPL6;NOLC1;EMG1;DDX31;PAK1IP1;RPL18A;EIF2A;RPL37A;UTP6;RPS9;RPS27;SURF6;MRPL22;RPL23A;RPS16;GTF3A;EXOSC10;RPL9;C1D;RPLP2;NOL9;DDX54;EXOSC4;XRN2;NIP7;RPL41;RPLP0;SNU13;RPL7A;MTREX;RPL19;WDR12;RPS15;RPL39;RCL1;MRM2;RPL5;PDCD11;EIF6;RPL13;IMP4;EXOSC8;NOC2L;RPL18;WDR3;RPL27A;PIH1D2
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.5761650687957964,-1.391990111920667,0.09391304347826086,0.21992819810029854,1.0,2/12,4.21%,PAEP;IL18
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.38187285457048287,-1.3916974765247885,0.04508856682769726,0.22003263432129477,1.0,25/73,19.29%,APAF1;XDH;CRADD;PPARG;RIPK1;CFLAR;NLRC4;ANP32B;HIP1;LAPTM5;CASP4;NOD1;ATP2A3;LCK;HSPE1;CASP1;TRAF2;BBC3;BID;TNFSF10;CASP8;IFT57;TRADD;CASP2;BEX3
prerank,cellular response to chemical stress (GO:0062197),-0.36614704491322214,-1.3913431217985217,0.02702702702702703,0.22034195304680296,1.0,29/96,20.90%,CYBB;LRRC8D;CYBA;NFE2L2;VRK2;FOXO3;SLC25A24;ATG7;NUDT2;MSRA;GSR;SELENOS;PRDX5;NCF1;NCF4;PRDX1;PIK3CA;NCF2;TMEM161A;PRDX2;RAD52;STX4;HSPA1A;DDX3X;ATM;CAT;RBM11;SIRT2;ZC3H12A
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.5710638867260102,-1.3911098743129753,0.10669077757685352,0.22041271224789258,1.0,8/13,23.03%,CANX;STAT3;JAK1;OASL;IL27RA;OAS2;STAT1;TYK2
prerank,regulation of leukocyte migration (GO:0002685),-0.5448296486154133,-1.3904740269332696,0.0727580372250423,0.22107435778535678,1.0,8/16,23.69%,RAC1;ANXA1;VEGFA;NCKAP1L;MIA3;BST1;HMOX1;ADTRP
prerank,regulation of chromosome segregation (GO:0051983),-0.5273541420290317,-1.3903173390883956,0.09540636042402827,0.2210311772471359,1.0,9/16,24.24%,CSNK2A1;PUM2;BUB1;MKI67;KIF2C;HORMAD1;SMC6;PUM1;SMC5
prerank,renal system development (GO:0072001),0.3928062565775911,1.39027023745918,0.05707196029776675,0.30795664925883853,1.0,16/52,11.28%,PCSK5;MME;PAX8;GREB1L;HNF1B;WT1;TRAF3IP1;SALL1;TFAP2A;AGTR1;MYOCD;HAS2;CEP290;TGFB2;PYGO2;PKD1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.37264851999032017,-1.3901954683044024,0.03278688524590164,0.2209609684206947,1.0,23/76,17.95%,ANXA4;IRAK2;SPI1;ARRB2;NLRC5;PRMT2;AIM2;RBCK1;TRAF3;ARRB1;IRAK3;MAP2K5;ERBIN;OTULIN;FOXJ1;NLRC3;NFKBIL1;TMSB4X;NFKBIB;FAF1;USP7;PARP10;CMKLR1
prerank,negative regulation of inflammatory response (GO:0050728),-0.32903361275489196,-1.3900413995505918,0.01597444089456869,0.22090660959477018,1.0,31/182,9.62%,LYN;APOE;AOAH;IGF1;FGR;CD163;MFHAS1;SYK;PLCG2;GNB1;PRKCD;MYH9;RB1;ADCY7;TNFRSF1B;PPARD;METRNL;PPARG;TNFAIP8L2;PTGER4;MAPK14;GNG2;GRN;PLK2;SIRPA;MDK;CYSLTR1;RHBDF2;MAPK7;OTULIN;SELENOS
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.3898000883747713,-1.3898348688909823,0.04088586030664395,0.2210090718376586,1.0,23/61,24.85%,PANK2;PSME4;PRKAG2;PSMB7;PSME3;PSMB9;AZIN1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3;NR1H4;OAZ3;NQO1;PSMB1;FGFR4
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.48427385036729653,-1.3898063792395774,0.07610619469026549,0.2207996909903475,1.0,3/24,1.57%,PRKCH;RUNX1;ROCK1
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.3859225935509373,-1.3892606979810347,0.046511627906976744,0.2213753074284298,1.0,28/64,22.34%,CORO1C;CDK6;CD36;ROCK1;RHOA;PEAK1;PLAU;MINK1;PTK2B;DAPK3;MACF1;JAG1;DUSP3;PIK3CB;UTRN;NF2;SLC9A1;ADAM15;CIB1;RASA1;PLEKHA2;BST1;CSF1;GSK3B;SFRP1;JUP;MAP4K4;CD3E
prerank,histone mRNA catabolic process (GO:0071044),-0.5468142097293284,-1.3888062449634484,0.11092150170648464,0.2218175774901672,1.0,7/15,21.34%,TUT7;DCP2;MTPAP;TENT4B;EXOSC10;ATM;EXOSC4
prerank,regulation of T cell mediated immunity (GO:0002709),-0.6062772098051863,-1.38872506921845,0.09734513274336283,0.22168597687372912,1.0,6/10,29.03%,CCR2;TNFRSF1B;HMGB1;AGER;RIPK3;ZBTB1
prerank,translesion synthesis (GO:0019985),-0.42313644717114485,-1.3886219059662703,0.06108202443280977,0.22156600905928595,1.0,17/42,24.58%,POLE2;RFC1;PRIMPOL;PCLAF;UBC;RPS27A;PCNA;RPA3;RFC2;POLD2;ISG15;PARP10;POLN;RFC3;TRIM25;POLDIP2;POLD4
prerank,cellular response to superoxide (GO:0071451),-0.6158366371024109,-1.3877953047188467,0.1097972972972973,0.22257666423215872,1.0,5/10,25.76%,ATP7A;PRDX1;PRDX2;ADPRS;MT3
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5197748101221281,-1.3877330995558714,0.08545454545454545,0.22241779776578768,1.0,5/17,8.17%,PTPRJ;DGKZ;PTPN22;DUSP3;LAPTM5
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.43843113210017426,-1.3875328259381923,0.06620209059233449,0.22239902995854582,1.0,13/36,22.00%,SDCBP;OGT;UCHL5;RYBP;RPL11;HSP90AB1;WAC;USP7;TAF9;TRIM39;UBXN1;BAG6;EIF3H
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.5681212747072543,-1.3871997155994964,0.10017574692442882,0.22264112780934564,1.0,3/12,10.70%,CD44;GCNT2;LCK
prerank,positive regulation of DNA binding (GO:0043388),-0.4538362814857866,-1.3867841207784315,0.08235294117647059,0.22297843347223298,1.0,14/31,20.67%,IGF1;RB1;NIBAN2;PPARG;EDF1;SKI;NME1;PLAUR;CEBPG;HMGB2;GATA3;MMP8;HMGB1;SIRT2
prerank,response to muscle stretch (GO:0035994),0.5329836533942116,1.3860315838182429,0.09954751131221719,0.31381753732273565,1.0,5/15,11.10%,DMD;RYR2;CDH2;GSN;TTN
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.34602836958995253,-1.3855678744388875,0.028192371475953566,0.22447966583034784,1.0,51/125,25.37%,EML4;KIF3B;KIF11;DYNC1H1;KNL1;INCENP;CENPF;DLGAP5;CENPA;EFHC2;KIF4A;PLK2;SUN2;ZWILCH;CENPE;CENPK;CKAP5;CENPN;NEK6;CENPL;BUB1;TAOK1;TBCE;BUB1B;MAP4;SPC25;NUSAP1;KIF2C;DYNC1LI2;TTK;SGO1;MAD1L1;STIL;PCNT;NUF2;AURKA;RPS27;NDC80;CENPH;RCC1;ERCC6L;PAFAH1B1;NUP107;NSL1;PPP1CC;CENPP;CCNB1;CENPO;SPC24;RANBP2;NUDC
prerank,cell projection organization (GO:0030030),-0.4602248004531159,-1.3847653233238617,0.08536585365853659,0.2253648830497105,1.0,9/30,10.11%,PLEK;RAC1;PARVB;CDC42;ITGB1;RHOQ;CAPG;NCKAP1L;PACSIN2
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.3406097754782454,-1.3846800242056827,0.02384737678855326,0.22522077020556677,1.0,50/153,23.07%,PRKCH;PRKCB;MAPKAPK3;PAK2;PRKCD;ROCK1;CAMK1D;ERN1;CSNK2A1;VRK2;RIPK1;TLK1;MAPKAPK2;SGK1;DYRK2;MAPK14;ULK2;CAB39;GAS6;PLK2;VRK3;STK38;TGFBR1;NEK6;MASTL;MORC3;CDK1;DYRK1A;MKNK1;TGFBR2;MAST2;MARK2;IKBKB;MAP3K10;TTK;MKNK2;LATS2;PNCK;AURKA;PKN3;ATM;WNK1;GSK3B;CDK5;CSNK1G3;MAST3;MAPK1;RPS6KA5;PRKDC;SMG1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.42906464244705955,-1.3842938937614595,0.08153078202995008,0.22550735045546572,1.0,17/40,13.83%,DAB2;CBL;INSR;ANXA2;ARRB2;TBC1D5;WASL;C3;ARRB1;DGKD;HIP1;VEGFA;B2M;CD63;RAB21;SERPINE1;GREM1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.3993920945913385,-1.3842684817010797,0.04401408450704225,0.2250421518131427,1.0,23/50,26.26%,AGO2;NUP50;NUP42;NUP88;RAE1;POLR2H;PUM2;POLR2F;POLR2L;NUP205;TPR;NUP188;POLR2A;EIF4G1;POLR2G;NUP153;NUP35;NUP107;POLR2I;NUP62;PUM1;RANBP2;NUP37
prerank,regulation of gene silencing by RNA (GO:0060966),-0.3993920945913385,-1.3842684817010797,0.04401408450704225,0.2250421518131427,1.0,23/50,26.26%,AGO2;NUP50;NUP42;NUP88;RAE1;POLR2H;PUM2;POLR2F;POLR2L;NUP205;TPR;NUP188;POLR2A;EIF4G1;POLR2G;NUP153;NUP35;NUP107;POLR2I;NUP62;PUM1;RANBP2;NUP37
prerank,regulation of catabolic process (GO:0009894),-0.5115515616072768,-1.384264938818154,0.08121827411167512,0.22479148217744188,1.0,12/18,34.65%,ITGB1;ZDHHC7;NEDD4L;ZDHHC2;FAP;FAF1;FAM83D;FURIN;CENATAC;RARRES2;TMEM9;HGS
prerank,chromatin remodeling at centromere (GO:0031055),-0.45156157629945104,-1.3842588453291216,0.07355516637478109,0.22454417066572016,1.0,13/31,25.88%,SMARCA5;KNL1;MIS18BP1;CENPA;CENPK;CENPN;CENPL;RBBP4;CENPH;RSF1;CENPP;CENPO;HJURP
prerank,mammary gland development (GO:0030879),0.4847847174224147,1.3837353773056686,0.10194174757281553,0.3165412643774157,1.0,6/21,14.32%,NRG1;ERBB4;APLN;OXTR;ARHGAP35;JAK2
prerank,actin crosslink formation (GO:0051764),-0.5756725777166619,-1.3834749560189568,0.09390444810543658,0.2254418281911985,1.0,6/12,11.84%,EPS8;FLNA;GAS2L3;BAIAP2;LCP1;BAIAP2L2
prerank,regulation of protein binding (GO:0043393),-0.3538626022501353,-1.383471577285381,0.02635658914728682,0.22519434091989404,1.0,33/114,21.40%,DAB2;CTSZ;LRP1;PRKCD;ROCK1;PEX14;AMFR;ACTB;STK3;RPL11;PPP1CA;NVL;B2M;ITGB1BP1;NES;PIN1;DERL1;APP;CRK;IFIT1;TMBIM6;IFIT2;HDAC5;MARK2;TFIP11;AURKA;RALB;TMC8;GSK3B;DTX3L;DISC1;KDM1A;RACK1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.41844108948003755,-1.3827495888797903,0.07666098807495741,0.22602526557185793,1.0,13/43,11.63%,GRB2;CBL;RAB7A;PTPRJ;SH3KBP1;CDC42;SNX6;TSG101;DUSP3;MVP;EPS15;SPRY2;STAM2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.48376373409381396,-1.3824300921123673,0.08191126279863481,0.22623611897733542,1.0,7/22,10.78%,IGF1;ROCK1;MEF2A;P2RX4;SLC9A1;AGT;MTPN
prerank,T-helper cell differentiation (GO:0042093),-0.5431400386023771,-1.382205487295154,0.10084033613445378,0.22635907604975805,1.0,4/14,5.95%,FOXP1;ATP7A;PTGER4;BATF
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.35422440919202397,-1.3817820146446338,0.03618421052631579,0.22672848104677112,1.0,38/109,19.99%,INPP4A;PLCG2;PLEK;PI4K2A;PIK3R5;PLBD1;MTM1;PIP4K2A;MTMR10;SLC27A1;SYNJ1;MTMR3;MTMR14;PITPNM1;PI4K2B;PIK3CB;PIK3CG;PI4KB;RAB5A;IMPA1;PIP4P1;MTMR6;PIK3CA;PLCB3;PIK3CD;PLCD1;PLA2G4A;PLAAT3;PIK3C2A;PLEKHA2;PGAP3;PTPN13;PLEKHA4;PDGFRB;IP6K3;PLA2G5;PLA2G12A;PIP5K1A
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5959994838041883,-1.3816340117904478,0.09876543209876543,0.22669000340411752,1.0,4/10,21.24%,NAMPT;TLR4;NOD2;KDR
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5937332689992648,-1.381070852001524,0.08521739130434783,0.22728086946605153,1.0,6/11,20.94%,CANX;STAT3;STAT4;JAK1;IL27RA;STAT1
prerank,regulation of blood coagulation (GO:0030193),-0.462189766234744,-1.380876210261968,0.07432432432432433,0.22732336406918566,1.0,13/27,36.80%,APOE;HPSE;TFPI;FAP;SERPINE1;APOH;ADTRP;ST3GAL4;F2R;F12;CAV1;HRG;FOXA2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.5043181135296316,-1.3803283238597783,0.0986159169550173,0.22792599872042837,1.0,8/18,28.80%,APOE;MSN;CTSC;RNF128;FAF1;ABCA2;VPS11;PTTG1IP
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.2770950000258068,-1.3801833598911677,0.0,0.22791530033735227,1.0,424/1668,22.11%,PID1;RBPJ;DAB2;APOE;MITF;FNIP2;ZMIZ1;ZEB2;FLI1;ELF4;FOXP1;RUNX1;PRKCB;TRPS1;IGF1;BACH2;TFEB;NAMPT;SP100;TCF4;RCOR1;RREB1;SDCBP;ELF2;LILRB1;REL;LITAF;TRAK1;BCL6;TET3;MIDEAS;RB1;JUN;ZNF568;MEF2A;CREBBP;ACTR2;ETV6;DEK;RUNX3;PPARD;OGT;AGO2;ARID5B;ANXA4;BPTF;ZBTB34;BACH1;TOX2;DNMT3A;NFE2L2;BRD7;PHF20;CCNL1;RNF111;IRF2;ZNF148;ARHGEF2;SBNO2;NFIC;BRD4;NFX1;NFYA;ARID1B;ZSCAN12;ATF3;PAXBP1;ATAD2;ELF1;UBP1;PPARG;CDK13;KDM3A;ELK3;GATAD2A;RNASEL;PIAS1;SMARCA5;RIPK1;MAML1;SPI1;BRCA1;WWP2;JMJD1C;PHF21A;ZNF3;ETV1;CTR9;STAT3;KLF13;FOXO3;MAML2;E2F2;CNOT1;IKZF1;LYL1;TLR4;ZSCAN26;ACTR3;IL18;STAT6;DHX9;USF2;NIPBL;CHD3;NFKB1;CNOT2;HHEX;NLRC5;ZBTB21;RUNX2;SMARCD3;RARG;NFATC2IP;SAP30;MLXIP;IRF5;CRLF3;SARS1;MAF;MEF2B;KLF6;SMARCC2;TCF20;NR1H2;MAPK14;CIITA;JAG1;CUX1;BATF;MDFI;SS18;PF4;SMYD2;NRF1;WASL;HGF;TEF;KDM7A;RHOQ;ETV3;LRP6;NFATC3;ARRB1;KDM3B;TAF6;FUS;ZBTB2;MYNN;MED24;AHR;CTNNB1;TBL1XR1;KLF3;MCPH1;EZH2;RPS14;DPF2;USP9X;STAT5B;STAT4;ATF6;PLAC8;WFS1;NR2F1;CREB3L2;KDM2A;SKI;VEGFA;BHLHE40;MAP2K5;EED;E2F1;SSU72;FIZ1;CNBP;ARID1A;ATMIN;RNF4;FNIP1;HELZ2;SPEN;THAP1;WBP2;CEBPG;E2F3;KMT2C;SP110;SLC9A1;CBFB;ITGB1BP1;MEF2D;PARP9;DDX5;HIF1A;MEF2C;SAP130;ATAD2B;TFEC;MAPK7;OLIG2;MRTFB;UBC;RPS27A;ASXL1;SP140;NUCKS1;EGR1;SUDS3;ARNT;HDAC10;BAZ2B;PROX2;TNIP2;RELA;PIN1;PSMC3;NEDD4L;ZNF569;IKZF3;MOV10;ZBTB20;APP;XBP1;CCNL2;XRCC6;FLCN;TCF25;CDK1;ZNF319;OSR1;TPR;CRK;MLLT10;KLF10;MED4;PRDM2;NFE2;GADD45A;KMT2D;IER2;SALL3;FOXJ1;HTATIP2;ZFP57;ARID3B;CHD8;RBM14;IL4I1;FOSL2;MLLT6;KAT7;BAZ1A;TCF7;HMGB2;ZFP41;SERPINE1;ZFX;UHRF1;FRK;ZBED4;PLK3;MED31;MTA3;ACVR2A;TNRC6C;IRF2BP2;HDAC5;TGIF1;SP2;DHX36;RXRA;FOXJ3;CALCOCO1;TET2;CREG1;E2F8;TFAP4;GREM1;BATF3;SIN3A;CRTC3;LIN37;EPC1;PPP1R12A;CD40;DR1;KLF2;ID2;CKAP2;ZBTB46;PPIL4;TCF3;IKBKB;DOT1L;YY1;POU2AF1;INO80;RELB;TXK;ZMIZ2;NSD1;POGZ;TFCP2;MAVS;AATF;MED13L;KLF8;ZNF177;HR;MRGBP;NUFIP1;HCLS1;NR4A1;BRIP1;ZBTB12;KMT5A;NRIP1;KLF11;IRX5;IKZF4;TNIP3;SOX10;PHF20L1;UBE2I;FOXJ2;AGRN;TAF9;ATXN1;ELP4;VHL;KMT2A;UXT;ZBTB25;TAF3;RARA;NFATC1;CSRNP1;ZBTB24;ATF5;MED6;REPIN1;SMAD7;NR3C1;TFE3;BRD2;GATA3;MYB;RIPPLY2;PPARGC1B;ARID5A;TCF12;NCOA6;RBBP8;HTATSF1;PLAG1;GMEB2;SSBP4;MIER1;CASZ1;ID1;RSF1;DDX3X;MEIS3;HOXD8;LMO2;MDM4;NOD2;HMGB1;HMGB3;COPS5;MED20;WDR77;LCORL;ATM;ELOC;DBX2;MAX;CHP2;SP9;KDM5B;C1QBP;LIN9;SUFU;EHF;BMPR2;RTF1;BRD9;CIC;ZFP28;GLMP;MAML3;RLF;MAZ;SIRT2;PKNOX1;ATF7;ZC3H12A;STAT1;JUP;RAI1;ZFP2;POU3F1;GTF2IRD1;LRRFIP1;ZSCAN21;KDM1A;HOXB2;ZKSCAN1;HAX1;HNRNPK;CCNK;NLRP3;ID3;SMURF2;ZBTB7A;TBX2;HEYL;SNAI2;CEBPB;EGR2;BBX;ZNF296;BARX2
prerank,regulation of histone deacetylation (GO:0031063),-0.5661965558469981,-1.3800116151072135,0.08673469387755102,0.22788122007592077,1.0,9/13,35.16%,AKAP8;NIPBL;PRMT6;SPHK2;APLNR;AKAP8L;ZBTB7B;CTBP1;ING2
prerank,cellular response to growth factor stimulus (GO:0071363),-0.3380523098019511,-1.379612596919524,0.013136288998357963,0.22820066133002723,1.0,64/151,26.84%,IQGAP1;NRP1;CD44;ERN1;MAPKAPK2;RAP1A;MT1G;FLT1;PTPN12;RUNX2;ANXA1;MAPK14;DUSP3;HGF;CTNNB1;STAT5B;VEGFA;MAP2K5;TGFBR1;ITGB1BP1;MEF2C;MAPK7;SPRY2;RELA;CCL5;CIB1;CPNE3;EEF1A1;ACVR2A;TGFBR2;KNSTRN;EHD1;STMN2;CRKL;ACAP2;NR4A1;APPL2;MAP2K3;TWF2;LIMS1;SMAD7;NR3C1;PTPN11;PDCD5;HSPB1;BMPR2;NDNF;APPL1;SIRT2;SFRP1;KDR;RACK1;SNAI2;TGFB1;URI1;LRP2;SHC1;RAB35;INPP5K;SMAD4;BMP2;PDE8A;RAPGEF2;ZFP36L1
prerank,sterol metabolic process (GO:0016125),-0.39678042009648246,-1.3793586013356687,0.05123674911660778,0.2283119559492393,1.0,15/60,15.10%,APOE;ABCA1;LIPA;ABCG1;PPARD;PRKAG2;CYP27A1;NSDHL;OSBPL5;PIP4P1;CLN6;CH25H;RXRA;CYP46A1;FDXR
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.44731466180903184,-1.3791599978877447,0.07439446366782007,0.2283173424274097,1.0,13/33,21.47%,RUNX1;CD74;FES;RIPK1;CCR1;PF4;ACIN1;ID2;IL34;HCLS1;CASP8;CSF1;HAX1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5968622506527159,-1.3780841102705539,0.09281961471103327,0.22964269158013711,1.0,3/10,4.50%,LRP1;PTPRJ;PTPN12
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5423448980957952,1.3780383607736046,0.10462287104622871,0.3251815137956326,1.0,9/13,25.62%,SAR1B;INSIG1;TMEM30A;GCC2;TM9SF4;CD81;SORL1;SEC16A;BRSK2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5254742518999465,-1.3775564153266904,0.10445205479452055,0.2301422282830046,1.0,5/17,13.47%,SASH1;CD36;TRIB1;LY96;NFKBIL1
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.47466997982729664,-1.3771469495968038,0.09106830122591944,0.23047927455277828,1.0,8/24,14.13%,LYN;CCR2;ANO6;CCR1;CCL5;SERPINE1;GREM1;PLA2G7
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.3719528607250371,-1.3770542671005124,0.04006968641114982,0.23036611544581131,1.0,29/83,20.15%,CDK6;RB1;BACH1;BRD4;GSPT1;GPR132;CRLF3;CDK18;PLK2;E2F1;E2F3;CDK14;EIF4EBP1;DBF4;CDKN3;CDC25A;PCNA;CUL4B;CACUL1;PLK3;CUL2;CCNE1;CDC34;LATS2;KLF11;CDKN2C;RCC1;MAX;CDK16
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3706922383082872,1.376133983854906,0.05263157894736842,0.3274072049417504,1.0,9/65,5.80%,KCND2;RORA;SLC8A3;SCN2A;TIGAR;FMN2;SUV39H1;TSC1;OPRD1
prerank,cellular response to interleukin-1 (GO:0071347),-0.3389707654531095,-1.3760779390666757,0.02264808362369338,0.23152503735899446,1.0,47/143,24.20%,MAP3K8;PSME4;IRAK2;TAB2;PELI1;PSMB7;PSME3;RC3H1;NFKB1;FBXW11;IRAK4;PSMB9;IRAK3;SIRPA;MYD88;NOD1;HIF1A;PSMA8;UBC;RPS27A;GBP2;EGR1;TNIP2;RELA;PSMC3;PSMD8;CCL5;PSMC4;PSMB10;PSMA1;CD40;IKBKB;PSMB8;IL1R2;GBP3;NOD2;PSMA5;PSMD4;PSMB3;PSMD3;SFRP1;ZC3H12A;RPS6KA5;CD47;MAP3K3;CCL7;PSMB1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5650806904487716,-1.3753882018673829,0.09215017064846416,0.2323188089150408,1.0,4/12,6.87%,APOE;ROCK1;TMED10;PICALM
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.4861491444286933,-1.374908396555436,0.08056042031523643,0.23275817051043265,1.0,8/25,8.89%,PTPRC;RUNX1;CCR2;PLCG2;MALT1;CARD11;ANXA1;CD28
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.5894446664511417,-1.3743753663062732,0.11301369863013698,0.23323736662809794,1.0,3/11,5.20%,ABCB7;ABCD2;COA8
prerank,cellular iron ion homeostasis (GO:0006879),-0.39270881447556333,-1.3740802168473287,0.04201680672268908,0.23339487443439197,1.0,31/55,42.08%,FTL;IREB2;ABCB7;FRRS1;ATP6V1A;TMEM199;HMOX2;FLVCR1;ATP6V1G1;CP;SLC11A2;ATP6V0D1;CYB561A3;HMOX1;FTH1;MYC;SMAD4;LCN2;ATP13A2;ATP6AP1;SLC11A1;ABCB6;TFR2;HAMP;GLRX3;CCDC115;NEDD8;CUL1;ACO1;NUBP1;HFE
prerank,Golgi to plasma membrane transport (GO:0006893),-0.40801594654232426,-1.3737617076122914,0.06608695652173913,0.233619891638422,1.0,20/47,21.25%,OPTN;GOLGA4;RAB31;GGA3;MACF1;EXOC4;GOLPH3L;OSBPL5;VPS35L;SYS1;RABEP1;ARFGEF2;RAB10;ARL3;VAMP4;EXOC2;RAB34;EXOC6;GOLGA7;BLZF1
prerank,JNK cascade (GO:0007254),-0.42335115703242704,-1.3731578185164333,0.0673758865248227,0.23420094437155659,1.0,11/40,9.70%,MAP3K5;MAP4K3;MINK1;IRAK2;TAB2;PTGER4;GPS1;TRIB1;NOD1;UBC;RPS27A
prerank,positive regulation of cellular respiration (GO:1901857),-0.5959022542549376,-1.3729121090968621,0.10217755443886097,0.234317605729012,1.0,3/11,11.52%,NUPR1;IL10RB;IFNAR1
prerank,protein localization to vacuole (GO:0072665),-0.5461831681418967,-1.3720000318900016,0.11403508771929824,0.2354173912781922,1.0,8/13,34.24%,MFSD1;RNF128;SH3GLB1;LMBRD1;GLMP;KPTN;ATP13A2;SH3BP4
prerank,regulation of protein kinase A signaling (GO:0010738),0.47338887816795755,1.371418927481074,0.09263657957244656,0.3347082679892742,1.0,9/20,24.60%,AKAP6;RAMP3;ADGRV1;PJA2;PRKAR1A;IAPP;PRKAR2B;PRKAR1B;LRRK2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.49612582073563694,1.3710505469461394,0.10114942528735632,0.3341750566277576,1.0,7/18,10.87%,ADCY8;EPHA5;OPRD1;PRKD1;CD200;ADCY1;RELN
prerank,stem cell development (GO:0048864),0.5203847727443631,1.3710316217669596,0.12189054726368159,0.33300990222185256,1.0,4/16,4.88%,NRG1;SOX11;CDH2;PDCD6
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.42429044537809235,-1.3702640446525978,0.07347670250896057,0.23769569306553687,1.0,12/39,11.63%,GRB2;CBL;PTPRJ;SH3KBP1;CDC42;PTPN12;TSG101;DUSP3;MVP;EPS15;SPRY2;STAM2
prerank,outflow tract septum morphogenesis (GO:0003148),0.4569061887660787,1.370040947067201,0.09296482412060302,0.3335432853314033,1.0,6/24,10.93%,ROBO1;ROBO2;ZFPM2;ACVR1;TBX1;TGFB2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.46476095262480155,-1.36997302631423,0.08419243986254296,0.2378634854239993,1.0,4/26,4.11%,LILRB3;CDK6;GPR137B;TLR4
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5826272429972525,1.3696814064144163,0.12037037037037036,0.33292602048541087,1.0,5/10,20.86%,ADGRV1;TSKU;WHRN;PDZD7;PLS1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.5203817783960666,-1.3692674822094764,0.1001788908765653,0.23866187791318325,1.0,8/16,20.76%,RB1;NIPBL;NAA50;MAU2;POGZ;SGO1;SMC1A;PDS5B
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.41279457045505946,-1.368826756924529,0.05040650406504065,0.23906797026887908,1.0,21/42,43.28%,CCR2;CCR1;PTK2B;PF4;CCL5;CIB1;WNK1;CCL7;CCL24;CCL4;CCL25;CCL19;ACKR3;CCL8;CXCL9;CXCL1;SH2B3;CCL14;RBM15;CXCL10;OXSR1
prerank,mesenchymal to epithelial transition (GO:0060231),0.571738437430169,1.3687851870605485,0.11031175059952038,0.3332902456572607,1.0,4/10,9.62%,PAX8;WT1;SALL1;CITED1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.5879932556459699,-1.3686271868734494,0.08149405772495756,0.23884948314595747,1.0,6/10,36.09%,CDC42;CDC42EP2;CDC42EP3;CDC42EP5;APC;CCR7
prerank,regulation of pseudopodium assembly (GO:0031272),-0.5879932556459699,-1.3686271868734494,0.08149405772495756,0.23884948314595747,1.0,6/10,36.09%,CDC42;CDC42EP2;CDC42EP3;CDC42EP5;APC;CCR7
prerank,positive regulation of integrin activation (GO:0033625),-0.5849439364866904,-1.368521545129547,0.11403508771929824,0.23874529443189077,1.0,3/11,2.79%,PLEK;RAP1B;PIEZO1
prerank,prostanoid biosynthetic process (GO:0046457),-0.5326944551606669,-1.368506282333137,0.10086956521739131,0.23850992474330793,1.0,4/15,14.49%,TBXAS1;CD74;DAGLB;PLA2G4A
prerank,plasma membrane tubulation (GO:0097320),-0.5586619002624634,-1.3684769351700132,0.08620689655172414,0.23829113941230842,1.0,9/13,32.17%,SNX9;SNX33;PACSIN2;BIN3;CHMP4A;MICALL1;PACSIN3;WHAMM;CAVIN2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.5832676417586079,-1.368289192675354,0.10892857142857143,0.23834443940318495,1.0,6/11,27.64%,RC3H1;ANXA1;SMAD7;ZC3H12A;SOCS5;TBX21
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.34065010799333645,-1.3679756988741514,0.0208,0.23855399841475486,1.0,34/150,13.40%,OSBPL8;GRB2;GAB2;MFHAS1;AXL;RAC1;PTPRJ;HPSE;PIK3R5;INSR;IGF1R;P2RX4;PIK3AP1;VAV1;IL18;ITGB1;PIK3CB;HGF;PIK3CG;GCNT2;GAS6;HIP1;FRS2;TGFBR1;CD28;ITGB1BP1;ADAM8;SPRY2;LCK;STRN;PIK3CA;F7;HSP90AB1;PIK3CD
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.3706131845642092,-1.3673940021808717,0.06158833063209076,0.23924106528169692,1.0,32/72,27.61%,ERCC6;RFC1;GPS1;POLR2H;POLR2F;POLR2L;UBC;RPS27A;LIG1;PCNA;CUL4B;COPS6;RPA3;RFC2;POLR2A;POLD2;ERCC4;LIG3;HMGN1;USP7;POLR2G;COPS5;RFC3;COPS4;COPS8;POLR2I;XAB2;POLD4;DDB1;XRCC1;ISY1;EP300
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.5046321951473759,-1.3668991111850686,0.09719934102141681,0.23971993170105713,1.0,9/20,22.63%,MALT1;IL18;RSAD2;B2M;TRAF2;IL18R1;DENND1B;NLRP3;IL6
prerank,regulation of cell killing (GO:0031341),-0.5215707627255711,-1.3667117341924853,0.1132404181184669,0.23975413982652066,1.0,2/16,1.55%,CYBA;RAC1
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.5294579542297275,-1.3660349993127303,0.1103202846975089,0.2404816038416498,1.0,11/15,40.70%,PRKCD;SIRT3;SPHK2;PLA2G6;RACK1;SAMD8;ORMDL2;ORMDL3;TNF;SPHK1;ORMDL1
prerank,granulocyte differentiation (GO:0030851),-0.5091261908658877,-1.3658937084882143,0.10571923743500866,0.24045509748356733,1.0,9/18,28.56%,DEK;SPI1;CBFA2T3;E2F1;RXRA;RARA;PML;EP300;LEF1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.448946762716792,1.3657727153292014,0.09198113207547169,0.337696999046593,1.0,5/25,3.38%,B3GALT1;FUT9;NDST4;B3GALT5;NDST3
prerank,sensory perception (GO:0007600),0.40393675039734706,1.3652326102556513,0.07906976744186046,0.337450573975011,1.0,20/45,17.27%,PCDH15;TMEM150C;MME;PNOC;TTC8;SCN9A;ADGRV1;WHRN;PDYN;CLRN1;KCNA2;USH2A;GNAL;OPRK1;CHRNA7;PENK;OPRL1;OPRM1;SCN10A;NIPSNAP1
prerank,amyloid fibril formation (GO:1990000),-0.40801668412552144,-1.3651773267408671,0.07705479452054795,0.24124530805553632,1.0,14/51,15.44%,TSPAN14;CD36;RIPK1;GGA3;TGFBI;USP9X;B2M;UBC;RPS27A;APP;PSENEN;CALCA;MFGE8;CST3
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.5355911261054482,-1.3650750710599888,0.1094017094017094,0.24113977552528165,1.0,6/15,16.54%,SAMHD1;YTHDF3;USP18;NLRC5;OAS3;ISG15
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.5539777831598629,-1.3649397746412,0.09982788296041308,0.24109277188464734,1.0,6/13,24.87%,KPNA4;IPO5;KPNA3;CBLB;NUP35;RANBP2
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.5073749668091969,-1.364867175004277,0.10896309314586995,0.24093865525374564,1.0,9/19,22.16%,MPP1;CAMK1D;MDK;CCL5;IL34;BST1;CMKLR1;CSF1;MAPK1
prerank,negative regulation of biosynthetic process (GO:0009890),-0.5269994451226029,-1.3647574637170572,0.10676156583629894,0.24085891270472493,1.0,4/16,5.76%,ABCB7;ABCD2;COA8;CIITA
prerank,embryonic organ morphogenesis (GO:0048562),0.4009488665611869,1.3647200468826783,0.05867970660146699,0.33718451325111254,1.0,12/42,17.23%,RYR2;HOXC4;SOX11;ACVR1;DSCAML1;HOXD3;NEUROD1;TBX1;HOXC9;HES1;FUZ;ALDH1A3
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5015980735361605,-1.3646915505921724,0.08465608465608465,0.2406882061566086,1.0,7/19,14.66%,APOE;IGF1;ROCK1;GGA3;PICALM;PIN1;FLOT2
prerank,mitochondrial protein processing (GO:0034982),0.5625795271833571,1.3641756150112159,0.11943793911007025,0.33703630320824624,1.0,4/11,11.39%,OMA1;ATP23;IMMP1L;PMPCB
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5047648086112634,-1.363806550576551,0.09169550173010381,0.2418108580608201,1.0,7/18,15.91%,ITGA4;ROCK1;ITGB1;ITGB7;PODXL2;GCNT1;SPN
prerank,regulation of JNK cascade (GO:0046328),-0.35215079035512264,-1.363505716275471,0.03161397670549085,0.24196767409534276,1.0,30/101,19.94%,MAP3K5;TAOK3;SDCBP;MFHAS1;IGF1R;RAP2A;MINK1;RIPK1;TRAF5;PTK2B;DUSP3;AXIN1;TRAF3;SIRPA;CD27;TAOK1;TRAF1;NCF1;APP;AIDA;GADD45A;FCGR2B;TRAF2;MAP3K10;MMP8;TAOK2;NOD2;HMGB1;COPS5;AGER
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.467201514394545,-1.3632238320477708,0.10178571428571428,0.24214522044634393,1.0,11/25,27.14%,TRA2B;SRRM1;MPHOSPH10;SF3B3;PRPF8;SRSF10;TXNL4A;SLU7;SF3B1;PRPF6;WDR83
prerank,cell chemotaxis (GO:0060326),-0.393489845597916,-1.3629653021894965,0.05555555555555555,0.24227241210981904,1.0,16/60,19.99%,NRP1;CCR2;PRKCD;ARRB2;CCR1;HGF;VEGFA;ABCC1;PLEKHG5;CCRL2;HMGB2;CXCR4;RAB13;NR4A1;PDGFRB;PIP5K1A
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4592208424752842,-1.362402116644186,0.10434782608695652,0.2428092261583397,1.0,5/27,4.70%,PID1;PRKCB;PRKCD;PIP4K2A;PTPRE
prerank,intestinal lipid absorption (GO:0098856),-0.5834224491699811,-1.3620785934326511,0.11952861952861953,0.24306536474320542,1.0,3/11,19.56%,CD36;LIMA1;LDLR
prerank,positive regulation of coagulation (GO:0050820),-0.5999078034910789,-1.361684658635187,0.10942760942760943,0.24314123102370563,1.0,6/10,32.22%,HPSE;SERPINE1;APOH;ST3GAL4;F2R;F12
prerank,positive regulation of hemostasis (GO:1900048),-0.5999078034910789,-1.361684658635187,0.10942760942760943,0.24314123102370563,1.0,6/10,32.22%,HPSE;SERPINE1;APOH;ST3GAL4;F2R;F12
prerank,regulation of developmental growth (GO:0048638),-0.45278818681832145,-1.3597587700594957,0.08532423208191127,0.24583074030199067,1.0,9/29,16.15%,APOE;IGF1;DNM2;INSR;NIPBL;STAT5B;APP;SIN3A;LATS2
prerank,membrane protein proteolysis (GO:0033619),-0.42482107814192466,-1.3594708274635214,0.07974481658692185,0.24597282142267965,1.0,18/37,33.38%,MYH9;MBTPS2;NFKB1;ADAM9;CTSH;RELA;PSENEN;HM13;ADAM19;TGFB1;PSEN2;PRTN3;BACE1;NGFR;DAG1;TRAF6;RHBDD1;ERAP1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5110665326265194,1.3592484294757645,0.09975669099756691,0.3448021456557383,1.0,5/16,10.93%,SOX5;SOX6;PTN;SOX9;TGFB2
prerank,regulation of establishment of planar polarity (GO:0090175),-0.36391423855826965,-1.3589460436399357,0.0391156462585034,0.2465728039888754,1.0,36/88,28.30%,RAC1;RHOA;PSME4;ARRB2;PSMB7;CDC42;PSME3;PSMB9;AP2A2;VANGL1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;SPEF1;PSMA1;VANGL2;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3;SMURF2;DVL2;PSMB1;PKHD1;AP2S1;PFN1;FZD1;FZD7;SMURF1;AP2A1;DAAM1;CELSR1;PSMA7
prerank,diol biosynthetic process (GO:0034312),-0.5296578130432026,-1.3588378154506697,0.1020066889632107,0.24649211362578646,1.0,8/15,25.06%,SPTLC2;ACER3;GCH1;SPHK2;QDPR;SPTLC3;ASAH1;ABCA2
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5512958623751305,1.357952474347374,0.12437810945273632,0.3458646085720652,1.0,2/11,2.57%,CACNA2D1;CACNB2
prerank,regulation of cardiac muscle contraction (GO:0055117),0.4099296836718039,1.3569982507698886,0.08663366336633663,0.3464582665859553,1.0,9/34,13.07%,PDE4B;ANK2;RYR2;PDE4D;ATP1B1;CALM1;ADRA1A;CALM3;CALM2
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.4211165680392803,-1.3568977694129674,0.07081174438687392,0.24913155248050364,1.0,16/39,25.15%,RPS24;RIOK3;RPS6;ERAL1;RPS14;NOP14;RPS28;MRPS11;EMG1;LSM6;RPS27;SURF6;RPS16;SNU13;RPS15;MRPS7
prerank,regulation of superoxide anion generation (GO:0032928),-0.5394006413919706,-1.3564324442436266,0.11733800350262696,0.24954672660865818,1.0,8/14,28.40%,SYK;PRKCD;ITGB2;AATF;TGFB1;ITGAM;CD177;FPR2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5280796208547036,-1.3558537378904567,0.1166077738515901,0.25014301413468054,1.0,4/15,7.23%,DAB2;PIK3CB;WASL;DGKD
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5532855695218805,-1.355624187005044,0.1335559265442404,0.250264076082197,1.0,5/12,14.50%,CBL;PTPRJ;IFT20;F7;CBLB
prerank,negative regulation of defense response (GO:0031348),-0.3698522311412551,-1.355346092243058,0.043327556325823226,0.250432879206516,1.0,17/77,9.62%,APOE;AOAH;MFHAS1;PRKCD;RB1;PPARD;METRNL;PPARG;DHX58;TNFAIP8L2;PTGER4;IRAK3;PPM1B;SIRPA;MAPK7;OTULIN;SELENOS
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5109727425479602,1.3551366753268153,0.12857142857142856,0.34876562931080873,1.0,10/16,26.01%,ANK2;RYR2;BCAP29;BCAP31;TAPT1;GABARAPL2;HSPA5;SEC16A;LRRK2;GBF1
prerank,cellular protein catabolic process (GO:0044257),-0.38539465697781583,-1.3550448229520524,0.05351170568561873,0.2506013277024227,1.0,19/59,18.40%,CTSB;CTSZ;RAB7A;MALT1;RIPK1;MYLIP;TCIRG1;AP2A2;CTSC;RNF123;CTSH;FAP;CTSS;AFG1L;DENND3;UBE2G1;BNIP3L;CASP8;RAB12
prerank,tRNA modification (GO:0006400),-0.379579962322039,-1.354990776635377,0.07321131447587355,0.25043804071591236,1.0,21/62,24.42%,OSGEP;METTL1;ELP5;PUS7;ALKBH1;ANKRD16;PUS1;TRMT44;QTRT1;MOCS3;METTL6;TRMT6;ADAT2;TYW5;AARS1;THUMPD1;BCDIN3D;METTL2B;METTL2A;TYW1;THADA
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.47108142124193914,1.3548931277293867,0.12289156626506025,0.34799377643469026,1.0,10/22,20.35%,PDE4B;DMD;CACNB2;GNB5;FMR1;STAC;CBARP;CRHR1;GPR35;CACNB3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.43996273860503177,1.3548473136684858,0.10375275938189846,0.3468702888576006,1.0,6/27,5.24%,TMEFF2;TJP1;ARHGAP6;CLASP2;DLC1;SHANK3
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5811125127509071,-1.3548372545604062,0.10110294117647059,0.25039276850908176,1.0,3/11,0.83%,CD44;CORO1C;RREB1
prerank,sphingosine metabolic process (GO:0006670),-0.5105801289375305,-1.3545602791593416,0.11327433628318584,0.25056460509786693,1.0,12/17,40.35%,SPTLC2;ACER3;SPHK2;SPTLC3;ASAH1;PLPP3;ABCA2;ACER2;SPHK1;PLPP2;PLPP1;SGPP1
prerank,neural tube development (GO:0021915),0.5083746081389828,1.354294099842409,0.12652068126520682,0.3467154589788157,1.0,4/15,11.92%,SOX11;ARL13B;PKD1;HES5
prerank,positive regulation of cell migration (GO:0030335),-0.3100460138036726,-1.353334614077711,0.010494752623688156,0.25221358871443755,1.0,76/253,21.91%,DAB2;PTPRC;NEDD9;NRP1;IGF1;FGR;RREB1;CCR2;SDCBP;PLCG2;MGAT5;AGO2;INSR;IGF1R;ARHGEF2;PLAU;S100A11;STAT3;CCR1;FLT1;NIPBL;ITGB1;PTK2B;RUFY3;KIF20B;ADAM9;ELP5;SEMA4A;FN1;DOCK5;HGF;MYADM;GCNT2;GRN;SUN2;VEGFA;CBLL1;MDK;TGFBR1;HIF1A;CTSH;NCKAP1L;SPRY2;ITGAX;XBP1;ARHGEF39;F7;CXCL16;CCL5;CIB1;CPNE3;SEMA4B;PIK3CD;MIA3;SEMA3D;CRKL;STX4;CLDN1;SPAG9;PDGFRB;TRADD;F10;ATM;CSF1;C1QBP;BMPR2;RAB11A;MAZ;FERMT3;KDR;PDGFA;RACK1;SEMA3B;SMURF2;SNAI2;MAP4K4
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.4019667508636419,-1.3530954945476281,0.08013937282229965,0.2523019533840402,1.0,17/52,21.55%,CNOT4;DCP1A;TUT7;CNOT1;RC3H1;CNOT2;PATL1;EXOSC5;DCP2;PAN3;CNOT6L;LSM6;CNOT8;DDX6;LSM5;EXOSC4;PNLDC1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.33452731621308235,-1.3529559740266752,0.030405405405405407,0.25223045818562334,1.0,47/145,22.46%,RAD51B;BRD4;PSME4;PSMB7;CNTRL;PSME3;GPR132;DYNC1H1;CENPF;HAUS5;PSMB9;SDCCAG8;HAUS6;CEP57;CKAP5;YWHAE;PSMA8;TPX2;PSMC3;KIF14;CEP70;HAUS4;CDC25A;DCTN1;CDK1;PSMD8;HAUS7;PSMC4;PSMB10;AVEN;PSMA1;ODF2;NINL;PSMB8;PCNT;AURKA;PSMA5;PSMD4;PAFAH1B1;PSMB3;RAB11A;PSMD3;CEP192;CDC25C;CETN2;TUBA4A;CEP41
prerank,dendritic cell migration (GO:0036336),-0.5255824928590253,-1.3526961228383094,0.11226252158894647,0.25239194361381395,1.0,7/16,19.36%,CCR2;EPS8;CCR1;PIK3CG;CCL5;CXCR4;HMGB1
prerank,pre-replicative complex assembly (GO:0036388),-0.37696796588140274,-1.3526599378586877,0.06608695652173913,0.2521894313753259,1.0,21/64,20.83%,PSME4;PSMB7;PSME3;PSMB9;MCM6;PSMA8;UBC;RPS27A;MCM3;PSMC3;PSMD8;ORC5;PSMC4;PSMB10;PSMA1;MCM2;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.4407221554341413,-1.3522212890846412,0.08600337268128162,0.25260864407691447,1.0,10/33,11.72%,BCAR3;CBL;ARAP1;DGKD;HIP1;PLAUR;AFAP1L2;AGT;NCF1;CCDC88A
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.4373050178291229,1.3521186911461995,0.08413461538461539,0.34951289443324757,1.0,8/28,17.35%,MAP2;MAP1B;MAPRE3;CLASP2;GAS2L2;ARL2;PRUNE1;MAP1A
prerank,insulin secretion (GO:0030073),0.47961711048542344,1.3517999120568236,0.12009237875288684,0.34890503231190795,1.0,4/19,10.49%,RIMS2;PTPRN2;MAFA;NEUROD1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.46940588288543666,-1.3516253240116354,0.11827956989247312,0.25326678477444375,1.0,10/24,21.40%,NR1H2;TXNDC12;WFS1;SELENOS;XBP1;TMBIM6;HSPA1A;UBXN1;LPCAT3;RACK1
prerank,regulation of interleukin-13 production (GO:0032656),-0.5482882388556671,-1.3512876430808558,0.10869565217391304,0.2535482200906844,1.0,7/13,18.85%,IL18;TNFRSF21;SPHK2;RARA;LILRA5;GATA3;LGALS9
prerank,regulation of autophagosome maturation (GO:1901096),-0.560808085340511,-1.3511339286970938,0.11876075731497418,0.2535142677754383,1.0,5/13,18.81%,UVRAG;UBQLN4;CLN3;TBC1D25;ADRB2
prerank,regulation of cellular response to heat (GO:1900034),-0.36393168133077186,-1.3509223709754576,0.047619047619047616,0.25359671694254654,1.0,30/77,27.61%,CREBBP;NUP50;MAPKAPK2;NUP42;NUP88;RAE1;YWHAE;NUP205;TPR;HSP90AB1;NUP188;RPA3;HSPH1;BAG3;DNAJC2;HSPA1A;NUP153;NUP35;ATM;GSK3B;DNAJB6;NUP107;DNAJC7;NUP62;MAPK1;CRYAB;RANBP2;NUP37;HSPA8;EP300
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5049489984338917,1.3503117231044004,0.11163895486935867,0.3504093400947693,1.0,2/17,1.17%,ANK2;RYR2
prerank,regulation of cell-cell adhesion (GO:0022407),0.41313032935035865,1.350200001207668,0.07783018867924528,0.34944025947519325,1.0,7/39,4.11%,PTPRG;TENM3;EFNA5;PTPRR;FUT9;EPHA7;AFDN
prerank,negative regulation of translational initiation (GO:0045947),-0.5495128663977764,-1.3499352249539323,0.11827956989247312,0.2548334400569643,1.0,6/13,11.55%,AGO2;EIF2AK1;EIF4EBP1;EIF4EBP2;EIF3E;TPR
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.5238511730289658,-1.349800704246848,0.12852112676056338,0.2547842310759328,1.0,10/15,36.48%,KYNU;KMO;KYAT1;IL4I1;QDPR;IDO2;HGD;FAH;HAAO;TAT
prerank,hyaluronan catabolic process (GO:0030214),-0.5057527220324629,-1.3496257269853296,0.12056737588652482,0.25478100223935723,1.0,5/18,9.43%,CD44;HEXA;LYVE1;SLC9A1;GUSB
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.4871288264031576,-1.3494818325612419,0.10600706713780919,0.2547255835059668,1.0,6/22,13.07%,STX7;MALT1;CYRIB;B2M;FBXO38;TRAF2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.5317255372731678,-1.3490095908834023,0.1306532663316583,0.2551726299240074,1.0,7/14,16.82%,CD74;LILRB1;PLCG2;LAPTM5;TICAM1;MAVS;GPRC5B
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.354696987038101,-1.3489116295403303,0.052980132450331126,0.25506102157023186,1.0,28/88,21.40%,FNIP2;SDCBP;SYK;PLEK;RAB7A;BCL2L11;PDCD6IP;SPIDR;TSG101;VEGFA;FNIP1;CDC42EP2;SDC4;CHGA;TPR;SH3GLB1;CHMP2A;BRK1;SLX4;FAF1;BID;RPS3;HAS3;SYNPO;GSK3B;VPS4A;MMP1;RACK1
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.5489491421194478,-1.3488918765833056,0.10016420361247948,0.2548404953118078,1.0,7/14,27.25%,ABCG1;PSENEN;DYRK1A;CLN3;ADAM19;PSEN2;BACE1
prerank,positive regulation of dendritic spine development (GO:0060999),0.47690762899255007,1.3483231231036379,0.11083743842364532,0.35171606336494327,1.0,7/20,10.87%,NLGN1;SHANK3;CUX2;FMR1;CAPRIN2;CPEB3;RELN
prerank,actin filament network formation (GO:0051639),0.5633760890572432,1.3480946485204512,0.13333333333333333,0.35095959357153744,1.0,6/11,15.56%,CARMIL1;CARMIL2;SPIRE1;COBL;FHOD3;PLS3
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5388048323321741,-1.3480199975551477,0.11205432937181664,0.2559313825530282,1.0,2/14,1.96%,ITGA4;ANO6
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.3581605661763882,-1.3480145087406192,0.03735144312393888,0.25567495208409846,1.0,19/92,10.64%,SASH1;NRP1;FOXP1;RREB1;PLCG2;RAC1;RIN2;PTK2B;ADAM9;PIK3CB;DOCK5;PIK3CG;NRP2;GRN;VEGFA;ITGB1BP1;HIF1A;CTSH;AGT
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.45259836068244086,-1.3480077581538126,0.10452961672473868,0.2554253738887619,1.0,6/26,8.82%,PLEK;RAC1;ROCK1;CDC42;PTGER4;SLC9A1
prerank,mesenchymal cell differentiation (GO:0048762),-0.3942591012508212,-1.3472801262587917,0.07484076433121019,0.2563189234473453,1.0,23/51,29.34%,RBPJ;ROCK1;HTR2B;FBXL17;HGF;LRP6;CTNNB1;TGFBR1;DDX5;HIF1A;MEF2C;LIMS1;FAM83D;GSK3B;S100A4;HEYL;SNAI2;TGFB1;TRIM28;BMP2;ENG;LEF1;DDX17
prerank,response to prostaglandin E (GO:0034695),-0.5790400605798118,-1.347025310429389,0.12545454545454546,0.25647451165772006,1.0,3/10,6.74%,GNB1;PTGER4;GNG2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.38754386198356655,-1.3470082043473641,0.06956521739130435,0.2562412793214147,1.0,19/55,20.83%,PSME4;PSMB7;PSME3;GPR132;PSMB9;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;AVEN;PSMA1;PSMB8;AURKA;ATF5;PSMA5;PSMD4;PSMB3;PSMD3
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.5099912279292539,-1.3469195446562658,0.10638297872340426,0.2561080700050858,1.0,4/17,3.81%,APOE;IGF1;ROCK1;GGA3
prerank,insulin receptor signaling pathway (GO:0008286),-0.3694523792645069,-1.3464503353747488,0.060658578856152515,0.2565365560534219,1.0,22/69,20.57%,ATP6V0D2;NAMPT;BCAR3;GRB2;ATP6V1E1;INSR;IGF1R;ATP6V1A;TCIRG1;AP3S1;RHOQ;BAIAP2;ATP6V1G1;ZNF106;PIK3CA;ATP6V0B;PIK3C2A;ATP6V0E1;IRS2;GSK3B;ATP6V0D1;APPL1
prerank,electron transport chain (GO:0022900),-0.5274504598077732,-1.3459387176066941,0.13414634146341464,0.2570723147296166,1.0,2/15,1.82%,ENOX2;POR
prerank,positive regulation of positive chemotaxis (GO:0050927),0.5005094328302944,1.3458702192348606,0.11316397228637413,0.35399097986124334,1.0,5/15,12.03%,NTRK3;CDH13;VEGFD;PGF;SCG2
prerank,neuron projection development (GO:0031175),0.31169261822041505,1.3457103855731951,0.015748031496062992,0.35315102867685266,1.0,37/168,12.42%,CNTNAP2;NLGN1;GRM7;MAP2;CTNND2;CNTN4;DCLK1;NYAP2;MYO16;GPM6A;RASGRF1;PAK3;SH3GL2;NEFH;PLP1;TMEM108;EPB41L3;BICDL1;GDNF;EPHB1;SHANK3;GPM6B;BDNF;FLRT3;ADGRV1;NCKAP1;TOR1A;NEDD4;BMP7;SRGAP2;TSKU;WHRN;NBL1;CDK5R1;TNIK;ATXN10;FRY
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.4151147574893701,-1.3452077747215216,0.07796610169491526,0.25792355305524794,1.0,14/39,26.43%,FXYD5;JAG1;MYADM;NF2;VEGFA;MAP2K5;MAPK7;MIA3;ASS1;WNK1;TGFB1;ADTRP;SPINT2;BMP2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.36920667400201973,-1.3450370084903251,0.050505050505050504,0.2579422789835057,1.0,24/72,21.68%,DDB2;DCP1A;RFC1;RNASE4;REXO4;UBC;RPS27A;DNASE1L1;RNASE6;PCNA;CUL4B;FEN1;RPA3;RFC2;POLD2;ERCC4;DDX1;DNA2;ENPP1;HORMAD1;RFC3;ZC3H12A;FAN1;XRN2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5700128619679918,-1.3446627445041304,0.1289198606271777,0.25827814790201326,1.0,3/11,7.48%,ATF3;MBTPS2;ATF6
prerank,cellular protein modification process (GO:0006464),-0.2776615542722404,-1.3444716065492028,0.0,0.25830524266421856,1.0,310/983,25.64%,F13A1;LYN;PTPRC;APOE;PRKCH;FNIP2;PPM1H;MAP3K5;B4GALT5;TAOK3;PRKCB;FGR;FAM20C;DAPK1;SYK;ZC3HAV1;PAK2;CDK6;PRKCD;ROCK1;MAP4K3;PTPRJ;BIRC6;ST3GAL1;DDB2;PPP4R2;RUNX3;MAP3K1;ST8SIA4;ERN1;FBXW8;DAPP1;MAP3K20;INSR;MAN2A1;MTM1;PEAK1;CSNK2A1;PSME4;PRKAG2;VRK2;CDK13;RNASEL;MINK1;MAML1;TLK1;ATG5;ABL2;MAPKAPK2;WWP2;SGK1;GRK3;DYRK2;PSMB7;TEC;ALG5;PSME3;ATG7;MTMR3;RAB1A;COG7;PARP14;PTPN12;PIM1;PTK2B;FBXO32;PTPRE;ATG10;FBXW11;UBXN7;PTPN22;MSRA;DAPK3;ANXA1;PARP4;TIPARP;PSMB9;STK3;KLHL25;FUT10;FBXL20;TRIOBP;DCAF10;FN1;C3;MACROD1;KLHL22;GCNT2;CDK18;NUB1;IRAK3;LRRC41;GAS6;CAMKK2;GRK5;DCAF8;PPM1B;WFS1;PLK2;GPS1;PPP1CA;EIF2AK2;SDHAF2;COQ8A;STK38;WDR5;TGFBR1;RAB5A;TRIB1;JAK1;CDK14;NEK6;UBA7;MPI;PARP9;HIF1A;PTPN6;PARP8;RSKR;MORC3;SIRT3;ATE1;SPSB2;PSMA8;MTMR6;UBE2L3;SUMF2;SIK1;TRIB2;PTP4A2;TGM2;CP;B3GNT2;TAOK1;UBL5;PSMC3;DUSP11;LCK;SEPHS1;APP;SPSB3;B4GALT7;DUSP6;CDK1;DYRK1A;RAB11B;MAP2K1;PPP4R1;CUL4B;HSP90B1;PSMD8;ASB5;SERP1;STK11;COPS6;IGFBP3;STK17B;FBXO10;FRK;LGALS1;STK24;PSMC4;MKNK1;PSMB10;ACVR2A;SOCS6;PIK3CD;GMFG;TNKS2;TGFBR2;PADI4;MAST2;FBXW2;MIA3;CUL2;MARK2;PSMA1;METAP1D;PPP1R12A;LARGE1;IKBKB;SPP1;GMFB;TXK;CCNE1;KLHL42;MFGE8;NPC1;PIGH;CDC34;CST3;SSH1;MKNK2;RAB13;LATS2;APLP2;STRADA;ISG15;RABGGTA;ASB4;UBE2I;PSMB8;DNAJC3;FBXL8;VHL;CDKL4;SKP2;WSB2;AURKA;PARP10;ZAP70;MAN2B1;RARA;GNMT;FBXO7;PTPRO;BRD2;PKN3;RYK;HCK;HCST;SOCS3;PTPN13;STK10;PMM2;TAOK2;DUSP5;IP6K3;UBE2M;SHISA5;MAK;PPEF1;PAK6;RABGGTB;COPS5;ATM;ELOC;FBXO31;CSF1;PSMA5;PSMD4;CHEK1;BMPR2;CDC42BPG;CDK16;STT3B;PSMB3;FBXO22;F5;WNK1;GSK3B;RAB11A;BAP1;COPS4;FBXW4;SIRT2;PTPN1;PSMD3;COPS8;CDK5;CSNK1G3;ILKAP;PRKAG1;GRK6;SRPK1;SOCS5;MAP4K4;MANBA;CCNF;MAPK1;RPS6KA5;FEM1B;ILK;NEK3;PTPN7;IL6;CD247;FUT4;PRKDC;TYK2;PPP1CC;P4HB;TGFB1;PPP1CB;PIM2;ERO1A;DDOST;GAD1;B3GNT9;PGAP1;DUSP2;LIPE;PSMB1;PPP2R5B;ZDHHC6;RCE1;QSOX1;DSP;RAB1B;DDB1;SSH2;HLCS;P3H1;CDK20;ST3GAL3;ZBTB16;TPTE;SIK3;DCAF17;PPP2R5A
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.4642507809149242,-1.34421733353487,0.12089810017271158,0.25839734159575084,1.0,5/25,10.13%,NELFB;BRD4;CDK13;EAPP;RNF8
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.4337240359657306,-1.3438725025670906,0.08029197080291971,0.2584261532059687,1.0,17/32,30.35%,NUP50;XPOT;NUP42;NUP88;RAE1;NOL6;NUP205;TPR;NUP188;NUP153;NUP35;NUP107;NUP62;RANBP2;NUP37;AAAS;NUP133
prerank,tRNA export from nucleus (GO:0006409),-0.4337240359657306,-1.3438725025670906,0.08029197080291971,0.2584261532059687,1.0,17/32,30.35%,NUP50;XPOT;NUP42;NUP88;RAE1;NOL6;NUP205;TPR;NUP188;NUP153;NUP35;NUP107;NUP62;RANBP2;NUP37;AAAS;NUP133
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.5858550361528541,-1.3432875587290916,0.1267605633802817,0.2590616915912642,1.0,9/10,38.87%,CDC42;KNSTRN;RACGAP1;SIRT2;CCNB1;ECT2;RCC2;APC;NEK2
prerank,response to histamine (GO:0034776),0.5663752137464891,1.343197609320781,0.13716814159292035,0.3564215376187574,1.0,4/10,7.52%,GABRB3;GABRB1;GABRB2;GABRG2
prerank,nucleotide-excision repair (GO:0006289),-0.34644345770860707,-1.3431532440086622,0.04411764705882353,0.259011847052006,1.0,36/101,22.36%,DDB2;RNF111;ERCC6;RFC1;GPS1;POLR2H;ATXN3;POLR2F;POLR2L;UBC;RPS27A;LIG1;PCNA;CUL4B;COPS6;RPA3;RFC2;POLR2A;POLD2;ERCC4;LIG3;SLX4;HMGN1;BRIP1;USP7;POLR2G;COPS5;MMS19;RFC3;COPS4;COPS8;POLR2I;CETN2;FAN1;XAB2;POLB
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.4482351879235128,-1.3428291357100648,0.09380234505862646,0.25929820574495105,1.0,8/29,12.00%,RUNX1;BRCA1;CNOT1;CNOT2;AXIN1;WBP2;CBFB;KMT2D
prerank,cellular response to reactive oxygen species (GO:0034614),-0.3820565536909488,-1.3414702527536762,0.06228373702422145,0.26119316632061307,1.0,12/59,10.98%,MAP3K5;PRKCD;JUN;NFE2L2;RIPK1;ANXA1;CAMKK2;SIRPA;MAPK7;PRDX5;RELA;NCF1
prerank,inner ear morphogenesis (GO:0042472),0.46576784634882273,1.3414278186328412,0.11031175059952038,0.35828573138710407,1.0,6/22,12.82%,PAX8;MYO6;SOX9;TFAP2A;TBX1;TMIE
prerank,RNA processing (GO:0006396),-0.3235142448993691,-1.34128254077401,0.022617124394184167,0.26121462259455813,1.0,57/176,24.74%,APOBEC1;MBNL1;RBM39;RBMS1;SON;SRRM1;RNASEL;TUT7;RBPMS;MPHOSPH10;SMU1;SNRNP35;FUS;SNRPG;HNRNPH1;SNRPF;HNRNPL;SF3B3;TSEN54;PRPF8;FASTKD2;DUSP11;HNRNPUL1;MTPAP;NUDT21;CELF1;RBMS2;NCBP1;ZRSR2;PDCD7;PPIG;SF3A1;PPP1R9B;NUFIP1;PRPF18;ATXN1;TFIP11;LSM6;RNPS1;TENT4B;SCNM1;MAGOH;SLU7;SF3B1;RBM3;LSM5;NOL9;DDX54;HNRNPK;XRN2;SRPK1;SRSF11;NONO;TARDBP;PRPF6;DDX39B;AKAP8L
prerank,tRNA transport (GO:0051031),-0.4219283304336465,-1.3411082282925235,0.07746478873239436,0.2611938393995968,1.0,18/35,30.35%,NUP50;XPOT;NUP42;NUP88;RAE1;NOL6;NUP205;TPR;NUP188;NUP153;NUP35;NUP107;NUP62;TOMM20L;RANBP2;NUP37;AAAS;NUP133
prerank,cellular glucose homeostasis (GO:0001678),-0.4113313705242696,-1.3407404678219008,0.09183673469387756,0.26148801232706287,1.0,10/41,11.08%,LRRC8D;ERN1;IGF1R;TRA2B;GAS6;HIF1A;NUCKS1;HK3;ZBTB20;XBP1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.3805822109731912,-1.3405267965106318,0.07504363001745201,0.26157846816958713,1.0,24/65,23.39%,NRROS;PMEPA1;SNX6;SKI;TGFBR1;TGFB1I1;SNX25;UBC;RPS27A;SPRED1;SPRY2;PIN1;SPRED2;HTRA3;TGFBR2;LDLRAD4;VASN;HSPA1A;SMAD7;IL17RD;SMURF2;ZBTB7A;EID2;TGFB1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4822379435603641,-1.3404777093630633,0.11187607573149742,0.26139776659345326,1.0,9/22,24.21%,BRD4;CDK13;ERCC6;EAPP;ALYREF;KAT7;HMGN1;CCNK;DDX39B
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.31375714031430707,1.34040940302896,0.02278481012658228,0.3590202250665272,1.0,40/152,17.09%,ADGRB3;ADGRL3;CHRM2;ADCY2;GRM8;ADCY8;GNAO1;LGR5;GPR37;P2RY12;ADCY5;RAMP3;GNAI1;ADRA1B;GABBR1;ADCY3;PTH1R;ADGRL2;ADCY1;CORT;GPR3;GHRH;CALCB;LPAR2;LGR4;NPY1R;GNAZ;HTR1B;ADRA1D;ADGRG1;GPR26;PRKACB;GNAL;OPRK1;ADGRB2;OPRL1;IAPP;RAMP2;ADGRL4;CRHR1
prerank,RNA modification (GO:0009451),-0.38720672274243073,-1.3401323238064056,0.06354515050167224,0.26165376809720287,1.0,25/54,35.14%,NSUN3;METTL1;ELP5;PUS7;ALKBH1;NSUN4;ANKRD16;QTRT1;TRMT6;ADAT2;TYW5;AARS1;THUMPD1;BCDIN3D;RBM15B;MRM2;METTL3;THG1L;CTU2;FTSJ1;CTU1;TRMT61A;ADARB1;PUS7L;CDKAL1
prerank,I-kappaB phosphorylation (GO:0007252),-0.5853707861181996,-1.3398418906766523,0.12277580071174377,0.26184257486039747,1.0,2/10,4.11%,TLR7;TLR4
prerank,negative regulation of cell motility (GO:2000146),0.3269682241143539,1.3393941981124584,0.03064066852367688,0.359692190649252,1.0,16/108,5.36%,ROBO1;MAGI2;NAV3;TMEFF2;SLIT2;PTPRT;SPOCK3;FRMD5;LIMCH1;IGFBP5;TCAF1;ADORA3;AFDN;DLC1;PTPRK;PODN
prerank,regulation of vacuole organization (GO:0044088),-0.48197128552495816,-1.3393787351655684,0.11558669001751314,0.262329540331534,1.0,5/20,8.68%,ANXA2;MTM1;IFT20;MTMR3;RAB5A
prerank,homologous chromosome segregation (GO:0045143),0.47369193897639184,1.339023507461398,0.10070257611241218,0.3591900306078655,1.0,6/20,14.25%,ZCWPW1;FMN2;PTTG1;IHO1;MEIKIN;MEIOB
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.4075858279087099,-1.3385917075899176,0.09540034071550256,0.26325179847079466,1.0,15/42,21.28%,RFC1;PRIMPOL;PCLAF;UBC;RPS27A;WRN;PCNA;RPA3;RFC2;POLD2;ISG15;PARP10;POLN;RFC3;TRIM25
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5136830848463656,1.33848307500236,0.1346153846153846,0.35903497376558535,1.0,3/15,5.01%,MAGI2;IGSF1;ACVR1
prerank,regulation of macroautophagy (GO:0016241),-0.3468052135660474,-1.3383633663933794,0.045531197301854974,0.26334610819018184,1.0,37/105,25.56%,ATP6V0D2;ATP6V1E1;ERN1;GNAI3;GAPDH;PRKAG2;ATP6V1A;SNX6;SNX5;EXOC4;USP36;ATP6V1G1;VPS26B;RRAGD;SESN1;PIK3CA;VPS26A;SH3GLB1;RB1CC1;ATP6V0B;WAC;CAPNS1;CLN3;ATP6V0E1;BNIP3L;TBC1D25;RHEB;ATP6V0D1;KDR;CDK5;PRKAG1;SNX32;SMG1;DCN;QSOX1;LAMTOR1;LAMTOR3
prerank,positive regulation of blood coagulation (GO:0030194),-0.5056805969900582,-1.3378615614319518,0.11596638655462185,0.26384118748058516,1.0,11/17,43.77%,ANO6;HPSE;SERPINE1;APOH;ST3GAL4;F2R;F12;HRG;F3;THBD;ENPP4
prerank,mRNA modification (GO:0016556),-0.47331783633504243,-1.337682431308515,0.10638297872340426,0.26387574438694744,1.0,8/22,15.81%,PUS7;CBLL1;PCIF1;PUS1;METTL14;VIRMA;TRMT6;WTAP
prerank,activation of adenylate cyclase activity (GO:0007190),0.40407787223200636,1.3374679152117603,0.09004739336492891,0.35986725322335683,1.0,9/35,13.09%,ADCY2;ADCY8;LGR5;ADORA3;ADCY5;ADCY3;ADCY1;LGR4;ADRB1
prerank,negative regulation of gene expression (GO:0010629),-0.3028301589616516,-1.3372441272966,0.010542168674698794,0.26430793725652274,1.0,86/302,22.35%,APOE;PTBP3;ATP2B1;FOXP1;RUNX1;MSR1;IGF1;NOTCH2;DAPK1;REL;XDH;RB1;ERN1;AGO2;GAPDH;DNMT3A;ZNF148;SPI1;WWP2;CCR1;CNOT1;PARP14;SRGN;NFKB1;PTGER4;PTPN22;DAPK3;TIPARP;PUS7;PICALM;MYADM;EZH2;JARID2;VEGFA;EIF2AK2;EED;DCP2;RPS13;PCIF1;CD28;PARP9;HIF1A;MEF2C;MOV10;APP;FLCN;MAP2K1;CELF1;CD46;TMBIM6;FCGR2B;TNRC6C;DHX36;SLC7A5;SETDB1;EPC1;ID2;FLOT2;YY1;CRKL;NCL;SHQ1;RBBP4;VHL;AURKA;PARP10;HSPA1A;LSM6;TOB1;RPS3;MMP8;LGALS9;DDX3X;NDFIP2;CNOT8;DDX6;LSM5;SFRP1;ZC3H12A;LSM14A;KDR;RACK1;SHMT1;RPS6KA5;CD3E;ANXA7
prerank,positive regulation of cellular component organization (GO:0051130),-0.3453435418049534,-1.337223064916224,0.05084745762711865,0.2640746360345125,1.0,14/107,2.64%,DAB2;APOE;FNIP2;RUNX1;PLEKHM2;ASAP1;SYK;LRP1;RB1;BCL2L11;SPIDR;INSR;ABCB7;IGF1R
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.4972595966019002,-1.3367003643197488,0.0946843853820598,0.2646772794358119,1.0,5/18,9.25%,ITGA4;PPARG;FLT1;MDK;MEF2C
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.39599314084509585,-1.3364981763335169,0.08333333333333333,0.26473167487411053,1.0,19/51,22.63%,CCR2;ANO6;IL6R;CCR1;GAS6;VEGFA;MDK;F7;CCL5;SERPINE1;PLA2G7;IL34;CMKLR1;LGALS9;HMGB1;CSF1;C1QBP;MAPK1;IL6
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.36156006145863545,-1.3363282199552124,0.0594059405940594,0.2647468387285682,1.0,29/73,28.38%,DEK;DNMT3A;SMARCA5;SPI1;ERCC6;ACTB;EZH2;JARID2;POLR2H;EED;POLR2F;WBP2;POLR2L;ZFP57;HDAC5;EPC1;RBBP4;SPHK2;TAF1A;POLR1F;SF3B1;SMYD5;BAZ1B;POLR1C;EP300;POLR1E;MYBBP1A;CREBZF;CGGBP1
prerank,cellular response to peptide (GO:1901653),-0.38653712248400807,-1.3362417924139898,0.08084358523725835,0.26462028933289955,1.0,17/56,11.08%,ITGA4;IGF1;VIM;LRP1;CD36;IGF1R;ARHGEF2;TLR4;CHMP5;SNX6;PTPN22;CASP4;NOD1;ABCC1;APP;TIMELESS;XBP1
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.42311351097882716,-1.3359834019286734,0.0829103214890017,0.26473314928120456,1.0,7/37,4.91%,APOE;SDCBP;RIN3;OPTN;BRCA1;NFKB1;ITGAV
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.5336435936458295,-1.3355555796718255,0.13799283154121864,0.2651493155039299,1.0,7/14,44.74%,ADAM8;IL6;PTGER3;TNF;IL1B;IL6ST;OSM
prerank,import into nucleus (GO:0051170),-0.3578933466751966,-1.3350162424959668,0.06108202443280977,0.2656791323257521,1.0,26/73,22.38%,BACH2;SYK;IPO5;NUP50;STAT3;NUP88;SNRPG;SNRPF;E2F3;TPR;HTATIP2;SMN1;NUP188;GEMIN7;SNUPN;APPL2;NUP153;HNRNPA1;FAM53A;TNPO3;APPL1;NUP107;GEMIN6;NXT2;NUP62;SPRN
prerank,regulation of sensory perception of pain (GO:0051930),0.5532283183458195,1.334710911801392,0.14965986394557823,0.3638339321633732,1.0,4/11,10.54%,CCN3;SPX;TMEM100;ZFHX2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.466438416378806,1.3346823426771748,0.13126491646778043,0.3627203089825436,1.0,6/19,7.14%,HS3ST5;HS6ST3;HS6ST2;NDST4;NDST3;GLCE
prerank,monocyte differentiation (GO:0030224),-0.5738680654808423,-1.3342386352373568,0.13333333333333333,0.26668237382209337,1.0,5/10,15.67%,MYH9;PPARG;MT1G;VEGFA;IL31RA
prerank,AMP metabolic process (GO:0046033),-0.5404698294562462,-1.333988211190257,0.1232638888888889,0.2668134190270389,1.0,3/13,8.98%,XDH;NUDT2;ADSS1
prerank,leukocyte tethering or rolling (GO:0050901),-0.5052182066084677,-1.3337399901189306,0.10320284697508897,0.2669648475679714,1.0,7/17,15.91%,ITGA4;ROCK1;ITGB1;ITGB7;PODXL2;GCNT1;SPN
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.5746285603884134,-1.3336492586693633,0.13471502590673576,0.266855183279851,1.0,3/11,5.01%,CD44;CD74;BCL2
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.4707759450120873,-1.3333172871229437,0.11965811965811966,0.26708988808691186,1.0,8/21,8.82%,CORO1C;ROCK1;RHOA;PEAK1;DAPK3;MACF1;DUSP3;SLC9A1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.579746566883204,-1.333227205414672,0.13285457809694792,0.2669718419930169,1.0,5/11,20.43%,PRDX5;PRDX1;PRDX2;CAT;PXDNL
prerank,melanocyte differentiation (GO:0030318),-0.5756560120291647,-1.3331195065333503,0.11512027491408934,0.266869749984718,1.0,4/11,11.94%,MITF;LRMDA;MEF2C;SLC24A5
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5413847860212901,1.33285997882531,0.15186915887850466,0.3649879125430082,1.0,4/11,10.56%,KCND3;KCNJ3;KCNIP2;ATP1B1
prerank,regulation of protein modification process (GO:0031399),-0.3928768679288094,-1.3325077709968882,0.07692307692307693,0.26758584182698714,1.0,13/50,11.72%,LYN;FNIP2;CORO1C;ATG7;ATG10;FN1;PUM3;FNIP1;SPRED1;PIN1;FLCN;SPRED2;CCDC88A
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.32339628084191074,-1.3321674352028445,0.022082018927444796,0.26782615548845423,1.0,42/182,14.80%,APOBEC1;APOE;FOXP1;RUNX1;MSR1;IGF1;NOTCH2;SDCBP;RIN3;REL;XDH;RB1;AGO2;OPTN;ZNF148;SPI1;WWP2;CCR1;PARP14;NFKB1;PTPN22;TIPARP;PICALM;MYADM;VEGFA;CD28;PARP9;HIF1A;MEF2C;MOV10;APP;FLCN;MAP2K1;CELF1;CD46;HSP90AB1;TNRC6C;SLC7A5;SETDB1;ID2;FLOT2;YY1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.29905644702251655,-1.331923373122018,0.009104704097116844,0.26792732246264994,1.0,115/314,27.66%,WWP1;RB1;BFAR;NFE2L2;PSME4;ARRB2;WWP2;FBXL17;AMFR;AREL1;PELI1;PSMB7;ANAPC1;TNFAIP1;PSME3;RHBDD2;FBXW11;PSMB9;FBXL20;RBCK1;ARRB1;KLHL22;UBR2;CTNNB1;TBL1XR1;ZFAND2A;WFS1;KCTD10;ZSWIM8;ATXN3;RNF4;ERLIN1;FBXO38;DNAJB9;SPSB2;PSMA8;SELENOS;UBC;RPS27A;DNAJB14;DERL1;PSMC3;KIF14;UBE4B;NEDD4L;SEL1L;SPSB3;PCBP2;CDK1;CUL4B;HSP90B1;PSMD8;MAEA;BUB1B;PSMC4;PSMB10;RNF185;CUL2;PSMA1;RNF34;KLHL42;UBE2G1;RNF216;CDC34;FAF1;UBE2C;PSMB8;FBXL8;SKP2;AURKA;ANAPC7;RNF121;HUWE1;DCAF12;UBXN1;FBXL6;FBXO31;PSMA5;PSMD4;STT3B;PSMB3;FBXW4;FOXRED2;SIRT2;PSMD3;SGTA;TRIM25;FAF2;BAG6;SMURF2;CCNF;MAN1B1;HECTD3;TOPORS;FEM1B;CCNB1;TRIM72;ZNRF1;KCTD2;PSMB1;EDEM1;RNF187;DDB1;SPOP;CLOCK;SIAH2;FBXL19;SMURF1;PML;VCP;CUL3;DCAF11;COP1;TBX21;UBE4A
prerank,regulation of double-strand break repair (GO:2000779),-0.41586558765865406,-1.3316930493737837,0.10782608695652174,0.26799696943275514,1.0,16/39,21.40%,PPP4C;PPP4R2;ACTR2;DEK;SPIDR;RNF169;RTEL1;RAD51;MGMT;TIMELESS;RAD51AP1;WRAP53;SHLD2;TRIP12;CHEK1;KDM1A
prerank,protein catabolic process (GO:0030163),-0.3749233555227044,-1.330747812238595,0.07446808510638298,0.26922548263321877,1.0,25/59,26.98%,APOE;CTSD;RIPK1;RNF41;LAMP2;DDI2;ATE1;PSMA8;CLN6;CUL4B;TRIM24;SOCS6;DENND3;UBE2G1;TPP1;RAB12;STT3B;PPT1;BAG6;MANBA;DDB1;LRSAM1;SIAH2;VCP;HSPA8
prerank,cyclooxygenase pathway (GO:0019371),-0.5878352026806656,-1.3300274042183071,0.14084507042253522,0.2701005120071485,1.0,2/10,12.84%,TBXAS1;CBR1
prerank,positive regulation of cell cycle process (GO:0090068),-0.34658610542974666,-1.3293755227888857,0.06937394247038917,0.27089576004286126,1.0,29/91,22.13%,IGF1;RHOA;MAP3K20;INSR;SVIL;CDC42;CEP295;DYNC1H1;KIF20B;KIF23;CD28;KIF14;DBF4;GEN1;TPR;FEN1;E2F8;RHNO1;RACGAP1;NUSAP1;INO80;AURKA;XRCC3;NDC80;PDGFRB;CSPP1;SIRT2;NUP62;RANBP1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.4720522028081859,1.32919034669078,0.09772727272727273,0.3707644803427567,1.0,5/20,8.49%,HECW1;PRKCE;HECW2;CASQ2;NEDD4
prerank,positive regulation of ruffle assembly (GO:1900029),0.5217510261270886,1.3291507189796261,0.13095238095238096,0.3696479603599489,1.0,4/13,5.46%,NLGN1;FAM98A;P2RY12;CARMIL2
prerank,protein deacylation (GO:0035601),-0.4627106324616037,-1.3290970864893066,0.10696095076400679,0.2710546500130612,1.0,8/23,22.00%,ABHD17C;SIRT3;HDAC10;HDAC5;SIN3A;SIRT2;PPT1;LYPLA1
prerank,plasma membrane repair (GO:0001778),-0.5472611114432677,-1.3286498797209358,0.1436077057793345,0.27147218370657267,1.0,4/13,6.20%,MYOF;MYH9;ARL8B;AHNAK2
prerank,nucleoside catabolic process (GO:0009164),0.5524560825655079,1.327891556607789,0.13406593406593406,0.37082233122235014,1.0,3/11,3.74%,UPP2;DPYD;DPYS
prerank,embryonic skeletal system development (GO:0048706),0.4015913417683488,1.3277829420311482,0.11401425178147269,0.36982873017749246,1.0,14/35,20.96%,PCSK5;HOXC4;SOX11;WNT9A;KIAA1217;DSCAML1;HOXD3;HOXC9;FUZ;UCMA;COL1A1;WNT5A;SULF1;DYNC2I1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.39770588130529927,-1.3277571815202074,0.09015025041736227,0.27261111399615934,1.0,20/46,26.48%,FOXP1;IGF1;PPARG;IL6R;IL18;CTNNB1;TRIB1;XRCC6;IGFBP3;CCL5;ID2;ANG;PDGFRB;RBPMS2;STAT1;IL6;PRKDC;HMOX1;CCN4;VIP
prerank,maturation of SSU-rRNA (GO:0030490),-0.4247053889314182,-1.3275178736636195,0.11498257839721254,0.2727379646327597,1.0,11/34,18.70%,RPS8;RIOK3;RPS14;NOP14;RPS28;DHX37;MRPS11;NGDN;UTP6;LSM6;RPS16
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5642340627485135,-1.327429870352813,0.12736660929432014,0.2726362538900734,1.0,7/11,32.83%,MAP3K5;PRKCD;STK24;CYP1B1;DIABLO;GSKIP;STK25
prerank,regulation of focal adhesion assembly (GO:0051893),-0.38702666822953935,-1.3272002074537972,0.08747855917667238,0.27272223137980806,1.0,13/54,8.99%,NRP1;CORO1C;RAC1;ROCK1;PTPRJ;RHOA;PEAK1;DAPK3;MACF1;DUSP3;VEGFA;SLC9A1;ITGB1BP1
prerank,chromosome organization (GO:0051276),-0.3429858694914865,-1.327021253163297,0.05090311986863711,0.2727710577950405,1.0,32/99,24.97%,DDB2;HHEX;TOP2A;EZH2;PWWP3A;RAE1;GPS1;RFWD3;UBC;RPS27A;NUCKS1;HDAC10;CUL4B;COPS6;HMGB2;HDAC5;PADI4;DOT1L;HMGN1;NUF2;LRWD1;NDC80;CENPH;COPS5;COPS4;COPS8;MTHFR;CETN2;ZBTB7A;HDAC8;MYC;DDB1
prerank,ncRNA transcription (GO:0098781),-0.5454482813033683,-1.3269590050609916,0.1232638888888889,0.27262193371181515,1.0,7/13,18.72%,SNAPC2;SPIN1;NIFK;USPL1;ANG;SNAPC3;GTF3A
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.3367117834493404,-1.3268638813564377,0.03697478991596639,0.27253025370580497,1.0,38/110,23.65%,APOE;ABCA1;FNIP2;SYK;FBLIM1;RB1;CD36;BCL2L11;SPIDR;RIOK3;CDC42;PREB;VEGFA;EIF2AK2;FNIP1;CDC42EP2;SAR1A;AIDA;TRAF2;SH3GLB1;ANKRA2;BRK1;FAF1;BID;TFIP11;RALB;RPS3;HCK;PTPN11;DDX3X;TMC8;GSK3B;MMP1;RACK1;GFAP;CRYAB;TGFB1;BIK
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.46087892129684965,-1.3266167777377627,0.1026936026936027,0.2726588275813609,1.0,17/25,33.62%,LYST;CHMP5;TMEM50A;CHMP7;CHMP1A;UBXN6;CHMP2A;LEPROTL1;LAPTM4B;RILP;CHMP4B;CHMP4A;CHMP2B;VCP;MVB12A;VPS4B;VTA1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4278373737639547,1.3259665163792667,0.09153318077803203,0.3720996686642621,1.0,4/26,4.23%,EFNA5;ADCY8;EPHA5;ADCY5
prerank,telomere capping (GO:0016233),-0.5084606545562926,-1.3256468413068982,0.125,0.27389479815850715,1.0,8/16,26.18%,DCLRE1C;DCLRE1A;TEN1;TFIP11;NBN;PRKDC;MRE11;DCLRE1B
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.39247865926893816,-1.325625461009707,0.08061749571183534,0.2736608671969275,1.0,21/47,27.09%,RREB1;PPARD;METRNL;PPARG;PIM1;MEDAG;LPL;XBP1;WDFY2;ID2;TFE3;CMKLR1;GDF3;SFRP1;ZC3H12A;CEBPB;ADIG;ZBTB16;BMP2;ZFP36L1;ZBTB7B
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.49967190006833917,-1.3256216940357606,0.12903225806451613,0.27340603496706667,1.0,9/18,24.61%,CD300A;SKI;MORC3;B4GALT7;NLRC3;PARP10;SFRP1;FTH1;MYC
prerank,regulation of exosomal secretion (GO:1903541),-0.49111327566934326,-1.325453918572713,0.11130742049469965,0.2733981795540962,1.0,6/19,14.44%,SDCBP;RAB7A;PDCD6IP;TSG101;SDC4;CHMP2A
prerank,regulation of secretion by cell (GO:1903530),0.3745290278030696,1.324858759897252,0.08495145631067962,0.37308862397519077,1.0,9/54,3.78%,RIMS2;RIMS1;STXBP5L;SYT1;RAB3C;CPLX1;SNCAIP;SYN1;RAB15
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.442613404446962,-1.324632989364651,0.1232638888888889,0.2744534791461954,1.0,5/28,4.70%,PID1;PRKCB;PRKCD;PIP4K2A;PTPRE
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.29598715078894866,-1.3245211625409046,0.008995502248875561,0.2743381859211142,1.0,94/348,22.80%,IQGAP1;LYN;DAB2;PTPRC;NRP1;FNIP2;CD44;BANK1;IGF1;BCAR3;CD74;SDCBP;PLCG2;PAK2;NIBAN1;RAC1;ITGA5;PTPRJ;SNX9;INSR;ARHGEF2;RAP2A;PRKAG2;RIPK1;IL6R;RAP1A;TAB2;IL15;TEC;RBPMS;CCND3;PTK2B;AXIN1;HGF;C3;ARRB1;CAB39;GAS6;CAMKK2;ALS2;VEGFA;CENPE;FNIP1;PLAUR;TGFBR1;SPRY2;PIN1;AGT;APP;XRCC6;FLCN;WDFY2;CAMKK1;CLEC6A;HSP90AB1;CACUL1;CIB1;ACVR2A;LCP2;RB1CC1;CD40;IL34;EIF4G1;CRKL;TTK;MAVS;CSPG4;HCLS1;MAP2K3;RALB;KRAS;PTPN11;TAOK2;DDX3X;RSPO1;JTB;CSF1;GDF3;AGER;BMPR2;NBN;KDR;PDGFA;RACK1;HAX1;PRKAG1;MAPK1;RPS6KA5;INHA;FGF18;ILK;S1PR2;IL6;APLNR
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5799235230264665,-1.3243620078399494,0.1258741258741259,0.2743519111761357,1.0,5/10,26.28%,LRP6;CTNNB1;RYK;WNT3;FZD1
prerank,ion transport (GO:0006811),0.32331516846875386,1.3236581785522008,0.05641025641025641,0.3740840832393176,1.0,18/111,8.85%,TRPM3;GABRB1;KCNN2;SLC24A4;SLC24A2;SLC8A3;SLC12A2;GLRA1;SLC1A2;SLC17A6;SLC24A3;SLC1A6;SLC12A1;SLC9A2;SLC26A3;SLC1A1;PKD1L3;SLC8A2
prerank,positive regulation of developmental growth (GO:0048639),0.3853076409210518,1.3234870704095798,0.116751269035533,0.3732305617434013,1.0,9/49,10.14%,RIMS2;RIMS1;PLCB1;SYT1;CDKL5;SYT2;BDNF;POU4F2;GHRH
prerank,cellular response to interleukin-7 (GO:0098761),-0.4967153802342451,-1.3224953353171296,0.14186851211072665,0.27680052984707537,1.0,7/17,19.53%,STAT3;STAT5B;JAK1;IL2RG;IL7R;IRS2;IL7
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.4967153802342451,-1.3224953353171296,0.14186851211072665,0.27680052984707537,1.0,7/17,19.53%,STAT3;STAT5B;JAK1;IL2RG;IL7R;IRS2;IL7
prerank,modulation by symbiont of host process (GO:0044003),-0.5817289873161153,-1.3216128239751523,0.14974182444061962,0.2779453344136571,1.0,4/10,9.70%,MRC1;B2M;UBC;RPS27A
prerank,regulation of cytokinesis (GO:0032465),-0.3573662971092526,-1.3216002556633717,0.06713780918727916,0.2777048389079427,1.0,25/78,22.51%,ZFYVE26;BIRC6;RHOA;SVIL;UVRAG;CDC42;KIF20B;KIF23;PLK2;PIN1;KIF14;FLCN;PLK3;SH3GLB1;E2F8;RACGAP1;KIF20A;AURKA;PRC1;CSPP1;RAB11A;VPS4A;CETN2;ZFYVE19;BECN1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.5695419260578665,-1.3207565366104486,0.14835164835164835,0.278793678869631,1.0,3/10,8.47%,SNX3;WWP2;DNAJA1
prerank,cellular response to oxidative stress (GO:0034599),-0.33764710029437595,-1.3205876981978024,0.04159733777038269,0.27877840994474434,1.0,36/118,23.55%,CYBB;DAPK1;CYBA;PRKCD;JUN;NFE2L2;VRK2;FOXO3;SLC25A24;NUDT2;MSRA;GSR;CAMKK2;HIF1A;SELENOS;PRDX5;ARNT;NCF1;NCF4;PRDX1;NCF2;MPV17;TMEM161A;PRDX2;RAD52;STX4;HSPA1A;RPS3;CAT;RBM11;SIRT2;ZC3H12A;MAPK1;SRXN1;HMOX1;ERO1A
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.4504975330978058,-1.3199644051762145,0.11564625850340136,0.27948385836713485,1.0,9/26,20.57%,BIRC3;CD36;IRAK3;NFKBIL1;FLOT2;OTUD4;APPL2;GPR108;APPL1
prerank,connective tissue development (GO:0061448),-0.41606251500516533,-1.3196333295014357,0.09927797833935018,0.2797423610301909,1.0,9/35,11.08%,CD44;SH3PXD2B;NAMPT;SPTLC2;ARID5B;ATP7A;CREB3L2;SULF2;XBP1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.3848048104318049,-1.3195690176032706,0.09044368600682594,0.27957276423469557,1.0,19/50,24.20%,PSME4;PSMB7;PSME3;PSMB9;AZIN1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3;OAZ3;NQO1;PSMB1
prerank,regulation of receptor recycling (GO:0001919),-0.4971972176296456,-1.3193763491923656,0.11929824561403508,0.2796340617112306,1.0,6/16,11.92%,ANXA2;OPTN;KIF16B;TBC1D16;SCRIB;RAB29
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.43250569633207353,-1.31853463353994,0.11578947368421053,0.2807148805709537,1.0,17/31,33.35%,ERN1;OPTN;HSPA9;ATXN3;DNAJB14;TMBIM6;BAG3;HSPA1A;HSPA2;PTPN1;HSPA13;HSPA8;HSPA1B;STUB1;DNAJC18;RHBDD1;DNAJB12
prerank,regulation of protein localization to nucleus (GO:1900180),-0.40016841487222143,-1.3182160125708458,0.09931506849315068,0.2809794157295454,1.0,21/43,31.45%,MFHAS1;NVL;PARP9;PIN1;FLCN;CDK1;TPR;KAT7;SIN3A;LATS2;GSK3B;DTX3L;SUMO3;CTNNA1;GTSE1;TGFB1;CARD10;EIF2AK3;ATP13A2;NGFR;ORMDL3
prerank,regulation of macrophage differentiation (GO:0045649),-0.5108196945771099,-1.3181845058352233,0.14462081128747795,0.2807614394305456,1.0,8/15,22.26%,RIPK1;PF4;ID2;IL34;C1QC;CASP8;CSF1;INHA
prerank,regulation of gene expression (GO:0010468),-0.27327921300216723,-1.3178554266956501,0.0013280212483399733,0.2810510823740251,1.0,250/903,23.13%,PID1;RBPJ;LYN;PTPRC;MBNL1;APOE;AHNAK;MITF;PTBP3;FOXP1;RUNX1;MSR1;IGF1;NOTCH2;TFEB;MSN;CD74;RREB1;LILRB1;P2RX7;PLCG2;REL;XDH;BCL6;AFF4;CDK6;RB1;CD36;ROCK1;DNM2;CREBBP;RUNX3;AGO2;BACH1;NFE2L2;MBNL2;INSR;IRF2;ZNF148;APBB2;SBNO2;SON;NFX1;TRA2B;NFYA;NSD3;SPI1;BRCA1;FOXN2;AFF1;WWP2;JMJD1C;CTR9;STAT3;CCR1;LYL1;TLR4;ZSCAN26;PARP14;RYBP;CHD3;RC3H1;RNF20;STAP1;NFKB1;SAP30;PTPN22;DAPK3;TIPARP;GPBP1L1;MAPK14;CIAO3;TAPBP;PF4;RPL11;PIK3CB;ZC3H7B;AHNAK2;TRAF3;FN1;GON4L;CRIP1;SRRT;FUS;PICALM;MYADM;GCNT2;AHR;HNRNPH1;GAS6;MBNL3;GCFC2;EZH2;USP36;REXO4;POFUT1;HNRNPDL;EDF1;VEGFA;HNRNPL;PUM2;BHLHE40;SIRPA;E2F1;MYD88;CNBP;TGFBR1;THAP1;CD28;PARP9;METTL4;HIF1A;LARP4;MEF2C;SLC8A1;CTSH;SERPINB9;FOXN3;NFKBIZ;UBE2L3;EGR1;HDAC10;HP1BP3;SPRY2;RELA;PIN1;ITGAX;MOV10;APP;MYOM1;PCBP2;FLCN;OSR1;MAP2K1;NUDT21;TICAM1;CELF1;PRDM2;KMT2D;CD46;HNRNPLL;SPIN1;MLLT6;KAT7;TCF7;TRIM68;SPTY2D1;TNRC6C;HDAC5;PIK3CD;DHX36;YTHDC1;CALCOCO1;POLR2A;ZNF326;SLC7A5;RPL6;TRIM11;SETDB1;PSPC1;BTG1;ANKRA2;ID2;SART3;TCF3;FLOT2;ZNF628;YY1;TXK;NSD1;POGZ;DTNBP1;CRKL;NKAPL;TRIM14;SRSF10;HCLS1;ATXN1;ADAM19;VHL;CASP8;AURKA;PARP10;HSPA1A;TOB1;TDRD7;KRAS;ATF5;LIMS1;SNRNP70;NR3C1;GATA3;TOB2;MYB;MARF1;PPARGC1B;RPS3;PLAG1;TRIM39;CXXC1;MMP8;CASZ1;LGALS9;PDCD5;NUP35;DDX3X;PAK6;SLC38A2;NDFIP2;ATM;CSF1;NFKBID;WNT3;SUFU;GSK3B;UBAP2;GRSF1;MAZ;C1D;NUP107;ATF7;SFRP1;ZFPL1;ZC3H12A;POU3F1;GTF2IRD1;KDR;HNRNPH2;ZSCAN21;RACK1;HNRNPK;PRKAG1;MEGF8;RBM38;SNAI2;CEBPB;MAPK1;RPS6KA5;CD3E;ANXA7;FGF18;IL6;APLNR;CHD7;NONO;ESR2;IFNGR1;SOX7;MEFV;TARDBP
prerank,regulation of cholesterol esterification (GO:0010872),-0.5679514187835022,-1.3174434159644353,0.16267123287671234,0.2814986036860537,1.0,2/10,0.54%,APOE;ABCG1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.5584611293353847,-1.3174105830639768,0.13636363636363635,0.2812900648495495,1.0,6/11,20.56%,RUNX1;RUNX3;CBFB;LGALS9;HMGB1;CD274
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.4825648176566821,-1.3170530563419731,0.14814814814814814,0.28159466834159996,1.0,9/17,33.13%,SELENOS;DERL1;SEL1L;HSP90B1;HM13;FAF2;VCP;AUP1;RHBDD1
prerank,protein localization to cell junction (GO:1902414),0.45774420883313416,1.3169639609805075,0.12933025404157045,0.38471017987066297,1.0,3/22,1.75%,NLGN1;TJP1;PCLO
prerank,regulation of vasoconstriction (GO:0019229),0.4294237161786602,1.3168091111314968,0.12837837837837837,0.38379709112327104,1.0,11/27,14.70%,CHRM3;KCNMB2;SMTNL2;ADRA1B;OXTR;AGTR1;PER2;ADRA1D;ADRA1A;ZDHHC21;ECE1
prerank,sphingosine biosynthetic process (GO:0046512),-0.5553850888770198,-1.3167639752017606,0.16026711185308848,0.2815232582030658,1.0,6/11,25.06%,SPTLC2;ACER3;SPHK2;SPTLC3;ASAH1;ABCA2
prerank,sphingoid biosynthetic process (GO:0046520),-0.5553850888770198,-1.3167639752017606,0.16026711185308848,0.2815232582030658,1.0,6/11,25.06%,SPTLC2;ACER3;SPHK2;SPTLC3;ASAH1;ABCA2
prerank,regulation of synapse organization (GO:0050807),0.4343291334367146,1.3166096556265443,0.11138014527845036,0.382992638780442,1.0,3/26,2.26%,CTNNA2;IL1RAPL1;CDKL5
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5496616194700348,1.3164898667758167,0.15151515151515152,0.38200892130929254,1.0,2/11,6.77%,AKAP6;KCNIP2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.41156090249037586,-1.3164432100975303,0.10975609756097561,0.2817862040404754,1.0,12/37,22.51%,NUPR1;BCL2L11;BCL2;GSDME;FIS1;STYXL1;LCK;BBC3;BID;RPS3;RACK1;BECN1
prerank,positive regulation of DNA repair (GO:0045739),-0.39221210253888067,-1.316393498571138,0.08551483420593368,0.2816200740825621,1.0,21/46,19.36%,SPIDR;BRCA1;ERCC6;DHX9;ABRAXAS1;EYA4;BABAM2;CEBPG;MGMT;RNF8;HDAC10;TIMELESS;PCNA;BABAM1;TMEM161A;EYA1;EYA3;RPS3;WRAP53;BRCC3;HMGB1
prerank,myotube differentiation (GO:0014902),0.4750142964719501,1.3160890297900136,0.13318284424379231,0.381603304461205,1.0,3/17,2.80%,ADGRB3;ADAM12;KCNH1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.43051398498398324,-1.3154448349749799,0.1152542372881356,0.2828915517648704,1.0,12/30,28.80%,CD44;CD74;RTEL1;TPT1;DYRK1A;TMEM161A;RPS3;KDM1A;SNAI2;DDX39B;BCL2L1;PTTG1IP
prerank,tRNA processing (GO:0008033),-0.37623914367058914,-1.3151854112235446,0.07165605095541401,0.28301951769147443,1.0,30/61,35.14%,FARS2;ADAT1;METTL1;SARS1;ELP5;TSEN54;ANKRD16;QTRT1;TRMT6;ADAT2;KARS1;DDX1;TYW5;AARS1;THUMPD1;ELAC2;RPP40;CPSF1;ZBTB8OS;THG1L;CTU2;POP1;FTSJ1;CTU1;TRMT61A;TRNT1;RTCB;TRMT10B;PTCD1;CDKAL1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.5532350252131573,-1.3148186997055338,0.14930555555555555,0.28333552136876267,1.0,3/12,5.01%,CD44;CD74;BCL2
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.3903467403235083,-1.314758306712267,0.09836065573770492,0.28315240778710765,1.0,17/47,27.39%,TAOK3;IGF1R;RAP2A;EIF2AK2;TAOK1;MAP2K1;GREM1;TAOK2;LGALS9;NOD2;COPS5;AGER;MAP4K4;MAPK1;MYC;MID1;MAPK8IP3
prerank,positive regulation of cell population proliferation (GO:0008284),-0.28924595999412633,-1.3144722321585054,0.0074850299401197605,0.28333280532090804,1.0,124/423,24.85%,PID1;RBPJ;LYN;PTPRC;PRKCH;FOXP1;IGF1;NAMPT;CD74;GAB2;SDCBP;CDK6;ACER3;HPSE;INSR;IGF1R;CSNK2A1;C5AR1;CDK13;IL6R;HTR2B;IL15;EAPP;IL18;FLT1;TCIRG1;DHX9;DPP4;PIM1;PTK2B;ITGAV;BCL2;KIF20B;RPS6;STX3;FN1;SLC35F6;CHTOP;GCNT2;GAS6;EZH2;GRN;GRK5;VEGFA;NME1;E2F1;MDK;CNBP;RPS15A;BST2;PRMT1;TGFBR1;ITGB1BP1;PTPN6;MEF2C;TBC1D8;CTSH;NES;RPS4X;RELA;KIF14;AGT;ITGAX;IL7R;XBP1;OSR1;KMT2D;CCL5;CACUL1;CIB1;GLP2R;TGFBR2;GREM1;S100A6;ID2;CAPNS1;DOT1L;IL34;CRKL;TTK;IL31RA;BST1;HCLS1;CNOT6L;STX4;RPS9;IRS2;RARA;KRAS;SERTAD1;HCK;PDGFRB;MEIS3;NOD2;RBPMS2;IL7;WDR77;CSF1;CHP2;CNOT8;PRC1;MAZ;SFRP1;TIPIN;STAT1;KDR;PDGFA;KDM1A;TBX2;FGF18;S1PR2;IL6;KITLG;TGFB1;HMOX1;CD47;MAP3K3;FGF9;FLT3;SHC1;MYC;PKHD1;RNF187;FGFR4
prerank,microglial cell activation (GO:0001774),-0.4655413702771,-1.3142352800710353,0.1146384479717813,0.2834702478798233,1.0,8/21,24.41%,ITGB2;C1QA;C5AR1;GRN;APP;AGER;IFNGR1;ITGAM
prerank,protein targeting to lysosome (GO:0006622),-0.4736722355401416,-1.3137643868483124,0.12392426850258176,0.28398833756547887,1.0,8/20,20.48%,RAB7A;GGA3;LAMP2;LAPTM5;AP3M1;GNPTAB;SNX16;VPS4A
prerank,signal transduction in response to DNA damage (GO:0042770),-0.38191325308235663,-1.3133571406393754,0.09421487603305785,0.28438704313261653,1.0,17/49,21.01%,GRB2;MAP3K20;ERCC6;MAPK14;BATF;RAD1;E2F1;GADD45A;RHNO1;DOT1L;BID;BRIP1;RAD9A;MDM4;ATM;CHEK1;NBN
prerank,pulmonary valve development (GO:0003177),0.46781247441744644,1.3124548421002333,0.11645569620253164,0.38752256221233156,1.0,3/18,1.35%,ROBO1;ROBO2;SLIT2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.4575939618362354,-1.3124467026873978,0.12690355329949238,0.2855545836793979,1.0,10/23,21.62%,SPI1;ADIPOR1;IFI35;PPM1B;RELA;NLRC3;TMSB4X;DDX3X;ZC3H12A;NLRP3
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5555812805107861,-1.3124112909991503,0.13402061855670103,0.28535206700990084,1.0,4/11,9.97%,ATP6V1A;ATG7;TMEM199;ATP6V1G1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.5756550192339229,-1.3119727336256697,0.15344827586206897,0.28578966710838183,1.0,4/10,18.28%,PIBF1;PARP14;NF2;SOCS3
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.5135034876104032,1.311296548429876,0.14350797266514806,0.3885464025659779,1.0,6/13,14.82%,ADCY8;SHANK3;ADCY1;RELN;LGMN;CHRNA7
prerank,regulation of cardiac conduction (GO:1903779),0.36719674840418415,1.3110547376978985,0.07175925925925926,0.387789352037307,1.0,16/54,14.48%,ANK2;RYR3;RYR2;SLC8A3;TRPC1;CORIN;AHCYL1;CASQ2;ATP1A3;FXYD6;SLC8A2;RYR1;ATP1B1;ATP2B4;ATP2B2;ATP2A1
prerank,negative regulation of innate immune response (GO:0045824),-0.4252715004415396,-1.310941789086561,0.10580204778156997,0.2872206822202027,1.0,10/34,13.11%,SAMHD1;YTHDF3;USP18;DHX58;NLRC5;IRAK3;GRN;NLRC3;OAS3;VSIG4
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.4460302185223289,-1.3108757802017479,0.13518197573656845,0.28708126781100324,1.0,9/24,22.95%,NIBAN2;BLM;RTEL1;DFFA;ERCC4;KMT2A;RPS3;BMPR2;ZRANB3
prerank,protein localization to lysosome (GO:0061462),-0.4320300266630198,-1.3105574393763246,0.12054329371816638,0.28733883706483565,1.0,11/28,23.59%,RAB7A;GGA3;MFSD1;LAPTM5;AP3M1;RNF128;SNX16;LMBRD1;VPS4A;GLMP;KPTN
prerank,positive regulation of MAPK cascade (GO:0043410),-0.3017210421429277,-1.310498599229047,0.016793893129770993,0.2871755843496629,1.0,38/245,10.46%,IQGAP1;PTPRC;APOE;NRP1;CD44;TAOK3;IGF1;NOTCH2;BCAR3;CD74;MFHAS1;PLCG2;CD36;ROCK1;PTPRJ;PIK3R5;INSR;IGF1R;C5AR1;ARRB2;HTR2B;RAP1A;CCR1;FLT1;PTK2B;PTPN22;PIK3CG;ARRB1;GCNT2;GAS6;EZH2;VEGFA;EIF2AK2;LAPTM5;GSDME;ADAM8;SPRY2;TAOK1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.47213609007346696,-1.3103122840475514,0.1280388978930308,0.28725570611475754,1.0,7/20,12.70%,CDK6;CTR9;HSPA9;PTK2B;PF4;PRMT1;CIB1
prerank,actin cytoskeleton reorganization (GO:0031532),-0.37013472325025026,-1.3100186501989644,0.08166666666666667,0.28749187765417133,1.0,11/63,5.43%,NEDD9;NRP1;GRB2;PLEK;MYH9;RHOA;FLNA;RAP2A;MINK1;PARVB;ANXA1
prerank,regulation of protein kinase B signaling (GO:0051896),-0.31565005502893617,-1.309011720866995,0.03376205787781351,0.28890428032783755,1.0,40/193,12.70%,OSBPL8;BANK1;GRB2;GAB2;MFHAS1;XDH;AXL;RAC1;PTPRJ;HPSE;PIK3R5;INSR;IGF1R;P2RX4;PIK3AP1;VAV1;ARRB2;RNF41;IL18;ITGB1;PIK3CB;HGF;PIK3CG;GCNT2;GAS6;HIP1;FRS2;TGFBR1;RCN3;CD28;ITGB1BP1;ADAM8;SPRY2;LCK;STRN;FLCN;PIK3CA;F7;HSP90AB1;CIB1
prerank,lipid catabolic process (GO:0016042),-0.4846523462945991,-1.3089279116396884,0.1373913043478261,0.28878115485387235,1.0,8/18,29.61%,LPL;PLAAT3;SIRT2;PPT1;LIPE;MT3;LIPH;HSD17B14
prerank,regulation of smooth muscle contraction (GO:0006940),0.4714328086574214,1.3087054634707498,0.12441314553990611,0.39125361871915904,1.0,7/20,15.27%,KCNB2;CHRM2;CHRM3;PLCE1;MYOCD;ZDHHC21;SETD3
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.44205868905506984,-1.308619338510401,0.14675767918088736,0.28903232211134056,1.0,8/26,10.11%,CCR2;HPSE;BRCA1;SARS1;C3;SULF2;HIF1A;ARNT
prerank,antibacterial humoral response (GO:0019731),-0.5035673113050995,-1.3084195387724928,0.1388888888888889,0.289075151424646,1.0,7/16,23.52%,RNASE7;RNASE6;CAMP;DEFA6;ANG;PLA2G6;RPL39
prerank,nuclear pore organization (GO:0006999),-0.5164032569332406,-1.3083790898743604,0.13250883392226148,0.2888693618848293,1.0,5/14,20.69%,NUP205;TPR;NUP153;NUP35;NUP107
prerank,regulation of cell division (GO:0051302),-0.36287412250017864,-1.3079338593926497,0.08094435075885328,0.28933745336519306,1.0,26/72,24.86%,ZFYVE26;BIRC6;HTR2B;UVRAG;BLM;PLK2;PIN1;FLCN;CIB1;PLK3;SH3GLB1;KIF20A;AURKA;KIF18B;CDK2AP2;PRC1;TXNIP;CSPP1;RAB11A;SIRT2;CETN2;RACK1;SFN;BECN1;MYC;SMYD5
prerank,lipid homeostasis (GO:0055088),-0.3750927508440764,-1.3079109020871165,0.09427609427609428,0.2891000824521647,1.0,19/57,26.48%,APOE;ABCA1;ABCG1;PPARG;USF2;RCN3;TLCD2;ZBTB20;XBP1;ABHD5;ACOX1;IRS2;DDX3X;TLCD1;ACOXL;THADA;ABCA2;PNPLA8;ORMDL2
prerank,protein polymerization (GO:0051258),-0.37817992039687476,-1.3078922055369815,0.07692307692307693,0.2888665423697009,1.0,19/55,22.40%,DIAPH1;GAS7;RAC1;PSTPIP2;PSTPIP1;WASL;CKAP5;CORO7;MSRB1;DIAPH3;PIN1;GPX4;CHMP2A;ANG;UBE2C;TTC17;RNF135;CHMP4B;CHMP4A
prerank,positive regulation of neuron differentiation (GO:0045666),0.40022194482453743,1.307792290982935,0.12009237875288684,0.39191130906400584,1.0,11/40,12.75%,BRINP3;BRINP1;SOX11;NRCAM;ZEB1;VWC2;HOXD3;ADRA2C;NEUROD1;NBL1;REST
prerank,negative regulation of cation channel activity (GO:2001258),0.4261471687751521,1.3074291241339147,0.1497584541062802,0.3914501319124037,1.0,11/26,20.78%,GNB5;CASQ2;FMR1;CALM1;CALM3;CALM2;CBARP;CRHR1;GPR35;UBQLN1;KCNAB1
prerank,granulocyte chemotaxis (GO:0071621),-0.3786538589037415,-1.307206676289531,0.10147299509001637,0.2897042271466441,1.0,12/55,13.40%,SYK;ITGB2;CKLF;ANXA1;PF4;PIK3CG;JAML;NCKAP1L;CCL5;CXADR;FCER1G;PIK3CD
prerank,cell cycle checkpoint signaling (GO:0000075),-0.5375919437651502,-1.3071744690216995,0.14210526315789473,0.2895180085150231,1.0,6/12,17.49%,NABP1;PLK2;ZWILCH;BUB1;BUB1B;WEE1
prerank,regulation of protein ubiquitination (GO:0031396),-0.3390716529015783,-1.3053898898122847,0.06414473684210527,0.29215038501744056,1.0,27/108,19.34%,SASH1;BIRC3;OGT;MALT1;BRCA1;ARRB2;AXIN1;ARRB1;WFS1;LAPTM5;DNAJA1;TGFBR1;UBE2L3;SPRY2;PRMT3;DERL1;UBE3A;HSP90AB1;NSMCE3;ISG15;TBC1D7;HSPA1A;SMAD7;RPS3;HUWE1;NDFIP2;UBXN1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.40842391139425904,-1.3051024773006075,0.11643835616438356,0.2923377697923114,1.0,20/39,26.24%,PI4K2A;ITPKB;PIP4K2A;PI4K2B;PIK3CB;TMEM150A;PIK3CG;PI4KB;TTC7A;PIK3CA;SOCS6;PIK3CD;PIK3C2A;SOCS3;IP6K3;SOCS5;SMG1;ITPKC;PIK3C2G;IP6K1
prerank,regulation of autophagosome assembly (GO:2000785),-0.42496485617967483,-1.304849025845159,0.11716171617161716,0.29247524214642806,1.0,13/33,25.71%,NUPR1;MTM1;PIP4K2A;IFT20;MTMR3;RAB3GAP1;RAB5A;SH3GLB1;RALB;CHMP4B;CHMP4A;RAB1B;LRSAM1
prerank,protein-containing complex disassembly (GO:0032984),-0.37696099186262844,-1.304359644689818,0.09982174688057041,0.2930424301388595,1.0,25/54,32.35%,TECPR1;UVRAG;LAMP2;TSG101;AXIN1;LRP6;CTNNB1;PPP1CA;EPG5;LIX1;GABARAP;CLN3;VPS33A;GSK3B;VPS4A;VPS16;DVL2;MYC;FZD1;VCP;HSPA8;FRAT1;STX17;GABARAPL1;CAV1
prerank,glucose import (GO:0046323),-0.5369310829367236,-1.3041796653014792,0.14756944444444445,0.29308679716897584,1.0,3/13,7.63%,SLC27A1;SLC2A1;ZDHHC7
prerank,regulation of neuroinflammatory response (GO:0150077),-0.4772332897427744,-1.304064650123499,0.14457831325301204,0.29300524953212814,1.0,4/19,4.21%,IGF1;NUPR1;TNFRSF1B;IL18
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.2625387632930289,-1.3038884407233866,0.0,0.29304844715858974,1.0,429/1646,23.04%,RBPJ;MDFIC;APOE;MITF;ZMIZ1;ZEB2;MAP3K5;FLI1;ELF4;FOXP1;RUNX1;PRKCB;TRPS1;IGF1;BACH2;TFEB;CD38;CD74;SP100;TCF4;RCOR1;RREB1;ELF2;REL;LITAF;TRAK1;BCL6;WWP1;MIDEAS;RB1;JUN;PEX14;DNM2;NIBAN2;ZNF568;MEF2A;CREBBP;ETV6;DEK;RUNX3;PPARD;OGT;ARID5B;ANXA4;BPTF;ZBTB34;BACH1;TOX2;NFE2L2;BRD7;INSR;PHF20;CCNL1;RNF111;IRF2;ZNF148;APBB2;SBNO2;NFIC;BRD4;NFX1;NFYA;ARID1B;ZSCAN12;ATF3;ATAD2;ELF1;NSD3;UBP1;PPARG;KDM3A;ELK3;GATAD2A;PIAS1;SMARCA5;SPI1;BRCA1;FOXN2;WWP2;JMJD1C;ZNF3;ETV1;CTR9;STAT3;KLF13;ERCC6;FOXO3;E2F2;IKZF1;LYL1;ZSCAN26;STAT6;DHX9;USF2;NIPBL;RYBP;CHD3;SNX6;RNF20;NFKB1;CNOT2;HHEX;ZBTB21;RUNX2;SMARCD3;FBXW11;PRMT2;SAP30;CENPF;MLXIP;IRF5;CRLF3;SNX5;MAF;MEF2B;DAPK3;KLF6;SMARCC2;BLM;GPBP1L1;TCF20;NR1H2;MAPK14;CIITA;AXIN1;CUX1;BATF;CBFA2T3;NRF1;TEF;KDM7A;ETV3;GON4L;LRP6;NFATC3;ARRB1;KDM3B;SRRT;FUS;PICALM;ZBTB2;CDK18;MYNN;MED24;AHR;CTNNB1;TBL1XR1;GAS6;GCFC2;KLF3;CAMKK2;EZH2;PBXIP1;JARID2;DPF2;REXO4;STAT5B;POFUT1;STAT4;ATF6;EDF1;NR2F1;CREB3L2;KDM2A;VEGFA;BHLHE40;EED;E2F1;CNBP;ARID1A;ATMIN;RNF4;SPEN;TGFBR1;THAP1;WBP2;CEBPG;E2F3;SP110;CDK14;CBFB;POLR3G;MEF2D;PARP9;DDX5;TGFB1I1;METTL4;HIF1A;MEF2C;POLR2L;TFEC;OLIG2;FOXN3;UBE2L3;SP140;NUCKS1;EGR1;SUDS3;ARNT;HDAC10;BAZ2B;AFAP1L2;HP1BP3;PROX2;CIART;RELA;AGT;ZNF569;IKZF3;ZBTB20;NCF1;TIMELESS;CCNL2;XRCC6;ZNF319;OSR1;ARHGEF11;DYRK1A;CHMP1A;CRK;MAP2K1;PCNA;KLF10;MED4;PRDM2;NFE2;KMT2D;MLLT11;SALL3;SPIN1;FOXJ1;HTATIP2;ZFP57;ARID3B;CHD8;FOSL2;MLLT6;KAT7;BAZ1A;CCDC85B;TCF7;HMGB2;ZFP41;ZFX;SPTY2D1;MED31;MTA3;IRF2BP2;HDAC5;TGIF1;SP2;DHX36;RXRA;FOXJ3;CALCOCO1;CREG1;E2F8;TFAP4;POLR2A;ZNF326;RPL6;BATF3;WAC;SIN3A;CALCA;EPC1;PSPC1;BTG1;KLF2;ID2;ZBTB46;TFAM;TCF3;IKBKB;ZNF628;YY1;SPP1;RELB;RGS14;CCNE1;ZMIZ2;PRMT6;NSD1;MAP3K10;TFCP2;AATF;KARS1;MED13L;IL31RA;KLF8;DNAJC2;ZNF177;BTAF1;HR;SRSF10;MRGBP;PHC3;QRICH1;HCLS1;NR4A1;BRIP1;ZBTB12;KMT5A;KLF11;IRX5;IKZF4;SOX10;PHF20L1;UBE2I;FOXJ2;ATXN1;ELP4;VHL;KMT2A;UXT;ZBTB25;MAP2K3;GPATCH3;RARA;NFATC1;CSRNP1;ZBTB24;ATF5;LIMS1;MED6;REPIN1;SMAD7;NR3C1;TFE3;BRD2;GATA3;MYB;SAMD1;PPARGC1B;ARID5A;TCF12;NCOA6;RBBP8;HTATSF1;PLAG1;GMEB2;CXXC1;TRIM16;HAS3;CASZ1;ID1;RSF1;PITHD1;NUP35;MEIS3;HOXD8;PAK6;MDM4;HMGB1;HMGB3;MED20;WDR77;LCORL;ELOC;NAA16;DBX2;MAX;SP9;KDM5B;LIN9;SUFU;EHF;BRD9;CDK16;MMS19;CIC;BAP1;ZFP28;CBFA2T2;RLF;MAZ;SIRT2;NUP107;PKNOX1;DTX3L;ATF7;SFRP1;ZFPL1;STAT1;RAI1;ZFP2;POU3F1;GTF2IRD1;LRRFIP1;ZSCAN21;CDK5;KDM1A;HOXB2;ZKSCAN1;NUP62;HNRNPK;CCNK;ID3;SMURF2;ZBTB7A;TBX2;HEYL;SNAI2;CEBPB;EGR2;BBX;SET;ZNF296;BARX2;RPS6KA5;MYRFL;MTF1;TADA1;ILK;SCMH1;NR1H4;IL6;MED18;EID2;CDC45;TCIM;HOXD9;CRYAB;HES7;CHD7;NONO;ESR2;SOX7;E2F5
prerank,ESCRT complex disassembly (GO:1904896),-0.5714225679317129,-1.3038680074427733,0.16489361702127658,0.2925463680278779,1.0,9/10,33.62%,CHMP5;CHMP7;CHMP1A;CHMP2A;VPS4A;CHMP2B;VPS4B;IST1;VTA1
prerank,ESCRT III complex disassembly (GO:1904903),-0.5714225679317129,-1.3038680074427733,0.16489361702127658,0.2925463680278779,1.0,9/10,33.62%,CHMP5;CHMP7;CHMP1A;CHMP2A;VPS4A;CHMP2B;VPS4B;IST1;VTA1
prerank,nitric oxide metabolic process (GO:0046209),-0.5215114025339069,-1.303839789426616,0.15505226480836237,0.29232791586891427,1.0,6/14,24.03%,CYB5R3;CYB5B;GCH1;ARG2;CYP1B1;NQO1
prerank,histone H3-K4 methylation (GO:0051568),-0.4431220726323672,-1.3032408611268436,0.1265377855887522,0.2931119673060053,1.0,13/26,28.48%,TET3;OGT;CTR9;WDR5;KMT2C;KMT2D;TET2;KMT2A;CXXC1;RBBP5;ASH2L;KDM6A;WDR5B
prerank,cellular response to calcium ion (GO:0071277),0.343220853593821,1.3028741963490214,0.085,0.399358419623952,1.0,18/67,13.01%,NLGN1;RYR3;SYT1;ADCY8;SYT10;KCNH1;SYT2;CPNE4;SYT5;ADGRV1;ADCY1;SYT11;SYT12;RYR1;CAPN3;CPNE8;PPIF;SYT7
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.4769261378373144,-1.3023326855974229,0.13485113835376533,0.29438067191616785,1.0,3/20,1.73%,IGF1;RB1;NIBAN2
prerank,nuclear pore complex assembly (GO:0051292),-0.5713927091228066,-1.3023123995018375,0.13884007029876977,0.2941466396463158,1.0,4/10,20.69%,NUP205;TPR;NUP153;NUP107
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.4809575632135065,-1.3017020757605406,0.13380281690140844,0.2948588811656517,1.0,8/18,27.34%,RIPK1;DDX5;MAP2K1;ZC3H12A;IL6;TGFB1;NCOR1;ESR1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.40766123348255784,-1.3010152680090992,0.12937062937062938,0.29570913367175156,1.0,6/36,9.13%,APOE;DNM2;HTR2B;PIK3CB;WASL;HIF1A
prerank,myeloid dendritic cell activation (GO:0001773),-0.5367683561944014,-1.3009176949045578,0.15824915824915825,0.29560702789419374,1.0,5/12,19.36%,DOCK2;BATF;TGFBR2;BATF3;HMGB1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.453392764093807,1.3006330260136536,0.1318181818181818,0.4027273048692501,1.0,3/20,1.22%,CHRM2;PLCB1;CHRM3
prerank,regulation of protein catabolic process (GO:0042176),-0.33737863745427943,-1.3004191501771079,0.05663430420711974,0.2961936648682221,1.0,39/99,26.85%,WWP1;RAB7A;SNX3;FLNA;CSNK2A1;WWP2;RNF41;AREL1;ATG7;CTSA;TIPARP;AXIN1;IRAK3;PLK2;AZIN1;SF3B3;PIN1;NEDD4L;ZDHHC2;ASB5;WDR91;STX5;EEF1A1;FAF1;RILP;HUWE1;FAM83D;MDM4;GSK3B;SIRT2;SMURF2;GFAP;OAZ3;FURIN;RAB26;DDB1;VIP;SMURF1;VCP
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4398299855500485,1.300327355114847,0.12780269058295965,0.4021259370948435,1.0,5/24,4.86%,TMEFF2;TJP1;ARHGAP6;CLASP2;DLC1
prerank,neutrophil migration (GO:1990266),-0.37468830381615065,-1.2997230952508587,0.08514190317195326,0.29705597607257644,1.0,27/58,36.42%,SYK;ITGB2;CKLF;IRAK4;PF4;PIK3CG;JAML;NCKAP1L;CCL5;CXADR;FCER1G;PIK3CD;PPIB;PIP5K1C;CCL7;PRTN3;PECAM1;CCL24;CD177;CXCR2;CCL4;CCL25;CCL19;EDN3;CCL8;CXCL9;EDN2
prerank,regulation of translation (GO:0006417),-0.31269605582536214,-1.2996701927050662,0.04813664596273292,0.2968740974528514,1.0,52/173,22.81%,DAPK1;VIM;NIBAN1;YTHDF3;GAPDH;GSPT1;NSUN3;FOXO3;CNOT1;DHX9;DAPK3;KLHL25;EIF4G3;PUS7;EIF4A2;PUM3;EIF5;ALKBH1;EIF2AK2;LARP4B;PCIF1;CD28;LARP4;RPS4X;MTPN;EEF2;CSDE1;APP;EIF3E;METTL14;DHX36;NOLC1;NCBP1;EIF4G1;NCL;DDX1;EIF2A;RBM4B;TOB1;RPS3;HSPB1;DDX3X;EIF5B;CNOT8;DDX6;RBM3;LSM14A;RACK1;EIF3H;SHMT1;IL6;PRKDC
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.48608284374135885,1.299279496194678,0.17942583732057416,0.4029900099892871,1.0,3/13,8.65%,NR3C2;PGR;BMP7
prerank,neurotransmitter uptake (GO:0001504),0.5177685494491405,1.2988149788044578,0.16461916461916462,0.40268819911075054,1.0,3/12,7.03%,SNAP25;SLC1A6;GLUL
prerank,icosanoid secretion (GO:0032309),-0.5361757267730913,-1.2984776695870703,0.1392857142857143,0.29852744649589064,1.0,7/12,39.07%,ANXA1;ABCC4;PLA2G5;PNPLA8;ACE;NOS2;NMUR2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.4789580970834279,-1.298352543303885,0.17043478260869566,0.29846538548047213,1.0,11/20,30.66%,PID1;DAB2;RHOQ;PICALM;PPFIA1;TMEM59;TGFB1;PPP2R5A;LZTFL1;BCL2L1;ABI3
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.49496362970146657,-1.2983224804926579,0.15292096219931273,0.2982450805653308,1.0,6/16,18.28%,PIBF1;PARP14;ADIPOR1;NF2;VHL;SOCS3
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5624370684437382,-1.298002994071483,0.14864864864864866,0.2984953851606328,1.0,6/10,27.85%,SMARCD3;CTNNB1;VEGFA;DISC1;KDM1A;DCT
prerank,regulation of stem cell differentiation (GO:2000736),-0.33897324176887833,-1.2971307776598395,0.07142857142857142,0.2996461383569469,1.0,28/89,20.83%,RUNX1;NELFB;PSME4;PSMB7;PSME3;PSMB9;JAG1;PUS7;EIF2AK2;CBFB;PSMA8;PSMC3;NUDT21;PSMD8;PSMC4;PSMB10;PSMA1;TCF3;PSMB8;KMT2A;GATA3;MYB;TCF12;LMO2;PSMA5;PSMD4;PSMB3;PSMD3
prerank,amino acid transmembrane transport (GO:0003333),-0.3921202931623497,-1.297100963908915,0.11623931623931624,0.29942647245973925,1.0,11/45,14.82%,LRRC8D;SLC38A6;SLC6A6;MFSD12;SLC38A10;SLC7A7;SLC38A7;SLC36A4;SFXN2;SLC7A5;SFXN1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.5383262672256144,-1.2965544319965718,0.15478260869565216,0.3000347629168371,1.0,5/12,21.77%,SNX3;CIITA;IFITM2;TRIM11;IFITM1
prerank,negative regulation of immune response (GO:0050777),-0.31560838991615064,-1.296372924153386,0.031201248049921998,0.3000687016440671,1.0,22/154,8.22%,LYN;FGR;CCR2;CD163;LILRB1;SYK;PLCG2;GNB1;CD300A;MYH9;ADCY7;SPI1;DHX58;RC3H1;PTGER4;MAPK14;GNG2;IRAK3;PPM1B;PLK2;CYSLTR1;RHBDF2
prerank,sensory perception of chemical stimulus (GO:0007606),0.49251089155553146,1.2958148294455705,0.14549653579676675,0.40762285053503083,1.0,6/15,14.29%,SLC24A4;SYT10;ADCY3;UBR3;MKKS;GNAL
prerank,regulation of myotube differentiation (GO:0010830),-0.45195852697654887,-1.2956432128453708,0.12937062937062938,0.3010112739267405,1.0,7/24,13.52%,PIEZO1;MAML1;MAPK14;SIK1;XBP1;HDAC5;SMYD1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5441112515501099,-1.2956377783272708,0.15017064846416384,0.3007493564004709,1.0,4/11,10.53%,DAB2;MSN;RAB21;EIPR1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.4485840378709709,-1.2956184659200838,0.1342512908777969,0.3005109949165164,1.0,8/24,18.95%,DCP2;TNKS2;ERCC4;TEN1;SLX4;TENT4B;HNRNPA1;EXOSC10
prerank,error-free translesion synthesis (GO:0070987),-0.45686960994186765,-1.295595790668436,0.15482695810564662,0.30027745196116407,1.0,9/22,26.85%,RFC1;UBC;RPS27A;PCNA;RPA3;RFC2;RFC3;POLDIP2;VCP
prerank,post-translational protein modification (GO:0043687),-0.2916013714481565,-1.2953740665482747,0.016105417276720352,0.300360412547521,1.0,87/332,20.89%,APOE;FAM20C;DDB2;FBXW8;PSME4;ATG5;PSMB7;PSME3;RAB1A;FBXO32;FBXW11;UBXN7;PSMB9;KLHL25;FBXL20;DCAF10;FN1;C3;KLHL22;NUB1;LRRC41;GAS6;DCAF8;WFS1;GPS1;WDR5;RAB5A;HIF1A;SPSB2;PSMA8;SUMF2;PTP4A2;CP;PSMC3;APP;SPSB3;RAB11B;CUL4B;HSP90B1;PSMD8;ASB5;COPS6;IGFBP3;FBXO10;LGALS1;PSMC4;PSMB10;SOCS6;FBXW2;MIA3;CUL2;PSMA1;SPP1;KLHL42;MFGE8;CST3;RAB13;APLP2;RABGGTA;ASB4;PSMB8;DNAJC3;FBXL8;VHL;SKP2;WSB2;FBXO7;SOCS3;UBE2M;SHISA5;RABGGTB;COPS5;ELOC;FBXO31;CSF1;PSMA5;PSMD4;STT3B;PSMB3;FBXO22;ESCO2;F5;RAB11A;COPS4;FBXW4;PSMD3;COPS8
prerank,cellular response to metal ion (GO:0071248),0.3123073168944636,1.2953070273796552,0.06818181818181818,0.4073952936664769,1.0,32/123,14.45%,NLGN1;DLG2;ANK3;RYR3;SYT1;ADCY8;SLC12A2;GLRA1;SYT10;KCNH1;SYT2;TIGAR;CPNE4;PRNP;SYT5;KCNA1;ADGRV1;ADCY1;SYT11;SYT12;GLRA2;SLC13A5;TFAP2A;RYR1;CAPN3;CPNE8;HSF1;PPIF;SYT7;PRKN;CDH1;LGMN
prerank,negative regulation of neuron differentiation (GO:0045665),0.44835115351500376,1.2946457781931855,0.13752913752913754,0.4075532017633299,1.0,8/22,17.30%,CNTN4;SOX9;BMP7;POU4F2;HES5;REST;HES1;HES3
prerank,DNA methylation (GO:0006306),-0.45708167394330634,-1.293870171812244,0.14839797639123103,0.30258369543537406,1.0,4/23,12.31%,DNMT3A;GATAD2A;METTL4;ZFP57
prerank,axonemal dynein complex assembly (GO:0070286),0.4175948101919323,1.29376848993889,0.12796208530805686,0.40796548649786657,1.0,6/27,10.14%,DNAAF3;DNAI4;ODAD3;DNAH17;DNAAF4;CFAP73
prerank,nucleus organization (GO:0006997),-0.37945237161994205,-1.293536794460739,0.11433447098976109,0.30285728227400205,1.0,18/47,22.40%,PDCD6IP;ATXN7;CHMP5;USP36;SUN2;NUP205;CHMP7;WDR73;CHMP1A;TPR;LEMD2;CHMP2A;CEP55;NUP35;VPS4A;REEP3;CHMP4B;CHMP4A
prerank,RNA catabolic process (GO:0006401),-0.3858791624781128,-1.2932992126280696,0.12773109243697478,0.30299027400832396,1.0,27/46,41.89%,ERN1;DCP2;RNASE6;FEN1;NCBP1;HSPA1A;LSM6;DNA2;LSM5;XRN2;MTREX;SND1;NUDT16;ZC3H12D;RNASEH2B;METTL3;ISG20;NUDT12;HSPA1B;SLFN14;AGO3;ZFP36;RNASE3;DXO;YTHDF2;RNASEH2A;METTL16
prerank,regulation of cellular catabolic process (GO:0031329),-0.3654637286703325,-1.2932215830048934,0.08538587848932677,0.3028583700822408,1.0,10/62,5.42%,DAPK1;PSAP;GPR137B;ROCK1;NUPR1;ITPR1;PIP4K2A;ABL2;MTMR3;DAPK3
prerank,regulation of centrosome duplication (GO:0010824),-0.42582321012869695,-1.2930525462129643,0.12717770034843207,0.30288841455295995,1.0,15/29,26.35%,PDCD6IP;CEP295;CHMP5;PLK2;CEP295NL;GEN1;CHMP1A;CHMP2A;STIL;XRCC3;CCNF;CHMP4B;PKHD1;CHMP2B;ALMS1
prerank,early endosome to late endosome transport (GO:0045022),-0.473059101402089,-1.2921502975706287,0.14802631578947367,0.3040810665013354,1.0,8/20,18.08%,RAB7A;KIF16B;STX8;EEA1;RAB5A;WDR91;SNX16;RILP
prerank,negative regulation of response to stimulus (GO:0048585),-0.37038135576301423,-1.2911955938545232,0.09375,0.30530215000467975,1.0,22/60,28.75%,LYN;VPS13C;MCTP1;CDK6;NR1H2;WFS1;MAP2K5;MAPK7;IGFBP3;FCGR2B;BRAP;APPL2;LPCAT3;UBASH3B;PTPN1;SOCS5;MAP3K3;KIF26A;FCRLB;CASK;SLC30A10;SPINK5
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.5200572437420339,-1.2911016919128526,0.17513134851138354,0.305186106218453,1.0,7/14,18.15%,CARD11;RELA;LCK;RAB29;CD226;TESPA1;RPS3
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.4739386182588561,-1.290876758758042,0.14310344827586208,0.30529347322305267,1.0,6/18,11.81%,LYN;CAMK1D;IL6R;PTK2B;MDK;F7
prerank,aortic valve development (GO:0003176),0.3925973753802411,1.2907710477101841,0.12755102040816327,0.41270680214874694,1.0,7/34,10.02%,ROBO1;ROBO2;SLIT3;SLIT2;TIE1;SOX9;SNAI1
prerank,neural crest cell differentiation (GO:0014033),0.4682562760802177,1.2906669753327467,0.14496314496314497,0.4116817164510375,1.0,4/18,4.88%,NRG1;SOX11;CDH2;PDCD6
prerank,ribosome assembly (GO:0042255),-0.38750700664076043,-1.29056839269804,0.11359724612736662,0.30552031429637444,1.0,20/47,26.05%,RPL11;ERAL1;RPS14;RPS28;DHX37;EFL1;MRPS11;RPL6;EIF2A;RPS27;MRPL22;RPL23A;DDX3X;C1QBP;RPLP0;BRIX1;RPS15;MRPS7;RPL5;EIF6
prerank,response to amino acid starvation (GO:1990928),-0.3507874581297157,-1.2903448814281122,0.09106239460370995,0.3056315452151286,1.0,23/72,25.87%,MAP3K5;ATP6V0D2;TFEB;ATP6V1E1;ATP6V1A;TCIRG1;EIF2AK2;ATP6V1G1;RRAGD;FLCN;SESN1;SH3GLB1;ATP6V0B;ATP6V0E1;RHEB;ATP6V0D1;CEBPB;MAPK1;WDR24;KPTN;LAMTOR1;LAMTOR3;MIOS
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.3796799851562956,-1.2892944042236796,0.11204013377926421,0.30714560719099304,1.0,26/48,36.02%,P2RX4;ANXA1;MAPK14;VEGFA;HIF1A;CIB1;CD40;TMSB4X;PIK3C2A;MAP2K3;HSPB1;HMGB1;KDR;FGF18;TGFB1;HMOX1;MAP3K3;ATP5F1B;NUS1;ETS1;ATP5F1A;FGF2;PLCG1;GATA2;SRPX2;PDGFB
prerank,cellular response to oxygen levels (GO:0071453),-0.5679967902234069,-1.289258776573288,0.15397631133671744,0.30691235962050417,1.0,9/10,41.68%,ATP6V1A;TMEM199;ATP6V1G1;ATP6V0D1;CPEB4;ATP6AP1;PICK1;CCDC115;NDUFS2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4275632592113403,1.2891563348438935,0.14728682170542637,0.4135392526085453,1.0,8/27,15.15%,ANK2;DMD;CACNB2;PDE4D;JPH4;CALM1;CALM2;JPH3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.3985219580676673,-1.2890388984180545,0.13659359190556492,0.30703074627847116,1.0,11/38,20.90%,CD36;RAC1;INSR;P2RX4;TLR4;SIRPA;HSP90AB1;KLF2;ASS1;MMP8;ZC3H12A
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.40665086145721757,-1.288867627789903,0.12222222222222222,0.3070536145556937,1.0,10/35,12.02%,ARHGAP24;ABL2;TNFAIP1;RIPOR2;KCTD10;SPRY2;RASAL3;CCDC125;FLCN;ITGA3
prerank,epithelial cell morphogenesis (GO:0003382),-0.48764827998207766,-1.288691254820042,0.1505016722408027,0.30707968908461336,1.0,12/17,35.78%,SIPA1L3;COL22A1;COL18A1;RILPL1;PKHD1;CCDC88C;RILPL2;GRHL2;MET;TNMD;CNMD;POF1B
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.49258421994087137,1.2884502335062509,0.1705607476635514,0.41382861344759947,1.0,6/15,13.86%,CELF4;RAI2;STOX2;TGFB2;UBR3;NR5A2
prerank,multivesicular body assembly (GO:0036258),-0.4286353793602848,-1.2884450824836804,0.15478260869565216,0.3072138354516149,1.0,17/30,34.65%,PDCD6IP;CHMP5;TSG101;CHMP7;CHMP1A;STAM2;CHMP2A;RAB11A;VPS4A;CHMP4B;CHMP4A;CHMP2B;MVB12A;VPS4B;IST1;VTA1;HGS
prerank,regulation of peptide hormone secretion (GO:0090276),0.3488928898586844,1.2882929753281842,0.08536585365853659,0.41294878848228395,1.0,16/67,16.06%,HTR2C;CACNA1C;CACNA1E;KCNC2;SNAP25;PAX8;ADRA2C;NEUROD1;RAPGEF4;FFAR1;PER2;SYT7;KCNS3;RFX3;GRP;PRKCA
prerank,positive regulation of organelle organization (GO:0010638),-0.4179280091678211,-1.2881578555738042,0.12351945854483926,0.30740823969287134,1.0,11/32,20.30%,P2RX7;ANXA2;UVRAG;SYNJ1;RAB3GAP1;ANXA1;KATNBL1;SHCBP1L;ADRB2;PLA2G5;GSK3B
prerank,hemopoiesis (GO:0030097),-0.34678531092359705,-1.2878057679660964,0.07462686567164178,0.30772965923488227,1.0,32/87,27.07%,PTPRC;RUNX1;NOTCH2;PLEK;ETV6;RUNX3;CDK13;RASGRP4;LYL1;FLT1;RUNX2;JAG1;FUT10;MFAP5;LCK;FLCN;TGFBR2;TET2;MKNK2;KMT2A;NCOA6;ARMC6;SFRP1;KDR;PRRC2C;KITLG;TGFB1;FLT3;TNFRSF13B;ZBTB16;ASH2L;RTKN2
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.547115309300359,-1.2875042327785642,0.16034482758620688,0.3079717980216574,1.0,7/11,23.39%,RIPK1;PF4;ID2;IL34;CASP8;CSF1;TGFB1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.47967081077714036,-1.2873085681061134,0.14051094890510948,0.30802712393612824,1.0,10/18,31.85%,RAD51B;BRD4;CDC25A;CDK1;RAB11A;CDC25C;CCNB1;RAD51C;RCC2;VPS4B
prerank,regulation of store-operated calcium entry (GO:2001256),-0.5640091666354864,-1.28719782249596,0.16903914590747332,0.30794241372229986,1.0,2/10,1.63%,CD84;SARAF
prerank,cGMP metabolic process (GO:0046068),0.50905924489388,1.2862816521842386,0.16891891891891891,0.4157799757340817,1.0,2/12,3.86%,GUCY1B1;PDE9A
prerank,cellular response to sterol (GO:0036315),0.5082024983365048,1.2860422382100356,0.18092909535452323,0.4150422391377761,1.0,5/13,12.48%,RORA;OSBPL7;INSIG1;SMO;RORC
prerank,regulation of glucose import (GO:0046324),-0.43030711307355385,-1.2860228933315117,0.14234234234234233,0.3096561202522531,1.0,12/30,20.57%,PID1;OSBPL8;IGF1;INSR;PRKAG2;RHOQ;SELENOS;APPL2;IRS2;PTPN11;ENPP1;APPL1
prerank,response to organophosphorus (GO:0046683),-0.4882136391337888,-1.2858494915300807,0.16216216216216217,0.3096894173321657,1.0,5/16,20.94%,P2RX7;P2RX4;TRIM16;RFC3;STAT1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.3779087078621741,-1.2855113050965763,0.1065989847715736,0.3099953629597421,1.0,11/48,7.18%,PTPRC;SAMHD1;YTHDF3;PPARG;USP18;PARP14;STAP1;NLRC5;NR1H2;IRAK3;GAS6
prerank,endothelial cell development (GO:0001885),-0.4437574334421559,-1.2854078885852904,0.1602787456445993,0.30988349074062455,1.0,13/25,32.84%,MSN;RAP1B;RAP1A;MYADM;COL22A1;COL18A1;PECAM1;MARVELD2;RAPGEF2;MET;TNMD;CNMD;EZR
prerank,positive regulation of neuron migration (GO:2001224),-0.5450817839418178,-1.2853900242162861,0.16753926701570682,0.30964319906439763,1.0,4/11,8.06%,ARHGEF2;NIPBL;KIF20B;MDK
prerank,negative regulation of hemostasis (GO:1900047),-0.5372380721812373,-1.2845804797588571,0.16751269035532995,0.3107204721572296,1.0,5/12,23.69%,APOE;TFPI;SERPINE1;APOH;ADTRP
prerank,aorta morphogenesis (GO:0035909),-0.4871796137130495,-1.2843136878546346,0.14261168384879724,0.31088430225167457,1.0,3/17,5.78%,RBPJ;LRP1;JAG1
prerank,membrane depolarization (GO:0051899),0.4020547669811291,1.2842876316449894,0.1336405529953917,0.41739502332109235,1.0,7/32,7.48%,CACNA1E;SCN2A;SCN1A;SCN3A;SCN9A;CACNG4;CACNG2
prerank,positive regulation of filopodium assembly (GO:0051491),0.43794837161003386,1.2841964811498876,0.1597222222222222,0.4163635272926711,1.0,4/24,1.83%,NLGN1;TENM2;TENM1;GPM6A
prerank,regulation of cilium assembly (GO:1902017),-0.3594334086657263,-1.283769996012625,0.08288288288288288,0.3115737943496311,1.0,19/62,17.15%,TBC1D15;IFT20;ATG5;TBC1D2B;TBC1D5;TBC1D1;TBC1D22A;SDCCAG8;TBC1D16;TBC1D22B;TBC1D8;TBC1D17;CCDC88A;TBC1D10B;TBC1D30;TBC1D24;DYNLT2B;TBC1D7;TBC1D9B
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4462779096871978,1.2833931859542747,0.16705336426914152,0.4168741415906208,1.0,5/21,3.38%,HS3ST5;HS6ST3;HS3ST4;HS6ST2;NDST3
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5407630842584923,1.2833901452641872,0.17647058823529413,0.41568202216052197,1.0,3/10,10.68%,DLGAP1;DLGAP2;DLGAP3
prerank,cellular response to amino acid starvation (GO:0034198),-0.3510968412504062,-1.2831643921251847,0.0976027397260274,0.31238705674359285,1.0,23/71,25.87%,MAP3K5;ATP6V0D2;TFEB;ATP6V1E1;ATP6V1A;TCIRG1;EIF2AK2;ATP6V1G1;RRAGD;FLCN;SESN1;SH3GLB1;ATP6V0B;ATP6V0E1;RHEB;ATP6V0D1;CEBPB;MAPK1;WDR24;KPTN;LAMTOR1;LAMTOR3;MIOS
prerank,calcium ion homeostasis (GO:0055074),0.3257428400929918,1.2830229647352882,0.05181347150259067,0.41528256492947596,1.0,22/95,16.07%,HTR2C;ANK2;TMTC2;RYR2;SLC24A4;SLC24A2;SLC8A3;SLC24A3;TMEM203;PTH1R;SLC8A2;EDN1;CALCB;ATP1B1;ATP2B4;CDH5;FAM20A;ATP2B2;ATP2A1;CHRNA7;ATP13A5;SNCA
prerank,regulation of protein sumoylation (GO:0033233),-0.48817031638895647,-1.2828904752693961,0.14731369150779897,0.31260878018601657,1.0,5/17,16.61%,ZMIZ1;PIAS1;CTNNB1;EGR1;UBA2
prerank,neuromuscular process (GO:0050905),0.479841946250002,1.2828820056293633,0.1905829596412556,0.41438412616056947,1.0,4/16,9.57%,NRXN1;MYCBP2;KCNA1;PRRT2
prerank,motor neuron axon guidance (GO:0008045),0.4774214883948633,1.282769942541834,0.14698162729658792,0.413448674926759,1.0,3/15,5.27%,SLIT2;SLIT1;TMEFF1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.420250632271594,-1.2827400627574677,0.13120567375886524,0.31256249813248443,1.0,13/30,28.82%,DAB2;FOXP1;PRMT2;DDX5;KLK3;TRIM68;SFRP1;KDM1A;ZBTB7A;HEYL;NCOR1;EP300;PIAS2
prerank,pore complex assembly (GO:0046931),-0.4697805222741752,-1.282675254975868,0.14893617021276595,0.31240017795920283,1.0,7/19,20.69%,P2RX7;ANO6;PDZD11;NUP205;TPR;NUP153;NUP107
prerank,activation of protein kinase A activity (GO:0034199),0.4782299206200618,1.2826279916617775,0.15632754342431762,0.4125796472390874,1.0,7/16,14.85%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1;PRKACB;PRKAR1A
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.5577863680397062,-1.2821943029123477,0.17915904936014626,0.3129427601589268,1.0,4/10,14.84%,SSBP1;DBF4;E2F8;INO80
prerank,ceramide metabolic process (GO:0006672),-0.3796176236904919,-1.2820746696711127,0.09272727272727273,0.3128622789579538,1.0,26/49,42.80%,SGMS1;SPTLC2;ACER3;SPTSSA;CLN6;SPTLC3;ASAH1;SAMD8;PLPP3;DEGS2;ABCA2;CERS3;ORMDL2;PLA2G15;CERK;ORMDL3;ACER2;CERS2;PNPLA1;FUT7;PLPP2;PPP2CA;PLPP1;ORMDL1;SMPD1;PPP2R1A
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.28640090207143765,-1.2820217045617142,0.0237741456166419,0.3126661183905942,1.0,59/308,14.38%,DAB2;APOE;PRKCH;ABCA1;B4GALT5;FGR;RREB1;CCR2;SDCBP;SYK;LRP1;CD36;ROCK1;NIBAN2;OGT;AGO2;GAPDH;IGF1R;FABP5;KDM3A;HTR2B;IL15;SLC27A1;IL18;STAT6;ADIPOR1;DYNC1H1;PTGER4;BATF;UCP2;PIK3CG;GCNT2;CTNNB1;GAS6;EZH2;KMT5B;PLAC8;VEGFA;EIF2AK2;MDK;TGFBR1;RBM19;CD28;TGFB1I1;KMT5C;CLEC9A;FABP4;AGT;ITGAX;XBP1;IL4R;FOXJ1;CLEC6A;ITK;SERPINE1;PIK3CD;TGFBR2;NFAM1;AGPAT1
prerank,RNA splicing (GO:0008380),-0.3365114597333911,-1.2818231462317107,0.07979626485568761,0.31270385539381534,1.0,31/95,24.21%,MBNL1;TRA2B;SRRM1;MPHOSPH10;SMU1;SNRNP35;FUS;SNRPG;SNRPF;SF3B3;PRPF8;NCBP1;ZRSR2;PDCD7;PPIG;PPP1R9B;SRSF10;PRPF18;LSM6;RNPS1;TXNL4A;SCNM1;MAGOH;SLU7;SF3B1;SRPK1;SRSF11;NONO;TARDBP;PRPF6;DDX39B
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.4621477083048007,-1.2817351532148806,0.1696113074204947,0.3125728725011311,1.0,8/20,16.05%,PLEK;ROCK1;RHOQ;LCP1;NCKAP1L;FMNL2;IKBKB;RAB13
prerank,potassium ion homeostasis (GO:0055075),0.4324449347484593,1.2816225103941503,0.1330166270783848,0.4134445843579085,1.0,7/23,12.53%,SLC12A2;SLC12A8;SLC12A1;ATP1A3;ATP1B1;SLC12A5;KCNMA1
prerank,lipid translocation (GO:0034204),-0.45433727123692264,-1.2815743263187902,0.147008547008547,0.31260108646433094,1.0,4/21,9.21%,ABCA1;ATP8B4;ATP11C;ABCC1
prerank,regulated exocytosis (GO:0045055),-0.3069246768676735,-1.2807724911408338,0.05188679245283019,0.3136998022026036,1.0,39/173,13.02%,F13A1;LYN;IGF1;PSAP;PLEK;PHACTR2;MYH9;CD36;ARHGAP17;FLNA;TAGLN2;RAB31;CD9;CYB5R1;RAB11FIP5;LAMP2;LHFPL2;SYNGR1;SRGN;ANXA5;TMED10;TLN1;PF4;FN1;HGF;CYRIB;PROS1;TEX264;GAS6;RIMS3;VEGFA;SYT4;CD63;WDR1;APP;RAB11B;SERPINE1;RAB10;ABCC4
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.47565289748173056,1.2802125118853978,0.15158924205378974,0.41388361941086765,1.0,4/16,5.44%,ARHGAP6;CLASP2;DLC1;APOD
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.47565289748173056,1.2802125118853978,0.15158924205378974,0.41388361941086765,1.0,4/16,5.44%,ARHGAP6;CLASP2;DLC1;APOD
prerank,digestive tract development (GO:0048565),0.39317413531074397,1.28015521730399,0.16262135922330098,0.41282298688019786,1.0,13/32,20.37%,PCSK5;CLMP;RARB;COBL;SALL1;TGFB2;SMO;PKD1;GLI3;EPHB3;BBS7;GLI2;KIT
prerank,negative regulation of platelet activation (GO:0010544),-0.5000420707650672,-1.28007671516584,0.14762741652021089,0.31463052827185206,1.0,3/16,3.36%,APOE;PRKCD;CD9
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.389943455673908,-1.2800516587855086,0.12323943661971831,0.3144063767566345,1.0,11/43,10.48%,JUN;PPARD;PPARG;SPI1;STAT3;FOXO3;NFATC3;DDX5;HIF1A;EGR1;RELA
prerank,regulation of neuron projection arborization (GO:0150011),0.48097114805203545,1.2799290125610172,0.18427518427518427,0.41212039752368457,1.0,8/15,22.34%,GRIP1;NTNG2;NTNG1;MFSD2A;MAP3K13;FZD4;WNT5A;DVL3
prerank,histone ubiquitination (GO:0016574),-0.4715421341629221,-1.2797456040043296,0.15141430948419302,0.31468112720375424,1.0,13/21,31.77%,CTR9;RNF20;UBR2;RNF8;UHRF1;WAC;HUWE1;DTX3L;UBE2N;RNF40;UBE2E1;UBE2U;UBE2A
prerank,protein import into peroxisome membrane (GO:0045046),-0.45568308543390085,-1.27901658541813,0.13961605584642234,0.31565189173705566,1.0,5/22,10.02%,RAB8B;PEX14;ABCD2;PEX26;FIS1
prerank,macrophage migration (GO:1905517),-0.5198334133670385,-1.279005744216681,0.17132867132867133,0.31540002820546215,1.0,4/13,12.64%,CCR2;P2RX4;CKLF;CCL5
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.49681451814192634,-1.2788255793327175,0.1602112676056338,0.3154446217822307,1.0,5/15,8.91%,RBPJ;PTPN12;RHBDF1;RHBDF2;MVB12B
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.43673128949188295,-1.27844930521517,0.14285714285714285,0.31577965072918684,1.0,8/25,24.21%,ERCC6;ALYREF;KAT7;ZNF326;HMGN1;HTATSF1;CCNK;DDX39B
prerank,glycolipid metabolic process (GO:0006664),-0.3845081637063934,-1.2778837702875567,0.1273996509598604,0.31648535163921004,1.0,19/47,29.06%,HEXA;PSAP;CTSA;GLTP;ARSA;ESYT1;ESYT2;SUMF2;GBGT1;NEU1;PGAP3;ASAH1;PGAP1;ABCA2;B4GALNT1;CPTP;ST3GAL4;B3GALNT1;CERK
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.376324452009566,-1.2778770987941224,0.12417218543046357,0.31622733160612215,1.0,15/46,18.75%,RBPJ;RB1;IL15;TLR4;LNPEP;NR1H2;PLCL2;TLE3;ACOT13;FLCN;STK11;IL18R1;TFE3;RHEB;ID1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.36747624814010343,-1.2774918787926708,0.11616161616161616,0.31663958080036947,1.0,21/57,23.48%,RPL7;RPS24;RPS6;RPL11;NOP14;NVL;RPS28;DHX37;CUL4B;RPL14;EMG1;DDX31;PAK1IP1;SHQ1;SURF6;RPS16;GTF3A;TGS1;NIP7;WDR12;RPS15
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.42572397959834346,1.2772953713896134,0.13221153846153846,0.4162904406243037,1.0,5/23,7.51%,ANK2;CACNA2D1;CASQ2;PRNP;FYN
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.3043544130467844,-1.2769582167316431,0.049342105263157895,0.31725778141531474,1.0,56/184,21.28%,PSME4;PSMB7;CNTRL;ANAPC1;PSME3;DYNC1H1;CENPF;HAUS5;PSMB9;SDCCAG8;HAUS6;CEP57;E2F1;CENPE;CKAP5;NEK6;YWHAE;PTPN6;PSMA8;UBC;RPS27A;TPX2;PSMC3;KIF14;KLHL18;CEP70;HAUS4;DCTN1;CDK1;PSMD8;HAUS7;BUB1B;PSMC4;PSMB10;TFAP4;PSMA1;ID2;INO80;PPP1R9B;ODF2;NINL;APPL2;UBE2C;PSMB8;PCNT;AURKA;ANAPC7;PSMA5;PSMD4;PAFAH1B1;PSMB3;APPL1;SIRT2;PSMD3;CEP192;CETN2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5104912338459716,1.2769325088456593,0.1855421686746988,0.415861095076915,1.0,5/12,18.99%,PDE4D;CALM1;CALM3;CALM2;GJD3
prerank,nitric oxide biosynthetic process (GO:0006809),-0.5215264744380833,-1.2765863191361186,0.18388791593695272,0.3176160492957538,1.0,6/13,24.03%,CYB5R3;CYB5B;GCH1;ARG2;CYP1B1;NQO1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3946128585434086,-1.2764610615938625,0.11379310344827587,0.317566341651402,1.0,18/39,27.19%,APOE;MSN;CD36;ROCK1;RAP1B;RAP1A;AGT;SPTY2D1;TRAF2;ANKRA2;PARP10;PTPN11;GFAP;VPS11;HJURP;RAPGEF2;HSPA8;BBS10
prerank,oligodendrocyte differentiation (GO:0048709),0.45278364306871666,1.2762693291101492,0.1723404255319149,0.4159438813725068,1.0,6/19,11.92%,SLC8A3;SOX6;SOX13;SOX9;PTPRZ1;HES5
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.36322713530405004,-1.2759653072981527,0.10517529215358931,0.31819264646391726,1.0,24/62,28.80%,MCL1;NFE2L2;ARHGEF2;BCL2;TXNDC12;DNAJA1;PLAUR;MAPK7;SELENOS;TPT1;XBP1;TMBIM6;TMEM161A;HSPA1A;HYOU1;HSPB1;DDX3X;SNAI2;BCL2L2;URI1;RTKN2;NOC2L;BCL2L1;PTTG1IP
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.4854843002870818,-1.2754010096974313,0.1657754010695187,0.31888793433431567,1.0,5/17,11.34%,PID1;NUPR1;CBFA2T3;FIS1;FLCN
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.4107142783517622,-1.2746604069062981,0.1482084690553746,0.3198943671259873,1.0,8/32,19.20%,GAPDH;PF4;RNASE7;RNASE6;CAMP;DEFA6;ANG;CXCL14
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.4149093225834617,-1.2746060681352003,0.15439856373429084,0.319711397422581,1.0,11/31,19.94%,SYK;PLCG2;TLR4;IRF5;MAPK14;MDK;LAPTM5;CD40;LGALS9;HMGB1;AGER
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5476404647734939,1.2745753553327135,0.1963882618510158,0.41819733753381166,1.0,1/10,0.67%,ANK3
prerank,basement membrane organization (GO:0071711),0.49409792620792276,1.2744577883616188,0.17349397590361446,0.41727235033032445,1.0,7/14,22.01%,NTNG2;NTNG1;FLRT2;NID2;RAMP2;NID1;NTN4
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.41841870273056436,-1.273790776472252,0.1353637901861252,0.3207988558815187,1.0,13/33,22.67%,PLCG2;PSME3;EZH2;E2F1;PTPN6;KIF14;ID2;INO80;APPL2;FAM83D;TRIM39;APPL1;TCIM
prerank,response to acidic pH (GO:0010447),-0.5135601308333515,-1.2736952208442411,0.18166089965397925,0.3207102451109609,1.0,5/13,17.84%,RAB11FIP5;SLC9A1;RAB11B;CTSS;GPR65
prerank,keratan sulfate metabolic process (GO:0042339),-0.41131968634632643,-1.273510366703234,0.14013840830449828,0.3207841846551571,1.0,11/31,19.30%,B4GALT5;HEXA;ST3GAL1;GNS;GALNS;SLC35D2;B3GNT2;PRELP;B4GALT3;FMOD;B4GALT1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.5167898728935703,-1.2732769673991287,0.19182948490230906,0.32086528058135444,1.0,8/13,30.31%,GNPDA1;UAP1L1;UAP1;GNPDA2;GFPT1;AMDHD2;RENBP;GNPNAT1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.4218569581325331,-1.2730730269166628,0.13403880070546736,0.32092649361458525,1.0,8/30,19.98%,NIBAN2;DCP2;ERCC4;TEN1;TENT4B;HNRNPA1;EXOSC10;BMPR2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.339777727133092,1.27277192014321,0.11004784688995216,0.4195930608097098,1.0,20/76,15.71%,GRM5;HTR2C;CHRM2;GRM1;P2RY12;OPRD1;PLCE1;ADRA1B;HOMER1;TRHR;PTH1R;CX3CR1;CCKBR;AGTR1;F2RL2;ADRA1D;ADRA1A;OPRK1;OPRL1;OPRM1
prerank,"phagocytosis, engulfment (GO:0006911)",-0.39739579698241395,-1.2712755213417017,0.14480408858603067,0.32376221281087647,1.0,10/36,12.80%,MSR1;ARHGAP25;MYH9;CD36;RAC1;ITGB2;CDC42;SH3BP1;ARHGAP12;FCGR2B
prerank,negative regulation of leukocyte activation (GO:0002695),-0.4857060109863701,-1.2704643593691338,0.18596491228070175,0.3248968032939226,1.0,7/15,15.67%,CD84;CD300A;CD300LF;MILR1;GRN;FCGR2B;IL31RA
prerank,neutrophil chemotaxis (GO:0030593),-0.3692335605794088,-1.2700601759550014,0.12254901960784313,0.32532248721041856,1.0,11/53,13.40%,SYK;ITGB2;CKLF;PF4;PIK3CG;JAML;NCKAP1L;CCL5;CXADR;FCER1G;PIK3CD
prerank,DNA methylation or demethylation (GO:0044728),-0.4729676937167118,-1.2699128053761775,0.1522491349480969,0.3250488273039357,1.0,2/19,3.22%,DNMT3A;GATAD2A
prerank,DNA alkylation (GO:0006305),-0.4729676937167118,-1.2699128053761775,0.1522491349480969,0.3250488273039357,1.0,2/19,3.22%,DNMT3A;GATAD2A
prerank,activation of protein kinase activity (GO:0032147),-0.3274994764238767,-1.2697210644794923,0.0749185667752443,0.32508761283854326,1.0,27/106,14.09%,OSBPL8;TAOK3;IGF1;PAK2;PRKCD;ADCY7;INSR;MALT1;MINK1;PRRC1;PIBF1;IL18;PTK2B;STK3;AXIN1;GAS6;VEGFA;ITGB1BP1;TPX2;TAOK1;KIF14;CCDC88A;STK11;TRAF2;TGFBR2;MARK2;CALCA
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.5274778632073467,-1.2695808440940695,0.16666666666666666,0.3250509110063376,1.0,6/12,39.23%,FDXR;TSPOAP1;FDX1;FDX2;STARD3;TSPO
prerank,translational elongation (GO:0006414),-0.33082508941326844,-1.2693254148598085,0.0825242718446602,0.32521763743588383,1.0,43/101,33.59%,MRPS10;ERAL1;MRPL42;TUFM;EEF1B2;CHCHD1;EEF2;GTPBP1;EEF1A1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;GTPBP2;MRPL17;MRPL15;RACK1;MRPL51;MRPL47;MRPL18;MRPS7;EEFSEC;EEF1D;MRPL54;MRPS25;MRPL39;MRPL53;MRPL11;MRPL33;MRPL28;MRPL30;MRPL43;MRPS17;MRPS5;MRPL1;MRPS28;MRPS35
prerank,androgen metabolic process (GO:0008209),-0.4668738798183934,-1.268865754551785,0.15306122448979592,0.32576262934535966,1.0,10/18,37.81%,HSD17B7;SPP1;SRD5A1;SRD5A2;HSD17B10;HSD3B2;SRD5A3;HSD17B3;AKR1D1;CYP19A1
prerank,ion homeostasis (GO:0050801),0.4145481368712513,1.2686538241789225,0.16129032258064516,0.4269461632930354,1.0,10/30,21.50%,UNC80;SLC4A10;SLC4A4;SLC4A11;SLC12A5;WNK4;WNK3;WNK2;SLC30A3;P2RY2
prerank,keratinocyte differentiation (GO:0030216),-0.4253480802624064,-1.2678697865682882,0.14017094017094017,0.32718580744389025,1.0,9/29,25.78%,CLIC4;ANXA1;ADAM9;JAG1;PIP5K1A;TXNIP;ASAH1;DSP;CERS3
prerank,T cell differentiation (GO:0030217),-0.3896986813354566,-1.2677429919337166,0.10743801652892562,0.32714438753925906,1.0,11/40,17.97%,PTPRC;SPI1;PTPN22;ANXA1;CD28;LCK;TCF7;FCER1G;PIK3CD;ZAP70;GATA3
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.5370460748247748,-1.2675679373544417,0.18227424749163879,0.32717505797760177,1.0,5/11,12.64%,LYN;SYK;PLAUR;JAK1;CCL5
prerank,axon extension (GO:0048675),0.42546034152686274,1.2668588025244265,0.1710843373493976,0.4295628297934181,1.0,6/23,4.04%,AUTS2;MAP1B;SLIT3;SLIT2;SEMA5A;SLIT1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.3607384323638789,1.2668041949780542,0.11959287531806616,0.4285030296708561,1.0,10/53,15.71%,HTR2C;CHRM2;CHRM3;HRH3;OPRD1;NPY1R;HTR1B;HRH2;HTR7;OPRM1
prerank,response to peptide hormone (GO:0043434),-0.37865824889438926,-1.2666563545935186,0.13097345132743363,0.3285174278019685,1.0,19/43,28.48%,ROCK1;OGT;STAT3;SLC27A1;STAT6;ANXA1;EIF2B3;STAT5B;STAT4;XBP1;TRIM16;EIF2B1;STAT1;STAT2;EIF6;ZFP36L1;ZBTB7B;EIF2B2;EIF2B4
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.3373180141149204,-1.2665390848650366,0.07253886010362694,0.3284308346494962,1.0,24/87,18.75%,ZMIZ1;CBL;JUN;NRROS;RHOA;LPXN;ARRB2;ITGB1;ADAM9;GCNT2;ARHGEF18;USP9X;SKI;TGFBR1;UBC;RPS27A;ITGB5;ZYX;TGFBR2;ZMIZ2;APPL2;FMOD;SMAD7;ID1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.5396508925355357,-1.266305377584545,0.18065693430656934,0.32855683115348405,1.0,6/11,17.10%,ITGB2;SPI1;STAP1;TICAM1;MAVS;STX4
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.38777593322721826,-1.2661266325982405,0.12687813021702837,0.32859955641290123,1.0,9/42,7.99%,CORO1C;RSU1;RAC1;RHOA;MINK1;PIK3CB;MYADM;GCNT2;ATXN3
prerank,positive regulation of neuron death (GO:1901216),-0.3827211088252756,-1.2660576651390978,0.12678571428571428,0.3284495854686804,1.0,10/46,10.03%,MAP3K5;ITGB2;C1QA;NUPR1;FOXO3;TLR4;PICALM;CTNNB1;GRN;EGR1
prerank,muscle tissue morphogenesis (GO:0060415),0.473658360271991,1.2660496193065287,0.1670886075949367,0.42890511858930175,1.0,5/16,20.43%,TBX1;TTN;MYLK;TGFBR3;EFEMP2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.43568523551160176,1.265691792427531,0.14841849148418493,0.4284739136713328,1.0,2/21,1.49%,ANK2;CACNA2D1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.33894839514897424,-1.2656531056127982,0.09136212624584718,0.32893254217647566,1.0,28/80,25.25%,KLC1;KIF3B;UVRAG;KIF11;RAB1A;COG7;TMED10;KIF23;KIF15;TAPBP;GOLPH3L;KIF4A;RINT1;CENPE;TMED3;COPA;RER1;RACGAP1;KIF2C;TMED2;KIF22;PLPP3;COG4;ARCN1;COPB2;RAB1B;ERGIC1;KIF26A
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.3923945216081685,-1.2653492846145358,0.12643678160919541,0.32921727765882125,1.0,10/42,13.35%,OPTN;IL6R;TLR4;RNASE7;CHGA;RNASE6;CAMP;HMGB2;SERPINE1;DEFA6
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.48740922367154005,1.2653455140700134,0.17647058823529413,0.42801043432797925,1.0,4/13,15.66%,SYT1;SYT10;HYAL3;CACNA1G
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.47126282432476546,-1.2652866609963753,0.1853932584269663,0.3290508147949461,1.0,7/18,12.02%,ABL2;TNFAIP1;RIPOR2;KCTD10;CCDC125;FLCN;ITGA3
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.5003913094261521,1.2652556219434536,0.17713004484304934,0.4270643910552768,1.0,6/14,20.36%,UPP2;DPYD;DPYS;DHODH;CAD;NT5M
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.37402462414663423,-1.2652464896108777,0.12248322147651007,0.32883254584366217,1.0,12/48,8.06%,NEDD9;NRP1;RREB1;RAC1;FBXW8;FLNA;CDC42;CUX1;TRIOBP;DOCK5;MYADM;MDK
prerank,limb development (GO:0060173),0.4071220782640253,1.2647590340955532,0.14386792452830188,0.4268282542040077,1.0,13/28,21.21%,PCSK5;BMPR1B;LNPK;KREMEN2;FGF10;IQCE;SALL1;KDF1;GLI3;KAT2A;SMOC1;LRP4;INTU
prerank,acetyl-CoA metabolic process (GO:0006084),0.48248671660846537,1.264715297426708,0.19158878504672897,0.42577844287144956,1.0,8/15,22.79%,HMGCS1;NUDT7;ACACA;MVK;ACAT1;MLYCD;ACSS1;MVD
prerank,purine-containing compound catabolic process (GO:0072523),-0.5026949867377267,-1.2644940042686994,0.1955403087478559,0.329945193794425,1.0,3/13,9.96%,GDA;XDH;NT5C2
prerank,histone lysine demethylation (GO:0070076),-0.43106889088912803,-1.2643298211937744,0.14991482112436116,0.32997836830279953,1.0,11/25,30.88%,KDM3A;JMJD1C;KDM7A;KDM3B;KDM2A;HR;KDM5B;KDM1A;KDM2B;KDM6A;RIOX2
prerank,cellular response to retinoic acid (GO:0071300),0.37138467816186094,1.2641710794924101,0.125,0.4258407664241187,1.0,17/42,20.48%,BRINP3;BRINP1;RORB;TESC;WNT9A;SOX9;LTK;TBX1;RET;EPHA3;BRINP2;FZD4;SNW1;ADNP2;WNT5A;WNT5B;FZD10
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.4078489307878989,-1.264050778596552,0.13577981651376148,0.3301989250944046,1.0,10/34,18.61%,IGF1;NSMCE2;RB1;INSR;DLGAP5;CD28;NUSAP1;AURKA;ANAPC7;PDGFRB
prerank,carbohydrate derivative transport (GO:1901264),-0.46798970185889277,-1.2639540743056787,0.16891891891891891,0.33009340937299597,1.0,7/18,17.26%,ABCG1;PLTP;SLC10A7;SLC15A3;NPC2;CLN3;SLC29A1
prerank,regulation of insulin secretion (GO:0050796),0.3223020044077692,1.2637893087853018,0.09414758269720101,0.42548038924449433,1.0,25/101,16.69%,CACNA1C;CACNA1E;EFNA5;KCNC2;SNAP25;EPHA5;ADCY5;CCN3;NR1D1;ADRA2C;NEUROD1;RAPGEF4;CAPN10;FFAR1;PER2;REST;SYT7;PRKN;KCNS3;INHBB;NLGN2;IRS1;RFX3;PRKCA;MYRIP
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.46043560162565966,-1.263460108849979,0.17010309278350516,0.33074878372696714,1.0,9/17,26.71%,CTR9;RNF20;ZC3H14;NUDT21;VIRMA;NCBP1;RNF40;ZC3H3;NELFE
prerank,cardiocyte differentiation (GO:0035051),0.5349768858204211,1.2633405307963324,0.2119047619047619,0.425265335314983,1.0,5/10,11.34%,NRG1;CBY1;MYOCD;TGFB2;EEF1AKMT4-ECE2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33467599485065286,1.262205172749267,0.0945273631840796,0.4264262036187775,1.0,18/75,12.43%,METAP2;KCTD8;PLCB1;RGS6;FRMPD1;GIT2;RAMP3;RGS20;PLCE1;GNG7;GRK4;FNTB;CAMKMT;CAMK2A;EDN1;MRAP;FNTA;CALM1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.47771572834925624,-1.2620843447221552,0.1806020066889632,0.3328490774931064,1.0,10/17,36.85%,RAET1E;AP1G1;LAMP1;CD226;SLAMF6;CRTAM;KLRC2;KLRD1;IL12A;IL12B
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.4601454374435308,1.2619777279392006,0.1738095238095238,0.4257658132448006,1.0,4/18,5.49%,CHRM2;PLCB1;CHRM3;HRH3
prerank,positive regulation of lipid localization (GO:1905954),-0.5305867526379409,-1.2617493941486433,0.17553191489361702,0.3331751853366408,1.0,4/11,9.75%,LRP1;NFKB1;C3;LPL
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.38620170671765436,-1.2614468246089527,0.15084745762711865,0.33345814819289155,1.0,7/43,5.22%,PID1;PRKCB;PRKCD;OGT;PIP4K2A;PTPRE;SNX5
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.5531129255127787,-1.261211207412548,0.1936619718309859,0.3336068432436858,1.0,6/10,26.43%,BRCA1;HDAC5;SPHK2;KMT2A;CHEK1;SMAD4
prerank,negative regulation of phosphorylation (GO:0042326),-0.3362794828954982,-1.2610863563578016,0.09740259740259741,0.33356690863402283,1.0,28/85,23.39%,PID1;LYN;CORO1C;XDH;NIBAN1;ROCK1;NUPR1;IBTK;STAP1;PPP1R15B;CBFA2T3;LRP6;MYADM;SIRPA;PAQR3;IGFBP3;CIB1;CRKL;ANKLE2;IRS2;CDKN2C;PTPN13;ZC3H12A;INHA;PLPP3;PRKDC;TARDBP;TGFB1
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.42318382829013335,-1.260772748405604,0.16,0.3338782015984471,1.0,6/26,6.87%,LYN;USP50;STAT3;PSME3;AIM2;PICALM
prerank,energy reserve metabolic process (GO:0006112),-0.4643915806704677,-1.2606314633025624,0.15833333333333333,0.3338461993495787,1.0,9/19,25.76%,PID1;PRKAG2;PHKG2;GBE1;GSK3B;GFPT1;PYGL;MYC;MT3
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.46455740773485776,-1.2602759630659568,0.17258883248730963,0.3341850431050941,1.0,5/19,17.48%,PRKCD;ABCD2;DAGLB;ABHD5;IRS2
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.3133903676051873,-1.260246078401944,0.07568438003220612,0.33396204475407076,1.0,50/132,26.74%,DHX9;RPL11;CRNKL1;ERAL1;EIF3A;SNRPG;GCFC2;RPS14;EIF5;COIL;SNRPF;RPS28;SART1;NUDT21;CELF1;HSP90AB1;SMN1;MRPS11;YTHDC1;RPL6;NCBP1;SART3;ZRSR2;GEMIN7;SNUPN;DDX1;SRSF10;SHQ1;PRPF18;RPS27;TXNL4A;RPL23A;WDR77;TGS1;SF3B1;GEMIN6;XAB2;SRPK1;RPLP0;BRIX1;PRKDC;RPS15;EIF2S2;PRPF6;DDX39B;MRPS7;RPL5;EIF6;RAMAC;ISY1
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.389190288314275,-1.259908499071117,0.14915254237288136,0.33426997913280093,1.0,8/39,5.78%,RBPJ;ZMIZ1;TSPAN14;CREBBP;MAML1;STAT3;MAML2;JAG1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.4089140771815611,-1.2598998901508114,0.13941480206540446,0.33400393776761206,1.0,8/32,4.20%,CORO1C;RREB1;ARPC2;RAC1;ACTR2;WASF2;CDC42;ACTR3
prerank,cell cycle G1/S phase transition (GO:0044843),-0.35887890931071953,-1.2598298383372666,0.11036789297658862,0.3338470908255614,1.0,22/61,19.74%,CDK6;RB1;GSPT1;GPR132;CRLF3;PLK2;E2F1;E2F3;EIF4EBP1;DBF4;CDKN3;CDC25A;CUL4B;CACUL1;PLK3;CUL2;CCNE1;CDC34;LATS2;CDKN2C;RCC1;MAX
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.38834781945787655,-1.2596473104803365,0.14113597246127366,0.3338595440868416,1.0,14/40,26.76%,CSNK2A1;GNA12;PTK2B;AXIN1;RPL11;NUB1;LAPTM5;UBE3A;UBQLN4;TRIM39;SGTA;RPL5;SMURF1;PML
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.31221738615575123,1.2594719506689491,0.08674698795180723,0.42971646423346266,1.0,30/110,17.09%,ADGRB3;ADGRL3;ADCY2;ADCY8;LGR5;ADCY5;RAMP3;ADRA1B;ADCY3;GPR101;PTH1R;ADGRL2;ADCY1;GPR3;ADRA2C;GHRH;CALCB;LPAR2;LGR4;ADRA1D;ADRA1A;ADRB1;ADGRG1;GPR26;GNAL;ADGRB2;IAPP;RAMP2;ADGRL4;CRHR1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.4033847501477801,-1.2589737407869614,0.15257048092868988,0.3347647688936012,1.0,12/33,21.24%,NUPR1;NFE2L2;GAS6;WFS1;MDK;CAST;MAPK7;TNIP2;SERPINE1;GATA3;NDNF;KDR
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.46902208496165504,-1.258547043219926,0.1590909090909091,0.3351923496605243,1.0,5/19,9.25%,RBPJ;RUNX1;PIM1;TGFBR1;MEF2C
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.4987388261296776,1.258463721266036,0.18807339449541285,0.43062760517517695,1.0,4/12,10.96%,PLCB1;SLIT2;CCN3;NBL1
prerank,protein targeting to peroxisome (GO:0006625),-0.413979538657074,-1.25827287796609,0.16835016835016836,0.3353843547450248,1.0,8/29,16.74%,RAB8B;PEX14;ABCD2;PEX26;ZFAND6;FIS1;PEX7;ABCD3
prerank,neuron fate commitment (GO:0048663),0.4907633810313583,1.2581415159648524,0.19642857142857142,0.430049818577085,1.0,2/14,4.43%,MYT1L;POU3F2
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.3129185520557081,-1.2579163215415974,0.06969205834683954,0.33580973358629884,1.0,52/150,23.43%,PID1;LYN;PTPRC;CORO1C;XDH;PAK2;NIBAN1;PRKCD;RB1;IBTK;PRKAG2;CEP85;PMEPA1;PPP1R15B;LRP6;MVP;MYADM;SIRPA;TRIB1;ITGB1BP1;PTPN6;SNX25;TRIB2;SPRED1;SPRY2;PAQR3;SPRED2;IGFBP3;CIB1;GREM1;SAMSN1;LDLRAD4;EIF4G1;DTNBP1;CRKL;DNAJC3;DEPTOR;SMAD7;PTPN13;HSPB1;ENPP1;UBASH3B;SIRT2;SFRP1;ZC3H12A;RACK1;SFN;PLPP3;PRKDC;TARDBP;TGFB1;GPD1L
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.34076104865252765,-1.257637471299976,0.09060402684563758,0.33603399545738527,1.0,16/76,11.84%,NRP1;P2RX7;PLEK;SNX9;FES;CDC42;PTK2B;STAP1;DYNC1H1;BAIAP2;KATNBL1;NES;NCKAP1L;WDR1;CDC42EP2;BAIAP2L2
prerank,negative regulation of cell migration (GO:0030336),0.29883021105381813,1.2575022345149656,0.07202216066481995,0.4302831083755183,1.0,18/137,5.36%,ROBO1;MAGI2;NAV3;PTPRG;TMEFF2;SLIT2;PTPRR;PTPRT;LIMCH1;IGFBP5;TCAF1;ADORA3;AFDN;CLASP2;ACVR1C;DLC1;PTPRK;PODN
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.5005231721417838,-1.2572509470229336,0.16399286987522282,0.3364461406522697,1.0,3/15,5.01%,CD44;CD74;BCL2
prerank,metal ion export (GO:0070839),0.40254018844042383,1.2572415223112088,0.14215686274509803,0.42970045032053833,1.0,9/31,17.14%,KCND3;KCNT2;SLC4A4;KCNIP2;ATP1A3;ATP1B1;ATP2B4;KCNE4;ATP1B2
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5188300077418253,1.2571661151504911,0.2004950495049505,0.42874524905080946,1.0,2/11,4.22%,DDX11;NOL11
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.4900285737850001,-1.256704329824253,0.20336134453781513,0.33716777349530397,1.0,3/15,5.73%,PPARD;PPARG;NR1H2
prerank,cell projection assembly (GO:0030031),-0.4472486407548659,-1.2562445734851224,0.15332197614991483,0.3377012941639587,1.0,6/22,9.89%,RAC1;PARVB;CDC42;RHOQ;CAPG;NCKAP1L
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.26924370871006137,-1.256168139917083,0.015536723163841809,0.33754771784445037,1.0,130/497,23.00%,RBPJ;MDFIC;FOXP1;CD38;RCOR1;DAPK1;BCL6;WWP1;MIDEAS;RB1;JUN;PEX14;NIBAN2;ZNF568;PPARD;GAPDH;ARID5B;BRD7;ZNF148;SBNO2;PPARG;ELK3;GATAD2A;SPI1;BRCA1;WWP2;S100A11;CNOT1;IKZF1;NIPBL;SNX6;HHEX;ZBTB21;RUNX2;FBXW11;PRMT2;CENPF;DAPK3;SMARCC2;NR1H2;CIITA;PUS7;CBFA2T3;AHR;CTNNB1;GAS6;GCFC2;EZH2;PBXIP1;JARID2;DPF2;EIF2AK1;EIF2AK2;BHLHE40;EED;E2F1;SPEN;PCIF1;SELENOS;FOXN3;SUDS3;HDAC10;CIART;RELA;TIMELESS;XRCC6;CHMP1A;KLF10;CHD8;KAT7;CCDC85B;HMGB2;MTA3;HDAC5;DHX36;TFAP4;SIN3A;CALCA;EPC1;PSPC1;ID2;PRMT6;MAP3K10;NCL;BTAF1;PHC3;KMT5A;IKZF4;UBE2I;ATXN1;TOB1;RARA;ATF5;LIMS1;NR3C1;GATA3;MYB;SAMD1;ARID5A;RPS3;ID1;RSF1;DDX3X;ENPP1;CNOT8;BMPR2;DDX6;GSK3B;CIC;BAP1;CBFA2T2;SIRT2;SFRP1;LSM14A;CDK5;KDM1A;RACK1;ID3;SMURF2;ZBTB7A;TBX2;HEYL;SHMT1;SET;RPS6KA5;SCMH1;EID2;CRYAB;NONO;SOX7
prerank,renal filtration (GO:0097205),-0.5460302815990814,-1.2559535439711567,0.17966101694915254,0.33761696083886467,1.0,5/10,18.60%,SULF2;TBC1D8B;MYO1E;ITGA3;XPNPEP3
prerank,regulation of primary metabolic process (GO:0080090),-0.31406503900151755,-1.2557044076791746,0.08156606851549755,0.3377628815564555,1.0,36/126,20.83%,APOE;PSAP;CREBBP;PPARD;NFYA;PSME4;PPARG;PSMB7;PSME3;ADIPOR1;SMARCD3;PSMB9;TBL1XR1;EDF1;AZIN1;HELZ2;PSMA8;PSMC3;PSMD8;PSMC4;IDI1;PSMB10;RXRA;PSMA1;SIN3A;ID2;ACACB;PSMB8;IRS2;NCOA6;LDLR;PSMA5;PSMD4;TGS1;PSMB3;PSMD3
prerank,mitochondrial translation (GO:0032543),-0.32413053017952037,-1.255690077690563,0.10016155088852989,0.33751894951459216,1.0,43/104,34.45%,NOA1;MRPS10;ERAL1;MRPL42;TUFM;FASTKD2;CHCHD1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;MRPL17;MRPL15;MRPL51;MRPL47;MRPL18;MRPS7;MRPL54;MRPS25;EARS2;MRPL39;MRPL53;MRPL11;MRPL33;MTRF1;GATB;MRPL28;MRPL30;MRPL43;MRPS17;MTIF3;MRPS5;MRPL1;MRPS28;MRPS35;RARS2;MRPS21
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.33755949775514954,-1.2553755042445236,0.10490693739424704,0.33779813206087017,1.0,30/88,19.26%,MYO5A;VPS13C;FTL;DNM2;VPS13A;KIF16B;AP1G1;ARRB1;EXOC4;EPS15;OSBPL5;VPS35L;SYS1;AP1S3;CORO7;APP;TXNDC5;RABEP1;ARFGEF2;CLINT1;RAB10;ARL3;CHMP2A;RP2;DTNBP1;STX4;EXOC2;AP1S2;DOP1B;EXOC6
prerank,peptidyl-serine modification (GO:0018209),-0.30545973876493154,-1.2549230813637866,0.08163265306122448,0.33829473772781316,1.0,51/166,23.07%,PRKCH;PRKCB;MAPKAPK3;PAK2;PRKCD;ROCK1;CAMK1D;CSNK2A1;VRK2;TLK1;MAPKAPK2;SGK1;DYRK2;MAPK14;ULK2;CAB39;GALNT3;GAS6;PLK2;VRK3;STK38;TGFBR1;GALNT1;NEK6;MASTL;MORC3;CDK1;DYRK1A;MKNK1;TGFBR2;MAST2;MARK2;IKBKB;MAP3K10;TTK;MKNK2;LATS2;PNCK;AURKA;PKN3;ATM;NDNF;WNK1;GSK3B;CDK5;CSNK1G3;MAST3;MAPK1;RPS6KA5;PRKDC;SMG1
prerank,positive regulation of translation (GO:0045727),-0.33030334564669955,-1.2547323373875765,0.08376068376068375,0.3383581295210423,1.0,27/94,20.12%,VIM;NIBAN1;YTHDF3;AGO2;DHX9;CNBP;LARP4B;PCIF1;CD28;LARP4;RPS4X;FASTKD2;EEF2;EIF3E;CCL5;PKM;BOLL;METTL14;DHX36;NGRN;FASTKD3;POLR2G;RPS9;RMND1;DDX3X;C1QBP;RBM3
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.4074225586785172,-1.2547272635670812,0.15993265993265993,0.3380936454951032,1.0,10/33,12.79%,LYN;SYK;PLAU;DPP4;ADAM9;PIK3CG;ITGB1BP1;NCKAP1L;CIB1;SERPINE1
prerank,calcium ion import (GO:0070509),0.406421811083851,1.2546844213697144,0.15602836879432624,0.43257564757177625,1.0,7/28,15.66%,CACNA1C;CACNA1E;CACNB2;SLC25A23;MICU3;ATP2A1;CACNA1G
prerank,positive regulation of double-strand break repair (GO:2000781),-0.38282261358456654,-1.2545796101807298,0.15502555366269166,0.33805685914768385,1.0,16/39,20.74%,ARID2;ACTR2;SPIDR;ERCC6;FUS;WDR48;KMT5B;PARP9;KMT5C;MGMT;TIMELESS;RAD51AP1;WRAP53;SHLD2;MMS19;DTX3L
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.5092812180181678,-1.2544804295607457,0.1969439728353141,0.3379606325292912,1.0,6/12,21.12%,TMEM199;GRN;CLN6;CLN3;VPS33A;PPT1
prerank,peptidyl-lysine modification (GO:0018205),-0.3250505155437098,-1.2544764937710389,0.10580204778156997,0.33769710508895023,1.0,36/99,30.35%,NSMCE2;NUP50;PIAS1;ATP7A;NUP42;NUP88;RAE1;SENP3;SIRT3;NUP205;HDAC10;TPR;NUP188;USPL1;UBA2;UBE2I;EYA1;NUP153;NUP35;SIRT2;NUP107;NUP62;EGR2;TOPORS;SUMO3;PLOD3;METTL21A;SAE1;RANBP2;TRIM28;NUP37;EP300;PLOD1;PIAS2;AAAS;NUP133
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.47291386692239246,-1.2543111304994325,0.16751269035532995,0.3377052784941693,1.0,6/17,12.70%,SYK;PIEZO1;ADAM9;NCKAP1L;CCL5;CIB1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.33428473434450207,-1.2542670707401034,0.10975609756097561,0.33750470257122256,1.0,26/84,20.83%,RB1;PSME4;PSMB7;ANAPC1;PSME3;PSMB9;PSMA8;UBC;RPS27A;PSMC3;CDK1;PSMD8;BUB1B;PSMC4;PSMB10;PSMA1;UBE2C;PSMB8;SKP2;AURKA;ANAPC7;FBXO31;PSMA5;PSMD4;PSMB3;PSMD3
prerank,negative regulation of secretion (GO:0051048),0.5168267392591999,1.2542466414120645,0.20803782505910165,0.43229537151708414,1.0,5/10,15.90%,NRG1;EGF;SPX;VAMP8;ERBB3
prerank,endodermal cell differentiation (GO:0035987),-0.412376678046125,-1.2541100061024832,0.13504823151125403,0.33749522443379076,1.0,7/31,9.97%,ITGA4;ITGB2;ITGA5;CTR9;ITGAV;FN1;ITGB5
prerank,DNA duplex unwinding (GO:0032508),-0.37572088402350445,-1.2528842333396832,0.1541038525963149,0.3394364434567927,1.0,22/50,26.01%,DDB2;DHX9;ANXA1;BLM;RTEL1;MCM6;RAD51;UBC;RPS27A;MCM9;SSBP1;WRN;CUL4B;DDX1;MCM2;NBN;CETN2;TWNK;ASCC3;DDB1;RECQL5;MRE11
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.3486114247236723,-1.25070694466078,0.11538461538461539,0.34310162615768675,1.0,27/68,26.72%,MTHFS;PANK2;SLC2A1;MTHFD1L;TPK1;CYB5R3;ABCC1;PDZD11;MTR;MTHFD2L;PDXK;ACP5;SLC23A1;SLC23A2;MMUT;ENPP1;LMBRD1;PNPO;MTHFR;SLC52A2;SHMT1;GSTO1;AASDHPPT;HLCS;FPGS;CYB5A;SLC52A1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.5391871163540949,-1.2506697940083924,0.2018018018018018,0.34287666966847563,1.0,7/11,37.67%,LRP6;CTNNB1;RYK;FZD1;LMX1A;NR4A2;WNT2
prerank,negative regulation of growth (GO:0045926),-0.3156869209018648,-1.2503641023952803,0.08469055374592833,0.34316838043360853,1.0,38/121,23.39%,NOTCH2;BCL6;RB1;PTPRJ;SIPA1;APBB2;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;CRLF3;BST2;FLCN;OSGIN1;STK11;ADAM15;CCDC85B;MT2A;BTG1;EI24;PPP1R9B;SPHK2;HSPA1A;CDKN2C;DDX3X;ENPP1;BMPR2;NME6;SFRP1;PPT1;RACK1;CGRRF1;ESR2;TGFB1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.43510884396840466,1.2501623849607435,0.16359447004608296,0.4395865588062968,1.0,3/19,8.94%,TJP1;AFDN;NEXMIF
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3469009145968942,-1.25012054393953,0.13620689655172413,0.3433848009912991,1.0,22/65,21.65%,PSME4;PSMB7;PSME3;GPR132;NABP1;PSMB9;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;AVEN;PSMA1;PSMB8;AURKA;PSMA5;PSMD4;CHEK1;PSMB3;VPS4A;PSMD3;ZFYVE19
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.4025511969078822,1.249939471258478,0.18906605922551253,0.4389231221661586,1.0,10/26,20.37%,GNB5;CASQ2;FMR1;CALM1;CALM3;CALM2;CBARP;CRHR1;GPR35;UBQLN1
prerank,regulation of activated T cell proliferation (GO:0046006),-0.3996236227366573,-1.2498738508888179,0.15693430656934307,0.34357628265728896,1.0,16/30,29.60%,IGF1;IL18;RC3H1;SCRIB;IL27RA;RPS3;LGALS9;HMGB1;AGER;CD274;TNFSF9;IL12RB1;CRTAM;RIPK3;IL2;IGFBP2
prerank,positive regulation of developmental process (GO:0051094),0.2888950452171487,1.2498712058638213,0.05333333333333334,0.4379495305904539,1.0,34/164,14.11%,NLGN1;NRXN1;GRIP1;PLCB1;ENPP2;BMPR1B;ARHGEF7;SOX5;SOX6;PTN;CLASP2;GDNF;ACVR1;SHANK3;ANAPC2;SPIRE1;WT1;MIEF1;ALK;SOX9;FMR1;BMP7;COBL;POU4F2;NEUROD1;CPEB3;RELN;BMP1;TAPT1;VLDLR;REST;PRKN;SYDE1;PACSIN1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.44325917984009733,-1.2497325203842704,0.17777777777777778,0.3435541557529816,1.0,13/21,33.28%,IGF1;JUN;ERN1;MEF2D;FOXJ2;ADAMTS1;MMP2;P2RY6;FGF9;LDLRAP1;FGF2;GJA1;MMP9
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.38992451140126727,-1.2484770806169758,0.1636060100166945,0.3454895537147978,1.0,11/39,21.24%,ITGA4;ANO6;NFE2L2;GAS6;MAPK7;TNIP2;SERPINE1;CD40;GATA3;NDNF;KDR
prerank,regulation of biomineral tissue development (GO:0070167),-0.4210910824925043,-1.2481900080426245,0.1636060100166945,0.34570343898568484,1.0,11/26,35.01%,ROCK1;GAS6;ANKH;ENPP1;CEBPB;TGFB1;NOTUM;HEY2;ROCK2;BMP2K;HEY1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.3951855023713581,-1.248081568239922,0.15881326352530542,0.34561887544566433,1.0,11/34,16.15%,MFHAS1;SPI1;RIPOR2;PICALM;SNX33;DNAJA1;NEDD4L;FLCN;SIN3A;LEPROTL1;LATS2
prerank,hyaluronan metabolic process (GO:0030212),-0.44166442316784593,-1.2480573013173926,0.18021201413427562,0.34539040945616445,1.0,5/23,9.43%,CD44;HEXA;LYVE1;SLC9A1;GUSB
prerank,RNA methylation (GO:0001510),-0.3560833486885327,-1.2478040788354072,0.14067796610169492,0.3455735131654564,1.0,20/60,25.45%,NSUN3;METTL1;CBLL1;NSUN4;DIMT1;PCIF1;TRMT44;METTL14;METTL6;VIRMA;TRMT6;WTAP;TGS1;BCDIN3D;METTL2B;METTL2A;THADA;RBM15B;BUD23;MRM2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.48212509847096713,-1.2475895000762287,0.18549747048903878,0.3456819765767201,1.0,9/16,35.75%,RAET1E;AP1G1;LAMP1;CD226;SLAMF6;CRTAM;KLRC2;KLRD1;IL12A
prerank,negative regulation of blood coagulation (GO:0030195),-0.38839097919026,-1.247022612874149,0.16550522648083624,0.34642760644718634,1.0,13/38,28.13%,APOE;PLAU;TFPI;PLAUR;F7;SERPINE1;F10;PDGFA;APOH;ADTRP;A2M;SERPINB2;F11
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.5455942878618127,-1.2469147645958008,0.20104895104895104,0.3463584321303234,1.0,5/10,22.07%,MTHFS;MTHFD1L;MTHFD2L;MTHFR;SHMT1
prerank,positive regulation of growth (GO:0045927),-0.3553339443386458,-1.2468932626182432,0.1284246575342466,0.3461205251294564,1.0,16/64,15.13%,RFTN1;SDCBP;INSR;CSNK2A1;CDC42;BCL2;DDX49;KLHL22;WFS1;TGFBR1;MTPN;CXCL16;CIB1;NCBP1;INO80;EIF4G1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.46319091615379404,-1.2451231170474,0.19824561403508772,0.34890219673328093,1.0,4/18,6.50%,PRKCB;PRKAG2;SLC2A1;C3
prerank,actin filament bundle assembly (GO:0051017),-0.4062394374301755,-1.244998110140952,0.16382252559726962,0.3488419503512194,1.0,8/33,11.84%,NEDD9;EPS8;BAIAP2;LIMA1;LCP1;MICAL1;HSP90B1;BAIAP2L2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.43590665576656956,-1.2444117537802817,0.16298811544991512,0.3495928538678318,1.0,8/24,21.80%,CD44;CD74;BCL2;TPT1;TMEM161A;TAF9;KDM1A;SNAI2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.2794635024402929,-1.2442119138128787,0.0350609756097561,0.3496459856495805,1.0,91/327,23.00%,MITF;ZMIZ1;TFEB;RREB1;RB1;DNM2;CREBBP;RUNX3;BACH1;INSR;IRF2;APBB2;SBNO2;NFX1;NFYA;NSD3;SPI1;FOXN2;JMJD1C;CTR9;STAT3;LYL1;ZSCAN26;RYBP;CHD3;RNF20;SAP30;DAPK3;GPBP1L1;GON4L;SRRT;FUS;AHR;GCFC2;EZH2;REXO4;POFUT1;EDF1;BHLHE40;E2F1;CNBP;TGFBR1;THAP1;RALY;HIF1A;MEF2C;FOXN3;UBE2L3;HDAC10;HP1BP3;RELA;PRDM2;KMT2D;SPIN1;MLLT6;KAT7;TCF7;SPTY2D1;POLR2A;RPL6;PSPC1;BTG1;TCF3;ZNF628;NSD1;SRSF10;HCLS1;ATXN1;VHL;ATF5;NR3C1;MYB;PPARGC1B;PLAG1;CXXC1;CASZ1;NUP35;PAK6;SUFU;NUP107;ATF7;ZFPL1;GTF2IRD1;ZSCAN21;SNAI2;CEBPB;RPS6KA5;CHD7;NONO;ESR2;SOX7
prerank,regulation of histone acetylation (GO:0035065),-0.3987883170558543,-1.2441735640911173,0.14833333333333334,0.3494453101916675,1.0,10/33,22.19%,BRD7;SPI1;BRCA1;ARRB1;FLCN;HDAC5;KMT2A;CHEK1;SET;RPS6KA5
prerank,Rho protein signal transduction (GO:0007266),-0.36544895681947964,-1.2439799364363224,0.12220309810671257,0.34952858649008434,1.0,11/53,11.45%,MYO9B;ROCK1;ARHGEF3;RHOA;EPS8;GNA12;CDC42;CDC42EP2;PLEKHG5;GNA13;ARHGEF11
prerank,sensory perception of light stimulus (GO:0050953),0.3208881824393205,1.2438551342476372,0.11165048543689321,0.4494640408694213,1.0,20/87,13.83%,PCDH15;GRM8;SLC4A10;CRYZ;POU6F2;COL11A1;RPGR;IMPG2;ABLIM1;ADGRV1;TRPM1;PDE6C;GPR143;CRYBB3;WHRN;EML2;PRPH2;ZIC2;CLRN1;USH2A
prerank,P-body assembly (GO:0033962),-0.5148724279194083,-1.2437271395542906,0.19796954314720813,0.3496932613920439,1.0,5/12,21.20%,RC3H1;DYNC1H1;PATL1;DDX6;LSM14A
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.33349583953970624,-1.2428149233845445,0.09983079526226735,0.3510622036955416,1.0,25/87,20.83%,CDK6;RB1;BRD7;PSME4;PSMB7;PSME3;GPR132;PRMT2;PSMB9;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;AVEN;PSMA1;PSMB8;AURKA;WEE1;CDKN2C;CDK2AP2;PSMA5;PSMD4;PSMB3;PSMD3
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.32889807251279224,-1.2427411833924624,0.10684474123539232,0.3509065923998054,1.0,27/88,20.83%,PSME4;FBXL17;PSMB7;PSME3;FBXW11;PSMB9;FBXL20;FBXO38;PSMA8;PSMC3;KIF14;CUL4B;PSMD8;PSMC4;PSMB10;CUL2;PSMA1;PSMB8;FBXL8;SKP2;FBXL6;FBXO31;PSMA5;PSMD4;PSMB3;FBXW4;PSMD3
prerank,muscle cell development (GO:0055001),0.3953634542571522,1.2425785795508795,0.17906976744186046,0.45101930148977293,1.0,9/30,13.98%,SGCZ;ANK2;DMD;SDC1;NEBL;TTN;DYSF;ALPK2;HES1
prerank,regulation of mitochondrial translation (GO:0070129),-0.4477942130323279,-1.2424976593898798,0.2117437722419929,0.35109110061022064,1.0,7/21,19.87%,NSUN3;ALKBH1;FASTKD2;NGRN;FASTKD3;RMND1;C1QBP
prerank,cellular potassium ion homeostasis (GO:0030007),0.49010439425810876,1.2423039620937473,0.19902912621359223,0.45041593206839936,1.0,5/13,17.14%,SLC12A2;ATP1A3;ATP1B1;KCNMA1;ATP1B2
prerank,cellular response to unfolded protein (GO:0034620),-0.4202206086066664,-1.2420996047157309,0.17750439367311072,0.3515181734445693,1.0,9/26,21.32%,ERN1;OPTN;HSPA9;TMBIM6;BAG3;HSPA1A;HSPA2;PTPN1;HSPA13
prerank,axoneme assembly (GO:0035082),0.3937675992714528,1.2415033323641247,0.16176470588235295,0.45089252217417686,1.0,4/30,3.47%,DNAAF3;CFAP74;DNAI4;RSPH1
prerank,cellular response to interleukin-15 (GO:0071350),-0.5014324085101088,-1.2414636310628702,0.19516407599309155,0.3521568197287332,1.0,6/13,10.81%,GRB2;STAT3;IL15;STAT5B;JAK1;IL2RG
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.5014324085101088,-1.2414636310628702,0.19516407599309155,0.3521568197287332,1.0,6/13,10.81%,GRB2;STAT3;IL15;STAT5B;JAK1;IL2RG
prerank,negative regulation of endopeptidase activity (GO:0010951),0.359127009522276,1.2413420988586883,0.1575,0.45008558564899454,1.0,5/47,4.76%,SPOCK1;SPOCK3;SERPINI1;SERPING1;TIMP3
prerank,negative regulation of T cell proliferation (GO:0042130),-0.41125453661756595,-1.2413110484444514,0.1925133689839572,0.3521283770041814,1.0,11/28,21.90%,LILRB1;RC3H1;TNFRSF21;SCRIB;SDC4;IL4I1;VSIG4;SPN;LGALS9;CD274;CEBPB
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.47032290289375456,-1.2412078811629188,0.1761744966442953,0.35206525603379524,1.0,5/18,17.07%,APOE;ABCG1;PSENEN;CLN3;ADAM19
prerank,regulation of mononuclear cell migration (GO:0071675),-0.43453827114254717,-1.2405993592845432,0.18974358974358974,0.3528551670722195,1.0,9/23,22.16%,LYN;MSN;MDK;CCL5;IL34;CMKLR1;STK10;CSF1;MAPK1
prerank,cholesterol biosynthetic process (GO:0006695),0.390707526803398,1.2405991959075806,0.14516129032258066,0.4505145309501062,1.0,10/31,14.49%,HMGCS1;DHCR24;CYP51A1;INSIG1;SQLE;DHCR7;SC5D;EBP;MVK;LSS
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.5445647311165799,-1.2398801230501273,0.19626168224299065,0.3538258545179407,1.0,5/10,19.32%,PID1;PRKCB;SELENOS;APPL2;ENPP1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.43948334725024585,-1.2393741729847667,0.16636851520572452,0.3544813298934128,1.0,5/22,10.48%,LYN;ABCG1;GSAP;PICALM;RELA
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.49499786813707236,-1.2392209932339988,0.20172413793103447,0.35446368590508726,1.0,4/14,7.30%,PTPRC;IGF1;TNFRSF1B;GRN
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4778431139156236,-1.2391966930491167,0.2056239015817223,0.35423181899511624,1.0,7/16,23.13%,ADCY7;ABCD2;SIRPA;NLRC3;APPL2;ZC3H12A;MEFV
prerank,RNA 3'-end processing (GO:0031123),-0.34350779720515606,-1.2390213366434952,0.1288135593220339,0.3542643174965617,1.0,29/69,32.71%,SRRM1;TUT7;CHTOP;CDC40;ALYREF;MTPAP;RPRD2;NUDT21;WDR33;NCBP1;THOC2;RNPS1;TENT4B;THOC6;PAPOLA;MAGOH;SLU7;CPSF3;SRSF11;DDX39B;DHX38;CPSF1;U2AF2;SRSF7;EIF4A3;SRSF5;TUT1;SARNP;U2AF1L4
prerank,base-excision repair (GO:0006284),-0.36256433654998504,-1.2380839981329586,0.1404109589041096,0.35571360718065426,1.0,21/48,25.67%,ERCC6;RFC1;NEIL3;LIG1;WRN;PCNA;FEN1;RPA3;RFC2;POLD2;PRMT6;LIG3;NEIL2;DNA2;HUWE1;ADPRS;RFC3;POLB;POLD4;MPG;XRCC1
prerank,positive regulation of DNA replication (GO:0045740),-0.47492864758363595,-1.2380250447377343,0.19160583941605838,0.3555301943179031,1.0,6/16,17.64%,BCAR3;DHX9;PCNA;KAT7;FAF1;DNA2
prerank,fatty acid biosynthetic process (GO:0006633),0.33125903983019883,1.2378417604377885,0.13432835820895522,0.4551888853644151,1.0,19/63,20.94%,ELOVL7;ABHD3;ACSM5;OLAH;HACD1;NDUFAB1;CYP1A1;ACACA;ABCD1;LTA4H;DECR2;TECRL;HSD17B8;MLYCD;ACSM3;ASAH2;ELOVL6;ACOT7;ELOVL2
prerank,regulation of macrophage migration (GO:1905521),0.5317050743974143,1.2378408459169339,0.21588089330024815,0.45403941848218177,1.0,4/10,8.43%,CD200R1;P2RY12;CD200;CX3CR1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.5470173724508913,-1.2377873206290162,0.18815331010452963,0.3557071916904378,1.0,4/10,16.54%,TUT7;UBC;RPS27A;ISG15
prerank,stem cell differentiation (GO:0048863),-0.38374155441761826,-1.2377286082766725,0.15025906735751296,0.3555250254237912,1.0,9/39,11.44%,PTPRC;NELFB;HTR2B;FBXL17;BATF;LRP6;JARID2;MEF2C;OSR1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.31014666980066086,-1.2374541217321107,0.09162717219589257,0.3557017523886895,1.0,45/119,26.24%,INPP4A;PLCG2;PI4K2A;PIK3R5;MTM1;ITPKB;PIP4K2A;SLC27A1;SYNJ1;MTMR3;MTMR14;PITPNM1;PI4K2B;PIK3CB;DPM3;TMEM150A;PIK3CG;PI4KB;TTC7A;RAB5A;IMPA1;MTMR6;PIK3CA;SOCS6;PIK3CD;PIK3C2A;PIGH;PLEKHA2;PGAP3;SOCS3;PTPN13;PLEKHA4;IP6K3;PIP5K1A;MPPE1;SOCS5;VAC14;PIP5K1C;SMG1;RAB4A;ITPKC;PIK3C2G;INPP5K;PIGZ;IP6K1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.5112442978256316,1.2373622947362621,0.21064814814814814,0.45393196982835715,1.0,5/11,20.37%,FYN;REST;PRKN;LANCL1;UBQLN1
prerank,triglyceride metabolic process (GO:0006641),-0.360533350254738,-1.2371654127433902,0.13389830508474576,0.35591069443152373,1.0,21/48,39.51%,APOE;FABP5;AGMO;LPL;FABP4;SEL1L;DGAT1;PLAAT3;APOBR;APOH;LMF1;LIPH;GK5;GPAT2;LPIN3;CAV1;PNPLA1;APOA2;SLC27A5;LIPG;FABP7
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.5104761163006685,-1.2370784097783374,0.22405271828665568,0.3557832181047805,1.0,7/12,31.48%,MCM6;MCM3;MCM2;GINS4;CDC45;MCM5;MCM7
prerank,response to chemokine (GO:1990868),-0.4968607124528676,-1.2370633982771355,0.20563847429519072,0.35553477121727994,1.0,4/13,5.46%,RHOA;LRCH1;DOCK8;RIPOR2
prerank,cholesterol homeostasis (GO:0042632),-0.3478511012014008,-1.2368763999124914,0.13356164383561644,0.35557366348268954,1.0,15/64,15.20%,APOE;ABCA1;ABCG1;IL18;GRAMD1B;NR1H2;CNBP;RALY;LIMA1;LPL;NPC2;XBP1;TTC39B;EHD1;NPC1
prerank,stress granule assembly (GO:0034063),-0.4550954802999743,-1.236651064324876,0.18537414965986396,0.35573347629109675,1.0,10/20,23.34%,YTHDF3;DYNC1H1;RPS23;CSDE1;G3BP1;DDX3X;DDX6;LSM14A;ATXN2L;PRRC2C
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.45232199915047056,-1.2360602285102542,0.19746376811594202,0.3565326978926992,1.0,3/20,6.76%,BRD7;BRCA1;ARRB1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.3365357336900294,-1.2358613045942555,0.11226252158894647,0.3566135318303274,1.0,16/80,11.10%,ABCG1;GSAP;VIM;NIBAN1;PRKCD;YTHDF3;PICALM;LARP4B;PCIF1;CD28;LARP4;SIRT3;RPS4X;RELA;EEF2;EIF3E
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5249546393160952,1.2356725621554505,0.20279720279720279,0.4563770311790283,1.0,7/10,27.59%,SARDH;BHMT;SMOX;ALDH7A1;HNMT;LRTOMT;SLC44A1
prerank,cellular lipid catabolic process (GO:0044242),-0.4104685595653397,-1.2355840403006937,0.17297297297297298,0.35683490064026857,1.0,5/27,7.31%,AOAH;PPARD;PLBD1;ABHD12;PLBD2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.35591753717048946,-1.2355512081153337,0.15053763440860216,0.35662667783871066,1.0,13/59,13.28%,MITF;JUN;NFKB1;RUNX2;MED24;CTNNB1;CBFB;RELA;MOV10;CDK1;MED4;MED31;TNRC6C
prerank,positive regulation of reproductive process (GO:2000243),0.39214229136264583,1.2355145485768897,0.171990171990172,0.45558533035109006,1.0,10/31,16.91%,PLCB1;GLRA1;CFAP69;PLA2G10;HYAL3;TACR3;INHBB;SYDE1;INHBA;PDE3A
prerank,artery morphogenesis (GO:0048844),-0.4060028338968973,-1.235499143494229,0.18505942275042445,0.3564339584096239,1.0,14/30,31.99%,NRP1;LRP1;JAG1;VEGFA;TGFBR1;SMAD7;PDGFRB;BMPR2;TBX2;LRP2;ENG;GJA5;ADAMTS9;HEY2
prerank,regulation of defense response to virus (GO:0050688),-0.48862494460836897,-1.2351869102396764,0.1824561403508772,0.3567213294858275,1.0,8/14,27.84%,DHX9;TRAF3;PPM1B;PCBP2;RNF216;C1QBP;ZMPSTE24;RNF26
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.4777479544634401,-1.2345090136946382,0.21694915254237288,0.357641176902118,1.0,8/16,25.44%,BLM;MCM6;RAD51;SSBP1;WRN;MCM2;TWNK;RECQL5
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.5022507325480581,-1.234297533952015,0.2188612099644128,0.3577472970330934,1.0,2/13,0.66%,CD44;CD74
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5071307921814087,1.2336424305594655,0.20601851851851852,0.45845263912548423,1.0,2/11,2.57%,NECAB1;ITM2A
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.48100341339300967,-1.2332811249104991,0.218213058419244,0.35933568106154057,1.0,3/17,5.78%,RBPJ;NOTCH2;JAG1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3363051861611528,-1.2331339334711109,0.1140495867768595,0.3592909821211061,1.0,28/71,22.43%,CTSB;CTSZ;PDCD6IP;MALT1;FBXL17;RNF41;DDI2;USP9X;ATXN3;CTSC;RNF123;CTSH;ATE1;PSMA8;UBC;RPS27A;CUL4B;FAP;CTSS;SOCS6;HM13;ISG15;CASP8;VPS4A;BAG6;ZRANB1;CHMP4B;RSPRY1
prerank,regulation of microtubule polymerization (GO:0031113),0.37099362756990606,1.2326763358589978,0.16511627906976745,0.4593376796751758,1.0,12/40,17.07%,NAV3;MAP2;MAPRE3;TUBB4A;OCLN;EML2;CDK5R1;CDK5RAP2;CDH5;ARL2;SNCA;PRUNE1
prerank,positive regulation of cell division (GO:0051781),-0.37963867048693173,-1.232610687651623,0.1678832116788321,0.3598839429685491,1.0,6/38,5.28%,RHOA;SVIL;HTR2B;CDC42;KIF20B;KIF23
prerank,positive regulation of histone modification (GO:0031058),-0.4036843385170076,-1.2324155694724201,0.17586206896551723,0.35999368550226984,1.0,13/33,27.09%,BRD7;BRCA1;AKAP8;NIPBL;CHTOP;ARRB1;SART3;KDM1A;RPS6KA5;APLNR;AKAP8L;UBE2N;ZBTB7B
prerank,sulfur compound transport (GO:0072348),-0.4099013923859632,-1.2323242625920163,0.18620689655172415,0.3598769077269618,1.0,4/27,4.06%,LRRC8D;SLC6A6;SLC26A11;SLC27A1
prerank,positive regulation of gene expression (GO:0010628),-0.26941135858460186,-1.232013081878418,0.02556818181818182,0.36010617465937383,1.0,87/442,14.39%,PID1;RBPJ;MITF;IGF1;MSN;CD74;FGR;LILRB1;P2RX7;VIM;PLCG2;NIBAN1;CD36;ROCK1;YTHDF3;DEK;ERN1;AGO2;GAPDH;NFE2L2;SMARCA5;RIPK1;BRCA1;HTR2B;STAT3;ERCC6;IL15;TLR4;STAP1;ACTB;PTGER4;PTPN22;MAPK14;BATF;PF4;RPL11;PIK3CB;FN1;PIK3CG;GAS6;POLR2H;VEGFA;EIF2AK2;E2F1;MYD88;LARP4B;POLR2F;TGFBR1;WBP2;PCIF1;CD28;DDX5;HIF1A;LARP4;MEF2C;POLR2L;CTSH;SERPINB9;RPS4X;CLEC9A;EGR1;SPRY2;AGT;ITGAX;MOV10;EEF2;APP;EIF3E;MYOM1;OSR1;DYRK1A;MAP2K1;TICAM1;CELF1;CD46;HNRNPLL;CLEC6A;ITK;METTL14;TNRC6C;PIK3CD;DHX36;CALCOCO1;POLR2A;NFAM1;AGPAT1;ID2
prerank,cellular response to fatty acid (GO:0071398),-0.5055852804361354,-1.2319220178413142,0.20921985815602837,0.35999890625660363,1.0,5/12,26.41%,PID1;LPL;ZC3H12A;NR1H4;KCNK4
prerank,positive regulation of TOR signaling (GO:0032008),-0.37473691831643174,-1.2313693146043914,0.15217391304347827,0.36071421560619654,1.0,16/40,25.87%,GPR137B;KLHL22;GAS6;FNIP1;PIP4P1;NCKAP1L;RRAGD;FLCN;PIK3CA;RHEB;HTR6;WDR24;LAMTOR1;LAMTOR3;SIK3;MIOS
prerank,positive regulation of cartilage development (GO:0061036),0.46083262669227343,1.2310625768675592,0.18764302059496568,0.46162624430959337,1.0,6/17,12.14%,BMPR1B;SOX5;SOX6;SOX9;BMP1;TAPT1
prerank,regulation of T cell migration (GO:2000404),-0.4589038750028924,-1.230884295242647,0.18696397941680962,0.36130432022086006,1.0,7/18,15.91%,RHOA;LRCH1;DOCK8;RIPOR2;APP;CCL5;SPN
prerank,T cell mediated immunity (GO:0002456),-0.49944758549769874,-1.2307537073356853,0.2167235494880546,0.3612762456174118,1.0,4/13,12.13%,MYO1G;JAG1;CTSH;CD46
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.4732519986645378,-1.2301275876171658,0.20210896309314588,0.3621804708344789,1.0,7/16,21.30%,NRP1;PTPRJ;RGS14;PIK3C2A;PDGFRB;PTPN1;PDGFA
prerank,maintenance of blood-brain barrier (GO:0035633),0.39264655720064745,1.2300654567160387,0.1820388349514563,0.462562400639241,1.0,11/30,18.10%,DMD;TJP1;SLC12A2;SLC1A1;OCLN;MFSD2A;CLDN5;CDH5;WNK3;MBP;LAMA2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.4344196624651601,1.2299303252901985,0.1794871794871795,0.46169364244136873,1.0,7/20,14.89%,SEMA6D;SEMA6A;SEMA3E;SEMA5A;SEMA3F;SEMA5B;SEMA4G
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.26643334187757695,-1.2298937302111588,0.03982930298719772,0.3623534673706945,1.0,135/417,28.61%,RBPJ;MDFIC;FOXP1;CD38;RCOR1;BCL6;WWP1;MIDEAS;RB1;JUN;PEX14;NIBAN2;ZNF568;PPARD;ARID5B;BRD7;ZNF148;SBNO2;PPARG;ELK3;GATAD2A;SPI1;BRCA1;WWP2;IKZF1;NIPBL;SNX6;HHEX;ZBTB21;RUNX2;FBXW11;PRMT2;CENPF;SMARCC2;NR1H2;CIITA;CBFA2T3;EIF4A2;AHR;CTNNB1;GAS6;GCFC2;EZH2;PBXIP1;JARID2;DPF2;BHLHE40;EED;E2F1;SPEN;FOXN3;SUDS3;HDAC10;CIART;RELA;TIMELESS;XRCC6;CHMP1A;KLF10;CHD8;KAT7;CCDC85B;HMGB2;MTA3;HDAC5;TFAP4;SIN3A;CALCA;EPC1;PSPC1;ID2;PRMT6;MAP3K10;BTAF1;PHC3;KMT5A;IKZF4;UBE2I;ATXN1;RARA;ATF5;LIMS1;NR3C1;GATA3;MYB;SAMD1;ARID5A;ID1;RSF1;CIC;BAP1;CBFA2T2;SIRT2;SFRP1;CDK5;KDM1A;ID3;SMURF2;ZBTB7A;TBX2;HEYL;SET;RPS6KA5;SCMH1;EID2;CRYAB;NONO;SOX7;TGFB1;DEAF1;SHC1;TSC22D4;GZF1;TRIM28;NCOR1;RBM15B;ZBTB16;DEDD2;MT3;INPP5K;CLOCK;ERN2;SMAD4;BMP2;PML;HSPA8;UIMC1;DEPDC1;TBX21;TLE2;MYBBP1A;CREBZF;CITED2;LEF1;DKK3
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.3944028997751304,-1.229599032755502,0.1680960548885077,0.36262369081260093,1.0,19/32,38.87%,RHOA;ANXA1;VEGFA;MAP2K5;ITGB1BP1;CIB1;HDAC5;PIK3C2A;KDR;HMOX1;CARD10;MAP3K3;TBXA2R;FGF2;KLF4;GATA2;SRPX2;HDAC7;HDAC9
prerank,peroxisomal membrane transport (GO:0015919),-0.4126820611462087,-1.229165131297008,0.19210977701543738,0.36314453690054005,1.0,7/27,16.74%,RAB8B;PEX14;ABCD2;PEX26;FIS1;PEX7;ABCD3
prerank,eye morphogenesis (GO:0048592),-0.45508823633009915,-1.2288805247162682,0.17513134851138354,0.36340813420937196,1.0,6/19,9.63%,STAT3;NIPBL;RARG;SKI;VEGFA;MFAP5
prerank,histone deubiquitination (GO:0016578),-0.45370743689117543,-1.2287160296883475,0.19689119170984457,0.3634206794588208,1.0,10/18,28.84%,ATXN7;USP36;USP3;USP7;BRCC3;USP16;ENY2;UIMC1;EPOP;USP51
prerank,N-terminal protein amino acid modification (GO:0031365),0.4720303129242763,1.2285117464593103,0.21395348837209302,0.46350135026352973,1.0,5/14,15.43%,METAP2;NAA10;NAA60;METAP1;PDF
prerank,receptor catabolic process (GO:0032801),-0.4258903344292367,-1.2282239615041,0.20922570016474465,0.3640331941750925,1.0,13/24,26.88%,ZNRF3;MYLIP;UVRAG;KIF16B;AP2A2;SNX25;SH3GLB1;RNF43;BECN1;TGFB1;AP2S1;SMURF1;AP2A1
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.3409337957989791,-1.2266528288617204,0.13322091062394603,0.3666815171633334,1.0,23/66,25.69%,PRKCD;IPO5;FLNA;CCT7;PARP9;CDK1;TPR;KAT7;MAVS;BAG3;HCLS1;CCT4;CHP2;DTX3L;ZC3H12A;JUP;GTSE1;TGFB1;RBM22;CARD10;TRIM28;ECT2;LARP7
prerank,multivesicular body organization (GO:0036257),-0.4024595393235534,-1.2263833916178253,0.19210977701543738,0.3669127138476918,1.0,17/31,34.65%,PDCD6IP;CHMP5;TSG101;CHMP7;CHMP1A;STAM2;CHMP2A;RAB11A;VPS4A;CHMP4B;CHMP4A;CHMP2B;MVB12A;VPS4B;IST1;VTA1;HGS
prerank,protein-containing complex assembly (GO:0065003),-0.28300776483948004,-1.2258468594868004,0.04501607717041801,0.367668526043352,1.0,62/259,17.39%,MITF;SKAP2;SH3PXD2B;CD74;WIPF1;CTSZ;P2RX7;PEX14;SNX9;CREBBP;ANO6;LPXN;RIPK1;SLC2A1;DHX9;RAB1A;PTK2B;TMED10;AIM2;BLM;AXIN1;TAPBP;TFG;FN1;WASL;PREB;CAPG;PICALM;CTNNB1;DET1;CTSC;TUBGCP4;SLC9A1;ITGB1BP1;TLE3;REPS2;DARS1;NCKAP1L;PDZD11;DNAJB14;TRAF1;SEC24A;PPP6R3;SEC24D;KMT2D;STX5;TCF7;CAPZA1;TRAF2;KPNA3;SEC31A;TFAP4;NIFK;CD40;ST13;TRAPPC5;TLE4;IL2RB;KMT2A;TMED2;CASP8;CLDN1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.43719100194397403,-1.22566394207419,0.21428571428571427,0.3674571065392722,1.0,9/21,17.89%,MCL1;BCL2;EYA4;PF4;MAP2K5;MAPK7;EYA1;HSPA1A;EYA3
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.43719100194397403,-1.22566394207419,0.21428571428571427,0.3674571065392722,1.0,9/21,17.89%,MCL1;BCL2;EYA4;PF4;MAP2K5;MAPK7;EYA1;HSPA1A;EYA3
prerank,mRNA transport (GO:0051028),-0.3179353448956576,-1.224877624409245,0.11343804537521815,0.3686220052543954,1.0,46/101,32.71%,NUP50;SRRM1;HHEX;NUP42;CHTOP;NUP88;RAE1;CDC40;AGFG1;NUP205;UPF2;ALYREF;TPR;NUP188;WDR33;YTHDC1;NCBP1;THOC2;RNPS1;NUP153;THOC6;NUP35;MAGOH;SLU7;CPSF3;NUP107;NUP62;SRSF11;SMG1;DDX39B;DHX38;RANBP2;RBM15B;CPSF1;NUP37;U2AF2;ZFP36L1;SRSF7;AAAS;NUP133;EIF4A3;EIF4E;SRSF5;SARNP;ALKBH5;U2AF1L4
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5159294348485759,-1.2247405670292084,0.21565217391304348,0.368590571646984,1.0,3/12,13.97%,APOBEC1;RESF1;SETDB1
prerank,telomere organization (GO:0032200),-0.371925167258103,-1.2247194259832939,0.17555938037865748,0.36834553111163854,1.0,17/43,26.18%,SP100;BLM;RTEL1;XRCC6;WRN;PCNA;RPA3;POLD2;ERCC4;DOT1L;DNA2;ATM;NBN;PRKDC;POLD4;MRE11;DCLRE1B
prerank,positive regulation of macrophage activation (GO:0043032),-0.46669236905294176,-1.2246463402847867,0.19642857142857142,0.3682141037162239,1.0,5/17,18.51%,TLR4;STAP1;TNIP2;KARS1;MMP8
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4036164049408061,1.2246388288249184,0.1873589164785553,0.4704094845016156,1.0,6/24,8.14%,ANK3;TCAF1;MIEF1;PRNP;FYN;MTCL1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3105179420119769,-1.2242336155882327,0.10945273631840796,0.3686746411003908,1.0,32/112,20.98%,ZMIZ1;CBL;JUN;NRROS;RHOA;LPXN;ARRB2;ITGB1;ADAM9;GCNT2;ARHGEF18;USP9X;SKI;TGFBR1;MEF2C;MAPK7;UBC;RPS27A;ITGB5;ZYX;TGFBR2;ZMIZ2;CRKL;APPL2;LIMS1;SMAD7;NR3C1;ID1;PDCD5;APPL1;SFRP1;USP9Y
prerank,dendritic spine morphogenesis (GO:0060997),0.45779263568842543,1.2241859056894346,0.2157303370786517,0.47029087986107226,1.0,4/15,5.24%,CTNND2;PAK3;EPHB1;SHANK3
prerank,ncRNA export from nucleus (GO:0097064),-0.38393571919122427,-1.223935823941835,0.17290552584670232,0.36893243581865054,1.0,14/36,21.46%,NUP50;XPOT;NUP42;NUP88;RAE1;NOL6;NUP205;TPR;NUP188;NUP153;PHAX;NUP35;NUP107;NUP62
prerank,positive regulation of hydrolase activity (GO:0051345),-0.30365770412649357,-1.2236963872046518,0.1060126582278481,0.3691379795049511,1.0,41/137,21.98%,BCAR3;PSAP;RSU1;SNX9;RHOA;DOCK10;DOCK11;SGSM2;RGS1;RAP1A;ITGB1;DOCK8;ARAP1;RAB3GAP1;PICALM;EZH2;ALS2;SH3BP1;RCN3;CTSH;TGM2;PIN1;SNX13;FLCN;WRN;SNX18;CCL5;HMGB2;CD40;TBC1D30;TBC1D7;AGRN;LIMS1;RPS3;MMUT;CHP2;GSK3B;SFRP1;RACK1;MAP4K4;RAP1GDS1
prerank,Notch signaling pathway (GO:0007219),-0.3494914344045138,-1.2236145328249164,0.14935064935064934,0.36898414127178253,1.0,19/59,21.80%,RBPJ;NOTCH2;CREBBP;PLXND1;MAML1;MAML2;DLGAP5;JAG1;POFUT1;MDK;PSENEN;MIB1;DTX1;DTX3;MAML3;DTX3L;STAT1;HEYL;SNAI2
prerank,translational termination (GO:0006415),-0.3200630335247552,-1.2233015830906777,0.12376237623762376,0.3692864371539593,1.0,38/95,34.45%,GSPT1;ABCE1;MRPS10;ERAL1;MRPL42;CHCHD1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;MRPL17;MRPL15;MRPL51;MRPL47;MRPL18;MRPS7;MRPL54;MRPS25;MRPL39;MRPL53;MRPL11;MRPL33;MTRF1;MRPL28;MRPL30;MRPL43;MRPS17;MRPS5;MRPL1;MRPS28;MRPS35;MRPS21
prerank,response to fatty acid (GO:0070542),-0.4678225391038655,-1.2232863061836576,0.20938628158844766,0.36904123616698636,1.0,4/17,9.75%,PID1;CD36;FOXO3;LPL
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.46777101544790906,-1.2232346224853308,0.2041522491349481,0.3688564212410726,1.0,10/15,43.14%,SELENOS;DERL1;SEL1L;HSP90B1;FAF2;VCP;AUP1;OS9;HERPUD1;SYVN1
prerank,plasma membrane organization (GO:0007009),-0.34488116373140704,-1.2229611698603167,0.1582608695652174,0.36906494382101446,1.0,18/61,17.10%,MYOF;P2RX7;MYH9;ARL8B;SNX9;ANO6;ABCD2;AHNAK2;SNX33;TLCD2;PACSIN2;SERP1;BIN3;ANXA6;CXCR4;CLN3;PLSCR4;STX4
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.4865113206597157,-1.2227624598958804,0.20454545454545456,0.36918003382798753,1.0,2/13,2.23%,CCR2;GNAI3
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.4793054518356743,-1.222663527182313,0.22597864768683273,0.36908673805238207,1.0,2/15,1.09%,CCR2;SYK
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.33511101993859227,-1.2226565291598936,0.12919463087248323,0.36882602999309627,1.0,36/78,34.61%,DAB2;HECTD1;RNF19A;NFE2L2;PIAS1;CBFA2T3;NUB1;DET1;TRIB1;TRIB2;RNF180;PLK3;ARIH1;GABARAP;HSPA1A;SMAD7;FBXO22;GSK3B;SIRT2;SGTA;RACK1;SOCS5;RNF19B;VCP;COP1;CDC20;KEAP1;USP5;CAV1;HSPBP1;HSPA1B;STUB1;CSNK1D;UBQLN2;NOP53;RAD23A
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.41649767620422706,-1.2226217196826248,0.17667844522968199,0.36860986722236166,1.0,9/25,12.75%,ITGA4;ITGB2;ITGA5;ITGB1;ITGAV;ITGB7;ITGAX;CD2;CXADR
prerank,lytic vacuole organization (GO:0080171),-0.3921325953456659,-1.222152693525067,0.16750418760469013,0.3691652696389412,1.0,16/32,31.14%,ABCA1;TFEB;GRN;GNPTAB;CLN6;MYO7A;CLN3;TPP1;VPS18;HPS4;TPCN2;LAMTOR1;ACP4;SNAPIN;ACP3;ARSB
prerank,positive regulation of signal transduction (GO:0009967),-0.28229858811401826,-1.2218757068094848,0.07919254658385093,0.3694001873424983,1.0,45/238,12.30%,RBPJ;SASH1;PTPRC;NRP1;ZMIZ1;PRKCB;IGF1;CD74;TSPAN14;CRADD;AXL;ITGA5;CREBBP;ERN1;MGAT5;FLNA;CSNK2A1;UCHL5;MAML1;STAT3;MAML2;PTK2B;HHEX;ITGAV;SNX5;MACF1;JAG1;C3;GAS6;SKI;SULF2;WLS;TGFBR1;ITGB1BP1;HIF1A;CD63;LY96;ASXL1;ARNT;IL7R;XBP1;ENHO;F7;SPIN1;CLEC6A
prerank,positive regulation of cell death (GO:0010942),-0.3498626652845401,-1.2216160497279829,0.1554054054054054,0.36962465886435814,1.0,19/59,21.79%,MAP3K5;LRP1;CD36;ITGB2;C1QA;SLC6A6;RIPK1;RARG;PICALM;EGR1;CELF1;HTATIP2;FCGR2B;EIF4G1;FAF1;GSK3B;ZC3H12A;HPR;HP
prerank,apoptotic process (GO:0006915),-0.28468326777378006,-1.221584109355696,0.07350689127105667,0.36941588270441633,1.0,52/203,19.13%,APAF1;NOTCH2;PAEP;DAPK1;PRKCD;ITGB2;BCL2L11;PPARD;OGT;GAPDH;RIPK1;CFLAR;TNFAIP1;NUDT2;PTK2B;BCL2;DAPK3;STK3;TNFRSF21;AHR;DPF2;HIP1;MYD88;CASP4;FASTKD2;APP;PIK3CA;FAP;GADD45A;STK11;CD2;ADAM15;CASP7;CIB1;IFIT2;PLK3;CASP1;TGFBR2;BBC3;MAP3K10;CXCR4;MCM2;BID;BNIP2;CASP8;TNFRSF25;CSRNP1;IFT57;TRADD;TAOK2;CASP2;PAK6
prerank,establishment of endothelial barrier (GO:0061028),-0.41155679891790886,-1.2215642837365575,0.20106761565836298,0.36917442243633825,1.0,6/29,6.88%,MSN;RAP1B;RAP2B;RAP1A;RAB1A;MYADM
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.45294338398016953,1.2214046847329296,0.19522776572668113,0.4751681754933195,1.0,6/16,19.73%,RORA;PDK3;RORC;PRKN;MLYCD;SIRT1
prerank,endothelial cell migration (GO:0043542),-0.37997478717616784,-1.221398694931327,0.1986062717770035,0.36919066852859056,1.0,12/37,16.25%,NRP1;MYH9;RHOA;PLXND1;LPXN;DPP4;VEGFA;PLEKHG5;PIK3CA;FAP;RAB13;NR4A1
prerank,protein kinase B signaling (GO:0043491),-0.4307930411052876,-1.2213329146398586,0.19546247818499127,0.36902660611838467,1.0,12/23,29.86%,IGF1;GAS6;CCL5;PLK3;SIRT2;KDR;TGFB1;ADTRP;MT3;ZFP36L1;TSC2;PAX2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.532655199450091,-1.2211050160361916,0.2205128205128205,0.3691444439624803,1.0,5/10,24.09%,LILRB1;FN1;HSP90AB1;LAPTM4B;FURIN
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5307067139597168,-1.2210889480790104,0.20103986135181975,0.3688929346765186,1.0,3/10,4.13%,CD36;SLC27A1;SLC2A1
prerank,primary neural tube formation (GO:0014020),-0.3994253329132411,-1.220770877151401,0.20593692022263452,0.3692006253686356,1.0,19/30,31.13%,MTHFD1L;LRP6;SKI;SCRIB;VANGL2;STIL;MTHFR;PHACTR4;TGFB1;DVL2;DEAF1;LRP2;TSC2;GRHL3;CELSR1;GRHL2;IFT122;PAX2;BCL10
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.3629371302152266,-1.2205497762085387,0.15993265993265993,0.36930621128380914,1.0,12/46,11.47%,LYN;PTPRC;TLR4;DUSP3;SIRPA;ITGB1BP1;SPRED1;SPRY2;PIN1;DUSP6;FLCN;SPRED2
prerank,cellular component assembly (GO:0022607),-0.2829743187548049,-1.2205238729417944,0.0770392749244713,0.36909069903103087,1.0,57/253,17.14%,MITF;NEDD9;SKAP2;CD74;WIPF1;FBLIM1;RAC1;YTHDF3;PEX14;SNX9;CREBBP;RHOA;EPS8;FLNA;STX7;LPXN;PARVB;CDC42;SLC2A1;PTK2B;ACTB;TAPBP;WASL;RHOQ;CAPG;PICALM;GAS6;DET1;BAIAP2;SH3BP1;TUBGCP4;CCDC40;LIMA1;REPS2;DARS1;LCP1;NCKAP1L;TLCD2;SPAG16;TRAF1;MICAL1;BAIAP2L2;FOXJ1;CAPZA1;TRAF2;KPNA3;SPEF1;TFAP4;NIFK;CD40;ST13;CHAF1A;DNAJB13;ESPN;IL2RB;RBBP4;KMT2A
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.4706104427680563,-1.2205015494651414,0.22597864768683273,0.36887094964286865,1.0,7/16,8.31%,ARHGAP24;OGT;ARHGAP17;PIK3CB;PIK3CG;ALS2;SH3BP1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.531890507457107,-1.2200765645289242,0.23725834797891038,0.3693325199069346,1.0,1/10,0.16%,APOE
prerank,lysosome organization (GO:0007040),-0.383222265111111,-1.2200315905352916,0.17224080267558528,0.3691392990524228,1.0,17/36,31.14%,ABCA1;TFEB;GRN;GNPTAB;CLN6;MYO7A;CLN3;TPP1;VPS33A;VPS18;HPS4;TPCN2;LAMTOR1;ACP4;SNAPIN;ACP3;ARSB
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.28962456838375095,-1.2198407605519301,0.08520900321543408,0.36921726872724814,1.0,45/190,17.36%,LYN;BANK1;ARHGAP25;P2RX7;XDH;MCL1;PLEK;PTPRJ;ITPR1;RIPK1;SPI1;ARRB2;RIOK3;CD22;ADIPOR1;BCL2;MAPK14;DUSP3;PIK3CB;CYRIB;MYADM;IFI35;MGRN1;UBR2;DGKD;PPM1B;SH3BP1;FNIP1;PLAUR;ARHGAP12;SPRED1;RELA;FLCN;CIB1;NLRC3;RNF34;TMSB4X;CDC34;DGKG;NLRX1;TBC1D7;TNIP3;DEPTOR;CASP8;MAP2K3
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.41331520354566614,-1.2196645063929448,0.20218579234972678,0.3692415273652752,1.0,11/26,28.50%,B4GALT5;GBGT1;TPI1;GCNT1;TKT;LARGE1;ALG6;GAL3ST4;ALG11;GK5;ST3GAL4
prerank,positive regulation of lyase activity (GO:0051349),0.45692556691273745,1.2194879999317532,0.2371638141809291,0.4782827935989328,1.0,5/14,23.55%,CACNA1C;GUCA1A;FXN;NOS1;NF1
prerank,T cell migration (GO:0072678),-0.49569071559680056,-1.2192476504385983,0.2188034188034188,0.36971508251430646,1.0,6/13,17.49%,MSN;MYO1G;PIK3CG;CXCL16;PIK3CD;ZAP70
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.4464899994125088,-1.2189234735542354,0.20458553791887124,0.37001650420001225,1.0,10/18,29.60%,IGF1;IL18;IL27RA;RPS3;HMGB1;AGER;TNFSF9;IL12RB1;IL2;IGFBP2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.5205786898236112,-1.2189219355081606,0.2231833910034602,0.36974735236995293,1.0,4/11,21.48%,CIITA;PF4;XBP1;TMEM106A
prerank,membrane organization (GO:0061024),-0.28444339859753975,-1.2187854921440695,0.07575757575757576,0.3697249577058416,1.0,63/227,16.37%,DAB2;MYOF;TMCC1;GRB2;CORO1C;ARPC2;ITSN1;CBL;SNX3;DNM2;SNX9;ACTR2;PDCD6IP;NEMP1;SH3KBP1;ARRB2;ACTR3;SYNJ1;SYNGR1;CHMP5;ACTB;ARPC3;GLTP;WASL;FCHO2;ARRB1;PICALM;MYADM;EPS15;HIP1;SUN2;AP2A2;RAB5A;AGFG1;FNBP1;IGF2R;REPS2;UBC;RPS27A;TLCD2;PACSIN2;IL7R;CHMP7;TRIP10;RABEP1;CHMP1A;SAR1A;STAM2;CCDC88A;BAIAP2L2;ARPC1A;SERP1;SH3GLB1;LEMD2;CHMP2A;TOR1AIP1;PIK3C2A;NPC1;ARPC5;VAMP4;CLN3;KIF20A;VAPB
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.37487936173461406,-1.218766620749232,0.18041237113402062,0.3694880924428128,1.0,21/39,29.38%,ABCA1;RAB8B;CANX;STEAP3;PREB;RCN3;SEL1L;RAB3D;RAB10;MIA2;MIA3;RAB13;PDIA4;RAB12;TVP23A;TANGO6;MON1A;AFM;PPY;COPG1;LTBP2
prerank,protein modification process (GO:0036211),-0.33610587671549713,-1.218434267933558,0.15425531914893617,0.36989280425834575,1.0,30/76,23.55%,ST3GAL1;PPP4R2;ST8SIA4;ABL2;WWP2;MSRA;PARP4;STK38;UBA7;UBE2L3;UBL5;SEPHS1;B4GALT7;SERP1;PADI4;FBXW2;PIGH;CDC34;RABGGTA;UBE2I;MAN2B1;GNMT;UBE2M;RABGGTB;FBXO22;BAP1;CSNK1G3;MANBA;PRKDC;ERO1A
prerank,sterol homeostasis (GO:0055092),-0.34083328003182123,-1.2183265557690004,0.14864864864864866,0.36983781719147435,1.0,15/65,15.20%,APOE;ABCA1;ABCG1;IL18;GRAMD1B;NR1H2;CNBP;RALY;LIMA1;LPL;NPC2;XBP1;TTC39B;EHD1;NPC1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.53212227049574,-1.218269275151743,0.21621621621621623,0.36966189655086906,1.0,5/10,24.51%,BCL2;MLLT11;KDR;RACK1;DCN
prerank,cell-matrix adhesion (GO:0007160),-0.31581810139262817,-1.2181331908550863,0.12046204620462046,0.3696306220166106,1.0,20/95,12.32%,ITGA4;CD44;LYVE1;RAC1;ITGB2;SIGLEC1;HPSE;PEAK1;ITGAL;ITGB1;ITGAV;ADAM9;FN1;ITGB7;ITGB1BP1;CD63;ITGB5;ZYX;ITGA3;ADAM15
prerank,lipid modification (GO:0030258),0.3675278330942497,1.2178440526744212,0.170316301703163,0.4806100158922007,1.0,4/37,2.69%,DGKB;PLPP4;PLPPR1;PLPPR4
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.370493502037204,1.21782220446959,0.1943127962085308,0.47948807815488886,1.0,9/32,9.63%,ARHGAP6;SEMA3E;MMP12;CLASP2;DLC1;APOD;NEXMIF;CDKN2A;PLET1
prerank,acylglycerol catabolic process (GO:0046464),-0.3952567206260089,-1.217795547325547,0.19022687609075042,0.3699736276956208,1.0,4/30,10.36%,FABP5;ABHD12;LPL;FABP4
prerank,regulation of tissue remodeling (GO:0034103),-0.4459634651673512,-1.217617345951406,0.1962134251290878,0.3700277767029382,1.0,4/18,8.06%,RUNX1;IL15;IL18;MDK
prerank,carnitine shuttle (GO:0006853),-0.520113341716561,-1.217323428715471,0.218213058419244,0.37032496907961343,1.0,3/11,14.94%,PRKAG2;CPT1A;ACACB
prerank,somite development (GO:0061053),0.5005081183613376,1.217161995261618,0.26066350710900477,0.4797420779224872,1.0,3/11,19.06%,SOX11;SMO;MEOX2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.3058546894994123,-1.2171490353274923,0.11525974025974026,0.37032749442121615,1.0,42/128,23.42%,DNM2;BACH1;OPTN;FBXL17;CNTRL;DYNC1H1;FBXW11;CCNY;HAUS5;SDCCAG8;HAUS6;CEP57;CKAP5;CDK14;YWHAE;MASTL;NES;CEP70;HAUS4;CDC25A;DCTN1;CDK1;HAUS7;PLK3;PPP1R12A;ODF2;NINL;PCNT;FBXL8;SKP2;AURKA;WEE1;PHLDA1;FBXL6;PAFAH1B1;CEP192;CDC25C;CETN2;TUBA4A;CEP41;CCNB1;PPP1CB
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.31418408945063425,-1.2167098752059642,0.12520064205457465,0.3708811893854808,1.0,21/108,12.24%,MDFIC;RUNX1;LRP1;SNX3;CSNK2A1;HHEX;CCNY;MACF1;AXIN1;MDFI;CTNNB1;SKI;PPP1CA;SULF2;WLS;CDK14;CBFB;OTULIN;APP;ITGA3;SPIN1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.5122532525993522,-1.2166875192368847,0.22491349480968859,0.3706586844563173,1.0,5/12,22.81%,RFWD3;PLK3;WAC;FBXO31;PRKDC
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.43065265976318473,-1.216061097788922,0.21212121212121213,0.3714411774102383,1.0,4/23,9.94%,PLEK;NUPR1;CBFA2T3;SIK1
prerank,dendritic cell chemotaxis (GO:0002407),-0.491696147469049,-1.215998943050075,0.218213058419244,0.37128677446669556,1.0,6/14,19.36%,CCR2;CCR1;PIK3CG;CCL5;CXCR4;HMGB1
prerank,negative regulation of cell cycle process (GO:0010948),-0.34125391940401995,-1.2158756372025386,0.16275167785234898,0.3712715576322853,1.0,19/61,21.65%,APAF1;BRCA1;RYBP;EZH2;EED;E2F1;RAD51;E2F8;EPC1;CHMP2A;PHC3;RBBP4;UXT;RBBP8;MAX;CHEK1;NME6;VPS4A;ZFYVE19
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.43258324871769493,-1.2158327933297346,0.2176991150442478,0.37107629183628266,1.0,12/22,34.12%,ROCK1;MGAT5;MASTL;NCKAP1L;STYXL1;IKBKB;GSK3B;FKBP1B;BOD1L1;PTPA;ROCK2;TNF
prerank,icosanoid metabolic process (GO:0006690),-0.37195237173426704,-1.2152364829612696,0.19210977701543738,0.3718669530592614,1.0,14/40,30.15%,TBXAS1;MAPKAPK2;ALOX5AP;ABCC1;DAGLB;GPX4;PLA2G4A;PON2;CYP1B1;PNPLA8;PON3;ALOX15;CYP2S1;PTGR1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.500121777239804,-1.2145734124969578,0.2099827882960413,0.37283180458356,1.0,6/12,21.01%,BLM;METTL4;KAT7;TICRR;TIPIN;NBN
prerank,toxin transport (GO:1901998),-0.5283837134201255,-1.2143911367921836,0.21649484536082475,0.3729049051067802,1.0,7/10,41.58%,ANTXR2;RAB29;SLC22A3;SLC22A2;ANTXRL;SLC29A4;ADAM10
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.3924870319994487,-1.2141567418889858,0.1849912739965096,0.37305829506058097,1.0,8/33,10.48%,JUN;PPARG;SPI1;STAT3;FOXO3;HIF1A;EGR1;RELA
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.5202444188403975,-1.2141082932220704,0.24394463667820068,0.3729017187889833,1.0,5/11,25.96%,MALT1;NFKBIZ;CLEC6A;NFKBID;IL12RB1
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.37878741861775705,-1.2141042469704115,0.1686541737649063,0.3726392222239188,1.0,19/36,29.30%,MAP3K20;ERCC6;RAD1;E2F1;TIMELESS;RHNO1;DOT1L;BRIP1;RAD9A;DNA2;ATM;CHEK1;TIPIN;NBN;CDC45;CLOCK;USP28;CEP63;DONSON
prerank,regulation of macrophage activation (GO:0043030),-0.39775894507477694,-1.2141037175244025,0.18823529411764706,0.37237175692052454,1.0,11/30,22.63%,CD74;MFHAS1;GPR137B;TLR4;TNIP2;FCGR2B;KARS1;IL31RA;MMP8;ZC3H12A;IL6
prerank,protein heterotetramerization (GO:0051290),0.4806478075518359,1.213976832487796,0.23556581986143188,0.48552050449964446,1.0,7/13,26.00%,GRIN2B;PKD1;HSD17B8;CPSF6;CPSF7;GRIN1;PKD2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.47238462664884123,-1.2138309196034578,0.22262773722627738,0.3726168310390687,1.0,5/14,11.47%,XDH;SPRED1;SPRY2;OSR1;SPRED2
prerank,regulation of lymphocyte activation (GO:0051249),-0.49897836111853894,-1.2134587929056633,0.23198594024604569,0.37300663106046045,1.0,8/12,31.27%,THEMIS2;LCK;IKZF3;CCL5;CRTAM;CD19;LAT;CD4
prerank,regulation of cell migration (GO:0030334),-0.26839084762128695,-1.2130657223323493,0.047345767575322814,0.37344656576552454,1.0,77/382,13.40%,DAB2;SASH1;MITF;NEDD9;PLXNC1;IGF1;MCTP1;CD74;FGR;CORO1C;CLIC4;SDCBP;ARID2;RAC1;ROCK1;YTHDF3;PTPRJ;MGAT5;RHOA;RAP2B;PLXNA1;INSR;DOCK10;FLNA;IGF1R;PLAU;PLXND1;RAP2A;MINK1;GNA12;SGK1;RNF41;STAT3;FOXO3;CCR1;FLT1;ITGB1;RNF20;PTK2B;RUFY3;ANXA1;ADAM9;MACF1;ELP5;JAG1;SEMA4A;DUSP3;HGF;CYRIB;MYADM;GCNT2;GRN;SUN2;NF2;VEGFA;CBLL1;MDK;BST2;TGFBR1;CTSH;SPRY2;KIF14;ITGAX;XBP1;FLCN;OSGIN1;ARHGEF39;F7;ADAM15;CXCL16;CCL5;CIB1;CPNE3;SERPINE1;STK24;SEMA4B;PIK3CD
prerank,cellular calcium ion homeostasis (GO:0006874),0.2896632498870043,1.2128065555523,0.0938337801608579,0.4869878132197042,1.0,29/133,16.13%,HTR2C;ANK2;TRPC5;RYR2;ADCY8;SLC24A4;SLC24A2;SLC8A3;HCRTR2;TRPC1;SLC24A3;TMEM203;PTH1R;LETM1;CCDC47;SLC8A2;RYR1;EDN1;CALCB;ATP1B1;MICU3;ATP2B4;CDH5;ATP2B2;ATP2A1;CHRNA7;SELENOK;ATP13A5;PDZD8
prerank,glycosphingolipid metabolic process (GO:0006687),-0.37269942748055335,-1.2126494792662312,0.1824561403508772,0.3739063084081543,1.0,11/42,14.55%,HEXA;PSAP;CTSA;GLTP;ARSA;ESYT1;ESYT2;SUMF2;CLN6;NEU1;LARGE1
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.5092261384503307,-1.2121228238247614,0.24610051993067592,0.37458564684859647,1.0,2/12,1.91%,IREB2;IDH1
prerank,cholesterol metabolic process (GO:0008203),-0.3378489349269739,-1.2115132600078717,0.14334470989761092,0.375404232387519,1.0,15/68,14.91%,APOE;ABCA1;ABCG1;PPARD;CYP27A1;NSDHL;OSBPL5;PIP4P1;CLN6;CH25H;IDI1;RXRA;HSD17B7;ACAT2;CYP46A1
prerank,negative regulation of metabolic process (GO:0009892),-0.3512075108999938,-1.2113608588399614,0.17206132879045996,0.37541282535144666,1.0,17/54,18.75%,RBPJ;RB1;IL15;TLR4;LNPEP;NR1H2;PLCL2;ZDHHC7;TLE3;FIS1;ACOT13;FLCN;STK11;IL18R1;TFE3;RHEB;ID1
prerank,intracellular lipid transport (GO:0032365),-0.4335511595878048,-1.2113242919424823,0.2150170648464164,0.3752007366662811,1.0,6/21,16.74%,ABCD2;PRKAG2;CPT1A;NPC2;ACACB;ABCD3
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.43596414051618687,-1.2111883102407213,0.2019704433497537,0.375195294002918,1.0,10/21,33.38%,MYH9;ADAM9;PSENEN;HM13;ADAM19;PSEN2;PRTN3;BACE1;DAG1;ERAP1
prerank,cellular response to nutrient levels (GO:0031669),-0.3426651938562864,-1.2106058649781295,0.15140845070422534,0.37602879233520625,1.0,17/62,21.84%,TFEB;LAMP2;ATG7;FNIP1;LPL;XBP1;RRAGD;FLCN;WRN;KLF10;STK24;EIF4G1;RALB;BMPR2;SFRP1;GAS2L1;KCNB1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.41841508416644935,-1.2105413925610844,0.20847457627118643,0.3758697771761032,1.0,11/24,25.99%,PID1;COX10;LYRM7;SDHAF4;GFPT1;SLC25A13;ACADVL;CYCS;MYC;MT3;COQ10B
prerank,cellular metal ion homeostasis (GO:0006875),0.30204597232782837,1.2099295073091179,0.10485933503836317,0.4923354335435114,1.0,22/102,14.82%,HTR2C;ANK2;RYR2;SLC24A4;SLC24A2;SLC8A3;SLC12A2;SLC24A3;ATP1A3;TMEM203;PTH1R;LETM1;SLC8A2;EDN1;CALCB;ATP1B1;KCNMA1;ATP2B4;CDH5;ATP2B2;ATP2A1;CHRNA7
prerank,chromatin remodeling (GO:0006338),-0.31505842599134065,-1.2099105364152907,0.12745098039215685,0.3767289923967999,1.0,23/100,19.83%,RB1;BPTF;ARID1B;SMARCA5;ERCC6;CHD3;ACTB;SMARCD3;SMARCC2;JARID2;ARID1A;BAZ2B;CHD8;BAZ1A;HDAC5;PADI4;DR1;INO80;RBBP4;INO80C;MYB;RSF1;KDM5B
prerank,response to cAMP (GO:0051591),0.3599702435362293,1.2095004805396767,0.18313253012048192,0.49208104824800647,1.0,7/37,10.58%,AKAP6;IGFBP5;SLC26A3;WT1;HCN2;CITED1;HCN1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.4347230125003134,-1.2094201621663918,0.2153846153846154,0.3773432556694258,1.0,9/20,23.39%,LYN;TLR4;IL18;PTPN22;TICAM1;CCL5;HCK;MTDH;TGFB1
prerank,response to interferon-beta (GO:0035456),-0.4266070462483681,-1.2091138645898238,0.21453900709219859,0.3776133793433477,1.0,16/22,45.63%,IFNAR2;AIM2;BST2;IFITM2;CDC34;STAT1;IFITM1;IRGC;PLSCR1;IKBKE;TRIM6;XAF1;IFITM3;SHFL;HTRA2;UBE2K
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.44074121101192276,-1.2080980430079513,0.215929203539823,0.37919609891755296,1.0,6/20,16.15%,IPO5;HHEX;INCA1;CDK5RAP1;TFAP4;LATS2
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4153057904042131,-1.2069987787587337,0.19856887298747763,0.381000371589099,1.0,5/26,8.64%,PRKAG2;BRCA1;ADIPOR1;NR1H2;ERLIN1
prerank,maintenance of protein location in nucleus (GO:0051457),-0.4335508706658777,-1.206563501824161,0.2054794520547945,0.38151825725055827,1.0,7/20,26.76%,SP100;SUN2;MORC3;TAF8;TAF3;TOPORS;PML
prerank,positive regulation of protein depolymerization (GO:1901881),-0.5201649539454399,-1.2056602418421298,0.23369565217391305,0.3829329031224534,1.0,4/11,15.02%,PLEK;NES;WDR1;STMN2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4401815474164789,1.2055621069762759,0.22018348623853212,0.4997168855119518,1.0,4/17,7.47%,CTNNA2;WASF1;ABI2;NCKAP1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.4717359745333445,1.2054174118518022,0.2350230414746544,0.4988397979257321,1.0,5/14,14.70%,CORIN;OXTR;AGTR1;EDN1;ECE1
prerank,peptide cross-linking (GO:0018149),-0.4135861261967918,-1.2053085779909531,0.2243150684931507,0.3832983172787488,1.0,4/25,10.16%,F13A1;ANXA1;FN1;TGM2
prerank,cellular response to pH (GO:0071467),-0.4545792610775896,-1.2052553274753048,0.2209106239460371,0.3831245999526453,1.0,6/17,26.41%,RAB11FIP5;SLC9A1;RAB11B;ASIC1;GPLD1;KCNK4
prerank,renal water homeostasis (GO:0003091),0.40713757520077015,1.2048346243225452,0.21515892420537897,0.4989086092546696,1.0,7/23,14.85%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1;PRKACB;PRKAR1A
prerank,regulation of multicellular organismal development (GO:2000026),-0.41878851885590507,-1.204526267096747,0.2135593220338983,0.38414436205379754,1.0,11/25,21.59%,HPSE;INSR;NIPBL;DUSP6;CDK1;DHX36;RACGAP1;GATA3;TRIP12;OAS2;BAG6
prerank,regulation of cell aging (GO:0090342),-0.5117387106273934,-1.2041671326168788,0.23851590106007067,0.3845388438056178,1.0,4/11,35.16%,NEK6;LMNA;NEK4;ING2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.2947755762236769,-1.2033931074899713,0.11916264090177134,0.3856850369962649,1.0,48/152,22.44%,ZEB2;DKK2;CSNK2A1;PSME4;PSMB7;PSME3;NFKB1;HHEX;USP8;DAPK3;MACF1;PSMB9;AXIN1;TBL1XR1;PPM1B;LRRK1;SKI;SULF2;WLS;PSMA8;PIN1;PSMC3;PSMD8;SPIN1;PSMC4;PSMB10;TNKS2;PSMA1;RSPO3;PSMB8;GPRC5B;JRK;PLEKHA4;DDX3X;RSPO1;PSMA5;PSMD4;TMEM198;PSMB3;WNK1;PSMD3;SFRP1;JUP;DISC1;CSNK1G3;SMURF2;ZRANB1;ILK
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.43066872664523553,-1.2028950196176433,0.23259762308998302,0.386331071928261,1.0,4/21,5.20%,ABCB7;ABCD2;BRCA1;COA8
prerank,cellular response to cAMP (GO:0071320),0.37541466597067713,1.202498713827208,0.21176470588235294,0.5030006499815947,1.0,6/30,10.58%,AKAP6;IGFBP5;SLC26A3;WT1;HCN2;HCN1
prerank,cell cycle G2/M phase transition (GO:0044839),-0.3020547777577911,-1.2016315945372493,0.12459546925566344,0.38842606681498837,1.0,45/129,25.40%,DNM2;OPTN;FBXL17;CNTRL;AKAP8;DYNC1H1;FBXW11;CCNY;HAUS5;SDCCAG8;HAUS6;CEP57;CKAP5;CDK14;YWHAE;MASTL;NES;CEP70;HAUS4;CDC25A;DCTN1;CDK1;HAUS7;PLK3;PPP1R12A;ODF2;NINL;PCNT;FBXL8;SKP2;AURKA;WEE1;PHLDA1;FBXL6;PAFAH1B1;CEP192;CDC25C;CETN2;TUBA4A;CEP41;CCNB1;PPP1CB;AKAP8L;CCNB2;CEP72
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.4302390514502944,-1.201033089343056,0.2109777015437393,0.38926959546802364,1.0,13/20,36.57%,APOE;MBTPS2;TTC39B;FMO5;LPCAT3;NR1H4;ACADVL;ABCA2;LDLRAP1;SREBF1;ARV1;DGKQ;GNB3
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.5237656587875138,-1.2010189339445059,0.23232323232323232,0.3890208163472496,1.0,5/10,18.85%,IL18;SPHK2;RARA;GATA3;LGALS9
prerank,regulation of dephosphorylation (GO:0035303),0.452531643564166,1.2009640594845548,0.2141119221411192,0.5052945733125914,1.0,8/15,22.74%,MTMR2;SMG5;CDK5RAP3;PPP1R16B;MTMR9;MTMR4;PPP1R17;SMG7
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.4971371295889381,-1.2006367802085376,0.24179620034542315,0.3894189049452644,1.0,5/12,17.36%,PARP11;TIPARP;PARP8;TNKS2;PARP10
prerank,heme catabolic process (GO:0042167),-0.4847995548552861,-1.199927875826526,0.22522522522522523,0.3902142653729593,1.0,7/14,31.51%,BLVRB;HMOX2;ABCC1;HMOX1;SLCO1B1;UGT1A4;UGT1A1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.4847995548552861,-1.199927875826526,0.22522522522522523,0.3902142653729593,1.0,7/14,31.51%,BLVRB;HMOX2;ABCC1;HMOX1;SLCO1B1;UGT1A4;UGT1A1
prerank,protein K63-linked ubiquitination (GO:0070534),-0.3769255190647634,-1.1996940397213551,0.19897084048027444,0.39037353229522775,1.0,12/41,15.18%,HECTD1;BFAR;TRAF5;WWP2;PELI1;TRAF3;RNF4;RNF8;TRAF1;TRAF2;UBE2G1;UBE2T
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.3311240672787353,-1.1990883729600317,0.16472545757071547,0.39124870180380794,1.0,15/70,10.62%,ITGA4;NRP1;RB1;RAC1;RHOA;PEAK1;LPXN;SPI1;PARVB;ITGAV;FN1;SIPA1L3;ITGB7;MEF2C;KIF14
prerank,peptide metabolic process (GO:0006518),0.3198311530262369,1.198952017916629,0.14987714987714987,0.508668744433984,1.0,17/75,16.45%,DMD;PCSK5;MME;TRHDE;MGAT3;IDE;SEC11C;ABCB9;GSTZ1;GSTP1;PCSK1;CPE;GGT1;GSTK1;LTA4H;GSTM5;DNPEP
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.2996487815581016,-1.1984776013328045,0.11831442463533225,0.39212437724274024,1.0,35/128,21.71%,ZMIZ1;CBL;JUN;NRROS;RHOA;RNF111;LPXN;ARRB2;ITGB1;RUNX2;ADAM9;SLC33A1;GCNT2;ARHGEF18;USP9X;SKI;TGFBR1;DDX5;TGFB1I1;UBC;RPS27A;ITGB5;ZYX;ACVR2A;TGFBR2;ZMIZ2;APPL2;SMAD7;ID1;GDF3;BMPR2;APPL1;USP9Y;SMURF2;MEGF8
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.28485807727743273,1.198400794526898,0.12467532467532468,0.5087041341277998,1.0,19/124,8.49%,CNTNAP2;NLGN1;MAP2;CNTN4;GPM6A;RASGRF1;SH3GL2;CSF1R;PLP1;TMEM108;CARMIL1;BICDL1;GDNF;GPM6B;KIFAP3;FLRT3;TOR1A;FAM161A;NEDD4
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.346972789703775,-1.1982609072854316,0.18760195758564438,0.39221236235564066,1.0,19/56,27.20%,DAB2;SDCBP;PMEPA1;RBPMS;TGFBR1;SNX25;PIN1;ACVR2A;GREM1;LDLRAD4;TTK;SMAD7;GDF3;BMPR2;INHA;TGFB1;SMAD4;BMP2;ENG
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.39785400087184525,-1.1970166032844005,0.22847100175746923,0.3942241160828448,1.0,11/28,28.76%,ARHGAP18;SH3BP1;WDR1;RASA1;BRK1;COTL1;HCLS1;HAX1;PFN1;DBNL;PLEKHG2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3932457328701327,-1.1968907508235236,0.20106761565836298,0.394183661478226,1.0,7/26,17.76%,NSMCE2;RB1;DLGAP5;CENPE;NEK6;UBE2C;ANAPC7
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.41629343276399106,-1.1968104917547866,0.22695035460992907,0.3940625271699068,1.0,5/25,4.20%,PLCG2;PLEK;ITPR1;P2RX4;CD22
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.37063097695434094,-1.196401756788807,0.19896193771626297,0.3945618439165999,1.0,10/37,14.34%,DDB2;RFC1;UBC;RPS27A;PCNA;CUL4B;RPA3;RFC2;POLD2;ERCC4
prerank,response to growth factor (GO:0070848),-0.3669588899989454,-1.196248128637394,0.22800718132854578,0.3945524462324669,1.0,18/41,24.61%,CTNNB1;STAT5B;MAP2K5;TGFBR1;MAPK7;CIB1;CPNE3;ACVR2A;TGFBR2;TBC1D7;TWF2;BMPR2;SFRP1;RACK1;URI1;LRP2;SHC1;MYC
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.437272371816616,-1.1961575582544552,0.22203098106712565,0.39443823860074556,1.0,12/18,38.87%,ANXA1;VEGFA;CIB1;PIK3C2A;KDR;HMOX1;MAP3K3;FGF2;GATA2;SRPX2;HDAC7;HDAC9
prerank,dendritic spine organization (GO:0097061),0.3912192489056347,1.1949139002939169,0.22350230414746544,0.5152805587243363,1.0,11/26,15.52%,CTNND2;MTMR2;PAK3;EPHB1;SHANK3;PRNP;FYN;ARC;LGMN;CHRNA7;EPHB3
prerank,positive regulation of leukocyte migration (GO:0002687),-0.4016698049557447,-1.1948580331101268,0.22377622377622378,0.3965897257052176,1.0,15/27,36.42%,IL6R;VEGFA;MDK;ADAM8;NCKAP1L;F7;MIA3;CSF1;IL6;PLVAP;TNF;EDN3;TNFRSF18;PRSS56;EDN2
prerank,retina homeostasis (GO:0001895),-0.4268710673505207,-1.1943143100222835,0.20770519262981574,0.39741633475119476,1.0,5/23,11.57%,ACTB;POTEF;B2M;SLC28A2;PRDX1
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.49565283031610297,-1.1942112227986015,0.25654450261780104,0.3973271593482276,1.0,3/12,4.68%,NUPR1;IL18;STAP1
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.4106223964309292,-1.193722534831732,0.23570190641247835,0.3979974596827702,1.0,9/26,20.38%,TET3;OGT;CTR9;KMT5B;KMT5C;KMT2D;TET2;KMT2A;EEF2KMT
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.5128587560859686,-1.193169558754859,0.2539130434782609,0.398730704289811,1.0,4/10,17.14%,DCLRE1C;RTEL1;DCLRE1A;TFIP11
prerank,amino acid transport (GO:0006865),-0.3474008900001539,-1.193146905679461,0.1986062717770035,0.3984846531708653,1.0,11/49,14.69%,SLC38A6;SLC6A6;SLC43A2;SLC38A10;SLC16A10;SLC7A7;SLC38A7;SLC36A4;SLC25A45;SLC7A5;SLC25A44
prerank,negative regulation of histone acetylation (GO:0035067),-0.5090804368525017,-1.19282353835041,0.2585034013605442,0.39880532546658726,1.0,7/11,34.05%,SPI1;BRCA1;SIN3A;SET;NOC2L;CTBP1;THAP7
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.26498551999643905,-1.1927614284907895,0.058734939759036146,0.3986500199504249,1.0,103/366,23.00%,MITF;TFEB;RREB1;RB1;DNM2;CREBBP;RUNX3;BACH1;INSR;IRF2;APBB2;SBNO2;NFX1;NFYA;NSD3;SPI1;FOXN2;JMJD1C;CTR9;STAT3;FOXO3;LYL1;ZSCAN26;RYBP;CHD3;RNF20;SAP30;DAPK3;GPBP1L1;GON4L;PUM3;SRRT;FUS;AHR;GCFC2;EZH2;REXO4;POFUT1;EDF1;BHLHE40;E2F1;CNBP;TGFBR1;THAP1;PCIF1;HIF1A;MEF2C;FOXN3;UBE2L3;NUCKS1;HDAC10;HP1BP3;RELA;MTPN;APP;CCDC88A;PRDM2;KMT2D;ORC5;SPIN1;MLLT6;KAT7;TCF7;SPTY2D1;POLR2A;RPL6;NOLC1;PSPC1;BTG1;TCF3;ZNF628;NSD1;SRSF10;HCLS1;EIF2A;ATXN1;RBM4B;VHL;ATF5;NR3C1;MYB;PPARGC1B;PLAG1;CXXC1;CASZ1;NUP35;PAK6;SUFU;RBM3;ESCO2;NUP107;ATF7;ZFPL1;GTF2IRD1;PDGFA;ZSCAN21;SNAI2;CEBPB;RPS6KA5;CHD7;NONO;ESR2;SOX7
prerank,Golgi ribbon formation (GO:0090161),-0.4863073310568444,-1.1927214505473995,0.2563667232597623,0.39844758355293836,1.0,6/13,24.21%,VTI1A;OPTN;STX16;VAMP4;TMED5;TRIP11
prerank,regulation of nuclear division (GO:0051783),-0.426552041329346,-1.1927198127322332,0.24302134646962234,0.3981731671659784,1.0,7/20,21.07%,CDK13;KIF20B;DAPK3;PIN1;MKI67;RCC1;CDC25C
prerank,macroautophagy (GO:0016236),-0.30499880625063314,-1.192397717885338,0.14308681672025725,0.39850691732611254,1.0,35/118,23.01%,PLEKHM1;ARL8B;CSNK2A1;PIP4K2A;TECPR1;PRKAG2;ATG5;UVRAG;LAMP2;ATG7;TCIRG1;MTMR3;MTMR14;ATG10;TBC1D5;TSG101;EPG5;LIX1;HDAC10;STAM2;UBXN6;RB1CC1;CHMP2A;GABARAP;EI24;CLN3;VPS33A;TOMM22;VPS4A;PRKAG1;VPS16;CHMP4B;CHMP4A;BECN1;TOMM70
prerank,regulation of lipid catabolic process (GO:0050994),0.4263053903588657,1.1919603271192305,0.25060240963855424,0.5208438423988596,1.0,5/19,14.91%,ALK;APOC1;ANGPTL3;ABCB11;ABCD1
prerank,nuclear membrane disassembly (GO:0051081),-0.4738080661826947,-1.1918477677404873,0.2323049001814882,0.39926715928132783,1.0,7/14,24.92%,PRKCB;NEK6;DCTN1;CDK1;CCNB1;AKAP8L;CCNB2
prerank,negative regulation of histone modification (GO:0031057),-0.4760828482152194,-1.1910217091276312,0.22013651877133106,0.40054142504582974,1.0,8/14,34.05%,BRCA1;JARID2;PRMT6;SPHK2;SET;NOC2L;CTBP1;THAP7
prerank,protein localization to plasma membrane (GO:0072659),0.28601214577304185,1.1907909099708502,0.15258855585831063,0.5223462696196398,1.0,16/129,5.82%,DPP10;KCNIP4;DPP6;KCNB2;ANK3;ANK2;RAB3C;MAP7;CACNB2;TESC;RAB15;EPB41L3;AFDN;CLASP2;NECTIN3;RAMP3
prerank,cation transmembrane transport (GO:0098655),0.34983662153799155,1.1902886573888427,0.2111650485436893,0.5222453973881201,1.0,10/44,17.38%,ASIC2;TRPM3;SLC25A19;TRPM1;ATP1B1;SFXN3;SLC25A38;SLC22A5;SLC6A5;TRPM2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5236136164914894,1.1900350739634638,0.26004728132387706,0.5215717475584384,1.0,5/10,16.80%,PRKCE;PTH1R;IRS1;SNCA;AKT2
prerank,cardiac cell development (GO:0055006),-0.5052980329316519,-1.188888544439516,0.2643884892086331,0.40425885616727414,1.0,4/11,12.75%,JAG1;VEGFA;SLC8A1;CXADR
prerank,regulation of microglial cell activation (GO:1903978),-0.457951820346082,-1.1888037212370162,0.22393162393162394,0.40412109096787807,1.0,7/15,22.63%,PTPRC;STAP1;GRN;CST7;MMP8;LDLR;IL6
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.346678161366075,1.1887970389056721,0.1774580335731415,0.5230745066198279,1.0,17/44,15.12%,OSBPL6;SLC27A2;OSBPL7;INSIG1;SQLE;DHCR7;ACOX2;SC5D;EBP;PER2;HSD3B7;OSBPL2;ABCB11;ACOT8;PSAT1;HSD17B4;CYP39A1
prerank,lipoxygenase pathway (GO:0019372),-0.467130512816934,-1.188703767817371,0.256140350877193,0.40404605484855466,1.0,10/14,48.10%,ALOX5AP;GPX4;PON2;PON3;ALOX15;ALOX12;PON1;LTC4S;ALOXE3;GPX1
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.3298275344048689,-1.1876826173191168,0.18688524590163935,0.40569185745931713,1.0,23/66,24.33%,SASH1;MAP3K5;TAOK3;PIK3R5;HTR2B;FLT1;PIK3CG;EZH2;VEGFA;ADAM8;TRAF2;CD40;IL34;MAP3K10;ARHGEF5;RPS3;PDGFRB;NOD2;PDGFA;FGF18;TGFB1;DVL2;FLT3
prerank,sensory perception of taste (GO:0050909),0.5069643033263219,1.1876270160208304,0.2818181818181818,0.5245546437017362,1.0,3/10,10.44%,ASIC2;PKD1L3;TAS1R1
prerank,regulation of microtubule-based movement (GO:0060632),0.5013868823366138,1.1876096031501444,0.27586206896551724,0.5233703314412073,1.0,5/11,18.37%,MAP2;NEFH;CFAP298;HAP1;TTC21B
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.3412164748555145,-1.1874688983315322,0.2063758389261745,0.4057809462985401,1.0,23/57,24.61%,MAP3K5;CTSD;DAPK1;SYK;USP50;MALT1;NLRC4;AIM2;ASPH;NOD1;GRAMD4;FIS1;CASP1;TNFSF10;CASP8;PDCD5;DDX3X;HMGB1;NLRP3;SOX7;MEFV;CYCS;MYC
prerank,negative regulation of cell adhesion (GO:0007162),-0.3235673573309796,-1.1872738332792951,0.18512396694214875,0.40586563715890384,1.0,15/72,8.99%,PTPRC;PLXNC1;RHOA;PLXNA1;SIPA1;PLXND1;LPXN;TGFBI;RIPOR2;JAG1;GCNT2;NF2;CBLL1;MDK;ITGB1BP1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5148074521604947,-1.1871656879352794,0.26545454545454544,0.4058186472430647,1.0,3/10,13.83%,LYN;MAP2K1;GREM1
prerank,snRNA processing (GO:0016180),-0.45790228656570114,-1.1869592900215165,0.24479166666666666,0.4059510029494271,1.0,6/16,20.44%,INTS8;INTS11;INTS6;INTS14;INTS1;INTS5
prerank,phosphate ion homeostasis (GO:0055062),-0.5135776522138839,-1.1866657773236082,0.2375,0.40622138211153497,1.0,4/10,36.77%,XPR1;ENPP1;FGFR4;FGF23
prerank,spliceosomal snRNP assembly (GO:0000387),-0.35829342539772446,-1.186642899586293,0.19204152249134948,0.40598157038639116,1.0,14/38,23.95%,SNRPG;COIL;SNRPF;PRPF8;SART1;SMN1;SART3;GEMIN7;SNUPN;SRSF10;WDR77;TGS1;GEMIN6;PRPF6
prerank,L-glutamate transmembrane transport (GO:0015813),0.5013473034213856,1.1865873278612042,0.2315270935960591,0.5244477064894105,1.0,3/10,7.87%,SLC1A2;SLC1A6;SLC1A1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.49936481482414574,-1.1864795001098072,0.26278659611992944,0.4060104536127834,1.0,4/11,10.33%,STAT3;DHX9;PUM2;XPO5
prerank,liver development (GO:0001889),-0.3811663967188436,-1.186308637705104,0.20949263502454993,0.40606483778357877,1.0,15/32,30.40%,ARID5B;ANXA1;CEBPG;CCDC40;XBP1;GFER;E2F8;AURKA;CEBPB;IL6;LSR;DNAAF1;NKX2-8;CITED2;MET
prerank,regulation of plasminogen activation (GO:0010755),-0.4832566605606337,-1.1862406313158544,0.2532894736842105,0.4059064536377433,1.0,2/12,0.93%,RUNX1;CTSZ
prerank,response to hydroxyurea (GO:0072710),-0.4947576309270404,-1.1861302641482228,0.25225225225225223,0.4058069506969698,1.0,6/11,15.34%,SPIDR;BLM;DDI2;TIMELESS;KAT7;NSMCE3
prerank,acylglycerol metabolic process (GO:0006639),-0.3733241907734238,-1.1860013289871523,0.2176991150442478,0.4057585608937082,1.0,18/37,35.13%,APOE;DGKZ;ABHD12;DGKD;LPL;SEL1L;DGAT1;PLAAT3;DGKG;APOBR;APOH;LMF1;DGKA;GK5;AWAT2;CAV1;PGS1;DGKQ
prerank,early endosome to Golgi transport (GO:0034498),-0.5025793990253036,-1.185460372431865,0.23963963963963963,0.4064768997139006,1.0,4/11,18.18%,SNX2;SNX8;STX5;SNX1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.3417305272639649,-1.1853552841838568,0.2147887323943662,0.40640945018918195,1.0,19/53,24.20%,PSME4;PSMB7;PSME3;PSMB9;AZIN1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3;OAZ3;NQO1;PSMB1
prerank,prostaglandin metabolic process (GO:0006693),-0.40172069122481224,-1.185296643944477,0.24394463667820068,0.4062378078782016,1.0,9/26,30.15%,TBXAS1;CD74;DAGLB;PLA2G4A;ACOX1;PNPLA8;CYP2S1;PTGES;PTGR1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.421438493419544,-1.1852464026622394,0.23076923076923078,0.40605708139952057,1.0,9/21,28.51%,BCL2L11;TXNDC12;SELENOS;XBP1;TMBIM6;HSPA1A;NCK1;EIF2AK3;BCL2L1
prerank,negative regulation of cyclase activity (GO:0031280),-0.46460701547666444,-1.185005367304612,0.23642732049036777,0.4062339043949523,1.0,2/14,2.23%,CCR2;GNAI3
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.46814294089605935,-1.1848722309598039,0.260655737704918,0.405925622567097,1.0,5/15,17.43%,AGO2;CNOT1;TNRC6C;DHX36;TOB1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.46814294089605935,-1.1848722309598039,0.260655737704918,0.405925622567097,1.0,5/15,17.43%,AGO2;CNOT1;TNRC6C;DHX36;TOB1
prerank,positive regulation of cilium assembly (GO:0045724),0.4342868292719819,1.1847309143977094,0.21739130434782608,0.5276453537893839,1.0,7/18,22.12%,SEPTIN9;TAPT1;ARHGAP35;FUZ;HAP1;BBS4;HTT
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.38059187202858374,1.184453297369471,0.18372093023255814,0.5270630535776909,1.0,8/31,15.62%,HOXC4;SOX11;DSCAML1;HOXD3;TFAP2A;TBX1;HOXC9;FUZ
prerank,regulation of proteolysis (GO:0030162),-0.34635729357952666,-1.1844185463690966,0.19686411149825783,0.4065085912949215,1.0,16/48,25.14%,GSAP;OGT;DNAJC1;FBXW11;ASPH;TRAF3;PLAUR;CLN6;LTBP4;CST3;CLN3;CASP8;CDK5;BAG6;FGFR4;SPOP
prerank,ephrin receptor signaling pathway (GO:0048013),-0.3210533019038557,-1.1844046660920375,0.17609046849757673,0.4062649704026503,1.0,20/82,12.01%,LYN;VAV3;SDCBP;ARPC2;ITSN1;RAC1;ROCK1;ACTR2;RHOA;CDC42;ACTR3;ACTB;ARPC3;WASL;AP2A2;VAV2;PSENEN;CRK;ARPC1B;ARPC1A
prerank,cellular response to interleukin-4 (GO:0071353),-0.5191801752385418,-1.1843617977485286,0.2638888888888889,0.4060739977688582,1.0,4/10,17.97%,STAT6;XBP1;TCF7;GATA3
prerank,photoreceptor cell development (GO:0042461),0.4560127399778612,1.1843252186770175,0.2669902912621359,0.5261326538719616,1.0,5/14,10.94%,RORB;AHI1;CDHR1;CEP290;MFSD2A
prerank,extracellular transport (GO:0006858),-0.48378644030865137,-1.1843074202613362,0.27058823529411763,0.40589256155205955,1.0,5/12,21.23%,WWP2;TSG101;CCDC40;ARRDC1;ADCY10
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.3947228992953931,-1.184164574187932,0.22280701754385965,0.40589928134059094,1.0,8/27,16.73%,CREBBP;PHF20;MORF4L1;TAF6;NAA50;KAT7;MRGBP;PHF20L1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.487771631528588,-1.1840298853156472,0.23979591836734693,0.40587399359070964,1.0,4/13,14.50%,CBL;SNX6;TSG101;CBLB
prerank,positive regulation of axonogenesis (GO:0050772),0.3508074196970227,1.1839325566782115,0.20689655172413793,0.5258555894437349,1.0,9/43,10.11%,ROBO1;ROBO2;SLIT2;NTRK2;CDKL5;SLITRK1;BDNF;PLXNA4;POU4F2
prerank,embryonic digestive tract development (GO:0048566),0.4242157965017704,1.1838353625115285,0.2482598607888631,0.5248891413421105,1.0,6/18,14.07%,PCSK5;SOX11;RARB;SALL1;TGFB2;GLI3
prerank,glycoprotein catabolic process (GO:0006516),0.43976465252973596,1.18370629078688,0.26490066225165565,0.5240283956477021,1.0,5/17,12.65%,MMP12;FBXO44;FBXO2;FBXO27;ADAMTS12
prerank,response to ketone (GO:1901654),0.3930921527102514,1.183626174431531,0.21040189125295508,0.5230169209499724,1.0,5/24,10.93%,SLIT3;SLIT2;YAP1;CATSPERD;TGFB2
prerank,positive regulation of cellular process (GO:0048522),-0.25384293017788456,-1.1835193423498123,0.05439330543933055,0.40652866250882175,1.0,173/565,27.29%,DOCK2;LYN;IGF1;NAMPT;GAB2;SDCBP;P2RX7;LRP1;CYBA;PRKCD;CD36;RAC1;SLC6A6;PTPRJ;CAMK1D;ACER3;NUPR1;TNFRSF1B;INSR;IGF1R;P2RX4;CSNK2A1;CDK13;IL6R;HTR2B;IL15;EAPP;CDC42;TLR4;FLT1;TCIRG1;DPP4;PTK2B;DYNC1H1;ITGAV;BCL2;KIF20B;RPS6;STX3;FN1;DDX49;SLC35F6;LRP6;CHTOP;KLHL22;GCNT2;GAS6;EZH2;GRN;GRK5;VEGFA;SIRPA;MDK;CNBP;RPS15A;PRMT1;TGFBR1;ITGB1BP1;PTPN6;TBC1D8;CTSH;ADAM8;RPS4X;TGM2;RELA;KIF14;ITGAX;MTPN;IL2RG;IL7R;XBP1;FLCN;CELF1;KMT2D;CXCL16;CCL5;HSP90AB1;CACUL1;CIB1;FCGR2B;FCER1G;GLP2R;DHX36;TGFBR2;CST7;GREM1;NCBP1;AGPAT1;CAPNS1;DOT1L;IL34;INO80;ACACB;EIF4G1;CRKL;TTK;IL31RA;BST1;HCLS1;FAF1;IL2RB;CNOT6L;VHL;STX4;RPS9;IRS2;RARA;LILRA5;KRAS;TFE3;SERTAD1;HCK;PDGFRB;DDX3X;MEIS3;PLA2G5;IL7;WDR77;ATM;CSF1;CHP2;CNOT8;C1QBP;CHEK1;PRC1;CSPP1;MAZ;SIRT2;SFRP1;TIPIN;ZC3H12A;KDR;PDGFA;EXOSC4;TBX2;SMC6;HPR;HP;EGR2;FGF18;S1PR2;IL6;P4HB;KITLG;TGFB1;CD47;DVL2;LMNA;SMC5;ECHDC3;FGF9;FLT3;SHC1;MYC;PKHD1;RNF187;FGFR4;FKBP1B;PRTN3;MT3;CCN2;CDCA7L;VIP;FZD7;ZFP36L1;ASH2L;RPS6KA3;CUL3;TBRG4;RTKN2;PDPN;TSPAN31;STAMBP
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3602711745306923,1.1834695898262382,0.21809744779582366,0.5221536487979346,1.0,14/37,20.96%,IFT81;DYNLL1;IFT22;TRAF3IP1;KIFAP3;DYNLL2;CEP131;DYNC2H1;DYNC2LI1;KIF3A;KIF3C;TTC21B;PCM1;DYNC2I1
prerank,negative regulation of reproductive process (GO:2000242),-0.44488012315264347,-1.1831607031042306,0.24691358024691357,0.4069410965178379,1.0,2/17,0.72%,IGF1;PAEP
prerank,regulation of metal ion transport (GO:0010959),0.4236467166709613,1.183024002258337,0.22401847575057737,0.5219771547527673,1.0,2/16,1.49%,ANK2;CACNA2D1
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.3630542149151306,-1.1826369832668833,0.2289156626506024,0.40763952504224665,1.0,15/40,24.80%,FGR;RNASE7;MYD88;GBP2;CHGA;RNASE6;CAMP;HMGB2;DEFA6;ANG;GBP7;GBP6;IL6;RPL39;GBP4
prerank,steroid hormone biosynthetic process (GO:0120178),-0.3904039663858594,-1.1824141997486397,0.22621184919210055,0.40780122983683814,1.0,14/29,39.23%,HSD17B7;FDXR;SRD5A1;SRD5A2;TSPOAP1;FDX1;HSD3B2;HSD17B14;FDX2;SRD5A3;STARD3;HSD17B3;CYP19A1;TSPO
prerank,regulation of gluconeogenesis (GO:0006111),-0.39590274149321875,-1.1823479996161588,0.22831858407079647,0.4076463369524672,1.0,8/27,27.61%,OGT;SELENOS;SIK1;USP7;GNMT;DDB1;ZNF692;EP300
prerank,regulation of cell motility (GO:2000145),-0.29815432850162177,-1.1821040817852702,0.1328125,0.4078547804035058,1.0,23/121,11.57%,DIAPH1;PLXNC1;CDK6;RAC1;ROCK1;RHOA;PLXNA1;DOCK10;FLNA;PLXND1;FES;MINK1;ABL2;SGK1;DAPK3;ARHGAP18;MACF1;CYRIB;PIN1;KIF14;CCDC125;OSGIN1;CRK
prerank,carboxylic acid transport (GO:0046942),-0.3426564759803415,-1.182041680142897,0.19672131147540983,0.40767491985630144,1.0,15/55,20.26%,SLC16A7;PSAP;SLC38A6;SLC6A6;SLC36A4;SLC66A1;SLC7A5;SLC16A6;CLN3;SLC23A1;SLC23A2;SLC6A9;SLC38A2;SLC25A10;SLC16A1
prerank,positive regulation of cell motility (GO:2000147),-0.27903024698208095,-1.1820013797110027,0.1130030959752322,0.4074777162518462,1.0,58/205,21.91%,DAB2;NEDD9;IGF1;FGR;SDCBP;MGAT5;INSR;IGF1R;PLAU;STAT3;CCR1;FLT1;ITGB1;PTK2B;RUFY3;ADAM9;ELP5;SEMA4A;HGF;MYADM;GCNT2;GRN;SUN2;VEGFA;CBLL1;MDK;TGFBR1;CTSH;SPRY2;ITGAX;XBP1;ARHGEF39;F7;CXCL16;CCL5;CIB1;CPNE3;SEMA4B;PIK3CD;CFAP20;SEMA3D;STX4;CLDN1;SPAG9;PDGFRB;TRADD;F10;ATM;CSF1;MAZ;FERMT3;KDR;PDGFA;RACK1;SEMA3B;CCDC25;SNAI2;MAP4K4
prerank,reticulophagy (GO:0061709),-0.48406352251211726,-1.1818349616195776,0.2711864406779661,0.4074992165352987,1.0,5/12,22.14%,ULK2;TEX264;RETREG1;RB1CC1;UFM1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.4507820132140403,-1.1817435798231508,0.265625,0.40740359819949706,1.0,6/17,21.80%,CD44;CD74;DYRK1A;RNF34;KDM1A;SNAI2
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.3682390668970316,-1.1816013156197862,0.2098138747884941,0.4073799870836802,1.0,14/35,25.67%,RFC1;LIG1;PCNA;FEN1;RPA3;RFC2;POLD2;LIG3;ADPRS;RFC3;POLB;POLD4;MPG;XRCC1
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3662385934786463,-1.1815266493890948,0.2167235494880546,0.407264533648494,1.0,10/39,11.64%,MYO5A;TRAK1;MYO1F;RAB1A;FBXW11;MYO1G;WASL;SYT4;MYO1E;MYO7A
prerank,mitochondrial translational termination (GO:0070126),-0.3132383413251641,-1.181460613988271,0.16336633663366337,0.4071100076234601,1.0,36/88,34.45%,MRPS10;ERAL1;MRPL42;CHCHD1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;MRPL17;MRPL15;MRPL51;MRPL47;MRPL18;MRPS7;MRPL54;MRPS25;MRPL39;MRPL53;MRPL11;MRPL33;MTRF1;MRPL28;MRPL30;MRPL43;MRPS17;MRPS5;MRPL1;MRPS28;MRPS35;MRPS21
prerank,regulation of protein phosphorylation (GO:0001932),-0.27104325170216287,-1.1807652831559134,0.09782608695652174,0.40810923894839674,1.0,87/256,27.20%,PID1;LYN;DAB2;FNIP2;CD74;FGR;CORO1C;XDH;NIBAN1;RAC1;ITGB2;INSR;BRD4;IBTK;ATF3;RAP2A;RIPK1;AKAP8;CCND3;PPP1R15B;AXIN1;FN1;HGF;C3;LRP6;ARRB1;MYADM;GAS6;CAMKK2;VEGFA;SIRPA;SMG8;FNIP1;PLAUR;PIN1;PAQR3;APP;FLCN;WDFY2;CCDC88A;IGFBP3;CIB1;ACVR2A;RB1CC1;CD40;PPIL4;IL34;NSD1;CRKL;MAVS;BST1;RALB;KRAS;PTPN13;HSPB1;RSPO1;AGER;ZC3H12A;MOB1B;KDR;PDGFA;RACK1;CEBPB;FGF18;ILK;PLPP3;PRKDC;TARDBP;TGFB1;ADTRP;DVL2;FGF9;PPP2R5B;AKAP8L;STAT2;ECT2;CDK2AP1;PPP2R5A;MT3;INPP5K;CCDC88C;PECAM1;BMP2;PDE8A;PML;PPP2R5E;ENG
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4215361562649229,-1.1803005870329164,0.22998296422487224,0.40878787880839135,1.0,7/21,20.02%,OSBPL8;OSBPL5;PLA2G4A;PLAAT3;PLA2G5;PLA2G12A;LPCAT3
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4626438315860302,1.1800900941878403,0.25217391304347825,0.5275698511952208,1.0,7/13,22.09%,CIAO1;ISCA2;NFU1;CIAO2B;LTO1;CIAO2A;BOLA2
prerank,response to interleukin-6 (GO:0070741),-0.5069637839468044,-1.1800447109308076,0.2591304347826087,0.4089899791924605,1.0,4/10,10.48%,PID1;SBNO2;NFKB1;RELA
prerank,sphingoid metabolic process (GO:0046519),-0.4821977130988018,-1.1799961826500363,0.27071823204419887,0.40880557187042793,1.0,9/12,40.35%,KDSR;SPHK2;SPTLC3;PLPP3;DEGS2;SPHK1;PLPP2;PLPP1;SGPP1
prerank,protein stabilization (GO:0050821),-0.2898908600256505,-1.1797215102516205,0.11920529801324503,0.40901653802588206,1.0,53/168,26.25%,IGF1;PRKCD;GAPDH;FLNA;LAMP2;COG7;ATP1B3;COA8;STK3;RPL11;GRN;CCT7;USP36;USP9X;WFS1;HIP1;MFSD1;MORC3;RAB21;TNIP2;PIN1;SEL1L;LAMP1;HSP90AB1;FLOT2;CRTAP;BAG3;USP7;TAF9;VHL;HSPA1A;SMAD7;CCT4;TRIM39;PPIB;MDM4;NAA16;GLMP;GOLGA7;BAG6;HYPK;HPS4;CRYAB;PLPP3;GTSE1;PIM2;RABL3;P3H1;AFM;MT3;RPL5;PFN1;RASSF2
prerank,photoperiodism (GO:0009648),-0.39941319939469355,-1.17942207725985,0.24475524475524477,0.40932863615545095,1.0,13/28,28.28%,FBXL17;PPP1CA;BHLHE40;SIK1;ID2;FBXL8;RBM4B;FBXL6;PPP1CC;PPP1CB;CLOCK;PML;FBXL3
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.44921246703443546,1.1790859808433092,0.23058252427184467,0.5286246508358947,1.0,6/14,16.87%,NME2;AK4;AK5;NMNAT2;ME1;AK3
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3695911286422904,-1.1790779044257396,0.2147887323943662,0.40967520424636034,1.0,5/35,9.25%,APOE;XDH;PPARG;FLT1;MEF2C
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4703198778063062,-1.1789248352031092,0.24521739130434783,0.4097025235736028,1.0,5/13,21.24%,NAMPT;TLR4;SELENOS;NOD2;KDR
prerank,cellular response to radiation (GO:0071478),-0.3653330261463562,-1.1787831120173424,0.22434782608695653,0.4096775411039863,1.0,12/40,17.62%,GRB2;SPIDR;BLM;MAPK14;RAD1;RAD51;GADD45A;RHNO1;RAD51AP1;INO80;NSMCE3;RAD9A
prerank,regulation of spindle assembly (GO:0090169),-0.4027359229779894,-1.1783482523342794,0.24863883847549909,0.4102171728662279,1.0,14/25,34.01%,PDCD6IP;CHMP5;DYNC1H1;RNF4;CHMP1A;TPR;CHMP2A;HSPA1A;CHMP4B;CHMP2B;VPS4B;HSPA1B;DRG1;NUMA1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3749226344375267,1.1782824333034383,0.2293144208037825,0.529256849234281,1.0,8/31,10.51%,DLG2;LRRC7;DLG3;PARD3;PRKCI;MTCL1;ANK1;CRB1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.41990903471744795,-1.1780424428963807,0.24869565217391304,0.4105108468529156,1.0,8/21,22.16%,PTK2B;STAP1;MDK;CCL5;IL34;CMKLR1;CSF1;MAPK1
prerank,protein heterooligomerization (GO:0051291),0.4257456729335889,1.1779321689909459,0.25609756097560976,0.5288801821535593,1.0,9/17,26.00%,GRIN2B;KCNC2;PKD1;HSD17B8;TMEM120A;CPSF6;CPSF7;GRIN1;PKD2
prerank,actomyosin structure organization (GO:0031032),0.3190386517542792,1.1778482545807516,0.17782909930715934,0.5279159046507395,1.0,16/75,12.80%,SORBS1;TJP1;FRMD5;CDC42BPA;EPB41L4B;EPB41L3;EPB41L4A;PHACTR1;FRMD3;CSRP1;TNNT2;TTN;CAPN3;PGM5;MYH10;FHOD3
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.44037629954895596,-1.1775178716392132,0.23181049069373943,0.4112636298312428,1.0,9/17,27.91%,COX4I1;COX10;AFG1L;COX8A;COX6C;NDUFA4;CYCS;COX5A;COX6A2
prerank,cytosolic calcium ion transport (GO:0060401),0.3819551630809602,1.1771143033830493,0.24358974358974358,0.5284431880742303,1.0,10/28,15.15%,CACNA1C;RYR2;CACNA2D1;SLC25A23;TRPM1;JPH4;SLC8A2;ADRA1A;MICU3;JPH3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3141284916144863,-1.1770609553114872,0.17609046849757673,0.41188467725643435,1.0,25/85,21.87%,DAB2;HECTD1;NUPR1;RNF19A;PIAS1;CBFA2T3;NUB1;DET1;ATXN3;TRIB1;TRIB2;PSMC3;RNF180;RNF185;ARIH1;GABARAP;TMEM259;HSPA1A;SMAD7;FBXO22;GSK3B;SIRT2;RACK1;BAG6;SOCS5
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.3598704515381913,-1.1769097772168504,0.2167577413479053,0.41190957901656106,1.0,11/46,10.62%,ITGA4;NRP1;RAC1;RHOA;PEAK1;LPXN;PARVB;ITGAV;FN1;ITGB7;KIF14
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.30832344668622536,-1.1768638110582677,0.15502555366269166,0.41171052823903326,1.0,34/101,26.05%,MSN;VIM;NIBAN1;YTHDF3;OGT;ATG7;ATG10;FBXW11;NR1H2;ASPH;LARP4B;PCIF1;CD28;LARP4;RPS4X;AGT;EEF2;EIF3E;CLN6;UHRF1;METTL14;EIF4G1;FAF1;CASP8;DDX3X;CSF1;RBM3;IL6;PRKDC;TGFB1;FGFR4;VPS11;RPL5;EIF6
prerank,regulation of centrosome cycle (GO:0046605),-0.4222146183007452,-1.1767544318842011,0.24528301886792453,0.411644684361648,1.0,12/21,27.63%,PDCD6IP;CHMP5;GEN1;CHMP1A;CHMP2A;AURKA;XRCC3;ATF5;CHMP4B;PKHD1;CHMP2B;MARK4
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.42949658411632063,-1.176615523931389,0.26306620209059234,0.41162266229656946,1.0,3/19,1.57%,PRKCH;RUNX1;ROCK1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.5153695692689977,-1.1765127291604422,0.2847341337907376,0.4115396483050614,1.0,4/10,10.11%,PRKCB;ITGA5;HIF1A;ARNT
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4262292848749039,-1.1763385666952508,0.25609756097560976,0.41159271548916665,1.0,6/20,17.40%,ZMIZ1;TGFBR1;HIF1A;EGR1;HSP90AB1;HSPA1A
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.4744480586266402,-1.1762827439062273,0.2586805555555556,0.41143489271858585,1.0,6/14,13.88%,RAB1A;SEC24A;SAR1A;SEC24D;SEC31A;MIA3
prerank,positive regulation of heart contraction (GO:0045823),0.430316957649185,1.1759767746928937,0.26303317535545023,0.5298728777395026,1.0,5/19,12.77%,RYR2;APLN;EDN1;TGFB2;ADRA1A
prerank,DNA dealkylation (GO:0035510),-0.5146654636418819,-1.1757574508241475,0.26573426573426573,0.41190281670001555,1.0,7/10,25.93%,ALKBH1;MGMT;FTO;ALKBH3;ASCC3;MPG;ASCC2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.5146654636418819,-1.1757574508241475,0.26573426573426573,0.41190281670001555,1.0,7/10,25.93%,ALKBH1;MGMT;FTO;ALKBH3;ASCC3;MPG;ASCC2
prerank,nuclear migration (GO:0007097),-0.47852455107159575,-1.1756463435953755,0.2630691399662732,0.41185194537400693,1.0,7/13,23.93%,DYNC1H1;FBXW11;SUN2;SYNE3;DCTN1;PAFAH1B1;SYNE2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3376248432447798,-1.175568839042687,0.1996370235934664,0.4117222951605117,1.0,17/56,21.07%,NSMCE2;RB1;RAD51B;BRD4;CCND3;DLGAP5;ANXA1;KLHL18;CDC25A;CDK1;EIF4G1;UBE2C;ANAPC7;DDX3X;RAB11A;ADAMTS1;CDC25C
prerank,arachidonic acid secretion (GO:0050482),-0.5115571102411814,-1.1754864144407986,0.26287744227353466,0.4113314554343346,1.0,5/10,39.07%,ANXA1;PLA2G5;PNPLA8;ACE;NMUR2
prerank,arachidonate transport (GO:1903963),-0.5115571102411814,-1.1754864144407986,0.26287744227353466,0.4113314554343346,1.0,5/10,39.07%,ANXA1;PLA2G5;PNPLA8;ACE;NMUR2
prerank,histone H2A ubiquitination (GO:0033522),-0.44163597656561204,-1.174868237193913,0.24825174825174826,0.4122565203413155,1.0,9/17,27.68%,DDB2;RYBP;UBR2;RNF8;CUL4B;DTX3L;DDB1;KDM2B;RNF2
prerank,acute inflammatory response (GO:0002526),-0.40205711697264407,-1.1746175158162602,0.2422145328719723,0.41244477121491613,1.0,12/23,41.93%,ANO6;IL6R;HPR;HP;CEBPB;IL6;SIGIRR;PLSCR1;VNN1;CD6;CTNNBIP1;F3
prerank,mRNA catabolic process (GO:0006402),-0.35476174848298836,-1.1745777402107584,0.20512820512820512,0.4122537632296856,1.0,26/44,43.66%,ERN1;TUT7;RC3H1;DCP2;DDX5;HSPA1A;LSM6;EXOSC10;LSM5;EXOSC4;XRN2;NUDT16;ZC3H12D;METTL3;NBDY;DHX34;NUDT12;HSPA1B;SLFN14;AGO3;ZFP36;DXO;YTHDF2;METTL16;XRN1;RNH1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.42502503448365847,-1.1739941296418777,0.23693379790940766,0.41250330971421223,1.0,8/20,19.63%,CENPF;KLHL22;BUB1;TPR;BUB1B;TTK;MAD1L1;ATM
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.42502503448365847,-1.1739941296418777,0.23693379790940766,0.41250330971421223,1.0,8/20,19.63%,CENPF;KLHL22;BUB1;TPR;BUB1B;TTK;MAD1L1;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.42502503448365847,-1.1739941296418777,0.23693379790940766,0.41250330971421223,1.0,8/20,19.63%,CENPF;KLHL22;BUB1;TPR;BUB1B;TTK;MAD1L1;ATM
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.393872269656426,-1.1733564316989349,0.22333333333333333,0.4134810756388601,1.0,11/30,24.55%,PTPRC;PLEK;FLT1;BATF;ARMC6;SFRP1;KDR;PRRC2C;TGFB1;FLT3;TNFRSF13B
prerank,DNA damage checkpoint signaling (GO:0000077),-0.3813068447536263,-1.1733183960849953,0.23344370860927152,0.41327777560207907,1.0,15/28,29.30%,MAP3K20;ERCC6;RAD1;E2F1;RHNO1;DOT1L;BRIP1;RAD9A;ATM;CHEK1;NBN;CLOCK;USP28;CEP63;DONSON
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.520832525153421,-1.1731925419849256,0.2851851851851852,0.4129803508355922,1.0,3/10,39.39%,REEP6;CNGB1;CACNA2D4
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.520832525153421,-1.1731925419849256,0.2851851851851852,0.4129803508355922,1.0,3/10,39.39%,REEP6;CNGB1;CACNA2D4
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4052071177167345,1.1727155260541497,0.24213075060532688,0.5361407815628852,1.0,3/22,6.09%,DDX11;NOL11;UTP15
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.41502726496472697,-1.172594879565135,0.24528301886792453,0.41378178051432685,1.0,2/22,0.73%,MDFIC;SP100
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.31570216511665566,-1.1701329459596996,0.18135593220338983,0.4181975742882202,1.0,35/85,28.30%,RAC1;RHOA;PSME4;ARRB2;PSMB7;CDC42;PSME3;PSMB9;AP2A2;VANGL1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;VANGL2;PSMB8;RYK;PSMA5;PSMD4;PSMB3;PSMD3;SMURF2;DVL2;PSMB1;AP2S1;PFN1;FZD1;FZD7;SMURF1;AP2A1;DAAM1;CELSR1;PSMA7
prerank,response to axon injury (GO:0048678),0.4182395029869963,1.1699771346451178,0.24330900243309003,0.5412754434892597,1.0,7/18,14.87%,P2RY12;APOD;FLRT3;DPYSL3;RTN4RL1;DHFR;FOLR1
prerank,cellular response to alcohol (GO:0097306),-0.35601090473537744,-1.1698516829670362,0.2542955326460481,0.4184252696907685,1.0,12/42,8.96%,GNB1;ADCY7;SPIDR;BRCA1;GRAMD1B;PTGER4;BLM;LRP6;GNG2;AHR;CTNNB1;RAD51
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.2850436444477549,-1.1698084798078152,0.14330218068535824,0.4182447086936611,1.0,18/151,7.18%,PTPRC;APOE;NRP1;CD44;NOTCH2;CD74;MFHAS1;CD36;C5AR1;ARRB2;HTR2B;RAP1A;CCR1;PTK2B;PTPN22;ARRB1;GCNT2;GAS6
prerank,cellular senescence (GO:0090398),-0.3944975251761145,-1.1687855083077714,0.24956369982547993,0.41990141707964035,1.0,10/27,26.76%,NSMCE2;PRKCD;SPI1;MAPK14;MAP2K1;ID2;TBX2;SMC6;SMC5;PML
prerank,response to reactive oxygen species (GO:0000302),-0.33908192869553444,-1.168455461867949,0.22727272727272727,0.42028336796529037,1.0,17/54,23.45%,APOE;JUN;COA8;ADAM9;CAMKK2;HIF1A;PRDX5;APTX;NCF1;PLK3;STK24;MPV17;RPS3;CAT;HP;MAPK1;HMOX1
prerank,steroid biosynthetic process (GO:0006694),0.32887816853674473,1.168232464411979,0.23486682808716708,0.5440070853876962,1.0,18/56,15.12%,OSBPL6;SLC27A2;OSBPL7;CYP51A1;INSIG1;SQLE;DHCR7;ACOX2;SC5D;EBP;HSD3B7;HSD11B1;OSBPL2;ABCB11;ACOT8;LSS;HSD17B4;CYP39A1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4965838427219663,-1.1681702760684172,0.27992957746478875,0.42054234666330187,1.0,3/11,6.76%,ARRB2;GRK3;ARRB1
prerank,mRNA methylation (GO:0080009),-0.4554181073779002,-1.16802635629995,0.2508833922261484,0.4205448587089263,1.0,6/15,15.81%,CBLL1;PCIF1;METTL14;VIRMA;TRMT6;WTAP
prerank,response to thyroid hormone (GO:0097066),-0.4768248687127946,-1.168001653221797,0.273224043715847,0.42030598918482476,1.0,5/13,21.26%,CTSB;CTSH;CTSS;LMO2;GAS2L1
prerank,regulation of protein targeting to membrane (GO:0090313),0.3732519704283758,1.1674798646951845,0.23130841121495327,0.5445063204525461,1.0,6/28,8.14%,ANK3;TCAF1;MIEF1;PRNP;FYN;MTCL1
prerank,cytoskeleton organization (GO:0007010),-0.29535988469706065,-1.1666580818226835,0.16585365853658537,0.42264961916814575,1.0,23/114,12.08%,DIAPH1;APOE;NEDD9;ARHGAP10;FGD6;RAC1;RHOA;CAPZB;SIPA1;SH3KBP1;FGD4;FGD3;PLD2;SIPA1L3;MDK;LARP4;DIAPH3;PACSIN2;SYNE3;SPRYD3;MICAL1;FMNL2;MICAL2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.3548887202151083,1.1665562982252107,0.23444976076555024,0.545455931870645,1.0,6/37,8.29%,EFNA5;BICD1;MAPRE3;CLASP2;TRAF3IP1;MAP6D1
prerank,neural tube closure (GO:0001843),-0.37104417709099774,-1.1661702848997866,0.25636363636363635,0.42330597930128677,1.0,20/34,31.13%,MTHFD1L;LRP6;SKI;SCRIB;VANGL2;STIL;MTHFR;PHACTR4;TGFB1;DVL2;DEAF1;LRP2;TSC2;KDM2B;GRHL3;CELSR1;GRHL2;IFT122;PAX2;BCL10
prerank,divalent inorganic cation homeostasis (GO:0072507),0.38252477165690335,1.1657971212303542,0.23349056603773585,0.5460193646640011,1.0,6/25,16.07%,ANK3;TMTC2;KCNA1;PRKN;FAM20A;SNCA
prerank,cellular response to glucose starvation (GO:0042149),-0.36147902891490935,-1.1656386098914029,0.2337228714524207,0.4240504033975169,1.0,14/41,23.59%,PRKAG2;FOXO3;MTMR3;SIK1;XBP1;SESN1;SH3GLB1;HNRNPA1;ZC3H12A;CPEB4;PRKAG1;BECN1;RRP8;KPTN
prerank,tube closure (GO:0060606),-0.37664092979544483,-1.1654516822055638,0.25,0.4240885798686181,1.0,19/31,31.13%,MTHFD1L;LRP6;SKI;SCRIB;VANGL2;STIL;MTHFR;PHACTR4;TGFB1;DVL2;DEAF1;LRP2;TSC2;GRHL3;CELSR1;GRHL2;IFT122;PAX2;BCL10
prerank,exit from mitosis (GO:0010458),-0.4851325845745667,-1.1650651067536024,0.28113879003558717,0.4245053505625909,1.0,6/12,22.39%,EPS8;PPP2R2D;CHMP7;CHMP2A;UBE2C;CHMP4B
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.34686366596785284,-1.1648079134219755,0.22013651877133106,0.42472955397193085,1.0,17/45,17.48%,FOXO3;RC3H1;ZC3H7B;PUM3;GCNT2;PUM2;PCIF1;PARP9;LARP4;MTPN;APP;NUDT21;YTHDC1;NOLC1;EIF2A;RBM4B;TDRD7
prerank,sphingolipid metabolic process (GO:0006665),-0.3007994295730349,-1.164706498083775,0.1797945205479452,0.42463417412153004,1.0,36/108,29.06%,SGMS1;HEXA;PSAP;TEX2;SPTLC2;ACER3;CTSA;GLTP;ARSA;ESYT1;SPTSSA;ESYT2;SUMF2;PRKD3;NEU1;KDSR;VAPB;SPHK2;SPTLC3;PPT1;ASAH1;SAMD8;PLPP3;ELOVL5;DEGS2;ABCA2;B4GALNT1;CERS3;HACD4;ORMDL2;PLA2G15;VAPA;CPTP;HACD3;B3GALNT1;CERK
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.42194667694871535,-1.1644374860842066,0.253781512605042,0.42489103673224765,1.0,2/20,1.96%,ITGA4;ANO6
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.2950401838763747,-1.1637407937836715,0.16298811544991512,0.42593347410142235,1.0,46/124,28.56%,GNB1;RAC1;RHOA;AGO2;PSME4;ARRB2;PSMB7;CDC42;PSME3;PSMB9;GNG2;CTNNB1;AP2A2;VANGL1;PSMA8;PSMC3;MOV10;PSMD8;PSMC4;PSMB10;PLCB3;TNRC6C;PSMA1;VANGL2;PSMB8;NFATC1;RYK;PSMA5;PSMD4;PSMB3;PSMD3;SFRP1;SMURF2;DVL2;PSMB1;AP2S1;PFN1;CCDC88C;FZD1;FZD7;SMURF1;AP2A1;DAAM1;CELSR1;PSMA7;LEF1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.3785549869033204,-1.1635043162802063,0.21392190152801357,0.4261062688680435,1.0,12/30,21.25%,OPTN;GOLGA4;RAB31;GGA3;MACF1;GOLPH3L;SYS1;RAB10;VAMP4;RAB34;GOLGA7;BLZF1
prerank,DNA strand elongation (GO:0022616),-0.4308055572794381,-1.1633204329805562,0.26475548060708265,0.4261598188356614,1.0,8/18,26.18%,GINS3;MCM3;POLD2;RFC3;NBN;GINS4;MRE11;DCLRE1B
prerank,regulation of calcium ion transport (GO:0051924),-0.33364957143229496,-1.163141019579376,0.21739130434782608,0.42621490635532555,1.0,10/54,7.60%,CD84;ATP2B1;LILRB1;SARAF;CRACR2A;P2RX4;CCR1;BCL2;CTNNB1;WFS1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.31857842437594747,-1.1631160983671176,0.19572368421052633,0.42598480788023907,1.0,21/76,21.87%,DAB2;HECTD1;RNF19A;PIAS1;AXIN1;CBFA2T3;NUB1;DET1;LAPTM5;TRIB1;TRIB2;RNF180;ARIH1;GABARAP;HSPA1A;SMAD7;FBXO22;GSK3B;SIRT2;RACK1;SOCS5
prerank,response to glucose (GO:0009749),-0.34713753785130785,-1.1628237685989795,0.24006908462867013,0.4262325654812683,1.0,18/46,29.86%,ERN1;IGF1R;TRA2B;EIF2B3;GAS6;SELENOS;LPL;ZBTB20;XBP1;IRS2;EIF2B1;RACK1;KCNB1;GPLD1;EIF2B2;EIF2B4;VAMP2;PAX2
prerank,adrenergic receptor signaling pathway (GO:0071875),0.4178084744857361,1.162809936124225,0.25874125874125875,0.551980027491872,1.0,8/20,14.36%,PDE4D;ADRA1B;GPR101;ADRA2C;ADRA1D;ADRA1A;ADRB1;ZDHHC21
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.35704322366301444,-1.1626141965504035,0.22898032200357782,0.42634845742173244,1.0,10/40,18.86%,IGF1;BCL2L11;HGF;PLAUR;MLLT11;BBC3;GHITM;BID;TNFSF10;PDCD5
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.40136721506510636,-1.162179418203911,0.23440134907251264,0.4268898341274474,1.0,13/26,28.62%,DHX58;IRAK3;PPM1B;TRIB1;PCBP2;NLRC3;NFKBIL1;C1QBP;SIRT2;MAPKBP1;CARD16;RNF26;SIGIRR
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3263181187473823,1.161972183513893,0.19002375296912113,0.5527448498641612,1.0,10/52,8.11%,RBFOX1;KHDRBS3;KHDRBS2;SRRM4;CELF4;CELF5;RBFOX2;NOVA1;RBFOX3;FMR1
prerank,protein localization to cell-cell junction (GO:0150105),-0.45214299525751606,-1.1617789786595645,0.26770293609671847,0.42737683721541003,1.0,6/15,13.80%,PAK2;ACTB;ARHGEF18;JAK1;SCRIB;TJP2
prerank,positive regulation of sodium ion transport (GO:0010765),0.47278482845724074,1.1617732662304254,0.26506024096385544,0.5520177919961347,1.0,4/12,15.28%,ANK3;AHCYL1;CNKSR3;WNK3
prerank,cell-cell junction maintenance (GO:0045217),0.48325730364845254,1.1612629202685079,0.2833333333333333,0.5520027941330238,1.0,5/11,18.57%,TJP1;CSF1R;FERMT2;NLGN2;PARD6A
prerank,hippo signaling (GO:0035329),0.3773638125260905,1.161234052646016,0.263681592039801,0.5508631460240909,1.0,8/26,12.96%,TJP1;TEAD4;DCHS1;FAT4;YAP1;TEAD1;WWC1;AMOTL1
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.450260441996243,-1.1612200579387917,0.2804232804232804,0.4281698123340594,1.0,5/16,16.94%,PID1;DNAJC30;FLCN;TMSB4X;SPHK2
prerank,vesicle transport along microtubule (GO:0047496),-0.40244517524606943,-1.1606207773925308,0.24742268041237114,0.42905696058381815,1.0,5/23,4.94%,TRAK1;KIF3B;RAB1A;DYNC1H1;FBXW11
prerank,organelle assembly (GO:0070925),-0.25602480588324633,-1.1605301117780555,0.09224011713030747,0.4289315974480869,1.0,98/384,22.54%,RAB8B;SH3PXD2B;SNX10;ASAP1;RAB7A;YTHDF3;GOLGA8B;ACTR2;PDCD6IP;FLNA;STX7;EHD4;IFT20;ATG5;KIF3B;PIBF1;PACS2;ACTR3;ATG7;CHMP5;RAB1A;RC3H1;DYNC1H1;CENPF;DLGAP5;HAUS5;CENPA;TSG101;RAB32;ULK2;PATL1;HAUS6;CFAP44;STARD9;EXOC4;CENPE;TUBGCP4;NEK6;CEP162;DHX37;SPAG16;RPS23;CSDE1;CHMP7;HAUS4;CHMP1A;STAM2;FOXJ1;RBM14;HAUS7;CFAP70;ABCC4;ARL3;RB1CC1;CFAP20;EHD1;CHMP2A;GABARAP;INO80;POGZ;RP2;CFAP43;EIF2A;DYNLT2B;NUDCD3;PCNT;G3BP1;EXOC2;PDE6D;BBIP1;RILP;RPS3;MRPL22;RCC1;ATG16L2;MAK;DDX3X;EXOC6;EMC6;SYNPO;DDX6;TMEM17;RAB11A;ATP6V0D1;VPS4A;RILPL1;LSM14A;ATXN2L;DISC1;NUP62;HYLS1;FLII;HPS4;CHMP4B;CHMP4A;CEP41;BECN1;TTLL3
prerank,negative regulation of nuclear division (GO:0051784),0.4738554549478658,1.1605005670352586,0.30412371134020616,0.5514761555010143,1.0,4/11,20.56%,AURKAIP1;BMP7;TOM1L1;FBXO5
prerank,positive chemotaxis (GO:0050918),-0.43785453008393715,-1.160095194073457,0.26825127334465193,0.42950150707023244,1.0,4/17,10.26%,NRP1;PTPRJ;VEGFA;SCRIB
prerank,regulation of mitotic cell cycle (GO:0007346),-0.27925218144873815,-1.1599348915878098,0.14026402640264027,0.42954529206806796,1.0,44/171,21.07%,IQGAP1;SDCBP;RB1;PSME4;CDK13;PSMB7;ANAPC1;PSME3;RNF20;KIF20B;DLGAP5;DAPK3;PSMB9;DUSP3;THAP1;NEK6;PSMA8;SIK1;SCRIB;AFAP1L2;PIN1;PSMC3;EIF4EBP1;APP;CDK1;PSMD8;MAEA;BUB1B;PSMC4;MKI67;PSMB10;TFAP4;PSMA1;BTG1;UBE2C;PSMB8;ANAPC7;DYNLT3;RCC1;PSMA5;PSMD4;PSMB3;PSMD3;CDC25C
prerank,negative regulation of leukocyte migration (GO:0002686),0.48975206796081716,1.1597597164212758,0.2904761904761905,0.5519581909435985,1.0,3/10,7.78%,SLIT2;CD200R1;CD200
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.33016293633526805,-1.1594662349927334,0.22547332185886404,0.430149176992485,1.0,30/60,34.58%,HGF;CTNNB1;CCT7;PKIB;NVL;PCNA;HSP90AB1;RFC2;TNKS2;GREM1;CHTF18;CCT4;PDGFRB;HNRNPA1;WRAP53;ATM;RFC3;MAPK1;POLG2;MYC;FGFR4;GRHL2;MAPK15;MAP3K4;NEK7;FGF2;TNKS;KLF4;CCT8;CCT5
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.42259278464017935,-1.1593974798066224,0.27040816326530615,0.4300058885629892,1.0,3/21,8.63%,DAB2;RBPMS;TGFBR1
prerank,histone monoubiquitination (GO:0010390),-0.4067656190404243,-1.159341303826037,0.26495726495726496,0.42982533035454884,1.0,13/24,30.27%,DDB2;CTR9;RYBP;RNF20;CUL4B;UHRF1;WAC;DTX3L;DDB1;RNF40;KDM2B;RNF2;UBE2E1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.2709767437230472,-1.1590876054555892,0.13129770992366413,0.43002568372285144,1.0,36/214,12.70%,LYN;PTPRC;APOE;NRP1;CD44;NOTCH2;CD74;MFHAS1;SYK;CD36;C5AR1;ARRB2;HTR2B;RAP1A;CCR1;TLR4;PTK2B;PTPN22;DUSP3;FN1;ARRB1;GCNT2;GAS6;SIRPA;ITGB1BP1;PTPN6;SPRED1;SPRY2;PIN1;APP;DUSP6;FLCN;SPRED2;MAP2K1;CCL5;CIB1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.36679851259397395,1.1586553939390607,0.2255125284738041,0.5532892935134176,1.0,9/30,14.49%,HMGCS1;DHCR24;CYP51A1;INSIG1;SQLE;DHCR7;EBP;MVK;LSS
prerank,positive regulation of metabolic process (GO:0009893),-0.29626189259756763,-1.1580841056315876,0.16613418530351437,0.4317116951587387,1.0,16/103,7.83%,CCR2;SYK;CD36;CAMK1D;OGT;INSR;IGF1R;FABP5;KDM3A;IL18;STAT6;ADIPOR1;DYNC1H1;UCP2;PLAC8;VEGFA
prerank,mismatch repair (GO:0006298),-0.38479242470993963,-1.157841093245901,0.2434325744308231,0.43193363972123144,1.0,7/27,13.96%,MCM9;LIG1;PCNA;EXO1;MLH3;RPA3;POLD2
prerank,keratan sulfate catabolic process (GO:0042340),-0.4914860001329026,-1.1577815509493055,0.27806563039723664,0.43177376595420797,1.0,5/11,17.32%,HEXA;GNS;GALNS;PRELP;FMOD
prerank,"wound healing, spreading of cells (GO:0044319)",-0.40121730682648293,-1.157422304046752,0.2457627118644068,0.4322066810701211,1.0,5/24,2.55%,CD44;ITGA5;ARHGAP24;RHOA;FLNA
prerank,nerve growth factor signaling pathway (GO:0038180),0.5072115184801813,1.1571542457820452,0.30158730158730157,0.5556410839056741,1.0,2/10,7.07%,MAGI2;BDNF
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.48175562798145066,-1.1571095957909998,0.27898550724637683,0.43250011772157293,1.0,5/12,21.26%,CTSB;CTSH;CTSS;LMO2;GAS2L1
prerank,supramolecular fiber organization (GO:0097435),-0.2603637519432394,-1.1569722150249184,0.11077844311377245,0.4324829866893773,1.0,65/333,16.16%,MYO5A;CORO1C;ARHGAP25;VIM;TSPAN14;CD36;RAC1;KLHL24;MYO1F;RHOA;ARHGAP17;MTM1;ARHGEF2;RIPK1;GGA3;CDC42;ATP7A;DYNC1H1;RUFY3;TGFBI;MYO1G;TRIOBP;TPM3;TPM4;P4HA1;USP9X;HIP1;MARCKSL1;SH3BP1;B2M;CKAP5;TGFBR1;TUBGCP4;UBC;RPS27A;CORO7;MYO1E;ARHGAP12;CDC42EP2;PIN1;KIF14;APP;B4GALT7;DCTN1;PSENEN;WDR73;MYO7A;P4HA3;CCDC88A;HSP90AB1;CIB1;PLK3;BIN3;SLAIN2;GREM1;CALCA;COL9A1;COL4A5;KIF2C;MFGE8;STMN2;CRTAP;CST3;PPP1R9B;RND2
prerank,macrophage differentiation (GO:0030225),-0.4688368422699607,-1.1567343363645928,0.28153564899451555,0.43264822527773156,1.0,6/13,19.75%,IL15;CDC42;VEGFA;IL31RA;CASP8;CSF1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.4654994691279779,1.1565898424002983,0.279126213592233,0.5545291198501371,1.0,4/11,13.07%,CASQ2;CALM1;CALM3;CALM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.4654994691279779,1.1565898424002983,0.279126213592233,0.5545291198501371,1.0,4/11,13.07%,CASQ2;CALM1;CALM3;CALM2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3338660411166689,-1.156367000379972,0.20833333333333334,0.43305173585896556,1.0,18/52,25.39%,BCL2;RNF31;USP36;E2F1;YWHAE;UBE2L3;UBL5;SH3GLB1;BBC3;BID;CASP8;HUWE1;BAP1;SFN;HPS4;NMT1;SAE1;VPS11
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.27677851229614975,-1.1562280270159215,0.14862681744749595,0.4330778326437976,1.0,52/170,25.13%,PTPRC;APOE;FOXP1;IGF1;TFEB;AFF4;CDK6;AFF1;MTMR3;KIF16B;CIAO3;TAPBP;CRIP1;AHR;HNRNPDL;TBC1D16;SIRPA;HIF1A;SLC8A1;NFKBIZ;PIN1;APP;PCBP2;PRDM2;TRIM68;TRIM11;ANKRA2;SART3;TXK;RASA1;POGZ;NKAPL;TRIM14;TOB1;TOB2;MARF1;TRIM39;RSPO1;LDLR;NFKBID;UBAP2;C1D;ZC3H12A;HNRNPK;MEGF8;APLNR;MEFV;TARDBP;PCBP4;MYC;RNF187;LAMTOR1
prerank,UV-damage excision repair (GO:0070914),-0.4843817276282961,-1.156054121684173,0.2765957446808511,0.43312921723084225,1.0,3/12,14.84%,DDB2;CUL4B;INO80
prerank,cellular response to lipid (GO:0071396),-0.2759797720118876,-1.1557962271552549,0.14086687306501547,0.4333410648479725,1.0,54/191,20.90%,PID1;LYN;MSN;LILRB1;VIM;AXL;RHOA;TNFRSF1B;SBNO2;FES;ABL2;CTR9;TLR4;TFPI;CHMP5;PTK2B;STAP1;NFKB1;ADAM9;MAPK14;PF4;AHR;SIRPA;MYD88;MEF2C;LY96;SELENOS;LPL;UBE2L3;TNIP2;RELA;XBP1;TICAM1;ADAM15;HMGB2;SERPINE1;CASP1;DEFA6;NFKBIL1;SPP1;NFKBIB;NRIP1;TNIP3;SPHK2;TWF2;NR3C1;NOD2;HMGB1;ATM;WNT3;TICAM2;CD274;SFRP1;ZC3H12A
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.4216427344794147,-1.1557033111650532,0.2709447415329768,0.4329552215696151,1.0,6/19,21.10%,POLR2H;POLR2F;POLR2L;POLR2A;POLR2G;POLR2I
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.4216427344794147,-1.1557033111650532,0.2709447415329768,0.4329552215696151,1.0,6/19,21.10%,POLR2H;POLR2F;POLR2L;POLR2A;POLR2G;POLR2I
prerank,regulation of oxidoreductase activity (GO:0051341),-0.4729505866554874,-1.1554362843502928,0.2937181663837012,0.4332117619948746,1.0,5/13,25.76%,ABL2;ATP7A;NOD2;HP;MT3
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.488918774546226,-1.1553350025582527,0.2827586206896552,0.43314537138653114,1.0,5/11,26.43%,EGR1;ASAH1;NR1H4;FGFR4;BMP2
prerank,nucleic acid-templated transcription (GO:0097659),-0.3496282285211185,-1.1547094531345528,0.23661485319516407,0.4341045871132671,1.0,18/42,22.26%,MEF2A;POLR2H;E2F1;POLR2F;THAP1;POLR2L;POLR2A;EPC1;NFKBIB;POLR2G;RNPS1;DTX1;POLR3A;MED20;MMS19;POLR2I;XAB2;TOPORS
prerank,positive regulation of cytokinesis (GO:0032467),-0.36602220530848373,-1.1547046695661638,0.2402135231316726,0.4338376219076521,1.0,7/32,14.67%,RHOA;SVIL;CDC42;KIF20B;KIF23;KIF14;RACGAP1
prerank,cellular response to UV (GO:0034644),-0.31457833840729194,-1.1546330955352964,0.20973154362416108,0.43368829772546524,1.0,34/76,33.64%,PRKCD;DDB2;CREBBP;CRIP1;CDC25A;PCNA;CUL4B;STK11;DHX36;ERCC4;RHNO1;TMEM161A;YY1;INO80;NSMCE3;CHEK1;MMP2;MMP1;KDM1A;MYC;DDB1;NOC2L;USP28;METTL3;CARD16;EP300;AQP1;ZBTB1;PPID;COPS9;ATF4;RHBDD1;MMP9;EIF2S1
prerank,mitochondrial translational elongation (GO:0070125),-0.3071319943300312,-1.1545474504215638,0.19732441471571907,0.4335792881655247,1.0,36/88,34.45%,MRPS10;ERAL1;MRPL42;TUFM;CHCHD1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;MRPL17;MRPL15;MRPL51;MRPL47;MRPL18;MRPS7;MRPL54;MRPS25;MRPL39;MRPL53;MRPL11;MRPL33;MRPL28;MRPL30;MRPL43;MRPS17;MRPS5;MRPL1;MRPS28;MRPS35;MRPS21
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4523368457385771,-1.1545014123506756,0.291958041958042,0.43339257913074275,1.0,5/15,16.60%,NIPBL;MTHFD1L;TGFBR1;TGFBR2;IRX5
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.4900214507183204,-1.1544722501194482,0.29442508710801396,0.43318096407102474,1.0,6/11,29.30%,BLM;TIMELESS;LIG3;TIPIN;ZRANB3;DONSON
prerank,response to UV (GO:0009411),-0.30479652876385505,-1.1543664021675835,0.19630872483221476,0.4331023249544525,1.0,20/95,15.34%,PRKCD;MAP4K3;DDB2;CREBBP;ERCC6;PRIMPOL;PCLAF;RELA;UBE4B;CDC25A;WRN;PCNA;FEN1;DHX36;ERCC4;RHNO1;TMEM161A;YY1;INO80;NSMCE3
prerank,protein import into nucleus (GO:0006606),-0.3179717311329896,-1.1542818018300987,0.2158894645941278,0.433006521469334,1.0,21/66,22.38%,SYK;KPNA4;IPO5;NUP50;STAT3;NUP88;E2F3;TPR;KPNA3;NUP188;CBLB;APPL2;NUP153;NUP35;FAM53A;TNPO3;APPL1;NUP107;NXT2;NUP62;SPRN
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.4446897849550822,-1.1541037845159061,0.27816901408450706,0.43306612077967793,1.0,4/15,17.88%,BCL2L11;ANXA1;UBE2L3;NR3C1
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.4866765841959678,-1.153750766120979,0.30743243243243246,0.43343679277307573,1.0,4/11,25.02%,RESF1;TPR;SETDB1;TRIM28
prerank,activation of protein kinase B activity (GO:0032148),-0.3798779480752096,-1.1534520256717489,0.2684563758389262,0.4337365014339878,1.0,7/29,11.72%,OSBPL8;IGF1;INSR;IL18;GAS6;ITGB1BP1;CCDC88A
prerank,positive regulation of RNA splicing (GO:0033120),-0.3894512358474917,-1.1531408247421153,0.25435540069686413,0.4340616606539483,1.0,11/29,20.12%,ERN1;TRA2B;DYRK1A;HNRNPLL;POLR2A;NCBP1;NCL;DAZAP1;HSPA1A;SLC38A2;RBM3
prerank,cellular response to virus (GO:0098586),-0.3747262280350021,-1.152921583152523,0.24912280701754386,0.43420883488820056,1.0,11/30,23.01%,RIOK3;MAPK14;GSDME;HIF1A;CCL5;POU2AF1;LGALS9;DDX3X;ZC3H12A;IL6;TOMM70
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.49500114200261724,-1.1529046209373037,0.307032590051458,0.4339586872597663,1.0,9/11,45.08%,UQCRC1;UQCRC2;CYCS;UQCRQ;UQCRB;UQCC3;UQCRFS1;UQCR10;UQCR11
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.44497089493063374,-1.1527075315624666,0.2641509433962264,0.43404870777648835,1.0,6/16,23.61%,SLC27A1;NR1H2;DAGLB;ABHD5;LDLR;GPLD1
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.436607778839339,-1.1526461912561856,0.3017241379310345,0.43388486315457864,1.0,5/16,11.34%,RREB1;METRNL;PIM1;FTO;FLCN
prerank,ERBB signaling pathway (GO:0038127),0.3115335590417774,1.1525533579156324,0.22650602409638554,0.5629359287365622,1.0,19/64,16.06%,NRG1;ERBB4;PTPRR;SHC3;TGFA;EGF;GAB1;SOS1;PLCE1;FAM83B;NRG2;SOX9;AREG;GAREM1;HSP90AA1;BRAF;ADAM17;ERBB3;PRKCA
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.39941220718250914,-1.1524605830884487,0.26430976430976433,0.43393892365205317,1.0,6/25,11.05%,SDCBP;RIN3;RAC1;ITGAV;PICALM;APP
prerank,isotype switching (GO:0045190),-0.503928291687856,-1.1520204925962811,0.2867256637168142,0.4344919787281521,1.0,2/10,10.13%,BATF;RNF8
prerank,positive regulation of cell adhesion (GO:0045785),-0.31955801961701785,-1.1516683310111804,0.214168039538715,0.43488691783135364,1.0,22/74,20.09%,SYK;RSU1;RAC1;PTPRJ;ITGAV;ADAM9;STX3;VEGFA;MDK;ADAM8;NCKAP1L;TGM2;FLCN;CCL5;CIB1;STX4;LIMS1;SMAD7;TFE3;ATM;C1QBP;NDNF
prerank,cellular response to organonitrogen compound (GO:0071417),0.29140478543939863,1.1514231829439896,0.1972972972972973,0.5644077566152236,1.0,20/99,12.36%,GABRB3;AKAP6;GABRB1;RYR3;SLIT2;GLRA1;IGFBP5;P2RY12;SLC26A3;WT1;HCN2;RRAGB;GABRB2;GABRG2;SOX9;GLRA2;HCN1;CPEB3;RPTOR;HTR1B
prerank,cellular response to nitrogen compound (GO:1901699),-0.41411528070063447,-1.1513041300557212,0.25226860254083483,0.4353343167583454,1.0,7/20,15.34%,SPIDR;RIOK3;BLM;DDI2;EPG5;TIMELESS;NSMCE3
prerank,regulation of inclusion body assembly (GO:0090083),0.49163698454958127,1.150849462245819,0.29550827423167847,0.5645145449155096,1.0,4/11,13.04%,SNCAIP;SACS;DNAJA4;DNAJB2
prerank,actin filament bundle organization (GO:0061572),-0.37343931573753053,-1.1507549300260735,0.2555746140651801,0.43607457396964755,1.0,9/33,18.99%,NEDD9;EPS8;BAIAP2;LIMA1;LCP1;MICAL1;BAIAP2L2;ESPN;RFLNB
prerank,regulation of viral entry into host cell (GO:0046596),-0.37974574907687136,-1.1505878194869872,0.24414715719063546,0.4361177495571223,1.0,12/30,23.32%,CD74;SNX3;CIITA;IFITM2;TRIM68;LGALS1;TRIM11;TRIM14;LGALS9;TRIM25;IFITM1;P4HB
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.3148903247025696,-1.1503358387855906,0.2222222222222222,0.43633188311857646,1.0,31/76,32.68%,BIRC3;MALT1;PIAS1;BRCA1;AXIN1;WDR48;WFS1;LAPTM5;UBE2L3;DERL1;DCUN1D4;UBE3A;NSMCE3;UBA2;TBC1D7;SMAD7;HUWE1;NDFIP2;ZC3H12A;SAE1;CUL3;PTTG1IP;RIPK2;TRAF6;XIAP;BCL10;DCUN1D5;CAV1;HSPBP1;FANCI;STUB1
prerank,rRNA modification (GO:0000154),-0.4178121876753746,-1.15017418771711,0.28596802841918295,0.43635619814670734,1.0,8/21,25.45%,NSUN3;NSUN4;DIMT1;GAR1;THUMPD1;NHP2;BUD23;MRM2
prerank,mitochondrial gene expression (GO:0140053),-0.36011430417609447,-1.1500700030595516,0.23247863247863249,0.43627955698776577,1.0,17/42,34.45%,FOXO3;NOA1;FASTKD2;MRPS6;MRPS11;TFAM;MRPS16;MRPS15;MRPL51;MRPL47;TWNK;MRPS7;GATB;MRPS17;MRPS28;RARS2;MRPS21
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.4799613115777044,1.1495800008012256,0.28604118993135014,0.56627627925237,1.0,3/10,7.32%,YOD1;UBE2J1;INSIG1
prerank,negative regulation of response to external stimulus (GO:0032102),-0.29636325899993804,-1.1492951528059832,0.19250425894378195,0.43752585756806306,1.0,24/105,13.47%,APOE;AOAH;MFHAS1;PRKCD;RB1;PPARD;METRNL;PPARG;DHX58;TNFAIP8L2;PTGER4;DUSP3;IRAK3;PPM1B;SIRPA;TRIB1;MAPK7;OTULIN;SELENOS;PCBP2;CRK;NLRC3;SERPINE1;NFKBIL1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2629772879756931,-1.14845646821366,0.13767019667170954,0.43883417218620646,1.0,68/259,22.86%,NRP1;RAB8B;MTSS1;SNX10;SDCBP;ASAP1;P2RX7;FGD6;RAC1;RAP1B;ACTR2;ANO6;RAP2B;FLNA;EMP1;EHD4;RAP2A;FXYD5;MINK1;IFT20;KIF3B;RAP1A;PARVB;PIBF1;ACTR3;FGD4;RAB1A;ITGB1;FGD3;CFAP44;EXOC4;PMP22;CEP162;SPAG16;CCDC88A;FOXJ1;CFAP70;ABCC4;SPEF1;ARL3;CFAP20;EHD1;RP2;PPP1R9B;CFAP43;DYNLT2B;NUDCD3;PCNT;EXOC2;PDE6D;PTPRO;BBIP1;RILP;ARFIP2;MAK;EXOC6;PIP5K1A;TMEM17;RAB11A;ATP6V0D1;RILPL1;DISC1;MAP4K4;HYLS1;CEP41;S1PR2;TTLL3;EMP3
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.4552951444173299,-1.1474086267354242,0.28213689482470783,0.44057787983622637,1.0,6/14,28.39%,SRSF10;RNPS1;C1QBP;PCBP4;U2AF2;SRSF7
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.45358198445855186,1.1470415748196336,0.29550827423167847,0.5711583610153332,1.0,6/12,21.70%,SORBS1;PRKCZ;IGF2;IRS1;SIRT1;SORL1
prerank,positive regulation of histone acetylation (GO:0035066),-0.40695653882784144,-1.1464774980183676,0.2595281306715064,0.44207313868200077,1.0,6/23,16.94%,BRD7;BRCA1;ARRB1;WBP2;KAT7;SPHK2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.49412447430741235,-1.1463081352030673,0.3031301482701812,0.44211543002558606,1.0,5/10,25.16%,YWHAE;SESTD1;PLN;VDAC1;FKBP1B
prerank,nuclear membrane organization (GO:0071763),-0.4267170254411038,-1.1461466157361409,0.3126142595978062,0.4421754572337883,1.0,9/19,24.74%,NEMP1;CHMP7;DCTN1;CHMP2A;TOR1AIP1;VPS4A;CHMP4B;TARDBP;AKAP8L
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4608956816189144,1.1460548628467833,0.2815533980582524,0.5710210922580222,1.0,4/12,8.20%,EFNA5;MELTF;SPRY4;KANK1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4608956816189144,1.1460548628467833,0.2815533980582524,0.5710210922580222,1.0,4/12,8.20%,EFNA5;MELTF;SPRY4;KANK1
prerank,cellular protein localization (GO:0034613),-0.2612642984366799,-1.1460186091362348,0.1451851851851852,0.44216120644319773,1.0,80/285,20.02%,SH3PXD2B;CD74;ITSN1;SNX9;SNX27;SNX8;FLNA;STX7;ARHGEF2;TBC1D15;RAP2A;UNC93B1;RAB31;SGSM2;TLK1;TBC1D2B;RAB20;TBC1D9;GGA3;PACS2;RAB1A;NIPBL;COG7;SNX6;HHEX;TMED10;STX8;CTSA;TBC1D5;TBC1D1;ARL11;STX3;TBC1D22A;RAB32;CTNNB1;TBC1D16;TBC1D22B;SIL1;LAPTM5;WLS;TBC1D8B;RAB5A;TMED3;CD63;TBC1D8;RAB21;TBC1D17;VPS26B;SNX13;RAB24;RRAGD;SAR1A;MYO7A;RAB29;VPS26A;FOXJ1;STX5;TBC1D10B;ARL5A;SEC31A;COPA;EHD1;TBC1D30;STX16;ARFIP1;AP3B1;STX4;AP3D1;TBC1D9B;TMED2;VPS33A;ARL1;SNX1;TBC1D25;ARFIP2;ID1;SLU7;TMED4;GRIN3B;TICAM2
prerank,negative regulation of nervous system development (GO:0051961),0.4141046232484055,1.145961296372674,0.2965686274509804,0.5700113962267211,1.0,4/17,12.75%,ROBO2;SLIT1;HOOK3;REST
prerank,regulation of bone mineralization (GO:0030500),-0.33066450031795713,-1.1456347487085972,0.24486301369863014,0.44262589968685795,1.0,16/55,19.98%,ATP2B1;P2RX7;ANO6;CCR1;SRGN;PTK2B;PKDCC;MEF2C;SLC8A1;OSR1;ACVR2A;GREM1;ISG15;ANKH;ENPP1;BMPR2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.3109604532673709,-1.1455657703200273,0.20202020202020202,0.44247706064642384,1.0,27/82,23.05%,CNTRL;DYNC1H1;CENPF;HAUS5;SDCCAG8;HAUS6;CEP57;CKAP5;YWHAE;TPX2;KIF14;CEP70;HAUS4;DCTN1;CDK1;HAUS7;ODF2;NINL;PCNT;AURKA;ATF5;PAFAH1B1;CEP192;CETN2;TUBA4A;CEP41;GTSE1
prerank,epidermal cell differentiation (GO:0009913),-0.35232674081386944,-1.1453241430854981,0.2465986394557823,0.4426694087430552,1.0,17/41,38.06%,CLIC4;ANXA1;ADAM9;JAG1;CTNNB1;PIP5K1A;TXNIP;ASAH1;DSP;CERS3;SPINK5;ERCC2;OVOL2;OVOL1;PITX2;GLI1;SPRR1A
prerank,signal peptide processing (GO:0006465),0.45742087587246905,1.1441633540309972,0.28216704288939054,0.5730192665380073,1.0,2/11,7.25%,PCSK5;SEC11C
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.40586566106415767,-1.1440788242761004,0.2667910447761194,0.44484533343746324,1.0,6/21,16.45%,PGD;DERA;RPE;HK3;TKT;PGLS
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.2709119516334443,1.1440086724370162,0.15926892950391644,0.5721850930070306,1.0,23/138,8.52%,PTPRD;PTPRG;ERBB4;PTPRT;NTRK3;EPHA6;NTRK2;SHC3;AHI1;EPHA7;EPHA5;CSF1R;PTN;SHC4;EPHB1;TIE1;MPZL1;ALK;BDNF;FYN;GFRA2;SHC2;EPHA10
prerank,response to peptide (GO:1901652),-0.364277707950625,-1.143758899910342,0.25892857142857145,0.4451261142056109,1.0,18/33,28.48%,STAT3;STAT6;IRF5;ANXA1;EIF2B3;STAT5B;STAT4;ERBIN;KAT7;NOD2;AGER;EIF2B1;MMP2;STAT1;CACNA1A;STAT2;EIF2B2;EIF2B4
prerank,regulation of fibroblast migration (GO:0010762),-0.4153646454970674,-1.1437125285572978,0.2657580919931857,0.4449475942404631,1.0,9/20,23.39%,CORO1C;RAC1;GNA12;ITGB1;ITGB1BP1;CLN3;APPL2;APPL1;TGFB1
prerank,regulation of interleukin-2 production (GO:0032663),-0.3530156128343553,-1.143615354086144,0.2339688041594454,0.444861645441567,1.0,11/43,13.11%,PTPRC;RUNX1;CCR2;PLCG2;MALT1;CARD11;ANXA1;LAPTM5;CD28;TRAF2;VSIG4
prerank,circulatory system development (GO:0072359),0.2777106815775257,1.1429470634393486,0.1752021563342318,0.5735672960656482,1.0,34/118,18.88%,FGF12;CACNA1C;PCSK5;ERBB4;NTRK3;ZFPM2;PRICKLE4;ACVR1;WT1;PLCE1;FLRT3;CACYBP;SOX9;SALL1;DNAAF4;POU4F2;POPDC2;TBX1;FBXW7;TGFB2;PKD1;EEF1AKMT4-ECE2;PDLIM4;CDH5;MKKS;ECE1;ERBB3;RAMP2;PDLIM7;KAT2A;ZDHHC16;RBM20;TEK;FOXC2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.4845161024200994,-1.1428468366032432,0.2956989247311828,0.44615785944047265,1.0,2/11,2.65%,PLCG2;P2RX4
prerank,protein K63-linked deubiquitination (GO:0070536),-0.37352484287420556,-1.1427345997917617,0.2828282828282828,0.44610123952491515,1.0,17/31,31.30%,USP50;OTUD5;USP8;ABRAXAS1;BABAM2;ATXN3;BABAM1;OTUD4;USP7;STAMBPL1;BRCC3;ZRANB1;USP16;STAMBP;UIMC1;ABRAXAS2;OTUD1
prerank,negative regulation of axonogenesis (GO:0050771),0.373291226448463,1.1418449255532583,0.25190839694656486,0.5750564405463117,1.0,3/27,2.17%,MAP2;DCC;LINGO1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.4741646121195316,-1.1414332018673563,0.3083623693379791,0.4483897993420794,1.0,2/12,4.21%,CCR2;IL18
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.39912820787610565,-1.141225775570282,0.26260869565217393,0.4485360571672262,1.0,6/24,4.20%,ARPC2;RAC1;ACTR2;WASF2;CDC42;ACTR3
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.305114850523179,-1.140730559845501,0.2340764331210191,0.44920458084835274,1.0,22/84,22.07%,APOE;IGF1;DAPK1;ROCK1;GAPDH;GGA3;CNOT1;DAPK3;PUS7;EIF2AK2;PCIF1;PIN1;DHX36;NCL;TOB1;RPS3;DDX3X;CNOT8;DDX6;LSM14A;RACK1;SHMT1
prerank,neurotrophin signaling pathway (GO:0038179),0.4038111569052321,1.140703965076662,0.2699530516431925,0.5765984173070297,1.0,4/21,7.07%,MAGI2;NTRK2;SOS1;BDNF
prerank,organonitrogen compound catabolic process (GO:1901565),-0.32264847736128194,-1.1405237505860069,0.2292768959435626,0.4493125821575592,1.0,22/57,26.95%,NPL;ANPEP;GNPDA1;LNPEP;CLN6;TRIM24;CPQ;IL4I1;MPST;PLA2G7;PLA2G4A;TPP1;PLA2G6;PLA2G5;GGACT;GNPDA2;PPT1;AMDHD2;PNPLA8;RENBP;LRSAM1;PLA2G15
prerank,regulation of kinase activity (GO:0043549),0.2935198931758136,1.140419619815301,0.2222222222222222,0.5761103592035944,1.0,25/89,17.02%,ERBB4;NTRK3;EPHA6;LDB2;NTRK2;EPHA7;EPHA5;CSF1R;EPHB1;TIE1;PLCE1;ALK;EPHA10;ROS1;LTK;EMP2;TTN;TYRO3;RET;EPHB4;EPHB3;ERBB3;EPHA3;CDKN1C;ROR1
prerank,regulation of protein polymerization (GO:0032271),0.35222366203636685,1.1398735755378624,0.25517241379310346,0.5761914977770337,1.0,4/35,4.42%,MAP2;MAPRE3;PAK3;TTBK1
prerank,RNA destabilization (GO:0050779),-0.4240976606250244,-1.139204409184625,0.28716216216216217,0.45163177270531557,1.0,5/18,13.10%,ROCK1;YTHDF3;FTO;CELF1;METTL14
prerank,contractile actin filament bundle assembly (GO:0030038),-0.4416092352575186,-1.1391642835687839,0.2859778597785978,0.45114566706475057,1.0,6/15,11.39%,RHOA;TNFAIP1;ITGB1;ARRB1;ITGB5;ZYX
prerank,stress fiber assembly (GO:0043149),-0.4416092352575186,-1.1391642835687839,0.2859778597785978,0.45114566706475057,1.0,6/15,11.39%,RHOA;TNFAIP1;ITGB1;ARRB1;ITGB5;ZYX
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3066344662803856,-1.1390277403584121,0.2146422628951747,0.45113824205978853,1.0,15/80,6.47%,NRP1;PLEKHM1;ARPC2;P2RX7;RAC1;ACTR2;EPS8;WASF2;DOCK11;CDC42;ACTR3;ARAP1;RIPOR2;WASL;RHOQ
prerank,cGMP-mediated signaling (GO:0019934),0.4513287671438143,1.138942379497332,0.28741092636579574,0.5771834632901478,1.0,4/13,3.86%,HTR2C;KCNC2;GUCY1B1;PDE9A
prerank,positive regulation of protein binding (GO:0032092),-0.3295117431203565,-1.1388488116284095,0.2268370607028754,0.4511743928022279,1.0,10/56,11.05%,APOE;LRP1;AMFR;STK3;RPL11;NVL;B2M;PIN1;DERL1;APP
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.4601770539613723,1.1387126578404807,0.3164251207729469,0.5765215105224903,1.0,3/12,10.85%,TMEFF2;EDN1;GSTP1
prerank,heterochromatin assembly (GO:0031507),0.3987404675314033,1.1376537948477732,0.29698375870069604,0.57787748697176,1.0,7/20,19.73%,SUV39H1;HMGA2;CDKN2A;BAHD1;HELLS;HMGA1;SIRT1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.39970390214895757,-1.1365197653229238,0.29401408450704225,0.4553780759064912,1.0,11/21,36.56%,AXIN1;LRP6;CTNNB1;PPP1CA;GSK3B;DVL2;FZD1;FRAT1;CAV1;APC;FRAT2
prerank,smooth muscle contraction (GO:0006939),-0.4508013138641548,-1.1364843580991486,0.29769736842105265,0.4551657500710548,1.0,7/14,23.91%,ROCK1;SLC8A1;EDNRA;PIK3C2A;CHRNB2;TPCN2;SMTN
prerank,fatty acid elongation (GO:0030497),0.45832850614313314,1.136339602160371,0.2936893203883495,0.5798625551311043,1.0,5/13,20.94%,ELOVL7;HACD1;ABCD1;ELOVL6;ELOVL2
prerank,embryonic heart tube development (GO:0035050),0.43581061082424066,1.1355941724243928,0.2857142857142857,0.5804493139674594,1.0,2/14,5.01%,RYR2;ACVR1
prerank,embryonic eye morphogenesis (GO:0048048),-0.48017187896685964,-1.1355250619900943,0.3173758865248227,0.45679153062619354,1.0,5/11,27.46%,RARG;LRP6;MFAP5;TBX2;KDM2B
prerank,regulation of blood circulation (GO:1903522),0.35009023876470435,1.1354378420566804,0.25471698113207547,0.5796533105888421,1.0,12/34,21.59%,KCNMB2;ADORA3;KCNIP2;TNNT2;AGTR1;PER2;KCNJ12;ECE1;TPM1;CELF2;KCNMB4;DMPK
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.43775951103084454,-1.135425278276352,0.29591836734693877,0.45670515801079703,1.0,2/17,1.10%,RUNX1;VIM
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.40532735072014603,-1.1354241424949194,0.30127041742286753,0.45642611497598634,1.0,10/21,31.85%,RAD51B;BRD4;CDC25A;CDK1;RAB11A;CDC25C;CCNB1;RAD51C;RCC2;VPS4B
prerank,T cell differentiation in thymus (GO:0033077),-0.45769153705675925,-1.1351443946737398,0.3086206896551724,0.4567116838966824,1.0,1/14,0.14%,PTPRC
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.31847408655559184,1.1350673611154978,0.2200488997555012,0.5793133060006422,1.0,13/51,11.96%,CNTNAP2;DCLK1;NYAP2;MYO16;GPM6A;WASF1;EPB41L3;BDNF;NCKAP1;BMP7;SRGAP2;NBL1;TNIK
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.4808601494251993,-1.1347099964638983,0.3095652173913043,0.4573066375647796,1.0,4/11,19.28%,ABCG1;AGT;PLA2G7;PLA2G5
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.45742494276390694,1.1346880628408136,0.2965686274509804,0.5789994888892329,1.0,5/13,20.94%,ELOVL7;HACD1;TECRL;ELOVL6;ELOVL2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.41775480285745725,-1.1342827028407756,0.28832116788321166,0.4578133937352862,1.0,10/19,24.41%,ITGB2;PIK3AP1;TLR4;LY96;TNIP3;LGALS9;TICAM2;NR1H4;TRIL;ITGAM
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.41651507425736367,-1.1340706496445143,0.2800658978583196,0.4579638047322449,1.0,5/18,10.64%,POR;ABL2;ATP7A;SIRT3;AGT
prerank,negative regulation of hormone secretion (GO:0046888),-0.49313276783079385,-1.134064108697192,0.3215547703180212,0.457688643886023,1.0,6/10,44.74%,RAB11FIP5;RAB11FIP1;GJA1;FGF23;IL1B;OSM
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.2791735633322723,-1.1336600381820223,0.20411392405063292,0.4581851196080436,1.0,41/138,22.96%,RBPJ;NOTCH2;CREBBP;PPARD;PPARG;MAML1;GTF2A1;MAML2;E2F2;RARG;NR1H2;TAF6;TBL1XR1;NR2F1;POLR2H;POLR2F;E2F3;POLR2L;NRBF2;HDAC10;HDAC5;GTF2E2;RXRA;POLR2A;DR1;TAF4B;TAF8;NR4A1;POLR2G;TAF9;TAF3;RARA;NR3C1;TAF4;MAML3;MAZ;POLR2I;GTF2F2;GTF2A2;NR1H4;ESR2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.38774175483488105,-1.1334501579722818,0.3017241379310345,0.45830619446535836,1.0,12/27,28.28%,FBXL17;PPP1CA;BHLHE40;SIK1;ID2;FBXL8;RBM4B;FBXL6;PPP1CC;PPP1CB;PML;FBXL3
prerank,positive regulation of calcium ion transport (GO:0051928),-0.3578365119336844,-1.1333864344748839,0.2530755711775044,0.4581579529965439,1.0,10/36,18.61%,ATP2B1;P2RX7;CRACR2A;P2RX4;CCR1;WFS1;CCL5;SPHK2;LILRA5;PDGFRB
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.33913911142047276,-1.1333777979716677,0.22986577181208054,0.4578947152538643,1.0,18/47,20.12%,APOE;FOXO3;NFKB1;NR1H2;PUM3;PCIF1;AGT;MTPN;APP;WDR91;UHRF1;NOLC1;EIF4G1;SSH1;EIF2A;RBM4B;CSF1;RBM3
prerank,regulation of cellular respiration (GO:0043457),-0.4387637592338626,-1.1328925008942154,0.30412371134020616,0.4585519048829724,1.0,4/17,11.52%,IL10RB;NOA1;CBFA2T3;IFNAR1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.33278491725465,1.1327319525655528,0.2536231884057971,0.5826390120381307,1.0,9/39,9.63%,SPOCK1;EFNA5;SEMA3E;MELTF;SPRY4;KANK1;NEXMIF;CDKN2A;PLET1
prerank,regulation of protein kinase C signaling (GO:0090036),-0.4553547077832041,-1.132513570916209,0.291958041958042,0.45903119160936795,1.0,6/14,16.94%,MYADM;DGKD;VEGFA;CD40;DGKG;SPHK2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.4473437171837531,1.1321926288176016,0.2938496583143508,0.5826900808872264,1.0,3/13,7.38%,CHST5;MGAT3;CHST7
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.41450894929803905,-1.1321707816155664,0.303236797274276,0.45944030560709553,1.0,9/19,33.43%,MTHFS;MTHFD1L;MTHFD2L;GGH;MTHFR;SHMT1;FPGS;SLC19A1;MTHFD1
prerank,cardiac muscle cell differentiation (GO:0055007),0.39801614055098183,1.1319022791700857,0.26150121065375304,0.5821029741395367,1.0,7/21,12.16%,NRG1;CBY1;ACVR1;WT1;MYOCD;TTN;ALPK2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.40468147857358533,-1.1310608390228243,0.30139372822299654,0.46138489753093076,1.0,8/21,19.63%,CENPF;KLHL22;BUB1;TPR;BUB1B;TTK;MAD1L1;ATM
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.44897332775471344,-1.130936370495023,0.3286467486818981,0.46135996178021643,1.0,5/14,17.40%,TXNDC12;SELENOS;XBP1;TMBIM6;HSPA1A
prerank,negative regulation of DNA recombination (GO:0045910),-0.3409064343261579,-1.1308614398787973,0.2844677137870855,0.46123313558548995,1.0,13/43,22.95%,CGAS;BLM;RTEL1;POLR2H;POLR2F;POLR2L;RADX;POLR2A;UBQLN4;POLR2G;SHLD2;POLR2I;ZRANB3
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.35687688671796414,1.1306065388591708,0.2746478873239437,0.5840895300225095,1.0,6/31,10.93%,NRG1;RYR2;ZFPM2;TNNT2;MYH7;TGFB2
prerank,histone acetylation (GO:0016573),-0.31343818758964725,-1.1304125804564082,0.23166666666666666,0.46181645689342943,1.0,16/69,18.54%,CREBBP;PHF20;SPI1;MORF4L1;TAF6;ZZZ3;WDR5;JADE2;NAA50;KAT7;EPC1;DR1;MRGBP;PHF20L1;TAF9;TRIM16
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.4105068508842746,1.1299977922866833,0.2833333333333333,0.5843909522798718,1.0,3/17,7.01%,PRKG1;TAFA5;APLN
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4493920579597516,-1.129431984591034,0.30158730158730157,0.4634569932681185,1.0,4/13,5.50%,IGF1;INSR;DYRK2;PHKG2
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.4883875752588901,-1.1292839077594135,0.31868131868131866,0.4634594889477421,1.0,4/10,21.40%,BRCA1;JARID2;MYB;KDM1A
prerank,regulation of stress fiber assembly (GO:0051492),-0.3077581266611262,-1.1285416669708805,0.24297520661157024,0.46460673381939305,1.0,15/74,8.99%,NRP1;PAK2;RAC1;ROCK1;RHOA;WASF2;CDC42;ARAP1;PTGER4;ARHGEF10;ARHGEF18;NF2;TGFBR1;SLC9A1;ITGB1BP1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.39620378510235754,1.1284708165735617,0.29901960784313725,0.5869485807096395,1.0,6/19,12.12%,GRM5;RYR2;VCAM1;PRNP;GPR143;BCAP31
prerank,histone deacetylation (GO:0016575),-0.3372082576072332,-1.1284008249577504,0.2639344262295082,0.4646047616297512,1.0,10/43,14.02%,RCOR1;MIDEAS;MORF4L1;TBL1XR1;SUDS3;HDAC10;RBM14;MTA3;HDAC5;SIN3A
prerank,regulation of protein transport (GO:0051223),-0.37838348346289746,-1.1278966161316313,0.2906574394463668,0.46533920350294256,1.0,16/27,34.12%,SNX3;DNAJC1;WWP2;RHBDF1;RHBDF2;DNAJA1;LCP1;ARFIP1;NDFIP2;PTPN1;P3H1;HSPA8;ATP13A2;LLGL2;GAPVD1;TNF
prerank,negative regulation of vascular permeability (GO:0043116),0.4617274486706571,1.1275099297727034,0.3054892601431981,0.5880048283187911,1.0,6/12,16.91%,SLIT2;SH3GL2;FERMT2;CLDN5;RAMP2;PDE3A
prerank,regulation of embryonic development (GO:0045995),-0.3586189968097427,-1.1273593792595822,0.2864,0.4661163517403709,1.0,11/34,21.59%,B4GALT5;NIBAN2;INSR;NIPBL;RBM19;CDK1;DHX36;RACGAP1;CFL1;TRIP12;BAG6
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.4373919291855203,-1.1264018714019435,0.3087971274685817,0.46770995888703765,1.0,6/16,10.78%,IGF1;ROCK1;MEF2A;SLC9A1;AGT;MTPN
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.3852409592796389,-1.1262049894222648,0.29333333333333333,0.4677984553929231,1.0,6/24,10.11%,PRKCB;ITGA5;NIBAN2;HHEX;HIF1A;ARNT
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.4415942980123607,-1.1254602440907466,0.2910321489001692,0.46899065003621526,1.0,2/16,1.10%,RUNX1;VIM
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.31614402693403276,-1.125407580804366,0.25254237288135595,0.4688210372757775,1.0,12/63,8.19%,MCL1;ROCK1;NUPR1;HTR2B;STAT3;TAB2;BCL2;PTPN22;EIF4G3;HGF;KLHL22;TIMP2
prerank,response to interleukin-1 (GO:0070555),-0.3078916106143188,-1.125299716621391,0.2504317789291883,0.46875056012837085,1.0,19/73,20.90%,IRAK2;RC3H1;NFKB1;ANXA1;YTHDC2;IRAK3;SIRPA;MYD88;HIF1A;GBP2;RELA;APP;CCL5;CD40;TAF9;LGALS9;GBP3;SFRP1;ZC3H12A
prerank,protein targeting to membrane (GO:0006612),-0.30220783032624843,-1.1245911378744045,0.24155405405405406,0.4698980604949183,1.0,26/83,25.24%,RAB8B;SDCBP;PEX14;ABCD2;SEC63;PEX26;SRP14;NACA;ZDHHC7;SIL1;FIS1;ZDHHC2;NCF1;ZDHHC12;GET3;ABCD3;TAOK2;ZDHHC1;NACAD;SGTA;GOLGA7;CHMP4B;CHMP4A;MICALL1;ZDHHC6;YIF1B
prerank,ceramide catabolic process (GO:0046514),-0.4385293027876069,-1.1245783346302192,0.31393298059964725,0.4696308935334009,1.0,2/14,1.92%,HEXA;ACER3
prerank,wound healing (GO:0042060),-0.3149113846284235,-1.1238974024442718,0.259567387687188,0.47073681885095986,1.0,12/62,9.08%,MYOF;IGF1;MYH9;ARL8B;HPSE;CFLAR;MACF1;FUT10;AHNAK2;PRCP;TGFBR1;JAML
prerank,regulation of gastrulation (GO:0010470),0.43900194929409686,1.12358193738931,0.3316953316953317,0.5963045785532246,1.0,2/14,4.30%,TENM4;CLASP2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.3997289157148397,-1.1234002106535306,0.296028880866426,0.47146085021539835,1.0,9/21,27.85%,SMARCD3;CTNNB1;VEGFA;MDK;NES;DISC1;KDM1A;LRP2;DCT
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.30534938289981,-1.1227103748697094,0.24829931972789115,0.4725762825779557,1.0,24/78,21.36%,PID1;DAB2;PRKCH;LRP1;STX7;ITGB1;ACTB;STX8;STX3;RHOQ;PICALM;ZDHHC7;ZDHHC8;ZDHHC2;ITGA3;CIB1;PPFIA1;CLN3;STX4;TMEM59;ZDHHC5;VPS4A;APPL1;CDK5
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.4897740800342903,-1.1226472376979901,0.3292894280762565,0.47240820501209047,1.0,1/10,0.19%,PRKCH
prerank,positive regulation by host of viral transcription (GO:0043923),-0.4451802546063478,-1.1224952887090045,0.3290203327171904,0.47243585938806537,1.0,5/15,28.56%,JUN;NUCKS1;TFAP4;EP300;LEF1
prerank,negative regulation of cell development (GO:0010721),-0.38432897326853355,-1.1224515831550503,0.2984822934232715,0.4722374904743374,1.0,8/25,23.92%,IGF1;LILRB1;B2M;APPL2;RFLNB;GSK3B;IL6;PAX6
prerank,epidermis development (GO:0008544),-0.3206468948448037,-1.1223984148963964,0.2703180212014134,0.4720624683847079,1.0,29/56,42.96%,EMP1;FABP5;FLOT2;DSP;CERS3;CCN2;ATP2C1;FOXN1;DCT;GRHL3;PLOD1;SPINK5;GRHL2;LAMC2;LAMB3;YBX1;GRHL1;OVOL2;EDAR;OVOL1;EDA2R;GLI1;SPRR1A;NTF4;SVEP1;LAMA3;FGF7;ATP2A2;UGCG
prerank,phosphatidylserine metabolic process (GO:0006658),-0.36714877052606,-1.1220736388019559,0.28596491228070176,0.47240315637300057,1.0,17/32,35.49%,OSBPL8;SLC27A1;ABHD12;OSBPL5;PLA2G4A;PLAAT3;PLA2G5;PLA2G12A;LPCAT3;PLA2G15;LPCAT4;SERINC1;PLSCR1;SERINC5;PLA2G3;PTDSS2;PLA2G4B
prerank,placenta development (GO:0001890),-0.46510052431299964,-1.1219733993950356,0.336283185840708,0.4723041836116246,1.0,4/12,17.07%,PPARG;E2F8;ANG;ADAM19
prerank,positive regulation of protein deacetylation (GO:0090312),-0.45126376233785825,-1.1218364864616388,0.31239388794567063,0.4723057758698748,1.0,8/14,35.16%,AKAP8;NIPBL;DYRK1A;APLNR;AKAP8L;ZBTB7B;CTBP1;ING2
prerank,regulation of lamellipodium assembly (GO:0010591),-0.36165297232069465,-1.1217873592122225,0.2697594501718213,0.47212295508836405,1.0,7/34,4.20%,ARPC2;RAC1;ACTR2;CAPZB;WASF2;CDC42;ACTR3
prerank,regulation of protein neddylation (GO:2000434),-0.48737049665578525,-1.1216797859789691,0.33158813263525305,0.472047367493027,1.0,7/10,34.95%,RPL11;HIF1A;DCUN1D4;RPL5;COPS9;DCUN1D5;DCUN1D1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.34652767117141503,-1.1214204388565305,0.2774869109947644,0.47228751750726544,1.0,14/39,24.97%,DDB2;RFC1;UBC;RPS27A;PCNA;CUL4B;RPA3;RFC2;POLD2;ERCC4;RFC3;FAN1;POLD4;DDB1
prerank,brain morphogenesis (GO:0048854),0.45071062481975277,1.1212229767906607,0.2909090909090909,0.6006878972377291,1.0,2/12,5.24%,CTNNA2;SHANK3
prerank,ganglioside biosynthetic process (GO:0001574),-0.44911495739034396,-1.1210399156916024,0.3315508021390374,0.47277009460953195,1.0,3/15,2.02%,B4GALT5;ST3GAL1;ST8SIA4
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.42429623568996966,-1.1208315044642536,0.31860036832412525,0.47290566856244864,1.0,6/15,17.76%,ANAPC1;CENPE;NEK6;TPR;UBE2C;ANAPC7
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.4479930578996641,-1.120202422623281,0.335676625659051,0.47384841937756583,1.0,3/13,4.60%,RREB1;METRNL;PIM1
prerank,selective autophagy (GO:0061912),-0.3239039999740833,-1.1197818435711144,0.28192371475953565,0.47438327618657616,1.0,14/56,16.91%,VIM;RAB7A;ATG5;WDFY3;DYNC1H1;ULK2;TEX264;UBC;RPS27A;RETREG1;RB1CC1;DYNC1LI2;USP30;PCNT
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.27999766377007007,-1.119259678000096,0.23140495867768596,0.4751211198540694,1.0,39/129,21.63%,ZEB2;DKK2;PSME4;PSMB7;PSME3;NFKB1;HHEX;USP8;DAPK3;PSMB9;AXIN1;TBL1XR1;PPM1B;LRRK1;WLS;PSMA8;PIN1;PSMC3;PSMD8;PSMC4;PSMB10;TNKS2;PSMA1;PSMB8;GPRC5B;JRK;PLEKHA4;DDX3X;RSPO1;PSMA5;PSMD4;TMEM198;PSMB3;WNK1;PSMD3;SFRP1;JUP;CSNK1G3;SMURF2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.396417125658699,-1.1189431010376938,0.3128390596745027,0.47547400547058494,1.0,6/21,10.86%,ARHGAP25;CYRIB;SH3BP1;ARHGAP12;SPRY2;RASAL3
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.25635811189465574,-1.1179500627225898,0.17894736842105263,0.47715623466024576,1.0,55/291,13.47%,PID1;LYN;LILRB1;DAPK1;P2RX7;VIM;GNB1;PRKCD;AXL;JUN;RAP1B;RHOA;TNFRSF1B;IPO5;P2RX4;SBNO2;FES;ABL2;RAP1A;CTR9;TLR4;CHMP5;PTK2B;STAP1;NFKB1;ACTB;ADAM9;MAPK14;PF4;GNG2;AHR;CAMKK2;SIRPA;MYD88;MEF2C;LY96;SELENOS;LPL;PRDX5;EGR1;TGM2;TNIP2;RELA;NCF1;XBP1;RRAGD;HSP90B1;TICAM1;MTR;HMGB2;SERPINE1;CASP1;DEFA6;DHX36;NFKBIL1
prerank,cardiac conduction system development (GO:0003161),-0.3806774658463218,-1.1178333593613072,0.29541595925297115,0.4770928216796768,1.0,12/24,39.60%,NOTCH2;MAML1;GJB6;SMAD4;GJA5;HEY2;GJA1;SMAD1;HEY1;NPPA;TBX18;SMAD5
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.34994783479331326,1.1178045206309524,0.27058823529411763,0.607843619385935,1.0,5/32,5.53%,NAV3;MAP2;TUBB4A;CLASP2;APC2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.45432583707514895,-1.1176882593499606,0.30824372759856633,0.477105570259443,1.0,5/13,17.43%,AGO2;CNOT1;TNRC6C;POLR2G;TOB1
prerank,cell proliferation in forebrain (GO:0021846),0.4696777923045351,1.1174173769843558,0.3231552162849873,0.6076182944294315,1.0,4/10,19.13%,HOOK3;NUMB;DOCK7;PCM1
prerank,positive regulation of receptor internalization (GO:0002092),0.3843216509526894,1.1173126417689825,0.2857142857142857,0.6066571469100194,1.0,5/22,8.11%,MAGI2;AHI1;EGF;APLN;FMR1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.45551918167685457,-1.116731363903599,0.3327272727272727,0.4786863534611411,1.0,5/14,24.18%,CCR2;PTK2B;CCL5;WNK1;CCL7
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.4075889027097464,-1.1162252413655305,0.3175438596491228,0.47938946328545046,1.0,6/17,15.45%,RB1;KNL1;CENPA;ZWILCH;CDK1;TTK
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4270088097098135,-1.1161437045767695,0.2906574394463668,0.47925702895179884,1.0,5/16,19.48%,CDK13;DHX9;DDX5;SCNM1;SLU7
prerank,lymphocyte chemotaxis (GO:0048247),-0.3593077467351764,-1.1160774391391455,0.3210702341137124,0.47910485572762374,1.0,8/34,13.40%,CKLF;PIK3CG;GAS6;ADAM8;CH25H;CXCL16;CCL5;PIK3CD
prerank,negative regulation of protein modification process (GO:0031400),-0.29949964812296037,-1.1159739691823807,0.2680921052631579,0.47903019567871624,1.0,27/79,25.94%,PID1;LYN;CORO1C;MFHAS1;XDH;NIBAN1;IBTK;PPP1R15B;LRP6;MYADM;SIRPA;PAQR3;IGFBP3;CIB1;CRTAP;CRKL;PTPN13;GSK3B;ZC3H12A;PLPP3;PRKDC;TARDBP;TGFB1;CDYL;P3H1;XRCC1;INPP5K
prerank,negative regulation of lyase activity (GO:0051350),-0.4265615288246463,-1.1158519322822549,0.3102836879432624,0.47897917834897136,1.0,2/16,2.23%,CCR2;GNAI3
prerank,negative regulation of peptidase activity (GO:0010466),0.3230038701309983,1.1154897732595888,0.26208651399491095,0.6099610856840924,1.0,5/47,4.76%,SPOCK1;SPOCK3;SERPINI1;SERPING1;TIMP3
prerank,response to insulin (GO:0032868),-0.30349181566135697,-1.115445834888019,0.24873949579831933,0.4794674253884609,1.0,14/80,13.39%,MYO5A;RAB8B;DENND4C;OGT;INSR;PPARG;RAB31;SLC27A1;RHOQ;SELENOS;XBP1;PKM;RAB10;HDAC5
prerank,regulation of histone methylation (GO:0031060),-0.45582522302759193,-1.1151990260510651,0.3181019332161687,0.4796720486842856,1.0,7/13,29.98%,CTR9;CHTOP;JARID2;NSD1;MTHFR;FAM47E;TTLL12
prerank,regulation of protein processing (GO:0070613),-0.3982890691921077,-1.1146702096449954,0.30256410256410254,0.480448787310341,1.0,5/21,18.18%,RUNX1;NLRC4;ADAM8;CLN3;TMEM59
prerank,positive regulation of secretion by cell (GO:1903532),0.2969511883986738,1.1144242616815652,0.255,0.6113544551527453,1.0,23/70,20.71%,CADPS;FRMD4A;SOX11;SLC12A2;CADPS2;CLASP2;RAB27B;PLA2G10;EDN1;TGFB2;TTN;MYH10;ARF6;UNC13B;RAB27A;SNCA;RAB3A;IL1A;STX1B;GRK2;CD33;TREM2;DNM1L
prerank,regulation of actin filament polymerization (GO:0030833),-0.31195801529072237,-1.1139637848814452,0.2781569965870307,0.4814955573244492,1.0,31/69,30.24%,PRKCD;SNX9;PTK2B;ARFGEF1;ARHGAP18;CYRIB;MYADM;BAIAP2;NCKAP1L;CDC42EP2;MTPN;BAIAP2L2;SSH3;RASA1;COTL1;SSH1;CDC42EP3;HCLS1;TWF2;HCK;HAX1;SSH2;NCK1;PFN1;DBNL;ALOX15;CCL24;PLEKHG2;CDC42EP5;NCK2;TWF1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.2890019507120949,-1.1134885284977243,0.2558139534883721,0.4821719495961043,1.0,28/104,19.06%,RB1;RHOA;UVRAG;SLC27A1;CCND3;ACTB;INCENP;BLM;TSG101;LRP6;CAB39;EZH2;TRIB1;SLC8A1;TRIB2;CDKN3;CDC25A;MAP2K1;GADD45A;CIB1;KSR1;CCNE1;RALB;CDKN2C;SERTAD1;CNPPD1;ADRB2;DDX3X
prerank,positive regulation of viral genome replication (GO:0045070),-0.37114753424393937,-1.1134349879271466,0.30153321976149916,0.48198576300261303,1.0,15/29,41.53%,TOP2A;CD28;IFIT1;CCL5;VAPB;DDX3X;SRPK1;DDB1;HACD3;PPID;ADARB1;RAD23A;TMEM39A;TARBP2;PKN2
prerank,negative regulation of telomere maintenance (GO:0032205),-0.4357932292767443,-1.113377433001236,0.3535714285714286,0.48181372446336157,1.0,6/15,21.01%,RTEL1;TNKS2;ERCC4;SLX4;ATM;NBN
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.3498718267795493,-1.1133709187712157,0.2993311036789298,0.4815364024499968,1.0,14/36,21.25%,RAB7A;OPTN;GOLGA4;RAB31;GGA3;MACF1;GOLPH3L;SYS1;RAB10;VAMP4;RAB34;GOLGA7;RILPL1;BLZF1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.4408204741855346,-1.113246711947166,0.32857142857142857,0.48149661628284485,1.0,6/13,35.64%,BCL2L11;VDAC2;BNIP3L;BNIP3;BLOC1S2;RTL10
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.3931553307200665,-1.1129645154358117,0.30783242258652094,0.48179345248067307,1.0,9/22,27.04%,ERI3;RPS21;NOP14;ERI2;EXOSC10;NOL9;WDR12;RPP40;EXOSC8
prerank,positive regulation of cell differentiation (GO:0045597),-0.257721262870256,-1.1125604322594913,0.2109375,0.48232759348324905,1.0,49/237,14.63%,DAB2;PRKCH;MSR1;IGF1;TCF4;SDCBP;CD36;SLC6A6;MEF2A;RHOA;PPARD;ARHGEF2;FES;PPARG;IL6R;RAP1A;CDC42;IL18;RIN2;NFKB1;RUNX2;MEDAG;PKDCC;RIPOR2;MAPK14;PF4;HGF;GCNT2;CTNNB1;EZH2;MDK;TGFBR1;TGFB1I1;MEF2C;LPL;AGT;XBP1;WDFY2;NUDT21;IGFBP3;HSP90AB1;ACVR2A;DHX36;SMYD1;TGFBR2;SIN3A;BTG1;ID2;TCF3
prerank,copper ion transport (GO:0006825),-0.4796314415206635,-1.1123143325612328,0.34397163120567376,0.48252638687048055,1.0,3/11,9.42%,ATP7A;STEAP3;SLC31A1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.4080200799071303,-1.1115365342085393,0.3158813263525305,0.48386872860266633,1.0,9/19,21.48%,NFKB1;WFS1;MAP2K5;MAPK7;MTPN;APP;KLF2;GATA3;TMEM106A
prerank,blood circulation (GO:0008015),0.3121702475211235,1.1114262451644077,0.24703087885985747,0.6175478651528776,1.0,7/49,10.08%,SGCZ;SGCD;SERPING1;GUCY1B1;COL4A3;SGCG;AGTR1
prerank,negative regulation of transport (GO:0051051),-0.32641393238854827,-1.1109281694721793,0.28498293515358364,0.48480654751503477,1.0,10/51,8.44%,MCTP1;LILRB1;RAB7A;SNX3;WWP2;ITGAV;NR1H2;SNX33;SIRPA;BST2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.4183884587499893,-1.110477635733705,0.3151618398637138,0.4854069477437782,1.0,3/19,5.76%,RUNX1;VIM;CIITA
prerank,megakaryocyte differentiation (GO:0030219),0.45682955665997543,1.1104539684362487,0.325635103926097,0.6186819169229685,1.0,4/11,23.37%,KIT;THPO;TAL1;UBA5
prerank,anterograde axonal transport (GO:0008089),0.3393030669915933,1.1103213021372265,0.28361858190709044,0.6178228500755746,1.0,12/37,17.66%,DLG2;KIF5C;KIF1B;RAB27B;KIF5A;AP3M2;NEFL;AP3S2;KIF3A;MAP1A;HAP1;BLOC1S6
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.3823474305001321,-1.1099627330668422,0.32941176470588235,0.48616339274179293,1.0,5/26,6.50%,OSBPL8;IGF1;INSR;RHOQ;C3
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.4839126121913723,-1.109960452022476,0.3525305410122164,0.485879875147625,1.0,2/10,12.31%,DNMT3A;ZFP57
prerank,regulation of calcium ion import (GO:0090279),0.3882043733357215,1.1096537182534398,0.32574031890660593,0.6181880199502577,1.0,7/21,19.72%,PLPP4;EGF;PRNP;FYN;WNK3;TRIM27;CCL2
prerank,negative regulation of catabolic process (GO:0009895),-0.3312234810912491,-1.1095625488219374,0.28546712802768165,0.48636788756933824,1.0,13/47,20.67%,SNX3;NUPR1;FLNA;CBFA2T3;IRAK3;ZDHHC7;AZIN1;SF3B3;PIN1;CST3;RILP;MDM4;SIRT2
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.41278104426058043,1.1091445614135145,0.3159144893111639,0.6181884732461774,1.0,8/16,19.83%,ST8SIA2;ST8SIA3;ST6GALNAC3;ST8SIA1;ST8SIA5;B3GALT4;B4GALT6;ST6GALNAC5
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.4573863194206219,-1.1089607919496414,0.34256055363321797,0.48729928222387925,1.0,8/12,41.49%,PPARG;ZC3H12A;TGFB1;NCOR1;ESR1;TNF;ZC3H10;ELAVL1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.429087119812186,-1.1084334310091615,0.3338926174496644,0.48809356016450073,1.0,5/16,11.34%,GPR137B;KLHL22;PIP4P1;RRAGD;FLCN
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.32727775770487566,-1.107607307385032,0.30677966101694915,0.4894771791944266,1.0,9/51,8.99%,NRP1;PLEK;RAC1;RHOA;CDC42;ARHGEF10;NF2;TGFBR1;ITGB1BP1
prerank,regulation of vasculogenesis (GO:2001212),-0.43983191519849,-1.106862531130769,0.32269503546099293,0.49067826647660817,1.0,3/14,4.26%,XDH;RAP1A;RIN2
prerank,membrane repolarization (GO:0086009),0.4124297869023033,1.1060284617370182,0.30465116279069765,0.6245469736403765,1.0,5/15,17.14%,KCND3;KCNIP2;ATP1B1;KCNE4;ATP1B2
prerank,cellular response to UV-A (GO:0071492),0.45747116670354004,1.1058437721572048,0.32134831460674157,0.6237544483434042,1.0,3/11,9.75%,MME;OPN3;OPN5
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.3727780341912182,-1.1046207124096674,0.31382978723404253,0.49504585579528565,1.0,8/26,19.30%,B4GALT5;ST3GAL1;SLC35D2;B3GNT2;PRELP;B4GALT3;FMOD;B4GALT1
prerank,epithelial to mesenchymal transition (GO:0001837),-0.32957158935102737,-1.1044959271400356,0.2916666666666667,0.49501153581642643,1.0,19/47,29.34%,RBPJ;ROCK1;HGF;CTNNB1;TGFBR1;DDX5;HIF1A;LIMS1;FAM83D;GSK3B;S100A4;HEYL;SNAI2;TGFB1;TRIM28;BMP2;ENG;LEF1;DDX17
prerank,aorta development (GO:0035904),0.42643953880184254,1.1042181721007887,0.34190231362467866,0.6266159632554373,1.0,2/14,0.73%,ROBO1;ROBO2
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.4786057632546853,-1.104149892297089,0.34053156146179403,0.4954044183684425,1.0,2/10,0.40%,DSE;XYLT1
prerank,ribosomal small subunit assembly (GO:0000028),-0.42839794447502627,-1.10414920196776,0.3333333333333333,0.49511407124905044,1.0,8/16,25.15%,ERAL1;RPS14;RPS28;MRPS11;RPS27;PRKDC;RPS15;MRPS7
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.4376734916502842,-1.1040068077405474,0.34657039711191334,0.49512395892458433,1.0,5/13,19.63%,DDX5;SPRED1;SPRED2;EEF1E1;ATM
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.3286751725961219,-1.1025010366991428,0.3129370629370629,0.4979391648111691,1.0,8/47,10.40%,PLEK;BRCA1;SLC27A1;NFKB1;SIRPA;ERLIN1;SIK1;PRMT3
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.4891186390184477,-1.1023020548442701,0.3715753424657534,0.49803420771876034,1.0,4/10,27.09%,NCKAP1L;TGFBR2;LGALS9;ZBTB7B
prerank,regulation of cell population proliferation (GO:0042127),-0.23297339448902044,-1.1022934009894312,0.14265734265734265,0.4977603544487478,1.0,191/691,24.85%,LYN;RUNX1;IGF1;NAMPT;ABI1;GAB2;SDCBP;ARID2;BCL6;CDK6;JUN;NIBAN2;PTPRJ;BIRC6;ACER3;NUPR1;RHOA;BRD7;INSR;IGF1R;CSNK2A1;ARHGEF2;FES;CDK13;PIAS1;IL6R;HTR2B;S100A11;SGK1;RNF41;STAT3;IL15;EAPP;FLT1;STAT6;TCIRG1;DPP4;PTK2B;HHEX;ITGAV;RARG;BCL2;KIF20B;RPS6;JAG1;STX3;CBFA2T3;PF4;SMYD2;FN1;SLC35F6;CHTOP;GCNT2;IFI35;CTNNB1;EZH2;GRK5;STAT5B;STAT4;SKI;NF2;VEGFA;NME1;EIF2AK2;CNBP;RPS15A;PRMT1;TGFBR1;GSDME;ITGB1BP1;TGFB1I1;PTPN6;TBC1D8;CTSH;RPS4X;INCA1;HP1BP3;RELA;KIF14;AGT;ITGAX;CDKN3;IL7R;APP;TIMELESS;XBP1;STRN;XRCC6;OSGIN1;MAP2K1;CCDC88A;KLF10;CELF1;KMT2D;STK11;IGFBP3;EEF1E1;CACUL1;CIB1;HMGB2;UHRF1;SHCBP1;FRK;GLP2R;KSR1;TGFBR2;TFAP4;GREM1;BTG1;ID2;CAPNS1;DOT1L;IL34;CRKL;TTK;IL31RA;PPP1R9B;BST1;HCLS1;KLF11;RBBP4;CNOT6L;VHL;STX4;RPS9;HSPA1A;TOB1;IRS2;RARA;KRAS;ATF5;LIMS1;CDKN2C;GATA3;SERTAD1;HCK;PDGFRB;PDCD5;COL18A1;MEIS3;MDM4;IL7;WDR77;CSF1;CHP2;CNOT8;BMPR2;PRC1;ADAMTS1;BAP1;MAZ;SIRT2;PDS5B;SFRP1;TIPIN;COPS8;STAT1;GNRH1;JUP;KDR;PDGFA;NUP62;TBX2;IFITM1;CGRRF1;INHA;FGF18;S1PR2;IL6;EID2;PRKDC;BNIPL;SOX7;KITLG;TGFB1;PIM2;GPLD1;CD47;CYP1B1;TES;LMNA;FGF9;FLT3;SHC1;FTH1;MYC;NUDT6;PKHD1;RNF187;STAT2;FGFR4
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.2897924805165299,-1.102183498030953,0.2545454545454545,0.497685560069415,1.0,14/90,7.83%,CCR2;SYK;CD36;OGT;IGF1R;FABP5;KDM3A;IL18;STAT6;ADIPOR1;DYNC1H1;UCP2;PLAC8;VEGFA
prerank,GTP metabolic process (GO:0046039),-0.43040733198664266,-1.1020417931227209,0.32075471698113206,0.4977134142813689,1.0,5/15,11.01%,GNAI3;IMPDH2;RHOQ;EFL1;GTPBP1
prerank,proteoglycan metabolic process (GO:0006029),-0.37224810561928756,-1.1018427967074722,0.32111692844677137,0.49781053234541933,1.0,7/26,11.06%,XYLT1;IGF1;HPSE;CHST12;SULF2;CHST11;B4GALT7
prerank,mitochondrion organization (GO:0007005),-0.26542582728092656,-1.101347648532334,0.23993558776167473,0.49846086280477003,1.0,48/165,24.53%,PID1;VPS13C;TRAK1;DNM2;MEF2A;IMMP2L;MTM1;PYROXD2;ATP7A;NRF1;PITRM1;RAB32;HIGD2A;BCS1L;ATAD3A;SIRT3;FIS1;SSBP1;TIMM44;TMEM11;RAB29;TIMM22;IFIT2;CXADR;MPV17;AFG1L;TFAM;SLC25A4;USP30;NIPSNAP2;BID;BNIP3L;MIGA2;FBXO7;COX7A2;TOMM22;MTFR1L;MTX1;TOMM34;HAX1;POLG2;TWNK;TOMM70;MTFP1;BIK;ATP5F1B;CYCS;PTCD2
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.3500188541502112,-1.1012272443866036,0.3197879858657244,0.4984218835787486,1.0,15/36,32.10%,APOE;SP100;PPARG;MEF2C;ANGPT2;GADD45A;HMGB1;JUP;APOH;TGFB1;DCN;ADAMTS9;AGTR2;CSNK2B;FGF2
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.4108131653184851,-1.101183689691417,0.32887189292543023,0.49821433578163415,1.0,3/18,4.99%,AOAH;SAMHD1;DERA
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.2828721785839845,-1.1007348524671459,0.2562814070351759,0.49883160487146344,1.0,23/107,14.15%,ATP2B1;CCR2;SLC30A5;SLC10A7;HTR2B;CCR1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;SLC8A1;ATP2A3;ATP13A1;TPT1;LCK;SLC24A5;CCL5;MT2A;CD40
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.38718878538783463,-1.1002339952736884,0.33568904593639576,0.4995266045147333,1.0,8/22,17.60%,PRKCD;ARFGEF1;CYRIB;MYADM;SSH3;TMSB4X;SSH1;TWF2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.4524480049738218,-1.1002242798600843,0.3220640569395018,0.49925044092284426,1.0,4/13,13.58%,NRP1;CTNNB1;VEGFA;TGFBR2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.45582216129215575,-1.1001679069573267,0.3267504488330341,0.49906014752069394,1.0,3/12,8.64%,BRCA1;PIBF1;ERLIN1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.3284827639238704,1.100067341110685,0.2682291666666667,0.6358238327961304,1.0,10/39,11.28%,SLIT2;SEMA3E;PAX8;GDNF;TIE1;WT1;FGF10;SALL1;CITED1;PKD1
prerank,proteoglycan biosynthetic process (GO:0030166),-0.3613443736088011,-1.0998574014108216,0.31833910034602075,0.4993902515028668,1.0,7/31,12.23%,EXT1;XYLT1;IGF1;CHST12;CHST11;B4GALT7;XYLT2
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.35767082743089784,-1.099850072451341,0.3333333333333333,0.49911608563281346,1.0,11/33,25.36%,SNRPG;SNRPF;SSU72;NUDT21;WDR33;NCBP1;PAPOLA;CPSF3;MAZ;MED18;CPSF1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3398319846446538,1.0996186958705203,0.30963302752293576,0.6357202542082369,1.0,5/32,11.21%,AKAP6;TRPC1;RAMP3;NPSR1;CAPN3
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.3972893617879495,-1.0989609800832778,0.3368237347294939,0.5005968657054594,1.0,5/20,10.40%,BRCA1;SLC27A1;ERLIN1;SIK1;PRMT3
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.38486973473091846,-1.0988965298611684,0.32941176470588235,0.5004449620077469,1.0,9/24,14.75%,CANX;TAPBP;B2M;TAP2;SEC24A;SEC24D;FCER1G;SEC31A;TAPBPL
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.3011688232916249,-1.0988172687120312,0.28449744463373083,0.5003125885708124,1.0,12/75,10.38%,CCR2;STAB1;ROCK1;NIBAN2;PPARG;HHEX;SARS1;PF4;CTNNB1;KLK3;SPRED1;SPRY2
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.44163714106039076,-1.0981676188993348,0.3424408014571949,0.5013373364609786,1.0,5/14,19.87%,FASTKD2;NGRN;FASTKD3;RMND1;C1QBP
prerank,positive regulation of response to stimulus (GO:0048584),-0.34825948230655507,-1.0973697432082732,0.3129251700680272,0.5027045618105203,1.0,15/40,24.61%,PRKCD;CGAS;IL15;DHX9;RSAD2;B2M;EEF1E1;FCGR2B;MAVS;ARG2;TAF9;GATA3;ILK;ECHDC3;MYC
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.4322900447510394,-1.0969763373730947,0.37142857142857144,0.5032108164712147,1.0,6/15,17.98%,AGO2;CNOT1;TNRC6C;POLR2G;TOB1;TENT4B
prerank,positive regulation of hormone secretion (GO:0046887),0.40303163362611694,1.0969506806086649,0.31746031746031744,0.6412252419056276,1.0,5/17,16.00%,SOX11;EDN1;VAMP7;VAMP8;GRP
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.2699984749398433,-1.0964900946621843,0.24126984126984127,0.5038823972771357,1.0,49/144,25.39%,PRKCD;ITGB2;IPO5;FLNA;RUFY3;BCL2;ANP32B;KIF20B;RNF31;GAS6;USP36;E2F1;ITGB1BP1;YWHAE;UBE2L3;FIS1;UBL5;ZDHHC2;TPR;SAR1A;RAB29;CIB1;PLK3;SH3GLB1;BBC3;MAVS;BAG3;HCLS1;BID;PCNT;CASP8;HUWE1;CHP2;GSK3B;BAP1;ZC3H12A;JUP;SFN;KCNB1;HPS4;NMT1;GTSE1;TGFB1;RBM22;SAE1;ITGAM;TRIM28;ECT2;VPS11
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3806251640881311,1.0964869034513447,0.31234866828087166,0.6412488735222762,1.0,6/21,15.16%,DMD;PDE4D;MLXIPL;INPP5J;NLRP2B;CNKSR3
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.41384120452258,1.0963528979816652,0.35348837209302325,0.6403378688866721,1.0,4/15,11.17%,PAX8;GDNF;SOX9;SMO
prerank,endoderm formation (GO:0001706),-0.34657837192073226,-1.0962005918106072,0.30112721417069244,0.504189403150481,1.0,6/35,9.97%,ITGA4;ITGB2;ITGA5;ITGAV;FN1;ITGB5
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.3073644929287346,-1.095419547501225,0.2869415807560137,0.5054532349339576,1.0,20/66,20.57%,CDK6;RB1;BRD7;PSME3;CCND3;PRMT2;ANXA1;E2F1;PTPN6;KIF14;ID2;INO80;EIF4G1;APPL2;WEE1;CDKN2C;CDK2AP2;DDX3X;ADAMTS1;APPL1
prerank,homeostasis of number of cells (GO:0048872),0.4377477573404432,1.0951644530977571,0.3621495327102804,0.6421022333957906,1.0,3/12,8.43%,OCIAD1;CCN3;CX3CR1
prerank,protein localization to cell periphery (GO:1990778),0.2649783844175285,1.0950337742917786,0.2507042253521127,0.6412165056052448,1.0,13/133,4.30%,DPP10;KCNIP4;DPP6;KCNB2;ANK3;ANK2;RAB3C;MAP7;CACNB2;TESC;RAB15;EPB41L3;CLASP2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.48178685327957166,-1.0948076646187221,0.36614853195164077,0.5064136237686178,1.0,5/10,34.58%,CCT7;CCT4;WRAP53;CCT8;CCT5
prerank,piRNA metabolic process (GO:0034587),0.39212496192491386,1.0946450933549843,0.33248730964467005,0.641011581600428,1.0,3/19,9.54%,TDRD12;TDRD9;PIWIL4
prerank,rRNA 3'-end processing (GO:0031125),-0.47205508617740566,-1.0942952457147026,0.3533697632058288,0.5071181863841379,1.0,3/10,8.01%,ERI3;RPS21;ERI2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.3925452797243473,-1.0935919774880145,0.3316239316239316,0.5082725983926307,1.0,10/20,33.09%,AGO2;ZC3H7B;PUM2;TSNAX;PUM1;TSN;ZC3H7A;SNIP1;DROSHA;SPOUT1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.38434508263846434,-1.0930665323631903,0.3356164383561644,0.5087277037995699,1.0,8/23,22.73%,BCL2;E2F1;YWHAE;BBC3;BID;CASP8;SFN;NMT1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.38434508263846434,-1.0930665323631903,0.3356164383561644,0.5087277037995699,1.0,8/23,22.73%,BCL2;E2F1;YWHAE;BBC3;BID;CASP8;SFN;NMT1
prerank,negative regulation of synaptic transmission (GO:0050805),0.3683105436784849,1.0926687501137824,0.3097949886104784,0.6447318128237736,1.0,6/23,19.02%,SLC24A2;MTMR2;SYT11;GRIK3;SHANK2;SLC24A1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.42929282482657194,-1.092626987594908,0.35602094240837695,0.5093218168327933,1.0,5/15,12.82%,ITGA5;VEGFA;JAK1;JMJD8;PKM
prerank,female gamete generation (GO:0007292),-0.3617875438335959,-1.0920471608209519,0.3351063829787234,0.5102076427102868,1.0,9/29,20.99%,DIAPH2;USP9X;MDK;MCM9;KMT2D;TOB2;MARF1;HORMAD1;DMC1
prerank,cellular response to glucose stimulus (GO:0071333),-0.3576707985855509,-1.091982745209901,0.31918505942275044,0.5100564900941895,1.0,8/30,11.54%,ERN1;IGF1R;TRA2B;RAB11FIP5;GAS6;ZBTB20;XBP1;RAB11B
prerank,protein tetramerization (GO:0051262),0.29206866128774855,1.0913405264874927,0.2739018087855297,0.6468205934941951,1.0,18/67,17.38%,RYR3;GRIN2B;CRYZ;CBY1;HOMER1;RYR1;HCN1;PKD1;ACACA;KCNJ12;GOLGA2;OSBPL2;CTH;GLS;HSD17B8;SNCA;ALDH1A3;TRPM2
prerank,necroptotic process (GO:0070266),-0.42011583392232604,-1.0910323932107606,0.3412969283276451,0.5117168597418907,1.0,8/16,28.86%,RIPK1;TLR4;LY96;TICAM1;MLKL;TICAM2;ITPK1;RIPK3
prerank,regulation of viral release from host cell (GO:1902186),-0.39806056251051714,-1.0906516273100904,0.3409490333919156,0.5121793371743112,1.0,9/21,26.76%,TSG101;TRIM11;CHMP2A;VPS4A;TRIM25;DDB1;CHMP2B;TRIM28;PML
prerank,muscle tissue development (GO:0060537),0.4373615842551539,1.0906460394453505,0.38106796116504854,0.6473698904508581,1.0,6/13,28.53%,CSRP1;SMO;PGM5;NF1;CSRP2;PTCH1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.457676512832931,-1.0905443472550098,0.3567567567567568,0.5121068078802222,1.0,1/12,0.16%,APOE
prerank,regulation of angiogenesis (GO:0045765),-0.2575978489433603,-1.0901279295467254,0.2586750788643533,0.5126770651487266,1.0,51/192,23.77%,SASH1;RUNX1;PRKCB;SP100;CCR2;STAB1;ROCK1;NIBAN2;AGO2;PLXND1;PPARG;BRCA1;FLT1;ITGB1;HHEX;SARS1;PF4;CTNNB1;GRN;VEGFA;EGLN1;HIF1A;CTSH;KLK3;SPRED1;SPRY2;ITGAX;XBP1;HTATIP2;SERPINE1;PIK3CD;CD40;BTG1;FOXJ2;PGK1;HSPB1;AGGF1;ADAMTS1;SFRP1;ZC3H12A;STAT1;JUP;KDR;APOH;FGF18;IL6;APLNR;SERPINF1;MTDH;HMOX1;CYP1B1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4741040275896814,-1.0898749426382033,0.3595890410958904,0.5129049397073762,1.0,2/10,3.37%,NFE2L2;RIPK1
prerank,chromatin assembly (GO:0031497),-0.3428495518604464,-1.0897849279218454,0.31239092495637,0.5127803929752881,1.0,11/38,18.84%,SMARCA5;ANP32B;ASF1A;HMGB2;SPTY2D1;PADI4;SART3;CHAF1A;RBBP4;BRD2;RSF1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.42400040456123084,1.0893546068326503,0.32904884318766064,0.6493979684560147,1.0,3/14,10.56%,ANK2;KCNIP2;ATP1B1
prerank,protein localization to cilium (GO:0061512),-0.35185768377667004,-1.089064661893033,0.3408695652173913,0.5139845043347183,1.0,15/32,36.10%,SNX10;IFT20;RABEP1;RAB29;ARL3;EHD1;IFT140;IFT122;ODAD4;TULP2;MAPK15;INVS;CSNK1D;WDR19;ROPN1
prerank,positive regulation of isotype switching (GO:0045830),-0.4227108230166937,-1.0889560449126425,0.3540587219343696,0.5139061931308007,1.0,5/15,23.39%,KMT5B;KMT5C;CD40;SHLD2;TGFB1
prerank,neutral amino acid transport (GO:0015804),-0.3586993894978241,-1.0886639311259039,0.3384879725085911,0.5141915504476612,1.0,8/28,19.24%,SLC38A6;SLC6A6;SLC43A2;SLC36A4;CTNS;SLC7A5;SLC6A9;SLC38A2
prerank,mRNA 3'-end processing (GO:0031124),-0.2953501325411987,-1.0885430283341986,0.3136288998357964,0.5141421951428734,1.0,32/78,32.71%,SRRM1;CHTOP;SSU72;CDC40;APP;ALYREF;MTPAP;RPRD2;NUDT21;WDR33;NCBP1;THOC2;RNPS1;TENT4B;THOC6;PAPOLA;MAGOH;SLU7;CPSF3;GRSF1;SRSF11;DDX39B;DHX38;CPSF1;U2AF2;SRSF7;EIF4A3;SRSF5;TUT1;POLR2D;SARNP;U2AF1L4
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.2907892390999372,-1.0880812881524558,0.3146964856230032,0.5147874265012752,1.0,13/86,13.27%,RBPJ;DAB2;ZEB2;SDCBP;CREBBP;RNF111;RBPMS;TGFBR1;TGFB1I1;FLCN;STK11;HSP90AB1;ACVR2A
prerank,regulation of cytoplasmic translation (GO:2000765),-0.4305652999446598,-1.088057509274026,0.3564189189189189,0.5145421866929839,1.0,5/14,13.46%,DHX9;CNBP;PKM;UNK;DHX36
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.27613594734457125,-1.0877483123666616,0.2721417069243156,0.5148406418361787,1.0,14/117,8.22%,LYN;FGR;CD163;SYK;PLCG2;GNB1;MYH9;ADCY7;PTGER4;MAPK14;GNG2;PLK2;CYSLTR1;RHBDF2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.37266425504322215,-1.0877267575076934,0.3333333333333333,0.5145878934123858,1.0,10/23,21.65%,NABP1;PLK2;ZWILCH;BUB1;PLK3;BUB1B;WEE1;CHEK1;VPS4A;ZFYVE19
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.32315140166510087,1.0875992399634868,0.2982885085574572,0.6526110163109123,1.0,10/43,12.31%,NELL1;SOX11;BMPR1B;ACVR1;YAP1;PRKD1;SUCO;BMP7;FERMT2;ATRAID
prerank,positive regulation of histone deacetylation (GO:0031065),-0.4560009049243182,-1.0875625934908075,0.37315875613747956,0.5146300930703187,1.0,8/12,35.16%,AKAP8;NIPBL;VEGFA;APLNR;AKAP8L;ZBTB7B;CTBP1;ING2
prerank,positive regulation of actin nucleation (GO:0051127),0.44024905751878807,1.08749516113611,0.36065573770491804,0.6516298346403103,1.0,4/11,10.85%,WASF1;ABI2;NCKAP1;GSN
prerank,camera-type eye development (GO:0043010),0.36363050740800645,1.0872439256062072,0.3037383177570093,0.6509942491142547,1.0,6/25,11.92%,CACNA1C;TENM3;WT1;TSKU;CEP290;HES5
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.38528649168524526,-1.0872320108853337,0.33797909407665505,0.5150132340438545,1.0,3/22,3.16%,APOE;PPARD;PPARG
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.4046078710199842,-1.0872165338016693,0.3363148479427549,0.5147551869235769,1.0,6/18,25.75%,SLC35F6;BID;HSPA1A;ACAA2;GSK3B;TMEM14A
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.4154755317376937,-1.0870343571039596,0.3588850174216028,0.5148443681704672,1.0,7/16,22.81%,KMT5B;PARP9;KMT5C;WRAP53;SHLD2;DTX3L;PRKDC
prerank,clathrin-dependent endocytosis (GO:0072583),-0.36586722163998087,-1.0870159194558588,0.325044404973357,0.5145916347949193,1.0,7/26,7.99%,ITSN1;SIGLEC1;CANX;ITSN2;FCHO2;PICALM;AP2A2
prerank,negative regulation of receptor internalization (GO:0002091),-0.45105336193544343,-1.0869479477166595,0.35906040268456374,0.5144319746161116,1.0,2/12,1.02%,SDCBP;RIN3
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.2743485256964684,-1.0863610954473375,0.2900158478605388,0.5153536710946822,1.0,19/116,14.30%,LYN;FGR;CD163;SYK;PLCG2;GNB1;MYH9;ADCY7;PTGER4;MAPK14;GNG2;PLK2;CYSLTR1;RHBDF2;SELENOS;FCGR2B;GLP2R;CALCA;ADCYAP1R1
prerank,amyloid-beta metabolic process (GO:0050435),0.40390496005541343,1.085461549714685,0.3491686460807601,0.6543175640532489,1.0,3/16,5.37%,MME;MGAT3;IDE
prerank,regulation of osteoclast differentiation (GO:0045670),-0.34938441985505264,-1.0852979732716346,0.34843205574912894,0.5172902830143669,1.0,5/33,8.36%,LILRB3;GPR137B;CCR1;TLR4;PRXL2A
prerank,positive regulation of angiogenesis (GO:0045766),-0.2800132072393448,-1.0850878508180744,0.28192371475953565,0.5174465369982638,1.0,22/108,14.29%,SASH1;RUNX1;PRKCB;ITGA5;AGO2;BRCA1;FLT1;ITGB1;GRN;VEGFA;MDK;JAK1;HIF1A;CTSH;ITGAX;XBP1;JMJD8;SERPINE1;PKM;PIK3CD;CD40;BTG1
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.39336001410719235,-1.0849892371764087,0.3548387096774194,0.5173662686172203,1.0,11/19,33.62%,PDCD6IP;CHMP5;CHMP1A;TPR;CHMP2A;HSPA1A;CHMP4B;CHMP2B;VPS4B;HSPA1B;DRG1
prerank,ceramide transport (GO:0035627),-0.4571870866111626,-1.0849593233764647,0.3626760563380282,0.517133991568206,1.0,3/12,5.92%,PSAP;PLTP;GLTP
prerank,positive regulation of histone methylation (GO:0031062),-0.3760184977922931,-1.0849441145154575,0.32798573975044565,0.5168718558275878,1.0,7/24,8.54%,OGT;BRCA1;CTR9;CHTOP;CTNNB1;JARID2;WDR5
prerank,regulation of cartilage development (GO:0061035),0.39027322567719136,1.0845499862647634,0.35697940503432496,0.6553170442687336,1.0,7/18,12.14%,BMPR1B;SOX5;SOX6;SOX9;MBOAT2;BMP1;TAPT1
prerank,regulation of filopodium assembly (GO:0051489),0.3317689710151854,1.0843843931759092,0.2951219512195122,0.6545049459726276,1.0,4/38,1.83%,NLGN1;TENM2;TENM1;GPM6A
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3149372722824876,-1.0837986010712235,0.3305227655986509,0.518941435606026,1.0,21/54,33.33%,OGT;ARRB2;RPL11;ARRB1;CTNNB1;DNAJA1;SPRY2;PRMT3;ISG15;HSPA1A;SMAD7;RPS3;UBXN1;HDAC8;RPL5;U2AF2;COPS9;SQSTM1;CAV1;HSPA1B;PRR7
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2596921147243096,-1.0837286347171124,0.28139904610492844,0.518794027216147,1.0,36/172,16.22%,INPP4A;PLCG2;PI4K2A;DDHD1;PIK3R5;MTM1;DGKZ;CSNK2A1;PIP4K2A;SLC27A1;TAMM41;SYNJ1;MTMR3;MTMR14;PITPNM1;CEPT1;PI4K2B;PLD2;PIK3CB;GPD1;PIK3CG;DGKD;PI4KB;RAB5A;IMPA1;MTMR6;PIK3CA;ABHD5;CPNE3;PIK3CD;AGPAT1;PLA2G4A;PIK3C2A;PLEKHA2;DGKG;CLN3
prerank,gland development (GO:0048732),0.2977872869521283,1.083575973455909,0.31265508684863524,0.655283005776815,1.0,16/59,16.75%,NRG1;PAX8;PRKCSH;WT1;FGF10;SOX9;HOXD3;COBL;CDK5RAP3;SALL1;TBX1;ARHGAP35;HES1;EPHB3;IGSF3;TGFBR3
prerank,positive regulation of ERAD pathway (GO:1904294),-0.43339734153275367,-1.0835202215826656,0.3397548161120841,0.5189230219873797,1.0,9/13,33.77%,NFE2L2;ATXN3;RNF185;TMEM259;SGTA;BAG6;CAV1;RNFT1;UBQLN2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.36249763760721265,1.0829874365421048,0.32235294117647056,0.6555178382834269,1.0,5/24,3.44%,DSCAM;SEMA6D;SEMA6A;SEMA3E;SEMA5A
prerank,motile cilium assembly (GO:0044458),0.4328367126519543,1.0823890191484002,0.36342042755344417,0.655832803947352,1.0,1/12,0.58%,DNAAF3
prerank,cellular response to amyloid-beta (GO:1904646),-0.3439691642783672,-1.0822862934920445,0.3105263157894737,0.5211787313250413,1.0,11/35,12.80%,ITGA4;IGF1;LRP1;CD36;IGF1R;TLR4;SNX6;CASP4;ABCC1;APP;FCGR2B
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3717579475619898,-1.0820170806737455,0.3500931098696462,0.5214438419940531,1.0,4/25,4.68%,PRKCD;ARHGAP24;CAPZB;STAP1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.46269217002244223,1.081898382634779,0.3914027149321267,0.6558837731096716,1.0,3/10,5.46%,SEMA5A;CARMIL1;CARMIL2
prerank,autophagy of nucleus (GO:0044804),-0.4164134265007837,-1.0818843472977784,0.36468646864686466,0.5214231115328766,1.0,4/16,13.61%,ATG5;ATG7;ULK2;RB1CC1
prerank,regulation of transmembrane transport (GO:0034762),-0.3535560965407311,-1.0818012433496988,0.3374558303886926,0.5213096038354054,1.0,6/31,5.01%,PRKCB;WWP2;SLC2A1;PIM1;ACTB;BCL2
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.2890995397176388,-1.0816496083595442,0.3021346469622332,0.5213587082048622,1.0,24/85,24.64%,MTSS1;IGF1;CDK6;NUPR1;RUNX3;C5AR1;GRN;VEGFA;NME1;B2M;OSR1;NLRC3;UHRF1;NR4A1;LIMS1;NOD2;SFRP1;FGF18;PRKDC;TGFB1;DEAF1;FGF9;MYC;PKHD1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.4112217849739732,-1.0815928090730969,0.3824561403508772,0.5211791538453737,1.0,5/15,20.84%,RNF213;ZNRF3;SPEF1;RSPO3;SFRP1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.36747792432602333,-1.0815069390219316,0.3522935779816514,0.5210729418522565,1.0,6/26,9.70%,ALPK1;IRAK2;TAB2;NOD1;UBC;RPS27A
prerank,regulation of cellular protein localization (GO:1903827),0.3172019483300613,1.081413298112253,0.30424528301886794,0.6558323978140864,1.0,7/45,8.44%,MAP2;GPC6;GPC5;EGF;BDNF;TOR1A;TRIM46
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.3623368159059415,-1.081328971092322,0.3442340791738382,0.5211193119464438,1.0,7/28,10.48%,IRAK2;TAB2;NOD1;OTULIN;UBC;RPS27A;RELA
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.37341965790944853,-1.080983352048259,0.3339449541284404,0.5215545717698923,1.0,8/24,20.30%,IGF1;INSR;DYRK2;SELENOS;PPP1R3E;IRS2;ENPP1;GSK3B
prerank,phosphate ion transport (GO:0006817),-0.42119048909742335,-1.0806575034546675,0.3774597495527728,0.5219302327666723,1.0,6/16,30.89%,SLC37A1;XPR1;SLC20A2;SLC25A10;SLC37A2;SLC20A1
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.4295116357830955,-1.0800576439092713,0.35233160621761656,0.5228698087282057,1.0,7/13,32.17%,ENTPD6;ENTPD3;ENPP1;NUDT15;SMPDL3A;DCTPP1;ENTPD7
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.4718056454804693,-1.079683676432915,0.3787085514834206,0.5233804489980792,1.0,3/10,20.25%,CCR2;CCL5;WNK1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.23984580207164669,-1.0795962080372479,0.2318840579710145,0.5232740510724743,1.0,66/348,14.39%,PID1;RBPJ;MITF;IGF1;MSN;CD74;LILRB1;P2RX7;PLCG2;CD36;ROCK1;AGO2;NFE2L2;INSR;ANXA2;BRCA1;ARRB2;STAT3;TLR4;STAP1;PTPN22;TBC1D5;MAPK14;PF4;RPL11;PIK3CB;FN1;ARRB1;GAS6;WFS1;VEGFA;MAP2K5;E2F1;LAPTM5;MYD88;TGFBR1;CD28;HIF1A;CD63;MEF2C;CTSH;SERPINB9;MAPK7;EGR1;SCRIB;SPRY2;ITGAX;MOV10;MTPN;APP;MYOM1;RESF1;OSR1;MAP2K1;TICAM1;CELF1;RAB29;CD46;TNRC6C;PIK3CD;DHX36;CALCOCO1;GREM1;SETDB1;KLF2;ID2
prerank,positive regulation of catabolic process (GO:0009896),-0.30370268713552917,-1.0784427776337941,0.32046979865771813,0.525225658301865,1.0,13/65,12.52%,WWP1;RAB7A;CSNK2A1;WWP2;RNF41;AREL1;ATG7;TIPARP;AXIN1;PLK2;NEDD4L;ASB5;STX5
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.3308240923183244,1.0782382991936699,0.3236009732360097,0.6626642729765517,1.0,5/33,7.01%,PRKG1;IGFBP5;TAFA5;APOD;APLN
prerank,protein O-linked glycosylation via serine (GO:0018242),0.45486663281241385,1.0782048140264955,0.36342592592592593,0.6615211373097011,1.0,3/10,12.07%,GALNT13;GALNT16;POGLUT3
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.35138131342460355,-1.0780758136235968,0.33558178752107926,0.5257278722868307,1.0,5/29,7.95%,AGO2;TUT7;ZC3H7B;SRRT;PUM2
prerank,regulation of cell cycle phase transition (GO:1901987),-0.28518421751780787,-1.0780293346758805,0.31095406360424027,0.5255281598420103,1.0,28/91,24.97%,PSME4;PSMB7;ANAPC1;PSME3;PSMB9;PSMA8;PSMC3;DBF4;CDK1;PSMD8;BUB1B;PSMC4;PSMB10;TFAP4;PSMA1;UBE2C;PSMB8;ANAPC7;TRIM39;PSMA5;PSMD4;PSMB3;PSMD3;TCIM;GTSE1;CCNB1;PSMB1;DDB1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.41391268179074503,1.0779788129268342,0.37825059101654845,0.6608839038695289,1.0,6/13,21.70%,SORBS1;PRKCZ;IGF2;IRS1;SIRT1;SORL1
prerank,cellular response to hydroxyurea (GO:0072711),-0.46226410508282434,-1.07789852056828,0.38267148014440433,0.5255143035996597,1.0,5/10,15.34%,SPIDR;BLM;DDI2;TIMELESS;NSMCE3
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.35795619881635693,-1.0777739253491754,0.36502546689303905,0.5254852330177447,1.0,10/28,22.81%,ACTR2;ERCC6;KMT5B;PARP9;KMT5C;TFIP11;WRAP53;SHLD2;DTX3L;PRKDC
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.3704533544665114,-1.0774844838586042,0.35294117647058826,0.5257606220280476,1.0,5/24,7.30%,MCL1;NUPR1;FOXO3;CTNNB1;GRN
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4442953598612372,-1.0765975114305342,0.36952714535901926,0.527282461811352,1.0,5/12,22.40%,SEC63;GET3;SGTA;CHMP4B;CHMP4A
prerank,protein localization to organelle (GO:0033365),-0.2677698841314098,-1.076331876073432,0.2820097244732577,0.5275205979884365,1.0,46/133,26.97%,SNX10;DCP1A;OPTN;IFT20;LAMP2;DHX9;COG7;HHEX;RPL11;LAMP5;GBP5;DNAJA1;SYS1;YWHAE;TRAM2;GBP2;PACSIN2;PAQR3;APP;LAMP1;TSPAN17;SERP1;STX5;ARL3;EHD1;UBAC2;TOR1AIP1;DDX1;ISG15;ARL1;DDX3X;RAB11A;LMBRD1;SGTA;ZBTB7A;TOPORS;TRAM1L1;HMOX1;MICALL1;IFT140;LMNA;RAB35;CYB5A;ARFRP1;OTOF;VAPA
prerank,respiratory system development (GO:0060541),-0.34613930698242146,-1.075509554494727,0.32094594594594594,0.5289969236801179,1.0,18/32,42.78%,VEGFA;CCDC40;ITGA3;BAG6;CHD7;FGF9;RBP4;DNAAF1;WNT7B;PDPN;ABCA3;FGF2;SMCHD1;STRA6;DISP1;LOXL3;FGF7;BASP1
prerank,peptidyl-methionine modification (GO:0018206),0.43768546621785903,1.0754323211826577,0.35365853658536583,0.6663363361856179,1.0,5/12,19.36%,METAP2;NAA60;METAP1;PDF;NAA30
prerank,response to nitric oxide (GO:0071731),0.43323752355557243,1.0752925599861876,0.3728813559322034,0.6654638757809728,1.0,2/13,2.89%,KCNC2;GUCY1B1
prerank,second-messenger-mediated signaling (GO:0019932),-0.2893595345449866,-1.074967967112782,0.3137254901960784,0.5297867889100359,1.0,13/82,10.64%,APOE;MCTP1;CCR2;PLCG2;CD36;P2RX4;HTR2B;CCR1;DGKD;CAMKK2;HRH1;INPP5A;AGT
prerank,mesonephros development (GO:0001823),0.44260368682754314,1.0747039654226345,0.35648148148148145,0.6657407485275064,1.0,3/11,8.65%,PAX8;FGF10;BMP7
prerank,glial cell development (GO:0021782),-0.36622683271632106,-1.0746453274956242,0.36155202821869487,0.530166633401602,1.0,10/25,28.48%,CDK6;NRROS;EIF2B3;MDK;APP;SOX10;EIF2B1;MT3;EIF2B2;EIF2B4
prerank,mitochondrion localization (GO:0051646),-0.39266447717071895,-1.0739642133376137,0.36180904522613067,0.5312390601066531,1.0,3/19,2.65%,TRAK1;MEF2A;MTM1
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.36891974466836563,-1.0737645663834863,0.3408304498269896,0.5313743905028274,1.0,4/25,5.85%,CBL;PPARG;SNX6;TSG101
prerank,negative regulation of mRNA processing (GO:0050686),-0.41783075886908494,-1.073660046546227,0.3616298811544992,0.5312781366602572,1.0,7/15,33.98%,SRSF10;RNPS1;C1QBP;PCBP4;U2AF2;SRSF7;BARD1
prerank,peptidyl-amino acid modification (GO:0018193),0.4480985038516553,1.0733049636738599,0.3581395348837209,0.6680891918444521,1.0,3/10,15.43%,METAP2;METAP1;PDF
prerank,negative regulation of cell cycle (GO:0045786),-0.2909841464020941,-1.0721143832409734,0.30655737704918035,0.5342274924902344,1.0,17/73,16.25%,LILRB1;CDK6;RB1;NUPR1;RUNX3;IPO5;SIPA1;HHEX;TAF6;INCA1;SCRIB;CDK5RAP1;CHMP1A;TFAP4;BTG1;LATS2;NR4A1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.42968887233081665,-1.0721024525139928,0.3637901861252115,0.5339570615666613,1.0,4/13,10.48%,PPARD;PPARG;NFATC3;RELA
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.43229131022256795,-1.071793297472983,0.3996383363471971,0.5343394998435462,1.0,4/14,13.39%,RHOA;MAP2K5;ITGB1BP1;HDAC5
prerank,response to sterol (GO:0036314),0.4386314390198761,1.0716486020668716,0.37317073170731707,0.6710999041046328,1.0,3/11,12.48%,RORA;INSIG1;RORC
prerank,negative regulation of cellular process (GO:0048523),-0.2306716396976437,-1.0715841755537683,0.21522693997071743,0.534483722076429,1.0,155/521,26.76%,LYN;PLXNC1;VPS13C;SP100;ABI1;LILRB1;ARID2;BCL6;CDK6;MYH9;RB1;SNX3;NIBAN2;PTPRJ;NUPR1;RUNX3;TNFRSF1B;BRD7;PLXNA1;SIPA1;APBB2;PLXND1;LPXN;CD9;ATG5;HTR2B;S100A11;RNF41;PTK2B;RARG;BCL2;ANP32B;CRLF3;TGFBI;RIPOR2;BLM;NR1H2;TXNDC12;CBFA2T3;SMYD2;TNFRSF21;TAF6;IFI35;UBR2;CTNNB1;WFS1;SKI;NF2;CBLL1;NME1;EIF2AK2;SIRPA;MDK;BST2;GSDME;ITGB1BP1;TGFB1I1;PTPN6;INCA1;CDKN3;APP;STRN;FLCN;OSGIN1;CHMP1A;MAP2K1;KLF10;CELF1;STK11;IGFBP3;ADAM15;EEF1E1;TMBIM6;CCDC85B;CIB1;FCGR2B;FRK;SPEF1;TFAP4;MIA3;ANXA6;BTG1;CHMP2A;RASA1;EI24;PPP1R9B;SPN;TMEM109;NR4A1;APPL2;KLF11;RBBP4;SPHK2;VHL;BNIP3L;HSPA1A;TOB1;ATF5;CDKN2C;GATA3;PDCD5;COL18A1;DDX3X;MDM4;ENPP1;BMPR2;LPCAT3;TXNIP;NME6;ADAMTS1;BAP1;SIRT2;PDS5B;SFRP1;COPS8;GNRH1;PPT1;RACK1;NUP62;IFITM1;CGRRF1;INHA;CHMP4B;BECN1;IL6;CRYAB;BNIPL;ESR2;SOX7;TGFB1;PIM2;GPLD1;CYP1B1;TES;LMNA;RND1;FTH1;MYC;NUDT6;PKHD1;SMYD5;ACTN1;CCN4;PRTN3;P3H1;TPTE;MT3;NCK1;CCN2;SMAD4;BMP2;PDE8A;CASK;RAPGEF2;PML
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3805352944146363,-1.0712369049889474,0.36006825938566556,0.5349169565950557,1.0,5/22,13.46%,MED24;PSMC3;MED4;PSMC4;DHX36
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.30123260511917316,-1.0708706775293269,0.33774834437086093,0.5353812874433791,1.0,31/64,35.22%,AFF4;NELFB;CDK13;CTR9;POLR2H;POLR2F;POLR2L;ELOF1;POLR2A;NCBP1;POLR2G;ELP4;ELOC;RTF1;POLR2I;CCNK;GTF2F2;GTF2F1;SSRP1;NELFE;POLR1E;ELOA;MNAT1;SETD2;POLR2D;NELFA;CDK12;GTF2H1;ERCC2;POLR2B;CDK7
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.35398436571592334,-1.0703844886421274,0.3475177304964539,0.5361188586600992,1.0,10/31,21.34%,DCP1A;PATL1;EXOSC5;DCP2;POLR2G;LSM6;CNOT8;DDX6;LSM5;EXOSC4
prerank,carbohydrate homeostasis (GO:0033500),-0.29970813990222106,-1.0701665882069882,0.3218588640275387,0.5362555996043683,1.0,19/67,25.94%,INSR;IGF1R;PPARG;STAT3;ADIPOR1;RPS6;WFS1;STK11;APPL2;TENT4B;CYB5R4;SLC8B1;KCNB1;PYGL;IL6;PAX6;RBP4;FGFR4;INPP5K
prerank,limb morphogenesis (GO:0035108),-0.39048852883451124,-1.0700482794124713,0.3528399311531842,0.5361941238830696,1.0,4/20,7.78%,MBNL1;NIPBL;LRP6;SKI
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.25907104503343337,-1.0698892854859932,0.3047619047619048,0.5362361460779672,1.0,46/166,22.96%,RBPJ;NOTCH2;CREBBP;PPARD;PPARG;SMARCA5;MAML1;GTF2A1;MAML2;E2F2;RARG;NR1H2;TAF6;TBL1XR1;NR2F1;POLR2H;POLR2F;E2F3;POLR2L;NRBF2;HDAC10;HDAC5;GTF2E2;RXRA;POLR2A;TFAM;TAF4B;TAF8;NR4A1;POLR2G;TAF9;TAF3;RARA;TAF1A;POLR1F;NR3C1;NCOA6;TAF4;RSF1;MAML3;MAZ;POLR2I;GTF2F2;GTF2A2;NR1H4;ESR2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.4151299390433707,1.0693896089181465,0.3617021276595745,0.6758271179329358,1.0,3/14,3.06%,SLIT2;PRKG1;IGFBP5
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3817246142746646,-1.068873329584108,0.362876254180602,0.5380039590096937,1.0,6/22,13.88%,MAN1C1;AMFR;UBC;RPS27A;SEL1L;RNF185
prerank,axonal transport (GO:0098930),-0.3367934448213704,-1.068471440495705,0.3474576271186441,0.5386121365371963,1.0,14/36,20.75%,KIF3B;DYNC1H1;FBXW11;AP3S1;KIF4A;HIF1A;RAB21;AP3M1;DCTN1;DTNBP1;AP3B1;AP3D1;PAFAH1B1;AP3B2
prerank,mitotic nuclear membrane organization (GO:0101024),-0.3124350517876159,-1.0682191558127223,0.34125636672325976,0.5385463744156717,1.0,21/51,26.26%,NUP205;CHMP7;CDK1;NUP188;LEMD2;CHMP2A;ANKLE2;UBE2I;RCC1;NUP35;VPS4A;SIRT2;NUP107;REEP3;CHMP4B;CHMP4A;CCNB1;LMNA;CCNB2;CHMP2B;NUP37
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.3124350517876159,-1.0682191558127223,0.34125636672325976,0.5385463744156717,1.0,21/51,26.26%,NUP205;CHMP7;CDK1;NUP188;LEMD2;CHMP2A;ANKLE2;UBE2I;RCC1;NUP35;VPS4A;SIRT2;NUP107;REEP3;CHMP4B;CHMP4A;CCNB1;LMNA;CCNB2;CHMP2B;NUP37
prerank,regulation of axon guidance (GO:1902667),-0.4702051460706507,-1.068155307075136,0.3794266441821248,0.5383683959828304,1.0,4/10,15.65%,NRP1;ZSWIM8;VEGFA;ZSWIM6
prerank,regulation of centriole replication (GO:0046599),-0.3949940656566736,-1.0678974578531049,0.35951134380453753,0.5386084209305525,1.0,9/17,27.54%,BRCA1;CEP295;PLK2;CEP295NL;RBM14;STIL;NUP62;ALMS1;MDM1
prerank,dicarboxylic acid transport (GO:0006835),0.352867279370529,1.0675790577708395,0.34545454545454546,0.6793930775405024,1.0,7/28,14.88%,SLC1A2;SLC1A6;SLC1A1;SLC13A5;SLC26A8;FOLR1;FOLR2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4327292655975714,-1.0675187216830895,0.38169257340241797,0.5391115530237712,1.0,6/14,22.61%,FLNA;ITGB1BP1;CD63;BST1;LIMS1;PHACTR4
prerank,cellular response to alkaloid (GO:0071312),0.3966429260915091,1.0674442917179932,0.3469879518072289,0.678462990767077,1.0,6/17,12.36%,RYR3;RYR2;CASQ2;RYR1;CASP6;HTR1B
prerank,sensory perception of pain (GO:0019233),-0.3817043477238593,-1.067405753849897,0.3673835125448029,0.5390426669860571,1.0,3/21,2.65%,CCR2;P2RX7;P2RX4
prerank,glycosaminoglycan metabolic process (GO:0030203),0.30140451374431104,1.0672523973075607,0.3556581986143187,0.6777225578700998,1.0,9/54,7.02%,HS3ST6;HS3ST5;GPC6;GPC5;HS6ST2;PXYLP1;HS3ST1;SDC1;B3GAT2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3740978361144819,-1.0672057999024103,0.3486394557823129,0.539161967253917,1.0,8/24,21.24%,NFE2L2;GAS6;MAPK7;TNIP2;SERPINE1;GATA3;NDNF;KDR
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.4148268398760575,1.0669958333386198,0.381294964028777,0.6771399587135555,1.0,7/13,23.08%,SAR1B;BCAP31;TMEM30A;TM9SF4;CD81;SORL1;SEC16A
prerank,regulation of spindle organization (GO:0090224),-0.39868179078278415,-1.0668797740963867,0.36900369003690037,0.5394991141102107,1.0,5/18,11.23%,DYNC1H1;RAE1;RNF4;TPX2;DCTN1
prerank,muscle contraction (GO:0006936),0.25823314213764126,1.0668555873817356,0.32904884318766064,0.6762866800040149,1.0,21/126,13.03%,SORBS1;DMD;DTNA;GLRA1;GNAO1;CASQ2;TNNI1;ACTA1;KCNIP2;MYL12B;OXTR;TNNT2;RYR1;MYH7;TTN;CALD1;MYLK;DYSF;CALM1;ADRA1A;KCNJ12
prerank,regulation of sequestering of calcium ion (GO:0051282),0.42140746864217304,1.0661100454655446,0.3817733990147783,0.677053213947678,1.0,3/12,5.76%,ANK2;RYR2;CASQ2
prerank,TOR signaling (GO:0031929),-0.36291543334772514,-1.065968644557028,0.3736842105263158,0.5411205704814284,1.0,7/26,11.72%,CARD11;RPS6;FNIP1;EIF4EBP1;EIF4EBP2;FLCN;CCDC88A
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.34630702319380285,-1.0655960996592497,0.38421052631578945,0.5416107229125051,1.0,15/32,22.49%,PRKCD;ROCK1;FOXO3;TMED10;PUM3;PICALM;PCIF1;MTPN;APP;NOLC1;EIF2A;RBM4B;RBM3;SAMD8;NR1H4
prerank,regulation of DNA replication (GO:0006275),-0.3150364759033227,-1.0649098807606872,0.36971830985915494,0.542664781220376,1.0,11/49,17.64%,BCAR3;S100A11;DHX9;BLM;NUCKS1;PCNA;CCDC88A;ORC5;KAT7;FAF1;DNA2
prerank,cellular response to organic substance (GO:0071310),0.26140040676248266,1.064777899138641,0.31070496083550914,0.679280108423369,1.0,13/116,5.82%,IL1RAPL1;AKAP6;ROBO2;NCOA2;SLIT3;SLIT2;BMPR1B;IGFBP5;CSF1R;MME;ACVR1C;ACVR1;RAMP3
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.37735488659190564,-1.0647487381488387,0.3606837606837607,0.5424203723230011,1.0,7/22,24.44%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;GOLGA7;ZDHHC6
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.37735488659190564,-1.0647487381488387,0.3606837606837607,0.5424203723230011,1.0,7/22,24.44%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;GOLGA7;ZDHHC6
prerank,histone H2B ubiquitination (GO:0033523),-0.47799772933337115,-1.0643589323395286,0.3883333333333333,0.5429026199648463,1.0,7/10,30.27%,CTR9;RNF20;RNF8;WAC;DTX3L;RNF40;UBE2E1
prerank,regulation of transposition (GO:0010528),0.41690946532417283,1.0643252756654453,0.3755868544600939,0.6792244473893725,1.0,3/13,9.54%,TDRD9;AICDA;PIWIL4
prerank,negative regulation by host of viral transcription (GO:0043922),-0.4366739123759282,-1.0642369330317691,0.39045936395759717,0.5428672747455476,1.0,6/12,25.94%,JUN;PSMC3;CCL5;TFAP4;TARDBP;INPP5K
prerank,ear morphogenesis (GO:0042471),0.3744381320474349,1.0641591981352139,0.37028301886792453,0.6784309177025484,1.0,5/20,12.82%,PAX8;MYO6;TFAP2A;TBX1;TMIE
prerank,cognition (GO:0050890),0.31555290093507876,1.0638493551551498,0.3230769230769231,0.678020198469824,1.0,13/42,17.93%,GRM5;SHROOM4;MGAT3;CUX2;HRH3;TTC8;SOBP;SLC8A2;MFSD2A;LINS1;CHRNA7;TUSC3;FAM107A
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.4438964429961475,-1.0637026222658787,0.38219895287958117,0.5436220556095038,1.0,5/12,34.58%,CCT7;CCT4;WRAP53;CCT8;CCT5
prerank,regulation of mitotic spindle organization (GO:0060236),-0.33720143325812646,-1.063416554535385,0.35855855855855856,0.543934072429469,1.0,12/35,22.39%,PDCD6IP;CHMP5;DYNC1H1;RAE1;TPX2;DCTN1;CHMP1A;TPR;CHMP2A;HSPA1A;NUP62;CHMP4B
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.3659617184050625,-1.063118173058451,0.3674911660777385,0.5442674246934642,1.0,9/23,31.54%,PREB;SELENOS;DERL1;SEL1L;HSP90B1;FAF2;VCP;RANGRF;AUP1
prerank,regulation of cytoplasmic transport (GO:1903649),-0.44374366057214565,-1.0627194609779504,0.3819444444444444,0.5448028549065467,1.0,4/11,22.16%,DNAJC13;MAP2K1;USP7;MAPK1
prerank,negative regulation of insulin secretion (GO:0046676),0.3857886941001019,1.0625021573733864,0.3747072599531616,0.6801016049536643,1.0,6/17,14.92%,CCN3;REST;PRKN;INHBB;KLF7;IRS1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.41237897812506735,-1.062483388656821,0.36789297658862874,0.5450067921908422,1.0,4/16,17.87%,NUDT2;IMPDH2;ADSS1;PFAS
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.39893008161300403,-1.0624285953798531,0.37372013651877134,0.5448148543353475,1.0,10/18,45.93%,HHEX;THOC2;ENY2;NUP133;SARNP;ZC3H11A;PABPN1;PCID2;POLDIP3;DDX25
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4389142185420859,-1.062001636729321,0.3900343642611684,0.5454606373000075,1.0,1/13,0.03%,PID1
prerank,regulation of trophoblast cell migration (GO:1901163),-0.4203115296923904,-1.0617877935947169,0.3973288814691152,0.5456186149938466,1.0,3/14,7.83%,YTHDF3;AGO2;VEGFA
prerank,negative regulation of developmental process (GO:0051093),0.28134797070349765,1.0616364970583227,0.33070866141732286,0.6810094724853903,1.0,16/69,15.62%,OMA1;DCC;GRIN3A;NFIB;RPS6KA6;ARHGEF15;SOX9;KANK1;POU4F2;TBX1;ALPK2;HYAL3;PRKN;PTPRS;KLF7;FUZ
prerank,negative regulation of signal transduction (GO:0009968),-0.24363948365843913,-1.0614023050865746,0.3022556390977444,0.5460991733995469,1.0,57/249,21.87%,PID1;LYN;PTPRC;PRKCB;LRP1;XDH;PLEK;PRKCD;RB1;NIBAN2;PTPRJ;CSNK2A1;PIP4K2A;WWP2;HERC4;CNOT1;PTPN12;PTPRE;HHEX;BCL2;MDFI;PIK3CB;ARRB1;MGRN1;IRAK3;EZH2;SULF2;TRIB1;ASXL1;SPRY2;AGT;IGFBP3;TMBIM6;CCL5;NFKBIL1;ARRDC1;RGS14;RNF43;OTUD4;BRAP;GPR108;TMEM25;NFATC1;GATA3;ENPP1;SUFU;UBASH3B;CYP26C1;APPL1;MAZ;PTPN1;SFRP1;RACK1;MEGF8;ZBTB7A;SNAI2;SOCS5
prerank,MAPK cascade (GO:0000165),-0.23769864304889454,-1.0613729386814208,0.2946708463949843,0.5458665671088376,1.0,98/295,24.85%,MAP3K8;MAP3K5;TAOK3;IGF1;GRB2;RASA3;MEF2A;CSF2RA;MAP3K20;PSME4;MINK1;ABHD17C;MAPKAPK2;HTR2B;RASGRP4;PSMB7;IL18;PSME3;NFKB1;ITGAV;FBXW11;RGL2;PTGER4;PSMB9;PIK3CB;HGF;CAMKK2;FRS2;JAK1;YWHAE;MEF2C;CTSH;PSMA8;UBC;RPS27A;SPRED1;TNIP2;TAOK1;PSMC3;PAQR3;IL2RG;RASAL3;DUSP6;CDK1;MAP2K1;PIK3CA;CSF2RB;PSMD8;CCL5;KSR1;PSMC4;PSMB10;PSMA1;IKBKB;RASA1;KARS1;IL31RA;BRAP;PSMB8;IL2RB;IRS2;KRAS;NRAS;PDE6D;RASA4;IL17RD;PDGFRB;TAOK2;DUSP5;LGALS9;PSMA5;PSMD4;PSMB3;RGL3;PSMD3;GOLGA7;KDR;PDGFA;MAP4K4;LYPLA1;MAPK1;FGF18;PTPN7;PPP1CC;SPTAN1;KITLG;TGFB1;PPP1CB;IL2RA;MAP3K3;PSMB1;FGF9;FLT3;SHC1;RASA2;MYC;RCE1;FGFR4
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2947883231697815,1.0613531127298101,0.34375,0.6805636260160338,1.0,18/59,17.23%,OSBPL6;SLC27A2;OSBPL7;ACSM5;ACOX2;NDUFAB1;PER2;ACACA;HSD3B7;OSBPL2;ABCB11;ACOT8;HSD17B4;CYP39A1;HSD17B8;MLYCD;ACSM3;ALDH1A3
prerank,membrane repolarization during action potential (GO:0086011),0.4146250814520243,1.0609649214006152,0.34988713318284426,0.6803756872331641,1.0,4/13,16.71%,KCND3;KCNIP2;ATP1B1;KCNE4
prerank,peptide hormone secretion (GO:0030072),0.35496573613935,1.0602786858535922,0.3640256959314775,0.6809378524363414,1.0,5/26,10.49%,RIMS2;MAFA;EDN1;GHRH;NEUROD1
prerank,folic acid metabolic process (GO:0046655),-0.38831469196184815,-1.0597622904489596,0.38803418803418804,0.5489175764739587,1.0,8/18,33.43%,MTHFS;MTHFD1L;MTHFD2L;MTHFR;SHMT1;FPGS;SLC19A1;MTHFD1
prerank,negative regulation of angiogenesis (GO:0016525),-0.28215264656306366,-1.0590075112363468,0.3333333333333333,0.5501734672214683,1.0,14/84,10.38%,CCR2;STAB1;ROCK1;NIBAN2;PPARG;E2F2;HHEX;SARS1;PF4;PIK3CB;CTNNB1;KLK3;SPRED1;SPRY2
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.43848161728310475,-1.0587036073694431,0.40384615384615385,0.5505191085257741,1.0,5/12,17.52%,CENPE;KIF2C;MAD1L1;NUF2;NDC80
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.44908667620863785,-1.0583904143579288,0.4169611307420495,0.5508455180204864,1.0,5/12,22.16%,LYN;BST2;IL34;CSF1;MAPK1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.3394850676075124,1.0574378298724276,0.34375,0.6870454044513978,1.0,7/29,9.24%,GRIK2;SHISA6;SLC4A10;SHISA9;NETO1;SLC8A2;CAMK2A
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.267578483849256,-1.056948838461368,0.33004926108374383,0.5535580528972692,1.0,39/117,31.70%,AOAH;IGF1;CD36;MTHFS;PPARD;PANK2;PPARG;KYNU;CPT1A;MTHFD1L;ME2;LPL;PDZD11;AGXT;BCO2;NPC1;SLC6A8;DLD;AMACR;ACOT2;SLC16A1;ACOT4;PDHB;AASDHPPT;ECHDC3;VDAC1;HLCS;PNPLA8;HOGA1;ACOT11;ALDH8A1;GPAT2;CYP2S1;SCP2;PTGR1;UGT1A7;UGT1A8;UGT1A1;SCPEP1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.3612959346008749,1.0561735197135047,0.3808411214953271,0.6891616770295954,1.0,8/23,20.94%,ELOVL7;FAR2;HACD1;ACSL3;ACSL6;ELOVL6;ACOT7;ELOVL2
prerank,positive regulation of ossification (GO:0045778),0.3217235565131377,1.05597947087837,0.3659090909090909,0.6884531813346414,1.0,11/39,12.31%,NELL1;SOX11;BMPR1B;PTN;ACVR1;GPM6B;ADGRV1;BMP7;TFAP2A;TGFB2;ATRAID
prerank,glucose homeostasis (GO:0042593),-0.2828590530036897,-1.055901270019702,0.3583617747440273,0.5554362470830293,1.0,22/83,25.94%,LRRC8D;INSR;IGF1R;PPARG;STAT3;ADIPOR1;RPS6;WFS1;HIF1A;NUCKS1;HK3;STK11;APPL2;CYB5R4;SLC8B1;KCNB1;PYGL;IL6;PAX6;RBP4;FGFR4;INPP5K
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.35970720144059454,-1.0557642004069656,0.3626760563380282,0.5554360799311538,1.0,7/25,18.86%,BCL2L11;PLAUR;MLLT11;BBC3;BID;TNFSF10;PDCD5
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.36045420360855757,-1.0556727489358713,0.3963963963963964,0.5553317673838668,1.0,7/24,16.92%,DNMT3A;SPI1;EZH2;JARID2;EED;EPC1;RBBP4
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3951167112667985,-1.0554017687225092,0.40998217468805703,0.5555747551993523,1.0,4/18,10.48%,ABCG1;GSAP;PICALM;RELA
prerank,negative regulation of lipid catabolic process (GO:0050995),0.3794457478829603,1.0551608980502571,0.36619718309859156,0.6894654382089471,1.0,3/17,10.94%,ALK;APOC1;MFSD2A
prerank,negative regulation of kinase activity (GO:0033673),-0.3013599026418499,-1.0546584366366136,0.3628620102214651,0.5567926970814003,1.0,10/62,10.21%,PTPRC;PAK2;RB1;PRKAG2;CEP85;LRP6;TRIB1;ITGB1BP1;TRIB2;SPRED1
prerank,body fluid secretion (GO:0007589),0.3993528572283343,1.0546474685135108,0.3700234192037471,0.6895686651082573,1.0,3/15,9.28%,ERBB4;APLN;OXTR
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.4030877863874516,-1.0545748173890037,0.3794266441821248,0.5566703759263109,1.0,5/18,12.13%,LILRB1;ITGAV;FN1;HIF1A;CD46
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4129302839969927,1.0544039414201496,0.3920595533498759,0.688951574037827,1.0,8/14,21.16%,ACOX2;EHHADH;ACOT8;ABCD1;DECR2;HSD17B4;CROT;ACOX3
prerank,mitochondrial transport (GO:0006839),-0.3088712445965407,-1.0543029771197525,0.37865748709122204,0.5569578304086993,1.0,21/53,29.09%,SLC25A24;BCL2;TMEM14C;PITRM1;BCS1L;FLVCR1;FIS1;TIMM44;TIMM22;SLC25A4;MAIP1;FBXO7;TOMM22;TOMM34;SLC25A13;TOMM70;TMEM14A;TOMM40;SLC25A31;BCL2L1;BNIP3
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3401180504218121,-1.0533965537730616,0.37985865724381623,0.5585261696031286,1.0,5/32,10.88%,APOE;PRKAG2;ADIPOR1;C3;ZBTB20
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.2948862715314111,-1.0531176754403566,0.3536379018612521,0.5588116347674906,1.0,6/66,1.97%,APOE;MTSS1;XDH;CDK6;NUPR1;RUNX3
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.3450806077686686,-1.0530033951323785,0.36741767764298094,0.5587467175126308,1.0,11/33,26.18%,RFC1;RTEL1;RAD51;PPP6R3;HSP90AB1;GAR1;SHQ1;WRAP53;NHP2;MRE11;DCLRE1B
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.3721949882917731,-1.0528917237294058,0.3670668953687822,0.5586959194979741,1.0,6/23,9.62%,MTM1;MTMR10;SYNJ1;MTMR3;PIP4P1;MTMR6
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.269848725181827,1.0522456741588453,0.3407960199004975,0.6934067249946578,1.0,19/95,11.27%,HS3ST6;HS3ST5;GPC6;GPC5;HS6ST2;CHSY3;PXYLP1;VCAN;HS3ST1;B4GALT4;DSEL;CHST5;SDC1;GLCE;CHST7;OMD;HAS2;CHST9;CHST14
prerank,thymus development (GO:0048538),0.41815839841967134,1.0522327812966052,0.3816091954022989,0.69221038924412,1.0,5/13,19.14%,FGF10;TBX1;HES1;EPHB3;FADD
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.4625434961015588,-1.0518988798805444,0.427797833935018,0.5604885876853088,1.0,2/10,9.89%,TLR4;NCKAP1L
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.3973292421860335,-1.0518132485811207,0.3944954128440367,0.5603640599951807,1.0,5/17,19.55%,PLBD1;PLA2G4A;PLAAT3;PLA2G5;PLA2G12A
prerank,positive regulation of vasculogenesis (GO:2001214),-0.45624757015796674,-1.051467830136372,0.39404553415061294,0.560755290070774,1.0,5/10,26.68%,RAP1A;RIN2;ASB4;KDR;RAPGEF2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.3761373117351326,-1.0513554658551274,0.39464285714285713,0.5606861589767126,1.0,5/20,13.28%,AGO2;CNOT1;MOV10;CELF1;TNRC6C
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.4287011971088861,-1.0509831572491468,0.40176991150442476,0.5611828737498713,1.0,8/13,40.63%,RPS21;NOP14;NOL9;RPP40;RCL1;TBL3;BMS1;KRI1
prerank,autophagosome assembly (GO:0000045),-0.3108628093101423,-1.0505864834375238,0.3701188455008489,0.5617410660033659,1.0,22/52,34.97%,RAB7A;ATG5;PACS2;ATG7;RAB1A;ULK2;RB1CC1;GABARAP;ATG16L2;EMC6;BECN1;VMP1;RAB19;RAB1B;SMURF1;TRAPPC8;ATG101;STX17;GABARAPL1;TP53INP2;UBQLN2;ATG9A
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.45309771608236693,-1.0498526740405953,0.4134948096885813,0.5630031054664131,1.0,4/10,20.02%,PTPN22;IFI35;WDFY1;TICAM2
prerank,negative regulation of neuron projection development (GO:0010977),0.2932386483803951,1.049487760415452,0.3401015228426396,0.6980311809493686,1.0,4/56,2.17%,NLGN1;SPOCK1;DCC;LINGO1
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.280616691082583,-1.0491709661307627,0.3640776699029126,0.5641312277100315,1.0,19/91,11.58%,PTPRC;NRP1;RAB8B;FGR;SYK;FES;ABL2;CD22;DNAJC13;ITGAV;PICALM;HIP1;RINT1;RAB5A;RAB21;PACSIN2;RAB3D;RAB11B;MAP2K1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.2970117604765131,-1.0487486655608331,0.35333333333333333,0.5647448447398178,1.0,30/62,35.22%,AFF4;NELFB;CDK13;CTR9;POLR2H;POLR2F;POLR2L;ELOF1;POLR2A;NCBP1;POLR2G;ELP4;ELOC;RTF1;POLR2I;CCNK;GTF2F2;GTF2F1;SSRP1;NELFE;ELOA;MNAT1;SETD2;POLR2D;NELFA;CDK12;GTF2H1;ERCC2;POLR2B;CDK7
prerank,negative regulation of locomotion (GO:0040013),0.41769116461794326,1.0486028928351687,0.37155963302752293,0.6989956797512711,1.0,2/12,1.70%,SPOCK3;FRMD5
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.3561684174788423,-1.0485731928860975,0.38738738738738737,0.5648095237585752,1.0,9/26,17.89%,MCL1;BCL2;EYA4;PF4;MAP2K5;MAPK7;EYA1;HSPA1A;EYA3
prerank,phospholipid dephosphorylation (GO:0046839),0.3200152408825071,1.0485525844474979,0.3471882640586797,0.6978999655911761,1.0,5/37,3.12%,PLPP4;MTMR2;PLPPR1;PLPPR4;SYNJ2
prerank,positive regulation of glucose import (GO:0046326),-0.3823513693444407,-1.048544015340968,0.4058219178082192,0.5645682215950902,1.0,4/21,6.47%,OSBPL8;IGF1;INSR;RHOQ
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.3833592281423972,-1.0481226917195783,0.3828264758497317,0.5651407313432171,1.0,5/20,10.16%,PACS2;BCL2;WFS1;FIS1;TGM2
prerank,regulation of ruffle assembly (GO:1900027),0.35500297396429437,1.0480404037371234,0.37819025522041766,0.6980910587386391,1.0,5/23,8.20%,NLGN1;FAM98A;P2RY12;CARMIL2;KANK1
prerank,hemidesmosome assembly (GO:0031581),0.43568555699297074,1.047951639544384,0.4074074074074074,0.6971163463211114,1.0,2/11,8.51%,DST;CD151
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.3616572680362325,-1.0479077738121896,0.3701657458563536,0.5653160322308902,1.0,7/23,24.84%,REXO4;DNASE1L1;HMGB2;DFFA;ENDOG;HMGB1;DNASE2
prerank,melanosome organization (GO:0032438),-0.3605097413906394,-1.04746040222974,0.3953488372093023,0.5659519264906898,1.0,7/26,17.11%,LYST;AP1G1;RAB32;RAB29;DTNBP1;AP3B1;AP3D1
prerank,negative regulation of protein depolymerization (GO:1901880),-0.35410971725703444,-1.0473306407274345,0.39198606271777003,0.56590761641508,1.0,9/24,15.02%,ATXN7;ARHGEF2;LIMA1;TPX2;TAOK1;PIK3CA;CIB1;SPEF1;STMN2
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.44727250085509085,-1.0464483109390557,0.41155234657039713,0.5674843056635285,1.0,5/11,25.69%,EXOSC5;TENT4B;EXOSC10;EXOSC4;LARP7
prerank,fluid transport (GO:0042044),0.435770284272899,1.0461970686264588,0.3972602739726027,0.7005113613897808,1.0,3/12,19.87%,SLC4A11;AQP11;AQP4
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.32065676950979866,-1.0456430160474448,0.40341880341880343,0.5689021977093172,1.0,9/44,11.72%,NRP1;RAC1;RHOA;CDC42;ARHGEF10;NF2;TGFBR1;ITGB1BP1;CCDC88A
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.37222707225227314,-1.0453986178217956,0.39750445632798576,0.5691240345772612,1.0,5/22,10.51%,ABCB7;HSCB;HSPA9;CIAO3;IBA57
prerank,aminoglycan metabolic process (GO:0006022),-0.4529704387480024,-1.0444452779854043,0.41206896551724137,0.5708659737086105,1.0,4/10,12.23%,XYLT1;B4GALT7;CLN6;XYLT2
prerank,protein monoubiquitination (GO:0006513),-0.3360937228142146,-1.0439790524642378,0.39767054908485855,0.5715418470092114,1.0,14/36,27.06%,CTR9;RNF20;UBE2R2;KLHL22;MGRN1;UHRF1;WAC;UBE2T;HUWE1;DTX3L;TRIM25;TOPORS;RNF40;CUL3
prerank,establishment of protein localization to organelle (GO:0072594),-0.2819706763705711,-1.0438563837859884,0.36394557823129253,0.5714794686511265,1.0,23/72,22.38%,SYK;IPO5;NUP50;STAT3;LAMP2;NUP88;LAMP5;E2F3;TPR;LAMP1;TSPAN17;NUP188;APPL2;NUP153;FAM53A;RAB11A;TNPO3;APPL1;NUP107;NXT2;NUP62;NEURL1B;SPRN
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3901154807654316,1.0437530107048563,0.3972286374133949,0.7056584256215445,1.0,4/17,11.99%,PCSK5;PCSK6;APOC1;ANGPTL3
prerank,ethanol metabolic process (GO:0006067),0.4225173691525238,1.0436755220609106,0.3932853717026379,0.7045981844295183,1.0,4/12,25.40%,ACSS2;ALDH1A1;ACSS1;ALDH2
prerank,regulation of RNA export from nucleus (GO:0046831),-0.4449139834051583,-1.0430173145101718,0.4165202108963093,0.5729694307258694,1.0,5/11,31.34%,DHX9;TPR;NUP153;AKAP8L;SETD2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.4168581366925648,1.0421942608552506,0.4117647058823529,0.707349952142706,1.0,4/12,11.17%,PAX8;GDNF;SOX9;SMO
prerank,glycerophospholipid catabolic process (GO:0046475),0.3391987526631128,1.0401469891582682,0.3834080717488789,0.7114529015464613,1.0,6/27,10.59%,ENPP2;ABHD16A;GDPD1;PLA2G4E;PLA2G10;ENPP6
prerank,proteolysis (GO:0006508),-0.23987409172820762,-1.0397946490214067,0.34222919937205654,0.5796037215065639,1.0,51/252,18.91%,CTSB;FAM111A;ADAM33;CTSD;CTSZ;ANPEP;OGT;PLAU;MALT1;SRGN;DPP4;CTSA;LNPEP;DDI2;HGF;PITRM1;PCSK7;PRCP;ATG4C;CTSC;RNF123;CASP4;RNPEPL1;CNDP2;CTSH;KLK3;PSENEN;CAPN15;F7;FAP;UBE3A;CPQ;CTSS;HTRA3;CASP7;CASP1;DPP7;PSMC4;FBXW2;CTSE;LAP3;HM13;CLN3;TPP1;ADAM19;VHL;CASP8;MMP8;XPNPEP3;MMP17;CASP2
prerank,positive regulation of transferase activity (GO:0051347),0.24671699586980575,1.0397312807955017,0.37467700258397935,0.7112738773100965,1.0,34/142,16.23%,ERBB4;NTRK3;EPHA6;NTRK2;EPHA7;EPHA5;CSF1R;MAGEC2;EPHB1;TIE1;MAP2K7;ALK;XRCC5;CD200;EPHA10;ROS1;CHTF8;LTK;FBXW7;TYRO3;RET;EPHB4;NAF1;DCUN1D2;BMI1;RPS2;IGF2;MAPKAPK5;HSP90AA1;CHRNA7;EPHB3;ERBB3;EPHA3;PNKP
prerank,inositol lipid-mediated signaling (GO:0048017),-0.3016754813654528,-1.0395981999263841,0.37349397590361444,0.5796876980123773,1.0,14/50,15.00%,IGF1;GAB2;RHOA;OGT;IGF1R;PLCL2;PIK3CB;PIK3CG;PI4KB;PIK3CA;PLCB3;PIK3CD;PLCD1;PIK3C2A
prerank,autonomic nervous system development (GO:0048483),0.38261086906434827,1.0394228167486785,0.3880952380952381,0.710876457418714,1.0,3/17,4.57%,PHOX2A;SOX11;GDNF
prerank,regulation of cellular localization (GO:0060341),0.3021066264942733,1.039331593348517,0.36910994764397903,0.7098907898351818,1.0,17/46,20.91%,MAP2;EFNA5;EPHA5;ADCY5;TRIM46;NR1D1;GSN;BRSK1;WWC1;PRKN;CSNK1E;HSP90AA1;REEP5;GOSR1;PARD6A;FER;TTL
prerank,histone H4 acetylation (GO:0043967),-0.3079125621645089,-1.0382847767351484,0.4236706689536878,0.5821325599902981,1.0,11/47,18.54%,OGT;PHF20;KANSL2;MORF4L1;ZZZ3;WDR5;JADE2;KAT7;EPC1;KMT2A;TRIM16
prerank,negative regulation of cellular component movement (GO:0051271),-0.40002444659085545,-1.0380626740685437,0.43031358885017423,0.5823160270022386,1.0,9/15,25.27%,SP100;CD9;PIN1;CCDC125;CRK;GATA3;PKHD1;ACTN1;SPINT2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.40203094310158904,-1.0378303177041788,0.4188034188034188,0.58249468253253,1.0,4/15,23.39%,LILRB1;IRAK3;SMAD7;TGFB1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.36954695221442824,-1.037780300321993,0.3960923623445826,0.5822922534777104,1.0,6/22,16.15%,IPO5;HHEX;INCA1;CDK5RAP1;TFAP4;LATS2
prerank,sprouting angiogenesis (GO:0002040),0.29505979379442926,1.0377606346556616,0.3783783783783784,0.712883639026964,1.0,8/51,7.80%,ROBO1;SLIT2;CDH13;SEMA3E;SEMA5A;VEGFD;PGF;ADGRA2
prerank,ATP transport (GO:0015867),-0.457609043659568,-1.0374282932833476,0.42105263157894735,0.5827052045747527,1.0,5/10,25.47%,SLC25A24;SLC25A42;SLC25A4;CD47;SLC17A9
prerank,sterol biosynthetic process (GO:0016126),0.319817585811642,1.0370855888901536,0.38990825688073394,0.7134914713546457,1.0,10/33,14.49%,HMGCS1;DHCR24;CYP51A1;INSIG1;SQLE;DHCR7;SC5D;EBP;MVK;LSS
prerank,cellular response to hormone stimulus (GO:0032870),0.2802941407777527,1.0361508170832128,0.38,0.7147173414569349,1.0,9/69,7.67%,ROBO2;NCOA2;SLIT3;SLIT2;THRB;PAX8;WT1;RAMP3;ATP1A3
prerank,negative regulation of cell division (GO:0051782),-0.4335656380494921,-1.0358488565138657,0.42980935875216636,0.5858008738994203,1.0,9/11,40.18%,BLM;E2F8;TXNIP;VPS4A;ZFYVE19;MYC;ORC6;SUSD2;AURKB
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.33432389256031625,-1.0358403962244342,0.41047297297297297,0.5855042371175615,1.0,11/30,25.39%,RNF31;USP36;UBE2L3;UBL5;SH3GLB1;HUWE1;PDCD5;BAP1;HPS4;SAE1;VPS11
prerank,modulation by host of symbiont process (GO:0051851),-0.33536439619734726,-1.0357344475366035,0.3920863309352518,0.5854058483333864,1.0,11/31,28.56%,JUN;SAP30;NUCKS1;CCL5;TFAP4;TARDBP;LRRC19;INPP5K;EP300;AQP1;LEF1
prerank,vascular process in circulatory system (GO:0003018),-0.4160081251957408,-1.0355003135312675,0.4091710758377425,0.5852829556973955,1.0,6/13,34.06%,ROCK1;ITGB1BP1;ACE2;SCPEP1;ACE;ROCK2
prerank,regulation of tube diameter (GO:0035296),-0.4160081251957408,-1.0355003135312675,0.4091710758377425,0.5852829556973955,1.0,6/13,34.06%,ROCK1;ITGB1BP1;ACE2;SCPEP1;ACE;ROCK2
prerank,protein K48-linked deubiquitination (GO:0071108),-0.3638754881699303,-1.0354873997915293,0.39658119658119656,0.5849964174581727,1.0,8/23,20.49%,USP50;OTUD5;USP8;MINDY2;ATXN3;OTUD4;MINDY1;BAP1
prerank,hepaticobiliary system development (GO:0061008),-0.3717359130283945,-1.034566812333449,0.41956882255389716,0.5866446070196274,1.0,5/20,11.35%,ARID5B;NIPBL;CEBPG;XBP1;GFER
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3508232181948535,-1.034448796759219,0.3960923623445826,0.5865970284559413,1.0,9/25,23.39%,IGF1;RB1;NIBAN2;SIN3A;DOT1L;NSD1;GATA3;ZBTB7A;TGFB1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.4472924083573071,-1.0342866427156439,0.4068965517241379,0.5866242256466228,1.0,5/11,21.24%,HPSE;PRCP;VEGFA;NDNF;KDR
prerank,sodium-independent organic anion transport (GO:0043252),0.44882252120022736,1.0341156798987803,0.4352078239608802,0.7188356670055739,1.0,4/10,15.06%,SLCO4A1;SLCO2B1;SLC16A2;SLCO3A1
prerank,cellular response to hexose stimulus (GO:0071331),-0.3578445241724516,-1.034005871353918,0.39316239316239315,0.5869147586382505,1.0,6/23,11.08%,ERN1;IGF1R;TRA2B;GAS6;ZBTB20;XBP1
prerank,regulation of neuron death (GO:1901214),0.2705853150376678,1.0337086521714216,0.3842239185750636,0.7186219160878741,1.0,25/82,19.50%,GRID2;TRIM2;GRIN2B;DCC;CD200R1;EPHB1;TSC1;DHCR24;PRNP;FYN;CD200;REST;PRKN;PPARGC1A;CHRNA7;SNCA;LANCL1;UBB;IKBKG;GRM4;FOS;EFNB2;NSMF;NAE1;WNT5A
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.3386427287051276,-1.0335299692811544,0.4273356401384083,0.5876201189926262,1.0,4/33,4.75%,APOE;SP100;CORO1C;ADIPOR1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.40301037836420833,1.033295710995158,0.4188235294117647,0.7184710520542974,1.0,2/13,11.87%,SOX11;PER2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.33570225368874895,-1.0332372648211776,0.3956228956228956,0.5879346841565979,1.0,7/33,12.72%,RUNX1;PRMT2;AXIN1;CBFB;DDX5;KLK3;TRIM68
prerank,neuron projection extension (GO:1990138),-0.3445439521053863,-1.03319921435979,0.4051724137931034,0.5877040554927945,1.0,9/32,12.65%,IQGAP1;NRP1;ALCAM;ULK2;NRP2;CTNNB1;USP9X;LLPH;HSP90AB1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.35499790809267473,-1.0330452594313406,0.44559585492227977,0.5877011753303601,1.0,5/24,3.59%,PTPRC;PLCG2;ITPR1;IBTK;HTR2B
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.2765047172079817,-1.0328488702500347,0.4050179211469534,0.5877669053281218,1.0,19/86,18.25%,APOE;PLEK;RB1;RAC1;SNX9;FES;PTK2B;BAIAP2;NCKAP1L;WDR1;CDC42EP2;APP;DCTN1;BAIAP2L2;SLAIN2;STMN2;CDC42EP3;RPS3;HCK
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.26906687127376344,1.0325165849388616,0.35036496350364965,0.7192629234711603,1.0,16/69,12.05%,PLCB1;PLCL1;NYAP2;MYO16;PIK3C2B;KCNH1;CSF1R;PLCH2;PLCE1;PLCZ1;PIRT;GPR143;EDN1;LTK;PLCD3;TYRO3
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.39707066055455686,-1.0322567385864254,0.4170940170940171,0.5887435776564911,1.0,5/16,10.72%,TNFRSF1B;CD22;PTPN22;AHR;IKZF3
prerank,cell junction organization (GO:0034330),0.2737407241383968,1.0322494415737669,0.38875305623471884,0.718715735257235,1.0,12/71,8.85%,GRM5;CTNND2;PPFIA2;TJP1;SLC8A3;PAK3;SEMA3E;SDK1;PRKCI;SLC6A1;OCLN;SLC8A2
prerank,positive regulation of phosphorylation (GO:0042327),-0.2398546490490003,-1.032190910550728,0.37025796661608495,0.5885795854899314,1.0,44/240,15.46%,LYN;DAB2;NRP1;IGF1;CD74;SDCBP;P2RX7;NIBAN1;AXL;RAC1;INSR;IGF1R;RAP2A;RIPK1;FLT1;CCND3;PFKFB3;AXIN1;HGF;C3;ARRB1;GAS6;CAMKK2;VEGFA;FNIP1;PLAUR;HIF1A;NCKAP1L;ARNT;PIN1;ZBTB20;PFKFB4;APP;FLCN;WDFY2;CCL5;CIB1;ACVR2A;RB1CC1;CD40;IL34;CRKL;ANG;MAVS
prerank,aspartate family amino acid catabolic process (GO:0009068),0.37315899728275537,1.031892865581233,0.3847980997624703,0.7184773071494068,1.0,10/19,28.02%,ASPA;GOT1;AASS;SDSL;ALDH7A1;SLC25A21;SDS;HYKK;DDO;GOT2
prerank,fat cell differentiation (GO:0045444),-0.29358083255690914,-1.0315170273221055,0.4184027777777778,0.5897067960024264,1.0,4/57,3.16%,PID1;OSBPL8;METRNL;PPARG
prerank,negative regulation of secretion by cell (GO:1903531),-0.32680519304910954,-1.0314419745666552,0.4088586030664395,0.5895326877938695,1.0,9/38,10.44%,APOE;LILRB1;TNFRSF1B;ANXA1;RSAD2;RHBDF1;RHBDF2;SYT4;CHGA
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.3961446271286194,1.0312717585636006,0.4222737819025522,0.7188650127053158,1.0,5/14,16.87%,NME2;ENPP3;AK4;AK5;AK3
prerank,protein glycosylation (GO:0006486),-0.2592855557086653,-1.031086403367838,0.4015873015873016,0.5899570013730226,1.0,42/125,23.92%,B4GALT5;TRAK1;TET3;ST3GAL1;ST8SIA4;MGAT5;OGT;GALNT7;MAN1C1;GALNT10;ALG5;COG7;FUT10;DPM3;GCNT2;POFUT1;GALNT1;ALG12;MPI;MAGT1;POMK;B3GNT2;B4GALT7;SERP1;POMGNT1;TET2;LARGE1;NPC1;PMM2;MGAT2;POMT1;ALG6;B4GALT1;MGAT4B;STT3B;GFPT1;GCNT4;GALNT6;FUT4;PLOD3;DDOST;B3GNT9
prerank,ncRNA 3'-end processing (GO:0043628),-0.4117619053406073,-1.0310299540764036,0.4225352112676056,0.589757542998513,1.0,5/14,21.70%,INTS8;INTS6;INTS14;INTS5;ELAC2
prerank,long-term memory (GO:0007616),0.36015551533732254,1.0309043513563612,0.41885964912280704,0.7185655135283453,1.0,9/19,17.75%,RASGRF1;CAMK4;PRNP;NFATC4;CPEB3;PJA2;ARC;KAT2A;CALB1
prerank,arachidonic acid metabolic process (GO:0019369),-0.3274995457462264,-1.0308520862908386,0.3953900709219858,0.5898271529390989,1.0,10/35,29.82%,TBXAS1;DAGLB;CBR1;GPX4;PLA2G4A;CYP1B1;PNPLA8;ALOX15;CYP2S1;PTGES
prerank,negative regulation of JNK cascade (GO:0046329),-0.33535745148114404,-1.0307295931876288,0.4096989966555184,0.5897613554842186,1.0,6/31,11.64%,TAOK3;PTPN22;DUSP3;SIRPA;DNAJA1;AIDA
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.43466587594247474,1.0306735623005299,0.4068965517241379,0.7179297936394277,1.0,3/10,12.31%,NELL1;CDK5RAP3;ATRAID
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3924167904978222,-1.030244407011743,0.4426807760141093,0.5905494727273084,1.0,5/16,23.56%,PRPF39;SART1;CWC15;WBP11;RBM22
prerank,positive regulation of cellular component movement (GO:0051272),-0.35441310742257237,-1.0301440028878626,0.4178082191780822,0.590452815989212,1.0,5/24,13.93%,LYN;VEGFA;TGFBR1;STK11;CFAP20
prerank,autophagosome maturation (GO:0097352),-0.33687678489332534,-1.029843824544946,0.41742286751361163,0.5907772123459866,1.0,11/32,23.79%,TECPR1;UVRAG;LAMP2;TSG101;EPG5;LIX1;GABARAP;CLN3;VPS33A;VPS16;VMP1
prerank,regulation of T cell chemotaxis (GO:0010819),-0.44045487796666183,-1.029757600110793,0.42586206896551726,0.5906480737740496,1.0,3/11,20.25%,CCR2;CCL5;WNK1
prerank,regulation of nervous system development (GO:0051960),0.3155995253094241,1.0296316414825173,0.40816326530612246,0.7194401918900779,1.0,13/37,17.49%,TENM4;PTN;YAP1;CX3CR1;PTPRZ1;GBX2;PER2;HES5;HES1;NPHP3;PRUNE1;HES3;DOCK7
prerank,cellular glucan metabolic process (GO:0006073),-0.4423591030030798,-1.029424296888802,0.433931484502447,0.5910687171075744,1.0,5/11,21.93%,PRKAG2;PHKG2;GBE1;GSK3B;PYGL
prerank,protein insertion into membrane (GO:0051205),0.32041470039236486,1.0288087827736407,0.4226327944572748,0.7203346090684064,1.0,8/32,9.60%,GET4;PRNP;RTP4;COX18;REEP1;CCDC47;UBE2J2;RTP2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.33093475069686035,-1.0288007009073894,0.4249146757679181,0.5920259519428728,1.0,16/33,26.84%,IGF1;PIK3R5;IGF1R;HTR2B;PIK3CB;PIK3CG;PIK3CA;PIK3CD;PIK3C2A;GATA3;C1QBP;SIRT2;NYAP1;PIK3C2G;TPTE;ZFP36L1
prerank,regulation of peptidase activity (GO:0052547),-0.3776293644203898,-1.0277774953417678,0.41312056737588654,0.5939357575933251,1.0,11/19,42.04%,RCN3;CTSH;CST7;CST3;PSMB8;FURIN;ATP13A2;CAV1;ECM1;PSMA3;PINK1
prerank,chromatin organization (GO:0006325),-0.255377691414844,-1.0276708110571169,0.38449111470113084,0.5938667828971939,1.0,29/132,19.83%,RB1;BPTF;SMARCA5;SPI1;SMARCD3;SMARCC2;EZH2;JARID2;PWWP3A;ARID1A;HIRIP3;NUCKS1;HDAC10;BAZ2B;HP1BP3;BAZ1A;HMGB2;HDAC5;PADI4;SETDB1;DR1;INO80;HMGN1;RBBP4;LRWD1;INO80C;MYB;RSF1;KDM5B
prerank,Wnt signaling pathway (GO:0016055),-0.2705060887949933,-1.027587931981936,0.4006568144499179,0.593735713879664,1.0,30/92,28.56%,PLCG2;SNX3;RARG;AXIN1;LRP6;CTNNB1;WLS;UBC;RPS27A;STRN;VPS26A;TCF7;RYK;DDX3X;WNT3;GSK3B;SFRP1;CSNK1G3;ZRANB1;PLPP3;DVL2;USP34;CCDC88C;WNT7B;FZD1;FZD7;BCL9;WNT6;FRAT1;LEF1
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.31507791890565867,-1.02757553443946,0.40966010733452596,0.5934500943270112,1.0,14/41,23.76%,CD44;PIEZO1;GCNT2;MDK;PLAUR;JAK1;LCK;CCL5;ADAM19;SMAD7;AGER;CD3E;PLPP3;CD47
prerank,protein lipidation (GO:0006497),-0.2978826163626481,-1.0270117690075318,0.397196261682243,0.5944022768320935,1.0,19/59,27.22%,ATG5;ATG7;ATG10;DPM3;ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;PIGH;PGAP3;ZDHHC1;ZDHHC5;MPPE1;HHAT;ZDHHC13;GPLD1;ZDHHC6;PIGZ;PGAP2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.4142285069323496,-1.0266466107678833,0.4315068493150685,0.594904754173551,1.0,2/13,8.06%,ITGA4;MDK
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.38134450702535183,-1.026586758794849,0.4337979094076655,0.5947204265753088,1.0,5/19,18.95%,DCP2;TEN1;TENT4B;HNRNPA1;EXOSC10
prerank,dephosphorylation (GO:0016311),0.23980244801603348,1.026325692147564,0.3690773067331671,0.7258236758460698,1.0,33/147,17.12%,PTPRD;PTPRG;PTPRN2;PLPP4;PTPRR;PTPRT;PPM1E;MTMR2;PLPPR1;PLPPR4;PXYLP1;PTPRK;PTPN3;ACP6;PPP2R1B;PTPRB;PTPRZ1;PPP2R2A;THTPA;CTDNEP1;MTMR7;DUSP4;DUSP10;DUSP18;PTPRS;PTPN4;PHPT1;PLPPR2;PNKP;DUSP8;THNSL2;PPM1G;CTDSP1
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.27814965724991747,-1.0263121080721718,0.38461538461538464,0.5949916338331798,1.0,36/80,35.96%,BIRC3;MALT1;BRCA1;AXIN1;WFS1;LAPTM5;UBE2L3;PIN1;DERL1;DCUN1D4;ARRDC4;UBE3A;NSMCE3;TBC1D7;SMAD7;HUWE1;NDFIP2;KDM1A;TOPORS;UBE2N;CUL3;PTTG1IP;RIPK2;TRAF6;XIAP;BCL10;DCUN1D5;CAV1;HSPBP1;FANCI;STUB1;TSPYL5;MTA1;DCUN1D1;PEF1;KLHL40
prerank,positive regulation of dephosphorylation (GO:0035306),0.331006168284899,1.0262629914869295,0.39568345323741005,0.7247647064186853,1.0,13/27,21.40%,CAMTA1;DLC1;PPP1R16B;CALM1;CALM3;CALM2;CDH5;MTMR9;CNEP1R1;PPP1R7;NSMF;CDCA2;SYMPK
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.45129093170786894,-1.0260415686489093,0.4358108108108108,0.5952464188285742,1.0,2/10,5.73%,ABCD2;NR1H2
prerank,neuron remodeling (GO:0016322),0.43102945356287176,1.0259728368933851,0.4230769230769231,0.7243227435521328,1.0,1/10,0.11%,ADGRB3
prerank,muscle organ development (GO:0007517),0.291898090356739,1.0256793234918147,0.40153452685422,0.7239070762870102,1.0,11/54,13.88%,SGCD;DMD;MKX;SOX6;TEAD4;SGCG;TBX1;SGCE;CAPN3;ITGA11;FKTN
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.35643412506153993,-1.0255957960276514,0.4469178082191781,0.5958983801139653,1.0,8/23,13.83%,IGF1;NIBAN2;PIEZO1;MAML1;MAPK14;MEF2C;SMYD1;GREM1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.4141902620482998,-1.0251015379961215,0.4290909090909091,0.5966541274452792,1.0,7/13,28.58%,STX3;SNX33;HSP90AB1;STX4;GPD1L;TMEM35A;RANGRF
prerank,visual perception (GO:0007601),0.26375789763818264,1.025055814563529,0.38221153846153844,0.7243147464548574,1.0,16/84,11.96%,GRM8;SLC4A10;CRYZ;POU6F2;COL11A1;RPGR;IMPG2;ABLIM1;ADGRV1;TRPM1;PDE6C;GPR143;CRYBB3;EML2;PRPH2;ZIC2
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.4244902747625934,-1.0250342704969349,0.44485981308411215,0.5964951483900063,1.0,5/12,24.92%,PRKCB;NEK6;CDK1;CCNB1;CCNB2
prerank,phosphate ion transmembrane transport (GO:0035435),-0.42126802913882166,-1.0249871188062867,0.4425385934819897,0.5962744932649963,1.0,6/12,30.89%,SLC37A1;XPR1;SLC20A2;SLC25A10;SLC37A2;SLC20A1
prerank,snRNA metabolic process (GO:0016073),-0.3927980821075714,-1.0240785708799112,0.44821731748726656,0.5979624469279066,1.0,6/17,23.12%,INTS8;INTS11;INTS6;INTS1;INTS5;MTREX
prerank,macrophage chemotaxis (GO:0048246),-0.4510298883464326,-1.0236363598602047,0.44858156028368795,0.5986106474122078,1.0,7/10,44.64%,CKLF;CCL5;EDNRB;EDN2;TAFA4;CXCL17;CCL3
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.4127613486648611,1.0234975312358459,0.4419134396355353,0.7259889693128504,1.0,4/12,13.71%,FHL2;PRNP;HOMER3;ATP2B4
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4127613486648611,1.0234975312358459,0.4419134396355353,0.7259889693128504,1.0,4/12,13.71%,FHL2;PRNP;HOMER3;ATP2B4
prerank,membrane lipid biosynthetic process (GO:0046467),-0.2955074976003072,-1.02326953424863,0.4,0.5991031653619554,1.0,29/58,40.35%,SGMS1;SPTLC2;ACER3;SPTSSA;GBGT1;PRKD3;KDSR;VAPB;SPHK2;SPTLC3;SAMD8;PLPP3;ELOVL5;DEGS2;CERS3;HACD4;VAPA;ST3GAL4;HACD3;ST8SIA6;ACER2;ALDH3B1;CERT1;CERS2;SPHK1;ELOVL1;PLPP2;PLPP1;SGPP1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.3557211828210969,-1.022826314990792,0.4265975820379965,0.5997578100018348,1.0,8/22,27.74%,RPS20;DDX5;SPRED1;SPRED2;EEF1E1;ATM;RPS15;PLA2R1
prerank,relaxation of cardiac muscle (GO:0055119),-0.4167933246873144,-1.0223604315320987,0.42021276595744683,0.6004657436460996,1.0,5/13,19.56%,P2RX4;SLC8A1;CHGA;PIK3CA;PLN
prerank,tRNA metabolic process (GO:0006399),-0.3883752774675821,-1.0215697098914767,0.42517006802721086,0.6018221807409618,1.0,6/17,20.70%,FARS2;ADAT1;SARS1;KARS1;AARS1;DARS2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.32877376632128924,-1.0208754605856465,0.4209650582362729,0.6030456286513164,1.0,8/33,18.14%,CDK6;RB1;BRD7;PRMT2;PLK3;WEE1;CDKN2C;CDK2AP2
prerank,transepithelial transport (GO:0070633),0.3933170773464072,1.0208464544422804,0.42696629213483145,0.7317440306636013,1.0,3/15,7.87%,SLC12A2;SLC1A2;SLC1A1
prerank,primary alcohol metabolic process (GO:0034308),-0.3537931472887436,-1.020676926313573,0.4311594202898551,0.6031496545215824,1.0,2/25,0.78%,IGF1;DHRS3
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4292450172001858,-1.020657277014359,0.44919786096256686,0.6028733553391177,1.0,7/12,23.69%,MDK;LCK;MIA3;ASS1;WNK1;FUT4;ADTRP
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.28839712176914156,1.0204641322978891,0.4132420091324201,0.7315879032362719,1.0,12/52,16.11%,DPP10;SORBS1;PRKCE;RAMP3;GNAI1;PRKCI;NKD2;ARF6;STAC;ATP2B4;WNK3;EPHA3
prerank,regulation of cellular senescence (GO:2000772),-0.3454218797115032,-1.020458490307652,0.41074523396880414,0.6030286299961989,1.0,6/28,15.88%,CDK6;CGAS;B2M;NEK6;EEF1E1;ARG2
prerank,collagen fibril organization (GO:0030199),0.26004033295981505,1.0204338554657473,0.3910761154855643,0.7304295875474678,1.0,15/88,11.62%,P3H2;COL27A1;TLL1;DST;COL11A1;COLGALT2;COL25A1;PLOD2;COL4A3;COL23A1;COL19A1;CD151;TGFB2;BMP1;COL7A1
prerank,regulation of microtubule depolymerization (GO:0031114),0.340603927384951,1.0204309215134821,0.4363207547169811,0.729226064770669,1.0,4/25,5.53%,NAV3;MAP1B;CLASP2;APC2
prerank,protein maturation (GO:0051604),0.2575504306311951,1.0203255869328787,0.3963730569948187,0.7282713657898056,1.0,20/95,15.81%,METAP2;PCSK5;MMP16;PCSK2;TESC;MME;ECE2;PCSK6;CIAO1;NAA10;MMEL1;PCSK1;EEF1AKMT4-ECE2;NDUFAB1;CPE;NAA60;LIPT2;ECE1;TASP1;ADAM17
prerank,negative regulation of potassium ion transport (GO:0043267),-0.40810118180288296,-1.0198627577073085,0.44173913043478263,0.6040061575214504,1.0,3/13,10.66%,PTK2B;CAB39;NEDD4L
prerank,sympathetic nervous system development (GO:0048485),-0.39583457402079103,-1.0197390903229289,0.4322469982847341,0.6039603077490845,1.0,3/15,7.15%,NRP1;NRP2;CTNNB1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.43025989982906443,-1.0194893951340318,0.44014084507042256,0.6041979568744336,1.0,7/12,41.36%,CCR2;CLEC6A;IL12RB1;ZBTB1;SLC11A1;IL12B;IL1B
prerank,mRNA metabolic process (GO:0016071),-0.2727967613267015,-1.01901991922906,0.4230118443316413,0.6049329009539741,1.0,37/90,35.74%,ERN1;SON;RNASE4;SNRPG;SNRPF;DCP2;DDX5;PRPF8;PCBP2;NUDT21;CELF1;NCBP1;SF3A1;PRPF18;HSPA1A;LSM6;CPSF3;LSM5;SRSF11;NONO;AKAP8L;NUDT16;ZC3H12D;U2AF2;HIPK3;TBRG4;METTL3;SRSF7;SRSF5;HNRNPR;NUDT12;HSPA1B;ALKBH5;SF3B4;SNRPD3;KIN;SLFN14
prerank,organelle disassembly (GO:1903008),-0.33170943513154744,-1.0184024634419715,0.42086956521739133,0.6059195603035986,1.0,8/33,13.61%,KLC1;ULK2;TEX264;CDK1;STX5;PLK3;RETREG1;RB1CC1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.30526321587818633,-1.0180494787179704,0.4113597246127367,0.6063628132906316,1.0,9/45,11.79%,IQGAP1;GRB2;CBL;PTK2B;KIF16B;DGKD;ERBIN;REPS2;PIK3CA
prerank,triglyceride homeostasis (GO:0070328),-0.35005866149400655,-1.0178179705568977,0.43611584327086883,0.6065406215112786,1.0,5/26,11.08%,APOE;IL18;LPL;APOC4;XBP1
prerank,cellular response to inorganic substance (GO:0071241),0.3550235195819596,1.017743628901934,0.41019417475728154,0.7337695453806683,1.0,4/21,8.11%,DDX11;KCNC2;GUCY1B1;FMR1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.33543499871624705,-1.0176228446980373,0.44804088586030666,0.6066557031460882,1.0,9/29,20.02%,PLBD1;NR1H2;TMEM86B;PLA2G4A;PLAAT3;PLA2G6;PLA2G5;PLA2G12A;LPCAT3
prerank,glucose metabolic process (GO:0006006),0.283006595887225,1.0176015233725941,0.4197247706422018,0.7329491534633833,1.0,13/58,14.31%,OMA1;PFKFB1;GOT1;APOD;ENO1;GAPDHS;G6PC3;G6PC1;ALDOB;SLC25A11;PER2;HECTD4;PPARGC1A
prerank,sodium ion import across plasma membrane (GO:0098719),0.38058276640742245,1.017327333175879,0.4244604316546763,0.7324537187713211,1.0,4/17,8.36%,SLC12A2;SLC9A2;HCN2;SLC6A1
prerank,regulation of signal transduction (GO:0009966),-0.24208648541312303,-1.0169377752126065,0.40924092409240925,0.6078371676254789,1.0,33/190,12.21%,MDFIC;RUNX1;SP100;DHRS3;CD36;SNX3;CREBBP;OGT;ELF1;IRAK2;RASGRP4;FBXL17;GRK3;AMFR;CDC42SE2;RGS3;AXIN1;RIC8B;GRK5;POFUT1;ZDHHC7;RGS11;CBFB;ITGB1BP1;CD63;NUCKS1;APP;CRK;RGS12;RFNG;ITGA3;CD46;IGFBP3
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.4131819538472914,-1.0168899399339617,0.4460694698354662,0.6076371578169869,1.0,4/13,10.48%,ITGB2;RHOA;MDK;RELA
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.45184077902117004,-1.0168180904242146,0.43463497453310695,0.6074622054697436,1.0,6/10,34.05%,BRCA1;SET;NOC2L;KLF15;CTBP1;THAP7
prerank,positive regulation of myelination (GO:0031643),0.41897389478780583,1.0165841749158917,0.42725173210161665,0.7332755553010151,1.0,2/11,1.83%,TENM4;PARD3
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.35781043758273706,1.0165048346883605,0.42761692650334077,0.7322900359564684,1.0,4/19,10.73%,ROBO1;SEMA6A;TSPAN12;SMOC2
prerank,anion transmembrane transport (GO:0098656),-0.2842664278859502,-1.0159385351289678,0.4180602006688963,0.6090069883032145,1.0,16/67,17.76%,LRRC8D;SLC16A7;MFSD12;SLC27A1;LRRC8C;SLC36A4;SFXN2;ABCC1;SLC25A42;SLC7A5;SFXN1;SLC25A4;SLC23A1;SLC23A2;SLC6A9;SLC6A8
prerank,cellular response to organic cyclic compound (GO:0071407),-0.2557595348455107,-1.015744948162283,0.42923794712286156,0.6091243196552647,1.0,26/141,10.16%,DIAPH1;MSN;P2RX7;GNB1;RAP1B;SPIDR;P2RX4;FES;BRCA1;RAP1A;RIOK3;IL18;TFPI;ACTB;TIPARP;BLM;GNG2;AHR;CTNNB1;HRH1;EPG5;RAD51;MEF2C;UBE2L3;EGR1;TGM2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.3917876086325548,-1.0150958014241966,0.44798657718120805,0.6102569293536743,1.0,8/15,26.85%,ATF3;DHX36;MKNK2;HNRNPA1;DDX3X;ZC3H12A;GSTO1;VCP
prerank,regulation of feeding behavior (GO:0060259),0.4112204733531043,1.014982181438186,0.4147465437788018,0.7350169325212907,1.0,2/11,8.34%,SGIP1;LEPR
prerank,protein deneddylation (GO:0000338),-0.4496288668888997,-1.014786768269088,0.4489112227805695,0.610618312017083,1.0,5/10,20.89%,GPS1;COPS6;COPS5;COPS4;COPS8
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.37454326019917383,-1.0144865064274426,0.44565217391304346,0.6109615266444831,1.0,3/18,10.66%,SLC43A2;CAB39;NEDD4L
prerank,protein methylation (GO:0006479),-0.31349587071394514,-1.0144035188681662,0.43409490333919154,0.6108228817091237,1.0,9/40,15.15%,NSD3;GSPT1;PRMT2;EZH2;PRMT1;METTL22;PRMT3;PRMT6;NSD1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.37905436044718255,1.0143046290910345,0.44221105527638194,0.735680917966082,1.0,3/14,8.98%,PPP2R2B;PPTC7;PPP2R2A
prerank,negative regulation of catalytic activity (GO:0043086),-0.352690083990016,-1.0133319598251365,0.43463497453310695,0.6127129021911343,1.0,9/24,25.76%,PARP9;NES;IFIT1;PPP1R12A;CLN3;APBA3;PLN;HP;MT3
prerank,negative regulation of immune system process (GO:0002683),-0.39001510459748906,-1.0129293511334136,0.4427350427350427,0.6132239422385389,1.0,6/16,28.75%,LYN;FCGR2B;HMOX1;ADTRP;FCRLB;SPINK5
prerank,replicative senescence (GO:0090399),0.39709845476535854,1.0127361577688394,0.4236111111111111,0.7385427387374358,1.0,5/12,19.24%,MME;ROMO1;CDKN2A;TERT;CHEK2
prerank,cilium movement (GO:0003341),0.2921587716464009,1.012653227804728,0.4250614250614251,0.7375440920860173,1.0,20/47,27.63%,DNAI4;ODAD3;CFAP91;DNAH17;DNAAF4;CFAP73;GAS8;ZBBX;DNAH5;DNHD1;CFAP53;DNAAF5;DNAH1;SPEF2;CAMSAP3;CFAP206;CABYR;DNAH9;RSPH4A;CFAP100
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3981546732913503,1.0125152440898404,0.44988864142538976,0.7367172940703264,1.0,6/13,19.14%,GRIN2A;TBC1D10A;LGMN;CIDEB;PERP;FADD
prerank,pre-miRNA processing (GO:0031054),-0.40286619851207683,-1.0112715195387643,0.4450354609929078,0.6165499037578568,1.0,2/14,3.76%,AGO2;TUT7
prerank,regulation of protein acetylation (GO:1901983),-0.42614983435293124,-1.0110684216292316,0.4665523156089194,0.6166654123547073,1.0,4/12,20.30%,CEP295;TAOK1;DDX3X;GSK3B
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.39553010255418763,-1.0108682824455237,0.44658493870402804,0.6167719318845433,1.0,6/16,22.40%,CHMP5;TMEM50A;CHMP7;LEPROTL1;CHMP4B;CHMP4A
prerank,striated muscle cell differentiation (GO:0051146),0.3803478695373678,1.0108105556277456,0.43765281173594134,0.7400072264572576,1.0,5/16,10.28%,NRG1;CBY1;SDC1;MYOCD;POPDC2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.2675588711509979,-1.0105564762370691,0.43769968051118213,0.6171278526973355,1.0,24/88,22.07%,APOE;DAPK1;GAPDH;DNAJC1;CNOT1;NFKB1;DAPK3;PUS7;EIF2AK2;PCIF1;DHX36;NCL;CST3;CLN3;TOB1;RPS3;DDX3X;CNOT8;DDX6;LSM14A;CDK5;RACK1;BAG6;SHMT1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.3784090344416111,-1.010252014503155,0.45422535211267606,0.6174726481117706,1.0,5/17,21.76%,BCL2;FIS1;BBC3;BID;SFN
prerank,C4-dicarboxylate transport (GO:0015740),0.38850771201588996,1.0099463645300113,0.427536231884058,0.7410953016655414,1.0,5/14,11.27%,SLC1A2;SLC1A6;SLC1A1;SLC13A5;SLC25A11
prerank,iron-sulfur cluster assembly (GO:0016226),-0.34957898136279547,-1.0096840008962464,0.45549738219895286,0.618383922998668,1.0,5/24,10.51%,ABCB7;HSCB;HSPA9;CIAO3;IBA57
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.32748622870496796,-1.0092366704321358,0.46153846153846156,0.6190034048128867,1.0,9/31,22.73%,BCL2;E2F1;YWHAE;BBC3;BID;CASP8;GSK3B;SFN;NMT1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.43282540336716796,-1.0091357826206397,0.4582560296846011,0.6188942131929299,1.0,3/10,10.38%,XDH;PIK3CB;SPRY2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3211747906676549,-1.0090686334534869,0.4408783783783784,0.6187301794542077,1.0,9/35,12.79%,CBL;RAC1;PIK3CB;C3;PICALM;HIP1;B2M;RAB21;SERPINE1
prerank,negative regulation of protein kinase activity (GO:0006469),-0.27037806889090643,-1.0086246196849313,0.4269293924466338,0.6193725235521005,1.0,14/88,10.21%,PTPRC;CORO1C;PAK2;RB1;PRKAG2;CEP85;DUSP3;LRP6;MVP;TRIB1;ITGB1BP1;SLC8A1;TRIB2;SPRED1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.43838233003131766,-1.0085030898399385,0.43804537521815007,0.619323887475764,1.0,3/10,11.87%,PRKCD;CD9;ADAMTS18
prerank,positive regulation of transporter activity (GO:0032411),-0.412323392533933,-1.0082552821056951,0.45166959578207383,0.619534512938376,1.0,3/13,17.14%,SGK1;RXRA;KMT2A
prerank,lamellipodium organization (GO:0097581),0.3261373429533074,1.0081156310573895,0.42142857142857143,0.7447585882247167,1.0,6/29,5.06%,ARHGEF7;CDH13;WASF1;P2RY12;CARMIL1;ABLIM1
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.4383544864799442,-1.008095739283411,0.4578096947935368,0.6195539230390351,1.0,5/10,33.64%,NFE2L2;QRICH1;EIF2AK3;ATF4;EIF2S1
prerank,smoothened signaling pathway (GO:0007224),0.3149681459013104,1.0071518173933096,0.4304932735426009,0.7461269551703261,1.0,15/32,28.53%,PTCH2;TMEM231;EVC2;ARL13B;SMO;HES5;GLI3;GLI2;ULK3;DISP3;CC2D2A;DISP2;B9D1;HIPK2;PTCH1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.41508504674124846,-1.0070735096857801,0.4394213381555154,0.6214042137728628,1.0,3/12,3.82%,IGF1;INSR;DYRK2
prerank,negative regulation of ion transport (GO:0043271),0.3404609491898552,1.006995180710102,0.4148148148148148,0.7453472666736416,1.0,11/24,20.44%,GPM6B;HRH3;CASQ2;NEDD4;SYT11;HTR1B;WNK4;WNK3;SNCA;WNK2;CD33
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.3240662401746812,-1.0060145266168323,0.4185639229422067,0.623357148984284,1.0,13/29,28.56%,CREBBP;CTNNB1;TLE3;KMT2D;TCF7;TLE4;MYC;RBBP5;ASH2L;BCL9;EP300;TLE2;LEF1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.3462787160502909,-1.0059409310722645,0.4467005076142132,0.6231769479055763,1.0,6/24,10.11%,HPSE;BRCA1;C3;SULF2;HIF1A;ARNT
prerank,chromatin assembly or disassembly (GO:0006333),-0.4319919266629261,-1.0058861866809177,0.45818815331010454,0.6229761710511292,1.0,5/11,27.39%,HIRIP3;CHAF1A;RBBP4;HDAC8;NOC2L
prerank,carbohydrate catabolic process (GO:0016052),-0.3108286203860855,-1.0058602347230288,0.449820788530466,0.622714609436687,1.0,15/38,29.81%,GAPDH;DERA;HK3;TPI1;PKM;NEU1;MAN2C1;MAN2B1;PGK1;MANBA;PGM1;PGAM2;PGAM4;PGAM1;ALDOA
prerank,cellular response to catecholamine stimulus (GO:0071870),0.3396223510707685,1.0057904196930578,0.4520547945205479,0.7472762134468094,1.0,2/23,1.17%,PDE4B;RYR2
prerank,regulation of lipid kinase activity (GO:0043550),-0.4269287355153554,-1.0052842690403005,0.48063380281690143,0.6236228349377532,1.0,4/11,25.80%,RB1;WDR91;PPP2R5A;RBL2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.4006515639881758,-1.0048358128457395,0.43826086956521737,0.6242738639594182,1.0,4/15,9.94%,SLC27A1;NR1H2;C3;SIK1
prerank,carnitine metabolic process (GO:0009437),-0.41228372500520183,-1.0048167170388695,0.4421768707482993,0.623989440579105,1.0,4/12,22.07%,CPT1A;ACADM;TMLHE;SHMT1
prerank,negative regulation of GTPase activity (GO:0034260),-0.3505126604751026,-1.0044860475667678,0.44991212653778556,0.6243873748035943,1.0,5/22,20.25%,LRCH1;ARFGEF1;TMED2;RASA4;WNK1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.23056379802719504,-1.004285498382998,0.4312210200927357,0.6245020558440452,1.0,83/248,28.61%,DAB2;APOE;ZEB2;ZNRF3;DKK2;PSME4;AMFR;PSMB7;PSME3;NFKB1;HHEX;CCNY;USP8;DAPK3;PSMB9;STK3;BICC1;AXIN1;LRP6;CTNNB1;TBL1XR1;PPM1B;LRRK1;PPP1CA;SDHAF2;MDK;WLS;CDK14;TLE3;PSMA8;OTULIN;PIN1;PSMC3;PSMD8;STK11;CHD8;PSMC4;PSMB10;TNKS2;GREM1;PSMA1;UBAC2;LATS2;TLE4;PSMB8;GPRC5B;JRK;PTPRO;PLEKHA4;DDX3X;RSPO1;PSMA5;PSMD4;TMEM198;PSMB3;WNK1;GSK3B;PSMD3;SFRP1;JUP;CSNK1G3;SMURF2;SNAI2;ILK;SOX7;TGFB1;DVL2;PSMB1;TMEM170B;USP34;CCDC88C;SIAH2;BMP2;FZD7;VCP;CUL3;TMEM131L;FRMD8;TLE2;FRAT1;PSMA7;NOTUM;DKK3
prerank,acylglycerol homeostasis (GO:0055090),-0.36598072384757974,-1.0042749777178148,0.4503311258278146,0.6241991448841402,1.0,4/20,10.56%,APOE;IL18;LPL;APOC4
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.42554629815239003,-1.0042517959830377,0.4558058925476603,0.6236149102557728,1.0,6/11,40.89%,CCT7;CCT4;LARP7;CCT8;CCT5;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.42554629815239003,-1.0042517959830377,0.4558058925476603,0.6236149102557728,1.0,6/11,40.89%,CCT7;CCT4;LARP7;CCT8;CCT5;MEPCE
prerank,negative regulation of neuron death (GO:1901215),-0.26374529946809266,-1.0042503396722378,0.44554455445544555,0.6233010186141678,1.0,28/93,22.40%,APOE;TNFRSF1B;SNX6;PTK2B;BCL2;GRN;WFS1;MDK;MEF2C;ADAM8;INPP5A;CHGA;KIF14;RETREG1;TRAF2;RASA1;EIF4G1;CLN3;FBXO7;CSF1;NDNF;GSK3B;CPEB4;PPT1;CDK5;SET;CHMP4B;CHMP4A
prerank,negative regulation of cell projection organization (GO:0031345),0.2833841833477337,1.0039218022685306,0.45215311004784686,0.7510661514571659,1.0,10/48,13.71%,SPOCK1;GRIN2B;DCC;PRNP;FYN;KANK1;TSKU;DPYSL3;RTN4RL1;PTPRS
prerank,neuron projection regeneration (GO:0031102),0.41839445985094253,1.003861413100387,0.4416475972540046,0.750026157583986,1.0,4/10,14.87%,PTN;RTN4RL1;DHFR;FOLR1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.41754222488390486,-1.0037555400601001,0.45183887915936954,0.6240271402364279,1.0,4/11,20.84%,DAB2;RSPO3;PLEKHA4;SFRP1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.3696186093632213,1.0031967667444006,0.4513064133016627,0.75056262892275,1.0,6/18,20.94%,ELOVL7;HACD1;ACSL3;ACSL6;ELOVL6;ELOVL2
prerank,regulation of mitotic nuclear division (GO:0007088),-0.29122146956345135,-1.0031623032810353,0.45699831365935917,0.6250245101925456,1.0,16/55,21.46%,IGF1;INSR;CDK13;KIF20B;DAPK3;CD28;PIN1;MKI67;NUSAP1;AURKA;PDGFRB;RCC1;CHEK1;NME6;CDC25C;NUP62
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.3153381291491383,-1.0025453054158127,0.449820788530466,0.6260127454905922,1.0,7/38,12.70%,BANK1;XDH;PTPRJ;ARRB2;PIK3CB;FLCN;CIB1
prerank,response to UV-A (GO:0070141),0.39166606798099757,1.0024746122818406,0.4668141592920354,0.7512966688814247,1.0,3/14,9.75%,MME;OPN3;OPN5
prerank,organic substance transport (GO:0071702),-0.2558726726896525,-1.0017229374749248,0.425,0.6274659453036111,1.0,36/121,25.34%,ABCA1;ABCG1;PLTP;MYH9;RAB7A;MFSD12;ABCD2;TOM1;CENPF;RCN3;FLVCR1;TAP2;CHMP1A;HSP90B1;ARRDC4;MIA3;ABCA9;ARRDC1;CHMP2A;ABCA13;LMAN2L;SLC50A1;ABCD3;SLC23A1;RILP;SNX4;ABCA4;TXNIP;PPT1;SLC22A18;LRP2;ARRDC2;ATP8A1;CHMP2B;ABCA2;SLC22A3
prerank,purine-containing compound salvage (GO:0043101),-0.41805792277663884,-1.001682916457908,0.47027972027972026,0.6272289367938616,1.0,6/12,30.35%,HPRT1;DCK;DGUOK;PNP;ADA;GMPR2
prerank,endocrine system development (GO:0035270),0.34953428388533814,1.0015289933954759,0.4558139534883721,0.7525747186308726,1.0,5/21,10.61%,PAX8;WT1;HOXD3;SALL1;TBX1
prerank,aggrephagy (GO:0035973),-0.33879036300732335,-1.00146844115683,0.4603960396039604,0.627393391321486,1.0,8/27,16.91%,VIM;ATG5;WDFY3;DYNC1H1;UBC;RPS27A;DYNC1LI2;PCNT
prerank,activin receptor signaling pathway (GO:0032924),0.3817333147416344,1.0013064564132104,0.46115288220551376,0.751992100130223,1.0,6/15,19.57%,ACVR1C;ACVR1;INHBB;INHBA;ACVR2B;AMHR2
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.4392512822146132,-1.0012927923672503,0.4503424657534247,0.627158288118725,1.0,4/10,26.88%,MYLIP;AP2A2;AP2S1;AP2A1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.4392512822146132,-1.0012927923672503,0.4503424657534247,0.627158288118725,1.0,4/10,26.88%,MYLIP;AP2A2;AP2S1;AP2A1
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.3522741602225976,-1.001050497411966,0.445993031358885,0.6273979171139383,1.0,9/21,37.35%,PPARD;AGXT;ACOX1;CYP26C1;PLA2G15;HOGA1;LPIN3;FAH;HAO1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.28811526037926694,-1.0007676554334288,0.47217537942664417,0.6276945950182956,1.0,20/54,27.39%,RPL7;RPL11;RPL10A;NVL;RPL14;RPL6;PAK1IP1;SURF6;RPL23A;GTF3A;NIP7;RPLP0;BRIX1;SNU13;RPL7A;WDR12;NHP2;RPL5;EIF6;NOC2L
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.2966206669810076,-1.0005780170902892,0.46410684474123537,0.6277693947743838,1.0,13/50,23.03%,OGT;ARRB2;ARRB1;DNAJA1;SPRY2;PRMT3;ISG15;HSPA1A;SMAD7;RPS3;UBXN1;DTX3L;HDAC8
prerank,glycoprotein biosynthetic process (GO:0009101),-0.2710805256773124,-1.000408662734941,0.4469820554649266,0.6278335434163596,1.0,18/79,15.20%,B4GALT5;XYLT1;IGF1;ST8SIA4;ALG5;COG7;ATP7A;FUT10;CHST12;GCNT2;CHST11;MPI;B3GNT2;B4GALT7;SERP1;GCNT1;LARGE1;NPC1
prerank,response to organonitrogen compound (GO:0010243),-0.3145582810590468,-1.0003912434971214,0.4551971326164875,0.627558132858571,1.0,14/38,26.85%,KYNU;IRF5;IRAK3;RCN3;DERL1;SEL1L;UBXN6;KAT7;RNF185;ERLEC1;NR1H4;IL6;HLCS;VCP
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.3267553580086665,-1.0003384936726836,0.4948630136986301,0.6273644125745763,1.0,4/31,5.00%,CDK6;RB1;BRD7;PRMT2
prerank,smooth muscle tissue development (GO:0048745),0.4224344458241506,1.0001395643133786,0.46472019464720193,0.7538942741851428,1.0,5/10,28.53%,SMO;MYLK;EFEMP2;NF1;PTCH1
prerank,bile acid biosynthetic process (GO:0006699),0.33794414112812543,0.9995243109541542,0.45036319612590797,0.7543293332559844,1.0,10/24,15.12%,OSBPL6;SLC27A2;OSBPL7;ACOX2;HSD3B7;OSBPL2;ABCB11;ACOT8;HSD17B4;CYP39A1
prerank,cartilage development (GO:0051216),-0.29613036033148316,-0.999285410682282,0.4340277777777778,0.6293331407846863,1.0,9/49,11.44%,CD44;RUNX1;RUNX3;ATP7A;RUNX2;CREB3L2;SULF2;MEF2C;OSR1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3444701420245761,-0.998959928930164,0.47217235188509876,0.6297415637226363,1.0,5/26,3.59%,PTPRC;PLCG2;ITPR1;IBTK;HTR2B
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.3655768050196172,-0.9988537559208647,0.4586206896551724,0.6296630772854657,1.0,7/18,32.99%,BCL2L11;ANXA1;UBE2L3;NR3C1;ZFP36L1;AQP1;PCK2
prerank,DNA replication checkpoint signaling (GO:0000076),-0.38567635408404977,-0.9987899114074767,0.48896434634974534,0.6294916364985769,1.0,7/16,22.65%,TIMELESS;TICRR;TOPBP1;RAD9A;DNA2;TIPIN;CDC45
prerank,regulation of phospholipase C activity (GO:1900274),0.384813456443124,0.9986943155428837,0.4460093896713615,0.7553400906841905,1.0,2/15,1.52%,NTRK3;BICD1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.24143288425620787,-0.998576629243782,0.46116504854368934,0.6296328027206187,1.0,51/161,28.61%,DAB2;APOE;ZNRF3;DKK2;PSME4;AMFR;PSMB7;PSME3;PSMB9;STK3;BICC1;AXIN1;LRP6;SDHAF2;MDK;TLE3;PSMA8;PSMC3;PSMD8;STK11;CHD8;PSMC4;PSMB10;GREM1;PSMA1;UBAC2;LATS2;TLE4;PSMB8;PTPRO;PSMA5;PSMD4;PSMB3;GSK3B;PSMD3;SFRP1;SNAI2;TNN;DVL2;PSMB1;TMEM170B;CCDC88C;SIAH2;BMP2;CUL3;TMEM131L;FRMD8;TLE2;PSMA7;NOTUM;DKK3
prerank,epithelial tube morphogenesis (GO:0060562),0.3074026057723593,0.9982119503339398,0.41975308641975306,0.7553702916320535,1.0,8/32,15.22%,RYR2;SLIT2;CSF1R;ACVR1;FGF10;PKD1;HES1;PODXL
prerank,peptidyl-lysine acetylation (GO:0018394),-0.43262786736970915,-0.9979997824044776,0.46059544658493873,0.6305421296206065,1.0,4/10,27.61%,CREBBP;KAT7;BAG6;EP300
prerank,establishment of protein localization to membrane (GO:0090150),-0.2805376998946507,-0.9977713485248916,0.46440677966101696,0.6307396012248966,1.0,20/66,21.04%,RFTN1;SDCBP;SEC63;RAB3GAP1;NACA;ZDHHC7;ZDHHC2;NCF1;SYNE3;RAB11B;RAB10;ZDHHC12;NPC1;BID;TAOK2;ZDHHC1;GRIN3B;NACAD;RAB11A;GOLGA7
prerank,skeletal system development (GO:0001501),-0.24751291228159866,-0.9973829050281685,0.48172757475083056,0.6312971192786151,1.0,19/148,11.57%,EXT1;CD44;AKAP13;XYLT1;SH3PXD2B;TRPS1;IGF1;ANKRD11;SLC10A7;ATP7A;PTGER4;PKDCC;DYM;CREB3L2;SULF2;TGFBR1;TGM2;PRELP;PRDX1
prerank,regulation of receptor internalization (GO:0002090),-0.3204368778318104,-0.9970881876367129,0.45674740484429066,0.6316394008329855,1.0,8/35,9.20%,SDCBP;RIN3;INSR;ARRB2;TBC1D5;ARRB1;VEGFA;CD63
prerank,establishment of vesicle localization (GO:0051650),0.35995936372649046,0.9970126660079202,0.4426229508196721,0.7573370805788834,1.0,5/18,9.01%,KIF5C;KIF5A;TOR1A;SYT11;F8A1
prerank,positive regulation of vasculature development (GO:1904018),-0.26401375339414357,-0.9968197674606022,0.44240400667779634,0.6318848756382075,1.0,27/94,23.77%,SASH1;RUNX1;PRKCB;AGO2;BRCA1;FLT1;ITGB1;GRN;VEGFA;HIF1A;CTSH;ITGAX;XBP1;SERPINE1;PIK3CD;CD40;BTG1;HSPB1;AGGF1;ZC3H12A;JUP;KDR;FGF18;APLNR;MTDH;HMOX1;CYP1B1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.338359714974555,0.9966665234368464,0.4556354916067146,0.757059837417349,1.0,5/23,13.02%,SLC12A2;SLC12A8;SLC12A1;SLC12A5;CLCN3
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.4367848175812853,-0.9963578913241681,0.47653429602888087,0.6325627371491177,1.0,7/10,43.29%,ACADM;ACAD11;ACADVL;ACADS;GCDH;IVD;ACADL
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.322098799291158,0.9958336532531054,0.42755344418052255,0.7580312224077663,1.0,11/28,17.93%,ADCY8;PTN;SHANK3;NSG1;ADCY1;RELN;ARC;LGMN;CHRNA7;CALB1;FAM107A
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.3471542799766378,-0.9955635631672728,0.4846846846846847,0.633892867987202,1.0,8/24,19.35%,IRAK2;TAB2;NOD1;UBC;RPS27A;RNF34;CASP8;NOD2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.37612231457064893,0.995479387994059,0.43703703703703706,0.757786626465415,1.0,3/16,1.86%,AKAP6;ERBB4;ZFPM2
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.42574778686892345,-0.9947965905650491,0.45563139931740615,0.6351735079782407,1.0,4/10,17.54%,PPARG;RARG;RXRA;RARA
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.3305885342848114,-0.9944698481615867,0.4647887323943662,0.6355753232699801,1.0,4/30,6.76%,AKAP13;RAC1;ARHGEF3;ARRB1
prerank,ameboidal-type cell migration (GO:0001667),0.2811074870046356,0.9939898508453651,0.4674698795180723,0.7605322086118446,1.0,15/51,16.05%,ERBB4;SEMA6D;SEMA6A;SEMA3E;SEMA5A;GDNF;CCN3;SRGAP2;SEMA3F;TBX1;SEMA5B;AMOTL1;SEMA4G;RADIL;NRTN
prerank,calcium-mediated signaling (GO:0019722),0.25428294270142093,0.9939439338300273,0.4509283819628647,0.7594664029010807,1.0,15/93,10.56%,GRM5;ANK2;CACNA1C;RYR2;CHRM3;RCAN2;P2RY12;VCAM1;PRNP;PLCE1;CX3CR1;GPR143;AGTR1;EDN1;ATP1B1
prerank,regulation of steroid metabolic process (GO:0019218),-0.3506698068278185,-0.992667794455167,0.46017699115044247,0.6391496103779006,1.0,16/23,36.57%,APOE;ABCG1;PANK2;TTC39B;FMO5;ASAH1;NR1H4;ACADVL;ABCA2;LAMTOR1;UGT1A8;UGT1A1;STUB1;ARV1;DGKQ;GNB3
prerank,RNA interference (GO:0016246),-0.3750041261462983,-0.9923416944835032,0.4664310954063604,0.6395169788763048,1.0,5/17,25.03%,AGO2;DHX9;CELF1;TSNAX;TSN
prerank,regulation of intracellular pH (GO:0051453),0.31128759568060166,0.9923034776252605,0.4413793103448276,0.7624349928545332,1.0,5/34,5.66%,SLC4A10;SLC4A4;SLC9A2;SLC26A3;CA2
prerank,heterochromatin organization (GO:0070828),0.3807333562490165,0.9920325904665597,0.47126436781609193,0.7619469156054403,1.0,6/14,19.73%,HMGA2;SNAI1;BAHD1;MECOM;PRDM16;SIRT1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.39788580990040223,0.9914064471018345,0.47815533980582525,0.7623944937705986,1.0,2/12,2.34%,DSCAM;RORB
prerank,regulation of fibrinolysis (GO:0051917),-0.4091640248064442,-0.9911294980321786,0.4903677758318739,0.6418256088871497,1.0,6/13,35.97%,FAP;SERPINE1;APOH;F11;F12;HRG
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.3549437801042615,-0.9910530154236974,0.4755244755244755,0.6416671549465637,1.0,7/21,26.84%,RUNX1;ROCK1;CBFB;GDF3;SFN;MAFF;ZFP36L1
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.4182989114777601,-0.9909279327011724,0.5017421602787456,0.6416270503928012,1.0,4/11,15.17%,PICALM;SNX33;NEDD4L;LEPROTL1
prerank,regulation of neuroblast proliferation (GO:1902692),0.3776918712393566,0.9908970007490746,0.4560975609756098,0.7625329347563555,1.0,3/15,8.43%,TAFA1;PTN;CX3CR1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.39387701772847117,-0.9908575654550557,0.44563279857397503,0.6414706993598784,1.0,4/14,19.19%,KMT5B;KMT5C;CD226;SHLD2
prerank,positive regulation of nuclear division (GO:0051785),-0.3445376884261495,-0.9908424215111267,0.489247311827957,0.6411761369313275,1.0,8/25,21.46%,IGF1;INSR;CD28;NUSAP1;AURKA;PDGFRB;SIRT2;NUP62
prerank,lipid droplet formation (GO:0140042),0.4286125179284142,0.9907707333940002,0.4740566037735849,0.7616663241530971,1.0,3/10,19.24%,SQLE;ZFYVE1;CDS1
prerank,autophagosome organization (GO:1905037),-0.29494702555995245,-0.9900805793614522,0.4731369150779896,0.6425525119448003,1.0,14/50,24.95%,RAB7A;ATG5;PACS2;ATG7;RAB1A;ULK2;RB1CC1;GABARAP;ATG16L2;EMC6;BECN1;VMP1;RAB19;RAB1B
prerank,protein O-linked glycosylation (GO:0006493),-0.2609229320138572,-0.9899445254966149,0.46710526315789475,0.6425095889530721,1.0,22/96,14.55%,B4GALT5;TRAK1;TET3;ST3GAL1;OGT;GALNT7;GALNT10;DPM3;GALNT3;POFUT1;GALNT1;XXYLT1;ST6GAL1;C1GALT1;POMK;B3GNT2;GXYLT1;GALNT12;POMGNT1;GCNT1;TET2;LARGE1
prerank,positive regulation of axon extension (GO:0045773),-0.3555660618976712,-0.9896665641656158,0.4421768707482993,0.6427860133236093,1.0,5/22,7.83%,NRP1;GOLGA4;RUFY3;MACF1;VEGFA
prerank,protein depolymerization (GO:0051261),-0.32999997959409655,-0.9896304250527477,0.4551971326164875,0.6425423232792808,1.0,10/27,18.37%,CKAP5;WDR1;KIF14;MICAL1;MICAL2;KIF2C;STMN2;TWF2;KIF18B;CFL1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.40150472359123557,0.9894594022102928,0.4701834862385321,0.7627752735758166,1.0,2/12,2.18%,AKAP6;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.40150472359123557,0.9894594022102928,0.4701834862385321,0.7627752735758166,1.0,2/12,2.18%,AKAP6;CAMTA1
prerank,positive regulation of protein modification process (GO:0031401),-0.23279109528474212,-0.9892883422501743,0.48089171974522293,0.6429712021931014,1.0,37/203,16.02%,LYN;DAB2;CD74;NIBAN1;PRKCD;RAC1;INSR;RAP2A;RIPK1;CEP295;ATG7;CCND3;ATG10;RAB3GAP1;AXIN1;HGF;C3;ARRB1;GAS6;CAMKK2;VEGFA;FNIP1;PLAUR;TAOK1;PIN1;APP;FLCN;DYRK1A;WDFY2;CIB1;ACVR2A;RB1CC1;CD40;IL34;CRKL;MAVS;ANKLE2
prerank,regulation of epithelial cell migration (GO:0010632),-0.28985733982310535,-0.9892712655170739,0.4671280276816609,0.642690261303977,1.0,9/51,9.44%,SASH1;CORO1C;RREB1;PLCG2;ADIPOR1;MACF1;DOCK5;HIF1A;CTSH
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3403497608239304,0.9889873996298835,0.46604215456674475,0.7627890975525873,1.0,6/20,15.81%,MAPRE3;TTBK1;CCNYL1;PKD1;SPDYA;ADAM17
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.38278025083691114,-0.9888058167785977,0.4537521815008726,0.6433631586719561,1.0,4/15,19.24%,PAOX;SAT1;MOXD1;SAT2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.372916755093855,-0.9882080200829336,0.4709897610921502,0.6443330739597599,1.0,5/18,13.88%,AMFR;UBC;RPS27A;SEL1L;RNF185
prerank,regulation of amyloid fibril formation (GO:1905906),-0.39231963126373487,-0.9881170150430915,0.4899817850637523,0.64422390900003,1.0,4/15,22.74%,APOE;APP;LDLR;CRYAB
prerank,artery development (GO:0060840),0.3250871364481435,0.9877995949111185,0.4836272040302267,0.7646600080755525,1.0,2/23,0.73%,ROBO1;ROBO2
prerank,neural crest cell migration (GO:0001755),0.3024490080347681,0.987795006052048,0.44390243902439025,0.763490891509299,1.0,13/36,16.05%,ERBB4;SEMA6D;SEMA6A;SEMA3E;SEMA5A;GDNF;SEMA3F;TBX1;SEMA5B;FOLR1;SEMA4G;RADIL;NRTN
prerank,amino acid import across plasma membrane (GO:0089718),0.33731149987671566,0.9877540100144614,0.46411483253588515,0.7624240880761938,1.0,7/24,16.73%,SLC1A2;SLC1A6;SLC47A1;SLC1A1;SLC6A13;SLC16A2;SLC6A5
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.30483543820433723,-0.9876559881358354,0.46102819237147596,0.6449146255829987,1.0,16/42,33.99%,RARS1;FARS2;SARS1;CARS2;DARS1;EEF1E1;KARS1;TARS2;AARS1;DARS2;IARS1;EARS2;TARS3;WARS2;VARS2;RARS2
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.30424388802939406,-0.987426168158021,0.4798061389337641,0.645097019410126,1.0,17/40,33.15%,MCL1;PRKCD;ARMT1;SMYD2;RFWD3;WDR76;RADX;KMT5A;FEM1B;SMG1;UBE2V2;MYC;UBE2N;USP51;PARG;ANKLE1;NEK4
prerank,regulation of response to stress (GO:0080134),0.42730733272474647,0.9871809875680976,0.48847926267281105,0.7627454199356731,1.0,4/10,20.27%,ADCY8;DYRK3;OPRM1;STOX1
prerank,positive regulation of exocytosis (GO:0045921),0.30475752507553144,0.9866449632623756,0.4692874692874693,0.7630460825555198,1.0,6/35,6.30%,CADPS;CADPS2;RAB15;CLASP2;RAB27B;SDC1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3987121695236505,-0.9862540905514848,0.4819277108433735,0.6473362865901523,1.0,2/13,6.62%,STX7;CYRIB
prerank,anterior/posterior pattern specification (GO:0009952),0.27707864816335026,0.9860232566969589,0.48448687350835323,0.763398561380499,1.0,15/53,19.48%,PCSK5;HOXC4;WT1;HOXD3;TBX1;HES5;HOXC5;HOXC9;HES1;ATP6AP2;HOXB6;HOXC6;HES3;CELSR2;ACVR2B
prerank,organophosphate catabolic process (GO:0046434),-0.4107229761595268,-0.9858191565023927,0.48154657293497366,0.647936450436705,1.0,3/11,7.31%,PLBD1;ABHD12;PLBD2
prerank,snRNA 3'-end processing (GO:0034472),-0.36394093960420215,-0.9852521116171804,0.5074626865671642,0.648864578569421,1.0,11/19,33.87%,INTS8;EXOSC5;INTS6;INTS14;INTS1;INTS5;EXOSC4;EXOSC8;TUT1;USB1;EXOSC3
prerank,actin-myosin filament sliding (GO:0033275),0.302796362057899,0.984786852374077,0.4730392156862745,0.7643683279053934,1.0,6/38,11.10%,DMD;TNNI1;ACTA1;TNNT2;MYH7;TTN
prerank,muscle filament sliding (GO:0030049),0.302796362057899,0.984786852374077,0.4730392156862745,0.7643683279053934,1.0,6/38,11.10%,DMD;TNNI1;ACTA1;TNNT2;MYH7;TTN
prerank,protein localization to nucleus (GO:0034504),-0.25210295934081106,-0.9845234450413962,0.48281786941580757,0.6501623018479717,1.0,28/102,22.38%,SYK;IPO5;NUP50;STAT3;HHEX;RPL11;NUP88;E2F3;YWHAE;MORC3;GBP2;WRN;TPR;NUP188;TOR1AIP1;TAF8;APPL2;TAF3;NUP153;FAM53A;TNPO3;APPL1;NUP107;NXT2;NUP62;ZBTB7A;TOPORS;SPRN
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.3331325880417487,-0.9843614092658991,0.45340501792114696,0.6501860739926117,1.0,9/29,21.34%,DCP1A;PATL1;EXOSC5;DCP2;LSM6;CNOT8;DDX6;LSM5;EXOSC4
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.23434507853664435,-0.9843291333776923,0.5032154340836013,0.6499372429715615,1.0,58/186,28.61%,DAB2;APOE;RNF213;LRP1;ZNRF3;DKK2;PSME4;AMFR;PSMB7;PSME3;PSMB9;STK3;BICC1;AXIN1;MDFI;LRP6;SDHAF2;MDK;TLE3;PSMA8;PSMC3;PSMD8;STK11;CHD8;PSMC4;PSMB10;GREM1;PSMA1;UBAC2;RNF43;LATS2;TLE4;PSMB8;NFATC1;PTPRO;PSMA5;PSMD4;PSMB3;GSK3B;PSMD3;SFRP1;RACK1;SNAI2;DVL2;PSMB1;TMEM170B;CCDC88C;SIAH2;BMP2;CUL3;TMEM131L;TSC2;FRMD8;TLE2;PSMA7;NOTUM;SHISA2;DKK3
prerank,protein localization to cell surface (GO:0034394),0.3229595719610093,0.9842380572551612,0.47,0.764650251988142,1.0,7/26,14.37%,ANK2;PIGU;PTPRK;FGF10;EMP2;ARF6;RIC3
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2400850494929222,-0.9839247576260141,0.4902597402597403,0.6505139162572646,1.0,53/159,27.26%,TCF4;CYBA;SNX9;IMMP2L;UVRAG;DHX9;CENPF;DLGAP5;CENPA;AXIN1;FCHO2;PICALM;HIGD2A;EPS15;HIP1;CENPE;CCDC40;NUP205;DNAJB14;TPR;TBCE;HSP90AB1;TRAF2;GPX4;CHMP2A;HSPA4;PIK3C2A;POGZ;VAMP4;SHQ1;TESPA1;FMOD;HSPA1A;POMP;NUP153;COX7A2;ADRB2;VAMP1;PSMD4;NUP107;CD3E;CHMP4B;CHMP4A;EID2;TGFB1;COG4;TMEM35A;AP2S1;DNAAF1;NCK1;SMAD4;BBS10;HIGD1A
prerank,lipid oxidation (GO:0034440),-0.40099131256498344,-0.9837960709297386,0.4804964539007092,0.6504832611355548,1.0,4/12,26.75%,ADIPOR1;PLA2G7;ACOX1;ALOX15
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.3715550065877693,0.983083445708389,0.4567307692307692,0.7663764267425229,1.0,6/16,21.08%,HFM1;SHOC1;CORT;MEIOB;MSH4;RMI1
prerank,regulation of microtubule-based process (GO:0032886),-0.30575325526019137,-0.9829082693080717,0.48881239242685026,0.6521380574895026,1.0,11/36,20.30%,DIAPH1;ROCK1;MACF1;TAOK1;MARK2;KLHL42;AURKA;MEMO1;ATF5;CDK2AP2;GSK3B
prerank,polyamine metabolic process (GO:0006595),-0.39821846592470767,-0.9826960824340384,0.4836488812392427,0.6522697347016458,1.0,5/13,21.13%,PAOX;SAT1;HDAC10;SAT2;SMS
prerank,cellular response to drug (GO:0035690),0.32598932072321696,0.9821844339838376,0.4742014742014742,0.7675472610981084,1.0,2/25,1.60%,PDE4B;PPM1E
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2775816119151337,-0.9817725935826509,0.49584026622296173,0.6539177601411875,1.0,18/59,22.81%,PRKCD;ROCK1;CSNK2A1;DYRK2;TGFBR1;CDK1;DYRK1A;MAP2K1;TGFBR2;MARK2;MAP3K10;CHEK1;CDC42BPG;WNK1;GSK3B;CDK5;MAPK1;PRKDC
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.4006329107967831,-0.9817439333633204,0.46410684474123537,0.6536629618114497,1.0,2/13,2.65%,NUPR1;MTM1
prerank,endoderm development (GO:0007492),-0.4021496338747823,-0.9813015233857675,0.4882154882154882,0.6543084110379674,1.0,7/13,38.50%,KIF16B;DUSP5;SOX7;DUSP2;DUSP1;EOMES;SOX17
prerank,lamellipodium assembly (GO:0030032),0.3245015010114301,0.9812788996313918,0.46853146853146854,0.7687329701652584,1.0,6/26,8.93%,ARHGEF7;CDH13;P2RY12;CARMIL1;ABLIM1;SRGAP2
prerank,nuclear membrane reassembly (GO:0031468),-0.2840686370501453,-0.9812229850034505,0.488135593220339,0.6541593581676787,1.0,21/54,26.26%,NUP205;CHMP7;CDK1;NUP188;LEMD2;CHMP2A;ANKLE2;UBE2I;RCC1;NUP35;VPS4A;SIRT2;NUP107;REEP3;CHMP4B;CHMP4A;CCNB1;LMNA;CCNB2;CHMP2B;NUP37
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.32977468521416387,-0.9810202372168615,0.47368421052631576,0.6542933592185224,1.0,9/29,26.01%,RFC1;RTEL1;PPP6R3;HSP90AB1;GAR1;SHQ1;WRAP53;NHP2;MRE11
prerank,negative regulation of transmembrane transport (GO:0034763),-0.4275155073446556,-0.9809165458834537,0.498220640569395,0.6542087810166288,1.0,4/10,25.94%,PRKCB;IRS2;OAZ3;INPP5K
prerank,gene silencing by miRNA (GO:0035195),-0.31471506516908265,-0.9809053646479099,0.49559082892416223,0.6539162564516395,1.0,7/32,13.28%,AGO2;CNOT1;ZC3H7B;PUM2;XPO5;MOV10;TNRC6C
prerank,steroid metabolic process (GO:0008202),-0.2675480839922787,-0.9808000134858164,0.5183887915936952,0.6538404335104114,1.0,35/72,39.23%,LIPA;CYP27A1;HSD17B7;CYP46A1;FDXR;NPC1;CYP2R1;SRD5A1;AMACR;CYP26C1;CYP1B1;SRD5A2;LRP2;DHRS4;FDX1;HSD17B10;HSD3B2;HSD17B14;SCP2;FDX2;UGT1A7;UGT1A8;UGT1A1;ARV1;STARD3;DHRS11;BAAT;NR1I2;AKR1C1;HSD17B3;AKR1D1;CYP19A1;SULT2A1;VDR;TSPO
prerank,macromolecule catabolic process (GO:0009057),-0.33461785722027726,-0.9806146131262761,0.4697508896797153,0.6539264615006313,1.0,12/26,26.70%,UVRAG;KIF16B;SNX25;CLN6;TRIM24;SH3GLB1;TPP1;PPT1;BECN1;TGFB1;LRSAM1;SMURF1
prerank,protein processing (GO:0016485),0.24675917450973953,0.9804912593998686,0.5151515151515151,0.7696367796932803,1.0,19/102,14.70%,OMA1;METAP2;PCSK5;MMP16;PCSK2;MME;ECE2;ATP23;PCSK6;PRSS12;SEC11C;MMEL1;PCSK1;EEF1AKMT4-ECE2;CPE;GGT1;F9;LGMN;ECE1
prerank,myotube cell development (GO:0014904),-0.4198229843271602,-0.9803935401142995,0.4938704028021016,0.654067515249251,1.0,2/10,7.78%,IGF1;SKI
prerank,regulation of neuron apoptotic process (GO:0043523),0.24753963940484644,0.9799776039638105,0.4926829268292683,0.7698186565373084,1.0,21/96,14.45%,GRID2;TRIM2;NTRK2;EPHA7;GDNF;PRKCI;PRNP;BDNF;PTPRZ1;TFAP2A;NFATC4;FOXQ1;CITED1;TOX3;TGFB2;CDK5R1;TYRO3;VSTM2L;PRKN;PPARGC1A;LGMN
prerank,mucosal immune response (GO:0002385),-0.37986632818836186,-0.9798728448611631,0.48717948717948717,0.6548736659315023,1.0,7/15,44.29%,CAMP;DEFA6;RPL39;LTF;NOS2;RNASE3;IFNLR1
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.283231039918079,-0.9798480140927975,0.4612794612794613,0.6546021030425578,1.0,17/57,24.51%,BCL2L11;DDHD1;CAMKK2;PLAUR;FIS1;MLLT11;BBC3;BID;TNFSF10;AURKA;FBXO7;PDCD5;GSK3B;KDR;BIK;ZDHHC6;DCN
prerank,sarcomere organization (GO:0045214),0.3255787301408753,0.9797578911870135,0.48868778280542985,0.7692594467448884,1.0,6/27,17.04%,CSRP1;TNNT2;TTN;CAPN3;FHOD3;TPM1
prerank,organelle transport along microtubule (GO:0072384),-0.31793813437190915,-0.9789039828424367,0.4912891986062718,0.656304600252687,1.0,11/31,21.15%,TRAK1;PEX14;CDC42;RAB1A;FBXW11;LRPPRC;MAP1S;CLN3;UXT;PAFAH1B1;BORCS5
prerank,sulfur compound biosynthetic process (GO:0044272),-0.25175314332197474,-0.9784126132753006,0.5024711696869851,0.6570516544496955,1.0,23/104,20.36%,DSE;B4GALT5;ST3GAL1;CDO1;SLC10A7;SLC35D2;TPK1;CHST12;CHST11;CNDP2;B3GNT2;PRELP;CHST3;MPST;B4GALT3;CSPG4;AKR1A1;PAPSS1;FMOD;CHAC2;MAT2A;B4GALT1;BGN
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.253167843057311,-0.9782804208443074,0.4934640522875817,0.6570083869187139,1.0,16/102,13.39%,MYO5A;RAB8B;DENND4C;PRKCD;ADCY7;INSR;PPARG;RAB31;NFKB1;RHOQ;SELENOS;RELA;XBP1;PKM;RAB10;HDAC5
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.39531705713810206,0.978138374118306,0.49382716049382713,0.7723256645286055,1.0,6/12,19.25%,HUS1B;CLSPN;STK33;SETMAR;CHEK2;NAE1
prerank,negative regulation of cell differentiation (GO:0045596),-0.23449238210399218,-0.9779257017756529,0.5126903553299492,0.6574778119489302,1.0,44/181,21.80%,ABCA1;ABCG1;XDH;CDK6;RB1;NELFB;PPARG;CTR9;PTK2B;ADIPOR1;ITGAV;ANP32B;NR1H2;JAG1;SKI;SDHAF2;E2F1;TGFBR1;ASXL1;TRIB2;SPRED1;SPRY2;OSR1;SPRED2;CHADL;CCDC85B;METTL14;GREM1;TRIO;ID2;LDLRAD4;VASN;SMAD7;GATA3;MYB;DTX1;IL17RD;PTPN11;ENPP1;SUFU;SIRT2;SFRP1;ANKRD26;SNAI2
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.3919412451298509,-0.977914351244976,0.4709897610921502,0.6568643605127902,1.0,9/15,34.54%,AP3S1;AP3M1;DTNBP1;AP3B1;AP3D1;AP3B2;BLOC1S4;SNAPIN;BLOC1S2
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.3919412451298509,-0.977914351244976,0.4709897610921502,0.6568643605127902,1.0,9/15,34.54%,AP3S1;AP3M1;DTNBP1;AP3B1;AP3D1;AP3B2;BLOC1S4;SNAPIN;BLOC1S2
prerank,negative regulation of protein catabolic process (GO:0042177),-0.30694715858173616,-0.977507649969293,0.4936936936936937,0.6574224031791027,1.0,14/40,20.67%,ROCK1;SNX3;FLNA;CTSA;IRAK3;AZIN1;TIMP2;SF3B3;PIN1;CST3;SNRNP70;RILP;MDM4;SIRT2
prerank,telomere maintenance via telomerase (GO:0007004),-0.3340489800567607,-0.9771899725693614,0.4982638888888889,0.6577701789914393,1.0,9/28,26.01%,RFC1;RTEL1;PPP6R3;HSP90AB1;GAR1;SHQ1;WRAP53;NHP2;MRE11
prerank,regulation of vasculature development (GO:1901342),-0.3283223225451513,-0.9770840153600102,0.48703703703703705,0.6576917508418958,1.0,9/26,26.25%,SP100;PLXND1;CTNNB1;EGLN1;HTATIP2;SFRP1;IL6;HMOX1;VASH2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.42198093803897924,-0.9768757634066678,0.4991212653778559,0.6577976296382796,1.0,3/10,11.05%,SYNGR1;RAB5A;APP
prerank,cellular component maintenance (GO:0043954),0.38568541977824755,0.9763922138531519,0.4888888888888889,0.7757222607214621,1.0,4/12,7.51%,MTMR2;LNPK;PRNP;FYN
prerank,apoptotic DNA fragmentation (GO:0006309),-0.36860914926484534,-0.9763882480966192,0.5114638447971781,0.6585713658656094,1.0,5/16,24.84%,HMGB2;DFFA;ENDOG;HMGB1;DNASE2
prerank,negative regulation of cell communication (GO:0010648),0.33035472621958867,0.9763411469387969,0.4879807692307692,0.7746895843198311,1.0,5/21,15.90%,GLRA1;ACVR1;NLRP12;OPRM1;ERBB3
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.30806782301091973,-0.9760963115888538,0.5067340067340067,0.6589010619809678,1.0,6/37,9.25%,IGF1;JUN;ERN1;PPARG;MEF2D;MEF2C
prerank,cellular response to amino acid stimulus (GO:0071230),0.3062666850558047,0.9759077448348553,0.5033407572383074,0.7746607090422539,1.0,9/33,11.46%,GLRA1;SESN3;RRAGB;UBR1;FYN;GLRA2;CASTOR2;CPEB3;RPTOR
prerank,positive regulation of kinase activity (GO:0033674),-0.25232769961154944,-0.9754733569112937,0.5146103896103896,0.6599217936447304,1.0,15/107,8.35%,IQGAP1;PTPRC;CD74;AXL;SNX9;INSR;IGF1R;PRKAG2;RAP1A;TAB2;FLT1;PTK2B;GAS6;ALS2;CENPE
prerank,gluconeogenesis (GO:0006094),0.2942519254029564,0.975267005408897,0.4755244755244755,0.775184658004604,1.0,10/39,14.31%,PFKFB1;GOT1;ENO1;GAPDHS;G6PC3;G6PC1;ALDOB;SLC25A11;PER2;PPARGC1A
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.3355438850026392,0.9746299817265903,0.5119617224880383,0.7756453713435629,1.0,5/20,13.69%,SLC8A3;SLC25A23;LETM1;PMPCB;MICU3
prerank,tRNA aminoacylation (GO:0043039),-0.30763096573388293,-0.9745957449733047,0.5017182130584192,0.6614751186496999,1.0,9/37,23.68%,RARS1;FARS2;SARS1;DARS1;EEF1E1;KARS1;AARS1;DARS2;IARS1
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.4000408065214052,-0.9742458363179555,0.5008264462809917,0.6618858015612494,1.0,2/12,5.78%,NELFB;JAG1
prerank,regulation of osteoblast differentiation (GO:0045667),0.2528035274985413,0.9739204974408712,0.51,0.7763842770532755,1.0,25/82,20.56%,NELL1;SOX11;RORB;BMPR1B;ACVR1;YAP1;PRKD1;SUCO;SOX9;BMP7;CITED1;FERMT2;MEN1;ATRAID;REST;NOCT;RIOX1;TMEM64;PTK2;SMOC1;RANBP3L;ACVR2B;WWTR1;LRP3;FBXO5
prerank,tRNA 5'-leader removal (GO:0001682),0.38265928640315183,0.9738977025158475,0.4688995215311005,0.7752867965152008,1.0,6/13,21.45%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.33042290660397255,-0.9738012518814977,0.4966101694915254,0.6625235993414065,1.0,13/27,30.08%,ERN1;RNASE4;KHNYN;RNASE6;NYNRIN;CPSF3;ZC3H12A;NHP2;NUDT16;ZC3H12D;LACTB2;ZC3H12C;POP1
prerank,positive regulation of cyclase activity (GO:0031281),0.3710931638654129,0.9735541651472805,0.5034802784222738,0.7750257995369456,1.0,1/14,0.82%,CACNA1C
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.3928352466788185,-0.9730669129955418,0.5245614035087719,0.6637721871846137,1.0,5/14,19.93%,MDFI;TMSB4X;NFKBIB;FAF1;SUFU
prerank,positive regulation of protein maturation (GO:1903319),-0.4187632209615074,-0.972642531351679,0.47368421052631576,0.6643472764864923,1.0,5/11,33.97%,NLRC4;ADAM8;CCBE1;RHBDD1;TFR2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.35686651658733165,0.972629755941952,0.5086848635235732,0.7762928381613614,1.0,6/17,18.29%,AHI1;SOX9;TMEM100;KDF1;RFX3;SULT2B1
prerank,rRNA transcription (GO:0009303),-0.37006547624295383,-0.9723059155222882,0.49401709401709404,0.6647599615645425,1.0,7/17,27.73%,SPIN1;NIFK;ANG;GTF3A;GTF3C5;BRF1;POLR1E
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.2652538488830317,-0.9720690194560218,0.5034602076124568,0.6649517637100167,1.0,18/72,15.57%,APOE;PRKCD;ATXN7;ARHGEF2;ARFGEF1;CYRIB;MYADM;LIMA1;TPX2;TAOK1;DYRK1A;PIK3CA;CHADL;SSH3;CIB1;SPEF1;STMN2;SSH1
prerank,mitochondrion disassembly (GO:0061726),-0.31339773540594756,-0.9720461513062768,0.5116279069767442,0.6646708907574471,1.0,9/34,17.82%,ATG5;ATG7;ULK2;FIS1;RB1CC1;MARK2;GABARAP;USP30;FBXO7
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.3063067200409902,-0.9715370541417373,0.512998266897747,0.6654581118858389,1.0,7/35,8.31%,NRP1;RAC1;FLNA;PLXND1;SEMA4A;NRP2;SH3BP1
prerank,negative regulation of cell activation (GO:0050866),-0.38625244620008703,-0.971187867040097,0.504258943781942,0.6658784316592018,1.0,1/14,0.16%,APOE
prerank,central nervous system neuron development (GO:0021954),0.3680102251553943,0.9711823547335293,0.5,0.7789205466635613,1.0,2/15,1.99%,MAP2;NTRK2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.403124302729182,-0.9710302686500335,0.4878472222222222,0.6658965051595912,1.0,5/12,27.44%,BRCA1;YTHDC1;CDYL;RBM15B;METTL3
prerank,protein localization to chromatin (GO:0071168),-0.361397881862522,-0.9708110121425972,0.4947916666666667,0.6660346957659791,1.0,11/18,39.68%,NIPBL;MCM9;CHMP7;LEMD2;LRWD1;ESR1;FAM47E;RAD21;WAPL;MRNIP;RUVBL2
prerank,dicarboxylic acid catabolic process (GO:0043649),0.37942970651127306,0.9706105553448428,0.47058823529411764,0.7792994446721437,1.0,4/13,14.45%,ASPA;GOT1;GLUL;ACOT8
prerank,cellular response to light stimulus (GO:0071482),-0.26862018844780533,-0.9701457037461044,0.5127768313458262,0.6670969229622412,1.0,34/66,40.18%,GNB1;PRKCD;CREBBP;CDC25A;PCNA;DHX36;ERCC4;RHNO1;TMEM161A;YY1;INO80;NSMCE3;KDM1A;MYC;NOC2L;USP28;METTL3;EP300;GPR52;AQP1;ZBTB1;COPS9;CNGB1;ATF4;RHBDD1;EIF2S1;RRH;SAG;MAPK13;USP47;SDE2;TRIAP1;RUVBL2;AURKB
prerank,histone lysine methylation (GO:0034968),-0.31382398926732047,-0.9698019903253421,0.48596491228070177,0.6674959312213002,1.0,15/33,28.48%,SMYD2;SMYD3;EZH2;WDR5;KMT2D;SMYD1;SETDB1;DOT1L;KMT2A;CXXC1;SETD6;RBBP5;ASH2L;KDM6A;WDR5B
prerank,pharyngeal system development (GO:0060037),0.3643624562500535,0.9695832164303512,0.4872389791183295,0.7808375486900476,1.0,5/15,14.87%,BMP7;TBX1;TGFB2;HES1;FOLR1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3866194401734025,-0.9689308540902681,0.4991304347826087,0.6690613310417174,1.0,6/14,22.16%,MDK;CCL5;IL34;CMKLR1;CSF1;MAPK1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.3711439669156199,-0.9682941304543031,0.4991596638655462,0.6700644800434946,1.0,7/16,26.84%,RC3H1;MOV10;DHX36;ZC3H12A;TARDBP;ZC3H12D;ZFP36L1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.2972760782273539,0.9680807397355469,0.49534883720930234,0.7836405583292685,1.0,8/35,16.32%,PAM;FAR2;HMGCLL1;GGT1;ACACA;ACAT1;HSD17B8;GGT5
prerank,negative regulation of protein secretion (GO:0050709),-0.302175397733283,-0.9680348402431941,0.5256637168141592,0.6702927394523779,1.0,6/38,10.44%,APOE;RAB11FIP5;RSAD2;RHBDF1;RHBDF2;CHGA
prerank,negative regulation of dephosphorylation (GO:0035305),-0.35969601217702146,-0.9679905212948017,0.5,0.6700672586564639,1.0,3/18,8.85%,MFHAS1;ZCCHC9;GPATCH2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3355043036562812,-0.9678087614306486,0.5068493150684932,0.6701696110818403,1.0,7/23,20.02%,PLBD1;PLA2G4A;PLAAT3;PLA2G6;PLA2G5;PLA2G12A;LPCAT3
prerank,protein localization to chromosome (GO:0034502),-0.30782059784258226,-0.9668278002912727,0.5468483816013628,0.6719817874819028,1.0,8/34,16.40%,RB1;CENPA;MCM9;CHMP7;XRCC4;TNKS2;LEMD2;TPP1
prerank,regulation of neurogenesis (GO:0050767),0.2689513267552363,0.9665903490027365,0.5106888361045131,0.7863444943630425,1.0,17/55,19.13%,SOX11;MME;YAP1;HOOK3;NUMB;CX3CR1;RASSF10;PER2;HES5;REST;HES1;OPRM1;PRUNE1;HES3;DOCK7;SNW1;PCM1
prerank,positive regulation of protein transport (GO:0051222),-0.26783045081647194,-0.9663010358957137,0.5192926045016077,0.6727954400995342,1.0,16/67,16.91%,IGF1;ABCG1;RUFY3;TMED10;KIF20B;ADAM9;GOLPH3L;ADAM8;MYOM1;TPR;RAB29;PLK3;ANG;ARHGEF5;CLN3;PCNT
prerank,microtubule anchoring (GO:0034453),0.3969373680145547,0.9661486917203272,0.5,0.7862510654775063,1.0,2/12,4.30%,BICD1;CLASP2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.3559056550749129,0.9657022360560614,0.5092165898617511,0.7862722654202156,1.0,2/17,1.35%,ROBO1;SLIT2
prerank,global genome nucleotide-excision repair (GO:0070911),-0.33219772195914743,-0.9655205967584564,0.5096322241681261,0.6742001369563371,1.0,6/26,14.34%,DDB2;RNF111;UBC;RPS27A;CUL4B;ERCC4
prerank,positive regulation of wound healing (GO:0090303),-0.3056009445977572,-0.9649220726199799,0.49829351535836175,0.6751248943288013,1.0,7/36,12.79%,RREB1;HPSE;ITGB1;ARFGEF1;ANXA1;XBP1;SERPINE1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.35340133990867195,-0.964658462750924,0.5390199637023594,0.6753737156916233,1.0,7/20,21.85%,MCL1;ITGAV;BCL2;CASP2;GSK3B;APPL1;BCL2L2
prerank,cellular response to interferon-beta (GO:0035458),-0.3902338530758388,-0.9640564307287286,0.5353356890459364,0.6763379996730298,1.0,5/14,28.53%,AIM2;IFITM2;CDC34;STAT1;IRGC
prerank,regulation of ERAD pathway (GO:1904292),-0.411362153644689,-0.9640186003183534,0.5102389078498294,0.6760843568246471,1.0,5/11,21.59%,ATXN3;RNF185;TMEM259;UBXN1;BAG6
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.38348019103716363,0.963961590441192,0.5047619047619047,0.789770538561857,1.0,3/12,9.57%,SNAP25;STX2;PRRT2
prerank,regulation of cell differentiation (GO:0045595),-0.23627843375994068,-0.9638162343397223,0.5430894308943089,0.6762000355968226,1.0,29/148,17.97%,RUNX1;PRKCB;TRPS1;BCL6;CDK6;ROCK1;SLC6A6;CREBBP;RUNX3;FES;RUNX2;ANP32B;EIF2AK2;MDK;TGFBR1;CBFB;DDX5;SIK1;CDK5RAP1;LTBP4;HSP90AB1;GREM1;ID2;FLOT2;TAF8;VHL;PLEKHB1;SMAD7;GATA3
prerank,base conversion or substitution editing (GO:0016553),-0.4084629270595828,-0.9623309022196691,0.5137931034482759,0.6791120088047842,1.0,1/11,0.05%,APOBEC1
prerank,substantia nigra development (GO:0021762),-0.3005793923909956,-0.9616049973243327,0.5380434782608695,0.6803506670756916,1.0,7/37,10.09%,RHOA;ZNF148;CDC42;ACTB;RAD1;YWHAE;SUDS3
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3342230984211663,0.9604254288370773,0.49176470588235294,0.7978002585852408,1.0,3/22,2.21%,MAP2;MAP1B;MAPRE3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.24488217954265554,0.9602583879048159,0.5344352617079889,0.7970737538853406,1.0,22/93,16.07%,DMD;NTRK3;TENM1;PDE4D;MLXIPL;OPRD1;RAMP3;PRKD1;BDNF;INPP5J;CREBL2;SPTBN4;CAPRIN2;SH2D3C;RPTOR;NLRP2B;CNOT9;ATP2B4;HSP90AA1;CNKSR3;BRAF;SNCA
prerank,cellular response to leucine (GO:0071233),-0.42299793920429407,-0.959805253107797,0.5144927536231884,0.6835907651035437,1.0,4/10,11.77%,KLHL22;UBR2;RRAGD;SESN1
prerank,response to leucine (GO:0043201),-0.42299793920429407,-0.959805253107797,0.5144927536231884,0.6835907651035437,1.0,4/10,11.77%,KLHL22;UBR2;RRAGD;SESN1
prerank,regulation of chemotaxis (GO:0050920),-0.3165407982228546,-0.9596253152993099,0.5301204819277109,0.6836800703602022,1.0,11/30,24.71%,P2RX4;DUSP3;STX3;CYRIB;ZSWIM8;ZSWIM6;CXCR4;STX4;PDGFRB;TGFB1;ZSWIM4
prerank,embryonic digit morphogenesis (GO:0042733),-0.35033465043069445,-0.9591697242817251,0.5109489051094891,0.6843686464215125,1.0,3/18,11.44%,CREBBP;MAP3K20;OSR1
prerank,apoptotic nuclear changes (GO:0030262),-0.32488557459558814,-0.958725656587722,0.5343915343915344,0.6850287673788977,1.0,9/24,26.19%,TOP2A;ACIN1;HMGB2;DFFA;ENDOG;HMGB1;DNASE2;DEDD2;ERN2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.22862108124999278,0.9578293003653435,0.5454545454545454,0.8021005928035325,1.0,28/140,16.92%,HTR2C;CACNA1C;RYR2;CACNA2D1;ADCY8;GRM1;ADCY5;PLCE1;ADRA1B;TRPM1;CX3CR1;JPH4;CCKBR;PLCZ1;AGTR1;EDN1;LPAR2;FFAR1;BCAP31;F2RL2;ADRA1D;ADRA1A;TAC1;JPH3;OPRL1;CXCR3;IAPP;GPR157
prerank,neuron maturation (GO:0042551),0.3474181241446998,0.9575943850692652,0.4938875305623472,0.801533760297289,1.0,2/18,2.37%,ADGRB3;SRRM4
prerank,myelin assembly (GO:0032288),0.4025129556868143,0.955862004484691,0.5208333333333334,0.8048509499245369,1.0,2/10,3.91%,TENM4;EPB41L3
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.36954124441146985,-0.9555005505280104,0.5352839931153184,0.6916453396250837,1.0,2/16,5.50%,AOAH;PHKG2
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.29778728352515155,-0.9551509274468518,0.5292096219931272,0.6920325225727343,1.0,20/37,41.98%,ENTPD6;DNASE1L1;RNASE6;NCBP1;ENTPD3;XRN2;MTREX;NUDT15;SND1;NUDT16;RNASEH2B;ISG20;ENTPD7;NUDT1;DNASE1;NUDT5;RNASE3;DNASE1L2;RNASEH2A;ENTPD1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.3061058194547033,0.9550072213844338,0.5199063231850117,0.8047107122402457,1.0,12/29,22.83%,GLYAT;ACSM5;ACOT8;ACAT1;MLYCD;ACSM3;ACSL6;ACOT12;ACOT7;CROT;GPAT4;OXSM
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.3061058194547033,0.9550072213844338,0.5199063231850117,0.8047107122402457,1.0,12/29,22.83%,GLYAT;ACSM5;ACOT8;ACAT1;MLYCD;ACSM3;ACSL6;ACOT12;ACOT7;CROT;GPAT4;OXSM
prerank,skeletal system morphogenesis (GO:0048705),0.28091645381942576,0.9543697252887838,0.5233644859813084,0.8051099638455669,1.0,8/42,15.62%,HOXC4;SOX11;DSCAML1;HOXD3;TFAP2A;MMP13;HOXC9;FUZ
prerank,mitochondrial membrane organization (GO:0007006),-0.30997986704415986,-0.9542701044163844,0.5577264653641207,0.6936057134431984,1.0,15/32,34.09%,HSPA9;BCL2;MICOS13;TMEM11;GHITM;SLC25A4;MAIP1;MTX1;DNAJC11;SLC25A31;BCL2L1;BNIP3;CHCHD6;SAMM50;MICOS10
prerank,transcription preinitiation complex assembly (GO:0070897),-0.39883235067706996,-0.9541834342860198,0.5033783783783784,0.6934827929543427,1.0,3/12,27.73%,DR1;GTF2A2;POLR1E
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.35905704754995516,0.9541419558134704,0.527027027027027,0.8045575740376769,1.0,6/17,13.09%,ADRA1B;GPR101;ADRA2C;ADRA1D;ADRA1A;ADRB1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2734857112421456,0.9538628453118001,0.5298329355608592,0.8041095293195747,1.0,7/48,8.71%,ADCY2;ADCY8;PANK3;GUCY1B1;ADCY5;ADCY3;ADCY1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.3369131436312517,-0.9538102219735604,0.5272407732864675,0.6939883049760898,1.0,4/21,10.69%,MFHAS1;YWHAE;MASTL;STYXL1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.23981352616222734,0.9535012952158249,0.5736040609137056,0.8039295149238771,1.0,17/98,13.71%,DPP10;ANK3;SORBS1;PRKCE;TCAF1;RAMP3;TFDP2;MIEF1;PRKCI;PRNP;FYN;MTCL1;NKD2;ARF6;STAC;PRKN;ATP2B4
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.28574220034286196,0.9533735187817602,0.5200945626477541,0.8030983175104358,1.0,12/38,20.52%,RORA;OTUD7A;NLRP12;NR1D1;GSTP1;OTUD7B;TNIP1;TRIM59;CCDC22;SIRT1;PER1;TREM2
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.3298468364902942,-0.9530908936402561,0.5266781411359724,0.6952257225716978,1.0,11/24,35.49%,SLC27A1;PLA2G4A;PLA2G5;PLA2G12A;PNPLA8;PLA2G15;LPCAT4;ABCA3;PGS1;PLA2G3;PLA2G4B
prerank,protein complex oligomerization (GO:0051259),-0.2541307264496899,-0.9528187032972687,0.5506756756756757,0.6954776541770742,1.0,28/85,25.50%,LRRC8D;RNF213;PDCD6IP;EHD4;CARD11;NLRC4;LRRC8C;BLM;FUS;ALS2;TMEM120B;PRMT1;SLC9A1;NUDT21;EHD1;CHMP2A;IKZF4;CLDN1;MAT2A;HGSNAT;ZC3H12A;RNF135;TWNK;TRIM72;UPB1;PRF1;ECT2;MS4A1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.40196007346372825,-0.9526000574106815,0.517921146953405,0.6956474572223356,1.0,2/11,13.66%,SP100;TFAP4
prerank,negative regulation of protein processing (GO:0010955),-0.3968211698879841,-0.9518558170349856,0.5247863247863248,0.6969741700429599,1.0,3/12,18.18%,CTSZ;SERPINE1;TMEM59
prerank,RNA transport (GO:0050658),-0.26533702872919224,-0.9516956793424726,0.5617391304347826,0.6969994885053248,1.0,31/71,32.71%,RFTN1;SRRM1;CHTOP;RAE1;CDC40;CKAP5;XPO5;ALYREF;TPR;NUP188;TGFBR2;NCBP1;THOC2;RNPS1;NUP153;THOC6;HNRNPA1;MAGOH;SLU7;NUP62;SRSF11;DDX39B;DHX38;U2AF2;ZFP36L1;SRSF7;EIF4A3;EIF4E;SRSF5;SARNP;U2AF1L4
prerank,positive regulation of biomineral tissue development (GO:0070169),0.28980499053025166,0.9513773658883079,0.5259433962264151,0.8071239340617891,1.0,9/40,9.33%,NELL1;BMPR1B;PTN;ACVR1;GPM6B;ADGRV1;BMP7;AMELX;TFAP2A
prerank,female gonad development (GO:0008585),-0.3477475854182159,-0.9508760997170499,0.5432525951557093,0.6984190041634951,1.0,10/19,38.04%,VEGFA;ANG;NUP107;CEBPB;INHA;EIF2B2;EIF2B4;CYP19A1;FSHR;LHCGR
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.27419484598525046,-0.9505258770319767,0.5491525423728814,0.6988552088713887,1.0,15/49,23.13%,PMEPA1;RIOK3;CDC42;PTGER4;KIF14;AIDA;NLRC3;LDLRAD4;TFIP11;DDX3X;HMGB1;TMC8;GSK3B;CRYAB;MEFV
prerank,alpha-amino acid metabolic process (GO:1901605),0.2783161598561962,0.9504152369623412,0.5166240409207161,0.8084860915919221,1.0,12/45,17.58%,ASPA;GOT1;GLUL;ALDH18A1;GPT;FOLH1;ASNS;RIMKLB;GLS2;GLS;GPT2;CBS
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.3043348623857603,-0.9501868151302908,0.5261261261261261,0.699305103192669,1.0,16/35,34.58%,RTEL1;CTNNB1;CCT7;PKIB;DHX36;TNKS2;CCT4;HNRNPA1;ATM;MAPK1;MAPK15;MAP3K4;NEK7;TNKS;CCT8;CCT5
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.364377448620952,-0.9494632253901556,0.5224137931034483,0.7005658218175624,1.0,8/15,27.15%,LRP1;DPP4;FAP;CST3;IL6;TGFB1;FGFR4;PDPN
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.33369817990727946,-0.9490987733498737,0.5459272097053726,0.7010532261793833,1.0,6/25,15.42%,NRP1;SDCBP;NCKAP1L;APP;CCL5;ANG
prerank,inositol phosphate metabolic process (GO:0043647),0.27435944529920603,0.9490056855215994,0.5310344827586206,0.81095071134721,1.0,12/46,12.62%,PLCB1;NUDT11;PLCH2;PLCE1;IP6K2;INPP5J;ITPKA;INPP4B;PLCZ1;PLCD3;CALM1;PPIP5K2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.2865337110203605,-0.9484370554704872,0.5316666666666666,0.7021939507918988,1.0,13/45,27.20%,DAB2;SDCBP;RBPMS;TGFBR1;ACVR2A;TTK;GDF3;BMPR2;INHA;TGFB1;SMAD4;BMP2;ENG
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.22449251273121412,0.9482744797435011,0.5879265091863517,0.8116739012762466,1.0,25/142,14.41%,CACNA1C;TRPC5;RYR2;ADCY8;HCRTR2;TRPC1;ADCY5;PLCE1;ADRA1B;CX3CR1;CCKBR;SLC8A2;PLCZ1;RYR1;AGTR1;EDN1;CALCB;LPAR2;FFAR1;BCAP31;ADRA1D;ADRA1A;TAC1;ATP2B4;ATP2B2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3431519771316511,0.9476494463938223,0.530952380952381,0.8121344595352331,1.0,5/17,15.81%,MAPRE3;CCNYL1;PKD1;SPDYA;ADAM17
prerank,chondrocyte differentiation (GO:0002062),0.2921305957289558,0.9469823205941864,0.514218009478673,0.8126846078002501,1.0,9/32,11.92%,NFIB;BMPR1B;SOX5;SOX6;CCN3;HMGA2;SOX9;AMELX;HES5
prerank,mitochondrial fission (GO:0000266),0.36534201192718363,0.9468472535255936,0.5483870967741935,0.8118404988196664,1.0,3/16,6.08%,DNM3;MIEF1;DNM1
prerank,dopamine metabolic process (GO:0042417),0.33727691137146476,0.9467061899535256,0.5172413793103449,0.8110325662862141,1.0,6/18,16.07%,SNCAIP;MAOA;MAOB;TGFB2;PRKN;SNCA
prerank,regulation of cell death (GO:0010941),-0.25088308103267504,-0.9463651577603921,0.5663865546218487,0.706371008706015,1.0,32/94,26.56%,CTSZ;LRP1;CD36;ACER3;TNFRSF1B;ATG5;HTR2B;SLC25A24;NOA1;TXNDC12;CELF1;RAB29;CCL5;SPEF1;CHMP2A;EIF4G1;TMEM109;FAF1;BNIP3L;HSPA1A;ZC3H12A;RILPL1;HPR;HP;CHMP4B;BECN1;CRYAB;CCN4;MT3;NCK1;CCN2;PDE8A
prerank,apoptotic cell clearance (GO:0043277),0.2954049057796906,0.9456316493393319,0.5401459854014599,0.8125776992593297,1.0,5/30,6.42%,XKR4;XKR6;RHOBTB2;ITGB3;XKR8
prerank,regulation of axon extension (GO:0030516),-0.29897876348915753,-0.9454698453884336,0.5365025466893039,0.7080246710623199,1.0,5/37,5.63%,APOE;DNM2;GOLGA4;RUFY3;MACF1
prerank,negative regulation of macrophage activation (GO:0043031),0.3465231621353919,0.9453772643647316,0.5264423076923077,0.8120681735871083,1.0,4/16,9.98%,LRFN5;CD200;SYT11;NR1D1
prerank,cellular response to gamma radiation (GO:0071480),-0.35565342910672826,-0.9452623354564154,0.531578947368421,0.7081401566897221,1.0,7/17,22.74%,MAP3K20;XRCC6;WRN;TMEM109;ATM;KDM1A;CRYAB
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.241528306168776,-0.9443825307853183,0.585,0.7097193594658957,1.0,28/113,21.24%,NRP1;IGF1;NOTCH2;RREB1;C5AR1;HTR2B;NRP2;GRN;VEGFA;NME1;MDK;TGFBR1;JAML;HIF1A;ARNT;XBP1;OSR1;HMGB2;PIK3CD;ANG;NR4A1;CLDN1;NRAS;AGGF1;NOD2;BMPR2;SFRP1;KDR
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.2710095271116308,-0.9441914292530517,0.5424954792043399,0.7097911906060819,1.0,18/60,25.02%,NFKB1;RUNX2;MED24;CTNNB1;CBFB;RELA;MOV10;CDK1;MED4;MED31;TNRC6C;DHX36;MED6;MED20;CEBPB;IL6;CCNB1;TRIM28
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3132207460316086,0.9440064271278937,0.5245098039215687,0.8144764623718711,1.0,6/22,12.99%,EPB41L4B;PTPRK;FGF10;PRKD1;AREG;KLF9
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.35369189603621587,-0.9439949076041394,0.52,0.7098740725716088,1.0,4/18,18.76%,CEP295;CCT7;CCT4;WRAP53
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2743885356805687,-0.9432169077485841,0.5440677966101695,0.7112688779628754,1.0,8/53,12.65%,APOE;NUPR1;UCHL5;GNA12;PSME3;RHBDF1;PSMC3;HSP90AB1
prerank,programmed necrotic cell death (GO:0097300),-0.3528545787857027,-0.9429582977581832,0.5667808219178082,0.7114965600318726,1.0,8/18,28.86%,RIPK1;TLR4;LY96;TICAM1;MLKL;TICAM2;ITPK1;RIPK3
prerank,positive regulation of cellular senescence (GO:2000774),-0.41684981842775404,-0.9427597550391842,0.5380710659898477,0.7115861132715814,1.0,4/10,15.88%,CGAS;B2M;EEF1E1;ARG2
prerank,regulation of monooxygenase activity (GO:0032768),-0.33740691423814595,-0.9427250175892573,0.5289855072463768,0.7113286257549662,1.0,3/23,6.31%,DNM2;POR;WASL
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3101621154587386,-0.9417243196437276,0.5355285961871751,0.7131678957261397,1.0,4/29,4.65%,FGR;DGKZ;FLT1;PTK2B
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.27387690090738215,-0.9411725543016918,0.551304347826087,0.7140297328095966,1.0,10/55,10.67%,CD44;HEXA;LYVE1;HPSE;GNS;GALNS;SLC9A1;GUSB;SDC4;PRELP
prerank,zymogen activation (GO:0031638),0.28307534127208533,0.9411333046371936,0.5320665083135392,0.8207317245045547,1.0,15/39,22.81%,GRIN2A;OMA1;PRSS12;TBC1D10A;GGT1;F9;LGMN;CIDEB;PERP;KLK1;FADD;KLKB1;MMP14;KLK2;C1RL
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.3705162038052729,-0.9407050054089842,0.5343642611683849,0.7147122735573218,1.0,5/15,27.66%,ERN1;TSEN54;DDX1;CPSF1;ZBTB8OS
prerank,positive regulation of cell development (GO:0010720),0.2998593608647171,0.9406293528520053,0.5230414746543779,0.8208591005886388,1.0,9/31,18.95%,SOX11;MME;NUMB;CX3CR1;RASSF10;RFX3;OPRM1;PDE3A;SNW1
prerank,dorsal/ventral pattern formation (GO:0009953),0.33309616839789224,0.9401909122058504,0.5344418052256532,0.8208570302311876,1.0,4/20,10.96%,BMPR1B;ACVR1;DSCAML1;NBL1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.29512776618251096,0.9401633515806945,0.5602836879432624,0.8197607419940629,1.0,13/32,21.40%,MAGI2;CAMTA1;DLC1;PPP1R16B;CALM1;CALM3;CALM2;CDH5;CNEP1R1;PPP1R7;NSMF;CDCA2;SYMPK
prerank,ganglion development (GO:0061548),-0.40305563184991944,-0.9400807965946161,0.5474060822898033,0.7157573761685206,1.0,3/11,7.15%,NRP1;NRP2;CTNNB1
prerank,response to amyloid-beta (GO:1904645),-0.2860827434843636,-0.9389279372261189,0.5469026548672566,0.7179016694035723,1.0,11/44,12.80%,ITGA4;IGF1;LRP1;CD36;IGF1R;TLR4;SNX6;CASP4;ABCC1;APP;FCGR2B
prerank,positive regulation of phospholipase activity (GO:0010518),-0.33115624682008493,-0.9385279228021777,0.5769230769230769,0.718413088302869,1.0,7/22,19.28%,ABL2;FLT1;GNA13;CCL5;ARL1;PDGFRB;PLA2G5
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.33740467814203506,0.938393560812426,0.5319148936170213,0.8231774564676981,1.0,3/18,7.07%,SOX6;CCN3;BDNF
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.3843349877258141,-0.9381251957475536,0.5646853146853147,0.7189147097616713,1.0,7/12,27.34%,STAT3;BCDIN3D;ZC3H12A;IL6;TGFB1;NCOR1;ESR1
prerank,response to cholesterol (GO:0070723),-0.35198934021369954,-0.9375534344265114,0.5339130434782609,0.7198167848706872,1.0,7/17,25.06%,GRAMD1B;LRP6;TGFBR1;TGFBR2;TGFB1;GPLD1;ABCA2
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.3833986399881123,0.9374750852205012,0.5437352245862884,0.8244622271641142,1.0,2/11,10.93%,ZFPM2;TGFB2
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.2213986592604366,-0.9374488401440677,0.6390625,0.7196943538989583,1.0,43/199,20.30%,RBPJ;ATP2B1;PAEP;CORO1C;RB1;ROCK1;SPI1;RAB11FIP5;IL15;TLR4;SRGN;ADIPOR1;PTGER4;LNPEP;NR1H2;PLCL2;GAS6;GRN;SDHAF2;MDK;TLE3;MEF2C;SPRED1;SPRY2;ACOT13;FLCN;SPRED2;STK11;FCGR2B;LDLRAD4;IL18R1;VASN;SMAD7;PTPRO;TFE3;GATA3;IL17RD;RHEB;ID1;WDR77;AGER;BMPR2;GSK3B
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.32417842398237623,0.9372320269236932,0.5440180586907449,0.8239188387452776,1.0,5/20,13.39%,SPRY4;APLN;SMOC2;CREB3L1;SPRY1
prerank,regulation of lipid metabolic process (GO:0019216),-0.25198906793223214,-0.936655546866996,0.577391304347826,0.7211079606156519,1.0,18/88,14.94%,PSAP;CREBBP;PPARD;PANK2;NFYA;PRKAG2;PPARG;ADIPOR1;SMARCD3;TBL1XR1;EDF1;HELZ2;NPC2;IDI1;RXRA;SIN3A;ID2;ACACB
prerank,negative regulation of histone methylation (GO:0031061),-0.4080481384175681,-0.9361678013209268,0.5561594202898551,0.7218525810253146,1.0,3/10,8.54%,BRCA1;JARID2;WDR5
prerank,organic cation transport (GO:0015695),0.3319534970249327,0.9360483946897811,0.56,0.8258141607668893,1.0,3/20,5.80%,SLC25A19;SLC47A1;SLC5A7
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.34585077579584483,-0.9356362717636447,0.5616438356164384,0.7226650347948764,1.0,4/20,9.96%,IMPDH2;HPRT1;ADSS1;NT5C2
prerank,polyol metabolic process (GO:0019751),0.26942187652498867,0.9354971348251321,0.5532879818594104,0.8260762718584015,1.0,12/46,12.62%,PLCB1;NUDT11;PLCH2;PLCE1;IP6K2;INPP5J;ITPKA;INPP4B;PLCZ1;PLCD3;CALM1;PPIP5K2
prerank,protein secretion (GO:0009306),0.2601745357622119,0.9339954767435157,0.5889423076923077,0.828745232743557,1.0,6/56,5.60%,RIMS2;OLFM2;PCSK5;RAB3C;RAB15;MAFA
prerank,blood vessel morphogenesis (GO:0048514),-0.2753047903412959,-0.9337522300750837,0.5933333333333334,0.7263811035156905,1.0,19/54,28.52%,RBPJ;NRP1;SYK;FLT1;VEGFA;TGFBR1;TGFBR2;RASA1;SMAD7;ID1;AGGF1;KDR;APLNR;TGFB1;CYP1B1;ADM;ENG;GJA5;CCBE1
prerank,extracellular matrix assembly (GO:0085029),0.3085582708767386,0.9335333538309782,0.5336538461538461,0.8287207490401705,1.0,9/23,22.01%,NTNG2;NTNG1;GPM6B;HAS2;RAMP2;FBLN5;EFEMP2;TNXB;NTN4
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.23246147792876076,0.9334686288621624,0.5974025974025974,0.8277361928308848,1.0,29/101,20.77%,ROBO1;TENM1;MAPRE3;ETAA1;PDGFD;CSF1R;EGF;CCNYL1;HMGA2;SLC8A2;EDN1;PKD1;RPTOR;FERMT2;SPDYA;CALM1;CALM3;CALM2;ATP2B4;ADAM17;SNCA;PIH1D1;TELO2;IRAK1;WNT5A;SIRT1;TPD52L1;KIT;HRAS
prerank,negative regulation of DNA binding (GO:0043392),-0.31014181278768266,-0.9334680191254189,0.5860869565217391,0.7266510261884954,1.0,9/28,22.72%,SP100;JUN;MDFI;E2F1;TFAP4;SIN3A;RSF1;KDM1A;SUMO3
prerank,glutamate metabolic process (GO:0006536),0.3274500382506308,0.9334250583130013,0.5146341463414634,0.8266695492652614,1.0,7/19,17.21%,GOT1;GLUL;ALDH18A1;GGT1;GLS2;GLS;ALDH5A1
prerank,visual system development (GO:0150063),-0.29467412416479544,-0.9332418074692743,0.5590828924162258,0.7268290579402311,1.0,6/37,7.50%,SH3PXD2B;C1QA;C3;SMG9;ATF6;SIPA1L3
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.3020046565739115,0.9329672994502729,0.5721040189125296,0.8266650216040119,1.0,9/29,20.94%,ELOVL7;HACD1;ACACA;HSD17B8;ACSL3;ACSL6;ELOVL6;FASN;ELOVL2
prerank,phosphatidic acid metabolic process (GO:0046473),-0.27804544328439207,-0.9328234799146778,0.5469798657718121,0.7274069217121878,1.0,19/48,29.96%,DDHD1;DGKZ;SLC27A1;PLD2;GPD1;DGKD;ABHD5;AGPAT1;PLA2G4A;DGKG;PLA2G6;PLA2G5;PLA2G12A;GPD1L;LCLAT1;DGKA;LIPH;GPAT2;LPCAT4
prerank,cellular response to hypoxia (GO:0071456),-0.2333465094544153,-0.9327020139868921,0.6134868421052632,0.7273190490713809,1.0,50/126,29.09%,CREBBP;BACH1;PSME4;PSMB7;PSME3;PSMB9;VEGFA;EGLN1;HIF1A;PSMA8;ADAM8;UBC;RPS27A;ARNT;HP1BP3;PSMC3;PSMD8;PLK3;PSMC4;PSMB10;CUL2;PSMA1;PSMB8;VHL;BNIP3L;PGK1;ACAA2;HYOU1;MDM4;ELOC;PSMA5;PSMD4;NDNF;PSMB3;SIRT2;PSMD3;SFRP1;P4HB;HMOX1;LMNA;PSMB1;MYC;MT3;ZFP36L1;HIGD1A;CARD16;EP300;PSMA7;AQP1;BNIP3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.4082807585246108,-0.9325494562547619,0.5431654676258992,0.7273192919996219,1.0,2/10,13.66%,SP100;TFAP4
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3648017031403935,-0.9324826363087687,0.5619694397283531,0.7271284999819795,1.0,1/15,0.19%,PRKCH
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.35229979232860553,-0.9323417586207011,0.5663865546218487,0.7270871713058537,1.0,9/16,29.34%,ARID1A;DDX5;PPARGC1B;DDX54;ESR2;TADA3;ESR1;SAFB;DDX17
prerank,regulation of mRNA processing (GO:0050684),-0.2978982405586864,-0.9322497827487539,0.5694200351493849,0.7269608638891641,1.0,13/32,26.84%,RBM39;SON;DHX9;CWC22;YTHDC1;NCBP1;SRSF10;PAPOLA;HNRNPK;SRPK1;PTCD2;LARP7;ZFP36L1
prerank,regulation of protein localization to centrosome (GO:1904779),0.39516433517684146,0.9322344422310509,0.5384615384615384,0.8273223584774959,1.0,4/10,18.57%,BICD1;NSFL1C;UBXN2B;PARD6A
prerank,regulation of protein localization to cell surface (GO:2000008),-0.2980975122257047,-0.9321113312541838,0.5893470790378007,0.7268895923793759,1.0,10/33,17.10%,RAB11FIP5;STX3;PICALM;SNX33;CTNNB1;NEDD4L;RAB11B;HSP90AB1;LEPROTL1;STX4
prerank,icosanoid biosynthetic process (GO:0046456),-0.41341361599886495,-0.9318614332774751,0.5446265938069217,0.727058755973506,1.0,3/10,19.28%,ALOX5AP;PLA2G4A;PLA2G5
prerank,spliceosomal complex assembly (GO:0000245),-0.28034592713810386,-0.9318403759724159,0.5500848896434635,0.7267657307765959,1.0,16/46,24.21%,CRNKL1;SNRPG;GCFC2;CELF1;SMN1;YTHDC1;NCBP1;ZRSR2;SF3A1;DDX1;SRSF10;TXNL4A;SF3B1;SRPK1;PRPF6;DDX39B
prerank,bicarbonate transport (GO:0015701),0.30934023147279144,0.9315666895320482,0.5393258426966292,0.827920591349056,1.0,4/25,10.07%,SLC4A10;SLC4A4;CA2;SLC4A11
prerank,meiosis I (GO:0007127),0.32010421791454663,0.9315007975588241,0.541860465116279,0.8269505794799037,1.0,6/23,14.25%,ZCWPW1;TDRD9;PTTG1;MEIKIN;BRDT;MEIOB
prerank,positive regulation of ion transport (GO:0043270),-0.2767647229005632,-0.9312418363840498,0.5745393634840871,0.7277475869921806,1.0,13/48,18.23%,ATP2B1;P2RX7;ANO6;CRACR2A;P2RX4;CCR1;WFS1;CCL5;SCN4B;SCN3B;CHRNB2;LILRA5;SNX4
prerank,negative regulation of fat cell differentiation (GO:0045599),0.288507476361479,0.9308281134785977,0.5141509433962265,0.8275242587033013,1.0,3/34,2.59%,RORA;ZFPM2;RUNX1T1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.301953589638286,0.9304115859148147,0.566079295154185,0.8274923965723946,1.0,4/27,8.69%,FGF12;SCN2B;PTPN3;FXYD6
prerank,regulation of fat cell differentiation (GO:0045598),-0.25345721432564666,-0.9303940865974224,0.554806070826307,0.7292218577924297,1.0,30/74,26.84%,PPARD;PPARG;MEDAG;E2F1;LPL;ASXL1;TRIB2;FTO;XBP1;WDFY2;CCDC85B;TRIO;ID2;TAF8;CMKLR1;GATA3;ENPP1;GDF3;SIRT2;SFRP1;ZC3H12A;ANKRD26;CEBPB;IL6;ADIG;TGFB1;ZBTB16;GPS2;BMP2;ZFP36L1
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.35840775241539674,-0.9300484311645293,0.545774647887324,0.7296768252292106,1.0,6/16,14.29%,RIPOR2;MAPK14;MEF2C;IGFBP3;SMYD1;BTG1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.379531942904495,-0.9300380953036383,0.5752066115702479,0.729355454338704,1.0,3/13,9.25%,RBPJ;PIM1;MEF2C
prerank,protein palmitoylation (GO:0018345),-0.30863873815701154,-0.9299402042583971,0.565,0.7292383546455424,1.0,10/30,24.44%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;ZDHHC5;GOLGA7;HHAT;ZDHHC13;ZDHHC6
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.34200044423765513,-0.9296686049753422,0.561344537815126,0.7295158696564447,1.0,5/18,22.94%,NFE2L2;HIF1A;MAPK7;HSPB1;NONO
prerank,Golgi localization (GO:0051645),-0.3975659121683466,-0.9290744195104345,0.5680272108843537,0.7304177075473901,1.0,2/11,4.09%,UVRAG;CDC42
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.3678750277359907,0.9287158204690212,0.5185185185185185,0.8306572755553796,1.0,2/12,3.06%,PRKG1;IGFBP5
prerank,vitamin D metabolic process (GO:0042359),0.37386621445978924,0.9286169685377352,0.5331807780320366,0.8297587725089404,1.0,4/13,15.09%,CUBN;CYP1A1;LGMN;GC
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.3209082554280857,0.9285339953924447,0.5592417061611374,0.828805966435441,1.0,5/22,13.81%,TAFA1;TOX;PTPRZ1;RASSF10;SLC16A2
prerank,organelle fission (GO:0048285),-0.31958624540916103,-0.9284064524905369,0.5563258232235702,0.7314648514549604,1.0,3/24,1.72%,TMCC1;CORO1C;DNM2
prerank,secretion (GO:0046903),0.3615275838488922,0.9278259096407854,0.5465393794749404,0.8294530686757035,1.0,4/14,18.27%,RIMS1;PRKCI;ABCB11;FBLN5
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.32133815599709287,-0.927589946019423,0.5498281786941581,0.7328486113694864,1.0,7/23,23.01%,BCL2L11;TIMM22;HSPA4;TIMM29;MAIP1;TOMM22;TOMM70
prerank,response to iron ion (GO:0010039),-0.38403783770802463,-0.9263879398996188,0.5625,0.7350467892293053,1.0,3/12,9.13%,BCL2;B2M;HIF1A
prerank,regulation of isotype switching (GO:0045191),-0.37597778822561856,-0.9263859869724885,0.5768535262206148,0.7347090259224005,1.0,4/14,22.76%,KMT5B;KMT5C;SHLD2;SLC15A4
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.38133407513519263,-0.9260399705850775,0.5671902268760908,0.7351015270591196,1.0,4/12,12.54%,RB1;CTNNB1;BUB1;FEN1
prerank,endothelial cell proliferation (GO:0001935),-0.3483264820716563,-0.9257805868902992,0.5777777777777777,0.7353220236681336,1.0,3/17,8.99%,ERN1;THAP1;ITGB1BP1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.391468243826244,-0.924846379884352,0.5629370629370629,0.7369802010406317,1.0,2/11,2.64%,IGF1;IGF1R
prerank,ovarian follicle development (GO:0001541),-0.37073802677473866,-0.9245627296262794,0.5532646048109966,0.7372833517745233,1.0,6/13,28.48%,VEGFA;ANG;CEBPB;INHA;EIF2B2;EIF2B4
prerank,heart morphogenesis (GO:0003007),0.2623553757168118,0.9240472202073549,0.6020942408376964,0.8379065956315145,1.0,11/50,13.98%,RYR2;DLC1;ACVR1;SOX9;TBX1;TGFB2;TTN;ALPK2;EPHB4;FLRT2;HES1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.394490087164343,0.9239065427146407,0.5422535211267606,0.8370976214254366,1.0,2/10,3.70%,PDE4D;PDE11A
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3097856845239092,-0.9236564639108341,0.5587734241908007,0.7388290138374652,1.0,9/27,24.85%,NIBAN2;PARP4;HGF;PDGFRB;ATM;BMPR2;PDGFA;MYC;FGFR4
prerank,modulation by symbiont of entry into host (GO:0052372),0.3424995453109406,0.9227729611419256,0.5745192307692307,0.8388222483838439,1.0,1/16,0.53%,HS3ST5
prerank,epiboly involved in wound healing (GO:0090505),0.355416231408581,0.92270314295795,0.5738095238095238,0.8378459607170705,1.0,6/16,12.27%,TMEFF2;MRTFA;CARMIL2;TOR1A;CD151;ARHGAP35
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3129019040185359,0.922660001023541,0.5569007263922519,0.8367920243659048,1.0,8/21,16.13%,SLC8A3;SLC25A23;LETM1;FATE1;BCAP31;MICU3;ATP2A1;PDZD8
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3021995062285193,0.9223448827878317,0.5856481481481481,0.8364389909021211,1.0,6/26,11.04%,ANK2;CASQ2;NETO1;NEDD4;ATP1B1;KCNG1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2837952471312996,0.922087905767944,0.5465994962216625,0.8359294656735451,1.0,16/36,22.43%,TGFA;EGF;SHANK3;AREG;ADRA2C;EDN1;FBXW7;RELN;ARC;JAK2;ADAM17;CCL2;NCOA3;HDAC2;NLGN3;HDAC6
prerank,negative regulation of calcium ion transport (GO:0051926),-0.3566531368877269,-0.922074797571507,0.547945205479452,0.7417947979540557,1.0,6/15,32.13%,LILRB1;TMBIM6;PLN;INPP5K;PACSIN3;SLC30A1
prerank,positive regulation of response to wounding (GO:1903036),-0.31828999709912187,-0.9215800827387952,0.5826086956521739,0.7424721356314012,1.0,5/24,8.06%,ITGB1;ARFGEF1;ANXA1;GRN;MDK
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.387455846600703,0.9214787387034499,0.5408653846153846,0.8363206574123461,1.0,4/11,14.75%,PTS;CALM1;DHFR;HSP90AA1
prerank,establishment of spindle localization (GO:0051293),-0.36334918723920706,-0.9213745180213251,0.6007326007326007,0.7425575079552299,1.0,4/14,18.37%,DYNC1H1;MAP4;NUSAP1;CFL1
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.3467197617364011,-0.9213301461774561,0.5853658536585366,0.7422977762410288,1.0,2/18,1.41%,RUNX1;RB1
prerank,positive regulation of chemotaxis (GO:0050921),-0.2796664624553177,-0.9210050838626282,0.5856164383561644,0.7426227827243745,1.0,16/43,23.39%,NRP1;CCR2;P2RX4;IL6R;STX3;VEGFA;MDK;F7;TMSB4X;STX4;PDGFRB;HSPB1;KDR;MEGF8;IL6;TGFB1
prerank,positive regulation of protein secretion (GO:0050714),-0.25574620220712996,-0.9209955766094147,0.6135593220338983,0.742298665003329,1.0,9/69,11.16%,IGF1;ABCG1;TLR4;TMED10;ADAM9;GOLPH3L;WLS;ADAM8;MYOM1
prerank,protein dephosphorylation (GO:0006470),0.22008248028687705,0.9208426417302944,0.6317135549872123,0.8368319955074823,1.0,18/135,8.98%,PTPRD;PTPRG;PPP2R2B;PTPRN2;PTPRR;PTPRT;PPM1E;MTMR2;EYA2;PTPRK;TNS2;PTPN3;PPTC7;RPRD1A;PPP2R1B;PTPRB;PTPRZ1;PPP2R2A
prerank,mRNA stabilization (GO:0048255),-0.283540863191888,-0.9205184820893659,0.5879310344827586,0.7429542021729654,1.0,8/40,13.09%,MAPKAPK2;DHX9;MAPK14;FUS;E2F1;MYD88;TENT5A;BOLL
prerank,xenobiotic transport (GO:0042908),-0.34468735580930043,-0.9204697360807886,0.568904593639576,0.7427130436577725,1.0,10/17,38.51%,ABCC1;SLC7A5;SLC22A18;SLC22A3;ABCC3;ABCA3;GJA1;NR1I2;SLC22A2;SLC29A4
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.375339038857217,-0.9204554324202704,0.5975820379965457,0.7424007512562512,1.0,4/13,11.01%,GNAI3;RHOQ;EFL1;GTPBP1
prerank,positive regulation of macrophage migration (GO:1905523),-0.3382027827267353,-0.9202426861323818,0.5734265734265734,0.7424950096655183,1.0,7/19,22.16%,P2RX4;MDK;CCL5;IL34;CMKLR1;CSF1;MAPK1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.34959964476808036,-0.9200267072742946,0.5691202872531418,0.7426165567012346,1.0,3/16,17.39%,CLDN10;CLDN18;CLDN1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.2992371288655817,-0.9198904303972661,0.5845323741007195,0.7425424590266866,1.0,13/29,34.12%,PAK2;RIPK1;AGT;TRAF2;BID;TNFSF10;SFRP1;DEDD2;PML;AGTR2;BCL10;CAV1;TNF
prerank,glycoprotein metabolic process (GO:0009100),-0.26730972643772216,-0.9197842434147739,0.5883306320907618,0.7424296832718887,1.0,26/53,34.02%,B4GALT5;ST8SIA4;HPSE;MAN1C1;MAN2A1;HIF1A;B4GALT7;GCNT1;LARGE1;GANC;MAN2B1;ERP44;MGAT4B;STT3B;MANBA;MAN1B1;GANAB;AGA;GAL3ST4;ST3GAL4;ADAMTS9;ST8SIA6;CNMD;OGA;FBXO6;MAN2A2
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.2958292647099853,-0.919704401154551,0.5944444444444444,0.7422475279093402,1.0,9/33,18.37%,IGF1;SLC35F6;HGF;VAT1;FLCN;GHITM;HSPA1A;ACAA2;HUWE1
prerank,negative regulation of glycolytic process (GO:0045820),-0.40703076403117844,-0.9196217833864527,0.5714285714285714,0.74173520879338,1.0,2/10,6.03%,NUPR1;CBFA2T3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.40703076403117844,-0.9196217833864527,0.5714285714285714,0.74173520879338,1.0,2/10,6.03%,NUPR1;CBFA2T3
prerank,epithelium development (GO:0060429),-0.23537177037572582,-0.9180662689873219,0.6258278145695364,0.7447033692177242,1.0,38/107,33.43%,CTSB;ANXA4;TAGLN2;PPARG;CPT1A;VEGFA;RCN3;TIMELESS;CDK1;OSR1;PCNA;FOXJ1;CBR1;TPP1;SOX10;STIL;PGK1;WNT3;EHF;STAT1;KDR;TBX2;SNAI2;ANXA7;TGFB1;ACADVL;VDAC1;WNT7B;BMP2;SPINK5;GRHL2;IFT122;PAX2;DAG1;VCL;SOX8;PPP2R3A;MTHFD1
prerank,regulation of TORC1 signaling (GO:1903432),-0.2964732286909004,-0.9174742420436249,0.6037414965986394,0.7456523634732498,1.0,7/33,12.09%,GPR137B;KLHL22;PIP4P1;RRAGD;FLCN;SESN1;STK11
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.2922375355638225,-0.9171607129496055,0.5905923344947736,0.7459623643825464,1.0,16/35,29.34%,ZMIZ1;KDM3A;PMEPA1;ARID1A;WBP2;DDX5;UBE3A;CALCOCO1;NR3C1;PPARGC1B;DDX54;ESR2;TADA3;ESR1;SAFB;DDX17
prerank,tRNA wobble base modification (GO:0002097),-0.37489306672683675,-0.9170236778511885,0.5736568457538995,0.7458994944424842,1.0,4/14,16.97%,ALKBH1;MOCS3;ADAT2;ELP4
prerank,fatty acid metabolic process (GO:0006631),-0.2328742345394334,-0.9169221231601208,0.644891122278057,0.7457662870498941,1.0,28/115,27.27%,AOAH;CD36;PPARD;ABCD2;PPARG;CPT1A;ADIPOR1;ALOX5AP;ACADM;LPL;XBP1;ACSL5;GPX4;PON2;ABCD3;MCAT;ACOX1;ACSBG1;ACOT2;ACOT4;ACAD9;ECHDC3;PNPLA8;PON3;SLC27A3;ALOX15;PLA2G15;LIPH
prerank,regulation of endopeptidase activity (GO:0052548),0.2553978705894961,0.9168188859320213,0.6282051282051282,0.845696209913857,1.0,5/59,4.76%,SPOCK1;SPOCK3;SERPINI1;SERPING1;TIMP3
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.27526959838584747,-0.9167442205324277,0.5883333333333334,0.7458017327852816,1.0,18/46,29.96%,DDHD1;DGKZ;SLC27A1;PLD2;GPD1;DGKD;ABHD5;AGPAT1;PLA2G4A;DGKG;PLA2G5;PLA2G12A;GPD1L;LCLAT1;DGKA;LIPH;GPAT2;LPCAT4
prerank,bone morphogenesis (GO:0060349),0.35151528155160383,0.9164411083551265,0.5540229885057472,0.8454708194713035,1.0,3/14,10.24%,BMPR1B;TFAP2A;MMP13
prerank,skin development (GO:0043588),-0.2580331877663624,-0.9161599925752948,0.6029654036243822,0.7466306337462761,1.0,16/65,25.78%,CLIC4;ATP7A;ANXA1;ADAM9;JAG1;ITGA3;CLDN1;PIP5K1A;TXNIP;PDGFA;ASAH1;SFN;LSR;DSP;COL5A2;CERS3
prerank,regulation of phospholipase activity (GO:0010517),-0.40158683933472494,-0.9160223702506528,0.5884413309982487,0.7465743753247588,1.0,1/10,1.17%,LRP1
prerank,leukotriene metabolic process (GO:0006691),-0.3401507795035572,-0.9158968309637131,0.5859649122807018,0.74650400206069,1.0,12/19,43.06%,MAPKAPK2;ALOX5AP;ABCC1;PLA2G4A;PLA2G5;ALOX15;PTGR1;ALOX12;MGST2;MGST3;LTC4S;DPEP2
prerank,response to light stimulus (GO:0009416),0.2511446120765862,0.915846621367327,0.6055276381909548,0.8457947715649872,1.0,11/55,12.02%,MAPK10;MAP2K7;GTF2H2;TRPM1;OPN3;OPN1MW;OPN1MW3;OPN5;OPN4;BRSK1;MEN1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3566916978353898,-0.9154437602355548,0.5797872340425532,0.7471190385091417,1.0,6/16,19.63%,RTEL1;DHX36;TNKS2;ERCC4;SLX4;ATM
prerank,cellular copper ion homeostasis (GO:0006878),-0.36066816094673604,-0.9150120885197408,0.5595667870036101,0.7476768963485042,1.0,4/14,13.43%,ATP7A;SLC31A1;APP;MT2A
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.33945665969027067,-0.9142994235490015,0.5742049469964664,0.7488476576856248,1.0,5/17,14.12%,PTPRC;CD300A;PPP1R15B;HSP90AB1;PPP1R12A
prerank,cardiac myofibril assembly (GO:0055003),-0.35804239776430535,-0.9142223297869951,0.592128801431127,0.7486564593523768,1.0,2/15,7.52%,MEF2A;NRAP
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.24567501000466552,-0.9140185070236158,0.5986733001658375,0.748747552200178,1.0,27/84,21.84%,MBNL1;RBM39;MBNL2;SON;TRA2B;SMU1;MBNL3;HNRNPL;CWC22;DDX5;CELF1;YTHDC1;NCBP1;NCL;DAZAP1;WTAP;SRSF10;RNPS1;NSRP1;HNRNPA1;MAGOH;C1QBP;RBM3;RBM11;HNRNPK;ZBTB7A;SRPK1
prerank,cellular amino acid catabolic process (GO:0009063),0.23090949022330381,0.9131039613004247,0.6546762589928058,0.8514880833484139,1.0,28/87,24.10%,GLDC;ASPA;GOT1;SARDH;GLUL;HMGCLL1;MCCC2;GSTZ1;MCCC1;BCAT1;AASS;ABAT;SDSL;DBT;GLS2;GLS;ACAT1;ALDH5A1;CBS;BCAT2;ALDH7A1;CARNS1;SLC25A21;BCKDHB;NOS1;SHMT2;HNMT;ACADSB
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3169588305013602,0.9122895211952791,0.5766590389016019,0.852387626677791,1.0,7/21,17.45%,PDE4D;PDE9A;NUDT11;NUDT7;ACAT1;MLYCD;NUDT3
prerank,negative regulation of lipid metabolic process (GO:0045833),0.30851054698447844,0.9117204678716682,0.5763097949886105,0.8526180039011759,1.0,3/22,7.27%,APOD;ALK;APOC1
prerank,bile acid metabolic process (GO:0008206),0.2984874211396604,0.9117041022747048,0.6014669926650367,0.8515070094241168,1.0,10/27,15.12%,OSBPL6;SLC27A2;OSBPL7;ACOX2;HSD3B7;OSBPL2;ABCB11;ACOT8;HSD17B4;CYP39A1
prerank,histone H4 deacetylation (GO:0070933),-0.3927435689179559,-0.9111783154605291,0.5892547660311959,0.7544658632597867,1.0,1/10,0.80%,RCOR1
prerank,import into cell (GO:0098657),-0.2820057763374472,-0.9102161480347011,0.6218057921635435,0.7561148790398317,1.0,13/41,25.71%,LRRC8D;SLC6A6;SLC27A1;LRRC8C;SLC12A7;SLC12A6;SLC7A5;SLC5A3;SLC29A1;SLC11A2;NEURL1B;LRP2;LRSAM1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.3403313665935053,-0.9095011472193694,0.5848056537102474,0.7572977308616228,1.0,7/18,32.44%,FLNA;POLR2L;MAF1;RASL11A;UBTF;EIF2AK3;ATF4
prerank,in utero embryonic development (GO:0001701),-0.31397490975334746,-0.9090330766021676,0.5983050847457627,0.7579247659830647,1.0,5/25,11.34%,MBNL1;ZNF568;VEGFA;TGFBR1;FLCN
prerank,mammary gland epithelium development (GO:0061180),0.3579900681960997,0.908964750462612,0.5920745920745921,0.8571745444795477,1.0,2/14,3.22%,ERBB4;CSF1R
prerank,peptidyl-arginine modification (GO:0018195),-0.35724769025284475,-0.9084066724338652,0.5845070422535211,0.7588834649338705,1.0,7/15,39.14%,PRMT1;PADI4;ART4;PRMT5;PADI1;KRTCAP2;PRMT8
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2891527268717992,-0.9082438918211077,0.6219512195121951,0.7589025401943426,1.0,12/34,20.81%,PTPRJ;PTPN12;PTPN22;DUSP3;PTPN6;DUSP6;PTPRO;PTPN13;PTPN11;DUSP5;UBASH3B;PTPN1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.32113329824204606,0.9076376495210043,0.5793269230769231,0.8593215802067283,1.0,5/18,14.16%,ASPA;GOT1;ADI1;FOLH1;ASNS
prerank,ubiquinone biosynthetic process (GO:0006744),-0.3521959296645306,-0.9073361724900778,0.5867768595041323,0.7604753182397046,1.0,3/15,15.10%,COQ8A;NDUFA9;FDXR
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.36055256782415035,-0.9071221347200471,0.598939929328622,0.760590536347768,1.0,6/14,18.01%,BRCA1;CTR9;CTNNB1;WDR5;KMT2A;MYB
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.3514877007411713,-0.9069436261476641,0.5819209039548022,0.7606307649300863,1.0,3/15,15.12%,IGF1;HGF;GHITM
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.360039378906893,-0.9063153635613271,0.6082644628099173,0.761589419279285,1.0,4/15,18.45%,PLCG2;EZH2;KLHL18;FAM83D
prerank,positive regulation of bone mineralization (GO:0030501),0.28718179936504945,0.9060575904310688,0.6200980392156863,0.8621304924765457,1.0,8/35,9.33%,NELL1;BMPR1B;PTN;ACVR1;GPM6B;ADGRV1;BMP7;TFAP2A
prerank,atrial septum morphogenesis (GO:0060413),-0.40376669455166314,-0.9057014203697383,0.59391771019678,0.7625511370299628,1.0,1/10,0.56%,NOTCH2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2627248508828547,0.9056896791265089,0.624390243902439,0.8618848086801766,1.0,8/44,11.69%,TENM1;PRKCE;CARMIL1;CARMIL2;SPIRE1;NCKAP1;GSN;ARF6
prerank,protein localization to condensed chromosome (GO:1903083),-0.3704251739445896,-0.9056520582249968,0.5989208633093526,0.7623075949962991,1.0,4/12,15.45%,KNL1;ZWILCH;CDK1;TTK
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3866692031764116,-0.9046944638204255,0.5976027397260274,0.7639655688983111,1.0,5/11,34.58%,CCT7;CCT4;WRAP53;CCT8;CCT5
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.3523508857578753,-0.9046782620141988,0.6053097345132743,0.763650261274705,1.0,3/14,14.15%,ERN1;NUDT21;NCBP1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.35982329950778513,-0.9045994627456128,0.6069565217391304,0.7634666322889736,1.0,4/14,13.40%,NRP1;VEGFA;PIK3CA;PIK3CD
prerank,hexose biosynthetic process (GO:0019319),0.2679797055979229,0.9038721249026375,0.5966587112171837,0.8651751245769265,1.0,10/42,14.31%,PFKFB1;GOT1;ENO1;GAPDHS;G6PC3;G6PC1;ALDOB;SLC25A11;PER2;PPARGC1A
prerank,extracellular matrix organization (GO:0030198),0.1973388703774959,0.9036264542258146,0.778125,0.8646111203401584,1.0,71/276,20.57%,ADAM12;MMP16;TNR;P3H2;ADAMTS17;COL27A1;LAMC3;TLL1;MMP12;VCAN;DST;ADAMTS16;SCUBE1;COL11A1;ITGB8;ADAMTSL1;GFOD2;GPM6B;VCAM1;MMP15;ITGB3;ITGA9;VIT;COLGALT2;COL25A1;THSD4;PLOD2;COL4A3;COL23A1;COL19A1;CD151;MMP13;HAS2;SMOC2;CTSK;GSN;TGFB2;HTRA1;TTR;BMP1;COL7A1;ADAMTS5;ITGA11;ADAMTS12;CREB3L1;ADAMTS6;FLRT2;CDH1;CAPNS2;COL24A1;NID2;SPARC;CAPN2;ST7;ADAMTSL2;LAMA2;COL1A1;FBLN5;LOXL1;LAMA5;COL26A1;SMOC1;TNC;SH3PXD2A;KLKB1;LOX;JAM3;COL4A4;NID1;MMP14;ITGA2B
prerank,regulation of DNA metabolic process (GO:0051052),-0.2749490543863838,-0.9035443947913585,0.6404886561954625,0.765309833729947,1.0,15/44,25.67%,NUCKS1;IL7R;ALYREF;KAT7;TICRR;RADX;MPV17;NBN;PDGFA;WDR70;HDAC8;SMG1;UBE2V2;MYC;UBE2N
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.28207223076706434,-0.903354354213828,0.6205128205128205,0.7653438429060888,1.0,10/38,17.56%,PTPRC;NEDD9;RAP2B;MVP;GAS6;AGT;APP;IL34;GPRC5B;LILRA5
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2939133978126129,-0.9032316344508615,0.6084656084656085,0.7652600664174117,1.0,14/31,33.92%,RTEL1;PKIB;DHX36;TNKS2;SLX4;ATM;NBN;MAPK1;MRE11;PML;MAPK15;MAP3K4;NEK7;TNKS
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.34427044005572827,-0.9030020256085906,0.600358422939068,0.7654028008341714,1.0,5/15,16.88%,RAB3GAP1;SRP14;ZFAND2A;RAB10;SRPRB
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.3357433226786092,-0.9027246183830718,0.6070796460176991,0.7656484874876138,1.0,9/19,30.08%,IGF1;ZC3H12A;NLRP3;MEFV;CARD16;CPTP;FFAR4;GHRL;PYDC1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.26627497082282026,-0.9025694647891345,0.6341880341880342,0.7656167643139854,1.0,13/49,23.54%,ZCCHC9;LRCH1;ARFGEF1;EGLN1;GPATCH2;MAPK7;CST7;CST3;TMED2;RASA4;WNK1;SH2D4A;URI1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.292504273884653,-0.9022505552474042,0.5957066189624329,0.765924259775194,1.0,9/29,17.60%,PRKCD;ARFGEF1;CYRIB;MYADM;LIMA1;PIK3CA;SSH3;SSH1;TWF2
prerank,positive regulation of translational initiation (GO:0045948),-0.33517107551319014,-0.902179635681294,0.585278276481149,0.7657083761985732,1.0,5/18,19.06%,YTHDF3;CCL5;BOLL;POLR2G;DDX3X
prerank,polyol biosynthetic process (GO:0046173),-0.350099176741365,-0.9016779078314816,0.6088495575221239,0.7664109140711595,1.0,7/16,26.24%,ACER3;ITPKB;CYP27A1;CYP2R1;IP6K3;ITPKC;IP6K1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.3510036371688695,-0.9011048508039508,0.6092150170648464,0.7672575855212246,1.0,1/16,0.56%,NOTCH2
prerank,protein oxidation (GO:0018158),0.3700332684702783,0.9009139147394737,0.5730858468677494,0.8701515306691373,1.0,11/11,63.02%,LOXL1;LOX;TMX3;SUMF1;APOA1;LOXL4;LOXL2;PRDX3;CHCHD4;LOXL3;APOA2
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.3792639873636694,0.9008537614309369,0.5847255369928401,0.8691513430442668,1.0,2/10,8.65%,SOX11;BMP7
prerank,regulation of multicellular organism growth (GO:0040014),-0.3494737972846628,-0.8999726405947824,0.6127886323268206,0.7692734188248289,1.0,3/15,11.05%,IGF1;STAT5B;APP
prerank,acidic amino acid transport (GO:0015800),0.3277507833331753,0.8996556121602794,0.580046403712297,0.8709360629712865,1.0,5/17,9.46%,SLC1A2;SLC1A6;SLC1A1;SLC6A1;SLC6A13
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.31379866183334454,-0.8996015994836998,0.5944540727902946,0.7696768505435692,1.0,13/23,31.15%,LTBP4;ITGA3;LATS2;SMAD7;SMURF2;EID2;TGFB1;SMAD4;ENG;BCL9;NREP;DKK3;SMAD2
prerank,response to organic cyclic compound (GO:0014070),-0.2629398041661066,-0.8993248578522933,0.6326530612244898,0.7699046424846403,1.0,18/52,28.06%,KYNU;STAT3;IL18;ANXA1;TIPARP;CTNNB1;STAT5B;CCL5;SPP1;CHRNB2;SFRP1;TGFB1;CYP1B1;FGFR4;ABCA2;HLCS;ESR1;ALPL
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3414478594192057,-0.8992040616881445,0.6146010186757216,0.7698030395500415,1.0,4/17,14.72%,ROCK1;VEGFA;PPP1R12A;IKBKB
prerank,skeletal muscle organ development (GO:0060538),-0.30143175724441473,-0.8988252193779077,0.6132879045996593,0.7702508579768872,1.0,4/26,14.55%,SVIL;CFLAR;MEF2C;LARGE1
prerank,regulation of lipase activity (GO:0060191),0.3440754915917291,0.8982321611000118,0.6155717761557178,0.8732607720792576,1.0,4/13,16.07%,PCSK5;PCSK6;ANGPTL3;SNCA
prerank,tRNA methylation (GO:0030488),-0.28799187923380154,-0.8981865501920028,0.6115992970123023,0.7712166935952474,1.0,13/34,34.55%,METTL1;PRORP;DALRD3;TRMT44;METTL6;BCDIN3D;METTL2B;METTL2A;THADA;HSD17B10;FTSJ1;TRMT61A;TRMT61B
prerank,amino acid import (GO:0043090),0.3182773346286865,0.8979444326514887,0.6108490566037735,0.8728188081220375,1.0,7/21,13.81%,SLC47A1;SLC1A1;SLC6A1;SLC6A13;SFXN3;SLC25A38;SLC16A2
prerank,response to glucocorticoid (GO:0051384),0.29312132469543745,0.8978604583978521,0.6086956521739131,0.8718615690525542,1.0,3/26,4.75%,SLIT3;SLIT2;GOT1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.34753554099916306,-0.8977609203090506,0.5905245346869712,0.7717515051805707,1.0,8/14,41.98%,ENTPD6;ENTPD3;NUDT15;NUDT16;ENTPD7;NUDT1;NUDT5;ENTPD1
prerank,protein alkylation (GO:0008213),-0.3136706339418963,-0.8977538636465242,0.6007067137809188,0.7714175650654734,1.0,5/22,10.40%,GSPT1;PRMT2;PRMT1;METTL22;PRMT3
prerank,cGMP biosynthetic process (GO:0006182),0.37667658057010467,0.8976586267239088,0.5883720930232558,0.8712510173510544,1.0,1/10,2.89%,GUCY1B1
prerank,lipid biosynthetic process (GO:0008610),0.2372255467256526,0.8972972458961731,0.6610576923076923,0.8710375476385341,1.0,24/77,26.19%,PAM;CYP51A1;GPAM;AGPAT3;ACSM5;OLAH;NDUFAB1;ACSS2;ACACA;MVK;LSS;HSD17B8;MLYCD;ACSM3;CLN8;ACSL6;GPAT4;PDSS1;MVD;OXSM;PRKAA2;PRLR;MBOAT1;FDFT1
prerank,negative regulation of chemokine production (GO:0032682),-0.35681762407345324,-0.8972216775797145,0.6110091743119266,0.7721716951818349,1.0,7/14,28.62%,SIRPA;MAP2K5;OAS3;LGALS9;IL6;MEFV;SIGIRR
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.39368940738605784,-0.8966168262840764,0.6024096385542169,0.7730325373524336,1.0,4/10,27.34%,PSMC3;PSMC4;HMGB1;ESR1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.24415823424953748,-0.8963831414845003,0.6915422885572139,0.7731645554532267,1.0,21/78,23.30%,IPO5;CCND3;HHEX;ACTB;CCNY;BLM;INCA1;CDK5RAP1;CDKN3;CDC25A;GADD45A;TFAP4;CCNE1;LATS2;CDKN2C;SERTAD1;CNPPD1;CDC25C;CCNK;CCNF;CCNB1
prerank,negative regulation of ATPase activity (GO:0032780),0.33289537857642726,0.8962104532102106,0.6291866028708134,0.8724248921470279,1.0,5/16,19.73%,TSC1;TNNT2;PPIF;VCPKMT;SIRT1
prerank,protein destabilization (GO:0031648),-0.2859161313797442,-0.8952952221146686,0.6531302876480541,0.7750470958642386,1.0,6/32,10.59%,CREBBP;GGA3;FBXW11;SERF2;CTSH;DERL1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.3854361123025336,0.8952514211909558,0.5724137931034483,0.8735984455176476,1.0,3/10,13.04%,SACS;DNAJA4;DNAJB2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.21529305131927454,-0.8952014642128291,0.7091503267973857,0.774885797151293,1.0,57/173,25.74%,CTSZ;VTI1A;CAPZB;RAB1A;COG7;DYNC1H1;TMED10;TRAPPC11;TFG;PREB;PROS1;GAS6;CTSC;TMED3;SEC24A;DCTN1;SAR1A;F7;SEC24D;RAB29;STX5;CAPZA1;MIA2;COG2;COG5;SEC31A;MIA3;COPA;TRAPPC5;DYNC1LI2;VAMP4;LMAN2L;VAPB;TMED2;HYOU1;F10;TMED4;TICAM2;CNIH4;F5;MPPE1;DCTN4;BET1L;TMED5;SPTAN1;COG4;PGAP1;TRIP11;ARCN1;DCTN5;TRAPPC3;COPB2;RAB1B;MCFD2;ERGIC1;YIF1B;TRAPPC2L
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.29313462164335324,-0.8951557743298239,0.6262626262626263,0.7746368849550774,1.0,10/30,24.98%,MGAT5;ALG5;DPM3;ST6GAL1;MAGT1;NUDT14;MGAT2;STT3B;DDOST;MCFD2
prerank,rRNA methylation (GO:0031167),-0.3188046321878236,-0.8945275310885132,0.6290322580645161,0.7755546405752655,1.0,6/22,25.45%,NSUN3;NSUN4;DIMT1;EMG1;BUD23;MRM2
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.3170589180609862,-0.8942204581559294,0.6234676007005254,0.775848933102233,1.0,10/23,30.08%,IGF1;GAS6;ZC3H12A;NLRP3;MEFV;CARD16;CPTP;FFAR4;GHRL;PYDC1
prerank,negative regulation of myotube differentiation (GO:0010832),0.3575111197614086,0.893275632119715,0.5899772209567198,0.8771482451561887,1.0,2/12,7.07%,CCN3;BDNF
prerank,microtubule depolymerization (GO:0007019),-0.3375046613861362,-0.8928705768700214,0.6126760563380281,0.7782968058410856,1.0,11/17,40.27%,CKAP5;KIF14;KIF2C;STMN2;KIF18B;KIF19;NCKAP5L;KIF18A;KATNB1;CCSAP;KIF24
prerank,Golgi inheritance (GO:0048313),-0.37808194259145633,-0.8928633797508161,0.6095551894563427,0.7779625337452318,1.0,3/11,12.93%,CDK1;STX5;PLK3
prerank,protein targeting to mitochondrion (GO:0006626),-0.25998918593903597,-0.8928399234917204,0.6557377049180327,0.7776535004169122,1.0,15/52,23.01%,IMMP2L;PITRM1;TOMM40L;FIS1;TIMM21;TIMM44;TIMM22;HSPA4;TIMM29;GRPEL2;FBXO7;TOMM22;TOMM34;TOMM20L;TOMM70
prerank,oligodendrocyte development (GO:0014003),-0.3438352837749159,-0.8927665073435375,0.6206293706293706,0.7774765819980998,1.0,6/15,28.48%,B4GALT5;EIF2B3;SOX10;EIF2B1;EIF2B2;EIF2B4
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.37399265067856247,-0.8927373538033009,0.6174055829228243,0.7771940676164001,1.0,4/12,25.19%,IMPDH2;ADSS1;PFAS;ATIC
prerank,regulation of cholesterol transport (GO:0032374),-0.3253611708839832,-0.8925378956356875,0.625,0.7772604748863429,1.0,5/20,15.21%,LRP1;NFKB1;NR1H2;TTC39B;ABCA13
prerank,Rac protein signal transduction (GO:0016601),0.32057560627663484,0.8919389187056118,0.6004842615012107,0.8792670261933481,1.0,5/18,11.54%,CDH13;WASF1;ABI2;NCKAP1;FARP2
prerank,regulation of protein dephosphorylation (GO:0035304),0.26940068250894966,0.8915168999905814,0.633495145631068,0.8791747487705591,1.0,16/37,23.08%,CAMTA1;DLC1;TSC1;PPP1R16B;CALM1;CALM3;CALM2;CDH5;TIPRL;CNEP1R1;PPP1R7;NSMF;CDCA2;SYMPK;HTT;ENSA
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.2923348596272238,0.8913127659108547,0.6277056277056277,0.878477829091179,1.0,6/27,16.92%,HTR2C;GRM1;AGTR1;F2RL2;OPRL1;GPR157
prerank,regulation of hippo signaling (GO:0035330),0.32752760510555956,0.8898093519610276,0.6123456790123457,0.8809084422811339,1.0,8/17,17.63%,SOX11;WWC1;WTIP;MARK3;SCHIP1;SHANK2;CIT;DLG5
prerank,glutathione derivative metabolic process (GO:1901685),0.3140580071276722,0.889515462019706,0.6238532110091743,0.8792985328146611,1.0,6/20,20.24%,GSTZ1;GSTP1;GSTK1;GSTM5;GSTA4;GSTT1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3140580071276722,0.889515462019706,0.6238532110091743,0.8792985328146611,1.0,6/20,20.24%,GSTZ1;GSTP1;GSTK1;GSTM5;GSTA4;GSTT1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3199529838197109,0.8892725821886978,0.6233480176211453,0.8787495863944704,1.0,6/18,13.98%,TENM4;PTN;PTPRZ1;DAAM2;HES5;HES1
prerank,autophagy of mitochondrion (GO:0000422),-0.27805009571185274,-0.8886895532157375,0.6694078947368421,0.7847927200049634,1.0,9/38,17.82%,ATG5;ATG7;ULK2;FIS1;RB1CC1;MARK2;GABARAP;USP30;FBXO7
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.22905973690702916,-0.8885669695294615,0.6771004942339374,0.7846903311320587,1.0,35/104,26.70%,PPARG;PMEPA1;SNX6;SKI;TGFBR1;TGFB1I1;SNX25;UBC;RPS27A;SPRED1;SPRY2;PIN1;SPRED2;HTRA3;ACVR2A;TGFBR2;GREM1;LEMD2;LDLRAD4;VASN;HSPA1A;SMAD7;IL17RD;RBPMS2;GDF3;BMPR2;SMURF2;ZBTB7A;EID2;TGFB1;LRP2;SKIL;SMAD4;BMP2;SMURF1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.289121383735168,-0.888473472632607,0.6129032258064516,0.7845311061471232,1.0,9/31,23.01%,PEX14;PEX26;TOMM40L;TIMM21;TIMM44;PEX7;GRPEL2;TOMM20L;TOMM70
prerank,negative regulation of double-strand break repair (GO:2000780),-0.2899781382382377,-0.8881531412312806,0.6471600688468159,0.7848526553949955,1.0,8/30,19.65%,CGAS;ERCC6;RNF169;RADX;UBQLN4;TFIP11;SHLD2;TRIP12
prerank,B cell activation involved in immune response (GO:0002312),-0.3602920624280349,-0.8879944916830989,0.6232876712328768,0.7848298943997605,1.0,6/13,33.87%,BATF;RNF8;FCGR2B;GAPT;CD19;EXOSC3
prerank,response to retinoic acid (GO:0032526),0.2445364660540438,0.8877873479085844,0.6932084309133489,0.8811046499316142,1.0,17/59,20.48%,BRINP3;BRINP1;RORB;TESC;WNT9A;SOX9;LTK;TBX1;RET;EPHA3;BRINP2;FZD4;SNW1;ADNP2;WNT5A;WNT5B;FZD10
prerank,atrioventricular valve development (GO:0003171),0.34527592010456465,0.8875701074807054,0.59375,0.8804906337917215,1.0,3/14,10.93%,SLIT3;ACVR1;TGFB2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.3427441470403204,-0.8872428963645195,0.6252158894645942,0.7860037938982944,1.0,2/16,1.52%,APOE;CD36
prerank,regulation of phospholipid metabolic process (GO:1903725),0.38126408413729757,0.8869515114066178,0.5979899497487438,0.880819817976881,1.0,4/10,18.53%,MTMR2;MFSD2A;MTMR9;MTMR4
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.3323384611601653,0.8867434617462266,0.6285046728971962,0.8801218877826258,1.0,4/14,7.89%,ELAVL4;DAZL;TIRAP;YBX3
prerank,striated muscle cell development (GO:0055002),0.3409508626009865,0.8867402956709624,0.6303854875283447,0.8789898997684383,1.0,3/14,11.23%,SDC1;CAPN3;PGM5
prerank,canonical Wnt signaling pathway (GO:0060070),-0.2458865060723105,-0.8866797721911224,0.6754098360655738,0.7867766544244499,1.0,21/68,28.56%,RARG;AXIN1;LRP6;CTNNB1;PPP1CA;RAB5A;TCF7;GATA3;RYK;WNT3;GSK3B;SFRP1;PLPP3;DVL2;WNT7B;FZD1;FZD7;BCL9;WNT6;FRAT1;LEF1
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.24468645832818103,-0.8866324032724462,0.6902800658978583,0.7865137292357299,1.0,19/69,22.94%,APOE;SNX6;PTK2B;BCL2;GRN;WFS1;MDK;HIF1A;MEF2C;ADAM8;KIF14;RETREG1;RASA1;CLN3;NDNF;CPEB4;PPT1;SET;NONO
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.29796104938668744,0.8865357247099938,0.6513761467889908,0.8783800792437758,1.0,4/26,11.46%,PLCB1;UBE2E2;FGF10;RPTOR
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.2362913325759856,-0.8861023285487599,0.687392055267703,0.7872740957043274,1.0,32/88,32.39%,APOE;NRP1;XDH;HTR2B;NRP2;VEGFA;TGFBR1;HIF1A;ARNT;HMGB2;PIK3CD;ANG;NR4A1;NRAS;AGGF1;BMPR2;STAT1;KDR;APOH;FGF18;VASH2;BMP2;VIP;CCL24;GHRL;NRARP;FGF16;TNMD;ATP5F1A;FGF2;CAV1;CNMD
prerank,protein homotetramerization (GO:0051289),0.25118961453215105,0.8856119292722969,0.648854961832061,0.8793999472329417,1.0,13/49,17.38%,RYR3;CRYZ;CBY1;RYR1;HCN1;ACACA;KCNJ12;GOLGA2;OSBPL2;CTH;GLS;ALDH1A3;TRPM2
prerank,organelle fusion (GO:0048284),-0.30999523084672087,-0.8853073706714836,0.5986038394415357,0.7885257989150881,1.0,9/22,28.65%,EEA1;FIS1;USP30;STX4;MIGA2;VPS18;CYP26C1;VPS11;THG1L
prerank,vasoconstriction (GO:0042310),-0.37798781013426686,-0.8852298084033494,0.6287215411558669,0.7883296332857311,1.0,4/11,15.00%,HTR2B;SLC8A1;EDNRA;PIK3C2A
prerank,glutamine family amino acid metabolic process (GO:0009064),0.27372220023547766,0.8846949791099971,0.6329113924050633,0.8804049638054355,1.0,9/33,17.21%,GOT1;GLUL;ALDH18A1;GGT1;RIMKLB;GLS2;GLS;CAD;ALDH5A1
prerank,regulation of cell development (GO:0060284),-0.27743181029872077,-0.8834658035673553,0.6557377049180327,0.7916495456126114,1.0,12/36,25.98%,NOTCH2;CTNNB1;GRN;BHLHE40;HMGB2;RHEB;WNT3;FBXO22;HEYL;HES7;HES6;CLOCK
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.30011639779037236,0.8834580083857401,0.6506329113924051,0.8821596759514182,1.0,4/24,6.15%,PEX5L;PDE4D;PDE11A;GNAI1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.3648436224553565,0.8832295738050234,0.6211031175059952,0.8815323881992172,1.0,3/11,15.23%,PCBP3;NOVA1;NOVA2
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.2075641820641863,-0.8829905821245511,0.7843137254901961,0.792285213625307,1.0,35/198,15.27%,PTPRC;INPP4A;PLCG2;PAK2;PLBD1;ITPKB;PIP4K2A;PANK2;NADK;HTR2B;STAT3;SYNJ1;PFKFB3;DUSP3;PIK3CB;PIK3CG;LGALS13;PPP1CA;COQ8A;IMPA1;PIP4P1;LPL;HK3;INPP5A;TAOK1;PFKFB4;PIK3CA;PLCB3;PIK3CD;GPX4;PLCD1;AGPAT1;PLA2G4A;PLAAT3;NUDT14
prerank,fatty acid beta-oxidation (GO:0006635),-0.2594113423724643,-0.8826654567025524,0.6620926243567753,0.7925831727173605,1.0,20/51,33.46%,PPARD;ABCD2;ACADM;ACAD11;ACAT2;ABCD3;MCAT;ACOX1;ACAA2;AMACR;ACADVL;ACOXL;HSD17B10;ACADS;ECHDC2;ACAD10;SCP2;ECHS1;HADH;SLC25A17
prerank,protein homooligomerization (GO:0051260),0.2129908652401452,0.8819835446836689,0.7862595419847328,0.8832576609809465,1.0,26/114,18.38%,MPP2;RYR3;KCNC2;ADCY8;CRYZ;SLC1A2;CBY1;LETM1;RYR1;HCN1;GSDMD;SCARA5;ACACA;KCNJ12;GOLGA2;OSBPL2;ARC;CTH;GLRA3;RS1;GLS;AQP11;ALDH1A3;TRPM2;TMEM120A;RBMX
prerank,protein localization to microtubule organizing center (GO:1905508),-0.35301538869860305,-0.881516251981545,0.613013698630137,0.7945465846641309,1.0,2/15,3.85%,SNX10;PIBF1
prerank,outer dynein arm assembly (GO:0036158),0.3374825189895817,0.8813670649672112,0.5985748218527316,0.8835300132909262,1.0,5/14,17.67%,ODAD3;DNAH17;DNAAF4;LRRC49;DNAH5
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.3403870862820203,-0.8809353494408808,0.624113475177305,0.7953911197073557,1.0,3/16,11.25%,CREBBP;NAA25;NAA50
prerank,response to ATP (GO:0033198),-0.3319792173186419,-0.88022268267967,0.6264274061990212,0.7964765738252348,1.0,4/18,15.57%,P2RX7;P2RX4;HSP90B1;SSH1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.2496703983779613,0.8800135099434275,0.6843373493975904,0.8855297894922494,1.0,11/52,16.11%,DPP10;SORBS1;PRKCE;RAMP3;PRKCI;NKD2;ARF6;STAC;ATP2B4;WNK3;EPHA3
prerank,regulation of chondrocyte differentiation (GO:0032330),0.2964464225510263,0.8791169110823196,0.606694560669456,0.8864672493851817,1.0,7/24,12.65%,BMPR1B;SOX5;WNT9A;SOX6;SOX9;MBOAT2;ADAMTS12
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.30844800752991797,-0.8788507927196267,0.6311188811188811,0.7988896613683244,1.0,3/22,6.22%,CCR2;GNAI3;CAP1
prerank,muscle cell migration (GO:0014812),-0.37729243394364126,-0.8785901610254288,0.6259124087591241,0.7990632917686147,1.0,2/10,8.99%,ROCK1;ITGB1BP1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.36437815150439185,-0.878044845047506,0.6082474226804123,0.7998187473326399,1.0,4/11,15.09%,P4HA1;EGLN1;P4HA3;CRTAP
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.25965265894101563,-0.8780080353069855,0.6811091854419411,0.7995263240821613,1.0,16/52,26.99%,MTHFS;IDH1;MTHFD1L;ME2;DGLUCY;MTHFD2L;OGDH;ASS1;ACOT4;MTHFR;SHMT1;MDH1;D2HGDH;MDH2;FPGS;HOGA1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.23945233495294163,-0.8771966079117963,0.6983870967741935,0.8007911209875447,1.0,12/73,16.21%,FNIP2;CD44;BCAR3;AXIN1;GAS6;VEGFA;FNIP1;SPRY2;APP;HSP90AB1;EIF4G1;HCLS1
prerank,regulation of cellular component organization (GO:0051128),0.21090258701083145,0.8766809636192112,0.7741935483870968,0.8909153301778961,1.0,18/135,10.08%,NRG3;SPOCK1;RIT2;TJP1;PAK5;SNCAIP;CDH13;MELTF;PTCH2;MLLT3;STON1;PLCE1;ANGPTL7;CHPT1;NEDD4;TMEM97;ROS1;AGTR1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.36342353592591875,-0.8760514792639561,0.6563071297989032,0.8027220018107057,1.0,6/12,46.12%,PPP1R3E;INPP5K;PPP1R3A;AKT1;PPP1R3D;PPP1R3B
prerank,axonal transport of mitochondrion (GO:0019896),-0.36470909431022086,-0.8760328745369039,0.6232394366197183,0.8023930888308318,1.0,2/11,9.13%,TRAK1;HIF1A
prerank,histone H3-K36 demethylation (GO:0070544),-0.3792147347557264,-0.875778399570269,0.6465661641541038,0.8025553985702362,1.0,2/10,7.77%,KDM7A;KDM2A
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.24459571486559675,-0.8753658827590176,0.7296849087893864,0.802983435700232,1.0,31/69,33.77%,AMFR;RHBDD2;WFS1;ERLIN1;DNAJB9;SELENOS;DNAJB14;DERL1;UBE4B;SEL1L;HSP90B1;RNF185;RNF121;STT3B;FOXRED2;SGTA;TRIM25;FAF2;BAG6;MAN1B1;EDEM1;VCP;UBE4A;AUP1;STUB1;UBXN4;DNAJC18;SEL1L2;FBXO6;DNAJB12;UBQLN2
prerank,cellular response to ATP (GO:0071318),-0.35445038156982966,-0.8752748322678358,0.6383701188455009,0.8027986573262726,1.0,4/14,15.57%,P2RX7;P2RX4;HSP90B1;SSH1
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.32325697850021096,-0.8750124586290128,0.656198347107438,0.8029829812304856,1.0,1/19,0.16%,APOE
prerank,sulfur compound catabolic process (GO:0044273),0.2692225212143301,0.8749220159817455,0.6476683937823834,0.8939144119867772,1.0,13/38,16.69%,HEXB;VCAN;NUDT7;OMD;GLB1;GGT1;CTH;ACAT1;MLYCD;IDUA;GGT5;ADO;IDS
prerank,transport along microtubule (GO:0010970),-0.35175718951506973,-0.8747154530960075,0.6607460035523979,0.8032376189000797,1.0,7/13,30.07%,CDC42;APP;BAG3;APBA1;BORCS5;COPG1;SPG11
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.32838070726641183,-0.8739923108323828,0.6384479717813051,0.80429150938394,1.0,6/18,25.17%,CCT7;DCP2;SHQ1;CCT4;EXOSC10;NHP2
prerank,skeletal muscle tissue development (GO:0007519),-0.27773886043072166,-0.8738170849656866,0.6739130434782609,0.8042647757786128,1.0,15/32,40.93%,SVIL;CFLAR;SKI;MEF2C;LEMD2;EGR2;IGSF8;CAV1;CAV2;KLHL40;SIX4;MYORG;MYOZ2;SELENON;KLHL41
prerank,negative regulation of cellular component organization (GO:0051129),-0.23979607570953157,-0.8737907532489949,0.6998313659359191,0.8039701719725483,1.0,22/74,22.74%,MCTP1;LILRB1;DNM2;RIOK3;CDC42;WASL;RTEL1;SNX33;IRAK3;VEGFA;SPRY2;AIDA;FAP;TFIP11;HSPA1A;DDX3X;HSPA2;TMC8;GSK3B;DNAJB6;NR1H4;CRYAB
prerank,regulation of protein secretion (GO:0050708),-0.22287594136797353,-0.873697644820197,0.767402376910017,0.8038072622018139,1.0,19/119,12.73%,APOE;IGF1;ABCG1;ITPR1;DNAJC1;RAP1A;SLC2A1;DPP4;TMED10;ADAM9;RSAD2;GOLPH3L;RHBDF1;RHBDF2;ADAM8;EIPR1;MYOM1;CCL5;ITPR3
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.33443102322716045,-0.8734048036115735,0.6451612903225806,0.8040217239133602,1.0,7/16,21.40%,BRCA1;CTR9;CTNNB1;WDR5;KMT2A;MYB;KDM1A
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.28686405930569264,0.8731550662738472,0.6447963800904978,0.8968170398545358,1.0,5/23,11.17%,EGF;PAX8;GDNF;SOX9;SMO
prerank,protein export from nucleus (GO:0006611),-0.29634981947431993,-0.8731216239447683,0.6427378964941569,0.8042201944865882,1.0,13/27,32.74%,NUP42;XPO6;XPO5;TPR;STRADA;CCHCR1;EGR2;TGFB1;SMURF1;CSE1L;STYX;XPO7;ANKLE1
prerank,tRNA 5'-end processing (GO:0099116),0.32952300692126024,0.8723864982688674,0.6132075471698113,0.8974520814537224,1.0,6/15,21.45%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,peroxisome organization (GO:0007031),-0.29713454471359857,-0.8719251144774449,0.6587837837837838,0.8062332473001149,1.0,6/25,16.74%,PEX14;ABCD2;FIS1;PLAAT3;PEX7;ABCD3
prerank,membrane fusion (GO:0061025),0.2713746405880033,0.871695144271302,0.6800947867298578,0.8979230378637508,1.0,5/33,11.82%,DNM3;RIMS1;DNM1;DYSF;NSFL1C
prerank,regulation of myelination (GO:0031641),0.2937259341257159,0.8714220741193301,0.6455399061032864,0.8974106851368513,1.0,5/25,11.92%,TENM4;PARD3;PTN;PTPRZ1;HES5
prerank,peptidyl-asparagine modification (GO:0018196),-0.28347941108350605,-0.8711836384368914,0.6592082616179001,0.8073631320780399,1.0,10/31,24.98%,MGAT5;ALG5;DPM3;ST6GAL1;MAGT1;NUDT14;MGAT2;STT3B;DDOST;MCFD2
prerank,response to metal ion (GO:0010038),-0.23945783548549066,-0.8708153617608443,0.7051926298157454,0.8077225712917091,1.0,13/67,13.59%,SLC30A5;ANXA11;MT1X;MT1A;BCL2;ADAM9;CRIP1;PPP1CA;HIF1A;NEDD4L;ITPR3;MT2A;SEC31A
prerank,defense response to tumor cell (GO:0002357),-0.3800915874327852,-0.8703518269517143,0.6316695352839932,0.8083014391083156,1.0,4/10,14.89%,DAPK1;SPI1;LAPTM5;PRDX2
prerank,positive regulation of cell aging (GO:0090343),-0.3776877514132362,-0.8703364585633696,0.6479591836734694,0.8079729301793644,1.0,4/11,15.88%,CGAS;B2M;EEF1E1;ARG2
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.27786414781723245,-0.8703165928310661,0.6822916666666666,0.8076572099308575,1.0,8/33,14.33%,ITGA5;E2F2;PIK3CB;VEGFA;JAK1;JMJD8;PKM;KLF2
prerank,regulation of receptor binding (GO:1900120),-0.38391172603801843,-0.8702347281953758,0.6262975778546713,0.8074618162862873,1.0,3/10,12.32%,B2M;ATP2A3;ADAM15
prerank,positive regulation of cell growth (GO:0030307),-0.22950321527616696,-0.8700314218559133,0.7516447368421053,0.8075462226796932,1.0,20/96,15.13%,IGF1;SDCBP;CSNK2A1;GOLGA4;ITSN2;CDC42;RUFY3;BCL2;MACF1;DDX49;KLHL22;TGFBR1;SYT4;NEDD4L;MTPN;CXCL16;CIB1;NCBP1;INO80;EIF4G1
prerank,fatty acid oxidation (GO:0019395),-0.2486988430469949,-0.869973470243732,0.6791808873720137,0.807321742467474,1.0,21/57,33.46%,PPARD;ABCD2;ADIPOR1;ACADM;ACAD11;ACAT2;ABCD3;MCAT;ACOX1;ACAA2;ACADVL;ALOX15;HSD17B10;ACADS;ECHDC2;ACAD10;SCP2;ECHS1;HADH;ADH5;SLC25A17
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.3105932607558253,-0.8696115274316679,0.6584564860426929,0.8076594788275449,1.0,4/21,5.68%,BIRC3;USP50;AIM2;PSMB9
prerank,pseudouridine synthesis (GO:0001522),-0.35113263397272176,-0.8695263177517297,0.6642728904847397,0.8074573784711336,1.0,3/13,14.10%,PUS7;PUS1;GAR1
prerank,positive regulation of protein polymerization (GO:0032273),0.2355517966964017,0.8694522535505437,0.6990521327014217,0.9008556342168873,1.0,12/65,14.78%,NAV3;TENM1;PRKCE;CARMIL1;TTBK1;NCKAP1;OCLN;CDK5R1;ARF6;CDK5RAP2;HSP90AA1;ARL2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.3539194048407484,-0.8691751189414757,0.6221837088388215,0.807811560853758,1.0,5/13,26.43%,NRROS;CD46;GREM1;GREM2;BMP2
prerank,regulation of cellular pH (GO:0030641),0.2854146894861009,0.8689973538051619,0.6711409395973155,0.9007604366858527,1.0,4/29,5.66%,SLC4A10;SLC4A4;SLC9A2;CA2
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.36185947758018566,-0.8684858684004365,0.6512820512820513,0.8084810851555689,1.0,3/11,10.21%,SYNJ1;IMPA1;INPP5A
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.36185947758018566,-0.8684858684004365,0.6512820512820513,0.8084810851555689,1.0,3/11,10.21%,SYNJ1;IMPA1;INPP5A
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2823375424476242,0.868296610580026,0.6627634660421545,0.9011777508405758,1.0,5/25,13.20%,OMA1;POMT2;TOR1A;UGGT2;KLHL15
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.2849448902214812,-0.8673134780964017,0.675,0.8100421870108423,1.0,17/31,35.22%,POLR2H;POLR2F;POLR2L;CMTR2;POLR2A;NCBP1;POLR2G;POLR2I;GTF2F2;GTF2F1;RAMAC;MNAT1;POLR2D;GTF2H1;ERCC2;POLR2B;CDK7
prerank,7-methylguanosine RNA capping (GO:0009452),-0.2849448902214812,-0.8673134780964017,0.675,0.8100421870108423,1.0,17/31,35.22%,POLR2H;POLR2F;POLR2L;CMTR2;POLR2A;NCBP1;POLR2G;POLR2I;GTF2F2;GTF2F1;RAMAC;MNAT1;POLR2D;GTF2H1;ERCC2;POLR2B;CDK7
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.29981363880942064,-0.8670409990787598,0.6644067796610169,0.810218691796598,1.0,13/25,43.11%,CSNK2A1;RPL11;HSP90AB1;TRIM39;SGTA;RPL5;PML;PSMF1;PSME3IP1;LAMP3;HFE;OPHN1;RPS7
prerank,negative regulation of hippo signaling (GO:0035331),0.3543183374482322,0.8664010989101252,0.6206896551724138,0.9042443422486564,1.0,7/12,21.87%,WWC1;WTIP;MARK3;SHANK2;CIT;DLG5;AJUBA
prerank,carbohydrate transport (GO:0008643),0.3621207955416159,0.8663146103242529,0.6463963963963963,0.9032930226014442,1.0,1/11,1.11%,SLC2A5
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3377141519316165,0.8659187087596506,0.6415094339622641,0.9030589055176507,1.0,4/13,20.17%,CAMK4;TOX;ZC3H8;GLI2
prerank,regulation of endocytic recycling (GO:2001135),-0.36796798554392707,-0.8659087739183902,0.6198347107438017,0.8121178949334505,1.0,3/11,14.42%,EIPR1;RAB11B;EHD1
prerank,positive regulation of embryonic development (GO:0040019),-0.32121282401242984,-0.8652969738225531,0.6551126516464472,0.8129714763036067,1.0,4/19,11.44%,B4GALT5;NIBAN2;RBM19;OSR1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.35393161350644764,-0.8650791910224748,0.6404494382022472,0.8130384438580714,1.0,3/12,10.38%,XDH;PIK3CB;SPRY2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.30866604714258183,-0.8650679558522679,0.6689774696707106,0.8127031437094236,1.0,6/22,13.84%,MGAT5;IL10RB;CRLF3;IL7R;CCL5;OCIAD2
prerank,negative regulation of cell growth (GO:0030308),0.2110554017115487,0.8632830691709824,0.8095238095238095,0.9077009097935963,1.0,15/121,9.16%,MAP2;SLIT3;SLIT2;DCC;RERG;CDA;CCN3;MSX1;WT1;RBBP7;IP6K2;ENO1;TRIM46;CAPRIN2;CDKN2A
prerank,regulation of telomere maintenance (GO:0032204),-0.2890886605563005,-0.8627579208349087,0.6777408637873754,0.8168547188670944,1.0,10/26,26.76%,RTEL1;DHX36;ERCC4;USP7;NBN;HDAC8;SMG1;MYC;MRE11;PML
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.28750166962112045,0.8626928606797705,0.65625,0.9078994600919318,1.0,4/26,6.34%,AKAP6;CAMTA1;FHL2;PRNP
prerank,regulation of keratinocyte migration (GO:0051547),0.3440687454792871,0.8625371121841959,0.6506329113924051,0.9071163783679742,1.0,3/12,11.69%,EPB41L4B;FGF10;ARF6
prerank,negative regulation of protein polymerization (GO:0032272),0.2870890260633778,0.8616501443145732,0.6682692307692307,0.9079627762276788,1.0,8/27,16.96%,MAP2;SLIT2;TUBB4A;KANK1;EML2;CDH5;SNCA;KANK4
prerank,negative regulation of cell population proliferation (GO:0008285),-0.19192266591400167,-0.8614286918208429,0.8609077598828697,0.8191465679327167,1.0,92/351,24.63%,LYN;MTSS1;ABI1;ARID2;CD300A;CDK6;NIBAN2;PTPRJ;NUPR1;RUNX3;BRD7;PPARG;S100A11;RNF41;PTK2B;RARG;CBFA2T3;SMYD2;IFI35;CTNNB1;SKI;NF2;NME1;EIF2AK2;E2F1;B2M;E2F3;TRIB1;GSDME;ITGB1BP1;TGFB1I1;PTPN6;MORC3;INCA1;CDKN3;APP;B4GALT7;STRN;FLCN;MAP2K1;KLF10;FAP;CELF1;STK11;IGFBP3;EEF1E1;CIB1;NLRC3;FRK;TFAP4;GREM1;BTG1;ANG;APPL2;KLF11;RBBP4;VHL;PARP10;HSPA1A;TOB1;ATF5;CDKN2C;GATA3;PDCD5;COL18A1;MDM4;BMPR2;ADAMTS1;BAP1;SIRT2;PDS5B;SFRP1;COPS8;GNRH1;NUP62;IFITM1;CGRRF1;IL6;BNIPL;SOX7;TGFB1;HMOX1;PIM2;GPLD1;TNN;CYP1B1;TES;LMNA;FTH1;MYC;RBP4;NUDT6
prerank,aminoglycan catabolic process (GO:0006026),0.28467564520288413,0.8607626014117192,0.6644295302013423,0.9088129682403037,1.0,7/28,16.69%,GPC6;GPC5;SDC1;GLB1;SDC2;IDUA;IDS
prerank,negative regulation of coagulation (GO:0050819),-0.3433151426100851,-0.8607106348578067,0.6627906976744186,0.8201844606876612,1.0,2/14,4.37%,APOE;TFPI
prerank,negative regulation of transposition (GO:0010529),-0.3333394239751726,-0.8602955919542437,0.657243816254417,0.8206323911373327,1.0,3/16,10.75%,TUT7;UBR2;MOV10
prerank,embryonic heart tube morphogenesis (GO:0003143),0.2502595884404296,0.8602893220951361,0.7201946472019465,0.9087157231466655,1.0,9/43,18.47%,RYR2;AHI1;ACVR1;SMO;HES1;MKKS;FOLR1;NPHP3;BBS7
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.30141092180988077,-0.8602036206698266,0.666098807495741,0.8204442653279003,1.0,6/23,13.84%,IL10RB;PIBF1;PTK2B;CRLF3;CCL5;OCIAD2
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.3094330998164624,-0.8601090562560783,0.670753064798599,0.8202514575722221,1.0,3/22,4.68%,PLEK;ROCK1;STAP1
prerank,chordate embryonic development (GO:0043009),-0.25204713095757375,-0.8600374726779763,0.7105691056910569,0.8200227567090327,1.0,7/55,8.63%,MBNL1;XYLT1;ZNF568;BRCA1;VEGFA;SULF2;TGFBR1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.25145013972964514,0.8599167105796356,0.6870229007633588,0.908394939440279,1.0,11/45,17.19%,BRINP3;BRINP1;AURKAIP1;PTPN3;ZW10;BMP7;TOM1L1;TRIM35;NABP2;CDKN1C;BRINP2
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.37754230758806445,-0.8591381517491056,0.666083916083916,0.821371654909041,1.0,3/10,11.64%,PTPN22;DNAJA1;AIDA
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.3294957787250151,-0.8586508863349201,0.6894639556377079,0.821979957252183,1.0,6/14,21.80%,TGFBR1;CHADL;GREM1;PTPN11;RFLNB;SNAI2
prerank,neuron projection organization (GO:0106027),-0.3311908843728564,-0.8583525986096029,0.6459412780656304,0.8221888855178953,1.0,4/15,11.23%,INSR;ABCD2;APP;DCTN1
prerank,sodium ion homeostasis (GO:0055078),0.30420417431178076,0.8580569062143423,0.6446700507614214,0.9114291800037136,1.0,4/21,10.56%,SLC12A2;SLC12A1;ATP1A3;ATP1B1
prerank,regulation of response to oxidative stress (GO:1902882),-0.3605368926866732,-0.8577724793009419,0.6706484641638225,0.8229515792725521,1.0,1/11,0.63%,MCTP1
prerank,histone H3 acetylation (GO:0043966),-0.2603397657686555,-0.8572791742206725,0.7231543624161074,0.8235578622632534,1.0,15/40,35.41%,SPI1;WDR5;JADE2;KAT7;DR1;TAF9;TRIM16;TADA1;TADA3;LEF1;TAF5;TAF5L;JADE3;KAT6A;YEATS2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.35042635424096613,0.8572054848264853,0.6372315035799523,0.9121629460577924,1.0,3/11,9.23%,POMT2;TOR1A;UGGT2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.33366016880819355,-0.8571915976135551,0.660958904109589,0.8233524767842361,1.0,4/15,25.77%,RPL11;SMAD7;DTX3L;RPL5
prerank,regulation of telomere capping (GO:1904353),-0.2988580862095727,-0.8571167850772583,0.6490299823633157,0.8231274161368513,1.0,14/23,41.27%,RTEL1;PKIB;TNKS2;USP7;ATM;NBN;MAPK1;MAPK15;MAP3K4;NEK7;TNKS;NEK2;AURKB;TERF2
prerank,nitrogen compound transport (GO:0071705),-0.21131358676153827,-0.8571063171711306,0.7835218093699515,0.8227866980764522,1.0,40/141,27.52%,LRRC8D;MYH9;RAB7A;SLC6A6;SLC43A2;SLC15A3;TOM1;CENPF;SLC16A10;SLC7A7;RCN3;FLVCR1;ABCC1;CHMP1A;HSP90B1;SLC25A45;ARRDC4;SEC14L1;SLC7A5;MIA3;ARRDC1;CHMP2A;LMAN2L;SLC23A1;SLC6A8;RILP;SNX4;SLC38A2;TXNIP;PPT1;SLC52A2;SLC15A4;LRP2;ARRDC2;CHMP2B;SLC22A3;SLC52A1;PDPN;SLC7A2;SLC7A4
prerank,detection of mechanical stimulus (GO:0050982),0.3091097906654616,0.8569230984856249,0.674364896073903,0.9116539678595622,1.0,4/19,11.28%,CDH2;PKD1L3;TTN;PKD1
prerank,peptide catabolic process (GO:0043171),-0.29787846478121394,-0.8565808171429878,0.6649572649572649,0.8234386415584278,1.0,6/23,18.22%,ANPEP;LNPEP;CTSH;CPQ;TPP1;CHAC2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.35160222003061214,0.8565232805871802,0.6418269230769231,0.911366405414351,1.0,3/11,10.36%,SLC25A19;ENPP3;THTPA
prerank,protein localization to kinetochore (GO:0034501),-0.3354937921450233,-0.8559029202902084,0.653211009174312,0.8243467104314363,1.0,4/14,15.45%,KNL1;ZWILCH;CDK1;TTK
prerank,heart trabecula morphogenesis (GO:0061384),0.30308321184666676,0.8557458534260896,0.6715328467153284,0.9120026728828058,1.0,3/18,10.93%,NRG1;BMP7;TGFB2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.3316678838945287,0.8551567796737963,0.6550925925925926,0.9122073846148334,1.0,6/14,23.97%,XRCC5;NABP2;PINX1;TERT;BRCA2;TINF2
prerank,sulfur amino acid metabolic process (GO:0000096),-0.29940279297263217,-0.85486327005624,0.6974358974358974,0.8259894496123817,1.0,7/24,21.21%,CDO1;MSRA;MTR;MPST;MMUT;SMS;MTHFR
prerank,copper ion homeostasis (GO:0055070),-0.3226160070757722,-0.8541431720687158,0.6625441696113075,0.8270648176788523,1.0,4/17,13.43%,ATP7A;SLC31A1;APP;MT2A
prerank,autophagy of peroxisome (GO:0030242),-0.3625308069550881,-0.853314530620875,0.6725978647686833,0.8283276408053122,1.0,7/12,36.12%,RB1CC1;USP30;ATM;TRAPPC8;SQSTM1;PEX5;PJVK
prerank,positive regulation of protein acetylation (GO:1901985),-0.3662247666569264,-0.8532090019349633,0.6654804270462633,0.8281727906940789,1.0,3/12,19.06%,CEP295;TAOK1;DDX3X
prerank,amino sugar metabolic process (GO:0006040),-0.3699034660845507,-0.8531078953326792,0.6573770491803279,0.8279961509133769,1.0,2/10,9.46%,ST3GAL1;ST6GAL1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.3340507868735002,0.8526852353157278,0.6527777777777778,0.9164807417194104,1.0,7/14,22.52%,PKIA;ATP2B4;PRKAR1A;SIRT1;PRKAR2B;HTT;PRKAR1B
prerank,negative regulation of heart contraction (GO:0045822),0.3438987384003681,0.8524117943650962,0.6444444444444445,0.9159703944771939,1.0,3/11,8.28%,PDE4D;SPX;SPTBN4
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.34898382936714684,-0.8519270773287209,0.6839378238341969,0.8299143614869725,1.0,5/12,24.51%,DSE;CHST12;CSPG4;BGN;DCN
prerank,establishment of spindle orientation (GO:0051294),-0.2808477723413423,-0.85152589110995,0.703125,0.8303045113918367,1.0,12/28,34.01%,ITGB1;FBXW11;CENPA;DCTN1;MAP4;NDC80;PAFAH1B1;PKHD1;SPDL1;GJA1;LLGL2;NUMA1
prerank,cellular response to ketone (GO:1901655),-0.27014309240137574,-0.8509233200545392,0.710801393728223,0.8311028603832616,1.0,9/35,17.88%,MSN;GNB1;PTGER4;GNG2;AHR;ADAM15;SPP1;SPHK2;NR3C1
prerank,protein localization to centrosome (GO:0071539),-0.32855139139227374,-0.8507890952584948,0.6795952782462057,0.831012802324836,1.0,5/17,20.89%,SNX10;PIBF1;NUDCD3;STIL;CEP192
prerank,ether lipid biosynthetic process (GO:0008611),0.3641882873372464,0.8505789799969696,0.6443914081145584,0.9187663351819536,1.0,2/10,7.13%,LPCAT2;CHPT1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.35004279937057836,0.8499547796176224,0.6167076167076168,0.9189566354139069,1.0,3/10,11.69%,EPB41L4B;FGF10;ARF6
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.3672068181491114,-0.8493277037344795,0.6566371681415929,0.8334343510703858,1.0,6/11,26.53%,FRS2;MEF2C;GREM1;TGFB1;BMP2;FZD7
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.23930037014194072,-0.848769328302917,0.7593582887700535,0.8341119094068782,1.0,29/68,35.22%,SNRPG;SNRPF;POLR2H;SSU72;POLR2F;POLR2L;NUDT21;SMN1;WDR33;POLR2A;NCBP1;TTF1;TAF1A;POLR1F;PAPOLA;CPSF3;MAZ;MED18;CPSF1;POLR1C;UBTF;POLR1E;MNAT1;TAF1D;SNRPD3;GTF2H1;ERCC2;PRMT5;CDK7
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.3482276618474718,-0.8486638927524023,0.657243816254417,0.8339444327221904,1.0,5/12,15.01%,ACTB;ZDHHC7;SCRIB;RAB10;VANGL2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3263964396324486,0.8483117955952982,0.6598173515981736,0.9214704037024197,1.0,7/14,22.15%,SPRY4;APLN;CREB3L1;SPRY1;FUZ;SULF1;GPC1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.3470597030734774,-0.8482123127098866,0.6661045531197302,0.8344506632096486,1.0,2/13,6.32%,NFE2L2;HGF
prerank,central nervous system neuron axonogenesis (GO:0021955),0.340533875633165,0.848017693450533,0.6476426799007444,0.9209256264783783,1.0,6/12,18.96%,MYCBP2;EPHB1;SPTBN4;ARHGAP35;HSP90AA1;B4GALT6
prerank,regulation of histone modification (GO:0031056),-0.34172847174059995,-0.8477778388404981,0.6412859560067682,0.8349250300919264,1.0,6/13,31.10%,AKAP8;FLCN;MTHFR;AKAP8L;UBE2N;PARG
prerank,COPII-coated vesicle budding (GO:0090114),-0.2368336359010793,-0.84716748743809,0.7696245733788396,0.8357104542235113,1.0,24/68,27.06%,CTSZ;RAB1A;TMED10;TFG;PREB;CTSC;SEC24A;SAR1A;PPP6R3;SEC24D;STX5;SEC31A;MIA3;TRAPPC5;VAPB;TMED2;TRAPPC9;F5;TRAPPC3;RAB1B;MCFD2;TRAPPC2L;VAPA;CUL3
prerank,central nervous system myelination (GO:0022010),0.3501789122172661,0.8470304851297066,0.6696428571428571,0.9219043939885369,1.0,2/11,3.30%,TENM4;PLP1
prerank,regulation of lipid storage (GO:0010883),-0.2939482861217131,-0.8465416705792739,0.6856127886323268,0.8365250034357132,1.0,5/22,10.93%,NFKB1;ITGAV;C3;LPL;FTO
prerank,glycine metabolic process (GO:0006544),0.34388124194029285,0.846031906557613,0.6658595641646489,0.9228965122860816,1.0,6/12,26.59%,GLDC;GLYAT;SDSL;RIDA;SHMT2;SDS
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.3021763562517624,-0.8455923032405405,0.6661045531197302,0.8379697577367476,1.0,3/20,9.40%,MTHFS;SLC27A1;CNDP2
prerank,sodium ion export across plasma membrane (GO:0036376),0.3377225971419512,0.8455250773980393,0.6801909307875895,0.9228517853533514,1.0,4/13,17.14%,SLC4A4;ATP1A3;ATP1B1;ATP1B2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.2675026894330356,-0.8452720211667865,0.7046632124352331,0.8382094224594017,1.0,10/35,18.28%,PTPRC;IL10RB;ADIPOR1;CRLF3;NF2;CCL5;OCIAD2;DOT1L;VHL;SOCS3
prerank,negative regulation of macroautophagy (GO:0016242),-0.28817634341083287,-0.8451491345582679,0.6895368782161235,0.8380444059952574,1.0,10/26,27.41%,NUPR1;MTM1;USP36;PIK3CA;UBQLN4;CHMP4B;CHMP4A;SMG1;QSOX1;TSC2
prerank,RNA polyadenylation (GO:0043631),-0.2855243666491898,-0.8447088990337585,0.7011494252873564,0.8381343260663786,1.0,8/26,20.55%,SSU72;APP;MTPAP;WDR33;TENT4B;PAPOLA;CPSF3;GRSF1
prerank,mRNA polyadenylation (GO:0006378),-0.2855243666491898,-0.8447088990337585,0.7011494252873564,0.8381343260663786,1.0,8/26,20.55%,SSU72;APP;MTPAP;WDR33;TENT4B;PAPOLA;CPSF3;GRSF1
prerank,regulation of muscle cell differentiation (GO:0051147),0.2683411765280897,0.8442492770942125,0.7315914489311164,0.9244396380414877,1.0,2/31,1.32%,CTNNA2;CDH2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.36057691300773753,-0.8440576125116753,0.6518010291595198,0.8389850098736548,1.0,4/11,23.61%,SLC27A1;NR1H2;LDLR;GPLD1
prerank,endoplasmic reticulum organization (GO:0007029),-0.23297952761010665,-0.8439675975943153,0.7901639344262295,0.8387849247994797,1.0,32/72,37.27%,TMCC1;TRAM2;APP;SERP1;STX5;RAB10;SEC31A;MIA3;LMAN2L;VAPB;DOP1B;LPCAT3;REEP3;SGTA;TRAM1L1;HMOX1;CYB5A;OTOF;VAPA;EIF2AK3;VAMP2;MAPK15;REEP6;GAK;MOSPD3;LMAN2;TOR1AIP2;CAV2;SEC31B;TLE6;LMAN1L;SEC16B
prerank,integrated stress response signaling (GO:0140467),0.3226029515613475,0.8439330424930441,0.6607929515418502,0.9239491282343448,1.0,1/14,0.59%,OMA1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.34652045757772776,-0.8438155756965391,0.671280276816609,0.8387054038586541,1.0,7/13,33.80%,GEN1;TPR;XRCC3;NDC80;CCNB1;ANAPC15;DUSP1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3074030504292297,0.8431022504957664,0.7011764705882353,0.9245556473410835,1.0,6/18,18.75%,CCN3;REST;PRKN;INHBB;IRS1;CRH
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.2989693316905505,-0.8422881996145518,0.7043478260869566,0.8411981600666055,1.0,7/21,15.02%,ATXN7;ARHGEF2;TPX2;TAOK1;CIB1;SPEF1;STMN2
prerank,regulation of cell growth (GO:0001558),0.1934087188820138,0.8422348291487045,0.8770053475935828,0.9253041892661396,1.0,30/204,13.04%,NRG3;AKAP6;SPOCK1;SLIT3;SLIT2;PAK5;RERG;CDA;CCN3;MELTF;PTCH2;MSX1;WT1;PLCE1;RBBP7;IP6K2;ENO1;CHPT1;TMEM97;CAPRIN2;CDKN2A;ROS1;EIF4G2;AGTR1;TGFB2;MFSD2A;RPTOR;SMARCA2;TAF9B;DNAJB2
prerank,neurotransmitter biosynthetic process (GO:0042136),0.3238527380049503,0.8421262708631257,0.6888361045130641,0.9243745320976062,1.0,5/14,23.56%,SLC5A7;CHAT;SLC6A4;NOS1;ALDH9A1
prerank,positive regulation of vascular permeability (GO:0043117),0.3369220594770278,0.8415678964710959,0.6492537313432836,0.9244155369055846,1.0,2/12,8.71%,TJP1;OCLN
prerank,membrane lipid catabolic process (GO:0046466),0.3608247591601477,0.8415454106528175,0.651685393258427,0.9233495412343338,1.0,1/10,2.27%,ENPP2
prerank,modulation by host of viral genome replication (GO:0044827),-0.3367522603263104,-0.8411818087855663,0.6660808435852372,0.8428896764866022,1.0,6/13,26.97%,YTHDC2;NUCKS1;PPIB;ZC3H12A;CCNK;VAPA
prerank,synaptic vesicle membrane organization (GO:0048499),0.3046942587122804,0.840944113442567,0.7088305489260143,0.9234401216055196,1.0,4/17,9.57%,SNAP25;STX2;TOR1A;PRRT2
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.24524700921489162,-0.8408652310828656,0.7482993197278912,0.843124713573042,1.0,17/51,26.70%,PPARG;SKI;HTRA3;ACVR2A;GREM1;LEMD2;SMAD7;RBPMS2;GDF3;BMPR2;SMURF2;GREM2;LRP2;SKIL;SMAD4;BMP2;SMURF1
prerank,embryonic hemopoiesis (GO:0035162),-0.3459275225833818,-0.840449582792748,0.6666666666666666,0.8435411506529442,1.0,8/12,41.24%,TGFBR2;KMT2A;KDR;KITLG;TPO;ATF4;SH2B3;ZFPM1
prerank,positive regulation of ATPase activity (GO:0032781),0.25403987045605897,0.8403996117231066,0.7382075471698113,0.9234157163382901,1.0,13/41,17.85%,RYR2;DYNLL1;FGF10;DYNLL2;TNNT2;ALDOB;ATP1B1;DNAJB2;ATP2A1;TPM1;GABARAPL2;ATP1B2;SETMAR
prerank,regulation of protein autophosphorylation (GO:0031952),-0.26708708620964544,-0.8401665200321455,0.7226027397260274,0.8437132581616988,1.0,15/36,27.20%,RAP2A;MVP;VEGFA;TAOK2;DDX3X;ENPP1;NBN;MOB1B;PDGFA;PPP2R5B;PPP2R5A;MRE11;RASSF2;PPP2R5E;ENG
prerank,cardiac muscle cell development (GO:0055013),0.2948946717518976,0.8400919339015769,0.7015590200445434,0.9229754457986901,1.0,4/20,12.80%,SORBS2;TTN;ALPK2;FHOD3
prerank,ceramide biosynthetic process (GO:0046513),-0.2593651954898534,-0.8400024165625666,0.7307692307692307,0.8436625102996648,1.0,3/40,2.02%,SGMS1;SPTLC2;ST8SIA4
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.22867704921659027,-0.839707989273694,0.7840531561461794,0.8438481662763044,1.0,23/75,26.48%,ITGA4;NRP1;HTR2B;NRP2;VEGFA;MDK;TGFBR1;HIF1A;ARNT;HMGB2;PIK3CD;ANG;NR4A1;NRAS;AGGF1;HMGB1;BMPR2;KDR;APLNR;HMOX1;VASH2;BMP2;VIP
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.3080559187453757,-0.8395262046741837,0.697986577181208,0.8438190743934032,1.0,6/20,27.20%,RBPJ;TGFBR1;HEYL;SNAI2;BMP2;ENG
prerank,cellular modified amino acid catabolic process (GO:0042219),0.3214559532979845,0.8394141002675535,0.6553398058252428,0.9231708231253688,1.0,4/15,16.32%,ABHD16A;SARDH;GGT1;GGT5
prerank,sulfate transport (GO:0008272),-0.33040044039240585,-0.8391869840070236,0.6944444444444444,0.8440842802285357,1.0,6/14,33.78%,SLC26A11;RACGAP1;SLC25A10;SLC26A4;SLC13A4;SLC26A7
prerank,positive regulation of intracellular transport (GO:0032388),0.2486110919855244,0.8387680877935367,0.7154046997389034,0.9234114642071505,1.0,10/38,14.48%,TENM1;PLA2G4E;ZFAND1;PRR5L;NEDD4;CEP131;CEP290;CAPN10;ICE1;ATP2A1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3395326444488281,-0.8365000749063195,0.715008431703204,0.8485597305506811,1.0,1/13,0.06%,RBPJ
prerank,eye development (GO:0001654),0.23269573305277216,0.8364012312360642,0.7875288683602771,0.9271324057161666,1.0,10/54,12.13%,CACNA1C;MEIS1;BMPR1B;SALL2;WT1;TSKU;CEP290;TGFB2;HES5;PBX1
prerank,cobalamin metabolic process (GO:0009235),-0.3218669908804621,-0.8363396517642548,0.7118353344768439,0.8484732340846604,1.0,4/17,20.46%,ABCC1;MTR;MMUT;LMBRD1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.330267941523324,-0.8358245315195355,0.7157534246575342,0.8490521650265058,1.0,4/15,10.66%,ATP1B3;SLC9A1;SLC8A1;NEDD4L
prerank,regulation of chromatin binding (GO:0035561),0.35266873803991383,0.8354865101749331,0.648960739030023,0.92792334130648,1.0,1/10,1.15%,DDX11
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.33245234941718765,0.8349146584758281,0.6788321167883211,0.9280011064123949,1.0,5/12,16.80%,PPARGC1A;ABCD1;IRS1;MLYCD;AKT2
prerank,gliogenesis (GO:0042063),-0.3271102904976376,-0.8348153157217204,0.6684027777777778,0.8505261497832495,1.0,5/15,15.66%,CDK6;CD9;ANXA1;METTL14;METRN
prerank,blood vessel endothelial cell migration (GO:0043534),0.28588939773690636,0.8338686531755417,0.7142857142857143,0.929087379815538,1.0,2/22,1.35%,ROBO1;SLIT2
prerank,ruffle organization (GO:0031529),-0.3215609820089546,-0.8337370984640564,0.695575221238938,0.8521433243815203,1.0,5/16,19.99%,PLEK;RAC1;LIMA1;ARFIP2;PIP5K1A
prerank,response to purine-containing compound (GO:0014074),-0.3147705244822406,-0.8335402127553376,0.7073578595317725,0.8521181535500323,1.0,2/17,2.65%,P2RX7;P2RX4
prerank,regulation of cell morphogenesis (GO:0022604),0.26298979503321424,0.8334846060125253,0.7254901960784313,0.9287649438566227,1.0,10/30,16.13%,EFNA5;NTNG2;NTNG1;MFSD2A;SH3D19;FERMT2;WTIP;ARC;SPARC;PDZD8
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.3136555836649454,-0.8330479057865424,0.6933333333333334,0.8526466061959451,1.0,6/17,26.68%,TFPI;UBE2L3;NR3C1;URI1;ADTRP;ATP1A1
prerank,C-terminal protein amino acid modification (GO:0018410),0.3494123938865376,0.832856654665315,0.6551724137931034,0.9288487099780752,1.0,5/11,20.91%,AGBL4;AGBL1;FOLH1;LCMT1;TTL
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.2563355658227512,-0.8322750268485378,0.7379679144385026,0.8536432047786316,1.0,10/40,15.42%,C5AR1;ABL2;HTR2B;RASGRP4;FLT1;GNA15;ITK;EDNRA;TXK;ANG
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.3344315338440068,-0.8320569180521323,0.6939799331103679,0.8536853175487376,1.0,4/14,25.19%,IMPDH2;ADSS1;PFAS;ATIC
prerank,protein targeting (GO:0006605),-0.20975932879992043,-0.8319022250030026,0.8423645320197044,0.8536006128664574,1.0,38/118,27.10%,SDCBP;TRAK1;KIF13B;SEC63;LAMP2;FUT10;RPL11;PITRM1;SRP14;NACA;ZFAND2A;ZDHHC7;ZFAND6;AP1S3;FIS1;ZDHHC2;NCF1;TIMM44;TIMM22;ZDHHC12;GABARAP;SRPRB;FBXO7;TAOK2;ZDHHC1;TOMM22;NACAD;GOLGA7;TOMM34;HPS4;TOMM70;MICALL1;EDEM1;ZDHHC6;YIF1B;AP4E1;LONP2;TOMM40
prerank,external encapsulating structure organization (GO:0045229),0.18869574984340604,0.8317102882543856,0.9148936170212766,0.9300142625137341,1.0,51/205,20.67%,ADAM12;MMP16;TNR;ADAMTS17;COL27A1;LAMC3;MMP12;VCAN;ADAMTS16;COL11A1;ITGB8;ADAMTSL1;GFOD2;VCAM1;MMP15;ITGB3;ITGA9;VIT;THSD4;COL4A3;COL23A1;COL19A1;MMP13;SMOC2;TTR;COL7A1;ADAMTS5;ITGA11;ADAMTS12;ADAMTS6;CDH1;COL24A1;NID2;SPARC;ST7;ADAMTSL2;LAMA2;COL1A1;FBLN5;LOXL1;LAMA5;SMOC1;TNC;SH3PXD2A;LOX;JAM3;COL4A4;NID1;MMP14;ITGA2B;TGM1
prerank,acyl-CoA metabolic process (GO:0006637),0.25668751700975806,0.8315940099975782,0.7321016166281755,0.9291272651805697,1.0,13/35,22.83%,HMGCS1;GLYAT;ACSM5;ACACA;MCEE;ACOT8;MLYCD;ACSM3;ACSL6;ACOT12;ACOT7;GPAT4;OXSM
prerank,cortical cytoskeleton organization (GO:0030865),-0.25182794020367627,-0.8308586981007642,0.7265100671140939,0.8550913977042064,1.0,11/41,16.16%,PLEK;RAC1;ROCK1;RHOA;RHOQ;LCP1;NCKAP1L;FMNL2;IKBKB;RAB13;RND2
prerank,glycolipid biosynthetic process (GO:0009247),0.25056894699159893,0.8308229069077413,0.767379679144385,0.9296142561013241,1.0,19/38,29.33%,ST8SIA3;PIGU;B3GNT5;PIGA;PGAP4;DPM2;ST8SIA1;ST8SIA5;B4GALT6;ST6GALNAC5;PIGO;PIGL;PIGN;DPM1;PIGB;PIGW;PIGQ;PIGF;PIGP
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.260484072553098,-0.8307797170777733,0.7530434782608696,0.8548726595978888,1.0,13/37,23.39%,PRKAG2;AXIN1;CAB39;SPRED1;SPRY2;APP;SPRED2;EIF4G1;SMAD7;SIRT2;MAPK1;S1PR2;TGFB1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.27428165455633613,0.8307175953588536,0.7093596059113301,0.9286967834687079,1.0,7/27,18.00%,SLC1A2;SLC1A6;SLC47A1;SLC1A1;SLC25A38;SLC6A5;SLC38A1
prerank,positive regulation of chromosome organization (GO:2001252),-0.3253406373458807,-0.8303072936592811,0.6954225352112676,0.8553597096935495,1.0,7/15,26.76%,RTEL1;FEN1;DHX36;SHCBP1L;NBN;MRE11;PML
prerank,positive regulation of cellular protein localization (GO:1903829),-0.2306545324292702,-0.830101874492427,0.7893835616438356,0.8553726429780989,1.0,28/69,34.51%,GPR137B;STX3;SNX33;PARP9;CDK1;CCDC88A;KAT7;HSP90AB1;SLC5A3;STX4;NDC80;GSK3B;DTX3L;NUP62;GTSE1;TGFB1;GPD1L;CARD10;TMEM35A;MARK4;EIF2AK3;RANGRF;NGFR;CENPQ;ORMDL3;NUMA1;TNF;APC
prerank,determination of bilateral symmetry (GO:0009855),0.2772246709027605,0.8289743819472225,0.7253521126760564,0.9309458166662158,1.0,8/24,20.14%,ODAD3;DNAAF4;TBX1;MKKS;NPHP3;DNAH5;BBS7;CFAP53
prerank,cellular component disassembly (GO:0022411),0.23573605704813352,0.8284887922436904,0.8029925187032418,0.9307727871460589,1.0,14/53,16.37%,MMP16;TLL1;MMP12;SCUBE1;MMP15;MMP13;CTSK;GSN;HTRA1;BMP1;ADAMTS5;DYRK3;CAPNS2;CAPN2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.31448910664921853,0.8280199461851456,0.7173396674584323,0.9305438874436787,1.0,4/15,10.61%,EDA;MSX1;AMELX;TBX1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.28365079783062763,0.8275161068625349,0.7034482758620689,0.9304295746573961,1.0,6/23,19.43%,GSTP1;CYP1A1;LTA4H;ASAH2;ELOVL6;ACOT7
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.31787040286479723,0.8272591854713474,0.6912114014251781,0.9298214164647137,1.0,3/15,7.07%,NTRK2;SOS1;BDNF
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.32623855106052385,-0.8268735721937498,0.7132987910189983,0.8607274073643743,1.0,2/14,5.66%,SLC27A1;CEPT1
prerank,peptidyl-threonine modification (GO:0018210),-0.23019474510813884,-0.8264863030682958,0.8056951423785594,0.8610376626905595,1.0,20/66,22.81%,PRKCD;ROCK1;CSNK2A1;DYRK2;GALNT3;TGFBR1;GALNT1;CDK1;DYRK1A;MAP2K1;TGFBR2;MARK2;MAP3K10;CHEK1;CDC42BPG;WNK1;GSK3B;CDK5;MAPK1;PRKDC
prerank,DNA catabolic process (GO:0006308),-0.35194352410001517,-0.825962969059811,0.686456400742115,0.8615904971357324,1.0,6/11,40.43%,REXO4;DNASE1L1;XRN2;ISG20;DNASE1;DNASE1L2
prerank,cellular response to osmotic stress (GO:0071470),-0.2981593331899186,-0.8255227744843536,0.7065972222222222,0.8619383940872818,1.0,4/21,9.69%,LRRC8D;ARHGEF2;CAB39;RCSD1
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.3028296233558927,-0.8254848521333223,0.6989795918367347,0.8616414100598564,1.0,4/18,17.14%,ASH1L;SMYD2;KMT2D;KMT2A
prerank,synaptic vesicle transport (GO:0048489),0.34990735992694716,0.8251862436574868,0.6722488038277512,0.9327343089360032,1.0,3/11,8.20%,KIF5C;KIF5A;TOR1A
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.26141436680514485,-0.8246895052689484,0.7368421052631579,0.8626966851364634,1.0,5/36,11.64%,TAOK3;PTPN22;DUSP3;SIRPA;AIDA
prerank,protein acylation (GO:0043543),-0.25754778273929124,-0.8244776264060537,0.7466216216216216,0.8627101310864231,1.0,12/38,27.61%,CREBBP;ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;ZDHHC5;HHAT;ZDHHC13;ZDHHC6;CLOCK;EP300
prerank,glycine transport (GO:0015816),0.35253097806174594,0.8243820969144691,0.6876404494382022,0.9331507500286166,1.0,3/10,16.73%,SLC6A17;SLC25A38;SLC6A5
prerank,ganglioside metabolic process (GO:0001573),0.2884567889634715,0.8233760882956765,0.6928251121076233,0.9339682379112877,1.0,3/20,3.49%,ST8SIA2;ST8SIA3;HEXB
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2735998220331872,-0.8228180074451956,0.7302158273381295,0.8652075563100932,1.0,5/28,10.61%,NUPR1;AXIN1;LAPTM5;CTSC;PSMC3
prerank,alanine transport (GO:0032328),-0.3593885941362409,-0.8225709013562578,0.7101200686106347,0.865292645847244,1.0,2/10,8.64%,SLC6A6;SLC36A4
prerank,vascular transport (GO:0010232),0.213281506954443,0.8221128232788096,0.8211764705882353,0.9352412267301073,1.0,18/81,15.06%,SLC12A2;SLC2A13;SLC4A4;SLC1A2;SLC24A3;SLC6A17;SLC1A1;LEPR;SLC6A1;SLC8A2;SLC6A13;SLC38A3;MFSD2A;SLCO2B1;ATP2B4;SLC16A2;SLC22A5;SLCO3A1
prerank,acute-phase response (GO:0006953),-0.33961920610946283,-0.8218713099572778,0.7084805653710248,0.8661197185346081,1.0,5/12,33.68%,IL6R;CEBPB;IL6;SIGIRR;PLSCR1
prerank,regulation of mitochondrial fusion (GO:0010635),-0.34114202904595836,-0.8214521415717277,0.6862068965517242,0.866528436368292,1.0,2/11,8.39%,PID1;VAT1
prerank,intestinal absorption (GO:0050892),0.33191886009043087,0.820877686284805,0.7381489841986456,0.9365478749966276,1.0,1/13,1.11%,SLC2A5
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.32063215867105394,-0.8205659853032519,0.7193605683836589,0.8676939096571445,1.0,8/14,40.42%,MALT1;TRAF2;COPS8;CARD10;TRAF6;CARD14;TNFSF15;TLR3
prerank,regulation of cell projection organization (GO:0031344),0.3259818988608195,0.8202061030873448,0.6887871853546911,0.9367698647260788,1.0,3/13,10.94%,NTNG2;NTNG1;MFSD2A
prerank,cardiac ventricle development (GO:0003231),-0.2994562170321719,-0.8195960501183283,0.7190635451505016,0.8690312701849495,1.0,9/20,35.01%,HECTD1;TMEM65;GATA3;MDM4;HEYL;ENG;GJA5;HEY2;HEY1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.31725417999523187,0.8195871640393207,0.6951501154734411,0.9368155246330974,1.0,3/13,12.12%,YOD1;UBE2J1;BCAP31
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.2696032939203058,-0.8193195100990933,0.75,0.8691573702061516,1.0,10/29,25.67%,AXIN1;UBE2L3;PIN1;DCUN1D4;ARRDC4;SMAD7;DTX3L;TOPORS;FEM1B;UBE2N
prerank,activation of phospholipase C activity (GO:0007202),-0.27118185579480714,-0.8191193041393638,0.7209705372616985,0.86912733447109,1.0,8/29,15.42%,C5AR1;HTR2B;RASGRP4;GNA15;ITK;EDNRA;TXK;ANG
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.2856493374952984,0.8177308189177197,0.7466367713004485,0.9392661937785041,1.0,5/22,15.09%,CUBN;RBP2;CYP1A1;LGMN;GC
prerank,tyrosine metabolic process (GO:0006570),-0.3468043307269556,-0.8172888166790004,0.7227891156462585,0.8719171786849272,1.0,7/11,43.31%,IL4I1;DCT;HGD;FAH;TAT;TH;THAP4
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.2656382731101793,-0.816778038069137,0.7240143369175627,0.87242512458369,1.0,17/32,40.74%,CTNNB1;CCT7;PKIB;TNKS2;CCT4;HNRNPA1;ATM;MAPK1;MAPK15;MAP3K4;NEK7;TNKS;CCT8;CCT5;NEK2;AURKB;HMBOX1
prerank,protein N-linked glycosylation (GO:0006487),-0.2292362166649075,-0.8166462053217254,0.793918918918919,0.8722848208003572,1.0,17/66,20.86%,ST3GAL1;MGAT5;MAN1C1;ALG5;DPM3;ALG12;ST6GAL1;MAGT1;B4GALT7;NUDT14;PMM2;MGAT2;ALG6;B4GALT1;MGAT4B;STT3B;GFPT1
prerank,extracellular matrix disassembly (GO:0022617),0.23208627899525228,0.8158595234317204,0.8118811881188119,0.9417340911028556,1.0,11/53,12.14%,MMP16;TLL1;MMP12;SCUBE1;MMP15;MMP13;CTSK;GSN;HTRA1;BMP1;ADAMTS5
prerank,maturation of 5.8S rRNA (GO:0000460),-0.3079086633595556,-0.8154708163145277,0.7147766323024055,0.873902337292294,1.0,8/17,26.05%,EXOSC10;C1D;NOL9;EXOSC4;PRKDC;MTREX;WDR12;EIF6
prerank,neurogenesis (GO:0022008),0.23846814855214535,0.8154691392472322,0.7780429594272077,0.9413551999823307,1.0,11/43,17.62%,SPOCK1;EPHB1;DCHS1;FAT4;NEUROD1;TGFB2;CDK5RAP2;BTBD3;CIT;BTBD6;HAP1
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.1989699702945796,-0.815389342314411,0.8913738019169329,0.8736667546331379,1.0,43/151,28.79%,APOE;B4GALT5;SGMS1;SPTLC2;ACER3;CDO1;CSNK2A1;SLC27A1;MOCS1;CEPT1;SPTSSA;PRKD3;GCNT1;MOCS3;GCH1;PLA2G4A;LARGE1;AKR1A1;ARG2;KDSR;VAPB;ASS1;SPHK2;TYW5;LPCAT3;SPTLC3;SAMD8;INHA;GSTO1;PLPP3;ELOVL5;FURIN;DEGS2;TYW1;CERS3;HACD4;GAL3ST4;ESD;VAPA;LCAT;ST3GAL4;HACD3;PCYT1A
prerank,cochlea morphogenesis (GO:0090103),0.3471878882260486,0.8148713436373684,0.6980676328502415,0.9413889099231212,1.0,2/10,10.61%,SOX9;TBX1
prerank,response to estradiol (GO:0032355),-0.26761257200673894,-0.8148053028751182,0.7692307692307693,0.8742990697141476,1.0,4/31,7.44%,STAT3;ANXA1;CTNNB1;STAT5B
prerank,regulation of chromatin organization (GO:1902275),-0.32401716793984836,-0.8147620288617721,0.7348353552859619,0.8739995220739019,1.0,3/14,13.22%,TLK1;METTL4;MKI67
prerank,amide transport (GO:0042886),-0.27954709137371836,-0.8143882718796743,0.7363796133567663,0.8742483875032933,1.0,5/26,15.21%,PLTP;SLC27A1;GLTP;TAP2;ABCA13
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.2679818847666904,0.8139988028580859,0.7566909975669099,0.9418851677036602,1.0,6/27,10.76%,CHSY3;PXYLP1;VCAN;B3GAT2;CHST7;CHST9
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.3070377198733355,0.813949451812333,0.7089552238805971,0.9408747357595437,1.0,2/16,5.95%,SLC2A5;SPX
prerank,glycerolipid metabolic process (GO:0046486),0.33670260587771,0.8138874361930702,0.69377990430622,0.9398863997033656,1.0,1/11,0.91%,DGKB
prerank,respiratory tube development (GO:0030323),-0.2718618362730785,-0.8128910086777582,0.7631133671742809,0.8765645153156423,1.0,15/28,41.73%,VEGFA;CCDC40;ITGA3;BAG6;FGF9;RBP4;DNAAF1;WNT7B;PDPN;ABCA3;FGF2;HECA;STRA6;LOXL3;FGF7
prerank,negative regulation of T cell differentiation (GO:0045581),-0.357408048130102,-0.81274129463136,0.7052980132450332,0.8764530206153803,1.0,2/10,12.26%,MDK;FOXJ1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.34023445833205923,-0.812223575412204,0.7130584192439863,0.8769644037104648,1.0,4/11,23.39%,MEF2C;DHX36;GREM1;TGFB1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.29245713392552475,0.8119795658219394,0.6975,0.9423354227215316,1.0,3/19,10.93%,SLIT3;ACVR1;TGFB2
prerank,myelination (GO:0042552),0.23813658220549422,0.8108416876528494,0.782051282051282,0.9432879209545781,1.0,6/46,5.17%,SLC8A3;PARD3;SCN2A;PLP1;EPB41L3;MAL
prerank,protein kinase A signaling (GO:0010737),-0.34426766516556373,-0.8107787255787483,0.717687074829932,0.879010633191523,1.0,6/12,36.43%,LCP1;MYOM1;RAB13;GAL;EZR;TCP11
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.2699734636828578,-0.8104443541284099,0.7646048109965635,0.879211196517163,1.0,4/29,10.88%,APOE;SLC27A1;NR1H2;ZBTB20
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3398922045892788,0.8104433836650586,0.6839506172839506,0.9429354726337785,1.0,4/10,16.16%,CDC73;CPEB3;HSF1;LEO1
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.2657292988060209,0.8102935732722172,0.7438423645320197,0.9421221075291683,1.0,8/25,20.86%,SOX11;BMPR1B;HES5;CDH5;ZNF423;UBE2O;ACVR2B;SULF1
prerank,vasculogenesis (GO:0001570),-0.26372751653277393,-0.8102082663627782,0.7453625632377741,0.879237805168166,1.0,15/32,32.35%,VEGFA;SPRED1;TGFBR2;RASA1;PDGFRB;AGGF1;KDR;APLNR;TGFB1;ADM;WNT7B;ENG;RASIP1;HEY2;CAV1
prerank,microtubule-based transport (GO:0099111),0.32432388941083035,0.8099307834930772,0.7268170426065163,0.9416996812923464,1.0,6/12,25.58%,DYNC1I1;DNAAF4;DYNC1I2;HTT;SPEF2;CABYR
prerank,stabilization of membrane potential (GO:0030322),0.29931543119747916,0.8097840583412342,0.7155756207674944,0.9408590982187842,1.0,2/16,6.15%,KCNK10;KCNK2
prerank,SNARE complex assembly (GO:0035493),-0.3596602777567088,-0.808263288578019,0.7272727272727273,0.8821454335605888,1.0,7/10,40.51%,UVRAG;VAMP4;VAMP1;VAMP2;VAMP3;CLTRN;STXBP1
prerank,coenzyme A metabolic process (GO:0015936),0.31170950243513657,0.8068284913051356,0.7191780821917808,0.9451703024666209,1.0,6/14,19.46%,PANK3;NUDT7;ACAT1;COASY;ACOT7;CROT
prerank,hexose metabolic process (GO:0019318),-0.2523384517449672,-0.8061901558558455,0.7946902654867256,0.8852677980918986,1.0,16/39,32.89%,PPARD;GALT;SORD;AKR1A1;FUOM;GALM;IRS2;GALK2;PMM2;PGM1;PMM1;GALK1;GHRL;ALDOA;SLC35A2;GDPGP1
prerank,inositol phosphate catabolic process (GO:0071545),-0.3319609699152388,-0.8060668949246732,0.7269565217391304,0.8850799222896331,1.0,3/12,10.21%,SYNJ1;IMPA1;INPP5A
prerank,extracellular structure organization (GO:0043062),0.18314262027780923,0.8054955996941288,0.9636363636363636,0.9465193014551003,1.0,50/204,20.57%,ADAM12;MMP16;TNR;ADAMTS17;COL27A1;LAMC3;MMP12;VCAN;ADAMTS16;COL11A1;ITGB8;ADAMTSL1;GFOD2;VCAM1;MMP15;ITGB3;ITGA9;VIT;THSD4;COL4A3;COL23A1;COL19A1;MMP13;SMOC2;TTR;COL7A1;ADAMTS5;ITGA11;ADAMTS12;ADAMTS6;CDH1;COL24A1;NID2;SPARC;ST7;ADAMTSL2;LAMA2;COL1A1;FBLN5;LOXL1;LAMA5;SMOC1;TNC;SH3PXD2A;LOX;JAM3;COL4A4;NID1;MMP14;ITGA2B
prerank,negative regulation of organelle assembly (GO:1902116),-0.25611431826460396,-0.8049778899309831,0.7826887661141805,0.8865302998418867,1.0,12/35,27.68%,NUPR1;MTM1;BRCA1;STYXL1;RBM14;TBC1D30;TBC1D7;CHMP4B;CHMP4A;SMAD4;MDM1;NBDY
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.2816620746119412,-0.8049480321643353,0.7526132404181185,0.8862017618132916,1.0,6/26,14.50%,CBL;SNX6;TSG101;NCF1;APP;CBLB
prerank,regulation of smoothened signaling pathway (GO:0008589),0.22578507527769592,0.8036012518564021,0.8253588516746412,0.9488363730033462,1.0,5/50,6.17%,RORA;IFT81;PTCH2;DCDC2;MOSMO
prerank,relaxation of muscle (GO:0090075),-0.3242130590569274,-0.8028862632769834,0.7266313932980599,0.8892369799240236,1.0,4/13,19.56%,P2RX4;SLC8A1;PIK3CA;PLN
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.3232798325466445,0.8022491541110051,0.7239709443099274,0.9501951448273308,1.0,6/12,21.95%,BICD1;HOOK3;CCDC68;KIF3A;PCM1;BBS4
prerank,intracellular protein transmembrane transport (GO:0065002),-0.24762200236235116,-0.8022445558079129,0.7688356164383562,0.8898908587621006,1.0,10/42,23.01%,PEX14;SEC63;PEX26;TOMM40L;TIMM21;TIMM44;PEX7;GRPEL2;TOMM20L;TOMM70
prerank,ncRNA metabolic process (GO:0034660),-0.25353039677649813,-0.802062390746345,0.781786941580756,0.8898363825582879,1.0,8/37,20.45%,AGO2;TUT7;EXD1;XPO5;NIFK;TDRKH;TENT4B;BCDIN3D
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.2377099950535171,-0.8019030503689275,0.8030050083472454,0.8897230358642426,1.0,16/50,24.92%,CCND3;ACTB;BLM;CDKN3;CDC25A;GADD45A;HSP90AB1;CCNE1;CDKN2C;SERTAD1;CNPPD1;CDC25C;CCNK;CCNF;CCNB1;CCNB2
prerank,cell junction maintenance (GO:0034331),-0.3178830302801926,-0.800427597829556,0.759515570934256,0.8917262606101372,1.0,7/14,30.62%,MYADM;DCTN1;CBLN2;CLDN1;PRTN3;CD177;F2R
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.2671913035435534,-0.8004087772817412,0.7932862190812721,0.8913824306167032,1.0,5/29,13.91%,VTI1A;GOLGA5;COG2;COG5;COPA
prerank,regulation of protein localization to membrane (GO:1905475),0.26276801989106413,0.8001344548526629,0.7930232558139535,0.9528546513553899,1.0,6/28,14.31%,GPC6;GPC5;FYN;GSN;PRKN;VAMP8
prerank,retinoid metabolic process (GO:0001523),0.21255945724982564,0.7995065012909884,0.8767772511848341,0.9528511264586257,1.0,13/71,17.23%,GPC6;GPC5;DHRS13;RETSAT;SDC1;OPN1MW;RBP2;TTR;CYP1A1;SDC2;ALDH1A1;RDH11;ALDH1A3
prerank,clathrin coat assembly (GO:0048268),-0.3136929920318503,-0.7991984776253496,0.765704584040747,0.8929352582856905,1.0,4/15,7.64%,FCHO2;PICALM;EPS15;HIP1
prerank,glutathione metabolic process (GO:0006749),0.23810475955923266,0.7986080059533847,0.8298850574712644,0.9533713765186741,1.0,12/38,24.03%,GSS;GSTZ1;GSTP1;GGT1;GSTK1;GSTM5;GGT5;GSTA4;GSTT1;GSTT2;HAGH;GCLC
prerank,response to gamma radiation (GO:0010332),-0.27308965347463743,-0.7982273786610282,0.7703180212014135,0.8940858988785338,1.0,9/24,24.61%,MAP3K20;XRCC6;WRN;TMEM109;ATM;KDM1A;FANCD2;CRYAB;MYC
prerank,positive regulation of phosphatase activity (GO:0010922),-0.28418235403192915,-0.7982232432992021,0.7539267015706806,0.8937172744273434,1.0,12/21,31.16%,CD300A;PLEK;PPP1R15B;MEF2C;HSP90AB1;PDGFRB;CHP2;GPLD1;BMP2;RIPK3;AGTR2;PTPA
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.27716372342436124,0.7980759673163647,0.7641509433962265,0.9531739881017967,1.0,4/21,10.76%,CHSY3;VCAN;CHST7;CHST9
prerank,regulation of hormone secretion (GO:0046883),0.3005179469244248,0.7977340144627941,0.7370892018779343,0.9526878645913943,1.0,3/15,14.26%,SOX11;EDN1;SCG5
prerank,mesenchyme morphogenesis (GO:0072132),0.2855595121569341,0.7973534998679886,0.7627118644067796,0.9522346122475162,1.0,3/17,10.93%,ACVR1;SOX9;TGFB2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.2955137234875727,-0.7973233086506212,0.7517006802721088,0.8947573379270389,1.0,6/19,30.12%,TPST1;SULT6B1;PAPSS1;ENPP1;SLC35B3;TPST2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.251358630206725,-0.7968699239101402,0.8066202090592335,0.8951338605149817,1.0,7/36,13.28%,GNB1;AGO2;GNG2;CTNNB1;MOV10;PLCB3;TNRC6C
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.206872120523786,0.7962632913248304,0.8636363636363636,0.9530053462333828,1.0,17/79,15.61%,SLIT2;BMPR1B;VWC2;PDCD6;SPRY4;VWC2L;APLN;NEDD4;EPN2;NBL1;ADAMTS12;CREB3L1;SPRY1;ATP2B4;TRIM33;BMPER;SPART
prerank,actin filament depolymerization (GO:0030042),-0.3306163917289697,-0.7955982169723703,0.7450271247739603,0.8967472954154803,1.0,5/11,18.37%,WDR1;MICAL1;MICAL2;TWF2;CFL1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.24679110366954032,-0.7952896098803562,0.7986111111111112,0.8968570018419791,1.0,12/42,27.64%,MEF2C;CCDC40;MICAL2;TGFBR2;VANGL2;STIL;MEGF8;TBX2;APLNR;DNAAF1;ENG;TBX21
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.32928062549077375,-0.7948250083705085,0.7486910994764397,0.8972311479284597,1.0,3/12,9.99%,IQGAP1;JAG1;MYO1E
prerank,regulation of cellular protein catabolic process (GO:1903362),0.2795513684062696,0.793385290694709,0.7828054298642534,0.9568455364503436,1.0,4/18,14.75%,NELL1;CDK5RAP3;ATRAID;HSP90AA1
prerank,transport across blood-brain barrier (GO:0150104),-0.21464994081668254,-0.7933006178336228,0.8706896551724138,0.8992897648310176,1.0,19/83,20.26%,SLC16A7;LRP1;CD36;SLC6A6;INSR;FABP5;SLC27A1;SLC2A1;ABCC1;ATP2A3;SLC28A2;ABCC4;SLC7A5;SLC5A3;SLC29A1;SLC6A9;SLC38A2;AGER;SLC16A1
prerank,ERAD pathway (GO:0036503),-0.21285237217108208,-0.7931293263425578,0.8778135048231511,0.8991869285785977,1.0,24/83,22.15%,AMFR;RHBDD2;WFS1;ATXN3;ERLIN1;RCN3;DNAJB9;SELENOS;DNAJB14;DERL1;UBE4B;SEL1L;HSP90B1;UBXN6;RNF185;RNF121;ERLEC1;STT3B;FOXRED2;SGTA;TRIM25;FAF2;BAG6;MAN1B1
prerank,regulation of ossification (GO:0030278),-0.2509992171213697,-0.7929611902508256,0.8006872852233677,0.8990882900935986,1.0,9/36,20.84%,RBPJ;LRP6;MDK;MEF2C;PTPN11;ANKH;ENPP1;BMPR2;SFRP1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.23439453895968412,-0.7927442127998565,0.8474025974025974,0.899038544273099,1.0,21/47,34.16%,HSPA9;ATP5MC1;MICOS13;TMEM11;TIMM22;GHITM;TIMM29;MAIP1;ATP5MC2;ATP5MF;MTX1;TOMM70;ATP5F1B;ATP5F1D;DNAJC11;CHCHD6;ATP5F1C;ATP5F1A;SAMM50;MICOS10;UQCC3
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.2905758644403569,-0.7927144503440524,0.7679180887372014,0.8987058568334393,1.0,5/19,13.46%,POLR3G;PRDX5;MAF1;CHD8;DHX36
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.31835054681203667,-0.7916923225620568,0.734982332155477,0.8999345956658737,1.0,2/13,2.04%,PTPRC;MGAT5
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.28216446890099645,0.7915154429244752,0.7559241706161137,0.9589234952432677,1.0,6/20,20.34%,FAR2;ACACA;HSD17B4;HSD17B8;ACSL3;FASN
prerank,nuclear envelope organization (GO:0006998),-0.29188080568812036,-0.7914923353028636,0.7589928057553957,0.8998804546551016,1.0,6/20,20.93%,NEMP1;SUN2;LEMD2;TOR1AIP1;VPS4A;REEP3
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.27565364531347725,-0.7908408575136029,0.7733812949640287,0.900559863143391,1.0,6/23,19.92%,ITGB1;FBXW11;CENPA;DCTN1;NDC80;PAFAH1B1
prerank,dermatan sulfate metabolic process (GO:0030205),-0.31809711229178006,-0.7907426913627656,0.7487001733102253,0.9003383582570477,1.0,5/13,24.51%,DSE;CHST12;CSPG4;BGN;DCN
prerank,vasculature development (GO:0001944),-0.30348284478821125,-0.7885917738413991,0.784070796460177,0.9033012868131904,1.0,9/16,40.05%,PIK3CA;STK11;PDGFRB;BMPR2;APLNR;FLT4;STRA6;PDGFRA;NOTCH4
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.31982787741717233,0.7882149856208053,0.7266187050359713,0.9634788697768447,1.0,3/11,10.96%,SLIT2;CCN3;NBL1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.2433948035409111,0.7879807632337096,0.8091954022988506,0.962801027884654,1.0,7/35,13.27%,MAGI2;TSC1;BOD1;CALM1;CALM3;CALM2;PPP4R4
prerank,glycerolipid catabolic process (GO:0046503),0.2818416580166649,0.7875871069106345,0.8009592326139089,0.9623370086882056,1.0,5/19,18.44%,GDPD1;PLA2G4E;ENPP6;PNPLA6;GDE1
prerank,regulation of protein localization (GO:0032880),-0.22513633782820766,-0.7875368168425675,0.8416523235800344,0.9045998495428452,1.0,15/58,22.80%,CTSD;PLEKHM2;USP8;PICALM;ZDHHC7;TPR;HSP90AB1;TRIM68;TRIM14;VPS4A;DNAJB6;TRIM25;KDM1A;RACK1;TRIM67
prerank,protein K11-linked ubiquitination (GO:0070979),-0.2687389469550429,-0.7874981917947085,0.8165467625899281,0.904288864244799,1.0,7/27,17.76%,ANAPC1;RNF4;UBE2L3;UBE2H;UBE2T;UBE2C;ANAPC7
prerank,cellular response to BMP stimulus (GO:0071773),0.20994787033639198,0.7867109222390619,0.8736842105263158,0.9626968147128911,1.0,17/66,21.46%,BMPR1B;ACVR1;VSTM2A;SOX9;TMEM100;BMP7;BMP15;TGFB2;ADAMTS12;RGMA;GDF15;TGFBR3;ACVR2B;AMHR2;RGMB;SMAD9;SCX
prerank,determination of left/right symmetry (GO:0007368),0.24059711315692578,0.786537998286555,0.7995110024449877,0.9618963425451895,1.0,11/36,20.14%,ODAD3;DNAAF4;TBX1;SMO;ENKUR;MKKS;RFX3;NPHP3;DNAH5;BBS7;CFAP53
prerank,aerobic electron transport chain (GO:0019646),-0.21576690191644765,-0.7861979927872471,0.8841567291311755,0.9059150758146934,1.0,26/68,34.16%,SDHAF2;NDUFA9;COX4I1;NDUFB2;COX10;AFG1L;NDUFS5;UQCRC1;COX8A;NDUFA1;UQCRC2;COX6C;NDUFA3;NDUFA4;CYCS;COX5A;NDUFB8;NDUFC2;COX6A2;NDUFC1;UQCRQ;NDUFS6;UQCRB;NDUFS3;NDUFB11;UQCC3
prerank,amide biosynthetic process (GO:0043604),0.22796334461546044,0.7860403034883031,0.8213457076566125,0.961601265982953,1.0,3/47,3.42%,DMD;PCSK5;PAM
prerank,serine family amino acid metabolic process (GO:0009069),-0.3038694375069749,-0.7856642743749608,0.7715289982425307,0.9063912534010615,1.0,2/16,5.16%,CDO1;SARS1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.34599386046540365,-0.7853814419923217,0.745945945945946,0.9064691268331766,1.0,4/10,31.76%,AGO2;TSNAX;TSN;DROSHA
prerank,nucleotide metabolic process (GO:0009117),0.26276136836351116,0.7851061480888275,0.7766749379652605,0.9620847071330468,1.0,6/23,16.70%,NME2;ENPP3;AK4;AK5;NMNAT2;ME1
prerank,positive regulation of telomerase activity (GO:0051973),-0.2551621220501179,-0.7846948873068142,0.7808695652173913,0.9071225915138527,1.0,15/33,34.29%,CTNNB1;PKIB;NVL;HSP90AB1;GREM1;CCT4;WRAP53;MAPK1;MYC;GRHL2;MAPK15;MAP3K4;NEK7;TNKS;KLF4
prerank,proton transmembrane transport (GO:1902600),-0.24769737375800543,-0.784490631456551,0.7964912280701755,0.9070554765971144,1.0,15/36,40.71%,ATP6V1A;UCP2;SLC9A1;ATP6V0E1;NNT;ATP5MF;ATP6V0D1;ATP5F1B;ATP1A1;SLC36A3;ATP6V0A4;ATP6V1B1;ATP1A4;ATP6V1F;ATP5PO
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.274465753233449,0.7844443778653648,0.7953488372093023,0.9620998013071351,1.0,6/22,16.88%,PPM1E;DUSP4;DUSP10;DUSP18;DUSP8;PPM1G
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.26942130839791395,-0.7842452749852368,0.7623400365630713,0.9070578882675454,1.0,8/23,29.14%,HERC4;MGRN1;ENPP1;SUFU;RACK1;MEGF8;VCP;IFT122
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.30464854607255326,-0.7841880876838843,0.768695652173913,0.9067585305130061,1.0,2/15,6.04%,DSE;CHST12
prerank,cilium assembly (GO:0060271),-0.1765445587649386,-0.7840494696913265,0.9868804664723032,0.9065834460965475,1.0,65/296,22.54%,RAB8B;SNX10;ASAP1;ACTR2;FLNA;EHD4;IFT20;KIF3B;PIBF1;CNTRL;ACTR3;RAB1A;DYNC1H1;HAUS5;SDCCAG8;HAUS6;CFAP44;EXOC4;CEP57;CKAP5;YWHAE;CEP162;CCDC40;SPAG16;CEP70;HAUS4;DCTN1;CDK1;SPATA6;FOXJ1;HAUS7;CFAP70;ABCC4;ARL3;TMEM80;GORAB;CFAP20;EHD1;VANGL2;RP2;CFAP43;ODF2;NINL;DYNLT2B;NUDCD3;PCNT;EXOC2;PDE6D;BBIP1;RILP;IFT57;MAK;EXOC6;PAFAH1B1;TMEM17;RAB11A;ATP6V0D1;CEP192;RILPL1;CETN2;DISC1;HYLS1;TUBA4A;CEP41;TTLL3
prerank,anion transport (GO:0006820),-0.2548333197558798,-0.7838186487571415,0.7918088737201365,0.9065697241517057,1.0,3/33,4.97%,LRRC8D;LRRC8C;VDAC2
prerank,regulation of pH (GO:0006885),-0.33549450345772647,-0.7834473729870942,0.7602040816326531,0.9067635719700999,1.0,7/11,40.39%,SLC9A1;SLC26A4;ATP6AP1;ATP6V0A4;ATP6V1B1;ATP1A4;LACC1
prerank,regulation of mitochondrial fission (GO:0090140),-0.27495842146252003,-0.7831790447320158,0.7870216306156406,0.9068328779457541,1.0,8/24,24.81%,DDHD1;CYRIB;FIS1;INF2;AURKA;KDR;DCN;STAT2
prerank,regulation of myoblast differentiation (GO:0045661),-0.25416725122399375,-0.7830212785913012,0.8154657293497364,0.9066967779153459,1.0,7/32,14.66%,RIPOR2;MAPK14;MEF2C;IGFBP3;SMYD1;BTG1;FLOT2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.3110967582961555,0.7829763486615539,0.7801418439716312,0.9634424429544766,1.0,1/12,1.61%,ADCY8
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.25428790719893146,0.7829339582764069,0.804177545691906,0.9624129557747949,1.0,9/30,20.94%,ELOVL7;SLC27A2;ACOX2;HACD1;ABCD1;TECRL;ACSL6;ELOVL6;ELOVL2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.28953914975655415,-0.7829034098556746,0.7875210792580101,0.9065093469446354,1.0,4/17,23.32%,NFE2L2;MAPK7;HSPB1;P4HB
prerank,positive regulation of secretion (GO:0051047),-0.334933588811387,-0.7828012691559748,0.7775862068965518,0.9062940685525347,1.0,6/11,39.79%,XBP1;GPLD1;AQP1;SCIN;TRH;NPR1
prerank,response to UV-B (GO:0010224),-0.3232305692108868,-0.7820546357878563,0.7630161579892281,0.907040825867954,1.0,3/12,12.09%,CRIP1;RELA;STK11
prerank,oogenesis (GO:0048477),0.29706247119602835,0.7818125234545342,0.7393364928909952,0.9631973716124942,1.0,6/15,23.35%,PTN;FMN2;IHO1;NANOS3;MEI4;NANOS1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.3120821832249446,-0.7816888710495125,0.761986301369863,0.9072080555964744,1.0,9/15,30.08%,KHNYN;NYNRIN;ZC3H12A;RPP40;NUDT16;ZC3H12D;LACTB2;ZC3H12C;POP1
prerank,protein insertion into ER membrane (GO:0045048),-0.2455200707603697,-0.7815734921956394,0.8009868421052632,0.9070019084110762,1.0,16/37,31.28%,TRAM2;APP;SERP1;STX5;GET3;EMC6;EMC9;SGTA;BAG6;TRAM1L1;HMOX1;CYB5A;OTOF;VAPA;VAMP2;UBL4A
prerank,transition metal ion transport (GO:0000041),-0.24613152052527829,-0.7812573554765807,0.7944535073409462,0.9070958225279422,1.0,5/35,10.17%,IREB2;SLC30A5;ATP7A;SLC31A1;CP
prerank,regulation of acute inflammatory response (GO:0002673),-0.2892947770288081,-0.780922255297234,0.7861060329067642,0.9072445320555906,1.0,8/18,44.74%,ADAM8;NLRP3;IL6;PTGES;F12;DNASE1;IL6ST;OSM
prerank,endochondral bone morphogenesis (GO:0060350),0.31981652943188166,0.780565927089309,0.7216494845360825,0.9641474881246169,1.0,1/11,2.92%,BMPR1B
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.21424865598036014,-0.780475201412396,0.8784246575342466,0.9075398941551118,1.0,26/69,34.16%,SDHAF2;NDUFA9;COX4I1;NDUFB2;COX10;AFG1L;NDUFS5;UQCRC1;COX8A;NDUFA1;UQCRC2;COX6C;NDUFA3;NDUFA4;CYCS;COX5A;NDUFB8;NDUFC2;COX6A2;NDUFC1;UQCRQ;NDUFS6;UQCRB;NDUFS3;NDUFB11;UQCC3
prerank,cilium-dependent cell motility (GO:0060285),-0.2774783620814665,-0.780335941803717,0.7859649122807018,0.9073826853984542,1.0,7/22,31.55%,EFHC2;CFAP44;DNAH8;DNAH3;TEKT5;DRC1;CFAP54
prerank,regulation of cell communication (GO:0010646),0.23945662678309765,0.7798016740194225,0.774818401937046,0.9642742234117713,1.0,4/35,7.50%,ANK2;RYR2;CASQ2;GRK4
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.3254835879534338,0.7797466396597006,0.7494199535962877,0.963281869196722,1.0,2/11,4.11%,TJP1;AFDN
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.3388772682374965,-0.7797445401275628,0.7551724137931034,0.9078619535467867,1.0,4/10,32.35%,MVP;ENPP1;ENG;CAV1
prerank,retinol metabolic process (GO:0042572),-0.3113153467404692,-0.7797291542875021,0.7636054421768708,0.9075150318144405,1.0,5/14,29.02%,DHRS3;CYP1B1;RBP4;RDH12;RDH10
prerank,proteasome assembly (GO:0043248),0.32155250957046017,0.7796749704033559,0.7132352941176471,0.9623236197528435,1.0,6/11,26.90%,PSMG2;PSMD5;PSMG1;ADRM1;PSMD11;PSMD13
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.33500861011741845,-0.779387482853558,0.7712765957446809,0.9076541367642592,1.0,6/10,26.95%,PLA2G7;PLA2G4A;PLA2G6;PLA2G5;PNPLA8;PLA2G15
prerank,nucleoside salvage (GO:0043174),0.32605176552312515,0.7791209343087968,0.7569892473118279,0.9621162648801462,1.0,2/10,4.16%,UPP2;CDA
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.30418791409331325,-0.7788063909370141,0.7650085763293311,0.9081382777872766,1.0,9/15,32.10%,P2RX4;VEGFA;TMSB4X;HSPB1;KDR;FGF18;MET;FGF16;FGF2
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.33402453343587984,-0.7784964725715664,0.7736486486486487,0.9082298968134647,1.0,6/10,35.13%,SMYD2;KMT5A;SETD6;SETD7;SETD2;SETD4
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.30597462861173647,0.7777493807818732,0.7417061611374408,0.9632280265026942,1.0,3/13,15.41%,PLCB1;GOLGA2;SOAT1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.3467775820587057,-0.7775229107933952,0.7847222222222222,0.9092664065836091,1.0,3/10,12.70%,HTR2B;DGKD;PRKD3
prerank,filopodium assembly (GO:0046847),-0.3003058383696719,-0.7774489944689721,0.7666068222621185,0.9090046627384293,1.0,5/16,15.90%,FGD6;FGD4;FGD3;SPEF1;PPP1R9B
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.24217265368222007,-0.7773880198603749,0.8420138888888888,0.908723399722753,1.0,2/40,5.01%,PID1;BCL2
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.21881990889606096,-0.7772816455147875,0.8661971830985915,0.9085136836976578,1.0,17/64,26.75%,CPT1A;DAGLB;ACSL5;AIG1;GPX4;PLA2G4A;ACOX1;ACSBG1;ACOT2;ACOT4;ACAD9;ELOVL5;ADTRP;CYP1B1;PNPLA8;SLC27A3;ALOX15
prerank,zinc ion transport (GO:0006829),-0.2824014406498079,-0.7772632671304358,0.8006872852233677,0.9081686434759814,1.0,9/21,37.96%,SLC30A5;SLC30A6;SLC39A3;MT3;SLC30A10;SLC30A1;SLC39A11;SLC30A8;SLC39A4
prerank,cellular response to leucine starvation (GO:1990253),0.3282485522582109,0.7771441867733445,0.7268623024830699,0.9631237096343132,1.0,2/10,6.68%,SESN3;RRAGB
prerank,histone H2A monoubiquitination (GO:0035518),-0.29282451136736243,-0.7762828781658049,0.7836879432624113,0.9091969907104968,1.0,3/17,11.66%,DDB2;RYBP;CUL4B
prerank,regulation of small molecule metabolic process (GO:0062012),-0.25675897845114287,-0.7756944886958774,0.8059964726631393,0.9096965947796148,1.0,5/28,13.22%,APOE;PANK2;ADIPOR1;TTC39B;FMO5
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.25009277314959744,-0.77488612626455,0.8,0.9104810931381349,1.0,6/31,12.04%,RAB1A;AXIN1;UBE2L3;PIN1;DCUN1D4;ARRDC4
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.2706909593910542,-0.7748350182185407,0.7926186291739895,0.9101872976423511,1.0,9/22,26.25%,RAP2A;VEGFA;GREM1;TAOK2;DDX3X;NBN;PDGFA;MRE11;RASSF2
prerank,negative regulation of wound healing (GO:0061045),-0.256774481412056,-0.7747225529243799,0.8023255813953488,0.9099870839486792,1.0,4/28,12.79%,APOE;TFPI;CRK;SERPINE1
prerank,acylglycerol biosynthetic process (GO:0046463),0.26547740427022243,0.7739096606630893,0.8,0.9671086772482381,1.0,5/23,14.12%,MOGAT3;PLCE1;GPAM;DGAT2L6;GPAT3
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.25980329790009954,-0.7737249462922149,0.8420107719928187,0.911077645800281,1.0,14/27,36.09%,FGR;FLT1;PTK2B;PDGFRB;NOD2;TGFB1;FLT3;FPR2;CD19;CCL19;FGF2;EPHA8;PDGFB;CCR7
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.23891622021191414,-0.7723773923313866,0.8571428571428571,0.9126407001522673,1.0,11/38,25.39%,RNF31;USP36;UBE2L3;UBL5;SH3GLB1;HUWE1;BAP1;HAX1;HPS4;SAE1;VPS11
prerank,diterpenoid metabolic process (GO:0016101),-0.2244715209469912,-0.7720727799911549,0.8816254416961131,0.9126796003933187,1.0,3/55,1.17%,APOE;DHRS3;LRP1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.27591005564617516,0.7717327287928754,0.7865168539325843,0.9682854134906591,1.0,9/20,25.20%,MCCC2;MCCC1;BCAT1;DBT;ACAT1;BCAT2;BCKDHB;ACADSB;AUH
prerank,branched-chain amino acid metabolic process (GO:0009081),0.27591005564617516,0.7717327287928754,0.7865168539325843,0.9682854134906591,1.0,9/20,25.20%,MCCC2;MCCC1;BCAT1;DBT;ACAT1;BCAT2;BCKDHB;ACADSB;AUH
prerank,negative regulation of interleukin-2 production (GO:0032703),0.2778781397611935,0.7714880060228482,0.7936507936507936,0.967588766389649,1.0,3/18,11.25%,NAV3;PRNP;HOMER3
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2110567607795209,-0.7714802309554222,0.896774193548387,0.9131405899500864,1.0,18/75,19.99%,PLEK;SYNJ1;ABHD12;CPNE3;PLCB3;PLCD1;PLA2G7;PLA2G4A;PIGH;PIGX;CLN3;PLAAT1;PDGFRB;GPCPD1;IP6K3;PLA2G6;PAFAH1B1;PIP5K1A
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.31432820623345104,-0.7704131321896212,0.756140350877193,0.9143141858692316,1.0,2/13,4.78%,NIBAN2;HHEX
prerank,protein prenylation (GO:0018342),0.3320404117102408,0.7700572558590788,0.7564402810304449,0.9687260436504931,1.0,3/10,11.86%,FNTB;AIPL1;FNTA
prerank,tetrapyrrole metabolic process (GO:0033013),-0.2899151363925997,-0.7698087624796387,0.79421768707483,0.9147972847727609,1.0,4/18,20.46%,ABCC1;MTR;MMUT;LMBRD1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.22690805918830353,-0.7696253678246704,0.8424778761061947,0.914676259861642,1.0,12/51,22.16%,CTNNB1;CCT7;PKIB;DCP2;TNKS2;TEN1;TENT4B;CCT4;HNRNPA1;EXOSC10;ATM;MAPK1
prerank,aerobic respiration (GO:0009060),-0.27894164288148116,-0.7696141721750049,0.7962003454231433,0.9143219866138528,1.0,7/20,30.58%,SIRT3;UQCRC1;MTFR1L;MDH2;UQCRC2;ATP5F1D;UQCRB
prerank,organic anion transport (GO:0015711),-0.2067771695774269,-0.7692179606247719,0.9266211604095563,0.9145259969999378,1.0,34/76,38.09%,LRRC8D;CYB5R1;SLC25A24;LRRC8C;SLC25A42;ABCC4;SLC25A4;SLC23A1;SLCO5A1;CYB5R4;SLC52A2;CYB5R2;CA4;SLC22A3;SLC17A9;SLC52A1;SLC4A1;SLC4A5;CPTP;SLC35B1;AQP1;SLC2A2;SLCO1B1;SLC4A8;SLC35A2;SLC19A1;RHAG;SLC25A17;SLC26A7;SLC2A6;SLC52A3;CA1;SLC22A6;CA3
prerank,cellular response to misfolded protein (GO:0071218),-0.28046920952036725,-0.7688462637161986,0.8131487889273357,0.9146866267584065,1.0,11/20,33.35%,ATXN3;DNAJB14;DERL1;RNF185;BAG6;VCP;CUL3;AUP1;STUB1;DNAJC18;DNAJB12
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.23925853157871368,0.7687167457313521,0.8649289099526066,0.9696782733943121,1.0,4/33,6.82%,PLCB1;UBE2E2;FGF10;CDC73
prerank,negative regulation of cell aging (GO:0090344),-0.29187428032099083,-0.7685311077017003,0.8006872852233677,0.9147597274688724,1.0,1/16,1.33%,CDK6
prerank,regulation of wound healing (GO:0061041),-0.23320736773265965,-0.7684504911656667,0.8561643835616438,0.9144988826055178,1.0,6/42,12.79%,PLAU;ITGB1;ARFGEF1;ANXA1;CRK;SERPINE1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.2554097195570716,-0.7678093410173538,0.828996282527881,0.9150021114199307,1.0,7/28,18.15%,RAC1;FES;CKAP5;DCTN1;SLAIN2;HSPA1A;RPS3
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.30974347771903066,-0.7670575389594023,0.7921635434412265,0.9156684772988167,1.0,4/13,16.61%,ATG7;ATG10;UBA7;UBA2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.3022253744671035,0.7667223318329887,0.7748344370860927,0.9716501714668,1.0,4/13,20.36%,UPP2;OGG1;UNG;NT5M
prerank,negative regulation of proteolysis (GO:0045861),-0.24344215575245548,-0.76633238329299,0.8552412645590682,0.9162971924875293,1.0,9/34,21.59%,ROCK1;DNAJC1;TIMP2;CST7;CST3;CLN3;TMEM59;CDK5;BAG6
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3066896795948707,0.7660011955538907,0.8122362869198312,0.9716850234625769,1.0,4/12,17.16%,UPP2;CDA;DHODH;CAD
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.2981444249227617,-0.765662466408964,0.8,0.91686524454339,1.0,2/16,4.56%,NUPR1;ATP7A
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.3286849122227818,-0.7653496520579967,0.7705779334500875,0.9169367811420726,1.0,4/11,42.99%,SIK1;EP300;C1QTNF12;CLK2
prerank,primary miRNA processing (GO:0031053),-0.32725616066354235,-0.7646628648294017,0.7707979626485568,0.9175687233470492,1.0,5/10,33.27%,SRRT;METTL3;SMAD2;DROSHA;SMAD1
prerank,hexose transmembrane transport (GO:0008645),0.2625164140500237,0.7639206424727482,0.8035320088300221,0.9737663195485681,1.0,6/21,18.08%,SLC2A5;SLC2A9;SLC5A10;SLC2A12;SLC2A8;SLC45A1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.32355817329410264,-0.763920305639947,0.7884267631103075,0.9182642368281889,1.0,5/11,28.51%,FAP;DFFA;SIRT2;ZC3H12A;BCL2L1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.33922545727096154,-0.7632520175255548,0.7628318584070797,0.9188155554611462,1.0,4/10,13.88%,LRCH1;RIPOR2;WASL;MIA3
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.2483559526435486,-0.7631990952809881,0.8451957295373665,0.9185185000029816,1.0,10/32,28.21%,DYRK2;DDX5;STK11;TMEM109;BAG6;RRP8;PML;USP28;EP300;MYBBP1A
prerank,regulation of glucose metabolic process (GO:0010906),0.23634509529898098,0.7619545733127292,0.851258581235698,0.9755439004906907,1.0,7/34,16.80%,RORA;PDK3;RORC;PRKN;IRS1;MLYCD;AKT2
prerank,lipid phosphorylation (GO:0046834),0.3257276544357553,0.7619466026118099,0.7766990291262136,0.974474900452488,1.0,1/10,0.91%,DGKB
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.2653426803453343,-0.7618358016743978,0.8104906937394247,0.9200438643377734,1.0,12/25,40.34%,HPRT1;DCK;DGUOK;SHMT1;PRPSAP1;PNP;ADA;GMPR2;MTHFD1;AMPD3;PRPS1;PRPS1L1
prerank,glucan catabolic process (GO:0009251),0.2860764244871484,0.7612765315508133,0.7926829268292683,0.9743460613299154,1.0,3/15,12.82%,PHKG1;CALM1;PHKA1
prerank,protein autoprocessing (GO:0016540),-0.2864573729426333,-0.7608716760954474,0.7900172117039587,0.9210186612548554,1.0,3/17,13.02%,FAM111A;CASP4;CASP1
prerank,regulation of telomerase activity (GO:0051972),-0.22738737526020378,-0.7608478679476578,0.8440677966101695,0.9206751071792652,1.0,18/45,34.29%,PARP4;CTNNB1;PKIB;NVL;HSP90AB1;GREM1;ERCC4;CCT4;WRAP53;ATM;MAPK1;MYC;GRHL2;MAPK15;MAP3K4;NEK7;TNKS;KLF4
prerank,glutamine family amino acid catabolic process (GO:0009065),0.2992712527977602,0.760494072198592,0.7741935483870968,0.9743732599890246,1.0,3/13,15.36%,GLUL;GLS2;GLS
prerank,establishment of mitotic spindle localization (GO:0040001),-0.2529455319890921,-0.7603422446297844,0.8219424460431655,0.9209751122802796,1.0,7/28,19.92%,ITGB1;FBXW11;CENPA;DCTN1;NUSAP1;NDC80;PAFAH1B1
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.25136126379196055,-0.7603118191470309,0.8145580589254766,0.9206398417318991,1.0,14/29,41.49%,FUS;E2F1;TENT5A;TENT5C;TENT5D;VIP;DHX34;SLC11A1;YBX1;PKP3;RBM24;PKP1;TAF15;ELAVL1
prerank,pigment granule transport (GO:0051904),-0.2867310596000696,-0.7602386627726282,0.8085470085470086,0.919989568669368,1.0,1/18,0.09%,MYO5A
prerank,melanosome transport (GO:0032402),-0.2867310596000696,-0.7602386627726282,0.8085470085470086,0.919989568669368,1.0,1/18,0.09%,MYO5A
prerank,peptidyl-lysine methylation (GO:0018022),-0.2567214719522485,-0.7593272663175128,0.8399311531841652,0.9208438471137392,1.0,12/26,35.13%,SMYD2;SMYD3;SMYD1;KMT5A;EEF2KMT;SETD6;METTL21A;SETD7;SETD2;ETFBKMT;ANTKMT;SETD4
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3189996989927448,-0.7591064024246003,0.7666666666666667,0.9207643690432831,1.0,7/11,42.04%,HIF1A;FBXO7;RACK1;NONO;ATF4;NR4A3;PINK1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.2942373136302904,0.75909381545771,0.7876543209876543,0.975274324144522,1.0,5/14,16.80%,MFSD2A;ABCB11;ABCD1;IRS1;AKT2
prerank,regulation of membrane depolarization (GO:0003254),0.2692485477623109,0.7590428740474039,0.8046511627906977,0.9742594284588152,1.0,4/18,15.84%,SCN2B;PTPN3;ABCD1;SCN10A
prerank,glycerol metabolic process (GO:0006071),0.3244151222872258,0.7589482327781716,0.7937649880095923,0.9733076815492582,1.0,4/10,23.83%,GOT1;ANGPTL3;COQ3;PDXP
prerank,skeletal muscle contraction (GO:0003009),0.2703962639028764,0.7588801615037241,0.8048780487804879,0.9723342936993545,1.0,3/19,11.89%,TNNI1;MYH7;STAC
prerank,response to amino acid (GO:0043200),0.24307966360210254,0.7586553891290507,0.8402948402948403,0.9715483315407994,1.0,9/31,19.90%,GLRA1;RRAGB;GLRA2;CPEB3;RPTOR;GLRA3;CAPN2;NSMF;RRAGA
prerank,sensory organ development (GO:0007423),0.21239877724612655,0.7573175355491473,0.8964705882352941,0.9723142908644644,1.0,12/51,19.31%,AHI1;MEIS1;BMPR1B;PAX8;SALL2;TGFB2;PBX1;ECE1;MAB21L1;RAB18;ZDHHC16;SMOC1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.20876220308893087,-0.7569377021318676,0.8877551020408163,0.9233136244997313,1.0,30/70,37.42%,PLBD1;CSNK2A1;SLC27A1;CEPT1;NR1H2;TMEM86B;PLA2G7;PLA2G4A;PLAAT3;PLAAT1;PLA2G6;PLA2G5;PLA2G12A;LPCAT3;GPLD1;PNPLA8;PLA2G15;LCAT;PCYT1A;LPCAT4;LPIN3;CSNK2B;ABCA3;DBI;PCTP;PLA2G3;PLA2G4B;PLB1;APOA2;PON1
prerank,miRNA metabolic process (GO:0010586),-0.2748835177429677,-0.7568804723091495,0.8304195804195804,0.9230145781967994,1.0,8/20,31.76%,AGO2;TUT7;XPO5;TENT4B;BCDIN3D;SND1;DDX17;DROSHA
prerank,positive regulation of protein processing (GO:0010954),-0.2747897941970741,-0.7564596392956041,0.8155668358714044,0.9232255505232512,1.0,3/19,9.63%,MYH9;NLRC4;ADAM8
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.3006047464307156,-0.7563407338475867,0.8122743682310469,0.9230108802361099,1.0,6/15,25.50%,GNPDA1;CHST3;LARGE1;GNPDA2;AMDHD2;RENBP
prerank,renal absorption (GO:0070293),0.3266611910900949,0.7560411992027661,0.7884615384615384,0.9730349352005971,1.0,6/10,27.48%,HAS2;GSN;WNK4;KCNQ1;SLC15A2;HYAL2
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.2644273379417389,-0.7549212997234208,0.8296041308089501,0.9245020632992982,1.0,6/24,17.99%,CKAP5;PIN1;KIF14;KIF2C;STMN2;KIF18B
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.2897301675067441,-0.7545148315744338,0.8211805555555556,0.924658977638433,1.0,5/16,20.12%,TRA2B;NCBP1;NCL;DAZAP1;RBM3
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.2788273076602318,-0.7542845650925123,0.8082191780821918,0.924583156871603,1.0,5/20,14.89%,PLEK;GRK3;MGRN1;CCL5;RGS14
prerank,phospholipid catabolic process (GO:0009395),0.25330748166985295,0.7542836475862799,0.831081081081081,0.9744852829253983,1.0,7/24,18.44%,ENPP2;GDPD1;PLA2G4E;ENPP6;ANGPTL3;PNPLA6;GDE1
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.22641682152971992,-0.7540879464928102,0.8779264214046822,0.9244706319869576,1.0,12/46,23.01%,PITRM1;TOMM40L;FIS1;TIMM21;TIMM44;TIMM22;GRPEL2;FBXO7;TOMM22;TOMM34;TOMM20L;TOMM70
prerank,endothelial cell differentiation (GO:0045446),-0.3149935603172409,-0.7538755589319138,0.7814113597246127,0.9243552179407948,1.0,4/12,21.24%,JAG1;EDF1;BMPR2;KDR
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.2928470247552062,-0.7536542623840855,0.8116197183098591,0.9242999644535158,1.0,2/15,3.16%,PPARD;PPARG
prerank,lung development (GO:0030324),-0.24089170711388874,-0.7532729154492496,0.867109634551495,0.9244273670784625,1.0,13/33,32.10%,VEGFA;RCN3;CCDC40;ITGA3;FOXJ1;BAG6;FGF9;RBP4;DNAAF1;WNT7B;PDPN;ABCA3;FGF2
prerank,cilium organization (GO:0044782),0.16917284719614742,0.7530028720299264,0.9940828402366864,0.9752078649845937,1.0,31/209,11.70%,SCLT1;RAB3IP;AHI1;IFT81;RPGR;DYNLL1;CPLANE1;ABLIM1;TTC8;TRAF3IP1;DCDC2;KIFAP3;CEP126;TMEM231;DYNLL2;ARL13B;CFAP298;FAM161A;TMEM67;DZIP1;TMEM216;EXOC3;TMEM138;CEP131;CCNO;GSN;CEP290;PKD1;DYNC2H1;BBS1;NEK1
prerank,phospholipid metabolic process (GO:0006644),-0.20775633730400758,-0.7527524068883411,0.923469387755102,0.9247585346783913,1.0,12/71,14.79%,PLBD1;PIP4K2A;ABHD12;PLBD2;LGALS13;PIP4P1;LPL;GPX4;PLCD1;AGPAT1;PLA2G4A;PLAAT3
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.28455047611839984,-0.7526448324706883,0.8044596912521441,0.9245281582703538,1.0,7/17,40.60%,PLA2G4A;PLA2G5;PLA2G12A;LPCAT4;PLA2G3;PLA2G4B;SERAC1
prerank,diacylglycerol metabolic process (GO:0046339),0.2565358512983157,0.7522081140352069,0.8163265306122449,0.9752338204526438,1.0,3/23,8.21%,DGKB;PLCE1;GPAM
prerank,negative regulation of centrosome duplication (GO:0010826),0.30435592991713367,0.7518601273972012,0.7916666666666666,0.9746339093045508,1.0,5/11,20.00%,TRIM37;TMEM67;CDK5RAP2;KAT2A;NPM1
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.3073596042557342,-0.7515361271890494,0.8217054263565892,0.925618818886204,1.0,2/13,6.91%,ABCE1;NUP88
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.2915398005729939,-0.7514210787921662,0.8129370629370629,0.9253912546049083,1.0,6/16,33.76%,TPT1;TMEM161A;RPS3;SNAI2;BCL2L1;ACKR3
prerank,negative regulation of signaling (GO:0023057),0.24935285313516037,0.7512009651948705,0.811704834605598,0.9745023160680929,1.0,6/25,17.97%,GLRA1;ACVR1;NLRP12;OPRM1;ERBB3;AP1AR
prerank,atrial septum development (GO:0003283),0.29808325969906213,0.7510808331277778,0.7917675544794189,0.9735989064627631,1.0,1/13,0.68%,ANK2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.27131935576875593,-0.7507764547115298,0.8226950354609929,0.9258799774895675,1.0,4/22,11.66%,DDB2;UBC;RPS27A;CUL4B
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.28694730369912547,-0.7507179825498257,0.8103756708407871,0.9255846715833183,1.0,5/16,25.18%,BRCA1;ERLIN1;APPL2;ACADVL;NCOR1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3025459407105554,-0.7506411195480148,0.8306306306306306,0.9253153339531592,1.0,7/14,38.77%,CCR1;CSF1;TRAF6;ATP6AP1;TNF;IL12B;POU4F1
prerank,protein hydroxylation (GO:0018126),0.27996172915806805,0.7498693726403473,0.8073394495412844,0.9741783493787625,1.0,2/15,7.62%,P3H2;PLOD2
prerank,blood vessel diameter maintenance (GO:0097746),-0.23573019097158335,-0.7491323576102966,0.8491921005385996,0.9268778479036701,1.0,6/34,14.33%,ROCK1;HTR2B;ITGB1BP1;AGT;EDNRA;KLF2
prerank,glycogen metabolic process (GO:0005977),-0.2511927153160289,-0.7490090703074446,0.8518518518518519,0.9266655625997069,1.0,4/27,10.24%,PRKAG2;GYG1;PHKG2;GBE1
prerank,digestive tract morphogenesis (GO:0048546),0.28713025127760305,0.7488749077575146,0.8071428571428572,0.9744523188950027,1.0,1/14,1.31%,SOX11
prerank,endocardial cushion morphogenesis (GO:0003203),0.26266438820183946,0.7485525142878439,0.8064516129032258,0.9738243081301994,1.0,3/18,10.93%,ACVR1;SOX9;TGFB2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.2847782233173228,-0.7475308630949091,0.8262411347517731,0.9281684575868244,1.0,4/16,19.19%,CGAS;RADX;UBQLN4;SHLD2
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.20763690251411945,-0.74745756634214,0.9389438943894389,0.9278960464519405,1.0,10/68,11.17%,GNAI3;TPST1;RHOQ;HPRT1;ADSS1;NT5C2;ACOT9;EFL1;GTPBP1;ACOT13
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.3250050591144994,-0.7470406620897159,0.803921568627451,0.9280465834907461,1.0,4/10,24.61%,TGFBR2;STAT1;PDGFA;MYC
prerank,urogenital system development (GO:0001655),0.3111600990493951,0.7468784211561914,0.7934272300469484,0.9749860347465371,1.0,4/11,21.58%,PAX8;SOX9;EPHB3;LHX1
prerank,establishment of melanosome localization (GO:0032401),-0.2804782596844441,-0.7466537502905792,0.828719723183391,0.9281639257748479,1.0,1/19,0.09%,MYO5A
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.2485660060800623,-0.7465971172202757,0.857379767827529,0.9278582888504144,1.0,8/30,20.36%,DSE;HEXA;CHST12;CHST11;CHST3;CSPG4;NDNF;BGN
prerank,heart looping (GO:0001947),-0.23341836938561308,-0.7457991289175114,0.8554216867469879,0.9285127631044001,1.0,11/39,27.64%,MEF2C;CCDC40;MICAL2;TGFBR2;VANGL2;STIL;TBX2;APLNR;DNAAF1;ENG;TBX21
prerank,catecholamine metabolic process (GO:0006584),0.28563372879293414,0.7455613303057909,0.7963800904977375,0.9756783537809262,1.0,3/14,13.51%,SNCAIP;DDC;PRKN
prerank,vitamin transport (GO:0051180),0.23670024704449133,0.7454705467285216,0.8564814814814815,0.9747321123135629,1.0,7/29,17.24%,CUBN;SLC35F3;FOLR1;FOLR2;AMN;GC;SLC2A8
prerank,response to interleukin-4 (GO:0070670),-0.3209746153295971,-0.7443134931244522,0.7946577629382304,0.9300167393314723,1.0,3/10,17.97%,XBP1;TCF7;GATA3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.3064563538283742,-0.7435714586455774,0.7954144620811288,0.9305594283119776,1.0,3/12,24.63%,TLR4;NOD2;RBP4
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.28809484764199184,0.7434707182352023,0.8227848101265823,0.9763994162940631,1.0,4/15,14.45%,SEMA5A;PRKD1;SMOC2;LGMN
prerank,iron ion transmembrane transport (GO:0034755),-0.32451591770805077,-0.7430305439656385,0.8082437275985663,0.9308730894978997,1.0,1/10,2.53%,ABCB7
prerank,odontogenesis (GO:0042476),0.23223094761873594,0.7421396907164283,0.8696741854636592,0.9771105301863257,1.0,6/35,14.63%,EDA;MSX1;AMELX;TBX1;TGFB2;INHBA
prerank,negative regulation of viral transcription (GO:0032897),-0.30582643569157647,-0.7421201458700996,0.8279932546374368,0.9315957374559406,1.0,3/13,15.94%,UBP1;TRIM11;TRIM14
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.2584638318049716,-0.741970650391986,0.846551724137931,0.9313982538782386,1.0,8/24,25.17%,FLVCR1;RSAD1;HMBS;COX10;PGRMC1;PPOX;UROD;SUCLA2
prerank,negative regulation of phosphatase activity (GO:0010923),-0.2535136990295248,-0.7412072932312347,0.8573913043478261,0.9319449386953315,1.0,9/25,27.53%,ZCCHC9;GPATCH2;MASTL;STYXL1;GSK3B;SH2D4A;URI1;FKBP1B;BOD1L1
prerank,embryonic organ development (GO:0048568),0.20350922987291303,0.7404216429392668,0.9160671462829736,0.9783766285492136,1.0,12/61,14.07%,PCSK5;GDNF;TEAD4;RARB;COBL;SALL1;NEUROD1;TGFB2;MFSD2A;PBX1;TEAD1;GLI3
prerank,vesicle coating (GO:0006901),-0.21082883270121558,-0.7401156983069828,0.9246575342465754,0.9321841117016686,1.0,20/61,27.06%,CTSZ;RAB1A;TMED10;TFG;PREB;CTSC;SEC24A;PPP6R3;SEC24D;STX5;SEC31A;TRAPPC5;TMED2;TRAPPC9;F5;TRAPPC3;RAB1B;MCFD2;TRAPPC2L;CUL3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.21082883270121558,-0.7401156983069828,0.9246575342465754,0.9321841117016686,1.0,20/61,27.06%,CTSZ;RAB1A;TMED10;TFG;PREB;CTSC;SEC24A;PPP6R3;SEC24D;STX5;SEC31A;TRAPPC5;TMED2;TRAPPC9;F5;TRAPPC3;RAB1B;MCFD2;TRAPPC2L;CUL3
prerank,COPII vesicle coating (GO:0048208),-0.21082883270121558,-0.7401156983069828,0.9246575342465754,0.9321841117016686,1.0,20/61,27.06%,CTSZ;RAB1A;TMED10;TFG;PREB;CTSC;SEC24A;PPP6R3;SEC24D;STX5;SEC31A;TRAPPC5;TMED2;TRAPPC9;F5;TRAPPC3;RAB1B;MCFD2;TRAPPC2L;CUL3
prerank,negative regulation of TOR signaling (GO:0032007),0.23190374750984677,0.7399589480374301,0.8894009216589862,0.9779213546266617,1.0,6/36,9.00%,PDCD6;TSC1;SESN3;UBR1;NPRL3;CASTOR2
prerank,alpha-amino acid catabolic process (GO:1901606),-0.24417534550022052,-0.7392139359580371,0.8534031413612565,0.932925144836491,1.0,15/29,41.44%,KYNU;KMO;KYAT1;IL4I1;IDO2;HOGA1;HSD17B10;HGD;DAO;FAH;HAAO;TAT;OTC;BLMH;ALDH4A1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.2691018802699272,-0.7388657200394662,0.8754448398576512,0.9329839533532235,1.0,6/19,27.61%,DYRK2;TMEM109;BAG6;PML;USP28;EP300
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.23554590969963485,0.7380886834438514,0.8635235732009926,0.9792361083856875,1.0,6/29,19.35%,TNNT2;MYH7;TTN;TGFBR3;TPM1;TNNC1
prerank,camera-type eye morphogenesis (GO:0048593),-0.31889606985628555,-0.7380547360934794,0.8140703517587939,0.9335954637452479,1.0,3/10,7.83%,LRP6;SKI;VEGFA
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.29293788658483955,0.7376737132290152,0.817966903073286,0.9786895234723336,1.0,5/12,22.76%,ACOT8;ABCD1;HSD17B4;ELOVL2;FADS2
prerank,magnesium ion transport (GO:0015693),0.298089786646064,0.7371383391665914,0.7908163265306123,0.9783027483690147,1.0,6/12,20.04%,NIPA1;MMGT1;NIPAL4;TUSC3;NIPAL2;MRS2
prerank,negative regulation of cell death (GO:0060548),0.18766300229694421,0.7361100770855373,0.9669211195928753,0.9786020234383914,1.0,21/88,19.69%,SOX11;CD200R1;TIGAR;CCN3;PRKD1;FYN;CD200;BMP7;PACRG;SRGAP2;AGR3;FERMT2;AMIGO2;PRKN;PPARGC1A;MECOM;SNCA;IKBKG;DUS2;ADNP2;RAD18
prerank,monocarboxylic acid transport (GO:0015718),-0.2156237921412891,-0.7357149016011199,0.9092409240924092,0.9360240424615797,1.0,11/51,22.49%,SLC16A7;CD36;SLC27A1;STARD5;ABCC4;RXRA;SLC16A6;SLC6A8;SLC10A6;SLC16A1;NR1H4
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.24546830890903779,0.7355367952814018,0.8552338530066815,0.9782870074685901,1.0,5/26,14.78%,NAV3;OCLN;CDK5R1;CDK5RAP2;ARL2
prerank,positive regulation of cell cycle (GO:0045787),-0.20746273222986528,-0.735236030192496,0.9080645161290323,0.9362085895699884,1.0,8/62,11.05%,NUPR1;CCND3;CCNY;DUSP3;LRP6;RPS15A;EIF4EBP1;APP
prerank,protein import into peroxisome matrix (GO:0016558),-0.30765918776806234,-0.7346070176688438,0.8006993006993007,0.9365910754127661,1.0,2/12,4.86%,PEX14;PEX26
prerank,endocardial cushion development (GO:0003197),0.2512904200510394,0.7335782260768599,0.8600508905852418,0.9796730068223023,1.0,3/21,10.93%,ACVR1;SOX9;TGFB2
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.3239258069780825,-0.7334322786162607,0.8057040998217468,0.9375961943610681,1.0,2/10,20.86%,HK3;GFPT1
prerank,regulation of rRNA processing (GO:2000232),-0.2842635556960816,-0.733362187677148,0.8578947368421053,0.9373022242227574,1.0,5/16,26.03%,USP36;DIMT1;SHQ1;BUD23;NUDT16
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.31820499855751794,-0.7332350226060043,0.7953667953667953,0.9370726416638996,1.0,4/10,20.56%,RC3H1;SCRIB;LGALS9;CD274
prerank,serine family amino acid catabolic process (GO:0009071),0.3136267951500662,0.7330813776077774,0.7915690866510539,0.979225531274888,1.0,5/10,26.59%,GLDC;THNSL2;CBS;SHMT2;SDS
prerank,negative regulation of cellular senescence (GO:2000773),-0.2967091215962947,-0.7325059936429259,0.8263888888888888,0.9375555106754452,1.0,1/13,1.33%,CDK6
prerank,positive regulation of protein sumoylation (GO:0033235),-0.3164986954487691,-0.7311436220290167,0.7948717948717948,0.938805278634117,1.0,3/10,23.80%,PIAS1;UBA2;SAE1
prerank,N-glycan processing (GO:0006491),-0.2759314329765178,-0.7309239444448942,0.8282312925170068,0.9386917894654578,1.0,3/18,2.55%,ST8SIA4;MAN1C1;MAN2A1
prerank,inner dynein arm assembly (GO:0036159),0.3028798237941417,0.7303312202724588,0.7898550724637681,0.9816457428800354,1.0,5/10,27.63%,DNAAF4;CFAP73;DNAAF5;DNAH1;CFAP100
prerank,negative regulation of blood pressure (GO:0045776),-0.2941320522170384,-0.729960164820461,0.8495575221238938,0.9394120502220502,1.0,5/13,37.12%,PRCP;BMPR2;SCPEP1;NOS2;NPPA
prerank,regulation of BMP signaling pathway (GO:0030510),0.1939913210471686,0.729400147571842,0.9476309226932669,0.9817577542704745,1.0,19/73,21.70%,SOX11;TWSG1;BMPR1B;VWC2;VWC2L;PCSK6;NBL1;HES5;TRIM33;CDH5;BMPER;SPART;ZNF423;UBE2O;ACVR2B;SKOR2;SMAD9;SULF1;SORL1
prerank,response to steroid hormone (GO:0048545),-0.23476719785676636,-0.729050542928659,0.8700173310225303,0.9400618480833035,1.0,12/31,28.58%,TFPI;WBP2;UBE2L3;UBE3A;NR3C1;TGFB1;URI1;ADTRP;ABCA2;CATSPER2;ATP1A1;CATSPERB
prerank,dopaminergic neuron differentiation (GO:0071542),-0.26865309208571836,-0.7288929888333064,0.8148788927335641,0.9398932770642643,1.0,5/19,18.20%,LRP6;CTNNB1;VEGFA;MANF;RYK
prerank,negative regulation of complement activation (GO:0045916),0.3037590091469616,0.7281825105897181,0.8081841432225064,0.9821096464536705,1.0,1/10,2.29%,SERPING1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.2793095851167661,0.7277679274671138,0.8357487922705314,0.9815796102499965,1.0,5/15,24.61%,LNPK;REEP1;RAB18;ATL2;TMEM170A
prerank,cellular respiration (GO:0045333),-0.22224238298799232,-0.7273854415620837,0.9182282793867121,0.9412588078723473,1.0,12/41,25.99%,SIRT3;COX10;LYRM7;SDHAF4;UQCRC1;MTFR1L;SLC25A13;MDH2;UQCRC2;CYCS;ATP5F1D;COQ10B
prerank,embryonic axis specification (GO:0000578),-0.28125184960968175,-0.7271618254011512,0.8487394957983193,0.9411411550980148,1.0,3/15,19.11%,STIL;RIPPLY2;HOXD8
prerank,regulation of osteoblast proliferation (GO:0033688),-0.28029462938722094,-0.7263728647357716,0.8473684210526315,0.9416804205954665,1.0,10/17,34.57%,HPSE;RHOA;EIF2AK2;GREM1;SFRP1;TNN;BMP2;SOX8;MN1;LTF
prerank,steroid catabolic process (GO:0006706),-0.31761142746891957,-0.7260281757254259,0.8083941605839416,0.9416895195788364,1.0,4/10,37.81%,SPP1;HSD17B14;FGF23;CYP19A1
prerank,mesoderm development (GO:0007498),-0.272074328846601,-0.7259936438720923,0.8394039735099338,0.9413563180663733,1.0,6/18,27.57%,IKZF1;VEGFA;IKZF3;HCK;HES7;MESD
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.30536671545558036,-0.725989661315251,0.8264758497316637,0.9409907237388562,1.0,2/11,10.66%,CAB39;NEDD4L
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.22874468164560208,-0.7255562600603044,0.8873483535528596,0.941100450036406,1.0,3/34,4.65%,FGR;FLT1;PTK2B
prerank,DNA modification (GO:0006304),-0.2536741422680895,-0.725358990404937,0.8464223385689355,0.9409320013885468,1.0,10/22,41.27%,EXOSC5;NEIL3;NEIL2;EXOSC4;MPG;MUTYH;EXOSC3;PARP2;SMUG1;TERF2
prerank,apical junction assembly (GO:0043297),-0.21230944846697186,-0.7252778899995279,0.9185059422750425,0.9406478207203561,1.0,9/53,17.39%,PAK2;RHOA;PDCD6IP;WDR1;CLDN10;STRN;RAB13;CLDN18;CLDN1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.2550616244477346,-0.7245673871886905,0.8310344827586207,0.9407125085149012,1.0,4/21,14.34%,DDB2;CUL4B;RPA3;ERCC4
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.2550616244477346,-0.7245673871886905,0.8310344827586207,0.9407125085149012,1.0,4/21,14.34%,DDB2;CUL4B;RPA3;ERCC4
prerank,sulfur amino acid catabolic process (GO:0000098),0.30874961304474746,0.7241468446147198,0.7923250564334086,0.984809822704573,1.0,4/10,24.29%,CTH;ADO;CBS;TST
prerank,myelin maintenance (GO:0043217),-0.31304039908866543,-0.7240369748195186,0.8333333333333334,0.9409436912076065,1.0,2/10,15.96%,ABCD2;CXCR4
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.291639496437668,0.7240067790905435,0.8305084745762712,0.9839498242005541,1.0,5/12,25.74%,GSS;GGT1;HAGH;GCLC;GGCT
prerank,epithelial structure maintenance (GO:0010669),0.3082847221675496,0.7238746445462999,0.7929411764705883,0.983034388564027,1.0,2/11,9.54%,STRAP;PIWIL4
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.26163151646148897,-0.7232654681502578,0.8576214405360134,0.9414269570438337,1.0,4/20,10.66%,ATP1B3;SLC9A1;SLC8A1;NEDD4L
prerank,melanosome localization (GO:0032400),-0.26163264968335287,-0.7231902577037369,0.8590381426202321,0.9411271073915171,1.0,1/21,0.09%,MYO5A
prerank,membrane lipid metabolic process (GO:0006643),-0.2551031710224893,-0.7221906667394644,0.8735042735042735,0.9418343035543161,1.0,9/22,38.78%,TEX2;AGMO;SPHK2;CYP1B1;CERK;SERINC1;ARV1;MGST2;SPHK1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.2919460731444994,-0.721010169169168,0.8164335664335665,0.9427560136025636,1.0,2/13,5.95%,FLNA;MDFI
prerank,canonical glycolysis (GO:0061621),-0.2526750780617739,-0.7205748658289878,0.8700361010830325,0.9424909345443454,1.0,10/24,34.07%,GAPDH;HK3;TPI1;PKM;PGK1;PGAM2;PGAM1;ALDOA;FOXK2;FOXK1
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.2526750780617739,-0.7205748658289878,0.8700361010830325,0.9424909345443454,1.0,10/24,34.07%,GAPDH;HK3;TPI1;PKM;PGK1;PGAM2;PGAM1;ALDOA;FOXK2;FOXK1
prerank,cellular response to heat (GO:0034605),-0.23216810621326456,-0.7202547535558875,0.8793103448275862,0.942461353075442,1.0,14/35,32.68%,ATXN3;YWHAE;TPR;HSP90AB1;DHX36;BAG3;HSPA1A;SLU7;TCIM;HMOX1;VCP;POLR2D;HSPA1B;STUB1
prerank,glycolytic process (GO:0006096),-0.2365071791533456,-0.718792235487915,0.888695652173913,0.9436765646555594,1.0,10/28,29.81%,GAPDH;HK3;TPI1;PKM;PGK1;PGM1;PGAM2;PGAM4;PGAM1;ALDOA
prerank,regulation of viral life cycle (GO:1903900),-0.2569693960116302,-0.7174685485369593,0.8672268907563025,0.9447265649248171,1.0,6/21,21.28%,AXL;TSG101;TRIM68;TRIM14;VPS4A;TRIM25
prerank,mitochondrion transport along microtubule (GO:0047497),-0.2865716425696636,-0.7169508302023845,0.8261648745519713,0.9449039236180623,1.0,4/13,17.26%,HIF1A;LRPPRC;MAP1S;UXT
prerank,ribosomal large subunit assembly (GO:0000027),-0.24546726432247734,-0.716878937547507,0.878682842287695,0.9446042526554865,1.0,7/24,25.77%,RPL11;FASTKD2;RPL6;RPL23A;RPLP0;BRIX1;RPL5
prerank,glutathione biosynthetic process (GO:0006750),0.2916556442294457,0.7151626135629905,0.8253588516746412,0.992023595230326,1.0,5/11,25.74%,GSS;GGT1;HAGH;GCLC;GGCT
prerank,regulation of transport (GO:0051049),-0.22655758294912232,-0.7139247092737506,0.90311986863711,0.947271508751239,1.0,5/36,10.91%,NRP1;FES;ACTB;DNAJA1;CLDN10
prerank,organic acid transport (GO:0015849),-0.18886516760362565,-0.7138948051750064,0.9746192893401016,0.9469227670594407,1.0,38/94,38.28%,LRRC8D;SLC6A6;PPARD;SLC43A2;SLC27A1;SLC16A10;SLC7A7;STARD5;SLC25A45;ABCC4;RXRA;SLC23A1;SLC23A2;SLC10A6;SLC38A2;SLC25A10;SLC16A1;NR1H4;SLC27A3;PDPN;SLC7A2;SLC7A4;ABCC3;SLCO1B1;SLC51A;SLC7A1;SLC19A1;SLC25A17;SLC26A7;SLC7A8;SLC6A12;AKR1C1;SLC38A5;SLC27A5;SLC6A19;SLC6A14;SLC22A6;SLC10A2
prerank,regulation of stem cell proliferation (GO:0072091),-0.27021798422177445,-0.713523403459992,0.8795811518324608,0.9469519773910677,1.0,3/17,12.73%,PTPRC;EIF2AK2;HMGB2
prerank,negative regulation of transferase activity (GO:0051348),-0.23666411531729353,-0.7134739418916758,0.8754266211604096,0.9466268371219075,1.0,6/28,20.74%,EIF4A2;ERCC4;IRS2;SMAD7;GSK3B;DTX3L
prerank,organophosphate biosynthetic process (GO:0090407),-0.22510580825120904,-0.7119881418587722,0.9033333333333333,0.9478506220812031,1.0,13/37,29.44%,ITPKB;MOCS1;TPK1;TPI1;MOCS3;TKT;IP6K3;PIP5K1A;PNPO;ITPKC;IP6K1;GK5;GPAT2
prerank,synaptonemal complex organization (GO:0070193),-0.27970549745156137,-0.7116676830147582,0.8489583333333334,0.9474384350010582,1.0,7/15,42.34%,HORMAD1;BAG6;TEX12;RAD21;RAD21L1;SYCP1;SYCE2
prerank,synaptonemal complex assembly (GO:0007130),-0.27970549745156137,-0.7116676830147582,0.8489583333333334,0.9474384350010582,1.0,7/15,42.34%,HORMAD1;BAG6;TEX12;RAD21;RAD21L1;SYCP1;SYCE2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.22468153251496975,0.7113836792086321,0.9030023094688222,0.9951639730137106,1.0,6/30,16.75%,SOX11;TWSG1;PCSK6;TRIM33;FOLR1;TGFBR3
prerank,sphingolipid biosynthetic process (GO:0030148),-0.19773691019136883,-0.7111266583337149,0.9513888888888888,0.9475986638134214,1.0,18/71,26.97%,SGMS1;SPTLC2;ACER3;SPTSSA;PRKD3;LARGE1;KDSR;VAPB;SPHK2;SPTLC3;ASAH1;SAMD8;PLPP3;ELOVL5;DEGS2;CERS3;HACD4;VAPA
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.1876168026453515,-0.7105980559271874,0.9738562091503268,0.9477703460674307,1.0,23/94,22.46%,CNTRL;DYNC1H1;HAUS5;SDCCAG8;HAUS6;CEP57;CKAP5;YWHAE;CEP162;CEP70;HAUS4;DCTN1;CDK1;HAUS7;ODF2;NINL;PCNT;PAFAH1B1;RAB11A;CEP192;CETN2;TUBA4A;CEP41
prerank,respiratory chain complex IV assembly (GO:0008535),0.24266461209546794,0.7096579217816726,0.878345498783455,0.9959806858095704,1.0,5/21,13.87%,COX16;COX18;COX19;COX15;SCO1
prerank,organic hydroxy compound transport (GO:0015850),-0.22477612417661538,-0.7094966563695986,0.8916666666666667,0.9485514707708695,1.0,19/36,39.92%,STARD5;NPC2;ABCC4;RXRA;SLC5A3;SLC10A6;SLC16A1;NR1H4;RBP4;GHRL;ABCC3;SLCO1B1;SLC51A;ABCG8;AKR1C1;SLC27A5;SLC10A2;STRA6;SLCO1C1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.25189336035327275,-0.7088281586348306,0.8923076923076924,0.9488566624081826,1.0,3/22,8.91%,TSG101;UBAP1;MVB12B
prerank,bicellular tight junction assembly (GO:0070830),0.20502743852869307,0.7076347405547482,0.9440203562340967,0.9971121604315305,1.0,11/46,19.63%,PARD3;AFDN;PRKCI;OCLN;CLDN5;PATJ;CDH5;ARL2;RAMP2;PARD6A;MPP7
prerank,positive regulation of telomere capping (GO:1904355),-0.26663805050325984,-0.7070590536952005,0.8716094032549728,0.950240070365701,1.0,10/17,40.18%,RTEL1;PKIB;TNKS2;MAPK1;MAPK15;MAP3K4;NEK7;TNKS;NEK2;AURKB
prerank,chemical homeostasis (GO:0048878),0.1976851664323035,0.7062731882554285,0.9543269230769231,0.9974679307325961,1.0,18/61,21.16%,SLC4A10;SLC4A4;SLC4A11;ACOX2;FBXW7;ANGPTL3;WNK4;ABCB11;EIF5A2;TM6SF2;WNK3;AQP11;CLN8;WNK2;AQP4;TREM2;ADCK1;ACOX3
prerank,myelination in peripheral nervous system (GO:0022011),0.2765410382600432,0.7059661695896086,0.8422273781902552,0.9967182748496285,1.0,1/13,1.83%,PARD3
prerank,epithelial cell development (GO:0002064),0.2453848766848612,0.7057848810673595,0.8872901678657075,0.9958494080256943,1.0,6/20,20.04%,DACT2;ROS1;PDZD7;TMEM79;ACTA2;WNT5B
prerank,regulation of astrocyte differentiation (GO:0048710),0.2798068903881126,0.7045999252487112,0.8525798525798526,0.9960456766876725,1.0,5/12,23.28%,HES5;HES1;SERPINE2;BIN1;EPHA4
prerank,negative regulation of cholesterol transport (GO:0032375),0.29776490544030887,0.7032339279562108,0.8648648648648649,0.9963932711197298,1.0,2/10,9.63%,APOC1;PLA2G10
prerank,pancreas development (GO:0031016),-0.28518498061434294,-0.702756018054532,0.8544839255499154,0.9540356904322301,1.0,4/12,38.11%,CCDC40;DNAAF1;MET;NKX6-1
prerank,glucose transmembrane transport (GO:1904659),0.26277484559760034,0.7017729863445167,0.8651685393258427,0.9967975067202531,1.0,5/18,18.08%,SLC2A5;SLC2A9;RAB4B;SLC2A8;SLC45A1
prerank,regulation of axon regeneration (GO:0048679),0.28619763156548805,0.7017473684318326,0.8598130841121495,0.9957793793504827,1.0,3/12,13.71%,PTN;RTN4RL1;PTPRS
prerank,protein import into mitochondrial matrix (GO:0030150),-0.2613821612415408,-0.701618282644227,0.8633217993079585,0.9547394795068119,1.0,7/18,27.10%,TOMM40L;TIMM21;TIMM44;GRPEL2;TOMM20L;TOMM70;TOMM40
prerank,response to hexose (GO:0009746),0.2323127376045796,0.7015151527351351,0.9115646258503401,0.9949726142027334,1.0,3/25,10.49%,SLC2A5;MAFA;NEUROD1
prerank,triglyceride biosynthetic process (GO:0019432),0.25124883593075364,0.7005876341876706,0.8439024390243902,0.9948905753943122,1.0,3/18,14.12%,MOGAT3;GPAM;GPAT3
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2571538778148991,-0.7004359184829623,0.8789473684210526,0.9555158799113356,1.0,7/19,32.72%,CAMKK2;USP36;FBXO7;HAX1;VDAC1;ATP13A2;SREBF1
prerank,bile acid and bile salt transport (GO:0015721),0.23800098668560496,0.700435154830871,0.8840579710144928,0.99401096412964,1.0,4/24,14.33%,NCOA2;SLCO2B1;NCOA1;ABCB11
prerank,neuron apoptotic process (GO:0051402),0.2415235642517647,0.7003221081271782,0.8532110091743119,0.9930824653435205,1.0,2/19,2.71%,TRPC5;SCN2A
prerank,acyl-CoA biosynthetic process (GO:0071616),0.26270363192947566,0.6986054465240953,0.8634259259259259,0.9938437849280366,1.0,6/16,20.34%,ACACA;ACAT1;HSD17B8;MLYCD;ACSS1;FASN
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.28131643502012516,-0.6985982156602738,0.8500851788756388,0.9568382400820306,1.0,3/13,19.32%,TPST1;SULT6B1;ENPP1
prerank,cellular macromolecule catabolic process (GO:0044265),0.20424678631526572,0.6985481495396564,0.9485294117647058,0.992857637340467,1.0,7/49,9.94%,EXOSC7;MAGEC2;IDE;FBXO44;FBXO2;RNASEH1;FBXO27
prerank,regulation of intracellular protein transport (GO:0033157),0.2144898422484341,0.6984125381596963,0.926509186351706,0.9919487070766743,1.0,7/32,15.69%,TENM1;ZFAND1;PRR5L;CEP131;CEP290;ICE1;GCC2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.27250483884690946,-0.6976338892244793,0.8658318425760286,0.9573381169517889,1.0,1/16,0.53%,IGF1
prerank,ncRNA catabolic process (GO:0034661),-0.23503420201592157,-0.6973528769860767,0.8880866425992779,0.9572308895107281,1.0,13/28,35.74%,EXOSC5;TENT4B;EXOSC10;EXOSC4;MTREX;SND1;DEDD2;NUDT16;ERN2;EXOSC8;POP1;EXOSC3;SLFN14
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.2791508855635305,0.6972602418805328,0.8600451467268623,0.9920639975921269,1.0,4/12,24.05%,INSIG1;TAPT1;HSPA5;INSIG2
prerank,negative regulation of cartilage development (GO:0061037),-0.2736428040655079,-0.6970721267611326,0.8655616942909761,0.9571170176437223,1.0,5/13,21.80%,TGFBR1;CHADL;GREM1;PTPN11;SNAI2
prerank,phospholipid biosynthetic process (GO:0008654),-0.22133501102196013,-0.6969182406870562,0.9047619047619048,0.9568821781796116,1.0,7/36,21.70%,SGMS1;CPNE3;IDI1;CLN3;SPHK2;PIP5K1A;SAMD8
prerank,lysine metabolic process (GO:0006553),-0.28577717695076,-0.696891502901746,0.8600682593856656,0.9561581631421228,1.0,3/12,17.93%,OGDH;PHYKPL;DLD
prerank,lysine catabolic process (GO:0006554),-0.28577717695076,-0.696891502901746,0.8600682593856656,0.9561581631421228,1.0,3/12,17.93%,OGDH;PHYKPL;DLD
prerank,monoacylglycerol metabolic process (GO:0046462),0.28110422085337605,0.6953730308260075,0.8523809523809524,0.9928463344534854,1.0,3/13,13.73%,ABHD16A;MOGAT3;DGAT2L6
prerank,regulation of mitochondrion organization (GO:0010821),-0.2063880105065861,-0.6937306621585406,0.9456140350877194,0.9587520387725895,1.0,7/47,15.14%,PID1;CYRIB;USP36;FIS1;FLCN;INF2;PRMT6
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.24986100087954163,-0.6934462033664367,0.8939130434782608,0.9586277245127565,1.0,7/21,28.45%,UCHL5;TUBD1;RAB34;TTC23;SFRP1;TEDC1;EVC
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.2926089708295166,-0.6929362667443237,0.8664323374340949,0.9587269299149989,1.0,3/11,14.33%,E2F2;PIK3CB;KLF2
prerank,regulation of intracellular transport (GO:0032386),0.20723577349891567,0.6928045092688206,0.9321608040201005,0.9942418182402932,1.0,9/38,18.37%,MAP2;NEFH;CAPN10;WWC1;SCFD1;GRIPAP1;REEP5;HAP1;TTC21B
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.2674804018962244,-0.6925438947203145,0.8917975567190227,0.9586961781509622,1.0,8/17,26.43%,TNFRSF1B;MDK;ID2;IL34;CXCR4;EGR2;TGFB1;BMP2
prerank,DNA packaging (GO:0006323),0.2591064563037811,0.6915725096894223,0.8987951807228916,0.9944033257678885,1.0,5/16,19.62%,NAA10;H1-0;BANF2;BANF1;CHAF1B
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.24466379339739452,0.6908163817773686,0.8787878787878788,0.9941193965484936,1.0,9/18,27.10%,COX16;COX18;COX19;SCO1;COX20;COX14;COA3;COA5;PET100
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.22434598968415936,0.6904966061453043,0.9223057644110275,0.9933858340751488,1.0,4/29,14.25%,ZCWPW1;IHO1;SYCP2;MEIOB
prerank,regulation of stem cell population maintenance (GO:2000036),-0.2566836188096231,-0.6903445813319437,0.9094017094017094,0.9602631693315625,1.0,2/18,4.77%,CNOT1;CNOT2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.24629616166367543,-0.6897577991832691,0.8848797250859106,0.9604157389148625,1.0,2/21,6.07%,RAB1A;RPL11
prerank,positive regulation of stem cell proliferation (GO:2000648),0.2545339845575665,0.6897539410266478,0.8632286995515696,0.9930554359885941,1.0,4/17,11.91%,SOX11;HMGA2;CITED1;FERMT2
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.28907615818852,-0.6890597999008221,0.8747855917667239,0.9606505272412299,1.0,6/12,40.34%,HPRT1;PRPSAP1;ADA;MTHFD1;PRPS1;PRPS1L1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.19751424092577707,-0.6889800521513503,0.9554030874785592,0.9599734714640591,1.0,19/56,33.15%,NDUFA9;BCS1L;TIMM21;NDUFAF2;NDUFB2;NDUFAF8;NDUFS5;NDUFA1;ACAD9;NDUFA3;NDUFAF7;NDUFB8;NDUFC2;NDUFC1;NDUFS6;NDUFS3;DMAC1;NDUFB11;TIMMDC1
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.19751424092577707,-0.6889800521513503,0.9554030874785592,0.9599734714640591,1.0,19/56,33.15%,NDUFA9;BCS1L;TIMM21;NDUFAF2;NDUFB2;NDUFAF8;NDUFS5;NDUFA1;ACAD9;NDUFA3;NDUFAF7;NDUFB8;NDUFC2;NDUFC1;NDUFS6;NDUFS3;DMAC1;NDUFB11;TIMMDC1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.2867365181656141,0.6887753520319468,0.8443877551020408,0.9929249426497303,1.0,2/11,8.34%,PTPRT;LEPROT
prerank,calcineurin-mediated signaling (GO:0097720),0.28827226452270266,0.6884999975861053,0.8242009132420092,0.9911250467564283,1.0,4/10,20.72%,NFATC4;ADGRB2;PPP3CB;PPP3R1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.28827226452270266,0.6884999975861053,0.8242009132420092,0.9911250467564283,1.0,4/10,20.72%,NFATC4;ADGRB2;PPP3CB;PPP3R1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.23631610526858973,0.6873441989426436,0.9014423076923077,0.9911420846883087,1.0,7/23,15.28%,EGF;BMP7;RPTOR;CALM1;CALM3;CALM2;WNK3
prerank,regulation of biosynthetic process (GO:0009889),0.2821093611243414,0.6867598435417078,0.851931330472103,0.9906415887897422,1.0,4/11,27.83%,GSTP1;SNCA;CCN6;ALOX5
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.2907093224660024,0.6862640317690285,0.85785536159601,0.9900956949946129,1.0,6/10,30.59%,MMGT1;EMC8;EMC2;EMC3;EMC4;EMC7
prerank,eosinophil chemotaxis (GO:0048245),-0.27116192393952043,-0.6862222966594874,0.8917089678510999,0.9616031559867199,1.0,5/14,36.06%,CCL5;CCL7;CCL24;CCL4;CCL8
prerank,eosinophil migration (GO:0072677),-0.27116192393952043,-0.6862222966594874,0.8917089678510999,0.9616031559867199,1.0,5/14,36.06%,CCL5;CCL7;CCL24;CCL4;CCL8
prerank,receptor recycling (GO:0001881),-0.2993193036195737,-0.6860428441526353,0.872113676731794,0.9613625968407193,1.0,5/10,36.76%,ARFGEF2;RAB11B;PHETA1;REP15;PHETA2
prerank,pyruvate metabolic process (GO:0006090),-0.19981464141181832,-0.6843780558082943,0.955595026642984,0.9624227080568527,1.0,16/52,29.81%,GAPDH;ME2;HK3;TPI1;PKM;PGK1;DLD;SLC16A1;PDHB;VDAC1;PGM1;HOGA1;PGAM2;PGAM4;PGAM1;ALDOA
prerank,regulation of actin nucleation (GO:0051125),-0.28411639511437836,-0.6839322177524164,0.8700361010830325,0.962430269874873,1.0,7/12,41.50%,ARFIP1;ARFIP2;ARF1;WHAMM;PICK1;SCIN;CORO1A
prerank,mitochondrial transcription (GO:0006390),-0.29663428192641117,-0.6830430105739966,0.8657487091222031,0.9628200813749052,1.0,3/10,22.79%,FOXO3;TFAM;TWNK
prerank,microtubule anchoring at centrosome (GO:0034454),-0.2962577259132423,-0.6819404114976588,0.8868243243243243,0.9633994526583521,1.0,3/10,16.38%,NIN;DCTN1;NINL
prerank,positive regulation of chromatin organization (GO:1905269),-0.28209365229704353,-0.6805431878352832,0.8896797153024911,0.9641633953637986,1.0,3/12,25.67%,SIN3A;MIER1;UBE2N
prerank,response to nutrient levels (GO:0031667),-0.2562204588130978,-0.6804940313446853,0.8953068592057761,0.9638337440922817,1.0,8/17,42.55%,EIF4G1;KCNB1;SCTR;CD68;ATF4;RPS6KB1;MTOR;ULK1
prerank,protein localization to mitochondrion (GO:0070585),-0.29262951768199247,-0.6800862795828388,0.8900169204737732,0.9637888093665005,1.0,3/11,16.67%,DNAJA1;ISG15;MAIP1
prerank,mesoderm formation (GO:0001707),0.24455242581989267,0.6796998956166109,0.8878048780487805,0.9947734037572996,1.0,3/17,10.02%,ITGB3;HMGA2;SNAI1
prerank,glycogen catabolic process (GO:0005980),0.25639159166843145,0.679209835610574,0.8894348894348895,0.9941960285291465,1.0,3/15,12.82%,PHKG1;CALM1;PHKA1
prerank,inorganic anion transport (GO:0015698),-0.2009693868952519,-0.6784135021282512,0.9539249146757679,0.9648189220671864,1.0,10/53,19.66%,CLIC4;ANO6;SLC26A11;TTYH3;PACC1;XPR1;RACGAP1;CLIC1;ENPP1;SLC25A10
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.20789578616452425,-0.6783942219111793,0.9405772495755518,0.9644632130045236,1.0,9/41,23.39%,RBPJ;JAG1;MEF2C;TGFBR2;SMAD7;GATA3;MYBPC3;HEYL;TGFB1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.2959790025487876,-0.6778014172901622,0.8614864864864865,0.9646108407425993,1.0,1/10,7.83%,VEGFA
prerank,gas transport (GO:0015669),0.27963105021916584,0.6774680599473988,0.8599137931034483,0.9946754530143849,1.0,1/10,5.66%,CA2
prerank,cytoplasmic microtubule organization (GO:0031122),-0.19332654384090153,-0.675733945118851,0.9688041594454073,0.9659334584603747,1.0,9/54,13.77%,RHOA;DYNC1H1;TUBGCP4;DCTN1;WDR73;CCDC88A;CIB1;PLK3;SLAIN2
prerank,protein homotrimerization (GO:0070207),-0.2698179567272497,-0.6752134084093735,0.8857142857142857,0.9656177973321235,1.0,3/14,17.71%,ALOX5AP;ASIC1;MLKL
prerank,protein trimerization (GO:0070206),-0.2698179567272497,-0.6752134084093735,0.8857142857142857,0.9656177973321235,1.0,3/14,17.71%,ALOX5AP;ASIC1;MLKL
prerank,negative regulation by host of viral process (GO:0044793),-0.2986446581627319,-0.6749698060549381,0.8898450946643718,0.965444467535837,1.0,6/10,36.06%,PSMC3;ZC3H12A;CCNK;VAPA;LTF;CCL8
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.279955037802004,0.673505254057058,0.8845208845208845,0.9969206434266166,1.0,5/11,23.06%,ST18;GSN;PIH1D1;FAS;CAAP1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.27485829689610564,0.6726413287738826,0.8709677419354839,0.9966337814916943,1.0,3/11,16.23%,ROMO1;TIMM10;AGK
prerank,positive regulation of mRNA processing (GO:0050685),-0.24364117745533143,-0.6722406997554451,0.9084628670120898,0.967170867308591,1.0,6/21,20.12%,TRA2B;DHX36;NCBP1;NCL;DAZAP1;RBM3
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.2501053129008136,-0.6714156219631385,0.8834459459459459,0.9674500656798204,1.0,6/17,20.67%,SPRED1;SPRY2;SPRED2;EIF4G1;SMAD7;SIRT2
prerank,GPI anchor biosynthetic process (GO:0006506),-0.22074986087377846,-0.6711337908912802,0.9310344827586207,0.9673018621874385,1.0,9/30,27.22%,DPM3;PIGH;PIGX;PGAP3;MPPE1;PGAP1;PIGS;PIGZ;PGAP2
prerank,signal transduction by p53 class mediator (GO:0072331),-0.2153651902313436,-0.6686645415091471,0.9411764705882353,0.9688177378588831,1.0,7/30,23.12%,BATF;DDX5;STK11;GREM1;MDM4;NBN;RRP8
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.2820765693521251,-0.6672753545148573,0.8758389261744967,0.969469719394608,1.0,5/11,26.43%,TGFBR1;TGFBR2;SMAD7;TGFB1;BMP2
prerank,RNA stabilization (GO:0043489),-0.2147126491662797,-0.6672614269187254,0.9461805555555556,0.9691061410251629,1.0,6/33,18.42%,FUS;E2F1;TENT5A;DHX36;TENT5C;PHAX
prerank,serine family amino acid biosynthetic process (GO:0009070),0.2741466092823025,0.6671843957294276,0.8657407407407407,1.0,1.0,5/12,23.25%,GGT1;CTH;PSAT1;CBS;PHGDH
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.23243120735077222,-0.666917887521593,0.9274047186932849,0.9690030256504457,1.0,10/25,34.07%,GAPDH;HK3;TPI1;PKM;PGK1;PGAM2;PGAM1;ALDOA;FOXK2;FOXK1
prerank,genitalia development (GO:0048806),0.2616489720277714,0.6668552306683811,0.8619854721549637,0.9992727979780222,1.0,3/12,19.50%,WT1;PKD1;WNT5A
prerank,leukotriene biosynthetic process (GO:0019370),-0.271490961566243,-0.6668463485665316,0.8902877697841727,0.9686796999799956,1.0,3/14,19.28%,ALOX5AP;PLA2G4A;PLA2G5
prerank,heterocycle biosynthetic process (GO:0018130),0.2554986295286051,0.6660497616856946,0.8920863309352518,0.9989266765273521,1.0,1/14,1.52%,GPHN
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.27951647753847253,-0.6658591407793077,0.8791208791208791,0.968669538729677,1.0,7/11,41.95%,AGO2;TNRC6C;EIF6;AGO3;ZFP36;NOTCH4;TRIM71
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.27951647753847253,-0.6658591407793077,0.8791208791208791,0.968669538729677,1.0,7/11,41.95%,AGO2;TNRC6C;EIF6;AGO3;ZFP36;NOTCH4;TRIM71
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.26514560049514335,-0.6646628733655672,0.8862478777589134,0.9691454673696341,1.0,5/14,33.75%,TSEN54;DDX1;CPSF1;ZBTB8OS;RTCB
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.24581806665260175,0.6636218441507609,0.8914027149321267,0.999797938917434,1.0,3/15,14.90%,NME2;AK4;AK5
prerank,mitochondrial fusion (GO:0008053),0.24062598120099354,0.6634167775966862,0.9096916299559471,0.998927265653825,1.0,2/18,5.93%,MFN1;MIEF1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.2637227559202996,-0.6630735390088613,0.8983050847457628,0.9699521410083967,1.0,4/13,23.95%,PRPF8;SART3;SRSF10;PRPF6
prerank,microtubule polymerization (GO:0046785),-0.22130665437282326,-0.6613612878699205,0.9620034542314335,0.9708612738523247,1.0,11/28,33.45%,CKAP5;TUBGCP4;TPX2;PIN1;SLAIN2;RANBP9;TUBGCP2;TPPP3;CCDC57;FGF13;CSNK1D
prerank,negative regulation of cilium assembly (GO:1902018),-0.2713545973155265,-0.6611625619650352,0.8962962962962963,0.9706306192369655,1.0,3/12,16.65%,MAP4;TBC1D30;TBC1D7
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.1759073292051015,-0.6603792015119571,0.9876543209876543,0.9707852049728702,1.0,14/87,15.07%,IMMP2L;COA8;SDHAF2;NDUFA9;BCS1L;TIMM21;UQCC1;NDUFAF2;NDUFB2;LYRM7;NDUFAF8;NDUFS5;SDHAF4;FASTKD3
prerank,development of primary male sexual characteristics (GO:0046546),-0.21017649241115188,-0.6598903030672397,0.9532062391681109,0.970754062420656,1.0,14/34,38.04%,LHFPL2;CSDE1;GATA3;KITLG;BIK;SRD5A2;LRP2;FGF9;SOX8;MEA1;SIX4;ADAM29;FSHR;LHCGR
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.21539958051267113,0.6597608226773537,0.9344660194174758,1.0,1.0,7/27,16.87%,NME2;RRM2B;AK4;GLRX;CTPS1;AK5;AK6
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.21086653740857705,-0.6597108681078837,0.9449225473321858,0.9705038850676113,1.0,14/31,37.81%,MOCS1;MOCS3;GCH1;FDXR;SRD5A1;SRD5A2;PYCR3;HSD3B2;SCP2;PYCR2;DHRS11;HDC;HSD17B3;CYP19A1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.2622453003384126,-0.6591526637264316,0.9069767441860465,0.9705030773889425,1.0,4/13,23.59%,SESN1;STK11;ATM;KPTN
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.26946684489709044,-0.6591270662159668,0.8952879581151832,0.9701508180272349,1.0,4/12,23.32%,APOC4;DGAT1;LPCAT3;P4HB
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.21846463391100346,-0.6585251116875767,0.9407665505226481,0.9702081487604385,1.0,3/28,6.76%,NIBAN2;WWP2;ARRB1
prerank,regulation of aerobic respiration (GO:1903715),-0.2625499109904661,-0.6570710634769071,0.9028960817717206,0.9709098224315406,1.0,2/15,6.03%,ATP7A;CBFA2T3
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.24487628912097903,0.6558751798073872,0.8891509433962265,1.0,1.0,4/15,19.24%,ATF2;HUS1B;NEK11;CHEK2
prerank,L-amino acid transport (GO:0015807),0.21407491006215842,0.6558109182471461,0.937046004842615,1.0,1.0,4/28,10.04%,SLC1A2;SLC1A6;SLC1A1;SLC38A3
prerank,regulation of phosphatase activity (GO:0010921),-0.2298133115799191,-0.6557532014891181,0.9353233830845771,0.9714271891504087,1.0,10/24,31.16%,ZCCHC9;GPATCH2;PPP6R3;HSP90B1;CHP2;SH2D4A;URI1;BMP2;RIPK3;PTPA
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.2672281123323567,-0.6544710630055917,0.9163763066202091,0.9719606467464326,1.0,3/13,22.53%,IDH1;OGDH;D2HGDH
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.21295288965620435,-0.6544267135736047,0.9514237855946399,0.97161650772336,1.0,3/32,5.66%,CSNK2A1;SLC27A1;CEPT1
prerank,glucan biosynthetic process (GO:0009250),-0.26708806669773644,-0.6538476494447252,0.9059233449477352,0.9712668280102578,1.0,5/12,32.15%,GYG1;GBE1;PGM1;PGM2;UGP2
prerank,glycogen biosynthetic process (GO:0005978),-0.26708806669773644,-0.6538476494447252,0.9059233449477352,0.9712668280102578,1.0,5/12,32.15%,GYG1;GBE1;PGM1;PGM2;UGP2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.2190605164543148,-0.6532740210892742,0.9485815602836879,0.9712657322363413,1.0,5/29,13.33%,DDB2;UBC;RPS27A;CUL4B;RPA3
prerank,regulation of fatty acid oxidation (GO:0046320),0.24111248210250064,0.6529426198686181,0.9230769230769231,1.0,1.0,5/16,16.06%,SOX9;PPARGC1A;ABCB11;ABCD1;MLYCD
prerank,microtubule bundle formation (GO:0001578),-0.20015474197469418,-0.6529204114178682,0.9541446208112875,0.9711348814130857,1.0,17/42,34.39%,NAV1;CCDC40;SPAG16;FOXJ1;SPEF1;MAP1S;KIF20A;GAS2L1;TTLL3;RP1;LRGUK;MARK4;AAAS;TPPP3;CFAP46;NUMA1;NCKAP5L
prerank,homocysteine metabolic process (GO:0050667),-0.2794699829968236,-0.6509341722548938,0.8714285714285714,0.9720671592650916,1.0,3/11,21.21%,MPST;MMUT;MTHFR
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.27495881811093653,0.6508833663665026,0.8974358974358975,1.0,1.0,4/10,19.36%,ZNHIT3;NAF1;PIH1D1;RUVBL1
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.2115579189550099,-0.6508680849416499,0.9503424657534246,0.9717359800561317,1.0,3/31,7.78%,CDK6;PPARG;SKI
prerank,positive regulation of calcium ion import (GO:0090280),0.25855550487755047,0.649650186966432,0.8896713615023474,1.0,1.0,3/12,19.72%,RAMP3;ATP2A1;CCL2
prerank,nuclear transport (GO:0051169),0.24135055599572353,0.649613555482516,0.9325301204819277,1.0,1.0,7/16,20.76%,NXT1;CITED1;BANF1;XPO1;HMGA1;NPM1;NUTF2
prerank,oxoacid metabolic process (GO:0043436),-0.21466069936518092,-0.6484209171389662,0.9400352733686067,0.9729875818437604,1.0,5/27,19.32%,TPST1;AGXT;SULT6B1;GNMT;ENPP1
prerank,water transport (GO:0006833),0.2715630885122412,0.6474416448853371,0.9016393442622951,1.0,1.0,12/12,72.86%,AQP11;AQP4;CFTR;AQP9;MIP;UPK3A;AQP6;AQP5;AQP7;SLC5A1;AQP1;PDPN
prerank,linoleic acid metabolic process (GO:0043651),0.23459968602825754,0.6471192654443625,0.9211136890951276,1.0,1.0,17/17,76.57%,GSTP1;ABCD1;ELOVL2;FADS2;ALOX5;FADS1;ALOX12B;GSTA1;ELOVL3;GSTM2;ACSL1;ALOXE3;ELOVL1;ALOX12;ALOX15;PNPLA8;ELOVL5
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.21774949793344656,-0.6460890802911525,0.9461805555555556,0.9741006926860463,1.0,9/27,30.22%,SLC27A1;CEPT1;PLAAT3;PLAAT1;PLA2G6;PNPLA8;ALOX15;PLA2G15;LPIN3
prerank,regulation of cilium movement (GO:0003352),-0.2853270107299968,-0.6449368194788208,0.9080068143100511,0.9744786025614536,1.0,4/10,29.64%,CCDC40;CFAP43;DNAAF1;DRC1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.19684454868518292,0.6440586306421595,0.9762470308788599,1.0,1.0,7/38,15.54%,NDUFB7;NDUFV2;NDUFA2;NDUFAB1;NDUFB9;NDUFA8;NDUFV3
prerank,tight junction assembly (GO:0120192),0.18328313181311354,0.6415431414420962,0.9873096446700508,1.0,1.0,11/49,19.63%,PARD3;AFDN;PRKCI;OCLN;CLDN5;PATJ;CDH5;ARL2;RAMP2;PARD6A;MPP7
prerank,T cell homeostasis (GO:0043029),0.27920449527757085,0.6414707250212295,0.8872901678657075,1.0,1.0,4/10,20.34%,ZC3H8;JAK3;FADD;FAS
prerank,covalent chromatin modification (GO:0016569),0.25226017076845797,0.6400902863280141,0.9304556354916067,1.0,1.0,14/14,74.80%,AURKC;HELLS;SIRT1;SIRT7;UFL1;PARK7;HDAC1;MBD2;AURKB;SETD5;CHD1;PARP2;MT3;HLCS
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.26935124336816213,0.6399963362243113,0.892271662763466,1.0,1.0,2/11,15.01%,CD200;ATP6AP2
prerank,calcium import into the mitochondrion (GO:0036444),-0.2799251337668599,-0.6384033897730588,0.8961937716262975,0.9780870929507879,1.0,5/10,30.46%,MCUB;MAIP1;MICU2;SMDT1;MCUR1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.2516704573423713,0.6370364576357577,0.9004854368932039,1.0,1.0,2/13,3.64%,HEXB;VCAN
prerank,mesenchyme development (GO:0060485),0.23710328813044296,0.6354680973885553,0.9253731343283582,1.0,1.0,2/15,8.65%,HMGA2;BMP7
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.2071326635659705,0.6347495741544368,0.9529702970297029,1.0,1.0,5/26,14.02%,GPR37;FYN;REST;PRKN;NOL3
prerank,catecholamine biosynthetic process (GO:0042423),-0.2711421566630128,-0.6344281315273398,0.9024390243902439,0.9800311324154632,1.0,3/11,17.97%,MOXD1;GCH1;GATA3
prerank,peptidyl-proline modification (GO:0018208),0.20864440400485149,0.6342854949162405,0.9635922330097088,1.0,1.0,7/25,22.67%,P3H2;PPIL3;PPIF;PPIH;FKBP4;CWC27;PPIL2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.2350345475201629,0.6336926292548691,0.9113924050632911,1.0,1.0,9/16,29.33%,PIGA;DPM2;PIGL;PIGN;PIGB;PIGW;PIGQ;PIGF;PIGP
prerank,monosaccharide transmembrane transport (GO:0015749),-0.24539816097122336,-0.6327766949500908,0.935374149659864,0.9805760281159783,1.0,4/16,17.06%,SLC5A3;SLC50A1;SLC23A1;SLC23A2
prerank,positive regulation of glucose metabolic process (GO:0010907),0.24603720783558825,0.6323254972218222,0.9284116331096197,0.9998828364512794,1.0,4/14,19.73%,PPARGC1A;IRS1;AKT2;SIRT1
prerank,negative regulation of defense response to virus (GO:0050687),-0.27977073355790427,-0.6317498908481389,0.9079861111111112,0.9808192496048453,1.0,4/10,27.84%,PPM1B;PCBP2;C1QBP;RNF26
prerank,cellular response to acid chemical (GO:0071229),0.211025042000768,0.6313242836493721,0.960880195599022,0.9994487023188144,1.0,8/27,19.90%,GLRA1;RRAGB;GLRA2;CPEB3;RPTOR;CAPN2;NSMF;RRAGA
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.24774275616361044,-0.6307733491685252,0.9393414211438474,0.980995781401937,1.0,6/15,34.58%,CCT7;SHQ1;CCT4;NHP2;CCT8;CCT5
prerank,regulation of chromosome organization (GO:0033044),0.2165334156983207,0.6306256342168107,0.9585253456221198,0.9988369881953559,1.0,6/22,17.85%,YLPM1;XRCC5;SMG5;CDT1;UPF1;SETMAR
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.20716179931427695,-0.6287700020449584,0.9603448275862069,0.9817934373811268,1.0,14/30,35.22%,POLR2H;POLR2F;POLR2L;TTF1;TAF1A;POLR1F;POLR1C;UBTF;POLR1E;MNAT1;TAF1D;GTF2H1;ERCC2;CDK7
prerank,fatty acid catabolic process (GO:0009062),-0.17484412340423103,-0.6276483650158801,0.9898819561551433,0.9820284323857976,1.0,22/67,31.90%,PPARD;ABCD2;ACADM;AIG1;ACAD11;ACAT2;ABCD3;MCAT;ACOX1;ACAA2;MMUT;ACADVL;ADTRP;PLA2G15;HSD17B10;ACADS;ECHDC2;ACAD10;SCP2;LPIN3;ECHS1;HADH
prerank,cristae formation (GO:0042407),0.20617278254847818,0.6275263882046005,0.9644549763033176,0.99966403585491,1.0,5/27,11.91%,ATP5MG;APOO;LETM1;ATP5MC3;ATP5ME
prerank,thyroid hormone generation (GO:0006590),-0.26799169170058756,-0.626308030655331,0.9151943462897526,0.9824194984858281,1.0,5/10,35.65%,CPQ;TG;SLC5A5;TPO;DUOX1
prerank,transcription by RNA polymerase III (GO:0006383),-0.20978209086152722,-0.6250080005705795,0.9580536912751678,0.9827387199421312,1.0,8/27,25.81%,POLR3G;POLR2L;SNAPC2;SNAPC3;GTF3A;GTF3C5;POLR3GL;BRF1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.23782072993141543,-0.6221334781933705,0.9527145359019265,0.9838678038587321,1.0,7/16,31.45%,ATP5MC1;ATP5MC2;ATP5MF;ATP5F1B;ATP5F1D;ATP5F1C;ATP5F1A
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.24341152898509244,-0.6212067604613648,0.9341216216216216,0.983970818457281,1.0,4/14,26.91%,FOXO3;TFAM;TWNK;EARS2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.2671280926908184,-0.6207345970516854,0.9272419627749577,0.9838402031388501,1.0,5/10,31.45%,ATP5MC1;ATP5MC2;ATP5F1D;ATP5F1C;ATP5F1A
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.25421630622159685,-0.6204615702689077,0.9333333333333333,0.9836069627540897,1.0,4/13,25.42%,MTHFD1L;GCH1;QDPR;FPGS
prerank,non-motile cilium assembly (GO:1905515),-0.20723645322882317,-0.6200144167648348,0.9617391304347827,0.9834663154344301,1.0,8/30,21.37%,PIBF1;DCTN1;TMEM80;GORAB;VANGL2;IFT57;TMEM17;DISC1
prerank,negative regulation of DNA replication (GO:0008156),-0.24947182858628425,-0.6197653280860373,0.9391891891891891,0.9832277940037227,1.0,1/13,3.61%,S100A11
prerank,regulation of transferase activity (GO:0051338),-0.23960907132296827,-0.618995161870031,0.9390243902439024,0.9832408411362547,1.0,5/17,22.28%,NLRC5;PARP4;JMJD8;ATM;FEM1B
prerank,eye photoreceptor cell development (GO:0042462),0.2355818948821473,0.6185530377113612,0.9413145539906104,1.0,1.0,2/15,10.89%,RORB;CEP290
prerank,protein acetylation (GO:0006473),-0.20161739612629748,-0.618078115359772,0.9712230215827338,0.9833368657717216,1.0,13/30,44.46%,CREBBP;NAA50;NAA16;ESCO2;CLOCK;EP300;KAT6A;NAA11;SPHK1;FOXO1;NAA15;KAT2B;NAA35
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.23556035262048186,0.6179931004807383,0.9174311926605505,1.0,1.0,4/14,18.69%,GSTP1;NLRP2B;PELI3;CCDC3
prerank,modified amino acid transport (GO:0072337),0.23421377248867015,0.6161670457064312,0.9405034324942791,1.0,1.0,3/15,14.88%,SLC6A13;FOLR1;FOLR2
prerank,phasic smooth muscle contraction (GO:0014821),-0.2692632496341593,-0.6159549543175143,0.93048128342246,0.9840479972776116,1.0,6/10,36.42%,HTR2B;TIFAB;PTGER3;EDNRB;EDN3;EDN2
prerank,rRNA catabolic process (GO:0016075),-0.2338660085739615,-0.6157906526866854,0.9538188277087034,0.9837560415455917,1.0,9/16,38.56%,EXOSC5;EXOSC10;EXOSC4;DEDD2;ERN2;EXOSC8;EXOSC3;SLFN14;PELO
prerank,cellular amide metabolic process (GO:0043603),-0.15845157944144933,-0.6153054270471021,1.0,0.9836245046854358,1.0,31/102,33.85%,MTHFS;ST3GAL1;PANK2;MTHFD1L;ST6GAL1;PDZD11;ACOT9;ACOT13;MTHFD2L;PLAAT3;PLAAT1;ACOT2;ACOT4;MTHFR;SHMT1;PLPP3;AASDHPPT;ABCA2;HLCS;FPGS;ORMDL2;PLA2G15;ACOT11;CERK;GNE;ORMDL3;ATF4;SLC19A1;DBI;MTHFD1;ACOT6
prerank,quinone biosynthetic process (GO:1901663),-0.24255408589278574,-0.6146685860926464,0.9493243243243243,0.9835596360894469,1.0,3/14,25.99%,COQ8A;FDXR;COQ10B
prerank,regulation of TOR signaling (GO:0032006),-0.17348707397085095,-0.6142313684036155,0.9947368421052631,0.9833924412321646,1.0,18/67,27.41%,GNA12;UBR2;GAS6;FNIP1;RRAGD;FLCN;PIK3CA;TBC1D7;DEPTOR;FAM83D;RHEB;HTR6;WDR24;PKHD1;LAMTOR1;LAMTOR3;MIOS;TSC2
prerank,myofibril assembly (GO:0030239),0.18258720646731136,0.6140857766767667,0.9816933638443935,1.0,1.0,6/42,12.80%,CSRP1;TNNT2;TTN;CAPN3;PGM5;FHOD3
prerank,male meiosis I (GO:0007141),-0.23470443836966937,-0.6125241862124825,0.9635416666666666,0.98381473823135,1.0,6/16,35.24%,FOXJ3;FOXJ2;ZSCAN21;SLC25A31;ING2;HSF2BP
prerank,GPI anchor metabolic process (GO:0006505),-0.20948239872439706,-0.6087555023637109,0.9685430463576159,0.985157399086142,1.0,8/26,27.22%,DPM3;PIGH;PGAP3;MPPE1;GPLD1;PGAP1;PIGZ;PGAP2
prerank,BMP signaling pathway (GO:0030509),0.16411485779196006,0.6084513812340516,0.9946524064171123,1.0,1.0,14/62,21.46%,BMPR1B;ACVR1;TMEM100;BMP7;BMP15;TGFB2;RGMA;GDF15;TGFBR3;ACVR2B;AMHR2;RGMB;SMAD9;SCX
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.18263426780949116,0.6075785875543896,0.9911699779249448,1.0,1.0,38/39,75.39%,GHRH;CAPN10;NLGN2;GRP;MYRIP;CRH;LRRC8A;MCU;BAD;TM7SF3;ISL1;SELENOT;RASL10B;AIMP1;AACS;ADCYAP1;GCK;GLUD1;ACSL4;TNFSF11;UCN;FGG;SCT;DRD2;TCF7L2;SOX4;PSMD9;HFE;NNAT;GPER1;TRH;SLC30A8;TFR2;DOC2B;GHRL;FFAR4;BLK;RBP4
prerank,prostanoid metabolic process (GO:0006692),-0.2453532203780181,-0.6066696467035934,0.9389179755671903,0.9857195520237466,1.0,5/13,36.14%,ACOX1;CYP2S1;PTGES;PTGR1;AKR1C1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.2659291183418201,-0.606415983389747,0.9288194444444444,0.9854639784333836,1.0,6/10,35.97%,SERPINE1;WNK1;SNAI2;CYP1B1;ACER2;HRG
prerank,regulation of epithelial cell differentiation (GO:0030856),0.2231498502361955,0.6061767268115421,0.9548387096774194,1.0,1.0,4/17,14.78%,APOLD1;SOX9;AJAP1;KLF7
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.2219646896371862,-0.6060315698426306,0.9557522123893806,0.9852657265863343,1.0,3/19,10.21%,NFATC3;HRH1;INPP5A
prerank,mRNA splice site selection (GO:0006376),-0.1980897312802061,-0.6059556286994635,0.9663716814159292,0.9849357653276838,1.0,6/30,19.48%,PRPF39;CELF1;YTHDC1;SF3A1;SRSF10;SLU7
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.20700926262686842,-0.6043876505199919,0.958041958041958,0.9852409634646795,1.0,4/26,11.05%,DUSP3;EIF4EBP1;KLHL18;APP
prerank,morphogenesis of an epithelium (GO:0002009),-0.2099864499741599,-0.6025212100406698,0.9561551433389545,0.9856897539914022,1.0,10/25,32.36%,ACTB;LRP6;ARHGAP12;TIMELESS;SOX10;KDM2B;DAG1;ACTG1;VCL;SOX8
prerank,cranial nerve development (GO:0021545),0.24753553779335985,0.6025171800672611,0.9125295508274232,1.0,1.0,3/11,15.90%,SALL1;TFAP2A;ERBB3
prerank,endodermal cell fate commitment (GO:0001711),-0.26397443828423106,-0.6000054520796064,0.9393939393939394,0.9863751921998118,1.0,1/10,3.75%,CTR9
prerank,regulation of phosphate metabolic process (GO:0019220),0.21855408510489466,0.6000003490409759,0.9636803874092009,1.0,1.0,2/16,8.49%,TIGAR;SMG5
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.22476052383340198,-0.5997960747497894,0.9632867132867133,0.9860907421224481,1.0,7/17,31.45%,ATP5MC1;ATP5MC2;ATP5MF;ATP5F1B;ATP5F1D;ATP5F1C;ATP5F1A
prerank,ubiquinone metabolic process (GO:0006743),-0.23323038750484393,-0.5996199159030613,0.9490662139219015,0.9857865787431093,1.0,4/15,31.12%,COQ8A;FDXR;COQ10B;AIFM2
prerank,negative regulation of myoblast differentiation (GO:0045662),0.23397576746813986,0.5973627274472378,0.9511002444987775,1.0,1.0,13/13,76.62%,SOX9;SRA1;MSTN;TBX3;SOSTDC1;BMP4;EID2B;DLL1;NOTCH1;PRICKLE1;ANKRD2;SOX8;TGFB1
prerank,spermatid development (GO:0007286),-0.19080672411027494,-0.5969732311632188,0.9792027729636048,0.9864962236369975,1.0,5/32,12.70%,YTHDC2;CEP57;ACRBP;RNF8;CIB1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.2511573539445668,-0.5964438969828477,0.9270833333333334,0.9863287423478824,1.0,6/11,39.41%,P2RX4;LMNA;SMAD4;RGS2;FOXO1;GLRX3
prerank,histone H2A acetylation (GO:0043968),-0.22405273157718844,-0.5960477733702751,0.949740034662045,0.9861303726327452,1.0,3/16,16.94%,MORF4L1;EPC1;SPHK2
prerank,regulation of microtubule nucleation (GO:0010968),0.24490472367358657,0.5949950911404664,0.9253393665158371,1.0,1.0,2/10,10.77%,ARHGEF7;EML2
prerank,lung epithelium development (GO:0060428),-0.25917927045475436,-0.5924972076872882,0.9354275741710296,0.9871833563926384,1.0,4/10,28.96%,RCN3;FOXJ1;WNT7B;GRHL2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.24207160417329834,-0.59219102651358,0.9390862944162437,0.986940410184711,1.0,2/12,16.52%,RAB1A;UBE2C
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.2247144833527089,0.5904881303576778,0.950354609929078,1.0,1.0,3/14,11.79%,ZNHIT3;RPF2;DDX18
prerank,heme biosynthetic process (GO:0006783),-0.20934974741378104,-0.590013619091786,0.9808027923211169,0.98739306072405,1.0,6/22,23.30%,FLVCR1;HMBS;COX10;PGRMC1;PPOX;UROD
prerank,nuclear body organization (GO:0030575),0.2377488972496763,0.5892423537595568,0.9365079365079365,1.0,1.0,1/12,1.78%,AFF2
prerank,tRNA wobble uridine modification (GO:0002098),-0.2374621503996004,-0.588532445556943,0.9562289562289562,0.9875888491252865,1.0,3/14,16.97%,ELP1;MOCS3;ELP4
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.25018929738722384,-0.5852182887493907,0.9468267581475128,0.9884341056083602,1.0,3/11,32.14%,VAPB;LPCAT3;MOSPD3
prerank,response to progesterone (GO:0032570),0.2080040380320952,0.5850160061382447,0.9672131147540983,1.0,1.0,4/18,17.15%,YAP1;CATSPERD;TGFB2;ACOD1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.21273941601578994,-0.5838987172232615,0.9621342512908778,0.9885623883224629,1.0,7/19,30.35%,HPRT1;DCK;POLD2;DGUOK;PNP;ADA;GMPR2
prerank,maintenance of protein localization in organelle (GO:0072595),-0.21054592785295834,-0.5796635233984427,0.9733570159857904,0.9897035109566239,1.0,5/19,26.76%,MORC3;TAF8;TAF3;TOPORS;PML
prerank,retinal metabolic process (GO:0042574),0.2347651104228491,0.5787648791809723,0.9640449438202248,1.0,1.0,3/12,17.23%,DHRS13;RDH11;ALDH1A3
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.2490952588940157,-0.57872435578084,0.9535714285714286,0.989642925954558,1.0,4/11,24.61%,TGFBR2;STAT1;PDGFA;MYC
prerank,protein localization to phagophore assembly site (GO:0034497),-0.2491776597556091,-0.5782985540741786,0.9506172839506173,0.9894195335102457,1.0,1/11,3.89%,PACS2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.21183765732993629,-0.5778589690559099,0.9753954305799648,0.9892073760912802,1.0,6/20,25.16%,PIN1;PPIL6;PPIG;PPIB;PPIL1;FKBP1B
prerank,transcription by RNA polymerase I (GO:0006360),-0.1853233959854899,-0.5763486844583395,0.984822934232715,0.989348498988371,1.0,14/34,35.22%,POLR2H;POLR2F;POLR2L;TTF1;TAF1A;POLR1F;POLR1C;UBTF;POLR1E;MNAT1;TAF1D;GTF2H1;ERCC2;CDK7
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.2554596168749219,-0.5750230969284919,0.9507042253521126,0.9894203931143529,1.0,4/10,24.21%,RFWD3;WDR76;FEM1B;DDX39B
prerank,ketone body metabolic process (GO:1902224),-0.2474928830640472,-0.5750124865211583,0.9449378330373002,0.9890541552334818,1.0,1/10,4.92%,OXCT1
prerank,regulation of exit from mitosis (GO:0007096),-0.17623816727476505,-0.5749505623158779,0.9909584086799277,0.9887038470261109,1.0,8/38,20.67%,ANAPC1;UBC;RPS27A;BUB1B;PPP1R9B;UBE2C;ANAPC7;SIRT2
prerank,estrogen metabolic process (GO:0008210),-0.226300879640766,-0.5743712362475464,0.9619377162629758,0.9885310182083689,1.0,6/15,31.51%,HSD17B7;CYP1B1;HSD17B10;HSD17B14;UGT1A7;UGT1A1
prerank,sphingolipid catabolic process (GO:0030149),-0.2253713795372848,-0.5741121759410378,0.9632224168126094,0.9882497265271972,1.0,11/15,47.33%,ACER3;PPT1;ASAH1;SMPDL3A;ACER2;PDXDC1;SPHK1;SMPD1;GLA;SMPD2;SMPD4
prerank,regulation of urine volume (GO:0035809),0.24573186040672862,0.573255719856388,0.94,1.0,1.0,10/10,75.44%,HAS2;HYAL2;ADCY6;TRPV5;NPPB;TFAP2B;NPR3;NPR1;INPP5K;ADM
prerank,positive regulation of locomotion (GO:0040017),0.19034145352247994,0.5729157243385539,0.9899244332493703,1.0,1.0,2/27,3.95%,CSF1R;P2RY12
prerank,L-serine metabolic process (GO:0006563),0.2479540937898536,0.5715766208079874,0.9483568075117371,1.0,1.0,5/10,26.59%,PSAT1;CBS;PHGDH;SHMT2;SDS
prerank,smooth muscle cell differentiation (GO:0051145),-0.234988914502747,-0.5709064917276635,0.9481605351170569,0.9888715522682897,1.0,7/12,38.61%,MEF2C;MRTFB;APLNR;EDNRB;HEY2;HEY1;TBX18
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.23667147390429627,0.5695940528014241,0.9702233250620348,1.0,1.0,2/11,6.82%,AHCYL1;CDC73
prerank,negative regulation of neurogenesis (GO:0050768),0.17743041258005332,0.5691921197081464,0.989821882951654,1.0,1.0,3/34,7.08%,LINGO1;PTN;HOOK3
prerank,negative regulation of response to wounding (GO:1903035),-0.21173052517809898,-0.5667433424790801,0.9611992945326279,0.9897260288771443,1.0,3/19,12.79%,MDK;CRK;SERPINE1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.20466711097421608,-0.5667114379986853,0.9822064056939501,0.9893669305222813,1.0,6/20,29.99%,HSP90AB1;HSPA4;HSPA1A;TMEM35A;BBS10;LONP1
prerank,secondary palate development (GO:0062009),-0.22748629957787442,-0.5653342965956416,0.9567474048442907,0.9893990909407894,1.0,6/14,37.18%,TGFBR2;CHD7;SMAD4;LEF1;SMAD2;WNT11
prerank,inositol phosphate biosynthetic process (GO:0032958),0.2343847826463738,0.5646332167890638,0.9732142857142857,1.0,1.0,3/11,12.62%,IP6K2;ITPKA;PPIP5K2
prerank,erythrocyte development (GO:0048821),-0.24839215088162953,-0.5603482554723478,0.9629629629629629,0.9904228089803988,1.0,2/10,21.72%,NCKAP1L;ZBTB7A
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.21879473887188006,-0.5594975949442021,0.9726962457337884,0.9902993742547238,1.0,2/16,10.44%,C3;CHGA
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.22968827490318022,-0.557710962876624,0.9665551839464883,0.9904174319402234,1.0,3/12,30.07%,TPR;TGFB1;AAAS
prerank,positive regulation of insulin secretion (GO:0032024),0.16806415396531693,0.5538711830616934,0.9975961538461539,1.0,1.0,7/36,20.62%,ADCY8;CAPN10;NLGN2;MYRIP;PPP3CB;LRRC8A;ANO1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.22171825759419017,-0.5529315572613047,0.9717813051146384,0.9912698858201221,1.0,8/13,47.42%,ALG12;ALG6;ALG11;SRD5A3;ALG1;ALG2;ALG9;ALG13
prerank,intraciliary retrograde transport (GO:0035721),0.22245082763714238,0.5519161188357632,0.9752808988764045,1.0,1.0,4/12,20.96%,DYNC2H1;DYNC2LI1;TTC21B;DYNC2I1
prerank,respiratory electron transport chain (GO:0022904),0.2152184831742843,0.5517272267830828,0.9859484777517564,1.0,1.0,14/14,78.50%,PPARGC1A;ETFB;ETFRF1;SDHB;SDHA;ETFDH;GPD2;ETFA;SLC25A12;NDUFA5;UQCRFS1;SLC25A18;SLC25A13;SLC25A22
prerank,zinc ion transmembrane transport (GO:0071577),-0.1992405519146371,-0.5512853354003071,0.9875444839857651,0.9913283361610212,1.0,3/22,16.33%,SLC30A5;SLC30A6;SLC39A3
prerank,male gonad development (GO:0008584),-0.1757165368899482,-0.5471625641248905,0.9965034965034965,0.991957940373541,1.0,14/34,38.04%,CSDE1;GATA3;KITLG;BIK;SRD5A2;LRP2;FGF9;SOX8;ING2;MEA1;SIX4;ADAM29;FSHR;LHCGR
prerank,maturation of LSU-rRNA (GO:0000470),-0.1870889403534261,-0.5465864378297103,0.9948186528497409,0.9917351816772146,1.0,11/26,34.21%,RPL7;RPL10A;NIFK;SNU13;RPL7A;WDR12;NHP2;EIF6;RPL7L1;MRPL1;BOP1
prerank,histone H3 deacetylation (GO:0070932),0.20675582344446533,0.5450294711823521,0.9805825242718447,1.0,1.0,15/15,79.34%,PER2;SIRT1;PER1;HDAC2;SIRT7;SFPQ;HDAC1;HDAC4;ELK4;SIRT6;SMARCAD1;HDAC3;HDAC9;HDAC8;SIRT2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.22740765151758827,0.5431433068006657,0.9671361502347418,1.0,1.0,4/11,19.43%,PANK3;ACAT1;COASY;ACOT7
prerank,coenzyme A biosynthetic process (GO:0015937),0.22740765151758827,0.5431433068006657,0.9671361502347418,1.0,1.0,4/11,19.43%,PANK3;ACAT1;COASY;ACOT7
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.22740765151758827,0.5431433068006657,0.9671361502347418,1.0,1.0,4/11,19.43%,PANK3;ACAT1;COASY;ACOT7
prerank,lipid droplet organization (GO:0034389),0.18557015700953708,0.5431369694442333,0.9750566893424036,1.0,1.0,4/22,19.24%,SQLE;ZFYVE1;RAB18;CDS1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.23385290688210164,0.5424734017799451,0.9676674364896074,1.0,1.0,6/10,30.33%,NAF1;NOP10;RPUSD4;RPUSD3;RPUSD1;TSR3
prerank,apical protein localization (GO:0045176),0.22767129821693521,0.5415205425304163,0.9626168224299065,1.0,1.0,5/10,23.59%,MAL;GOPC;JAM3;ATP8B1;INSC
prerank,nucleotide biosynthetic process (GO:0009165),0.1971822176047105,0.540923655911345,0.9825,1.0,1.0,5/18,17.92%,RRM2B;NMNAT2;ADSL;ME1;PPAT
prerank,apoptotic mitochondrial changes (GO:0008637),0.16983780961485756,0.5392886565057196,0.9977827050997783,1.0,1.0,10/32,25.74%,ERBB4;BOK;CAMK2A;ATP2A1;ATG3;DNM1L;HK2;BAK1;CCAR2;GGCT
prerank,DNA biosynthetic process (GO:0071897),-0.20427462518699474,-0.5365324987483591,0.9780033840947546,0.9935771745959827,1.0,4/16,24.58%,WRN;POLD2;RFC3;POLD4
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.19797377626193216,-0.5351581641668076,0.9783393501805054,0.993471664200356,1.0,7/18,37.64%,BCL2;SLC25A4;SLC25A31;BCL2L1;BNIP3;ALKBH7;HEBP2
prerank,positive regulation of rRNA processing (GO:2000234),0.23015180444074956,0.5347284782830735,0.9810874704491725,1.0,1.0,1/10,6.09%,UTP15
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.19920603602267206,-0.533772926437884,0.9832775919732442,0.9933804221820383,1.0,6/18,29.09%,DDHD1;FIS1;AURKA;KDR;DCN;BNIP3
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.2319826994043404,-0.5317763222852652,0.9756944444444444,0.9934109626983715,1.0,2/10,20.84%,BATF;SFRP1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.20273495673695885,-0.5315941252778035,0.9759036144578314,0.9930778436278708,1.0,8/16,36.85%,VEGFA;APLNR;HMOX1;NGFR;FGF2;GATA2;IL12A;IL12B
prerank,gastrulation (GO:0007369),0.20462108369435544,0.530922299635727,0.9860788863109049,1.0,1.0,15/15,79.56%,MKKS;NPHP3;LHX1;UGDH;WNT8B;TASOR;LRP5;GPC3;APELA;FGF8;NR4A3;EOMES;SMAD2;MEGF8;LMBRD1
prerank,gonad development (GO:0008406),0.1577965363335612,0.5302897404002054,1.0,1.0,1.0,6/41,14.63%,WT1;SOX9;SALL1;TGFB2;MKKS;INHBA
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.19042023570156083,0.5268044950229601,0.9827586206896551,1.0,1.0,9/18,29.73%,DNAAF4;RFX3;NPHP3;AQP4;CFAP53;SPEF2;CABYR;NEK10;DNAAF2
prerank,cellular response to estradiol stimulus (GO:0071392),0.1890299279161008,0.5255905616831444,0.9883449883449883,0.9994804160800522,1.0,2/18,10.11%,RAMP3;POU4F2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.1992810571035151,-0.5230165340987201,0.9884105960264901,0.9943110028085678,1.0,5/17,21.59%,GET3;EMC6;EMC9;SGTA;BAG6
prerank,vasodilation (GO:0042311),0.20495103357077699,0.5219351148815365,0.9761904761904762,0.9992056720118805,1.0,2/13,13.09%,KCNMA1;ADRB1
prerank,negative regulation of viral release from host cell (GO:1902187),0.20510858913553848,0.5168188744350632,0.9694117647058823,0.9991757129397667,1.0,2/13,15.66%,TRIM13;TRIM35
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.1848294213863485,-0.5151024102729712,0.9824868651488616,0.9952447840945408,1.0,8/20,45.87%,SIK1;NCOR1;EP300;UGT1A8;BCKDK;C1QTNF12;CLK2;WNT4
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.2179261862917397,0.5146879554645172,0.9724310776942355,0.9985811431294302,1.0,10/10,78.22%,PRKN;SNCA;HDAC6;DRD5;OXA1L;AOC3;GZMA;ETFBKMT;MT3;HP
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.16654882057613127,-0.5140995088733005,0.9983221476510067,0.9950287784220883,1.0,13/32,35.22%,POLR2H;POLR2F;POLR2L;TAF1A;POLR1F;POLR1C;UBTF;POLR1E;MNAT1;TAF1D;GTF2H1;ERCC2;CDK7
prerank,microtubule nucleation (GO:0007020),-0.188771200439679,-0.5134322391576165,0.9927536231884058,0.9947649762998838,1.0,7/19,33.45%,TUBGCP4;TPX2;SLAIN2;RANBP9;TUBGCP2;CCDC57;CSNK1D
prerank,metanephric mesenchyme development (GO:0072075),-0.21496287273345144,-0.5069166497254549,0.984182776801406,0.9953236313645681,1.0,6/10,45.87%,OSR1;STAT1;PAX2;SIX4;BASP1;WNT4
prerank,nucleotide-sugar metabolic process (GO:0009225),0.20095512333650564,0.5054541637713876,0.9846938775510204,0.9991339777304524,1.0,6/12,27.63%,FUT8;B4GALNT2;SLC35A3;GMDS;CSGALNACT1;GFPT2
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.20903321769391597,-0.5036889592011445,0.9840989399293286,0.9953711730768183,1.0,5/12,35.13%,MBTPS2;LPCAT3;ABCA2;SREBF1;DGKQ
prerank,epithelial cell-cell adhesion (GO:0090136),-0.20672258345825775,-0.4958984044840571,0.9838420107719928,0.9959821123678386,1.0,6/11,37.45%,ITGB5;JUP;DSP;VCL;PLEKHA7;THBS4
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.1685176156436184,0.4925771117691756,1.0,0.9999331686922609,1.0,5/23,19.35%,TNNT2;MYH7;TGFBR3;TPM1;TNNC1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.19568606331000243,0.4872117214479242,0.9927710843373494,0.9995983124977417,1.0,6/12,24.66%,MAOA;DDC;ODC1;HNMT;AMD1;SRM
prerank,diol metabolic process (GO:0034311),-0.17902331275393726,-0.48519243943231094,0.994475138121547,0.9967804934483643,1.0,10/19,41.40%,GCH1;SPHK2;PLPP3;DEGS2;GCHFR;SPHK1;PLPP2;PLPP1;SGPP1;AKT1
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.14484763543439838,-0.4780426084423686,0.9965870307167235,0.9970804594984916,1.0,10/41,30.15%,DAGLB;GPX4;PLA2G4A;ACOX1;ELOVL5;CYP1B1;PNPLA8;ALOX15;SCP2;PTGR1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.1869376744566547,-0.4699530031435798,0.9910071942446043,0.9973833939328234,1.0,4/13,32.08%,NUDT21;NCBP1;CPSF1;TUT1
prerank,establishment of skin barrier (GO:0061436),0.17398128963395496,0.4594773886585156,0.9976133651551312,1.0,1.0,15/15,82.62%,KDF1;TMEM79;STMN1;FA2H;ABCA12;ALOX12B;FLG;HRNR;ALOXE3;UGCG;ALOX12;MET;LSR;SFN;CLDN1
prerank,regulation of water loss via skin (GO:0033561),0.17398128963395496,0.4594773886585156,0.9976133651551312,1.0,1.0,15/15,82.62%,KDF1;TMEM79;STMN1;FA2H;ABCA12;ALOX12B;FLG;HRNR;ALOXE3;UGCG;ALOX12;MET;LSR;SFN;CLDN1
prerank,UV protection (GO:0009650),-0.19550725097299754,-0.4470055274891407,0.9965635738831615,0.9985060891591409,1.0,2/10,20.40%,FEN1;CAT
prerank,protein neddylation (GO:0045116),0.17462351036666574,0.4407074052995416,0.9976076555023924,1.0,1.0,3/13,19.25%,UBA3;DCUN1D2;NAE1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.17899162158452095,0.4181761834257625,0.9975669099756691,1.0,1.0,4/10,28.32%,MYOCD;SIRT1;PRKAA2;DIP2A
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.1519623233908948,-0.40846534352123315,1.0,0.9994394286999755,1.0,17/17,84.83%,NEIL3;NEIL2;MPG;MUTYH;SMUG1;TERF2;TDG;NEIL1;MBD4;ACD;TERF2IP;NTHL1;TINF2;ERCC5;UNG;TERF1;OGG1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.13200422048189725,0.3641738497513052,1.0,0.9999258798256386,1.0,5/17,22.79%,DPAGT1;DHDDS;DOLK;MPDU1;MVD
